Name	MOA	Target	Disease Area	Indication	Vendor	Purity	Id	Phase
[sar9,met(o2)11]-substance-p	tachykinin antagonist	TACR1			Tocris	0	BRD-K89787693-001-01-1	Preclinical
A-1070722	glycogen synthase kinase inhibitor	GSK3A, GSK3B			Tocris	97.36	BRD-K70329400-001-02-5	Preclinical
A-1120	retinoid receptor ligand	RBP4			Tocris	83.72	BRD-K59060513-001-02-5	Preclinical
A-317491	purinergic receptor antagonist	P2RX3			MedChemEx, MedChemEx	98.69	BRD-K38019854-323-01-4, BRD-K38019854-001-01-6	Preclinical
A-33903					Maybridge	96.18	BRD-A40302156-001-01-9	Phase 2
A-366	histone lysine methyltransferase inhibitor	EHMT1, EHMT2			MedChemEx, Tocris, MedChemEx, MedChemEx, Tocris	87.35	BRD-K06182768-001-06-4, BRD-K06182768-001-02-3, BRD-K06182768-001-03-1, BRD-K06182768-001-01-5, BRD-K06182768-001-04-9	Preclinical
A-412997	dopamine receptor agonist	DRD4			Tocris	95.39	BRD-K62066682-300-01-0	Preclinical
A-438079	purinergic receptor antagonist	P2RX7			Tocris	93.4	BRD-K13223831-003-01-7	Preclinical
A-582941	nicotinic receptor agonist	CHRNA7			Tocris	84.25	BRD-K79743788-001-01-2	Preclinical
A-61603	adrenergic receptor agonist	ADRA1A, ADRA1B, ADRA1D			Tocris	96.39	BRD-K13142315-004-01-2	Preclinical
A-674563	AKT inhibitor	AKT1, PKIA, PRKACA			Selleck	96.74	BRD-K78177893-001-02-4	Preclinical
A-7	calmodulin antagonist				Tocris, Tocris	92.44	BRD-K03301001-003-03-3, BRD-K03301001-003-02-5	Preclinical
A-769662	AMPK activator				Tocris, Selleck	90.56	BRD-K41918892-001-06-7, BRD-K41918892-001-05-9	Preclinical
A-784168	transient receptor potential channel antagonist	TRPV1			Tocris	90.02	BRD-K87665527-001-01-3	Preclinical
A-803467	sodium channel blocker	SCN10A			Selleck, Tocris	97.96	BRD-K28570407-001-02-0, BRD-K28570407-001-04-6	Preclinical
A-804598	purinergic receptor antagonist	P2RX7			Tocris	93.16	BRD-K76894955-001-02-1	Preclinical
A-839977	purinergic receptor antagonist	P2RX7			Tocris	92.75	BRD-K60427831-001-01-0	Preclinical
A-867744	acetylcholine receptor allosteric modulator	CHRNA3, CHRNA4, CHRNA7			Tocris	95.81	BRD-K33059059-001-01-0	Preclinical
A-887826	sodium channel blocker	SCN10A			Tocris	91.61	BRD-K20239555-001-01-2	Preclinical
A-922500	diacylglycerol O acyltransferase inhibitor	DGAT1			Tocris	96.89	BRD-K81614372-001-02-1	Preclinical
A-939572	stearoyl-CoA desaturase inhibitor	SCD			Tocris	94.18	BRD-K99308908-001-01-5	Preclinical
A-967079	transient receptor potential channel antagonist	TRPA1			Tocris	97.41	BRD-K70744942-001-01-2	Preclinical
A-987306	histamine receptor antagonist	ADORA1, AVPR1A, CCR1, CHRM1, CHRM2, CHRM3, CHRM4, DRD3, HTR1A, HTR1B, HTR2A, HTR2B, HTR3A, TACR2			Tocris	86.49	BRD-K68982262-001-01-4	Preclinical
AA-29504	GABA receptor positive allosteric modulator	GABRA1, GABRA4, GABRB3			Tocris	19.95	BRD-K13944729-001-01-7	Preclinical
abacavir	nucleoside reverse transcriptase inhibitor		infectious disease	human immunodeficiency virus (HIV-1)	Tocris, Selleck, MicroSource	98.81	BRD-K17443395-065-03-0, BRD-K17443395-065-01-4, BRD-K17443395-065-02-2	Launched
abafungin	sterol methyltransferase inhibitor				ChemImpex	92.48	BRD-K77432251-001-01-2	Phase 3
abamectin	benzodiazepine receptor agonist	GABBR1, GABBR2	infectious disease	gastrointestinal parasites	MicroSource	61	BRD-A25579302-001-04-8	Launched
abametapir	metalloproteinase inhibitor	MMP9			Sigma	92.8	BRD-K65498798-001-01-7	Phase 3
ABC-294640	sphingosine kinase inhibitor	SPHK2			Enzo, Selleck	99.82	BRD-A70814879-003-02-6, BRD-A70814879-001-01-2	Phase 1/Phase 2
abemaciclib	CDK inhibitor	CDK4, CDK6	oncology	breast cancer	Selleck	94.43	BRD-K33622447-066-01-9	Launched
abiraterone	androgen biosynthesis inhibitor	CYP11B1, CYP17A1	oncology	prostate cancer	Selleck	92.23	BRD-K50071428-001-03-3	Launched
abiraterone-acetate	androgen biosynthesis inhibitor	CYP17A1	oncology	prostate cancer	Selleck, Selleck	98.65	BRD-K24048528-001-01-7, BRD-K24048528-001-02-5	Launched
ABT-202	acetylcholine receptor agonist				Enamine	88.87	BRD-A29844814-300-01-5	Phase 1
ABT-239	histamine receptor antagonist	HRH1, HRH2, HRH3			Axon	99.38	BRD-K22749967-046-02-3	Phase 1
ABT-491	platelet activating factor receptor antagonist	PTAFR			EMDBio	93.81	BRD-K97233161-003-01-5	Phase 1
ABT-639	calcium channel blocker	CACNA1G, CACNA1H, CACNA1I			MedChemEx	96.74	BRD-K11792081-001-01-4	Phase 2
ABT-702	adenosine kinase inhibitor	ADK			Tocris, Tocris	87.52	BRD-K36021395-300-03-2, BRD-K36021395-300-02-4	Preclinical
ABT-724	dopamine receptor agonist	DRD4			Tocris	97.43	BRD-K37714784-305-02-1	Phase 2
ABT-737	BCL inhibitor	BCL2, BCL2L1, BCL2L2			Selleck, Selleck	87.14	BRD-K56301217-001-10-8, BRD-K56301217-001-07-4	Phase 1/Phase 2
ABT-751	tubulin polymerization inhibitor	TUBB			Selleck, Tocris, Selleck	96.81	BRD-K91623615-001-05-0, BRD-K91623615-001-06-8, BRD-K91623615-001-04-3	Phase 2
AC-186	estrogen receptor agonist	ESR2			Tocris	94.66	BRD-K53788420-001-01-1	Preclinical
AC-261066	retinoid receptor agonist	RARB			Tocris	92.33	BRD-K31144453-001-02-2	Preclinical
AC-264613	PAR agonist	F2RL1			Tocris, Tocris	95.07	BRD-K81548480-001-01-2, BRD-K81548480-001-02-0	Preclinical
AC-55541	PARP inhibitor	PARP2			MedChemEx	97.05	BRD-A27911617-001-01-7	Preclinical
AC-55649	retinoid receptor agonist	RARA, RARB			Tocris, Tocris	98.46	BRD-K93176058-001-03-6, BRD-K93176058-001-04-4	Preclinical
AC-710	PDGFR tyrosine kinase receptor inhibitor	CSF1R, FLT3, KIT, PDGFRA, PDGFRB			Tocris	98.87	BRD-K15819326-001-01-6	Preclinical
AC-7954-(+/-)	urotensin receptor agonist	UTS2R			Tocris, Tocris	95.87	BRD-A49544621-003-02-8, BRD-A49544621-003-03-6	Preclinical
acadesine	AMPK activator				Selleck, Tocris, Selleck	100	BRD-K53448858-001-09-6, BRD-K53448858-001-08-8, BRD-K53448858-001-07-0	Phase 3
acalabrutinib	Bruton's tyrosine kinase (BTK) inhibitor	BTK			MedChemEx	88.47	BRD-K64034691-001-01-9	Phase 3
acalisib	PI3K inhibitor	PIK3CB, PIK3CD			MedChemEx	98.55	BRD-K92517771-001-01-2	Phase 1
acamprosate	glutamate receptor antagonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, GRM5	neurology/psychiatry	abstinence from alcohol	MicroSource, Sigma	89.21	BRD-K26262077-238-01-5, BRD-K26262077-001-01-7	Launched
acarbose	glucosidase inhibitor	AMY2A, GAA, MGAM, SI	endocrinology	diabetes mellitus	Tocris, Tocris, MicroSource, Selleck	100	BRD-K44276885-001-06-6, BRD-K44276885-001-05-8, BRD-K44276885-001-08-2, BRD-K44276885-001-07-4	Launched
ACDPP	glutamate receptor antagonist	GRM5			Tocris	95.36	BRD-K68633617-003-02-9	Preclinical
acebutolol	adrenergic receptor antagonist	ADRB1, ADRB2	cardiology	hypertension, ventricular arrhythmias	MicroSource, Selleck	98.29	BRD-A29260609-003-26-0, BRD-A29260609-003-25-2	Launched
acecainide	polarization inhibitor	SCN5A			MicroSource	98.41	BRD-K07753030-003-17-6	Phase 3
aceclidine	acetylcholine receptor agonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	ophthalmology	glaucoma	Selleck, MicroSource, Selleck	100	BRD-A32673558-003-03-9, BRD-A32673558-001-02-5, BRD-A32673558-003-04-7	Launched
aceclofenac	prostanoid receptor antagonist	PTGS2	rheumatology	rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, periarthritis, lumbago, ischiadynia	MicroSource	98.5	BRD-K68538666-001-12-3	Launched
acedapsone			infectious disease	leprosy	MicroSource	77.47	BRD-K97417064-001-02-4	Launched
acedoben					MicroSource	95.14	BRD-K47195926-001-06-6	Phase 2
acefylline	adenosine receptor agonist	ADORA1	pulmonary	asthma	Prestwick	97.34	BRD-K44004064-001-07-3	Launched
aceglutamide			gastroenterology	peptic ulcer disease (PUD)	MicroSource	100	BRD-K13619941-213-01-8	Launched
acemetacin	cyclooxygenase inhibitor	PTGS1, PTGS2	rheumatology	osteoarthritis	MicroSource, Selleck	98.86	BRD-K67563174-001-17-6, BRD-K67563174-001-16-8	Launched
aceneuramic-acid		AZGP1, CES1, MBL2, REG1A, SELE, SELP, SIGLEC1			OxChem	100	BRD-K36262466-001-06-3	Phase 3
acenocoumarol	vitamin K antagonist	VKORC1	hematology	deep vein thrombosis (DVT)	MicroSource	99.56	BRD-A65051990-001-12-9	Launched
acepromazine	dopamine receptor antagonist	ADRA1A, ADRA1B, DRD1, DRD2, HTR1A, HTR2A	neurology/psychiatry	sedative	MicroSource	90.02	BRD-K37814297-050-09-6	Launched
acesulfame-potassium					Selleck, MicroSource, Selleck	88.18	BRD-K50850824-237-02-2, BRD-K50850824-237-03-0, BRD-K50850824-237-04-8	Phase 3
acetanilide	hydrogen peroxide decomposition inhibitor				MicroSource, Selleck	96.78	BRD-K11094367-001-10-1, BRD-K11094367-001-09-3	Preclinical
acetarsol			gastroenterology	diarrhea	MicroSource, Selleck	100	BRD-K99048103-001-19-2, BRD-K99048103-001-18-4	Launched
acetazolamide	carbonic anhydrase inhibitor	AQP1, CA1, CA12, CA14, CA2, CA3, CA4, CA7	ophthalmology	glaucoma	MicroSource	97.61	BRD-K43457670-001-27-8	Launched
acetohexamide	ATP channel blocker	ABCC8, KCNJ1, KCNJ10, KCNJ11	endocrinology	diabetes mellitus	MicroSource, MedChemEx	92.87	BRD-K52960356-001-13-0, BRD-K52960356-001-15-5	Launched
acetohydroxamic-acid	urease inhibitor	MMP12	infectious disease	urinary tract infections	MicroSource	0	BRD-K21615095-001-08-4	Launched
acetophenazine	dopamine receptor antagonist	DRD1, DRD2	neurology/psychiatry	psychosis	MicroSource	85.87	BRD-K42938903-332-01-1	Launched
acetriazoic-acid					MicroSource, MedChemEx	96.57	BRD-K46416130-001-06-9, BRD-K46416130-001-07-7	Preclinical
acetyl-farnesyl-cysteine	methyltransferase inhibitor	PPARG	dermatology	acne vulgaris (AV)	Cayman, Enzo	81.86	BRD-K79437791-001-06-5, BRD-K79437791-001-05-7	Launched
acetyl-l-leucine			neurology/psychiatry	vertigo	MicroSource	100	BRD-K27406233-001-07-7	Launched
acetyl-11-keto-beta-boswellic-acid	lipoxygenase inhibitor	HSD11B1, HSD11B2			AnalytiCon	0	BRD-A44696962-001-01-4	Phase 2
acetylcholine	acetylcholine receptor agonist	ACHE, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA2	neurology/psychiatry, gastroenterology, pulmonary	drowsiness, fatigue, headache, indigestion, chest congestion	MicroSource, Selleck	100	BRD-K82381502-003-24-9, BRD-K82381502-003-23-1	Launched
acetylcysteine	mucolytic agent	ACY1, CHUK, GRIN1, GRIN2A, GRIN2B, GRIN2D, GRIN3A, GSS, IKBKB, RELA, SLC7A11	gastroenterology	acetaminophen overdose, hepatic injury	Selleck, MicroSource, Selleck	88.97	BRD-K59058747-001-19-1, BRD-K59058747-001-20-9, BRD-K59058747-001-18-3	Launched
acetylsalicylsalicylic-acid	cyclooxygenase inhibitor				Prestwick	93.66	BRD-K46585355-001-14-3	Preclinical
acexamic-acid	5 alpha reductase inhibitor	GAST	dermatology	wound healing	MicroSource	100	BRD-K72215350-001-06-5	Launched
acifran	cholesterol inhibitor	HCAR2, HCAR3			Tocris, Tocris	98.05	BRD-A29520968-001-03-5, BRD-A29520968-001-02-7	Phase 3
acipimox	cholesterol inhibitor	HCAR2	endocrinology	hyperlipidemia	Tocris, MicroSource, Selleck	98.26	BRD-K63736853-001-06-3, BRD-K63736853-001-04-8, BRD-K63736853-001-03-0	Launched
acitazanolast	mediator release inhibitor		allergy	allergic rhinitis	LifeChem, LifeChem	96.68	BRD-K74236708-001-01-9, BRD-K74236708-001-02-7	Launched
acitretin	retinoid receptor agonist	RARA, RARB, RARG, RBP1, RXRA, RXRB, RXRG, STAT3	dermatology	psoriasis	Selleck, Selleck	96.4	BRD-K62012036-001-14-4, BRD-K62012036-001-13-6	Launched
acivicin	gamma glutamyltransferase Inhibitors	CTPS1			Enzo	100	BRD-K13050541-001-01-9	Phase 2
aclarubicin	topoisomerase inhibitor	TOP1, TOP2A	hematologic malignancy	acute myeloid leukemia (AML)	Vitas-M, Vitas-M	24.47	BRD-A80805100-001-02-7, BRD-A80805100-001-01-9	Launched
aclidinium	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	pulmonary	bronchitis, emphysema, chronic obstructive pulmonary disease (COPD)	Selleck	95.22	BRD-K74363950-004-01-0	Launched
ACPC	glutamate receptor antagonist				Enzo	85.02	BRD-K66465025-001-05-1	Phase 1
acriflavine	hypoxia inducible factor inhibitor	HIF1A	infectious disease	fungal infection	Sigma	32.92	BRD-M87138257-003-01-1	Launched
acriflavinium	hypoxia inducible factor inhibitor	HIF1A	infectious disease	fungal infection	MicroSource	37.65	BRD-K97874492-003-12-3	Launched
acrisorcin	other antifungal		infectious disease	fungal infection	MicroSource	61.47	BRD-M49658242-001-04-1	Launched
acrivastine	histamine receptor antagonist	HRH1	allergy	allergic rhinitis	Enzo	89.65	BRD-K50163129-001-01-4	Launched
acrylate	mucus protecting agent				Sigma	0	BRD-M00184283-001-01-1	Phase 3
ACT-132577	endothelin receptor antagonist	EDNRA, EDNRB	pulmonary	pulmonary arterial hypertension (PAH)	MedChemEx, MedChemEx, MedChemEx	80.39	BRD-K34843150-001-03-0, BRD-K34843150-001-02-2, BRD-K34843150-001-01-4	Launched
ACT-462206	orexin receptor antagonist	HCRTR1, HCRTR2			Tocris, Sigma	97.06	BRD-K19781342-001-02-2, BRD-K19781342-001-01-4	Phase 1
actarit	interleukin receptor agonist		rheumatology	rheumatoid arthritis	MicroSource	96.94	BRD-K33483813-001-10-0	Launched
ACTB-1003	FGFR inhibitor, VEGFR inhibitor	KDR, TEK			MedChemEx	95.17	BRD-K35936936-001-01-6	Phase 1
actinomycin-d	RNA polymerase inhibitor		oncology	Wilm's tumor, Ewing's sarcoma, rhabdomyosarcoma, testicular carcinoma	MedChemEx, MedChemEx	81.15	BRD-K16547679-001-01-5, BRD-A42383464-001-06-3	Launched
actinoquinol					MicroSource	85.47	BRD-K08837089-236-01-6	Preclinical
ACY-1215	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC6, HDAC8			Selleck	93.15	BRD-K82928847-001-04-7	Phase 1/Phase 2
acyclovir	DNA polymerase inhibitor	PNP	infectious disease	genitial herpes, shingles, chicken pox	Tocris, MicroSource, Tocris, Selleck, Selleck	100	BRD-K32318651-001-26-0, BRD-K32318651-001-23-7, BRD-K32318651-001-22-9, BRD-K32318651-001-21-1, BRD-K32318651-001-24-5	Launched
AC1NDSS5					Sigma	75.43	BRD-K10226125-245-01-5	Phase 1
AD-5467	aldose reductase inhibitor	AKR1B1			Maybridge, Maybridge	88.22	BRD-A80280426-001-02-0, BRD-A80280426-001-03-8	Phase 2
adapalene	retinoid receptor agonist	RARA, RARB, RARG, RXRA, RXRB, RXRG	dermatology	acne vulgaris (AV)	Tocris, Selleck, MicroSource	99.81	BRD-K33127281-001-06-4, BRD-K33127281-001-04-9, BRD-K33127281-001-05-6	Launched
adaprev	TGF beta receptor inhibitor	IGF2R, M6PR			TCI	59.36	BRD-A73427433-240-01-3	Phase 3
adaptavir	CC chemokine receptor antagonist	CCR5			Tocris	89.21	BRD-K37151368-001-01-7	Phase 2
adarotene	retinoid receptor agonist	RARB, RARG			MedChemEx	93.85	BRD-K00152668-001-01-5	Phase 1
adatanserin	serotonin receptor agonist, serotonin receptor antagonist	HTR1A, HTR2A			Enamine	87.69	BRD-K67789209-001-01-0	Phase 2
ADD-233089	benzodiazepine receptor agonist				MedChemEx	98.53	BRD-K43055376-001-01-2	Phase 1
adefovir	DNA polymerase inhibitor		infectious disease	hepatitis B	AKSci, Sigma	99.1	BRD-K77484724-001-02-0, BRD-K77484724-001-03-8	Launched
adefovir-dipivoxil	DNA polymerase inhibitor		infectious disease	hepatitis B	Selleck, Selleck	86.36	BRD-K96159438-001-07-1, BRD-K96159438-001-06-3	Launched
adelmidrol	anti-inflammatory agent				MicroSource	53.55	BRD-K78097265-001-01-6	Phase 2/Phase 3
ademetionine	methyltransferase stimulant, phosphodiesterase inhibitor	AMD1, CBS, COMT, GNMT, MAT1A, MAT2A	neurology/psychiatry	depression, attention-deficit/hyperactivity disorder (ADHD)	MedChemEx, MedChemEx	0	BRD-K78185697-001-02-5, BRD-K78185697-001-01-7	Launched
adenine	protein synthesis stimulant	ACACB, ACP1, APRT, MTAP, PECR, SRPK2			Selleck, MicroSource, Selleck, Selleck	97.86	BRD-K26060080-065-05-6, BRD-K26060080-001-11-9, BRD-K26060080-003-07-3, BRD-K26060080-001-10-1	Preclinical
adenosine	adenosine receptor agonist	ADORA1, ADORA2A, ADORA2B, ADORA3, PI4K2A, PI4K2B, TRPM4	cardiology	Wolff-Parkinson-White Syndrome (WPW)	MicroSource, Selleck	96.7	BRD-K01577834-001-15-1, BRD-K01577834-001-16-9	Launched
adenosine-phosphate	adenosine receptor agonist	ACSL1, ACSS1, ACSS2, ADCY1, ADK, CREB1, FBP1, HINT1, PDE4B, PDE4D, PIM1, PRKAA1, PRKAB1, PRKAB2, PYGL, TRPM4			MicroSource	100	BRD-A10111329-001-04-6	Launched
adenosine-triphosphate	adenosine receptor agonist	ABCA1, ABCB1, ABCB11, ABCC2, ABCC8, ABCC9, ABCG1, ABL1, ABL2, ACSL1, ACSS1, ACSS2, ACVR1, ACVR1B, ACVRL1, ADCY1, ADRBK1, ADRBK2, AFG3L2, AKT1, ALK, AMHR2, APAF1, ARAF, ASNA1, ASNS, ASS1, CDK15, GPR17, ITPR1, NAE1, NT5C2, P2RY1, P2RY11, P2RY13, P2RY2, P2RY4, PRKAA1, RYR1, RYR2, RYR3, SLC25A4, TNK2, TRPM4, TRPM7			MicroSource, Selleck, Selleck	83.47	BRD-A31990649-304-04-9, BRD-A31990649-304-02-3, BRD-A31990649-304-03-1	Phase 2
adiphenine	acetylcholine receptor antagonist	CHRNA1	neurology/psychiatry	spasms	MicroSource, Selleck	94.95	BRD-K60907894-003-23-5, BRD-K60907894-003-22-7	Launched
adipic-acid	solute carrier family member inhibitor	SLC22A6			Enamine	100	BRD-K10656395-001-02-1	Preclinical
adiporon	adiponectin receptor agonist	ADIPOR1, ADIPOR2			Selleck, Tocris, Selleck	98.48	BRD-K68810443-001-01-9, BRD-K68810443-003-01-5, BRD-K68810443-001-02-7	Preclinical
ADL5859	opioid receptor agonist	OPRD1			Selleck, Selleck	96.95	BRD-K39624409-003-02-6, BRD-K39624409-003-03-4	Phase 2
adoprazine	dopamine receptor antagonist, serotonin receptor agonist	DRD2, HTR1A			MedChemEx	95.25	BRD-K34870043-001-01-8	Phase 2
adrafinil	adrenergic receptor agonist		neurology/psychiatry	fatigue	MedChemEx, MedChemEx	96.69	BRD-A90926615-001-02-7, BRD-A90926615-001-01-9	Launched
adrenalone	adrenergic receptor agonist	ADRA1A	hematology	hemorrhage	Selleck, MicroSource	91.31	BRD-K82343404-003-02-4, BRD-K82343404-003-03-2	Launched
adrenosterone	11-beta hydroxysteroid dehydrogenase inhibitor	HSD11B1, HSD11B2			MedChemEx	98.71	BRD-K17368287-001-18-3	Preclinical
ADX-10059	glutamate receptor negative allosteric modulator	GRM5			Tocris	94.68	BRD-K77911775-003-01-8	Phase 2
ADX-47273	glutamate receptor modulator	GRM5			Selleck	96.63	BRD-K56543881-001-02-7	Preclinical
AEE788	EGFR inhibitor, VEGFR inhibitor	EGFR, ERBB2, ERBB4, FGFR2, FGFR3, KDR			Selleck, Selleck, Tocris	96.82	BRD-K40718343-001-03-4, BRD-K40718343-001-02-6, BRD-K40718343-001-04-2	Phase 1/Phase 2
AEG3482	HSP inducer				Tocris, Tocris	97.67	BRD-K77634909-001-03-5, BRD-K77634909-001-05-0	Preclinical
afalanine	dopamine receptor agonist	DRD2			MicroSource	98.01	BRD-K53205568-001-02-6	Phase 3
afatinib	EGFR inhibitor	EGFR, ERBB2, ERBB4	oncology	non-small cell lung cancer (NSCLC)	MedChemEx, Selleck, Selleck	99.28	BRD-K66175015-332-01-6, BRD-K66175015-001-13-2, BRD-K66175015-001-09-0	Launched
afimoxifene	estrogen receptor antagonist	ESR1, ESR2, ESRRG, PLD1, PRKCD, PRKCE, PRKCQ, PRKCZ			Sigma	47.39	BRD-K04210847-001-21-9	Phase 2
afloqualone	acetylcholine receptor antagonist		neurology/psychiatry	sedative	AKSci	97.87	BRD-K69247067-001-01-8	Launched
AFN-1252	FABI inhibitor				MedChemEx	95.38	BRD-K23791635-001-01-3	Phase 2
afobazole	anxiolytic		neurology/psychiatry	anxiety	MedChemEx	98.16	BRD-K37793595-003-01-7	Launched
AF38469	sortilin inhibitor	SORT1			MedChemEx	96.02	BRD-K47816470-001-01-8	Preclinical
AG-1024	insulin growth factor receptor inhibitor	IGF1R			Selleck	91.46	BRD-K08310154-001-03-8	Preclinical
AG-14361	PARP inhibitor	PARP1			Selleck, Selleck	95.36	BRD-K00615600-001-12-9, BRD-K00615600-001-13-7	Preclinical
AG-490	EGFR inhibitor, JAK inhibitor	EGFR, JAK2, JAK3			Selleck, Tocris, Selleck	90.64	BRD-K47105409-001-15-2, BRD-K47105409-001-14-5, BRD-K47105409-001-13-7	Preclinical
AG-555	tyrosine kinase inhibitor	CDK2			Tocris	58.16	BRD-K34428485-001-18-4	Preclinical
AG-556	tyrosine kinase inhibitor				Tocris	57.92	BRD-K81048131-001-02-4	Preclinical
AGI-5198	isocitrate dehydrogenase inhibitor	IDH1			Selleck	98.97	BRD-A56371469-001-03-3	Preclinical
AGI-6780	isocitrate dehydrogenase inhibitor	IDH2			Selleck	96.02	BRD-K04691817-001-01-8	Preclinical
AGM-1470	cell cycle inhibitor	METAP2			Enzo	58.76	BRD-A78111609-001-01-2	Phase 2
agmatine	nitric oxide synthase inhibitor	ADRA2C, ASIC3, CACNA1B, CHRNA1, GRIN1, KCNJ1, NISCH			Enzo	0	BRD-K49738308-065-04-9	Phase 3
AGN-192403	imidazoline receptor ligand	NISCH			Tocris, Tocris	100	BRD-A18074780-003-02-0, BRD-A18074780-003-04-6	Preclinical
AGN-194310	retinoid receptor antagonist	RXRA, RXRB, RXRG			MedChemEx	96.23	BRD-K70262971-001-01-9	Phase 3
AGN-195183	retinoid receptor agonist	RARA			MedChemEx	94.51	BRD-K32533226-001-01-3	Phase 1/Phase 2
agomelatine	melatonin receptor agonist, serotonin receptor antagonist	HTR2A, HTR2B, HTR2C, MTNR1A, MTNR1B	neurology/psychiatry	depression	Selleck	98.23	BRD-K84698278-001-03-4	Launched
AGP-103	membrane permeability inhibitor				Enzo	91.5	BRD-K91495480-001-02-2	Launched
AH-7614	free fatty acid receptor antagonist	FFAR4			Tocris	95.83	BRD-K10852420-001-02-5	Preclinical
AH11110	adrenergic receptor ligand	ADRA1B			Tocris	98.96	BRD-A64808605-003-02-7	Preclinical
AH6809	prostanoid receptor antagonist	PTGDR, PTGER1, PTGER2, PTGER3			Tocris, Tocris	96.06	BRD-K59339270-001-03-4, BRD-K59339270-001-02-6	Preclinical
AI-10-49	core binding factor inhibitor	CBFB			MedChemEx	92.82	BRD-K89899948-001-01-7	Preclinical
AIM-100	tyrosine kinase inhibitor	TNK2			Tocris	98.41	BRD-K85139301-001-01-3	Preclinical
ajmaline	sodium channel blocker	SCN5A	cardiology	Wolff-Parkinson-White Syndrome (WPW)	MicroSource	81.81	BRD-A48300215-001-04-8	Launched
AJ76-(+)	dopamine receptor antagonist	DRD2, DRD3, DRD4			Tocris	94.73	BRD-K76677554-003-02-1	Preclinical
AK-7	SIRT inhibitor	SIRT2			Tocris	96.33	BRD-K09143580-001-01-0	Preclinical
AKBA	lipoxygenase inhibitor	ALOX5			MedChemEx	90.39	BRD-K54907283-001-01-2	Phase 3
aklomide			infectious disease	coccidiosis	MicroSource	98.9	BRD-K26807903-001-04-3	Launched
AL-8697	p38 MAPK inhibitor	MAPK14			Tocris	99.77	BRD-K44731351-001-01-6	Preclinical
alacepril	angiotensin converting enzyme inhibitor	ACE	cardiology	hypertension	Key	98.51	BRD-K51784806-001-01-6	Launched
alafosfalin	bacterial cell wall synthesis inhibitor				Sigma	93.9	BRD-K80403280-001-02-1	Phase 1
alagebrium	glycosylation inhibitor				OxChem	87.59	BRD-K96029467-003-01-9	Phase 2/Phase 3
alanine		AARS, AARS2, ABAT, AGXT, AGXT2, GPRC6A, GPT, GPT2, KYNU, NFS1, PHYKPL, SLC1A4, SLC36A1, SLC7A8			Sigma	69.19	BRD-A33317514-001-01-3	Launched
alantolactone	apoptosis stimulant, STAT inhibitor	STAT3			Tocris	86.65	BRD-K53731810-001-04-3	Preclinical
alaproclate	serotonin receptor antagonist	SLC6A4			AlfaAesar	95.15	BRD-A14966924-003-07-7	Phase 2
alarelin	gonadotropin releasing factor hormone receptor antagonist	GNRH1			MedChemEx	96.08	BRD-K42140276-402-01-4	Launched
albendazole	tubulin polymerization inhibitor	TUBA1A, TUBB, TUBB4B	infectious disease	cystic hydatid disease, parenchymal neurocysticercosis	MicroSource, Selleck	93.82	BRD-K79131256-001-18-7, BRD-K79131256-001-17-9	Launched
albendazole-oxide	anthelmintic agent		infectious disease	cystic hydatid disease, parenchymal neurocysticercosis	Selleck	97.13	BRD-A67060370-001-02-9	Launched
albuterol	adrenergic receptor agonist	ADRB1, ADRB2	pulmonary	asthma	MicroSource, Selleck	94.73	BRD-A88254928-001-07-9, BRD-A88254928-065-04-1	Launched
alcaftadine	histamine receptor antagonist	HRH1	allergy	allergic conjunctivitis	MedChemEx	99.28	BRD-K55991142-001-01-6	Launched
alclofenac	cyclooxygenase inhibitor	PTGS1	rheumatology	rheumatoid arthritis	Sigma	96.73	BRD-K47492008-001-02-7	Launched
alclometasone-dipropionate	glucocorticoid receptor agonist	CYP3A4, NR3C1, SERPINA6	dermatology	corticosteroid-responsive dermatoses	Prestwick	97.41	BRD-A17407635-001-04-0	Launched
alcuronium	muscle relaxant	CHRM1, CHRM2, CHRM3, CHRM4, CHRNA7	neurology/psychiatry	muscle relaxant	Prestwick	89.64	BRD-A84907376-300-03-8	Launched
alda-1	aldehyde dehydrogenase activator	ALDH2			Tocris	96.06	BRD-K06890060-001-09-1	Preclinical
aldoxorubicin	topoisomerase inhibitor	TOP2A			MedChemEx, MedChemEx, MedChemEx	55.08	BRD-K68928792-001-03-2, BRD-K68928792-001-01-6, BRD-K68928792-001-02-4	Phase 3
alectinib	ALK tyrosine kinase receptor inhibitor	ALK, MET	oncology	non-small cell lung cancer (NSCLC)	Selleck, Selleck	98.17	BRD-K11267252-001-06-9, BRD-K11267252-001-04-4	Launched
alendronate	bone resorption inhibitor	ATP6V1A, FDPS, PTPN4, PTPRE, PTPRS	orthopedics	osteoporosis	Selleck, MicroSource, Selleck	0	BRD-K75527158-360-06-4, BRD-K75527158-360-05-6, BRD-K75527158-360-04-9	Launched
alexidine	phosphatidylglycerophosphatase inhibitor	PTPMT1			Selleck	91.99	BRD-A27883417-300-01-6	Preclinical
alfacalcidol	vitamin D receptor agonist	CYP27B1, VDR	endocrinology	vitamin D deficiency	Selleck, MedChemEx, Selleck	91.26	BRD-K49522529-001-02-9, BRD-K49522529-001-01-1, BRD-K49522529-001-03-7	Launched
alfadolone-acetate	benzodiazepine receptor agonist				Prestwick	100	BRD-K51751936-001-09-1	Phase 2
alfaxalone	chloride channel agonist, benzodiazepine receptor agonist	GABBR1	neurology/psychiatry	general anaesthetic	Prestwick	98.88	BRD-K41445866-001-18-8	Launched
alfuzosin	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, KCNH2	urology	benign prostatic hyperplasia (BPH)	MicroSource, Selleck	93.3	BRD-A09056319-003-08-5, BRD-A09056319-003-07-7	Launched
algestone-acetophenide			endocrinology	contraceptive	Prestwick	96.88	BRD-A41774846-001-01-4	Launched
alibendol	antispasmodic		gastroenterology	bile stimulation	Selleck	97.28	BRD-K60102752-001-02-2	Launched
alimemazine	histamine receptor agonist	HRH1	neurology/psychiatry	sedative	MicroSource	80.57	BRD-A49225603-045-10-0	Launched
alisertib	Aurora kinase inhibitor	AURKA			Selleck	98.27	BRD-K75295174-001-05-0	Phase 3
aliskiren-hemifumarate	renin inhibitor	REN	cardiology	hypertension	Tocris, MicroSource, Selleck	95.42	BRD-K30020243-051-04-1, BRD-K30020243-051-02-5, BRD-K30020243-051-03-3	Launched
alizapride	dopamine receptor antagonist	DRD2	gastroenterology	nausea	Selleck	97.32	BRD-A03061970-003-07-3	Launched
alizarin					Selleck, Selleck	92.04	BRD-K73191876-001-12-0, BRD-K73191876-001-11-2	Preclinical
allantoin	cosmetic		dermatology	skin protectant	MicroSource	97.81	BRD-A96407378-001-15-1	Launched
allicin	cytokine production inhibitor	TRPA1, TRPV1			AKSci	0	BRD-A60402836-001-01-0	Phase 2
allopregnanolone	GABA receptor positive allosteric modulator	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB2, GABRG2			Tocris	93.1	BRD-A03204438-001-02-0	Phase 2
allopurinol	xanthine oxidase inhibitor	XDH	rheumatology, urology	gout, kidney stones	Selleck, MicroSource, Selleck	100	BRD-K86307448-001-19-1, BRD-K86307448-001-17-5, BRD-K86307448-001-16-7	Launched
allopurinol-riboside	anti-leishmanial agent				Berry	100	BRD-A93407926-001-01-1	Phase 2
allylestrenol	steroidal progestin	ESR1, PGR, SLC6A9	obstetrics/gynecology	premature labor	ChemImpex	0	BRD-K12872829-001-01-0	Launched
allylisothiocyanate	TRPV agonist	TRPA1			MicroSource	0	BRD-K33219225-001-01-9	Preclinical
allylthiourea	nitrification inhibitor				Selleck, MicroSource	99.28	BRD-K89634775-001-08-1, BRD-K89634775-001-09-9	Preclinical
almitrine	neurotransmitter agonist	ATP1A1	pulmonary	chronic obstructive pulmonary disease (COPD)	AKSci	99.06	BRD-K82677201-001-01-6	Launched
almorexant	orexin receptor antagonist	HCRTR1, HCRTR2			MedChemEx	90.95	BRD-K84810405-003-01-1	Phase 3
almotriptan	serotonin receptor agonist	HTR1B, HTR1D	neurology/psychiatry	migraine headache	MicroSource, Selleck	93.42	BRD-K67601717-001-03-8, BRD-K67601717-037-02-4	Launched
aloe-emodin	anticancer agent	CASP8			Selleck	94.34	BRD-K04851519-001-06-8	Preclinical
alogliptin	dipeptidyl peptidase inhibitor	DPP4	endocrinology	diabetes mellitus	MicroSource, Selleck, Selleck	93.62	BRD-A27084604-057-01-0, BRD-K83003151-057-02-4, BRD-K83003151-057-01-6	Launched
aloin	angiogenesis inhibitor				Selleck, Selleck, MicroSource	50.52	BRD-K02074536-001-02-7, BRD-K02074536-001-03-5, BRD-K02074536-001-01-9	Preclinical
aloperine					Selleck	97.73	BRD-K96391852-001-02-8	Preclinical
alosetron	serotonin receptor antagonist	HTR3A			Enzo	99.02	BRD-K46742498-003-11-0	Withdrawn
aloxistatin	protease inhibitor	CTSG			MedChemEx, Adooq, Selleck, Selleck	86.09	BRD-K91188791-001-17-5, BRD-K91188791-001-15-9, BRD-K91188791-001-18-3, BRD-K91188791-001-14-2	Phase 3
alpelisib	PI3K inhibitor	PIK3CA, PIK3CB, PIK3CD, PIK3CG			Selleck	91.09	BRD-K54997624-001-06-0	Phase 3
alpha-Asarone	cytochrome P450 inhibitor, HMGCR inhibitor	HMGCR			Cayman	94.23	BRD-K72536715-001-01-5	Preclinical
alpha-D-glucopyranose					Sigma	0	BRD-K87424134-001-01-0	Preclinical
alpha-linolenic-acid	omega 3 fatty acid stimulant	ELOVL4, FADS1, FADS2, FFAR1, FFAR4, PTGS2, SLC8A1, TRPV1			Sigma, Enzo	84.81	BRD-K33396764-001-11-1, BRD-K33396764-001-08-7	Phase 3
alpha-methylhistamine-dihydrobromide-(R)-(-)	histamine receptor agonist	HRH3			Tocris	90.81	BRD-K80028314-303-02-6	Preclinical
alpha-methylhistamine-dihydrobromide-(S)-(+)	histamine receptor agonist	HRH3			Tocris	91.26	BRD-K28308851-303-01-8	Preclinical
alpha-methylserotonin	serotonin receptor agonist	HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR4			Tocris, Tocris	64.4	BRD-A17745711-050-06-2, BRD-A17745711-050-05-4	Preclinical
alpha-tochopherol	antioxidant		endocrinology	vitamin E deficiency	MicroSource	65.25	BRD-A82892199-001-04-1	Launched
alpha-tochopheryl-acetate	antioxidant		endocrinology	vitamin E deficiency	MicroSource	93.36	BRD-A61850409-001-10-7	Launched
alpidem	benzodiazepine receptor agonist	GABRA1			Sigma	98.59	BRD-K66896751-001-02-4	Withdrawn
alprenolol	adrenergic receptor antagonist	ADRB1, ADRB2, HTR1A	cardiology	angina pectoris	MicroSource	98.73	BRD-A00993607-003-24-6	Launched
alprostadil	prostanoid receptor agonist	CATSPER1, CATSPER2, CATSPER3, CATSPER4, PTGDR, PTGER1, PTGER2, PTGER4, PTGIR	cardiology	congenital heart defects	Tocris, Selleck	100	BRD-K52459643-001-15-1, BRD-K52459643-001-17-7	Launched
alrestatin	aldose reductase inhibitor	AKR1B1			Tocris, MicroSource	98.57	BRD-K35498378-001-06-1, BRD-K35498378-001-07-9	Preclinical
ALS-8176	RNA polymerase inhibitor				MedChemEx	95.6	BRD-K21415491-001-01-4	Phase 1
altanserin	serotonin receptor antagonist	HTR2A			Tocris, Tocris	96.89	BRD-K00610438-003-03-3, BRD-K00610438-003-02-5	Phase 2
althiazide	diuretic		cardiology	hypertension	MicroSource	99.56	BRD-A56675431-001-12-3	Launched
altinicline	nicotinic receptor agonist	CHRNA4, CHRNB2			Tocris	95.59	BRD-K52681925-050-01-6	Phase 2
altiratinib	VEGFR inhibitor, MET inhibitor	KDR, MET, TEK			MedChemEx	92.67	BRD-K78627070-001-01-5	Phase 1
altrenogest	progestogen hormone	PGR	endocrinology	estrus	MicroSource, Selleck	100	BRD-K14619660-001-02-3, BRD-K14619660-001-01-5	Launched
altretamine	DNA synthesis inhibitor		oncology	ovarian cancer	MicroSource, Selleck	99.9	BRD-K67043667-001-26-4, BRD-K67043667-001-25-6	Launched
alverine	muscle relaxant	HTR1A	gastroenterology	irritable bowel syndrome, diverticular disease	MicroSource, Selleck	94.35	BRD-K89055274-048-23-5, BRD-K89055274-048-22-7	Launched
alvespimycin	HSP inhibitor	HSP90AA1			Selleck, Selleck	96.5	BRD-K83988098-003-03-4, BRD-K83988098-001-02-0	Phase 2
alvimopan	opioid receptor antagonist	OPRD1, OPRK1, OPRM1	gastroenterology	postoperative ileus	MedChemEx	97.74	BRD-K07857022-002-01-1	Launched
alvocidib	CDK inhibitor	CDK1, CDK2, CDK4, CDK5, CDK6, CDK7, CDK8, CDK9, EGFR, PYGM			Tocris, Selleck	94.16	BRD-K87909389-003-04-2, BRD-K87909389-003-03-4	Phase 2
ALX-5407	Glycine transporter 1 inhibitor	SLC6A9			Tocris, Tocris	98.56	BRD-K53979406-003-03-6, BRD-K53979406-003-02-8	Phase 1
AM-1241	cannabinoid receptor agonist	CNR1, CNR2			Selleck	94.55	BRD-A66116161-001-02-3	Preclinical
AM-24	lipoxygenase inhibitor	ALOX5			Enamine	99.73	BRD-K59013864-001-01-1	Phase 2
AM-251	cannabinoid receptor antagonist	CNR1, GPR18, GPR55			Selleck, Tocris	94.81	BRD-K92000912-001-11-8, BRD-K92000912-001-12-6	Preclinical
AM-281	cannabinoid receptor antagonist	CNR1, CNR2, GPR55			Tocris	95.08	BRD-K59419204-001-02-7	Preclinical
AM-404	cyclooxygenase inhibitor, FAAH inhibitor, TRPV antagonist	CNR1, CNR2, FAAH, TRPV1			Tocris	94.19	BRD-K55462201-001-07-3	Preclinical
AM-580	retinoid receptor agonist	RARA			Tocris, Tocris	98.56	BRD-K06854232-001-19-9, BRD-K06854232-001-22-3	Preclinical
AM-630	cannabinoid receptor antagonist	CNR1, CNR2			Tocris, Tocris	97.26	BRD-K63533170-001-03-7, BRD-K63533170-001-02-9	Preclinical
AM-92016	potassium channel blocker	GRIN1			Tocris, Tocris	89.71	BRD-A11813248-003-03-2, BRD-A11813248-003-02-4	Preclinical
amantadine	glutamate receptor antagonist	DRD2, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A	infectious disease, neurology/psychiatry	influenza A virus infection, Parkinson's Disease	MicroSource, Selleck	100	BRD-K70330367-003-08-7, BRD-K70330367-003-07-9	Launched
ambazone	DNA damage inducer				Kemprotec, Vitas-M, Vitas-M	84	BRD-K11244467-002-01-8, BRD-K11244467-001-09-3, BRD-K11244467-001-08-5	Phase 1
ambenonium	cholinesterase inhibitor	ACHE	neurology/psychiatry	myasthenia gravis	Tocris	93.62	BRD-K11292736-300-02-8	Launched
ambrisentan	endothelin receptor antagonist	EDNRA, EDNRB	pulmonary	pulmonary arterial hypertension (PAH)	Selleck	97.47	BRD-K41185545-001-02-3	Launched
ambroxol	sodium channel blocker	CYP3A4	pulmonary	bronchitis	Tocris, MicroSource, Tocris, Selleck	97.34	BRD-K56558538-003-12-7, BRD-K56558538-003-14-3, BRD-K56558538-003-13-5, BRD-K56558538-003-11-9	Launched
amcinonide	glucocorticoid receptor agonist	ANXA1, NR3C1	dermatology	corticosteroid-responsive dermatoses	MicroSource	96.95	BRD-A36010170-001-04-0	Launched
AMD-3465	CC chemokine receptor antagonist	CXCR4			Tocris	65.06	BRD-K03019184-439-01-0	Preclinical
amdinocillin	bacterial cell wall synthesis inhibitor		infectious disease	urinary tract infections, gram-negative bacterial infections	Sigma	61.16	BRD-K41051431-001-02-4	Launched
AMD11070	CC chemokine receptor antagonist	CXCR4			MedChemEx	92.59	BRD-K42948882-305-01-1	Phase 1/Phase 2
ameltolide	anticonvulsant				Vitas-M	98.29	BRD-K48173020-001-01-8	Preclinical
amezinium	adrenergic receptor agonist	ADRB2			CombiBlocks	74.42	BRD-K51387999-067-01-6	Launched
amfenac	cyclooxygenase inhibitor	PTGS1, PTGS2	neurology/psychiatry	pain relief	Selleck	96.17	BRD-K82122102-323-01-1	Launched
amfepramone	adrenergic receptor agonist	SLC6A2, SLC6A3	endocrinology	obesity	Prestwick	97.41	BRD-A37288617-003-02-2	Launched
amflutizole	xanthine oxidase inhibitor	XDH			Enamine	96.22	BRD-K50813454-001-01-9	Phase 2
AMG-PERK-44	PERK inhibitor	EIF2AK4			Tocris	97.69	BRD-K04374714-003-01-1	Preclinical
AMG-208	tyrosine kinase inhibitor	MET			MedChemEx	99.83	BRD-K32285926-001-02-1	Phase 1
AMG-232	MDM inhibitor	MDM2			MedChemEx	98.92	BRD-K64925568-001-01-8	Phase 1/Phase 2
AMG-319	PI3K inhibitor	PIK3CD			MedChemEx	98.62	BRD-K21077415-001-01-5	Phase 2
AMG-337	MET inhibitor	MET			MedChemEx	92.73	BRD-K27061362-001-01-6	Phase 2
AMG-487	CC chemokine receptor antagonist				MedChemEx	98.21	BRD-K90239174-001-01-8	Phase 2
AMG-487-(+/-)	CC chemokine receptor antagonist	CXCR3			Tocris	97.4	BRD-A01307728-001-01-4	Phase 2
AMG-517	TRPV antagonist	TRPV1			Selleck	97.4	BRD-K34185671-001-02-8	Phase 1
AMG-548	MAP kinase inhibitor	MAPK11, MAPK12, MAPK13, MAPK14			Tocris, Tocris	87.61	BRD-K86673452-001-01-7, BRD-K86673452-001-02-5	Phase 1
AMG-837	free fatty acid receptor agonist	FFAR1			MedChemEx	97.49	BRD-K43802723-340-01-9	Phase 1
AMG-925	CDK inhibitor, FLT3 inhibitor	CDK4, CDK6, FLT3			MedChemEx	94.57	BRD-K97452254-001-01-3	Phase 1
AMG-9810	TRPV antagonist	TRPV1			Tocris, Tocris	98.34	BRD-K01995783-001-01-6, BRD-K01995783-001-02-4	Preclinical
AMG319	PI3K inhibitor	PIK3CD			Selleck	99.26	BRD-A58947127-001-01-6	Phase 2
AMG458	MET inhibitor	MET			Selleck, Selleck	93.71	BRD-K21782625-001-02-4, BRD-K21782625-001-03-2	Preclinical
AMG900	Aurora kinase inhibitor	AURKA, AURKB, AURKC			Selleck	92.61	BRD-K21728777-001-02-3	Phase 1
AMI-1	protein arginine N-methyltransferase inhibitor	PRMT1			ChemBridge	83.1	BRD-K75114721-304-02-6	Preclinical
amibegron	adrenergic receptor agonist	ADRB3			Tocris, Sigma	97.85	BRD-K24610819-003-02-6, BRD-K24610819-003-01-8	Phase 3
amidopyrine	analgesic agent		dermatology	dermatitis herpetiformis (DH)	MicroSource, Selleck, Selleck	94.77	BRD-K12568846-001-15-3, BRD-K12568846-001-14-6, BRD-K12568846-001-16-1	Launched
amifampridine	potassium channel blocker		neurology/psychiatry	Lambert-Eaton myasthenic syndrome (LEMS)	MedChemEx	89.6	BRD-K80262108-001-07-0	Launched
amiflamine	monoamine oxidase inhibitor	MAOA, SLC6A2			Enamine	69.64	BRD-A19401019-001-01-3	Phase 1
amifostine	reducing agent	ALPPL2, ENPP1	nephrology	renal toxicity	MicroSource	0	BRD-K73947551-001-04-4	Launched
amikacin	bacterial 30S ribosomal subunit inhibitor		infectious disease	gram-negative bacterial infections	Selleck, MicroSource, Selleck, Selleck, Selleck	100	BRD-A01603276-001-02-0, BRD-A30051119-002-01-8, BRD-K88043978-315-02-8, BRD-K88043978-315-03-6, BRD-A01603276-001-01-2	Launched
amiloride	sodium channel blocker	AOC1, ASIC1, ASIC2, ASIC3, PKD2, PKD2L1, PLAU, SCNN1A, SCNN1B, SCNN1D, SCNN1G, SLC9A1, TRPC7, TRPV2	cardiology	hypertension, congestive heart failure	MicroSource, Selleck, Selleck, Tocris	99.74	BRD-K97181089-003-24-7, BRD-K97181089-310-06-3, BRD-K97181089-003-22-1, BRD-K97181089-003-23-9	Launched
amineptine	dopamine receptor agonist	SLC6A2, SLC6A4			MedChemEx	97.45	BRD-K24219278-001-01-6	Withdrawn
aminocaproic-acid	plasminogen activator inhibitor	LPA, PLAT, PLG	hematology	fibrinolytic bleeding	Selleck, MicroSource, Selleck	100	BRD-K64931368-001-14-1, BRD-K64931368-003-01-4, BRD-K64931368-001-13-3	Launched
aminoglutethimide	glucocorticoid receptor antagonist	CYP11A1, CYP19A1	endocrinology, oncology	Cushing's syndrome, breast cancer	MicroSource, Selleck, Selleck	93.51	BRD-A25234499-001-18-3, BRD-A25234499-001-19-1, BRD-A25234499-001-17-5	Launched
aminoguanidine	nitric oxide synthase inhibitor	NOS2			MicroSource, Tocris	100	BRD-K25114078-003-08-1, BRD-K25114078-003-07-3	Phase 3
aminohydroxybutyric-acid			neurology/psychiatry	epilepsy	MicroSource	78.63	BRD-A40777960-001-04-2	Launched
aminolevulinic-acid-benzyl-ester					ChemImpex	94.33	BRD-K59998349-003-01-4	Phase 1
aminomethyltransferase	nitric oxide synthase inhibitor	NOS2			Tocris	92.48	BRD-A28318179-003-08-5	Preclinical
aminopentamide	acetylcholine receptor antagonist	CHRM1	gastroenterology	acute abdominal visceral spasm, hypertrophic gastritis (GHG), nausea	MicroSource	97.37	BRD-A69917777-065-02-2	Launched
aminophylline	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3, HDAC2, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D	pulmonary	asthma, bronchitis, emphysema	Key, Selleck	97.33	BRD-K97799481-205-02-7, BRD-K97799481-230-01-7	Launched
aminopterin	dihydrofolate reductase inhibitor	DHFR, SLC46A1			MicroSource, Sigma	0	BRD-K87544030-001-02-8, BRD-K87544030-001-01-0	Phase 3
aminopurvalanol-a	CDK inhibitor, tyrosine kinase inhibitor	CDK1, CDK2, CDK5, CDK6			Tocris, Tocris	94.83	BRD-K07762753-001-05-1, BRD-K07762753-001-04-4	Preclinical
aminosalicylate	cyclooxygenase inhibitor	ALOX5, CHUK, PLA2G2E, PTGS1, PTGS2	gastroenterology	inflammatory bowel disease, ulcerative colitis	MicroSource, Selleck, Selleck	97.87	BRD-K80267133-001-17-7, BRD-K80267133-001-18-5, BRD-K80267133-001-19-3	Launched
aminothiadiazole	inosine monophosphate dehydrogenase inhibitor	ADORA3, IMPDH1			Enamine, Vitas-M	0	BRD-K94837153-001-02-8, BRD-K94837153-001-01-0	Phase 2
aminothiazole	cyclin D inhibitor	NOS2			MicroSource, Selleck, Selleck	98.31	BRD-K13421763-001-06-2, BRD-K13421763-001-05-4, BRD-K13421763-001-07-0	Preclinical
amiodarone	potassium channel blocker	ADRB1, CACNA1H, CACNA2D2, KCNA7, KCNH2	cardiology	ventricular arrhythmias	MicroSource, Selleck, Selleck	91.22	BRD-K17561142-003-33-3, BRD-K17561142-003-35-8, BRD-K17561142-003-32-5	Launched
amiprilose	CD antagonist				Prestwick	96.74	BRD-K97643133-003-09-3	Phase 3
amisulpride	dopamine receptor antagonist	DRD2, DRD3, HTR2A, HTR7	neurology/psychiatry	psychosis, bipolar disorder, schizophrenia	Selleck, Tocris	94.44	BRD-A60197193-001-13-8, BRD-A60197193-001-14-6	Launched
amitifadine	serotonin transporter (SERT) inhibitor	SLC6A2, SLC6A3, SLC6A4			TygerSci	97.84	BRD-A68942014-003-01-7	Phase 3
amitraz	adrenergic receptor agonist	ADRA1A, ADRA2A	infectious disease	generalized demodicosis	MicroSource	0.09	BRD-K33335792-001-04-0	Launched
amitriptyline	norepinephrine inhibitor, norepinephrine reuptake inhibitor, serotonin receptor antagonist, serotoninâ€“norepinephrine reuptake inhibitor (SNRI)	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR2A, HTR2C, HTR6, HTR7, KCNA1, KCND2, KCND3, KCNQ2, KCNQ3, NTRK1, NTRK2, OPRD1, OPRK1, OPRM1, SIGMAR1, SLC6A2, SLC6A4	neurology/psychiatry	depression	MicroSource, Selleck	98.47	BRD-K53737926-003-27-8, BRD-K53737926-003-25-2	Launched
amlexanox	histamine receptor modulator	FGF1, IL3, PDE4A, PDE4B, PDE4C, PDE4D, S100A12, S100A13	dental, pulmonary, ophthalmology, allergy	aphthous ulcers, asthma, conjunctivitis, allergic rhinitis	MicroSource, Tocris	99.58	BRD-K29530284-001-06-2, BRD-K29530284-001-07-0	Launched
amlodipine	calcium channel blocker	CA1, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNA2D1, CACNA2D3, CACNB1, CACNB2, SMPD1	cardiology	hypertension, chronic stable angina, vasospastic angina, coronary artery disease (CAD)	MicroSource, Tocris, Selleck, Tocris, Selleck, Selleck	92.46	BRD-A22032524-074-09-9, BRD-A22032524-074-07-3, BRD-A22032524-001-03-5, BRD-A22032524-074-10-7, BRD-A22032524-074-06-5, BRD-A22032524-001-05-0	Launched
ammonium-glycyrrhizinate	thrombin inhibitor	HSD11B1, HSD11B2, SLCO1B1, SLCO1B3	dermatology	cosmetic	Selleck, Selleck	97.01	BRD-K15318383-201-01-5, BRD-K15318383-001-01-9	Launched
ammonium-lactate		HCAR1	dermatology	xerosis cutis, ichthyosis vulgaris	MicroSource	0	BRD-M29182745-001-01-4	Launched
ammonium-perfluorocaprylate	Pim kinase inhibitor	PIM1			Enamine	54.3	BRD-K32531356-001-01-9	Phase 1
AMN-082	glutamate receptor modulator	GRM7			Tocris, Tocris	91.79	BRD-K23335153-300-02-5, BRD-K23335153-300-03-3	Preclinical
amodiaquine	histamine receptor agonist	HNMT	infectious disease	malaria	Prestwick, MicroSource	98.24	BRD-K91290917-336-05-3, BRD-K91290917-300-01-8	Launched
amonafide	topoisomerase inhibitor	TOP2A, TOP2B			Selleck	90.78	BRD-K56334280-001-05-1	Phase 3
amorolfine	membrane integrity inhibitor		infectious disease	onychomycosis	Selleck, MicroSource	96.04	BRD-A37390343-003-02-7, BRD-A37390343-003-03-5	Launched
amoxapine	norepinephrine reputake inhibitor	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH1, HRH4, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR3A, HTR6, HTR7, SLC6A2, SLC6A3, SLC6A4	neurology/psychiatry	depression	MicroSource, Selleck, Selleck	96.84	BRD-K02265150-001-26-5, BRD-K02265150-001-25-7, BRD-K02265150-001-27-3	Launched
amoxicillin	penicillin binding protein inhibitor	CYP2C19, SLC15A1, SLC15A2, SLC22A6	infectious disease, gastroenterology	skin infections, duodenal ulcer disease, gonorrhea, ear infections, throat infections, genitourinary tract infections, respiratory tract infections	MedChemEx, MicroSource, Selleck, Selleck, Selleck, Selleck	96.19	BRD-K55044200-236-03-1, BRD-K55044200-001-16-1, BRD-K55044200-236-02-3, BRD-K55044200-236-04-9, BRD-K55044200-001-15-3, BRD-K55044200-001-14-6	Launched
AMPA-(RS)	glutamate receptor agonist	GRIN1			Tocris, Tocris	86.94	BRD-A34716233-004-03-5, BRD-A34716233-001-02-3	Preclinical
AMPA-(S)	glutamate receptor agonist	GRIN1			Tocris	87.14	BRD-K92493880-001-03-0	Preclinical
ampalex	glutamate receptor agonist	GRIA1, GRIA2, GRIA3, GRIA4			MedChemEx	99.54	BRD-K24771047-001-01-6	Phase 2
amperozide	dopamine receptor antagonist	FAAH, HTR2A	neurology/psychiatry	psychosis	Enzo	98.96	BRD-K52397688-003-06-4	Launched
amphotericin-b	membrane permeability enhancer		infectious disease	fungal infection	Selleck, MicroSource, MedChemEx, Selleck	74.84	BRD-K27352494-001-03-6, BRD-K27352494-001-04-4, BRD-K27352494-001-05-1, BRD-K27352494-001-06-9	Launched
ampicillin	bacterial cell wall synthesis inhibitor		infectious disease	respiratory tract infections, meningitis, bacterial septicemia, endocarditis, urinary tract infections, gastrointestinal infections	MedChemEx, Selleck, MicroSource, Selleck, MedChemEx, Sigma, Selleck, Selleck	84.41	BRD-K68432770-236-24-9, BRD-K68432770-236-21-5, BRD-K68432770-236-20-7, BRD-K68432770-236-19-9, BRD-K68432770-236-23-1, BRD-K68432770-236-22-3, BRD-K68432770-341-07-2, BRD-K68432770-341-05-6	Launched
ampiroxicam	cyclooxygenase inhibitor	PTGS1, PTGS2	neurology/psychiatry	pain relief	MedChemEx, MedChemEx, MicroSource, Selleck, Selleck	78.57	BRD-A39172021-001-14-5, BRD-A39172021-001-13-7, BRD-A39172021-001-10-3, BRD-A39172021-001-09-5, BRD-A39172021-001-11-1	Launched
amprenavir	HIV protease inhibitor		infectious disease	human immunodeficiency virus (HIV-1)	Selleck	95.63	BRD-K47827687-001-02-2	Launched
amprolium	thiamine uptake blocker		infectious disease	coccidiosis	Selleck, MicroSource	95.82	BRD-K90027121-300-13-2, BRD-K90027121-003-01-7	Launched
ampyrone	cyclooxygenase inhibitor				Prestwick	70.49	BRD-K20484910-001-14-7	Preclinical
amrinone	phosphodiesterase inhibitor	PDE3A, PDE3B, PDE4B, TNF	cardiology	congestive heart failure	MicroSource	92.25	BRD-K45924332-001-16-8	Launched
amrubicin	topoisomerase inhibitor	TOP2A, TOP2B	oncology	small cell lung cancer, small cell lung cancer	MedChemEx, MedChemEx	74.78	BRD-K13843533-001-02-5, BRD-K13843533-001-01-7	Launched
amsacrine	topoisomerase inhibitor	KCNH2, TOP2A	hematologic malignancy	acute lymphoblastic leukemia (ALL), acute lymphoblastic leukemia (ALL)	MicroSource, Enzo	95.69	BRD-K68346641-001-02-2, BRD-K68346641-001-01-4	Launched
amthamine	histamine receptor agonist	HRH2			Tocris	90.06	BRD-K39670393-303-02-1	Preclinical
amtolmetin-guacil	cyclooxygenase inhibitor	PTGS1, PTGS2	rheumatology	rheumatoid arthritis, osteoarthritis	OxChem	94.69	BRD-K70924353-001-01-2	Launched
amuvatinib	FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RAD51 inhibitor, RET tyrosine kinase inhibitor	KIT, MET			Selleck	97.82	BRD-K66538826-001-07-2	Phase 2
amygdalin	caspase activator	CASP3			Selleck, Selleck	95.98	BRD-K03504028-001-07-6, BRD-K03504028-001-08-4	Phase 2
amyl-nitrite	atrial natriuretic peptide receptor agonist	NPR1			Sigma	0	BRD-K03326591-001-01-4	Preclinical
amyleine	local anesthetic				Prestwick	96.77	BRD-A09062839-003-10-0	Preclinical
amylene-hydrate	local anesthetic				Sigma, MicroSource	0	BRD-K93502141-001-02-4, BRD-K93502141-001-01-6	Preclinical
AMZ30	protein phosphatase inhibitor				MedChemEx	88.11	BRD-K00256256-001-06-1	Preclinical
AM679	cannabinoid receptor agonist, lipoxygenase inhibitor	ALOX5AP, CNR1, CNR2			MedChemEx	96.62	BRD-K88443722-001-01-7	Preclinical
ANA-12	tropomyosin receptor kinase inhibitor	NTRK2			Tocris	96.82	BRD-A19609491-001-01-8	Preclinical
anabasine	acetylcholine receptor agonist				Enzo	90.14	BRD-A24284985-001-09-9	Preclinical
anacetrapib	cholesteryl ester transfer protein inhibitor	CETP			Selleck	97.01	BRD-K44366189-001-01-9	Phase 3
anagliptin	dipeptidyl peptidase inhibitor	DPP4	endocrinology	diabetes mellitus	MedChemEx, MedChemEx	82.68	BRD-K05355328-001-02-9, BRD-K05355328-001-01-1	Launched
anagrelide	phosphodiesterase inhibitor	PDE3A	hematology, hematologic malignancy	thrombocythemia, myeloproliferative neoplasms	MicroSource, Selleck, Selleck	98.12	BRD-K62200014-003-11-3, BRD-K62200014-001-02-6, BRD-K62200014-003-10-5	Launched
anamorelin	growth hormone secretagogue receptor agonist	GHSR			MedChemEx	90.17	BRD-K01174345-001-01-9	Phase 3
anandamide	cannabinoid receptor agonist	CACNA1G, CACNA1H, CACNA1I, CNR1, CNR2, GLRA1, GPR18, GPR55, KCNA2, KCNK3, KCNK9, TRPM8, TRPV1			Enzo	97.08	BRD-K42352790-001-05-3	Phase 2
anastrozole	aromatase inhibitor	CYP19A1	oncology	breast cancer	Tocris, MicroSource, Selleck	99.51	BRD-K52172416-001-14-8, BRD-K52172416-001-11-4, BRD-K52172416-001-10-6	Launched
andarine	androgen receptor modulator	AR			Selleck	97.04	BRD-K82164249-001-03-5	Phase 1
andrographolide	tumor necrosis factor production inhibitor	NFKB1			Selleck	96.85	BRD-A86619021-001-04-8	Phase 2
androstenone	steroid				SantaCruz	100	BRD-A64011898-001-01-0	Preclinical
androsterone	androgen receptor agonist				Prestwick	100	BRD-K12329651-001-18-8	Preclinical
anecortave-acetate	angiogenesis inhibitor		ophthalmology	macular degeneration	InterBioScreen	96.76	BRD-A53566267-001-01-9	Launched
anethole	glutathione transferase stimulant				MedChemEx, MicroSource, MedChemEx	0	BRD-K49060658-001-08-0, BRD-K49060658-001-05-6, BRD-K49060658-001-07-2	Launched
anethole-trithione	glutathione transferase stimulant				MedChemEx, Enzo	97.57	BRD-K92490248-001-06-6, BRD-K92490248-001-04-1	Launched
anguidine	protein synthesis inhibitor	SLC5A1			Enzo	100	BRD-K45724504-001-01-6	Phase 2
anidulafungin	fungal 1,3-beta-D-glucan synthase inhibitor		infectious disease	candidemia, fungal infection, esophageal candidiasis	MedChemEx	98.03	BRD-A75305484-001-01-3	Launched
aniracetam	glutamate receptor agonist	DRD2, GRIA1, GRIA2, GRIA3, GRIA4, HTR2A			Tocris, Tocris, Selleck	97.89	BRD-K88611939-001-25-7, BRD-K88611939-001-23-2, BRD-K88611939-001-22-4	Launched
anisindione	vitamin K antagonist	GGCX	hematology	deep vein thrombosis (DVT)	MedChemEx, Selleck, Vitas-M, MedChemEx, MicroSource, Selleck	89.62	BRD-K47458712-001-22-3, BRD-K47458712-001-17-3, BRD-K47458712-001-20-7, BRD-K47458712-001-21-5, BRD-K47458712-001-18-1, BRD-K47458712-001-19-9	Launched
anisodamine	lipid peroxidase inhibitor	ADRA1A			MicroSource	86.1	BRD-A29623586-001-01-3	Phase 3
anisomycin	DNA synthesis inhibitor	NHP2L1, RPL10L, RPL11, RPL13A, RPL15, RPL19, RPL23, RPL23A, RPL26L1, RPL3, RPL37, RPL8, RSL24D1			Tocris	87.39	BRD-K91370081-001-25-1	Preclinical
anisotropine	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3	gastroenterology	peptic ulcer disease (PUD)	Selleck	96.04	BRD-A06771424-004-01-7	Launched
anlotinib	VEGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor	KDR, PDGFRB			MedChemEx	98.2	BRD-K36949735-001-01-1	Phase 2/Phase 3
anpirtoline	serotonin receptor agonist	HTR1B			Tocris, Tocris	93.59	BRD-K55424922-003-03-6, BRD-K55424922-003-02-8	Phase 1
ANR-94	A1 adenosine receptor antagonist	ADORA2A			Tocris	96.91	BRD-K31170746-001-01-6	Preclinical
ansamitocin-p-3	apoptosis stimulant				MedChemEx, MedChemEx, MedChemEx	85.5	BRD-K53252847-001-03-9, BRD-K53252847-001-02-1, BRD-K53252847-001-01-3	Preclinical
antagonist-g	neuropeptide receptor antagonist	MAPK8			Tocris	77.63	BRD-K25863791-001-01-8	Phase 1
antalarmin	corticosteroid releasing factor receptor antagonist	CRHR1			Tocris	95.23	BRD-K01363385-003-01-5	Preclinical
antazoline	antihistamine	HRH1	ophthalmology, otolaryngology	conjunctivitis, nasal congestion	MicroSource, Tocris, Selleck	92.85	BRD-K99300445-001-01-2, BRD-K99300445-003-21-6, BRD-K99300445-003-20-8	Launched
anthralin	DNA synthesis inhibitor		dermatology	psoriasis	MedChemEx, MicroSource, MedChemEx	0	BRD-K04725460-001-12-1, BRD-K04725460-001-10-5, BRD-K04725460-001-11-3	Launched
anthranilic-acid					Enamine	97.76	BRD-K75167327-001-01-6	Preclinical
anthraquinone	CDC inhibitor	CDC25B			Vitas-M	83.65	BRD-K15957397-001-04-2	Preclinical
antimony-potassium					MicroSource	0	BRD-A53836783-409-01-6	Phase 2
antimonyl					MedChemEx	0	BRD-A74328360-409-01-0	Phase 1
antimycin-a	ATP synthase inhibitor	CYCS			Prestwick	32.64	BRD-A67709388-001-05-4	Preclinical
antioxine					Enamine, Sigma	0	BRD-K15541734-001-01-2, BRD-K15541734-001-02-0	Launched
AN2718	leucyl-tRNA synthetase inhibitor				Enamine, Enamine	96.45	BRD-K21920947-001-02-1, BRD-K21920947-001-01-3	Phase 1
AP-18	transient receptor potential channel antagonist	TRPA1			Tocris	91.72	BRD-K32143970-001-01-9	Preclinical
apabetalone	apolipoprotein expression enhancer	BRD3			Selleck	96.24	BRD-K20001883-001-02-7	Phase 3
apafant	platelet activating factor receptor antagonist	PTAFR			Tocris, Tocris	98.5	BRD-K28115081-001-02-7, BRD-K28115081-001-03-5	Phase 3
apalutamide	androgen receptor antagonist		oncology	prostate cancer	Selleck	97.61	BRD-K91308639-001-02-7	Launched
apatinib	RET tyrosine kinase inhibitor	CSK, KDR, KIT, RET			Selleck, Selleck	97.58	BRD-K25244359-066-02-6, BRD-K25244359-066-03-4	Phase 3
APC-100	anti-inflammatory agent, androgen receptor antagonist	AR			Sigma	93.42	BRD-K07449869-001-01-5	Phase 1/Phase 2
APcK-110	KIT inhibitor	KIT, STAT3			Tocris	95.57	BRD-K72748448-001-01-0	Preclinical
APD597	glucose dependent insulinotropic receptor agonist	GPR119			MedChemEx	96.93	BRD-K86226872-001-01-6	Phase 1
APD668	glucose dependent insulinotropic receptor agonist	GPR119			MedChemEx	98.92	BRD-K10859802-001-01-0	Phase 1
aphidicolin	RNA synthesis inhibitor				Enzo	98.81	BRD-K85140930-001-12-7	Phase 1
API-001	sigma receptor antagonist	SIGMAR1			MedChemEx	96.83	BRD-K26325692-003-01-3	Phase 2
API-1	AKT inhibitor	AKT1, AKT2, AKT3			Tocris	87.32	BRD-K97840621-001-01-5	Preclinical
apigenin	casein kinase inhibitor, cell proliferation inhibitor	AKR1B1, AR, CDK6, CFTR, CYP19A1, CYP1B1, HSD17B1			Tocris, Selleck	96.49	BRD-K01493881-001-29-4, BRD-K01493881-001-28-6	Preclinical
apixaban	coagulation factor inhibitor	F10	neurology/psychiatry, hematology, cardiology	stroke, systemic embolism, pulmonary embolism (PE), atrial fibrillation (AF), deep vein thrombosis (DVT)	Selleck, MicroSource	99.06	BRD-K67121414-001-02-5, BRD-K67121414-001-03-3	Launched
apocynin	NADPH oxidase inhibitor	NOX4			Selleck	94.64	BRD-K64990520-001-08-4	Phase 1
apoptosis-activator-II	carboxylesterase inhibitor	BCHE, CES1			Tocris, Selleck, Tocris	97.54	BRD-K15164005-001-06-4, BRD-K15164005-001-04-9, BRD-K15164005-001-05-6	Preclinical
APR-246	p53 activator	TP53			Adooq	97.6	BRD-A09004963-001-01-3	Phase 1/Phase 2
apraclonidine	adrenergic receptor agonist	ADRA1A, ADRA2A, ADRA2B, ADRA2C	ophthalmology	glaucoma, intraocular pressure	Ark	85.91	BRD-K38911213-003-01-6	Launched
apramycin	bacterial 30S ribosomal subunit inhibitor		infectious disease	gram-negative bacterial infections	MicroSource	0	BRD-K36062294-001-04-0	Launched
apratastat	matrix metalloprotease inhibitor, tumor necrosis factor production inhibitor	ADAM17, MMP1, MMP13, MMP9			Sigma	85.75	BRD-K06883221-001-01-9	Phase 2
apremilast	phosphodiesterase inhibitor	PDE4A, PDE4B, PDE4C, PDE4D	dermatology, rheumatology	psoriasis, psoriatic arthritis	Selleck	93.31	BRD-K93208532-001-02-5	Launched
aprepitant	tachykinin antagonist	TACR1	gastroenterology	nausea, vomiting	Selleck	96.84	BRD-K65170927-001-01-6	Launched
apricitabine	nucleoside reverse transcriptase inhibitor				Key	98.8	BRD-K55172746-001-01-3	Phase 3
aprindine	voltage-gated sodium channel blocker	CALM1, SCN5A	cardiology	cardiac arrythmia	Sigma	82.34	BRD-K53236343-003-03-7	Launched
aptiganel	glutamate receptor antagonist	GRIN1			Tocris, EMDBio	99.3	BRD-K63919159-003-08-8, BRD-K63919159-003-07-0	Phase 3
APTO-253	krÃ¼ppel-like factor expression enhancer	KLF4			MedChemEx	90.27	BRD-K68003372-001-01-6	Phase 1
APY-29	serine/threonine kinase inhibitor	ERN1			Tocris	94.48	BRD-K17511755-001-01-7	Preclinical
APY0201	phosphoinositide dependent kinase inhibitor	IL12A, IL12B, PIKFYVE			MedChemEx	88.96	BRD-K38627885-001-01-9	Preclinical
AP1903					MedChemEx	89.09	BRD-K28383148-001-01-4	Phase 1/Phase 2
AP26113	ALK tyrosine kinase receptor inhibitor	ALK, EGFR			Selleck	90.42	BRD-K56032964-001-02-1	Phase 2
AQ-RA741	acetylcholine receptor antagonist	CHRM2			Tocris, Tocris	94.68	BRD-K81729199-001-02-8, BRD-K81729199-001-03-6	Preclinical
AR-A014418	glycogen synthase kinase inhibitor	GSK3B			Tocris, Selleck	96.97	BRD-K67860401-001-07-2, BRD-K67860401-001-05-6	Preclinical
AR-C155858	monocarboxylate transporter inhibitor	SLC16A1, SLC16A7			MedChemEx	93.13	BRD-K42325600-001-01-8	Preclinical
AR-12	phosphoinositide dependent kinase inhibitor	PDPK1			Selleck, Adooq, Selleck, Tocris	92.43	BRD-K90497590-001-05-9, BRD-K90497590-001-07-5, BRD-K90497590-001-04-2, BRD-K90497590-001-08-3	Phase 1
AR-42	HDAC inhibitor	HDAC1			Selleck	94.12	BRD-K13167095-001-02-9	Phase 1
arachidonic-acid	cytochrome P450 inhibitor	CLCN2, KCNJ4, KCNK10, KCNK18, KCNK2, PRKCZ, PTGS1, TRPC6, TRPM2			Sigma, Enzo	50.81	BRD-K03070961-001-10-1, BRD-K03070961-001-08-5	Phase 1
arbidol	cytochrome P450 inhibitor	CYP3A4	infectious disease	influenza A virus infection	MedChemEx, Selleck, MedChemEx, Selleck	80.95	BRD-K73881242-003-06-1, BRD-K73881242-003-02-0, BRD-K73881242-003-04-6, BRD-K73881242-003-03-8	Launched
arbutin	melanin inhibitor	TYR			Selleck	100	BRD-K08037784-001-12-6	Phase 2/Phase 3
ARC-239	adrenergic receptor antagonist	ADRA2A, ADRA2B, ADRA2C			Tocris	96.55	BRD-K93188295-300-02-2	Preclinical
arctigenin	MEK inhibitor	CHUK, MAP2K1			Tocris, Tocris	98.04	BRD-K53523901-001-05-1, BRD-K53523901-001-04-4	Preclinical
arcyriaflavin-a	CDK inhibitor	CCND1, CDK4			Tocris, Tocris	87.14	BRD-K72726508-001-02-1, BRD-K72726508-001-03-9	Preclinical
ardeparin	thrombin inhibitor	SERPINC1, SERPIND1			MedChemEx	0	BRD-A83644949-236-01-6	Withdrawn
arecaidine-but-2-ynyl-ester	acetylcholine receptor agonist	CHRM2			Tocris	87.97	BRD-K63792901-075-02-1	Preclinical
arecaidine-propargyl-ester	acetylcholine receptor agonist	CHRM1, CHRM2, CHRM3, CHRM4			Tocris, Tocris	84.89	BRD-K23922020-075-03-7, BRD-K23922020-075-02-9	Preclinical
arecoline	acetylcholine receptor agonist	CHRM1, CHRM2, CHRM3, CHRM4			Selleck, MicroSource	99.05	BRD-K88646909-004-15-4, BRD-K88646909-004-16-2	Phase 1
argatroban	thrombin inhibitor	F2	hematology	heparin-induced thrombocytopenia (HIT)	Tocris, Selleck	97.13	BRD-A48261811-001-07-3, BRD-A48261811-001-08-1	Launched
arglabin	farnesyltransferase inhibitor	FNTA, NFKB1			MedChemEx	97.88	BRD-K62734952-001-01-0	Launched
aripiprazole	serotonin receptor agonist, serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR3A, HTR6, HTR7	neurology/psychiatry	depression, schizophrenia, bipolar disorder	Tocris, MicroSource, Selleck	98.35	BRD-K70358946-001-17-3, BRD-K70358946-001-15-7, BRD-K70358946-001-14-0	Launched
armodafinil	adrenergic receptor agonist	SLC6A3	pulmonary, neurology/psychiatry	obstructive sleep apnea, narcolepsy, shift work disorder (SWD)	MicroSource	93.1	BRD-K87278688-001-01-0	Launched
arofylline	phosphodiesterase inhibitor	PDE4A			Maybridge	98.45	BRD-K33852358-001-09-9	Phase 3
arotinolol	adrenergic receptor antagonist	ADRB3	cardiology, neurology/psychiatry	hypertension, tremors	AKSci	96.65	BRD-A28044053-001-01-7	Launched
ARQ-092	AKT inhibitor	AKT2			MedChemEx	97.73	BRD-K60171656-001-01-6	Phase 1
ARQ-621	kinesin-like spindle protein inhibitor	KIF11			Selleck	80.29	BRD-K43436647-001-01-7	Phase 1
ARRY-334543	EGFR inhibitor	ERBB2			Selleck	93.75	BRD-K46386702-001-02-1	Phase 2
arsanilic-acid		LYZ			MicroSource	100	BRD-K24179883-001-16-7	Phase 1
arsenic-trioxide	apoptosis stimulant	AKT1, CCND1, IKBKB, JUN, MAPK1, MAPK3, TXNRD1	gastroenterology	diarrhea	MicroSource	0	BRD-K47190141-396-01-1	Launched
artemether	antimalarial agent	ATP1A1	infectious disease	malaria	MicroSource, Selleck, MedChemEx, MedChemEx, Selleck	0	BRD-K39621635-001-09-7, BRD-K39621635-001-08-9, BRD-K39621635-001-07-1, BRD-K39621635-001-05-5, BRD-K39621635-001-06-3	Launched
artemisinin	DNA synthesis inhibitor	CYP2B6	infectious disease	malaria	Tocris, MicroSource, Tocris, Selleck	100	BRD-K13112821-001-14-1, BRD-K13112821-001-18-2, BRD-K13112821-001-16-6, BRD-K13112821-001-17-4	Launched
artemotil			infectious disease	malaria	MedChemEx, AKSci, MedChemEx	0	BRD-K96006160-001-03-7, BRD-K96006160-001-01-1, BRD-K96006160-001-02-9	Launched
artesunate	DNA synthesis inhibitor		infectious disease	malaria	MicroSource, Selleck	100	BRD-K54634444-001-05-9, BRD-K54634444-001-04-2	Launched
articaine	local anesthetic		neurology/psychiatry	local anesthetic	Selleck	90.48	BRD-A70514680-003-11-2	Launched
arundic-acid	astrocyte modulating agent	PTGS2, S100B			Tocris	17.19	BRD-K49223707-001-01-0	Phase 2/Phase 3
ARV-825	bromodomain inhibitor	BRD4			MedChemEx	94.44	BRD-A00047421-001-01-7	Preclinical
AS-1269574	glucose dependent insulinotropic receptor agonist	GPR119			Tocris	97.58	BRD-K07656463-001-01-5	Preclinical
AS-1892802	rho associated kinase inhibitor	ROCK1			Tocris	98.94	BRD-K27051047-001-01-0	Preclinical
AS-1949490	SHIP2 phosphatase inhibitor	INPP5D			Tocris, Tocris	98.99	BRD-K61936403-001-01-7, BRD-K61936403-001-02-5	Preclinical
AS-2034178	free fatty acid receptor agonist	FFAR1			Tocris	94.69	BRD-K75254015-001-01-9	Preclinical
AS-2444697	interleukin inhibitor	IRAK4			Tocris	92.16	BRD-K73565918-003-01-4	Preclinical
AS-252424	PI3K inhibitor	PIK3CG			Selleck, Selleck	82.97	BRD-K14988953-001-04-4, BRD-K14988953-001-03-6	Preclinical
AS-604850	PI3K inhibitor	PIK3CA, PIK3CG			Selleck	94.13	BRD-K63915849-001-03-7	Preclinical
AS-703026	MEK inhibitor	MAP2K1, MAP2K2			Selleck	97.03	BRD-K89014967-001-04-3	Phase 2
AS-77	potassium channel blocker	KCNA3, KCNA5, KCNN4			MedChemEx	99.13	BRD-K62427771-001-01-0	Preclinical
ASA-404	angiogenesis inhibitor				Selleck	95.25	BRD-K27938825-001-02-4	Phase 3
asaraldehyde	cyclooxygenase inhibitor	PTGS2			Selleck	95.62	BRD-K88219015-001-10-8	Preclinical
ASC-J9	androgen receptor enhancer	AR			MedChemEx, MedChemEx, Adooq	91.45	BRD-K30331124-001-01-7, BRD-K30331124-001-03-3, BRD-K30331124-001-02-5	Phase 2
ascomycin	calcineurin inhibitor	FKBP1A			Selleck	82.5	BRD-A72381333-001-01-0	Preclinical
ascorbic-acid	antioxidant	ALKBH2, ALKBH3, BBOX1, DBH, EGLN1, EGLN2, EGLN3, KDM5D, LCT, OGFOD1, OGFOD2, P3H1, P3H2, P3H3, P4HA1, P4HTM, PAM, PHYH, PLOD1, PLOD2, PLOD3, SLC23A1, SLC23A2, TMLHE	endocrinology	scurvy	MedChemEx, MedChemEx, Selleck, Sigma, Selleck, MicroSource	100	BRD-A85242401-001-11-5, BRD-A85242401-001-10-7, BRD-A85242401-001-05-7, BRD-A85242401-001-09-9, BRD-A85242401-001-07-3, BRD-A85242401-001-12-3	Launched
asenapine	dopamine receptor antagonist, serotonin receptor antagonist	ADRA1A, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD4, HRH1, HRH2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7	neurology/psychiatry	schizophrenia, bipolar disorder	Tocris, Tocris, Selleck	95.05	BRD-K95260951-050-03-1, BRD-M82363962-001-02-8, BRD-K95260951-050-02-3	Launched
asiatic-acid	apoptosis stimulant	PYGM			Selleck, Selleck	92.85	BRD-K35079116-001-02-5, BRD-K35079116-001-03-3	Preclinical
ASP-2535	glycine transporter inhibitor	SLC6A9			Tocris, Tocris	98.79	BRD-K07150325-001-02-5, BRD-K07150325-001-01-7	Phase 1
aspartame		TAS1R2, TRPV1			MicroSource, Selleck, Sigma, Selleck	85.8	BRD-K78841970-001-12-0, BRD-K78841970-001-13-8, BRD-K78841970-001-14-6, BRD-K78841970-001-11-2	Launched
aspirin	cyclooxygenase inhibitor	AKR1C1, ASIC3, EDNRA, HSPA5, IKBKB, NFKB1, NFKB2, NFKBIA, PRKAA1, PRKAA2, PRKAB1, PRKAB2, PRKAG1, PRKAG2, PRKAG3, PTGS1, PTGS2, RPS6KA3, TP53	neurology/psychiatry, endocrinology, dental	headache, fever, toothache, muscle pain	Tocris, MicroSource, Selleck, Selleck	99.34	BRD-K11433652-001-23-8, BRD-K11433652-001-17-0, BRD-K11433652-001-16-2, BRD-K11433652-001-18-8	Launched
ASP3026	ALK tyrosine kinase receptor inhibitor	ALK			MedChemEx, Tocris	94.84	BRD-K06542892-001-01-9, BRD-K06542892-001-02-7	Phase 1
AST-1306	EGFR inhibitor	EGFR, ERBB2			Selleck	97.14	BRD-K26838195-075-04-9	Phase 1
astaxanthin	antioxidant				Cayman	26.68	BRD-K51832961-001-01-4	Launched
astemizole	histamine receptor antagonist	HRH1, KCNH1, KCNH2			Tocris, MicroSource, Tocris	98.54	BRD-K37249724-001-24-0, BRD-K37249724-001-25-7, BRD-K37249724-001-28-1	Withdrawn
astragaloside-a	antiinflammatory agent				Selleck	100	BRD-K08188887-001-02-4	Preclinical
asunaprevir	HCV inhibitor				MedChemEx	97.98	BRD-K87028197-001-01-3	Phase 3
asymmetrical-dimethylarginine	nitric oxide synthase inhibitor	NOS2, NOS3			EMDBio	100	BRD-K36269323-300-02-6	Phase 1
AT-1015	serotonin receptor antagonist	HTR2A			Tocris	77.53	BRD-K06496777-003-01-4	Preclinical
AT-7519	CDK inhibitor	CDK1, CDK2, CDK4, CDK5, CDK6, CDK9			Selleck	92.34	BRD-K13390322-001-06-3	Phase 2
AT-9283	Aurora kinase inhibitor, JAK inhibitor	AURKA, AURKB, JAK2, JAK3, RPS6KA6, STK17A			Selleck	90.54	BRD-K24576554-001-04-8	Phase 2
ataluren	CFTR channel agonist, dystrophin stimulant	DMD	genetics, pulmonary	duchenne muscular dystrophy (DMD), cystic fibrosis	Selleck	97.28	BRD-K94830329-001-03-0	Launched
atazanavir	HIV protease inhibitor		infectious disease	human immunodeficiency virus (HIV-1)	Selleck	97.57	BRD-K09757388-065-04-0	Launched
ATB-346	cyclooxygenase inhibitor	PTGER2			MedChemEx, MedChemEx	94.79	BRD-A52551912-001-02-9, BRD-A52551912-001-01-1	Phase 2
atenolol-(+)	adrenergic receptor antagonist				Selleck	81.19	BRD-K68075732-001-11-8	Preclinical
atenolol-(+/-)	adrenergic receptor antagonist	ADRB1, ADRB2	cardiology	hypertension, angina pectoris	Tocris, MicroSource	85.31	BRD-A20239487-001-24-9, BRD-A20239487-001-25-6	Launched
atenolol-(-)	adrenergic receptor antagonist				Sigma, Tocris	92.98	BRD-K44993696-001-13-1, BRD-K44993696-001-12-3	Phase 2
atglistatin	adipose triglyceride lipase inhibitor				Selleck, Selleck	89.13	BRD-K43363084-001-01-3, BRD-K43363084-001-02-1	Preclinical
atipamezole	adrenergic receptor antagonist		neurology/psychiatry	reverse sedative	Tocris, MedChemEx	99.36	BRD-K39252998-003-02-3, BRD-K39252998-003-01-5	Launched
atiprimod	JAK inhibitor, STAT inhibitor	JAK2, STAT3			Tocris	98.03	BRD-K38527262-300-01-0	Phase 2
atizoram	phosphodiesterase inhibitor	PDE4A, PDE4B, PDE4C, PDE4D			Cayman	97.53	BRD-K76614248-001-01-2	Phase 2
ATN-161	integrin antagonist	ITGA5, ITGAV, ITGB1, ITGB3			MedChemEx, MedChemEx	93.15	BRD-K00521308-019-03-5, BRD-K00521308-019-01-9	Phase 2
atomoxetine	norepinephrine transporter inhibitor	GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, SLC6A2, SLC6A3, SLC6A4	neurology/psychiatry	attention-deficit/hyperactivity disorder (ADHD)	Selleck, Tocris, MicroSource	97.04	BRD-K20141153-003-12-9, BRD-K20141153-003-13-7, BRD-K20141153-001-01-6	Launched
atorvastatin	HMGCR inhibitor	AHR, DPP4, HMGCR	neurology/psychiatry, cardiology	stroke, heart attack	Tocris, MicroSource, Selleck	97.04	BRD-K69726342-238-03-2, BRD-K69726342-001-03-4, BRD-K69726342-238-02-4	Launched
atosiban	oxytocin receptor antagonist	AVPR1A, AVPR1B, AVPR2, OXTR	neurology/psychiatry, cardiology, endocrinology	stroke, angina pectoris, myocardial infarction, hyperlipidemia	MedChemEx, MedChemEx, MedChemEx	75.28	BRD-A85261566-001-02-5, BRD-A85261566-001-03-3, BRD-A85261566-001-01-7	Launched
atovaquone	mitochondrial electron transport inhibitor	DHODH	infectious disease	pneumonia	MicroSource, Selleck	97.44	BRD-A19795905-001-08-0, BRD-A19795905-001-07-2	Launched
ATPA	glutamate receptor agonist	GRIA2, GRIK1			Tocris, Tocris	95.4	BRD-A65145453-001-07-9, BRD-A65145453-001-06-1	Preclinical
atracurium	acetylcholine receptor antagonist	CHRNA2	critical care, neurology/psychiatry	endotracheal intubation, muscle relaxant	MicroSource, Selleck, Selleck	87.09	BRD-A75935363-344-06-6, BRD-A75935363-344-07-4, BRD-A75935363-344-05-8	Launched
atrasentan	endothelin receptor antagonist	EDNRA			MedChemEx	97.8	BRD-K16295392-003-01-3	Phase 3
atropine	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	ophthalmology	cycloplegia, mydriasis, amblyopia	MicroSource, Selleck	97.48	BRD-A27290375-330-01-1, BRD-A27290375-330-02-9	Launched
atropine-oxide	acetylcholine receptor antagonist				MicroSource	0	BRD-A70067498-001-01-8	Preclinical
AT13148	protein kinase inhibitor	AKT1, AKT2, AKT3, ROCK1, ROCK2, SGK3			MedChemEx, MedChemEx, MedChemEx, Selleck	91.13	BRD-K32127727-001-01-8, BRD-K32127727-001-02-6, BRD-K32127727-001-03-4, BRD-K32127727-001-04-2	Phase 1
AT13387	HSP antagonist	HSP90AA1			Selleck, Selleck	88.58	BRD-K58435339-001-06-3, BRD-K58435339-001-03-0	Phase 2
AT7867	AKT inhibitor	AKT2, GSK3B, PKIA, PRKACA			Selleck, Selleck	92.8	BRD-K12040459-001-07-8, BRD-K12040459-001-06-0	Preclinical
auranofin	NFkB pathway inhibitor	IKBKB, PRDX5, TRPA1	rheumatology	rheumatoid arthritis	MedChemEx, Selleck, MedChemEx	73.57	BRD-K73841932-001-01-5, BRD-K45995181-001-04-6, BRD-K45995181-001-05-3	Launched
aurora-a-inhibitor-i	Aurora kinase inhibitor	AURKA			Selleck, Tocris	99.42	BRD-K53561341-001-07-5, BRD-K53561341-001-09-1	Preclinical
aurothioglucose	PKC inhibitor	PRKCI	rheumatology	rheumatoid arthritis	MicroSource	0	BRD-A89825407-001-01-8	Launched
autotaxin-modulator-1	autotaxin inhibitor	ENPP2			MedChemEx	97.37	BRD-A94640958-001-01-7	Preclinical
AV-412	protein tyrosine kinase inhibitor	EGFR, ERBB2			MedChemEx	94.87	BRD-K23190681-001-01-1	Phase 1
AV-608	tachykinin antagonist	TACR1			MedChemEx	99.39	BRD-K96615647-001-01-2	Phase 2
avagacestat	gamma secretase inhibitor	PSEN1			Selleck	96.39	BRD-K83720053-001-03-8	Phase 2
avanafil	phosphodiesterase inhibitor	PDE5A	urology	erectile dysfunction	Selleck, MicroSource	92.35	BRD-K65781196-001-03-0, BRD-K65781196-001-04-8	Launched
avasimibe	ACAT inhibitor	CES1			Selleck, Selleck	96.76	BRD-K67901620-001-03-8, BRD-K67901620-001-02-0	Phase 3
avatrombopag	thrombopoietin receptor agonist	MPL	hematology	thrombocytopenia	MedChemEx	95.01	BRD-K68544925-001-01-1	Launched
AVE-0991	angiotensin receptor agonist	MRGPRX1			MedChemEx	93.56	BRD-K36154108-001-01-7	Preclinical
avibactam	beta lactamase inhibitor		infectious disease	intra-abdominal infections, urinary tract infections, pyelonephritis, intra-abdominal infections, urinary tract infections, pyelonephritis, intra-abdominal infections, urinary tract infections, pyelonephritis	MedChemEx, MedChemEx, MedChemEx	100	BRD-K85882401-323-01-5, BRD-K85882401-236-01-9, BRD-K85882401-236-02-7	Launched
AVL-292	Bruton's tyrosine kinase (BTK) inhibitor	BTK, YES1			Selleck	95.48	BRD-K87782578-001-01-4	Phase 2
AVN-944	inosine monophosphate dehydrogenase inhibitor	IMPDH1, IMPDH2			MedChemEx	99.41	BRD-K62196610-001-01-6	Phase 2
avobenzone	UV blocker	TYR	dermatology	cosmetic, sunscreen lotion	MicroSource, Selleck	90.89	BRD-K14401183-001-11-5, BRD-K14401183-001-10-7	Launched
avridine	immunostimulant				Sigma	0	BRD-K26665484-001-01-8	Preclinical
axitinib	PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	CSF1, FLT1, FLT4, KDR, PLK4	oncology	renal cell carcinoma (RCC)	Selleck, Selleck, Selleck, Adooq, Tocris	96.08	BRD-K29905972-001-10-5, BRD-K29905972-001-08-9, BRD-K29905972-001-06-3, BRD-K29905972-001-11-3, BRD-K29905972-001-12-1	Launched
AY-9944	hedgehog pathway modulator				Tocris	88.67	BRD-K77012840-300-01-6	Preclinical
AZ-10417808	caspase inhibitor	CASP3			Tocris, Tocris	97.36	BRD-K36258877-001-03-1, BRD-K36258877-001-04-9	Preclinical
AZ-10606120	purinergic receptor antagonist	P2RX7			Tocris	94.2	BRD-K09907507-300-01-4	Preclinical
AZ-12080282	hedgehog pathway inhibitor	DHH			Tocris	97.72	BRD-K05973499-300-01-0	Preclinical
AZ-628	RAF inhibitor	BRAF, RAF1			Selleck, Selleck, Selleck, Tocris	98.18	BRD-K05804044-001-12-8, BRD-K05804044-001-06-0, BRD-K05804044-001-09-4, BRD-K05804044-001-14-4	Preclinical
azacitidine	DNA methyltransferase inhibitor	DNMT1, DNMT3A	hematologic malignancy, hematology	myelodysplastic diseases (MDS), anemia, chronic myelomonocytic leukemia (CMMoL)	MicroSource, Selleck, Tocris	100	BRD-K03406345-001-21-1, BRD-K03406345-001-27-8, BRD-K03406345-001-24-5	Launched
azacyclonol	histamine receptor antagonist	HRH1			Selleck, Selleck	93.2	BRD-K97061094-001-20-6, BRD-K97061094-001-21-4	Preclinical
azaguanine-8	purine antagonist	PNP			Selleck, Selleck	84.14	BRD-K53114651-001-11-9, BRD-K53114651-001-12-7	Preclinical
azalomycin-b	bacterial 50S ribosomal subunit inhibitor				Selleck	77.98	BRD-K96104201-001-01-5	Preclinical
azaperone	dopamine receptor antagonist	DRD2, DRD3	neurology/psychiatry	sedative	MicroSource, Selleck, Selleck	98.29	BRD-K45861246-001-14-2, BRD-K45861246-001-13-4, BRD-K45861246-001-15-9	Launched
azapropazone	cyclooxygenase inhibitor	PTGS2			Prestwick	0	BRD-A70182876-001-10-8	Withdrawn
azaserine	purine antagonist				MicroSource	36.32	BRD-A67065070-001-04-7	Preclinical
azasetron	serotonin receptor antagonist	HTR3A, HTR3B	infectious disease	genitial herpes	Selleck	98.4	BRD-A44133049-003-07-8	Launched
azatadine	histamine receptor antagonist	HRH1	allergy	allergic rhinitis	MicroSource, Selleck	91.41	BRD-K77821588-050-01-7, BRD-K77821588-364-01-2	Launched
azathioprine	dehydrogenase inhibitor	HPRT1, IMPDH1, PPAT	transplant, rheumatology	renal homotransplantation, rheumatoid arthritis	Tocris, MicroSource, Selleck	98.13	BRD-K32821942-001-22-1, BRD-K32821942-001-21-3, BRD-K32821942-001-20-5	Launched
AZD1080	glycogen synthase kinase inhibitor	GSK3A, GSK3B			MedChemEx, MedChemEx, Selleck, Selleck	71.86	BRD-K61041538-001-05-5, BRD-K61041538-001-04-8, BRD-K61041538-001-01-4, BRD-K61041538-001-03-0	Phase 1
AZD1208	Pim kinase inhibitor	PIM1, PIM2, PIM3			MedChemEx	88.58	BRD-K21908111-001-01-8	Phase 1
AZD1283	purinergic receptor antagonist	P2RY12			MedChemEx	99.81	BRD-K77060810-001-01-5	Preclinical
AZD1446	acetylcholine receptor agonist	CHRNA4, CHRNB2			Key	81.54	BRD-A44188509-001-01-2	Phase 2
AZD1480	JAK inhibitor	JAK1, JAK2, JAK3			Tocris, MedChemEx	98.38	BRD-K65928735-001-06-8, BRD-K65928735-001-04-3	Phase 1
AZD1981	CRTH receptor antagonist	PTGDR2			Selleck	95.7	BRD-K83186168-001-01-8	Phase 2
AZD2014	mTOR inhibitor	MTOR			Selleck	95.64	BRD-K99113996-001-02-0	Phase 2
AZD2461	PARP inhibitor				Selleck	98.71	BRD-K85014146-001-02-5	Phase 1
AZD2858	glycogen synthase kinase inhibitor	GSK3B			Selleck	94.49	BRD-K85849709-001-01-5	Preclinical
AZD3264	IKK inhibitor	IKBKB			MedChemEx	90.52	BRD-K14287049-001-01-3	Preclinical
AZD3463	ALK tyrosine kinase receptor inhibitor, insulin growth factor receptor inhibitor	ALK, IGF1R			Selleck, Selleck	94.52	BRD-K24593301-001-01-5, BRD-K24593301-001-02-3	Preclinical
AZD3514	androgen receptor modulator	AR			Selleck	96.18	BRD-K84996356-001-01-1	Phase 1
AZD3759	EGFR inhibitor	EGFR			MedChemEx	98.14	BRD-K41626799-001-01-1	Phase 1
AZD3839	beta-secretase inhibitor	BACE1			Selleck	0	BRD-A54654253-001-01-8	Phase 1
AZD3965	monocarboxylate transporter inhibitor	SLC16A1			MedChemEx	97.59	BRD-K25210703-001-01-9	Phase 1
AZD3988	diacylglycerol kinase inhibitor	DGAT1			Tocris	97.67	BRD-K73984371-001-01-1	Preclinical
AZD4282	glutamate receptor antagonist	AGXT, AGXT2, ALAS1, ALAS2, BAAT, GARS, GATM, GCAT, GCSH, GLDC, GLRA1, GLRA2, GLRA3, GLRB, GLYAT, GLYATL1, GLYATL2, GNMT, GPR18, GPRC6A, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3B, GSS, PIPOX, SHMT1, SHMT2, SLC32A1, SLC36A1, SLC6A5, SLC6A9			Enzo	0	BRD-K72369578-001-04-1	Phase 1
AZD4547	FGFR inhibitor	FGFR1, FGFR2, FGFR3, FGFR4, IGF1R, KDR			Selleck	92.48	BRD-K28392481-001-05-1	Phase 2/Phase 3
AZD5069	CC chemokine receptor antagonist	CXCR2			MedChemEx	98.58	BRD-K34801930-001-01-9	Phase 2
AZD5363	AKT inhibitor	AKT1, AKT2, AKT3			Selleck	94.65	BRD-K99023089-001-03-7	Phase 2
AZD5438	CDK inhibitor	KCNH2			Selleck, Tocris, Selleck	97.1	BRD-K72414522-001-08-3, BRD-K72414522-001-10-9, BRD-K72414522-001-06-7	Phase 1
AZD5582	XIAP inhibitor	BIRC2, BIRC3, XIAP			MedChemEx	91.6	BRD-K88767641-001-01-7	Preclinical
AZD6482	PI3K inhibitor	PIK3CA, PIK3CB, PIK3CD, PIK3CG			Selleck, Tocris	99.6	BRD-K58772419-001-07-0, BRD-K58772419-001-08-8	Phase 1
AZD6738	ATR kinase inhibitor	ATR			Selleck	97.61	BRD-A36013532-001-01-3	Phase 1/Phase 2
AZD6765	glutamate receptor antagonist	GRIN1			Enamine	84.3	BRD-A94033181-001-01-4	Phase 2
AZD7545	pyruvate dehydrogenase kinase inhibitor	PDK1			Selleck	93.48	BRD-A87435144-001-01-6	Phase 1
AZD7687	diacylglycerol O acyltransferase inhibitor	DGAT1			MedChemEx	99.55	BRD-K31495718-001-01-1	Phase 1
AZD7762	CHK inhibitor	CHEK1, CHEK2			Selleck, Selleck, Tocris	94.21	BRD-K86525559-001-07-8, BRD-K86525559-001-04-5, BRD-K86525559-003-01-7	Phase 1
AZD8055	mTOR inhibitor	MTOR			Selleck	97.5	BRD-K69932463-001-10-6	Phase 1
AZD8186	PI3K inhibitor	PIK3CB, PIK3CD			Adooq, Selleck	99.82	BRD-K47289408-001-01-5, BRD-K47289408-001-02-3	Phase 1
AZD8330	MEK inhibitor				Selleck, Selleck	86.39	BRD-K37687095-001-07-7, BRD-K37687095-001-06-9	Phase 1
AZD8835	PI3K inhibitor	PIK3CA, PIK3CD			MedChemEx	97.11	BRD-K82894950-001-01-0	Phase 1
AZD8931	EGFR inhibitor	EGFR, ERBB2, ERBB3			Selleck	96.79	BRD-K98572433-001-02-9	Phase 2
AZD9272	glutamate receptor antagonist	GRM5			Tocris	97.51	BRD-K61043483-001-01-5	Preclinical
AZD9496	estrogen receptor agonist	ESR1			MedChemEx, MedChemEx	97.14	BRD-K73235735-001-02-7, BRD-K73235735-050-01-6	Phase 1
AZD9668	elastase inhibitor	ELANE			MedChemEx	98.48	BRD-K31476763-001-01-5	Phase 2
azelaic-acid	tyrosinase inhibitor	AKR1D1, SRD5A2, TYR	dermatology	rosacea	MicroSource	97.8	BRD-K08976401-001-18-5	Launched
azelastine	histamine receptor antagonist	HRH1	ophthalmology	conjunctivitis	MicroSource, Selleck	96.67	BRD-A68888262-003-16-9, BRD-A68888262-003-15-1	Launched
azeliragon	RAGE receptor antagonist	AGER			MedChemEx	90.27	BRD-K51899933-001-02-6	Phase 3
azelnidipine	calcium channel blocker	CACNA1C	cardiology	hypertension	MedChemEx, Selleck, Selleck	91.33	BRD-A01098288-001-06-0, BRD-A01098288-001-04-5, BRD-A01098288-001-02-9	Launched
azilsartan	angiotensin receptor antagonist	AGTR1, AGTR2	cardiology	hypertension	Tocris, Selleck	97.15	BRD-K81074237-001-03-1, BRD-K81074237-001-02-3	Launched
azilsartan-medoxomil	angiotensin receptor antagonist	AGTR1, AGTR2	cardiology	hypertension	Selleck, MicroSource, Selleck	92.61	BRD-K25723200-001-03-5, BRD-K25723200-237-01-9, BRD-K25723200-001-02-7	Launched
azimilide	potassium channel blocker	KCNA5, KCNE1, KCNH2, KCNQ1			MedChemEx	97.19	BRD-K38913877-300-01-9	Phase 3
azithromycin	bacterial 50S ribosomal subunit inhibitor	MLNR	infectious disease	pelvic inflammatory disease, pneumonia	Tocris, MicroSource, Selleck, Selleck	100	BRD-K74501079-001-17-3, BRD-K74501079-001-15-7, BRD-K74501079-335-01-9, BRD-K74501079-001-18-1	Launched
azlocillin	bacterial cell wall synthesis inhibitor		infectious disease	gram-positive bacterial infections, gram-negative bacterial infections	MicroSource, Selleck, MicroSource, Selleck	85.42	BRD-K60663764-236-04-7, BRD-A46717658-236-02-5, BRD-K60663764-236-05-4, BRD-K60663764-236-03-9	Launched
AZM-475271	src inhibitor	SRC			Tocris	93.7	BRD-K51329597-001-01-3	Preclinical
azodicarbonamide	DNA synthesis inhibitor				AMS, MatrixSci	0	BRD-K87036601-001-02-4, BRD-K87036601-001-01-6	Phase 2
azomycin-(2-nitroimidazole)	protein synthesis inhibitor				Selleck, Selleck	96.5	BRD-K26824830-001-02-0, BRD-K26824830-001-03-8	Preclinical
azosemide	electrolyte reabsorption inhibitor	SLC12A1, SLC12A2	cardiology	edema	AKSci	81.77	BRD-K68770713-001-01-8	Launched
aztreonam	bacterial cell wall synthesis inhibitor		infectious disease	urinary tract infections, respiratory tract infections, bacterial septicemia, skin infections, intra-abdominal infections, gynecologic infections	MicroSource, Selleck, Selleck	90.6	BRD-K62607865-236-02-4, BRD-K62607865-001-09-7, BRD-K62607865-236-01-6	Launched
AZ191	DYRK inhibitor	DYRK1B			Selleck, Tocris	92.78	BRD-K80935598-001-01-1, BRD-K80935598-001-02-9	Preclinical
AZ20	ATR kinase inhibitor	ATR, MTOR			Tocris, Selleck	98.44	BRD-K42436189-001-03-8, BRD-K42436189-001-01-2	Preclinical
AZ3146	monopolar spindle 1 kinase inhibitor				Selleck, Selleck, Tocris	93.84	BRD-K59146805-001-04-5, BRD-K59146805-001-03-7, BRD-K59146805-001-05-2	Preclinical
AZ505	histone lysine methyltransferase inhibitor	SMYD2			MedChemEx, MedChemEx	97.71	BRD-K76244476-362-02-5, BRD-K76244476-362-01-7	Preclinical
AZ5104	EGFR inhibitor	EGFR			Selleck	79.95	BRD-K81958169-001-01-1	Preclinical
AZ960	JAK inhibitor	JAK2			Selleck, Selleck	94.66	BRD-K64888243-001-04-5, BRD-K64888243-001-03-7	Preclinical
A0001					Sigma, Enzo	40.81	BRD-K57865272-001-02-0, BRD-K57865272-001-01-2	Phase 2
A12B4C3	polynucleotide kinase/phosphatase inhibitor	PNKP			Tocris	89.26	BRD-A30000356-001-01-9	Preclinical
A205804	ICAM1 expression inhibitor	ICAM1, SELE			Tocris, Tocris, Selleck	98.68	BRD-K77627880-001-04-0, BRD-K77627880-001-05-7, BRD-K77627880-001-03-2	Preclinical
A61603	adrenergic receptor agonist	ADRA1A			Tocris	80.43	BRD-A83650191-004-02-8	Preclinical
A66	PI3K inhibitor	PIK3CA			Selleck, Tocris	94.01	BRD-K49055432-001-04-2, BRD-K49055432-001-07-5	Preclinical
A740003	purinergic receptor antagonist	P2RX7			Tocris, Tocris	97.5	BRD-A78952587-001-01-5, BRD-A78952587-001-02-3	Preclinical
A77636	dopamine receptor agonist	CALY			Tocris	39.87	BRD-K72226571-003-01-2	Preclinical
A922500	diacylglycerol O acyltransferase inhibitor	DGAT1			Selleck	92.69	BRD-K28861668-001-01-9	Preclinical
bacampicillin	bacterial cell wall synthesis inhibitor		infectious disease	gram-positive bacterial infections, gram-negative bacterial infections	MicroSource, Sigma, MedChemEx	81.26	BRD-A41698174-003-13-8, BRD-A41698174-003-11-2, BRD-A41698174-003-12-0	Launched
bacitracin	bacterial cell wall synthesis inhibitor	A2M, IDE	infectious disease	first-aid antibiotic	MicroSource, Selleck, Selleck	13.46	BRD-A49374018-001-04-1, BRD-A23712469-001-08-7, BRD-A30186914-001-01-1	Launched
bacitracin-zinc	bacterial cell wall synthesis inhibitor		infectious disease	first-aid antibiotic	Selleck, MedChemEx, Selleck	37.33	BRD-A06016120-001-02-8, BRD-M45010341-001-01-5, BRD-A06016120-001-01-0	Launched
baclofen	benzodiazepine receptor agonist	GABBR1, GABBR2, KCTD12, KCTD16, KCTD8	neurology/psychiatry	multiple sclerosis, spasms	MicroSource	0	BRD-A84174873-003-07-4	Launched
baclofen-(R)	benzodiazepine receptor agonist	GABBR1, GABBR2			Selleck, Selleck	96.78	BRD-K62353271-001-04-7, BRD-K62353271-001-02-1	Preclinical
BADGE	PPAR receptor antagonist	PPARG			Tocris	94.12	BRD-A16694057-001-06-8	Preclinical
bafetinib	Bcr-Abl kinase inhibitor, LYN tyrosine kinase inhibitor	ABL1, BCR, LYN			Selleck	91.07	BRD-A75975749-001-01-4	Phase 2
BAG-956	phosphoinositide dependent kinase inhibitor	PIK3CG			Tocris	97.92	BRD-K00652956-001-01-5	Preclinical
baicalein	lipoxygenase inhibitor	ALOX5, GLO1, PREP, SELL, SELP, TNF, XDH			Selleck, Selleck, Tocris	97.14	BRD-K72327355-001-15-4, BRD-K72327355-001-13-9, BRD-K72327355-001-14-7	Preclinical
baicalin	beta glucuronidase inhibitor	PREP			Selleck, Selleck	87.7	BRD-K49962337-001-02-9, BRD-K49962337-001-01-1	Launched
bakuchiol	DNA polymerase inhibitor	HIF1A			MedChemEx, Enzo	89.43	BRD-K09785578-001-02-0, BRD-K09785578-001-01-2	Phase 2
balaglitazone	insulin sensitizer, PPAR receptor partial agonist	PPARG			MedChemEx	96.17	BRD-A00147595-001-01-5	Phase 3
balapiravir	RNA polymerase inhibitor				MedChemEx	95.37	BRD-K47976015-001-01-2	Phase 2
balicatib	cathepsin inhibitor	CTSK			Tocris, MedChemEx	97.04	BRD-K27204852-001-02-7, BRD-K27204852-001-01-9	Phase 2
balofloxacin	bacterial DNA gyrase inhibitor		infectious disease	gram-negative bacterial infections	Selleck, Selleck	97.5	BRD-A47790386-001-02-8, BRD-A47790386-001-03-6	Launched
balsalazide	cyclooxygenase inhibitor	ALOX5, PPARG, PTGS1, PTGS2	gastroenterology	ulcerative colitis	MicroSource	97.52	BRD-K41410256-304-02-2	Launched
bambuterol	adrenergic receptor agonist	ADRB2, BCHE	pulmonary	asthma	MicroSource	97.14	BRD-A17462676-003-11-6	Launched
BAM7	BAX activator	BAX			Selleck	97.43	BRD-K07442505-001-03-6	Preclinical
BAN-ORL-24	nociceptin/orphanin FQ receptor antagonist	OPRL1			MedChemEx, Tocris, Tocris	83.83	BRD-K47049295-300-03-1, BRD-K47049295-300-01-5, BRD-K47049295-300-02-3	Preclinical
barasertib	Aurora kinase inhibitor	AURKA, AURKB			MedChemEx	89.07	BRD-K31928526-001-02-1	Phase 2/Phase 3
barasertib-HQPA	Aurora kinase inhibitor	AURKB			Selleck, Selleck	96.94	BRD-K63923597-001-11-8, BRD-K63923597-001-10-0	Phase 2/Phase 3
barbital	sedative	CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GRIA2, GRIK2	neurology/psychiatry	sedative, seizures	MicroSource	98.75	BRD-K83359602-001-02-3	Launched
bardoxolone	nuclear factor erythroid derived, like (NRF2) activator	NOS2, PPARG			MedChemEx	85.92	BRD-K20545304-001-01-6	Phase 1
bardoxolone-methyl	nuclear factor erythroid derived, like (NRF2) activator	PPARG, STAT3			Selleck	90.44	BRD-K69694239-001-02-2	Phase 3
baricitinib	JAK inhibitor	JAK1, JAK2			Selleck	97.35	BRD-K53581288-001-02-9	Phase 3
barium-6-O-phosphonato-D-glucose		GPI			TCI	0	BRD-K67760597-240-01-5	Preclinical
barnidipine	calcium channel blocker		cardiology	hypertension	AKSci	92.07	BRD-K78781788-003-01-9	Launched
basic-fuchsin					SantaCruz	0	BRD-K26362911-003-01-1	Preclinical
basimglurant	glutamate receptor antagonist	GRM5			MedChemEx	99.2	BRD-K62387885-001-01-9	Phase 2
batimastat	matrix metalloprotease inhibitor	ADAM28, ADAMTS5, MMP12, MMP16, MMP2, MMP8			Selleck, Selleck	91.11	BRD-K82818427-001-04-8, BRD-K82818427-001-02-2	Phase 3
bavisant	histamine receptor antagonist	HRH3			MedChemEx	99.79	BRD-K79595931-312-01-3	Phase 2
BAX-channel-blocker	cytochrome C release inhibitor	BAX			Tocris, Tocris	94.54	BRD-A18763547-300-06-3, BRD-A18763547-300-05-5	Preclinical
BAY-K-8644-(+/-)	L-type calcium channel activator				Tocris	92.92	BRD-A05457250-001-08-4	Preclinical
BAY-K-8644-(s)-(-)	L-type calcium channel activator	CACNA1C			Tocris	90.62	BRD-K14329163-001-03-9	Preclinical
bay-w-9798	antioxidant				Vitas-M	98.03	BRD-K44471774-001-01-8	Phase 2
BAY-11-7082	NFkB pathway inhibitor	RELA			Tocris, Selleck, Selleck	100	BRD-K15025317-001-15-1, BRD-K15025317-001-14-4, BRD-K15025317-001-17-7	Preclinical
BAY-11-7085	NFkB pathway inhibitor	NFKBIA			Tocris	91.4	BRD-K48684885-001-04-2	Preclinical
BAY-41-2272	guanylyl cyclase activator	GUCY1A3, GUCY1B3			Tocris	96.5	BRD-K32033120-001-01-1	Preclinical
BAY-60-6583	adenosine receptor agonist	ADORA1, ADORA2A, ADORA2B, ADORA3			Tocris	92.52	BRD-K32952627-001-01-0	Preclinical
bay-60-7550	phosphodiesterase inhibitor	PDE2A			MedChemEx	93.86	BRD-K86932920-001-02-9	Preclinical
BAY-61-3606	syk inhibitor	SYK			MedChemEx	91.87	BRD-K53281329-300-01-5	Preclinical
BAY-85-8050					AlfaAesar	100	BRD-A11731518-001-01-7	Phase 1
BAY-87-2243	hypoxia inducible factor inhibitor	HIF1A			MedChemEx	96.05	BRD-K70463136-001-01-5	Phase 1
bazedoxifene	selective estrogen receptor modulator (SERM)	ESR1, ESR2	orthopedics, endocrinology	osteoporosis, menopause	Selleck, Selleck, Tocris	92.53	BRD-K90195324-003-02-5, BRD-K90195324-003-03-3, BRD-K90195324-015-01-1	Launched
BAZ2-ICR	bromodomain inhibitor	ZNF215			Tocris	86.63	BRD-K66830666-001-01-9	Preclinical
BC-11	urokinase inhibitor	PLAU			Tocris	78.51	BRD-K14646328-004-01-6	Preclinical
BCI-540	glutamate receptor agonist				MedChemEx	99.63	BRD-K23672206-001-01-4	Phase 2
BCTC	TRPV antagonist	TRPV1			Tocris	89.31	BRD-K66541497-001-01-7	Preclinical
BCX-1470	serine protease inhibitor, complement inhibitor	CFD			MedChemEx	94.08	BRD-K90472149-066-01-0	Phase 1
BD-1008	sigma receptor antagonist				Tocris	91	BRD-K17008822-303-02-1	Preclinical
BD-1047	adrenergic receptor antagonist	SIGMAR1			Tocris, Tocris	91.49	BRD-K36864847-303-03-3, BRD-K36864847-303-02-5	Preclinical
BD-1063	sigma receptor antagonist	SIGMAR1			Tocris	96.05	BRD-K29668683-300-02-2	Preclinical
BE-2254	adrenergic receptor antagonist	ADRA1A			Biotrend, Tocris	32.4	BRD-A24429032-003-03-2, BRD-A24429032-003-02-4	Phase 2
beclamide	anticonvulsant		neurology/psychiatry	sedative, seizures	MicroSource	96.76	BRD-K44824027-001-02-1	Launched
beclomethasone	glucocorticoid receptor agonist	NR3C1, SERPINA6	allergy	allergic rhinitis	AvaChem	90.36	BRD-A73385064-001-01-5	Launched
beclomethasone-dipropionate	glucocorticoid receptor agonist	GPR97, NR3C1	allergy	allergic rhinitis	MicroSource, Selleck, Selleck	98.04	BRD-K97810537-001-13-6, BRD-K97810537-001-12-8, BRD-K97810537-001-14-4	Launched
bedaquiline	ATPase inhibitor		infectious disease	tuberculosis	MedChemEx, MedChemEx, MedChemEx	92.56	BRD-K90817094-001-05-9, BRD-K90817094-001-02-6, BRD-K90817094-001-03-4	Launched
befuraline					Enamine	96.8	BRD-K99077012-001-01-9	Phase 2
begacestat	gamma secretase inhibitor	PSEN1			Tocris, Sigma	89.43	BRD-K58319700-001-02-9, BRD-K58319700-001-01-1	Phase 1
bekanamycin	bacterial 30S ribosomal subunit inhibitor		infectious disease	gram-negative bacterial infections	Selleck, MicroSource	100	BRD-K73425385-001-01-9, BRD-K73425385-065-04-8	Launched
belinostat	HDAC inhibitor	HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9	hematologic malignancy	peripheral T-cell lymphoma (PTCL)	Selleck	94.73	BRD-K17743125-001-08-4	Launched
bemegride	chemoreceptor agonist	GABRA1	critical care	poison antidote	Selleck	90.86	BRD-K14993104-001-05-9	Launched
bemesetron	serotonin receptor antagonist	HTR3A, HTR3B			Tocris, Tocris	96.71	BRD-A85587465-001-04-1, BRD-A85587465-001-03-3	Phase 3
bemotrizinol			dermatology	sunscreen lotion	MicroSource	0	BRD-A92974210-396-01-0	Launched
benaxibine					Vitas-M	97.7	BRD-A90642009-001-03-2	Phase 1
benazepril	angiotensin converting enzyme inhibitor	ACE	cardiology	hypertension	MicroSource, Tocris, Tocris, Selleck	98.78	BRD-K49807096-003-16-3, BRD-K49807096-003-15-5, BRD-K49807096-003-17-1, BRD-K49807096-003-14-8	Launched
bendamustine	DNA inhibitor		hematologic malignancy	chronic lymphocytic leukemia (CLL), non-Hodgkin lymphoma (NHL)	Selleck, Selleck	88.19	BRD-K17068645-003-05-9, BRD-K17068645-003-04-2	Launched
bendazac	cyclooxygenase inhibitor	PTGS1, PTGS2	neurology/psychiatry, rheumatology	muscle pain, joint pain	Key	97.29	BRD-K19515365-001-02-6	Launched
bendroflumethiazide	sodium/potassium/chloride transporter inhibitor	CA1, CA2, CA4, KCNMA1, SLC12A1, SLC12A3	cardiology	hypertension	MicroSource, Selleck	98.28	BRD-A80017228-001-25-7, BRD-A80017228-001-24-0	Launched
benethamine					Enamine	99.27	BRD-K13473780-001-02-1	Preclinical
benfluorex	gluconeogenesis inhibitor	HMGCR			MicroSource	98.31	BRD-A22305049-003-13-6	Withdrawn
benfluralin		CYP1A1, CYP1A2, CYP2B6, CYP3A4, ESR1, MMP1, SULT2A1, UGT1A1			Sigma	97.41	BRD-K33903083-001-03-5	Phase 3
benfotiamine	antioxidant	AGER	rheumatology	lumbago	MicroSource, Selleck, Selleck	93.58	BRD-K07359318-396-01-7, BRD-K05319475-001-04-2, BRD-K07359318-001-03-9	Launched
benidipine	calcium channel blocker	CACNA1C, CACNA1G	cardiology	hypertension	Selleck, Selleck	97.05	BRD-K97181463-003-02-9, BRD-K97181463-003-01-1	Launched
benperidol	dopamine receptor antagonist	DRD2	neurology/psychiatry	schizophrenia	Prestwick	88.46	BRD-K79425933-001-09-3	Launched
benproperine	antitussive	SCN5A	pulmonary	cough suppressant	AvaChem	97.04	BRD-A42423104-001-01-4	Launched
benserazide	DOPA decarboxylase inhibitor	DDC	neurology/psychiatry	Parkinson's Disease	MicroSource, Selleck	93.52	BRD-A61194565-003-28-8, BRD-A61194565-003-27-0	Launched
bentazepam	benzodiazepine receptor agonist		neurology/psychiatry	anxiety, sedative, muscle relaxant	Asinex	98.21	BRD-K89490285-001-08-1	Launched
bentiromide		HPN	gastroenterology	pancreas diagnostic agent	Selleck, Selleck	93.46	BRD-K58794715-001-01-8, BRD-K58794715-001-02-6	Launched
benurestat	urease inhibitor				MicroSource	92.03	BRD-K88553858-001-02-7	Phase 1
benzalkonium	Cationic surfactant		dermatology	abrasions, superficial cuts	MicroSource	0	BRD-K34234316-003-04-7	Launched
benzamil	sodium channel blocker	ASIC1, PKD2L1, SCNN1A, SCNN1B, SCNN1D, SCNN1G, SLC8A1			Tocris, Enzo	97.72	BRD-K87158025-003-08-7, BRD-K87158025-001-01-6	Phase 2
benzbromarone	chloride channel blocker	ABCC1	rheumatology	gout	MicroSource, Selleck	96.2	BRD-K11717138-001-30-3, BRD-K11717138-001-29-5	Launched
benzenemethanol,-2,5-dimethyl-[[(1-methylethyl)amino]methyl]					Enamine	83.87	BRD-A98083480-001-01-3	Preclinical
benzethonium	sodium channel blocker	SCN10A	infectious disease	first-aid antiseptic	MicroSource, Selleck	99.48	BRD-K72723676-003-17-8, BRD-K72723676-003-16-0	Launched
benznidazole	DNA synthesis inhibitor		infectious disease	Chagas disease	Toronto	86.94	BRD-K56156805-001-09-6	Launched
benzo[d]thiazole-2(3h)-thione					Ark	95.36	BRD-K55160477-001-04-7	Phase 1
benzocaine	sodium channel blocker	SCN10A	infectious disease	first-aid antiseptic	MicroSource, Selleck	99.51	BRD-K75466013-001-14-4, BRD-K75466013-001-13-6	Launched
benzoclidine					MicroSource	35.21	BRD-A45929034-001-09-5	Preclinical
benzofenac					Sigma	99.01	BRD-K26556907-001-01-8	Phase 1
benzoic-acid	food preservative	DAO, HRSP12, PRDX5, RAB9A	infectious disease	tinea pedis	MicroSource, Selleck, Selleck	98.16	BRD-K53397409-001-12-3, BRD-K53397409-001-11-5, BRD-K53397409-001-13-1	Launched
benzoin		CES1			Enamine	99.28	BRD-A55748233-001-08-7	Preclinical
benzonatate	local anesthetic	SCN5A	pulmonary	cough suppressant	MicroSource	99.74	BRD-K91699951-001-10-2	Launched
benzoquinonium-dibromide	cholinergic receptor antagonist	CHRNA1			Tocris	91.5	BRD-K18772613-303-02-4	Preclinical
benzotript	CCK receptor antagonist	CCKAR, CCKBR			Enamine	99.39	BRD-A87983072-001-01-1	Phase 1
benzoxiquine	antiinfective drug				MicroSource	99.67	BRD-K70327191-001-02-2	Preclinical
benzoyl-peroxide	oxidizing agent		dermatology	acne vulgaris (AV)	MicroSource, Sigma	0	BRD-K59986511-001-04-9, BRD-K59986511-001-06-4	Launched
benzoylpas					MicroSource, Vitas-M	97.57	BRD-K20431737-001-08-1, BRD-K20431737-001-09-9	Preclinical
benzthiazide	carbonic anhydrase inhibitor	CA1, CA12, CA2, CA4, CA9, SLC12A3	cardiology	hypertension, edema	MicroSource, Selleck	99.29	BRD-K21450440-001-14-6, BRD-K21450440-001-13-8	Launched
benztropine-mesylate	acetylcholine receptor antagonist	CHRM1, HRH1, SLC6A3	neurology/psychiatry	extrapyramidal symptoms (EPS), Parkinson's Disease	Selleck	97.24	BRD-K48061146-066-01-7	Launched
benzydamine	prostanoid receptor antagonist		dental, otolaryngology	mouth inflammation, throat inflammation	MicroSource, Selleck	98.35	BRD-K28542495-003-13-5, BRD-K28542495-003-12-7	Launched
benzyl-alcohol	local anesthetic		infectious disease	virus herpes simplex (HSV)	MicroSource, Sigma	0	BRD-K98494274-001-03-6, BRD-K98494274-001-05-1	Launched
benzyl-benzoate	lipase inhibitor	LIPE	allergy	sweet itch	MicroSource, MedChemEx, Sigma	0	BRD-K52072429-001-10-3, BRD-K52072429-001-12-9, BRD-K52072429-001-11-1	Launched
benzyl-isothiocyanate	methylazoxymethanol acetate inhibitor				MicroSource	2.87	BRD-K80253852-001-04-4	Preclinical
benzyldimethylhexadecylammonium	cationic surfactant				Acros	98.49	BRD-K23403298-003-01-9	Preclinical
benzyldimethyloctylammonium					Sigma	96.76	BRD-K11576103-003-01-1	Preclinical
benzylpenicillin	penicillin binding protein inhibitor		infectious disease	celluitis, meningitis, endocarditis, syphilis, pneumonia, bacterial septicemia	Selleck, MicroSource, Selleck	97.54	BRD-K55191674-236-06-0, BRD-K55191674-237-18-3, BRD-K55191674-236-07-8	Launched
bephenium-hydroxynaphthoate	anthelmintic agent		infectious disease	ascariasis	MicroSource, Selleck, Selleck	97.09	BRD-K47878171-086-06-0, BRD-K47878171-086-05-2, BRD-K47878171-086-07-8	Launched
bepotastine	histamine receptor antagonist	HRH1	ophthalmology	conjunctivitis	Selleck	90.86	BRD-K98624455-074-02-8	Launched
bepridil	calcium channel blocker	ATP1A1, CACNA1A, CACNA1H, CACNA2D2, CALM1, KCNQ1, KCNQ4, PDE1A, PDE1B, TNNC1	cardiology	angina pectoris	MicroSource, Tocris, Sigma	96.17	BRD-A91008255-003-24-8, BRD-A91008255-003-26-3, BRD-A91008255-003-25-5	Launched
berberine	LDL receptor activator	LDLR			MicroSource, Selleck	95.66	BRD-K14796088-003-26-8, BRD-K14796088-003-25-0	Phase 2/Phase 3
bergapten					MicroSource, Selleck	96.13	BRD-K12968785-001-13-3, BRD-K12968785-001-12-5	Preclinical
bergenin	interleukin inhibitor	IL1B, TNF			MicroSource, Selleck	97.98	BRD-K04176066-001-09-1, BRD-K04176066-001-08-3	Preclinical
besifloxacin	bacterial DNA gyrase inhibitor		ophthalmology	conjunctivitis	Selleck	93.81	BRD-K10196357-003-02-0	Launched
BET-BAY-002	bromodomain inhibitor				MedChemEx	97.66	BRD-K72735080-001-01-0	Preclinical
beta-amyloid-synthesis-inhibitor	beta amyloid synthesis inhibitor	APP			Maybridge	94.44	BRD-K38687824-001-02-5	Preclinical
beta-carotene					Selleck, Selleck, MedChemEx, MicroSource	0	BRD-K74225533-001-10-4, BRD-K74225533-001-08-8, BRD-K74225533-001-12-0, BRD-K74225533-001-09-6	Launched
beta-CCB	benzodiazepine receptor ligand	GABRA1, GABRG2			Tocris	98.04	BRD-K87349602-001-03-8	Launched
beta-elemene	apoptosis stimulant	MMP2, MMP9			Sigma	0	BRD-K21045639-001-01-2	Launched
beta-funaltrexamine	opioid receptor antagonist	OPRD1, OPRK1, OPRM1			Tocris, Tocris	95.83	BRD-K95110148-003-02-3, BRD-K95110148-003-01-5	Preclinical
beta-glycerophosphoric-acid					Vitas-M	0	BRD-K39061174-001-01-0	Preclinical
beta-hydroxy-beta-methylbutyrate	protein synthesis stimulant	MTOR			CombiBlocks	97.1	BRD-M02899238-238-01-6	Phase 2/Phase 3
beta-Hydroxybutyrate		HCAR2			Vitas-M	0	BRD-A41387824-001-06-0	Phase 1
beta-lapachone	topoisomerase inhibitor	TOP1			MedChemEx, MedChemEx, Selleck, Selleck	82.91	BRD-K28061410-001-07-4, BRD-K28061410-001-09-0, BRD-K28061410-001-05-8, BRD-K28061410-001-06-6	Phase 2
beta-naphthol					MicroSource	90.98	BRD-K21164796-001-02-8	Preclinical
betahistine	histamine receptor agonist, histamine receptor antagonist	HRH1, HRH3	neurology/psychiatry	Meniere's disease	MicroSource, Selleck	100	BRD-K91315211-300-06-5, BRD-K91315211-300-05-7	Launched
betaine	nitric oxide donor		metabolism	homocystinuria	MicroSource	0	BRD-K12014493-001-02-2	Launched
betamethasone	glucocorticoid receptor agonist	NR3C1	dermatology	corticosteroid-responsive dermatoses	MicroSource, Selleck	97.06	BRD-A02180903-001-04-5, BRD-K12955147-001-01-8	Launched
betamethasone-acetate	glucocorticoid receptor agonist	NR3C1	dermatology	corticosteroid-responsive dermatoses	MicroSource	93.5	BRD-A92177080-001-02-1	Launched
betamethasone-dipropionate	anti-inflammatory agent		dermatology	corticosteroid-responsive dermatoses	MicroSource, Selleck	96.86	BRD-K58148589-001-03-6, BRD-K58148589-001-02-8	Launched
betamethasone-valerate	glucocorticoid receptor agonist	NR3C1	dermatology	corticosteroid-responsive dermatoses	Selleck, MicroSource, Selleck	86.11	BRD-K34032314-001-02-5, BRD-K34032314-001-04-1, BRD-K34032314-001-03-3	Launched
betamipron	panipenem uptake inhibitor		nephrology	renal toxicity	MicroSource, Selleck	96.24	BRD-K82142815-001-19-1, BRD-K82142815-001-18-3	Launched
betaxolol	adrenergic receptor antagonist	ADRB1, ADRB2	ophthalmology	intraocular pressure, glaucoma, ocular hypertension	MicroSource, Selleck, Tocris, Selleck, Selleck, Selleck	96.12	BRD-A02759312-003-25-2, BRD-A02759312-001-02-5, BRD-A02759312-003-24-5, BRD-A02759312-001-03-3, BRD-A02759312-003-23-7, BRD-K17498618-344-02-6	Launched
betazole	histamine receptor agonist	HRH2	gastroenterology	gastric hypersecretion diagnostic	Prestwick	97.19	BRD-K20075662-300-04-0	Launched
bethanechol	acetylcholine receptor agonist	CHRM1, CHRM2, CHRM3, CHRM4	urology	urinary retention	MicroSource, Selleck, Selleck	100	BRD-A99833829-003-26-3, BRD-A99833829-003-27-1, BRD-A99833829-003-25-5	Launched
BETP	glucagon-like peptide receptor positive allosteric modulator	GLP1R			Tocris	98.36	BRD-A60153876-001-01-0	Preclinical
betrixaban	coagulation factor inhibitor	KCNH2	hematology	deep vein thrombosis (DVT)	MedChemEx	85.59	BRD-K45275534-001-01-3	Launched
betulinic-acid	apoptosis stimulant, NFkB pathway inhibitor	GPBAR1			Tocris, Selleck, Selleck	96.07	BRD-K45401373-001-21-7, BRD-K45401373-001-20-9, BRD-K45401373-001-22-5	Phase 1/Phase 2
bevantolol	adrenergic receptor antagonist	ADRA1A, ADRB1, ADRB2	cardiology	angina pectoris, hypertension	AKSci	94.05	BRD-A18233884-003-02-7	Launched
bevirimat-dimeglumine	HIV capsid assembly inhibitor				MedChemEx	87.82	BRD-K16898998-001-01-6	Phase 2
bexarotene	retinoid receptor agonist	RXRA, RXRB, RXRG	hematologic malignancy	cutaneous T-cell lymphoma (CTCL)	Selleck	98.35	BRD-K92441787-001-04-1	Launched
bezafibrate	PPAR receptor agonist	PPARA, PPARD, PPARG	cardiology	cholesterol	MicroSource, Selleck	99.25	BRD-K46018455-001-27-6, BRD-K46018455-001-26-8	Launched
BF2.649	histamine receptor antagonist	HRH3			Tocris, Tocris	97	BRD-K21673112-003-02-1, BRD-K21673112-003-01-3	Phase 3
BGT226	PI3K inhibitor	MTOR, PIK3CA, PIK3CB, PIK3CG			Selleck, Selleck	98.31	BRD-K29415052-050-05-5, BRD-K29415052-050-04-8	Phase 1/Phase 2
BHQ	ATPase inhibitor	ATP2A1			Tocris	1.34	BRD-K95603879-001-07-5	Preclinical
BI-D1870	ribosomal protein inhibitor	RPS6KA1, RPS6KA2, RPS6KA3, RPS6KA6			MedChemEx, Selleck, Selleck	84.09	BRD-A81370665-001-06-9, BRD-A81370665-001-04-4, BRD-A81370665-001-03-6	Preclinical
BI-224436	HIV integrase inhibitor				MedChemEx	93.15	BRD-K53422148-001-01-8	Phase 1
BI-2536	PLK inhibitor	BRD4, PLK1, PLK2, PLK3			Selleck	97.91	BRD-K64890080-001-13-8	Phase 2
BI-78D3	JNK inhibitor	MAPK8			Tocris, Tocris	94.21	BRD-K73982490-001-02-9, BRD-K73982490-001-03-7	Preclinical
BI-847325	MEK inhibitor, Aurora kinase inhibitor	AURKA, AURKB, AURKC, MAP2K1, MAP2K2			Selleck, Selleck	93.33	BRD-K37492701-001-02-9, BRD-K37492701-001-01-1	Phase 1
biapenem	bacterial cell wall synthesis inhibitor		infectious disease	bacterial septicemia, pneumonia, urinary tract infections	MedChemEx, MedChemEx, Sigma, MedChemEx, Selleck, Selleck	74.7	BRD-A80321291-001-01-6, BRD-A80321291-001-05-7, BRD-A80321291-001-04-0, BRD-A80321291-001-06-5, BRD-A80321291-001-02-4, BRD-A80321291-001-03-2	Launched
BIBN4096	calcitonin antagonist	CALCA, CALCRL, RAMP1			MedChemEx, MedChemEx, MedChemEx	86.32	BRD-K43927145-001-01-2, BRD-K43927145-001-02-0, BRD-K43927145-001-03-8	Phase 2
BIBR-1532	telomerase inhibitor	TERT			Tocris, Selleck	94.94	BRD-K04623885-001-10-9, BRD-K04623885-001-07-5	Preclinical
BIBU-1361	EGFR inhibitor	EGFR			Tocris, Tocris	96.69	BRD-K49294207-300-03-8, BRD-K49294207-300-04-6	Preclinical
BIBX-1382	EGFR inhibitor	EGFR, ERBB2			Tocris, Tocris	94.43	BRD-K70914287-300-02-8, BRD-K70914287-300-03-6	Phase 1
bicalutamide	androgen receptor antagonist	AR	oncology	prostate cancer	Tocris, MicroSource, Selleck	98.74	BRD-A29485665-001-14-4, BRD-A29485665-001-12-8, BRD-A29485665-001-11-0	Launched
bicifadine	serotonin receptor antagonist, dopamine reuptake inhibitor	DRD2, SLC6A2, SLC6A4			Tocris	95.01	BRD-A24208517-003-01-8	Phase 3
bicuculline-(+)	GABA receptor antagonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, KCNN1			Tocris, Selleck	97.77	BRD-A07870296-001-07-4, BRD-A07870296-001-06-6	Preclinical
bicuculline-methochloride-(-)	GABA receptor antagonist				Tocris, Tocris, Tocris	97.84	BRD-A57798559-004-02-3, BRD-A57798559-003-02-5, BRD-A57798559-005-02-0	Preclinical
bicyclol	NFkB pathway inhibitor	HSPA1A, HSPB1			Sigma	98.42	BRD-K16546375-001-01-4	Launched
bifemelane	acetylcholine release enhancer	MAOA, MAOB	ophthalmology, neurology/psychiatry	glaucoma, senile dementia	Tocris, Tocris	95.87	BRD-K18779551-003-08-6, BRD-K18779551-003-07-8	Launched
bifendate					AKSci	99.86	BRD-K26581543-001-01-6	Launched
bifonazole	sterol demethylase inhibitor	CYP2B6	infectious disease	tinea pedis, tinea cruris	MicroSource, Selleck	98.98	BRD-A94543220-001-24-7, BRD-A94543220-001-23-9	Launched
BIIB021	HSP inhibitor	HSP90AA1			Selleck, Tocris	97.64	BRD-K51967704-001-03-6, BRD-K51967704-001-04-4	Phase 2
bilastine	histamine receptor antagonist	HRH1	ophthalmology	conjunctivitis	MedChemEx	99.77	BRD-K51937257-001-01-4	Launched
bilobalide	GABA receptor modulator	GLRA1, GLRA2, GLRB, HTR3A, HTR3B			Selleck	98.12	BRD-A41714661-001-02-0	Preclinical
bimatoprost	prostanoid receptor agonist	AKR1C3, PTGER1, PTGER3, PTGFR	ophthalmology	intraocular pressure, glaucoma, ocular hypertension	Selleck	95.82	BRD-A45153512-001-01-0	Launched
BIMU-8	serotonin receptor agonist	HTR4			Tocris	96.53	BRD-A62743154-003-01-5	Preclinical
BINA	glutamate receptor positive allosteric modulator	GRM2			Tocris	99.13	BRD-A13293292-001-02-6	Preclinical
bindarit	NFkB pathway inhibitor	CCL2, CCL7, CCL8			Selleck	97.84	BRD-K36467523-001-02-8	Phase 2
BIO-1211	integrin antagonist	ITGA4, ITGB1			Tocris	93.1	BRD-K03399463-001-01-6	Phase 2
BIO-5192	integrin inhibitor	ITGA4, ITGB1			Tocris	98.15	BRD-K21318844-001-01-4	Preclinical
biotin	vitamin B	ACACA, ACACB, HLCS, MCCC1, MCCC2, PC, PCCA, PCCB, SLC5A6			MicroSource, Selleck	100	BRD-K89210380-001-14-5, BRD-K89210380-001-13-7	Launched
bipenamol	dipeptidyl peptidase inhibitor	CTSC			Sigma	81.11	BRD-K47690382-001-03-0	Phase 2
biperiden	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA2	neurology/psychiatry	Parkinson's Disease	MicroSource, Selleck	97.94	BRD-A00546892-001-02-6, BRD-A00546892-003-05-5	Launched
birinapant	XIAP inhibitor	BIRC2, XIAP			Selleck, Selleck	95.44	BRD-K71221037-001-01-6, BRD-K71221037-001-02-4	Phase 2
BIRT-377	lymphocyte function-associated antigen negative modulator	ICAM1			Tocris	97.8	BRD-K64880136-001-02-6	Preclinical
bis(maltolato)oxovanadium(IV)	tyrosine phosphatase inhibitor	PTPN1			Carbosynth	79.05	BRD-K16180792-001-01-7	Phase 2
bisacodyl	laxative		gastroenterology	constipation	MicroSource, Selleck	96.97	BRD-K39987650-001-24-1, BRD-K39987650-001-23-3	Launched
bisindolylmaleimide-ix	PKC inhibitor	AKT1, GSK3B, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, ROCK1, RPS6KB1, SIRT1			Selleck, Tocris, Tocris, Selleck	95.99	BRD-K06543683-066-02-1, BRD-K06543683-066-05-4, BRD-K06543683-066-03-9, BRD-K06543683-066-04-7	Preclinical
bismuth(iii)-trifluoromethanesulfonate	direct substitution catalyst				AlfaAesar	99.14	BRD-M56276249-001-01-1	Preclinical
bismuth-oxalate					MPBio	0	BRD-M02179497-001-01-1	Preclinical
bismuth-subcitrate-potassium			gastroenterology	duodenal ulcer disease	Selleck, Selleck	0	BRD-A03880619-001-01-0, BRD-A03880619-001-02-8	Launched
bismuth-subgallate	nitric oxide synthase inhibitor	NOS1			Sigma	0	BRD-K65978409-001-01-9	Launched
bismuth-subsalicylate	antacid		gastroenterology	diarrhea	MicroSource, MedChemEx, Selleck, MedChemEx, Selleck	5.83	BRD-K80528473-001-03-0, BRD-K80528473-001-08-9, BRD-K80528473-001-04-8, BRD-K80528473-001-07-1, BRD-K80528473-001-05-5	Launched
bisoctrizole					MicroSource	0	BRD-K00228584-396-01-8	Phase 2
bisoprolol	adrenergic receptor antagonist	ADRB1, ADRB2	cardiology	hypertension	MicroSource, Tocris, Selleck, Selleck	95.41	BRD-A89175223-051-14-8, BRD-A89175223-051-15-5, BRD-A89175223-051-13-0, BRD-A89175223-051-16-3	Launched
bisphenol-a	synthetic estrogen	AR, ESR1, ESR2, ESRRG, PPARG			Sigma	95.98	BRD-K41494493-001-13-8	Phase 1
bithionol	autotaxin inhibitor	ESR1, ESR2, MCL1			MicroSource	97.59	BRD-K39120595-304-04-7	Withdrawn
bitopertin	glycine transporter inhibitor, GlyT-1 inhibitor	SLC6A5, SLC6A9			MedChemEx	99.57	BRD-K13756951-001-01-4	Phase 3
bitoscanate	anthelmintic agent				MicroSource	0	BRD-K77548206-001-02-9	Preclinical
bivalirudin	thrombin inhibitor	F2	cardiology	angina pectoris	MedChemEx, Key, MedChemEx	93.05	BRD-K28054654-019-01-9, BRD-K73504359-001-01-3, BRD-K73504359-019-01-5	Launched
BIX-01294	histone lysine methyltransferase inhibitor	EHMT1, EHMT2			MedChemEx, Selleck, Selleck, Tocris	97.03	BRD-K26818574-001-06-3, BRD-K26818574-305-04-3, BRD-K26818574-305-07-6, BRD-K26818574-305-08-4	Preclinical
BIX-02188	MEK inhibitor	MAP2K5			Selleck, Selleck	94.2	BRD-K20290250-001-02-1, BRD-K20290250-001-01-3	Preclinical
BIX-02189	MEK inhibitor	MAP2K5, MAPK7			Tocris, Selleck	98.67	BRD-K73368362-001-08-3, BRD-K73368362-001-07-5	Preclinical
BL-5583	hypercalcaemic agent				Enamine	99.35	BRD-K75282704-001-02-4	Preclinical
blebbistatin-(+/-)	ATPase inhibitor	MYH2			Tocris	98.19	BRD-A75817871-001-06-7	Preclinical
blebbistatin-(-)	ATPase inhibitor				Selleck	94.77	BRD-K61295575-001-03-6	Preclinical
bleomycetin	EGFR expression inhibitor				InterBioScreen	0	BRD-A94813917-001-01-0	Phase 2
bleomycin	DNA synthesis inhibitor	LIG1, LIG3	hematologic malignancy, pulmonary, oncology	non-Hodgkin lymphoma (NHL), Hodgkin's lymphoma, pleural effusion, testicular carcinoma, squamous cell carcinoma	Selleck, Selleck, MedChemEx, MicroSource	51.47	BRD-A42083487-065-06-7, BRD-A42083487-065-05-9, BRD-A12918100-065-01-8, BRD-A42083487-001-01-3	Launched
blonanserin	dopamine receptor antagonist, serotonin receptor antagonist	DRD2, HTR2A	neurology/psychiatry	schizophrenia	Selleck	90.29	BRD-K25943794-001-02-3	Launched
BLU9931	FGFR inhibitor	FGFR4			MedChemEx	93.5	BRD-K72898849-001-01-8	Preclinical
BML-190	cannabinoid receptor inverse agonist	CNR2			Selleck, Tocris	98.01	BRD-K94379058-001-05-0, BRD-K94379058-001-06-8	Preclinical
BML-284	WNT agonist				MedChemEx	97.93	BRD-K42624714-001-04-1	Preclinical
BMS-CCR2-22	CC chemokine receptor antagonist	CCR2			Tocris	98.16	BRD-K15119094-001-01-1	Preclinical
BMS-182874	endothelin receptor antagonist	EDNRA			Tocris, Tocris	78.23	BRD-K56509348-003-03-9, BRD-K56509348-003-02-1	Phase 2
BMS-191011	potassium channel activator	KCNMA1			Tocris, Tocris	95.41	BRD-K95609758-001-03-7, BRD-K95609758-001-04-5	Preclinical
BMS-191095	KATP activator, potassium channel agonist				MedChemEx	96.19	BRD-K01231377-001-01-8	Phase 1
BMS-265246	CDK inhibitor	CDK1, CDK2			MedChemEx, Selleck	97.16	BRD-K62814476-001-04-1, BRD-K62814476-001-03-3	Preclinical
BMS-299897	gamma secretase inhibitor				EMDBio	97.26	BRD-K02950022-001-02-9	Phase 1
BMS-309403	fatty acid binding protein inhibitor	FABP4			Tocris	96.68	BRD-K87956243-001-01-9	Preclinical
BMS-345541	IKK inhibitor	CHUK, IKBKB			Selleck, Tocris	96.97	BRD-K13566078-001-02-3, BRD-K13566078-003-06-0	Preclinical
BMS-387032	CDK inhibitor, cell cycle inhibitor, MCL1 inhibitor	CDK2, CDK7, CDK9			Selleck, Selleck	92.86	BRD-K43389698-001-09-9, BRD-K43389698-001-07-3	Phase 1
BMS-470539	melanocortin receptor agonist	MC1R			Tocris	81.93	BRD-K22000702-300-01-4	Preclinical
BMS-536924	IGF-1 inhibitor	AKT1, CCNE1, CDK2, CYP3A4, ERBB2, IGF1R, KDR, LCK, MAPK1, MET, PDGFRA, PDGFRB			MedChemEx, Tocris	92.53	BRD-K34581968-001-04-6, BRD-K34581968-001-05-3	Preclinical
BMS-566419	inosine monophosphate dehydrogenase inhibitor	IMPDH1, IMPDH2			Tocris	94.41	BRD-K56932272-001-01-1	Preclinical
BMS-587101	integrin antagonist	ITGAL, ITGB2			Key	92.65	BRD-K20093108-001-02-3	Phase 2
BMS-599626	EGFR inhibitor, protein tyrosine kinase inhibitor	EGFR, ERBB2, ERBB4			Selleck, Tocris	97.06	BRD-K07106112-003-03-8, BRD-K07106112-300-01-2	Phase 1
BMS-626529	HIV attachment inhibitor				MedChemEx	98.85	BRD-K97883416-001-01-4	Phase 3
BMS-649	retinoid receptor agonist	RXRA			Tocris, Tocris	99.1	BRD-K25991633-001-01-9, BRD-K25991633-001-02-7	Preclinical
BMS-688521	leukocyte function-associated antigen receptor antagonist, ICAM1 antagonist	ICAM1			Key	99.64	BRD-K85649978-001-02-1	Preclinical
BMS-690514	EGFR inhibitor, VEGFR inhibitor	EGFR, ERBB2, FLT3, KDR			MedChemEx, MedChemEx	94.59	BRD-K76239644-001-02-6, BRD-K76239644-001-01-8	Phase 2
BMS-707035	HIV integrase inhibitor				Selleck	96.62	BRD-K49555808-001-03-9	Phase 2
BMS-754807	IGF-1 inhibitor	AKT1, IGF1R			MedChemEx, Selleck, Selleck	96.93	BRD-K13049116-001-04-0, BRD-K13049116-001-03-2, BRD-K13049116-001-05-7	Phase 2
BMS-777607	AXL kinase inhibitor, c-Met inhibitor, FLT3 inhibitor, hepatocyte growth factor receptor inhibitor, macrophage migration inhibiting factor inhibitor, tyrosine kinase inhibitor	AXL, MERTK, MET, MST1R, TYRO3			Selleck	98.03	BRD-K40738845-001-05-0	Phase 1/Phase 2
BMS-806	HIV attachment inhibitor				Selleck, Selleck	97.42	BRD-K55773932-001-03-8, BRD-K55773932-001-02-0	Phase 1
BMS-817378	c-Met inhibitor, VEGFR inhibitor	KDR, MET			MedChemEx	96.68	BRD-K81026553-234-01-8	Phase 1
BMS-833923	smoothened receptor antagonist	SMO			MedChemEx, Selleck, Selleck	94.83	BRD-K33245965-001-03-4, BRD-K33245965-001-01-8, BRD-K33245965-001-02-6	Phase 2
BMS-863233	CDC inhibitor	CDC7, PIM1			MedChemEx, MedChemEx	89	BRD-K12511835-003-01-2, BRD-K12511835-003-02-0	Phase 1/Phase 2
BMS-927711	calcitonin antagonist	CALCA			MedChemEx	95.12	BRD-K55781385-001-01-7	Phase 2
BMS-983970	notch signaling inhibitor				MedChemEx	96.07	BRD-K22316123-001-01-9	Phase 1
BMS-986020	lysophosphatidic acid receptor antagonist	LPAR1			MedChemEx, MedChemEx, MedChemEx	96.92	BRD-K23952234-236-02-6, BRD-K23952234-236-03-4, BRD-K23952234-236-01-8	Phase 2
BMY-14802	sigma receptor antagonist	HTR1A			Tocris	95.41	BRD-A15435692-003-02-3	Phase 2
BMY-45778	IP1 prostacyclin receptor agonist	PTGIR			Tocris	87.31	BRD-K84895041-001-02-4	Preclinical
BMY-7378	adrenergic receptor antagonist, serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA1D, HTR1A			Selleck, Tocris	97.28	BRD-K31054881-300-03-9, BRD-K31054881-300-04-7	Preclinical
BNC105	tubulin polymerization inhibitor				MedChemEx, MedChemEx	94.71	BRD-K20468903-001-01-6, BRD-K20468903-001-02-4	Phase 2
BNTX	opioid receptor antagonist	OPRD1, OPRK1, OPRM1			Tocris, Tocris, Tocris	94.95	BRD-A55484088-050-03-3, BRD-A55484088-050-04-1, BRD-A55484088-050-02-5	Preclinical
boceprevir	HCV inhibitor	CMA1, CTSA, CTSF, CTSK, CTSL, CTSS	infectious disease	hepatitis C	MedChemEx, MedChemEx, MedChemEx	82.09	BRD-A09735281-001-03-3, BRD-A09735281-001-02-5, BRD-A09735281-001-04-1	Launched
bonaphthone					Vitas-M, AMS	14.06	BRD-K34149328-001-01-3, BRD-K34149328-001-02-1	Phase 3
bopindolol	adrenergic receptor antagonist	ADRB1, ADRB2, ADRB3, HTR1A, HTR1B	cardiology	hypertension, coronary artery disease (CAD)	Enzo	91.96	BRD-A07563059-035-01-3	Launched
bornyl-acetate					Vitas-M, MicroSource	0	BRD-A41385909-001-02-1, BRD-A41385909-001-01-3	Preclinical
boronophenylalanine					Sigma, Acros	99.4	BRD-K50122911-001-01-2, BRD-K50122911-001-02-0	Phase 2
bortezomib	NFkB pathway inhibitor, proteasome inhibitor	PSMA1, PSMA2, PSMA3, PSMA4, PSMA5, PSMA6, PSMA7, PSMA8, PSMB1, PSMB10, PSMB11, PSMB2, PSMB3, PSMB4, PSMB5, PSMB6, PSMB7, PSMB8, PSMB9, PSMD1, PSMD2, RELA	hematologic malignancy	multiple myeloma, mantle cell lymphoma (MCL)	MedChemEx, Selleck, Selleck, Selleck, Selleck	97.62	BRD-K88510285-001-18-6, BRD-K88510285-001-17-8, BRD-K88510285-001-25-1, BRD-K88510285-001-22-8, BRD-K88510285-001-11-1	Launched
bosentan	endothelin receptor antagonist	EDNRA, EDNRB	pulmonary	pulmonary arterial hypertension (PAH)	Selleck	97.9	BRD-K74763371-002-04-0	Launched
bosutinib	Abl kinase inhibitor, Bcr-Abl kinase inhibitor, src inhibitor	ABL1, BCR, CAMK1D, CAMK2G, CDK2, FRK, FYN, HCK, LYN, MAP2K1, MAP2K2, MAP3K2, MAP4K5, SRC, STK10, STK24, STK4, TNK2, TXK	hematologic malignancy	chronic myeloid leukemia (CML)	Selleck, Tocris	99.19	BRD-K99964838-001-11-9, BRD-K99964838-001-12-7	Launched
BP-554	serotonin receptor agonist	HTR1A			Tocris, Tocris	94.12	BRD-K45479396-050-02-3, BRD-K45479396-050-01-5	Preclinical
BP-897	dopamine receptor agonist	ADRA1A, ADRA1D, ADRA2A, DRD1, DRD2, DRD3, DRD4, HTR1A, HTR2B			Prestwick	91.72	BRD-K17378184-300-05-9	Phase 2
BQ-123	endothelin receptor antagonist	EDNRA			Selleck	95.45	BRD-A59961917-001-01-0	Phase 2
BQ-788	endothelin receptor antagonist	EDNRB			MedChemEx, MedChemEx	87.22	BRD-K02490038-236-03-8, BRD-K02490038-236-01-2	Phase 1
BQU57	Ras GTPase inhibitor	RALA, RALB			MedChemEx, MedChemEx	91.26	BRD-A40257118-001-02-0, BRD-A40257118-001-01-2	Preclinical
BRD-7389	ribosomal protein inhibitor	RPS6KA1, RPS6KA2, RPS6KA3			Tocris	72.56	BRD-K15107389-001-03-6	Preclinical
BRD-9876	kinesin inhibitor	KIF11			Tocris	90.59	BRD-K89329876-001-07-8	Preclinical
BRD4770	histone lysine methyltransferase inhibitor	EHMT2			MedChemEx, MedChemEx	99.57	BRD-K72264770-001-03-2, BRD-K72264770-001-04-0	Preclinical
brefeldin-a	protein synthesis inhibitor	ARF1, CYTH2			Tocris, Selleck, Tocris	97.85	BRD-K77841042-001-15-8, BRD-K77841042-001-11-7, BRD-K77841042-001-14-1	Preclinical
bremelanotide	melanocortin receptor agonist	MC1R, MC2R, MC3R, MC4R, MC5R			MedChemEx	91.49	BRD-K06328344-015-01-7	Phase 3
brequinar	dihydroorotate dehydrogenase inhibitor	DHODH			EMDBio	98.43	BRD-K96123349-236-02-8	Phase 2
bretazenil	GABA benzodiazepine site receptor partial agonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6			Tocris, Tocris	98.49	BRD-K96936751-001-01-4, BRD-K96936751-001-02-2	Phase 2
bretylium	norepinephrine inhibitor	ATP1A1	cardiology	ventricular arrhythmias, ventricular fibrillation (VF), ventricular tachycardia (VT)	Sigma, MicroSource	49.99	BRD-K49669424-075-19-2, BRD-K49669424-001-01-6	Launched
brexpiprazole	dopamine receptor partial agonist	DRD2	neurology/psychiatry	depression, schizophrenia	MedChemEx	94.37	BRD-K00911143-001-01-9	Launched
briciclib	cyclin D inhibitor	CCND1			MedChemEx	94.31	BRD-K05531427-001-01-7	Phase 1
brigatinib	ALK tyrosine kinase receptor inhibitor, EGFR inhibitor	ALK, EGFR	oncology	non-small cell lung cancer (NSCLC)	MedChemEx, MedChemEx	93.49	BRD-K56981171-001-02-8, BRD-K56981171-001-01-0	Launched
brilliant-green					Acros	90.42	BRD-K60348325-065-09-9	Launched
brimonidine	adrenergic receptor agonist	ADRA2A, ADRA2B, ADRA2C	ophthalmology	intraocular pressure, glaucoma, ocular hypertension	Tocris, Tocris, Tocris, Selleck, Selleck	99	BRD-K68264559-001-14-2, BRD-K68264559-045-02-4, BRD-K68264559-001-13-4, BRD-K68264559-045-03-2, BRD-K68264559-045-04-0	Launched
brinzolamide	carbonic anhydrase inhibitor	CA1, CA12, CA14, CA2, CA4, CA5A, CA7	ophthalmology	intraocular pressure, glaucoma, ocular hypertension	MicroSource, Selleck, Selleck	99.04	BRD-K74913225-001-14-0, BRD-K74913225-001-12-4, BRD-K74913225-001-13-2	Launched
brivanib	FGFR inhibitor, VEGFR inhibitor	CYP3A4, FGFR1, FLT1, KCNH2, KDR			Selleck	97.4	BRD-K28428262-001-04-1	Phase 3
brivanib-alaninate	FGFR inhibitor, VEGFR inhibitor	FGFR3			Selleck, MedChemEx, Selleck	73.46	BRD-K57187269-001-03-2, BRD-K57187269-001-04-0, BRD-K57187269-001-02-4	Phase 3
brivaracetam	voltage-gated sodium channel blocker	SV2A	neurology/psychiatry	seizures	MedChemEx, MedChemEx	94.2	BRD-K00634421-001-02-8, BRD-K00634421-001-01-0	Launched
brivudine	DNA directed DNA polymerase inhibitor		infectious disease	shingles	TCI	95.52	BRD-A63675168-001-01-6	Launched
BRL-15572	serotonin receptor antagonist	HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR6			Selleck, Selleck, Tocris	98.84	BRD-A51829654-300-03-6, BRD-A51829654-300-02-8, BRD-A51829654-003-07-7	Preclinical
BRL-26314	cholesterol inhibitor	LPL			Sigma	97.68	BRD-A57806482-001-01-4	Phase 1
BRL-37344	adrenergic receptor agonist	ADRB1, ADRB2, ADRB3			Tocris, Tocris	92.21	BRD-K07507905-236-03-4, BRD-K07507905-236-02-6	Phase 2
BRL-44408	adrenergic receptor antagonist	ADRA2A, ADRA2B, ADRA2C			Tocris	12.04	BRD-A67949680-050-01-7	Preclinical
BRL-50481	phosphodiesterase inhibitor	PDE7A, PDE7B			Tocris, Tocris	98.33	BRD-K84266862-001-03-2, BRD-K84266862-001-04-0	Preclinical
BRL-52537	opioid receptor agonist	OPRK1			Tocris	95.52	BRD-A37347161-003-02-6	Preclinical
BRL-54443	serotonin receptor agonist	HTR1E, HTR1F			Selleck, Tocris	96.5	BRD-K17868609-001-04-3, BRD-K17868609-001-05-0	Preclinical
brolitene	muscle relaxant	RYR1			ChemBridge, Vitas-M	0	BRD-K76021681-001-01-4, BRD-K76021681-001-02-2	Launched
bromantan	dopamine reuptake inhibitor, serotonin reuptake inhibitor		neurology/psychiatry	neurasthenia	Enamine, Enamine	86.43	BRD-K86358349-001-01-2, BRD-K86358349-001-02-0	Launched
bromebric-acid	purine antagonist, DNA synthesis inhibitor				Sigma	91.08	BRD-K17874929-236-02-0	Preclinical
bromfenac	cyclooxygenase inhibitor	PTGS1, PTGS2			Selleck	96.65	BRD-K47679368-236-01-7	Withdrawn
bromhexine	mucolytic agent		pulmonary	chest congestion	MicroSource, Selleck	93.96	BRD-K47631482-003-07-0, BRD-K47631482-003-06-2	Launched
bromindione	anticoagulant				MicroSource	0	BRD-K50490982-001-08-2	Phase 2
bromocriptine	dopamine receptor agonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR6, HTR7	endocrinology, neurology/psychiatry	hyperprolactinemia, Parkinson's Disease, acromegaly	Tocris, MicroSource, Tocris	93.48	BRD-K14496212-066-03-0, BRD-K14496212-066-04-8, BRD-K14496212-066-02-2	Launched
bromopride	dopamine receptor antagonist	DRD2	gastroenterology	nausea, vomiting, gastroesophageal reflux disease (GERD)	MicroSource	96.6	BRD-K73642618-001-13-3	Launched
bromosporine	bromodomain inhibitor				Selleck, Tocris	98.35	BRD-K44665581-001-01-8, BRD-K44665581-001-02-6	Preclinical
bromperidol	dopamine receptor antagonist	DRD2	neurology/psychiatry	schizophrenia	MicroSource	98.85	BRD-K78643075-001-11-6	Launched
brompheniramine	histamine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1	allergy, otolaryngology	allergic rhinitis, common cold	MicroSource, Selleck	92.64	BRD-A68723818-050-32-5, BRD-A68723818-050-31-7	Launched
bronopol					MicroSource	0	BRD-K33457401-001-01-1	Launched
bropirimine	interferon inducer				LifeChem	99.22	BRD-K17500877-001-02-1	Phase 3
broxaldine					MicroSource	96.22	BRD-K36222532-001-01-8	Preclinical
broxaterol	adrenergic receptor agonist	ADRB2			Enamine	98.05	BRD-A08316590-001-01-3	Phase 3
broxuridine	antimetabolite				MedChemEx	94.39	BRD-K79095980-001-09-6	Phase 2
broxyquinoline	antiprotozoal agent				MicroSource, Selleck, Selleck	99.49	BRD-K23301018-001-10-9, BRD-K23301018-001-09-1, BRD-K23301018-001-11-7	Phase 1
bruceantin	protein synthesis inhibitor				MedChemEx	87.66	BRD-A36057565-001-01-0	Phase 2
brucine	glycine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5			MicroSource, Selleck, Selleck	95.02	BRD-A41995253-001-04-5, BRD-A41995253-330-01-4, BRD-A41995253-330-02-2	Preclinical
bryostatin-1	protein kinase C inhibitor	PRKCE			EMDBio	0	BRD-K47405978-001-02-5	Phase 2
BS-181	CDK inhibitor	CDK7			Selleck, Selleck, Tocris	96.53	BRD-K31313613-003-05-9, BRD-K31313613-003-04-2, BRD-K31313613-300-01-8	Preclinical
BTB06584	ATPase inhibitor	ATP5F1			Selleck, Selleck	0	BRD-K37933329-001-01-6, BRD-K37933329-001-02-4	Preclinical
BTB1	mitotic kinesin inhibitor	KIF18A			Tocris	95.56	BRD-K89000287-001-01-1	Preclinical
BTS					Tocris, Tocris	98.75	BRD-K64178227-001-10-8, BRD-K64178227-001-09-0	Preclinical
BTS-54505	dopamine reuptake inhibitor	SLC6A2, SLC6A3, SLC6A4			Tocris, Tocris	94.8	BRD-A68304895-003-02-2, BRD-A68304895-003-03-0	Withdrawn
BTS-72664	GABA receptor antagonist	GABBR1			Key	98.2	BRD-A65793993-001-01-6	Phase 1
BTT-3033	integrin inhibitor	ITGA2, ITGB1			Tocris	98.48	BRD-K01492390-001-01-9	Preclinical
BTZ043-racemate	DPRE1 inhibitor				Selleck	98.56	BRD-A53037217-001-02-0	Preclinical
BU-224	imidazoline receptor ligand	MAOA, MAOB			Tocris	98.23	BRD-K55344148-003-02-6	Preclinical
BU-239	imidazoline receptor ligand, imidazoline receptor agonist				Tocris	95.93	BRD-K11696279-003-02-3	Preclinical
bucetin	analgesic agent				MicroSource	98.09	BRD-A88684804-001-04-3	Withdrawn
bucillamine	immunosuppressant		rheumatology	rheumatoid arthritis	Kemprotec, AKSci	96.91	BRD-K24697665-001-02-2, BRD-K24697665-001-01-4	Launched
bucladesine	adenosine receptor agonist, cAMP stimulant	PRKACA	dermatology	skin ulcer	Tocris, MicroSource, Tocris	98.02	BRD-A94624445-236-18-8, BRD-A15931911-001-03-8, BRD-A94624445-236-17-0	Launched
buclizine	histamine receptor antagonist	CHRM1, HRH1	neurology/psychiatry	migraine headache	Key	99.32	BRD-A91444184-300-01-9	Launched
budesonide	glucocorticoid receptor agonist	NR3C1	gastroenterology	Crohn's disease	Sigma, Selleck, Tocris, MedChemEx, Tocris, MedChemEx, MicroSource, Selleck	54.98	BRD-A34299591-001-25-7, BRD-K90758956-001-02-9, BRD-A34299591-001-27-3, BRD-A34299591-001-28-1, BRD-A34299591-001-22-4, BRD-A34299591-001-26-5, BRD-A34299591-001-29-9, BRD-K90758956-001-03-7	Launched
budipine	glutamate receptor antagonist	GRIN1	neurology/psychiatry	Parkinson's Disease	AQBioPharma	94.36	BRD-K18324993-001-01-6	Launched
bufexamac	cyclooxygenase inhibitor	HDAC10, HDAC6			MicroSource, Selleck	95.88	BRD-K36660044-001-24-2, BRD-K36660044-001-23-4	Withdrawn
buflomedil	adrenergic receptor antagonist, calcium channel blocker	ADRA1A	cardiology	peripheral artery disease (PAD)	Selleck, MicroSource	98.69	BRD-K19462402-003-23-8, BRD-K19462402-003-24-6	Launched
bumetanide	solute carrier family member inhibitor	CFTR, GPR35, SLC12A1, SLC12A2, SLC12A4, SLC12A5	cardiology	edema, congestive heart failure	Tocris, MicroSource, Selleck	99.54	BRD-K38197229-001-31-5, BRD-K38197229-001-29-9, BRD-K38197229-001-28-1	Launched
bunazosin	adrenergic receptor antagonist	ADRA1A	ophthalmology	glaucoma, intraocular pressure	Enamine	97.77	BRD-K35034482-001-01-8	Launched
buparlisib	PI3K inhibitor	PIK3CA, PIK3CG			Selleck, Selleck	98.65	BRD-K42191735-001-08-7, BRD-K42191735-001-05-3	Phase 3
buparvaquone	antiprotozoal agent				MedChemEx	96.77	BRD-A07947329-001-01-4	Launched
buphenine	adrenergic receptor agonist	ADRB2	rheumatology	Raynaud's disease	MedChemEx, MicroSource	89.35	BRD-A36267905-003-19-2, BRD-A36267905-003-18-4	Launched
bupicomide	adrenergic receptor antagonist	ADRB1			Enamine	95.4	BRD-K51700582-001-01-2	Phase 1
bupivacaine	sodium channel blocker	KCNA5, PTGER1, SCN10A, SCN4A	neurology/psychiatry	peripheral nerve block, caudal epidural block, lumbar epidural block	MicroSource, Selleck	98.95	BRD-A01636364-003-15-1, BRD-A01636364-003-14-4	Launched
bupranolol	adrenergic receptor antagonist	ADRB1, ADRB2, ADRB3	cardiology, ophthalmology	hypertension, glaucoma	Enamine, Enamine	96.59	BRD-A48420483-001-01-5, BRD-A48420483-001-02-3	Launched
bupropion	dopamine uptake inhibitor	CHRNA3, SLC6A2, SLC6A3	neurology/psychiatry	depression	MicroSource, Tocris, Selleck	97.76	BRD-A05186015-003-20-6, BRD-A05186015-003-21-4, BRD-A05186015-003-19-8	Launched
buramate	antiepileptic				MicroSource	65.99	BRD-K30360804-001-01-3	Preclinical
buspirone	serotonin receptor agonist	DRD2, HTR1A	neurology/psychiatry	generalized anxiety disorder (GAD)	Tocris, MicroSource, Selleck	99.45	BRD-K93461745-003-24-3, BRD-K93461745-003-25-0, BRD-K93461745-003-23-5	Launched
busulfan	DNA inhibitor		hematologic malignancy	chronic myeloid leukemia (CML)	Selleck, MicroSource, Selleck	89.78	BRD-K23204545-001-18-0, BRD-K23204545-001-16-4, BRD-K23204545-001-15-6	Launched
butabindide	tripeptidyl peptidase inhibitor	TPP2			Tocris	0.47	BRD-K40581315-034-01-5	Preclinical
butacaine	local anesthetic		neurology/psychiatry	local anesthetic	MicroSource, Selleck	95.48	BRD-K99622919-001-23-0, BRD-K99622919-001-22-2	Launched
butaclamol	dopamine receptor antagonist	DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR2A			Enzo	98.69	BRD-K23082237-003-01-5	Phase 2
butalbital	GABA receptor antagonist	CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2	neurology/psychiatry	headache, muscle relaxant	Prestwick	98.11	BRD-K71350836-001-02-4	Launched
butamben	sodium channel blocker				MicroSource	99.12	BRD-K27217864-001-22-3	Withdrawn
butein	EGFR inhibitor, src inhibitor	ACE			Selleck, Selleck	88.13	BRD-K17497770-001-03-6, BRD-K17497770-001-04-4	Preclinical
butenafine	fungal squalene epoxidase inhibitor	SQLE	infectious disease	tinea pedis, tinea cruris, tinea corporis	Selleck	97.73	BRD-K90630139-003-05-9	Launched
buthionine-sulfoximine	glutathione transferase inhibitor	GCLM			Enzo	94.36	BRD-A47706533-001-02-6	Phase 1
butibufen	cyclooxygenase inhibitor				Carbosynth	95.48	BRD-A46136514-001-01-2	Withdrawn
butoconazole	bacterial cell wall synthesis inhibitor		infectious disease	vulvovaginal candidiasis	MicroSource, Selleck	99.34	BRD-A16665823-001-02-0, BRD-A16665823-008-12-4	Launched
butofilolol	adrenergic receptor antagonist				Sigma	96.62	BRD-A27274504-001-01-6	Phase 2
butorphanol-(+)-tartrate	opioid receptor agonist, opioid receptor antagonist	OPRD1, OPRK1, OPRM1	neurology/psychiatry, gastroenterology	muscle pain, headache, abdominal pain	Enzo	97.38	BRD-K42417338-045-01-9	Launched
butyl-paraben	DNA synthesis inhibitor				MicroSource	98.43	BRD-K08287586-001-14-3	Preclinical
butylated-hydroxyanisole	antioxidant				MicroSource	88.92	BRD-K93035859-001-07-6	Preclinical
butylated-hydroxytoluene	carbonic anhydrase inhibitor	CA2			MicroSource	97.99	BRD-K53153417-001-10-4	Phase 1
butylphthalide	potassium channel antagonist	KCNK2	neurology/psychiatry	stroke	MedChemEx	94.43	BRD-A59378440-001-01-3	Launched
butylscopolamine-bromide	cholinergic receptor antagonist		gastroenterology	abdominal pain	Selleck	94.79	BRD-A53951045-004-01-6	Launched
BU226	imidazoline receptor ligand				Tocris	97.75	BRD-K56115039-003-02-1	Preclinical
BVD-523	MAP kinase inhibitor				MedChemEx	99.21	BRD-K28965160-001-01-1	Phase 1/Phase 2
BVT-2733	11-beta hydroxysteroid dehydrogenase inhibitor	HSD17B1			MedChemEx	96.59	BRD-K01742705-001-01-7	Preclinical
BVT-948	tyrosine phosphatase inhibitor	PTPN1, PTPN11, PTPN2			Tocris, Tocris	94.31	BRD-K68567222-001-01-2, BRD-A22713669-001-04-3	Preclinical
BW-A4C	lipoxygenase inhibitor	ALOX5			Sigma	87.05	BRD-K80194255-001-01-9	Phase 1
BW-B70C	lipoxygenase inhibitor	ALOX5			Tocris	51.53	BRD-A55946879-001-03-7	Preclinical
BW-180C	opioid receptor agonist	OPRD1, OPRM1			Enzo	84.55	BRD-K57927309-001-01-7	Phase 2
BW-373U86	opioid receptor agonist	OPRD1			Tocris	96.77	BRD-K74990253-001-02-8	Preclinical
BW-616U	monoamine oxidase inhibitor	MAOA			Enamine	97.3	BRD-K07061232-001-01-8	Preclinical
BW-723C86	serotonin receptor agonist	HTR2A, HTR2B, HTR2C			Tocris, Tocris	88.95	BRD-A17428743-003-10-8, BRD-A17428743-003-09-0	Preclinical
BX-795	IKK inhibitor	CDK2, CHEK1, GSK3B, KDR, PDK1, PDPK1			MedChemEx, Selleck, Selleck, MedChemEx	94.52	BRD-K47983010-001-15-3, BRD-K47983010-001-09-6, BRD-K47983010-001-12-0, BRD-K47983010-001-14-6	Preclinical
BX-912	pyruvate dehydrogenase kinase inhibitor	CDK2, CHEK1, GSK3B, KDR, PDK1, PDPK1			Selleck	95.26	BRD-K49669041-001-08-4	Preclinical
BYK-204165	PARP inhibitor	PARP1			Tocris, Tocris	98.46	BRD-K61665160-001-01-5, BRD-K61665160-001-02-3	Preclinical
C-021	CC chemokine receptor antagonist	CCR4			Tocris	97.39	BRD-K98179423-300-01-3	Preclinical
C-1	protein kinase inhibitor	PRKCA			Tocris, Tocris	98.34	BRD-K72462751-001-03-5, BRD-K72462751-001-02-7	Preclinical
C-751					Key	98.92	BRD-K15337272-001-01-3	Preclinical
cabagin			gastroenterology	dyspepsia	AlfaAesar	0	BRD-K41504985-005-01-5	Launched
cabaletta	pharmacological chaperone				Enzo	97.42	BRD-K54028654-001-02-6	Phase 2
cabazitaxel	microtubule inhibitor	TUBA4A, TUBB, TUBB1	oncology	prostate cancer	Selleck	96.88	BRD-K06858286-001-01-3	Launched
cabergoline	dopamine receptor agonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR7	endocrinology	hyperprolactinemia	Tocris, Enzo	94.48	BRD-K86882815-001-05-7, BRD-K86882815-001-03-2	Launched
cabotegravir	HIV integrase inhibitor				MedChemEx, Selleck	97.41	BRD-K76819217-001-02-2, BRD-K76819217-001-01-4	Phase 2/Phase 3
cabozantinib	RET tyrosine kinase inhibitor, VEGFR inhibitor	KDR, MET	oncology	medullary thyroid cancer (MTC)	Selleck, Tocris	99.07	BRD-K51544265-001-04-2, BRD-K51544265-001-06-7	Launched
CaCCinh-A01	calcium-activated chloride channel inhibitor	CLCA1			Tocris	93.54	BRD-A90751343-001-01-0	Preclinical
cadralazine	adrenergic receptor antagonist		cardiology	hypertension	Key	57.47	BRD-A78134170-001-01-3	Launched
cafestol	pregnane X receptor agonist				Enzo	95.32	BRD-K46741531-001-02-4	Launched
caffeic-acid	HIV integrase inhibitor, lipoxygenase inhibitor, nitric oxide production inhibitor, tumor necrosis factor production inhibitor	ALOX5, MIF			Selleck, Selleck	88.37	BRD-K09900591-001-26-7, BRD-K09900591-001-25-9	Preclinical
caffeic-acid-phenethyl-ester	HIV integrase inhibitor	RELA			Tocris, Selleck	96.26	BRD-K96188950-001-16-9, BRD-K96188950-001-15-1	Preclinical
caffeine	adenosine receptor antagonist, phosphodiesterase inhibitor	ADORA1, ADORA2A, ADORA2B, ADORA3, ATM, ITPR1, ITPR2, ITPR3, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PDE6A, PDE6B, PDE6C, PDE7A, PDE7B, PDE8A, PDE8B, PDE9A, PIK3CA, PIK3CB, PIK3CD, PRKDC, RYR1, RYR2, RYR3	neurology/psychiatry	fatigue, drowsiness, fatigue, drowsiness	MicroSource	99.15	BRD-K02404261-001-16-7	Launched
calcifediol	vitamin D receptor agonist	VDR			Adooq, MedChemEx, Selleck, Selleck	93.33	BRD-K77175907-001-08-0, BRD-K77175907-002-01-3, BRD-K77175907-001-06-4, BRD-K77175907-001-10-6	Launched
calcipotriol	vitamin D receptor agonist	VDR	dermatology	psoriasis	Tocris, MedChemEx, MedChemEx	92.24	BRD-K56429665-001-07-0, BRD-K56429665-001-09-6, BRD-K56429665-002-01-1	Launched
calcitriol	vitamin D receptor agonist	VDR	endocrinology, orthopedics	hypocalcemia, hypoparathyroidism, osteoporosis	Selleck, Selleck, Selleck	96.4	BRD-K27316855-001-13-3, BRD-K27316855-001-15-8, BRD-K27316855-001-19-0	Launched
calcium-gluceptate					MicroSource, Selleck	100	BRD-K35952844-238-02-0, BRD-K35952844-238-01-2	Launched
calcium-levofolinate					Selleck, Selleck	100	BRD-K97009491-238-03-8, BRD-K97009491-238-02-0	Launched
Calhex-231	calcium sensing receptor negative allosteric modulator	CASR			Tocris	93.49	BRD-K19811997-003-01-3	Preclinical
calpeptin	calpain inhibitor				Tocris, Tocris	79.34	BRD-K26134695-001-04-4, BRD-K26134695-001-03-6	Preclinical
camicinal	motilin receptor agonist	MLNR			MedChemEx	85.54	BRD-K23248433-001-01-8	Phase 2
CaMKII-IN-1	calcium/calmodulin dependent protein kinase inhibitor	AKT1, CAMK2A, CAMK4, MYLK			MedChemEx, MedChemEx	96.28	BRD-K35772771-001-02-1, BRD-K35772771-001-01-3	Preclinical
camostat-mesilate	protease inhibitor	PRSS1	gastroenterology	pancreatitis	Tocris, Selleck	96.31	BRD-K43806473-066-03-9, BRD-K43806473-066-02-1	Launched
camphor-(+)		TRPV1			MedChemEx	0	BRD-K10034334-001-03-3	Phase 2
camphor-(1r)	TRPV activator				MicroSource	0	BRD-K15714472-001-04-5	Phase 1
camptothecin	topoisomerase inhibitor	TOP1			Selleck, Selleck, Tocris	89.88	BRD-K37890730-001-17-7, BRD-K37890730-001-15-1, BRD-K37890730-001-16-9	Phase 3
camylofine-chlorhydrate			gastroenterology	abdominal pain	Selleck, MicroSource, Selleck	96.03	BRD-A91733352-300-03-7, BRD-A91733352-300-04-5, BRD-A91733352-300-05-2	Launched
canagliflozin	sodium/glucose cotransporter inhibitor	SLC5A1, SLC5A2	endocrinology	diabetes mellitus	MicroSource, Selleck	98.9	BRD-K90868879-001-03-8, BRD-K90868879-001-02-0	Launched
candesartan	angiotensin receptor antagonist	AGTR1	cardiology	hypertension, congestive heart failure	Tocris, Selleck, MicroSource	98.75	BRD-K84091759-001-10-5, BRD-K84091759-001-07-1, BRD-K84091759-001-08-9	Launched
candesartan-cilextil	angiotensin receptor antagonist	AGTR1, AGTR2	cardiology	hypertension, congestive heart failure	MicroSource, Selleck	98.51	BRD-A65671304-001-08-3, BRD-A65671304-001-07-5	Launched
candicidin	fungal ergosterol inhibitor		infectious disease	vulvovaginal candidiasis	MicroSource	0	BRD-A37348498-015-01-4	Launched
canertinib	EGFR inhibitor	AKT1, EGFR, ERBB2, ERBB4			Selleck	95.13	BRD-K50168500-001-07-9	Phase 3
canrenone	mineralocorticoid receptor antagonist	NR3C2			MicroSource	82.77	BRD-A20644369-001-08-6	Withdrawn
cantharidin	protein phosphatase inhibitor		dermatology	blisters	MedChemEx, MedChemEx, Sigma, Tocris	47.3	BRD-K80684056-001-09-3, BRD-K80684056-001-06-9, BRD-K80684056-001-05-1, BRD-K80684056-001-04-4	Launched
capadenoson	adenosine receptor agonist	ADORA1			MedChemEx	99.55	BRD-K97025174-001-01-4	Phase 2
capecitabine	DNA synthesis inhibitor, thymidylate synthase inhibitor	TYMS	oncology	breast cancer, colorectal cancer	Selleck, Tocris, Selleck, MicroSource	97.88	BRD-K61192372-001-05-5, BRD-K61192372-001-06-3, BRD-K61192372-001-07-1, BRD-K61192372-001-08-9	Launched
capobenic-acid					MicroSource	52.98	BRD-K04282412-001-16-3	Preclinical
capreomycin	protein synthesis inhibitor		infectious disease	tuberculosis	MicroSource, MedChemEx	100	BRD-A33801468-065-04-1, BRD-A31362467-065-01-3	Launched
caprylic-acid					Enamine, Enamine	8.98	BRD-K35170555-001-09-5, BRD-K35170555-001-12-9	Launched
capsaicin	TRPV agonist	CFTR, TRPV1	neurology/psychiatry, rheumatology	muscle pain, rheumatoid arthritis	Tocris, MicroSource	95.04	BRD-K50590187-001-19-9, BRD-K50590187-001-20-7	Launched
capsazepine	TRPV agonist	TRPV1, TRPV4			Tocris, Tocris	92.83	BRD-K44849676-001-11-3, BRD-K44849676-001-10-5	Preclinical
captamine					MicroSource	0	BRD-K81645907-001-01-1	Preclinical
captan					AKSci	0	BRD-A79857384-001-03-6	Phase 1
captopril	angiotensin converting enzyme inhibitor	ACE, LTA4H, MMP2, MMP9	cardiology, endocrinology, nephrology	hypertension, congestive heart failure, myocardial infarction, diabetes mellitus, diabetic nephropathy	MicroSource, Selleck, Selleck	100	BRD-K54529596-001-25-5, BRD-K54529596-001-26-3, BRD-K54529596-001-28-9	Launched
caracemide	ribonucleotide reductase inhibitor	RRM1			Enamine	0	BRD-K62790656-001-01-1	Phase 2
caramiphen	cholinergic receptor antagonist	CHRM1, CHRM2	neurology/psychiatry	Parkinson's Disease	ChemDiv	87.71	BRD-K59895502-001-01-9	Launched
carazolol	adrenergic receptor antagonist	ADRB1, ADRB2, ADRB3	cardiology	angina pectoris, cardiac arrythmia, hypertension, myocardial infarction	Cayman	95.74	BRD-A50675490-001-01-0	Launched
carbachol	cholinergic receptor agonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA2	ophthalmology	intraocular pressure	MicroSource, Selleck	100	BRD-K75037734-003-14-7, BRD-K75037734-003-13-9	Launched
carbadox	other antibiotic		infectious disease, gastroenterology	dysentry, enteritis	MicroSource, Selleck, Selleck	99.18	BRD-K56735750-001-06-8, BRD-K56735750-001-09-2, BRD-K56735750-001-07-6	Launched
carbamazepine	carboxamide antiepileptic	SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	neurology/psychiatry	seizures	Tocris, MicroSource, Selleck	99.2	BRD-K71799949-001-38-0, BRD-K71799949-001-36-4, BRD-K71799949-001-35-6	Launched
carbaril	acetylcholinesterase inhibitor				MicroSource	54.75	BRD-K54208592-001-09-4	Launched
carbarsone	antiprotozoal agent		infectious disease	amebiasis	MicroSource	69.44	BRD-K94848716-001-11-6	Launched
carbazochrome			hematology	hemorrhage	Selleck	93.38	BRD-A11070335-236-02-1	Launched
carbendazim	microtubule inhibitor, tubulin polymerization inhibitor	TP53, TUBB	infectious disease	fungicide	Sigma	98.32	BRD-K12906202-001-06-2	Launched
carbenicillin	bacterial cell wall synthesis inhibitor		infectious disease	gram-negative bacterial infections	MedChemEx, MicroSource, Selleck, MedChemEx, Selleck	0	BRD-A13078313-304-09-9, BRD-A13078313-304-06-5, BRD-A13078313-304-05-7, BRD-A13078313-304-08-1, BRD-A13078313-304-07-3	Launched
carbenoxolone	11-beta hydroxysteroid dehydrogenase inhibitor	GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1, HSD11B1, PANX1, PANX2, PANX3	gastroenterology, dental	peptic ulcer disease (PUD), mouth inflammation	Selleck, MicroSource, Selleck	94.39	BRD-A29700858-304-03-4, BRD-A29700858-304-02-6, BRD-A29700858-304-01-8	Launched
carbetapentane	acetylcholine receptor antagonist	CHRM2	otolaryngology, pulmonary	common cold, nasal congestion, bronchitis	Tocris, MicroSource	93.21	BRD-K06181161-048-15-1, BRD-K06181161-048-16-9	Launched
carbetocin	oxytocin receptor agonist	OXTR	hematology	hemorrhage	MedChemEx	93.12	BRD-K56107812-001-01-7	Launched
carbidopa	aromatic L-amino acid decarboxylase inhibitor	DDC	neurology/psychiatry	Parkinson's Disease	Selleck, MedChemEx, Selleck, MedChemEx, Tocris, MicroSource	63.9	BRD-K78712176-001-14-1, BRD-A69512159-001-07-3, BRD-K78712176-001-11-7, BRD-K78712176-001-15-8, BRD-K78712176-001-12-5, BRD-K78712176-001-13-3	Launched
carbimazole	antithyroid agent	TPO	endocrinology	hyperthyroidism	Selleck, MicroSource, Selleck	86.2	BRD-K87156652-001-11-9, BRD-K87156652-001-12-7, BRD-K87156652-001-13-5	Launched
carbinoxamine	histamine receptor antagonist	HRH1	allergy, ophthalmology, otolaryngology, dermatology	allergic rhinitis, conjunctivitis, vasomotor rhinitis, dermatographism	MicroSource	98.35	BRD-A29426959-050-13-2	Launched
carboplatin	DNA alkylating agent, DNA inhibitor		oncology	ovarian cancer	Selleck, Tocris, MicroSource, Selleck	0	BRD-K90947825-001-05-0, BRD-K90947825-001-02-7, BRD-K90947825-001-03-5, BRD-K90947825-001-04-3	Launched
carboxyamidotriazole	calcium channel blocker	CXCL8			Sigma	99.81	BRD-K68408772-001-05-4	Phase 3
carboxylosartan	angiotensin antagonist	AGTR1			Cayman	98.87	BRD-K23533833-001-01-9	Phase 1
carboxypyridine-disulfide					Sigma	98.3	BRD-K26530649-001-01-6	Phase 2
cardiogenol-c	cardiomyogenesis inducer				Tocris, Tocris	95.96	BRD-K99174507-003-02-0, BRD-K99174507-003-03-8	Preclinical
cardionogen-1	WNT signaling inhibitor	CTNNB1			Tocris	91.85	BRD-K50905564-001-07-7	Preclinical
carebastine	histamine receptor antagonist	HRH1			ChemImpex	98.51	BRD-K49554218-001-01-0	Phase 1
carfilzomib	proteasome inhibitor	PSMA1, PSMA2, PSMA3, PSMA4, PSMA5, PSMA6, PSMA7, PSMA8, PSMB1, PSMB10, PSMB11, PSMB2, PSMB3, PSMB4, PSMB5, PSMB6, PSMB7, PSMB8, PSMB9	hematologic malignancy	multiple myeloma	Selleck	95.76	BRD-K15179879-001-03-2	Launched
carglumic-acid	carbamoyl phosphate synthase activator	CPS1	metabolism	hyperammonemia	MicroSource	100	BRD-K60240222-001-01-4	Launched
caricotamide	NADPH quinone oxidoreductase inhibitor	NQO2			Enamine	0	BRD-K90215590-001-01-4	Phase 2
cariporide	sodium/hydrogen exchanger inhibitor	SLC9A1			SantaCruz	97.4	BRD-K21670884-001-01-9	Phase 3
cariprazine	dopamine receptor antagonist	DRD2, DRD3	neurology/psychiatry	schizophrenia	MedChemEx	97.64	BRD-K57764956-001-02-8	Launched
carisoprodol	acetylcholine receptor antagonist	CYP2C19	neurology/psychiatry	muscle relaxant	MicroSource	100	BRD-A99939097-001-24-2	Launched
carmofur	thymidylate synthase inhibitor	TYMS	oncology	breast cancer, colorectal cancer	Selleck, MicroSource, Selleck	86.52	BRD-K11630072-001-13-2, BRD-K11630072-001-12-4, BRD-K11630072-001-11-6	Launched
carmoterol	adrenergic receptor agonist	ADRB2			BidePharm	24.66	BRD-K25095405-001-01-5	Phase 2
carmoxirole	dopamine receptor agonist	DRD2			Tocris, Tocris	91.82	BRD-K82484965-003-03-5, BRD-K82484965-003-04-3	Phase 2
carmustine	DNA alkylating agent, DNA inhibitor	GSR	hematologic malignancy, oncology	non-Hodgkin lymphoma (NHL), Hodgkin's lymphoma, multiple myeloma, glioblastoma, brainstem glioma, medulloblastoma, astrocytoma, ependymoma	MicroSource	0	BRD-K36234266-001-09-8	Launched
carnitine-(D/L)					MicroSource, Selleck	100	BRD-A89594340-003-12-3, BRD-A89594340-003-11-5	Phase 3
carnosine	antiglycating agent				SantaCruz	0	BRD-A96051074-001-02-2	Phase 2
caroverine	glutamate receptor antagonist, calcium channel blocker		neurology/psychiatry	tinnitus	Sigma	86.74	BRD-K65900713-003-01-0	Launched
caroxazone	monoamine oxidase inhibitor	MAOA, MAOB			Enamine	97.63	BRD-K92129045-001-01-6	Withdrawn
carprofen	cyclooxygenase inhibitor	PTGS1, PTGS2	rheumatology	osteoarthritis	Selleck, MicroSource	98.54	BRD-A17411484-001-10-1, BRD-A17411484-001-11-9	Launched
carsalam	analgesic agent				MicroSource	99.02	BRD-K13238618-001-05-9	Preclinical
carteolol	adrenergic receptor antagonist	ADRB1, ADRB2	ophthalmology	intraocular pressure, glaucoma, ocular hypertension	MedChemEx	98.62	BRD-A42167015-003-10-2	Launched
carumonam	bacterial cell wall synthesis inhibitor		infectious disease	urinary tract infections, gram-negative bacterial infections	Sigma	97.4	BRD-K71026158-304-01-0	Launched
carvedilol	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, GJA1, HIF1A, KCNH2, NDUFC2, NPPB, SELE, VCAM1, VEGFA	cardiology	myocardial infarction, hypertension	Tocris, MicroSource, MicroSource, Tocris, Selleck	93.97	BRD-A10977446-001-17-0, BRD-A10977446-001-14-7, BRD-A10977446-011-01-3, BRD-A10977446-001-13-9, BRD-A10977446-001-12-1	Launched
carzenide		CA1, CA12, CA14, CA2, CA6, CA9			MicroSource	92.92	BRD-K09295674-001-09-8	Preclinical
casanthranol-variant					MicroSource	0	BRD-K12413266-001-01-3	Launched
casin	GTPase inhibitor	CDC42			Tocris	87.75	BRD-A25043798-001-01-2	Preclinical
caspofungin	fungal 1,3-beta-D-glucan synthase inhibitor, bacterial cell wall synthesis inhibitor		infectious disease	candidemia, esophageal candidiasis, aspergillosis, fungal infection	MedChemEx, MedChemEx	51.17	BRD-A31685486-402-01-9, BRD-A31685486-402-02-7	Launched
caspofungin-acetate	fungal 1,3-beta-D-glucan synthase inhibitor		infectious disease	candidemia, esophageal candidiasis, aspergillosis, peritonitis	Selleck, Selleck	79.25	BRD-K49793107-402-03-4, BRD-K49793107-402-02-6	Launched
castanospermine	glucosidase inhibitor	GAA, GBA			Tocris, Tocris	100	BRD-K20897876-001-11-8, BRD-K20897876-001-10-0	Phase 2
catharanthine	tubulin polymerization inhibitor				Selleck, Selleck	82.42	BRD-K92377961-001-03-7, BRD-K92377961-001-02-9	Preclinical
cathepsin-inhibitor-1	cathepsin inhibitor	CTSB, CTSL, CTSV			Selleck	97.25	BRD-K40269473-001-02-2	Preclinical
CAY10505	PI3K inhibitor	PIK3CG			Selleck, Selleck	92.14	BRD-K40366680-001-04-1, BRD-K40366680-001-03-3	Preclinical
CB-03-01	androgen receptor antagonist	AR			MedChemEx, MedChemEx	85.47	BRD-K41779183-001-01-2, BRD-K41779183-001-02-0	Phase 3
CB-10-277	DNA synthesis inhibitor				Vitas-M	99.53	BRD-K59929863-001-01-9	Phase 1
CB-5083	valosin-containing protein inhibitor	VCP			MedChemEx, ApexBio	96.62	BRD-K49048664-001-02-0, BRD-K49048664-001-01-2	Phase 1
CB-839	glutaminase inhibitor	GLS			Broad Institute, MedChemEx	94.65	BRD-K58070273-001-03-3, BRD-K58070273-001-04-1	Phase 1/Phase 2
CBiPES	glutamate receptor positive allosteric modulator	GRM2			Tocris	98.08	BRD-K34675210-003-01-4	Preclinical
CBS,-N-Cyclohexyl-2-benzothiazolesulfenamide					AKSci	98.95	BRD-K64191834-001-03-1	Preclinical
CBS-1114	lipoxygenase inhibitor	ALOX5			Vitas-M	50.58	BRD-K91874254-001-01-4	Phase 1
CC-115	mTOR inhibitor, DNA protein kinase inhibitor	MTOR			MedChemEx, MedChemEx, MedChemEx	93.43	BRD-K16755045-003-01-7, BRD-K16755045-001-01-1, BRD-K16755045-003-02-5	Phase 1
CC-223	mTOR inhibitor	MTOR			MedChemEx, MedChemEx	84.46	BRD-K88737571-001-02-2, BRD-K88737571-001-01-4	Phase 1/Phase 2
CC-401	JNK inhibitor	MAPK8			MedChemEx	96.72	BRD-K45746021-003-01-9	Phase 1
CC-930	JNK inhibitor				MedChemEx	94.72	BRD-K48213016-001-01-8	Phase 2
CCG-1423	apoptosis stimulant	RHOC, SRF			Tocris	87.77	BRD-A79726147-001-01-5	Preclinical
CCG-50014	G protein signaling inhibitor	RGS4, RGS8			Tocris, Selleck, Selleck	97.23	BRD-K08893438-001-06-4, BRD-K08893438-001-04-9, BRD-K08893438-001-03-1	Preclinical
CCG-63802	G protein signaling inhibitor	RGS4			MedChemEx, MedChemEx	3.27	BRD-K26970495-001-02-7, BRD-K26970495-001-01-9	Preclinical
CCG-63808	G protein signaling inhibitor	RGS4			MedChemEx, MedChemEx	8.02	BRD-K68474505-001-02-7, BRD-K68474505-001-01-9	Preclinical
CCMI	acetylcholine receptor allosteric modulator	CHRNA7			Tocris, Tocris	93.64	BRD-K16338837-001-01-8, BRD-K16338837-001-02-6	Preclinical
CCMQ	homoquinolinic acid binding inhibitor				Tocris	65.42	BRD-K06159959-001-02-0	Preclinical
CCT-031374	WNT signaling inhibitor	CTNNB1			Tocris	89.63	BRD-K90999434-004-01-7	Preclinical
CCT018159	HSP inhibitor	HSP90AA1, HSP90AB1			Tocris, Tocris	96.84	BRD-K65503129-001-06-3, BRD-K65503129-001-07-1	Preclinical
CCT128930	AKT inhibitor	PKIA, PRKACA			Selleck	96.82	BRD-K76406695-001-02-9	Preclinical
CCT129202	Aurora kinase inhibitor	AURKA, AURKB, AURKC			Selleck, Selleck	82.82	BRD-K57136142-001-03-2, BRD-K57136142-001-02-4	Preclinical
CCT137690	Aurora kinase inhibitor	AURKA, AURKB, AURKC			Selleck, Selleck, Tocris	97.74	BRD-K03289018-001-02-7, BRD-K03289018-001-03-5, BRD-K03289018-001-04-3	Preclinical
CC4	nicotinic receptor agonist	CHRNB2			Tocris	82.66	BRD-K17751100-001-01-1	Preclinical
CD-1530	retinoid receptor agonist	RARG			Tocris	92.54	BRD-K09619322-001-03-8	Preclinical
CD-437	retinoid receptor agonist	RARG			Tocris, Tocris	94.37	BRD-K28907958-001-05-0, BRD-K28907958-001-04-3	Preclinical
CDBA					EMDBio	97.04	BRD-A08079565-001-01-8	Phase 3
CDK1-5-inhibitor	CDK inhibitor, glycogen synthase kinase inhibitor	CDK1, CDK5, GSK3B			Tocris	97.23	BRD-K87932577-001-02-4	Preclinical
CDK9-IN-6	CDK inhibitor	CDK9			MedChemEx	96.73	BRD-K43914553-001-01-5	Preclinical
CDPPB	glutamate receptor positive allosteric modulator	GRM5			Tocris	96.82	BRD-K02213468-001-02-3	Preclinical
cebranopadol	opioid receptor agonist	OPRL1, OPRM1			MedChemEx	95.64	BRD-K48141473-001-01-7	Phase 3
cediranib	KIT inhibitor, VEGFR inhibitor	CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB			Selleck	90.12	BRD-K86930074-001-05-0	Phase 3
cedrol					Vitas-M	0	BRD-A61188230-001-01-6	Phase 2
cedrol-(+)	sedative				Sigma	0	BRD-K96362839-001-01-9	Phase 2
cefaclor	bacterial cell wall synthesis inhibitor		infectious disease, otolaryngology	pneumonia, skin infections, urinary tract infections, respiratory tract infections, tonsillitis, pharyngitis	Selleck, MicroSource, Selleck	89.07	BRD-K20338176-001-18-5, BRD-K20338176-001-17-7, BRD-K20338176-001-16-9	Launched
cefadroxil	bacterial cell wall synthesis inhibitor	SLC15A1, SLC15A2, SLC22A6, SLC22A8	infectious disease, otolaryngology	urinary tract infections, skin infections, tonsillitis, pharyngitis	MicroSource	87.28	BRD-A56858165-001-04-4	Launched
cefalonium	bacterial cell wall synthesis inhibitor		infectious disease	gram-positive bacterial infections	MicroSource	0	BRD-K15514357-001-05-6	Launched
cefamandole	bacterial cell wall synthesis inhibitor		infectious disease	skin infections, urinary tract infections, respiratory tract infections	Sigma, MicroSource	32.02	BRD-K27130738-236-14-1, BRD-K27130738-236-15-8	Launched
cefamandole-nafate	bacterial cell wall synthesis inhibitor		infectious disease	skin infections, urinary tract infections, respiratory tract infections	MedChemEx, MedChemEx, MicroSource	43.32	BRD-K17903788-236-01-9, BRD-K17903788-236-02-7, BRD-K17903788-236-03-5	Launched
cefathiamidine	bacterial cell wall synthesis inhibitor		infectious disease	gram-positive bacterial infections	AKSci	68.39	BRD-K63835048-001-01-0	Launched
cefazolin	bacterial cell wall synthesis inhibitor	PON1	infectious disease	urinary tract infections, skin infections, bacterial septicemia, endocarditis, surgical prophylaxis, bone and joint infections	MedChemEx, MicroSource, MedChemEx	87.37	BRD-K99750640-236-20-3, BRD-K99750640-236-18-7, BRD-K99750640-236-19-5	Launched
cefcapene-pivoxil	bacterial cell wall synthesis inhibitor		infectious disease	skin infections, pneumonia, urinary tract infections	Sigma, AKSci, Astatech	90.61	BRD-K27515606-311-02-8, BRD-K27515606-311-01-0, BRD-K27515606-003-01-3	Launched
cefdinir	bacterial cell wall synthesis inhibitor	MPO	infectious disease, otolaryngology, pulmonary	pneumonia, tonsillitis, pharyngitis, bronchitis, skin infections, otitis, sinusitis	MicroSource, Selleck, Selleck	87.42	BRD-K15766189-001-09-8, BRD-K15766189-001-10-6, BRD-K15766189-001-08-0	Launched
cefditoren-pivoxil	bacterial cell wall synthesis inhibitor		infectious disease, pulmonary, otolaryngology	pneumonia, bronchitis, skin infections, tonsillitis, pharyngitis	MicroSource, Selleck, Selleck	88.24	BRD-K72167406-001-04-7, BRD-K72167406-001-02-1, BRD-K72167406-001-03-9	Launched
cefepime	bacterial cell wall synthesis inhibitor		infectious disease	pneumonia, urinary tract infections, skin infections, intra-abdominal infections	MicroSource	96.32	BRD-A12077521-003-01-5	Launched
cefetamet	bacterial cell wall synthesis inhibitor		infectious disease, otolaryngology, pulmonary	ear infections, pneumonia, otitis, sinusitis, bronchitis, urinary tract infections	Sigma	91.04	BRD-K27798832-001-01-5	Launched
cefetamet-pivoxil	bacterial cell wall synthesis inhibitor		infectious disease	gram-positive bacterial infections	AvaChem, AKSci, MedChemEx	87.11	BRD-K21372554-001-01-1, BRD-K21372554-003-01-7, BRD-K21372554-003-02-5	Launched
cefixime	bacterial cell wall synthesis inhibitor		infectious disease, otolaryngology, pulmonary	urinary tract infections, otitis, pharyngitis, tonsillitis, gonorrhea, bronchitis	Sigma, MedChemEx, Enzo	93.65	BRD-K71059170-341-02-5, BRD-K71059170-001-12-4, BRD-K71059170-001-11-6	Launched
cefmenoxime	bacterial cell wall synthesis inhibitor		infectious disease	gram-negative bacterial infections	MicroSource	85.33	BRD-A20839672-003-01-5	Launched
cefmetazole	bacterial cell wall synthesis inhibitor		infectious disease	urinary tract infections, skin infections	MedChemEx, MedChemEx, MicroSource	89.48	BRD-K48470486-236-11-6, BRD-K48470486-236-10-8, BRD-K48470486-236-12-4	Launched
cefminox	bacterial cell wall synthesis inhibitor		infectious disease	gram-negative bacterial infections	Key	83.7	BRD-K77073709-435-01-2	Launched
cefodizime	bacterial cell wall synthesis inhibitor		infectious disease	respiratory tract infections, skin infections, gonorrhea	AKSci, Kemprotec	73.75	BRD-K22641081-001-01-0, BRD-K22641081-304-01-8	Launched
cefonicid	bacterial cell wall synthesis inhibitor		infectious disease	gram-positive bacterial infections	MicroSource, MedChemEx, MedChemEx	83.1	BRD-K34058848-304-03-1, BRD-K34058848-304-02-3, BRD-K34058848-304-01-5	Launched
cefoperazone	bacterial cell wall synthesis inhibitor		infectious disease	gram-negative bacterial infections	MicroSource, Selleck	95.7	BRD-K02292852-001-04-7, BRD-K02292852-001-02-1	Launched
ceforanide	penicillin binding protein inhibitor		infectious disease	gram-negative bacterial infections	MicroSource, AvaChem	90.8	BRD-K37848908-001-06-4, BRD-K37848908-001-05-6	Launched
cefoselis	bacterial cell wall synthesis inhibitor				Selleck, MedChemEx, AKSci, Selleck	99.54	BRD-K72339976-065-03-9, BRD-K72339976-065-01-3, BRD-K72339976-065-04-7, BRD-K72339976-065-02-1	Launched
cefotaxime	bacterial cell wall synthesis inhibitor		infectious disease	respiratory tract infections, bone and joint infections, pelvic inflammatory disease, intra-abdominal infections, skin infections, bone and joint infections, meningitis, urinary tract infections, bacterial septicemia, gynecologic infections	MedChemEx, MicroSource, MedChemEx, Sigma	95.77	BRD-K78364995-236-18-3, BRD-K78364995-236-19-1, BRD-K78364995-236-17-5, BRD-K78364995-236-16-7	Launched
cefotetan	bacterial cell wall synthesis inhibitor		infectious disease	urinary tract infections, respiratory tract infections, skin infections, gynecologic infections, chlamydia, intra-abdominal infections, bone and joint infections, surgical prophylaxis	MicroSource	88.4	BRD-A78723049-001-01-2	Launched
cefotiam	bacterial cell wall synthesis inhibitor		infectious disease	bacterial septicemia, bone and joint infections, respiratory tract infections, skin infections, urinary tract infections	Prestwick, MedChemEx	88.63	BRD-K02275692-300-01-8, BRD-K02275692-300-02-6	Launched
cefotiam-cilexetil	bacterial cell wall synthesis inhibitor				SantaCruz, SantaCruz	23.99	BRD-A76661185-300-02-4, BRD-A76661185-300-01-6	Launched
cefoxitin	bacterial cell wall synthesis inhibitor		infectious disease	respiratory tract infections, urinary tract infections, intra-abdominal infections, gynecologic infections, bacterial septicemia, bone and joint infections, skin infections	MedChemEx, MedChemEx, MicroSource	98.36	BRD-K70976396-236-27-8, BRD-K70976396-236-26-0, BRD-K70976396-236-25-2	Launched
cefozopran	bacterial cell wall synthesis inhibitor				MedChemEx	90.83	BRD-K46970505-003-01-9	Launched
cefpiramide	bacterial cell wall synthesis inhibitor		infectious disease	gram-negative bacterial infections	MicroSource, Sigma, MedChemEx	86.38	BRD-K92872987-001-02-9, BRD-K92872987-001-01-1, BRD-K92872987-236-03-9	Launched
cefpirome	bacterial cell wall synthesis inhibitor		infectious disease	gram-negative bacterial infections	ChemImpex	91.01	BRD-K56542719-065-01-4	Launched
cefpodoxime	bacterial cell wall synthesis inhibitor		otolaryngology, infectious disease, pulmonary	pharyngitis, pneumonia, bronchitis, gonorrhea, skin infections, urinary tract infections, sinusitis, tonsillitis	Key, MicroSource	49.13	BRD-A34205213-001-03-9, BRD-A34205213-001-04-7	Launched
cefprozil	bacterial cell wall synthesis inhibitor		otolaryngology, infectious disease, pulmonary	pharyngitis, tonsillitis, otitis, sinusitis, respiratory tract infections, skin infections, bronchitis	MicroSource, Selleck, MedChemEx, Selleck	76.4	BRD-K24871708-001-01-4, BRD-K24871708-002-03-8, BRD-K24871708-002-04-6, BRD-K24871708-002-02-0	Launched
cefradine	bacterial cell wall synthesis inhibitor	CYP3A4	infectious disease, otolaryngology	respiratory tract infections, otitis, skin infections, urinary tract infections, tonsillitis, pharyngitis, pneumonia	MedChemEx, MedChemEx	65.46	BRD-K13797099-001-02-9, BRD-K13797099-001-01-1	Launched
cefsulodin	bacterial cell wall synthesis inhibitor		infectious disease	gram-negative bacterial infections	MedChemEx, MedChemEx, Sigma, MicroSource	29.68	BRD-K03907181-236-06-8, BRD-K03907181-236-05-0, BRD-K03907181-236-04-3, BRD-K03907181-236-07-6	Launched
ceftaroline-fosamil	bacterial cell wall synthesis inhibitor		infectious disease	skin infections, pneumonia	GLSyntech	63.93	BRD-K37252028-349-01-8	Launched
ceftazidime	bacterial cell wall synthesis inhibitor		infectious disease	respiratory tract infections, skin infections, bacterial septicemia, bone and joint infections, gynecologic infections, intra-abdominal infections, meningitis	Sigma, MedChemEx, MicroSource, MedChemEx, Selleck, Selleck	74	BRD-K52117081-345-03-1, BRD-K52117081-001-03-0, BRD-K52117081-396-01-8, BRD-K52117081-001-02-2, BRD-K57502136-345-02-6, BRD-K57502136-345-03-4	Launched
ceftibuten	bacterial cell wall synthesis inhibitor		pulmonary, otolaryngology	bronchitis, otitis, pharyngitis, tonsillitis	MicroSource, MedChemEx, MedChemEx, MedChemEx, Sigma	95.4	BRD-K11124378-001-04-6, BRD-K11124378-335-03-0, BRD-K11124378-335-01-4, BRD-K11124378-335-02-2, BRD-K11124378-002-01-0	Launched
ceftiofur	bacterial cell wall synthesis inhibitor		infectious disease	pneumonia, respiratory tract infections	MicroSource, Selleck, Selleck	93.8	BRD-K82960980-003-01-9, BRD-K82960980-003-03-5, BRD-K82960980-003-02-7	Launched
ceftizoxim	bacterial cell wall synthesis inhibitor		infectious disease	respiratory tract infections, urinary tract infections, gonorrhea, pelvic inflammatory disease, intra-abdominal infections, bacterial septicemia, skin infections, bone and joint infections, meningitis	MedChemEx, MedChemEx, Enzo	88.85	BRD-K04301924-236-03-2, BRD-K04301924-236-02-4, BRD-K04301924-236-01-6	Launched
ceftriaxone	bacterial cell wall synthesis inhibitor		infectious disease, otolaryngology	gonorrhea, pneumonia, otitis, skin infections, urinary tract infections, pelvic inflammatory disease, bacterial septicemia, bone and joint infections, intra-abdominal infections, meningitis, surgical prophylaxis	MicroSource, MedChemEx	85.48	BRD-K96734425-324-01-5, BRD-K96734425-304-01-7	Launched
cefuroxime	bacterial cell wall synthesis inhibitor		infectious disease	gram-negative bacterial infections	MedChemEx, MedChemEx, MicroSource	86.53	BRD-K02733959-236-06-9, BRD-K02733959-236-05-1, BRD-K02733959-236-07-7	Launched
cefuroxime-axetil	bacterial cell wall synthesis inhibitor		otolaryngology	pharyngitis, tonsillitis, otitis, sinusitis	Sigma, MicroSource	56.52	BRD-A22303829-001-01-6, BRD-A22303829-001-02-4	Launched
celecoxib	cyclooxygenase inhibitor	CA12, PDPK1, PTGS2	rheumatology, endocrinology	osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, primary dysmenorrhea (PD)	Tocris, MicroSource, Selleck	99.47	BRD-K02637541-001-22-2, BRD-K02637541-001-18-0, BRD-K02637541-001-17-2	Launched
celiprolol	adrenergic receptor antagonist	ADRA2A, ADRB1, ADRB2	genetics	Ehlers-Danlos syndrome (EDS)	Prestwick	97.27	BRD-A95602221-003-02-1	Launched
centazolone	monoamine oxidase inhibitor				Enamine	95.67	BRD-K31329721-001-08-2	Phase 1
centpropazine	inositol monophosphatase inhibitor				Enamine, Enamine	95.61	BRD-A28958257-001-02-0, BRD-A28958257-001-01-2	Phase 3
CEP-32496	RAF inhibitor	BRAF, RAF1			Selleck	97.13	BRD-K20722021-001-02-1	Phase 1/Phase 2
CEP-33779	JAK inhibitor	JAK2			Selleck, Selleck	86.12	BRD-K37237504-001-02-7, BRD-K37237504-001-03-5	Preclinical
CEP-37440	ALK tyrosine kinase receptor inhibitor	ALK			MedChemEx	97.19	BRD-K72827473-001-01-0	Phase 1
cephalexin	bacterial cell wall synthesis inhibitor		infectious disease, otolaryngology	respiratory tract infections, otitis, skin infections, bone and joint infections, genitourinary tract infections	MedChemEx, MedChemEx, Sigma, Selleck, MicroSource, Selleck	75.26	BRD-K90733503-001-08-7, BRD-K90733503-001-07-9, BRD-K90733503-001-06-1, BRD-K90733503-001-09-5, BRD-K90733503-001-10-3, BRD-K90733503-001-05-3	Launched
cephalomannine	DNA polymerase inhibitor				MedChemEx, Selleck, Selleck	94.06	BRD-K68904758-001-04-3, BRD-K68904758-001-02-7, BRD-K68904758-001-03-5	Preclinical
cephalosporin-c-zn	bacterial cell wall synthesis inhibitor				MicroSource	0	BRD-A44936478-001-01-1	Preclinical
cephalothin	bacterial cell wall synthesis inhibitor		infectious disease	skin infections, surgical prophylaxis	MicroSource	92.86	BRD-K28210218-236-08-1	Launched
cephapirin	bacterial cell wall synthesis inhibitor		obstetrics/gynecology	mastitis	MicroSource, Selleck	85.45	BRD-K49880111-236-09-2, BRD-K49880111-236-10-0	Launched
cepharanthine	NFkB pathway inhibitor				Selleck, MicroSource, Selleck	95.81	BRD-K96194081-001-12-8, BRD-K96194081-001-10-2, BRD-K96194081-001-11-0	Phase 2
cephradine	bacterial cell wall synthesis inhibitor		infectious disease	skin infections, respiratory tract infections, urinary tract infections	MicroSource	5.47	BRD-A90807417-001-04-5	Launched
ceramide	phosphoenolpyruvate carboxylase activator, serine/threonine protein phosphatase activator		dermatology	cosmetic	Tocris	100	BRD-K41707108-001-05-6	Launched
ceritinib	ALK tyrosine kinase receptor inhibitor	ALK, FLT3, IGF1R, INSR, TSSK1B	oncology	non-small cell lung cancer (NSCLC)	MedChemEx, MedChemEx, Selleck, Selleck	95.07	BRD-K22149900-001-06-2, BRD-K22149900-001-05-4, BRD-K22149900-001-03-9, BRD-K22149900-001-01-3	Launched
cerulenin	fatty acid synthase inhibitor	FASN	infectious disease	fungal infection	Enzo	41.25	BRD-K52075040-001-09-7	Launched
cetaben	cholesterol inhibitor, ACAT inhibitor	PPARA			Adooq	55.82	BRD-K86954340-001-01-7	Phase 2
cetilistat	triacylglycerol lipase inhibitor	PNLIP			Key, TCI	17.4	BRD-K94863486-001-02-2, BRD-K94863486-001-01-4	Phase 3
cetirizine	histamine receptor antagonist	HRH1	allergy	allergic rhinitis	MicroSource, Tocris, Selleck	98.06	BRD-A42571354-300-13-8, BRD-A42571354-300-12-0, BRD-A42571354-300-11-2	Launched
cetrimonium			dermatology	cosmetic	Selleck, MicroSource	100	BRD-K47079459-004-04-6, BRD-K47079459-004-05-3	Launched
cetrorelix	gonadotropin releasing factor hormone receptor antagonist	GNRHR, LHCGR	endocrinology	premature luteinizing hormone surges	Sigma	97.29	BRD-K76315403-015-02-5	Launched
cetylpyridinium			dental	gingivitis, mouth inflammation	MicroSource, Selleck, Selleck	98.97	BRD-K87700323-003-05-1, BRD-K87700323-003-04-4, BRD-K87700323-003-06-9	Launched
cevimeline	acetylcholine receptor agonist	CHRM1, CHRM3	rheumatology	sjogren's syndrome	Tocris	97.85	BRD-M98279124-300-01-1	Launched
cevipabulin	microtubule stimulant, tubulin polymerization inhibitor	TUBB			MedChemEx	89.67	BRD-A02473266-001-01-1	Phase 1
CE3F4	rap guanine nucleotide exchange factor inhibitor	RAPGEF3			Tocris	98.53	BRD-A47940219-001-01-4	Preclinical
CFM-1571	guanylate cyclase activator				Tocris, Tocris	95.4	BRD-K64341947-003-02-4, BRD-K64341947-003-03-2	Preclinical
CFM-2	glutamate receptor antagonist				Tocris	89.65	BRD-K42859542-001-03-3	Preclinical
CFTRinh-172	chloride channel blocker	CFTR			Tocris, Tocris, Selleck	90.25	BRD-K72004355-001-02-7, BRD-K72004355-001-03-5, BRD-K72004355-001-01-9	Preclinical
CF102	adenosine receptor agonist	ADORA1, ADORA2A, ADORA2B, ADORA3			Tocris	98.78	BRD-K52396582-001-06-7	Phase 2
CG-400549	FABI inhibitor				Astatech, Astatech	95.34	BRD-K48888725-001-02-7, BRD-K48888725-001-01-9	Phase 2
CGH2466	adenosine receptor antagonist	ADORA1, ADORA2B, ADORA3			Tocris, Tocris	94.17	BRD-K82028950-300-03-7, BRD-K82028950-300-02-9	Preclinical
CGK-733	ATM kinase inhibitor, ATR kinase inhibitor	ATM, ATR			Tocris, Tocris, Selleck, Selleck	97.37	BRD-A50737080-001-03-0, BRD-A50737080-001-06-3, BRD-A50737080-001-02-2, BRD-A50737080-001-05-5	Preclinical
CGM097	MDM inhibitor	MDM2			MedChemEx, MedChemEx	86.88	BRD-K79584249-001-02-1, BRD-K79584249-001-01-3	Phase 1
CGP-12177	adrenergic receptor agonist	ADRB1, ADRB2, ADRB3			Tocris	96.6	BRD-A40084411-003-07-7	Phase 1
CGP-13501	GABA receptor modulator	GABBR1			Tocris	91.07	BRD-K95851186-001-07-8	Preclinical
CGP-20712A	adrenergic receptor antagonist	ADRB1, ADRB3			Sigma	97.65	BRD-A31575449-066-07-8	Preclinical
CGP-37157	mitochondrial Na+/Ca2+ exchanger antagonist, sodium/calcium exchange inhibitor	SLC8A1			Tocris, Tocris	99.24	BRD-A35623999-001-06-5, BRD-A35623999-001-05-7	Preclinical
CGP-37849	glutamate receptor antagonist	GRIN2A, GRIN2B, GRIN2C, GRIN2D			Tocris, EMDBio	0	BRD-A90272038-001-02-5, BRD-A90272038-001-01-7	Phase 1
CGP-52411	EGFR inhibitor	EGFR			Tocris, Tocris	94.09	BRD-K13087974-001-02-5, BRD-K13087974-001-03-3	Preclinical
CGP-53353	EGFR inhibitor, PKC inhibitor	EGFR, PRKCB			Tocris, Tocris	94.62	BRD-K32292990-001-03-6, BRD-K32292990-001-04-4	Preclinical
CGP-54626	GABA receptor antagonist	GABBR1, GABBR2, KCTD12, KCTD16, KCTD8			Tocris, Tocris	93.07	BRD-A74208568-003-02-3, BRD-A74208568-003-01-5	Preclinical
CGP-55845	GABA receptor antagonist	GABBR1, GABBR2, KCTD12, KCTD16, KCTD8			Tocris, Tocris	97.05	BRD-A89672324-001-04-8, BRD-A89672324-001-03-0	Preclinical
CGP-57380	MAP kinase inhibitor	AURKB, LCK, MKNK1, MKNK2, SGK1			Tocris, Selleck, Tocris	92.47	BRD-K42500029-001-04-3, BRD-K42500029-001-03-5, BRD-K42500029-001-06-8	Preclinical
CGP-60474	CDK inhibitor	CDK1, CDK2			Tocris	98.36	BRD-K79090631-001-22-3	Preclinical
CGP-71683	neuropeptide receptor antagonist	NPY5R			Tocris, Tocris	98.57	BRD-K34321528-003-01-2, BRD-K34321528-003-02-0	Preclinical
CGP-74514	CDK inhibitor	CDK1			Tocris	95.63	BRD-K56239177-300-01-3	Preclinical
CGP-78608	glutamate receptor antagonist				Tocris	0	BRD-K60946979-003-01-7	Preclinical
CGP-7930	GABA receptor modulator	GABBR1			Tocris, Tocris	96.35	BRD-K65786282-001-08-3, BRD-K65786282-001-07-5	Preclinical
CGS-15943	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3			Tocris	96.89	BRD-K49049886-001-08-7	Preclinical
CGS-20625	benzodiazepine receptor agonist, GABA benzodiazepine site receptor partial agonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6			Tocris, Tocris	94.19	BRD-K68103045-001-02-9, BRD-K68103045-001-03-7	Phase 1
CGS-21680	adenosine receptor agonist	ADORA1, ADORA2A, ADORA2B, ADORA3			Selleck	94.58	BRD-K12614344-003-01-8	Preclinical
CGS-9896	GABA receptor antagonist	GABRA1, GABRB2, GABRG2			ChemDiv	96.33	BRD-K54093161-001-01-8	Preclinical
CH-170					Enamine	99.18	BRD-K24820488-001-01-7	Phase 1
CH-5183284	fibroblast growth factor inhibitor	FGFR1, FGFR2, FGFR3			Cayman, Selleck	98.42	BRD-K11683436-001-02-5, BRD-K11683436-001-01-7	Phase 1
CHC	monocarboxylate transporter inhibitor	SLC16A1			Tocris	89.98	BRD-K60302405-001-08-6	Preclinical
chenodeoxycholic-acid	11-beta hydroxysteroid dehydrogenase inhibitor, FXR agonist	HSD11B1, NR1H4	cardiology, gastroenterology	cerebral cholesterosis, gallstones	MicroSource, Selleck	100	BRD-K18135438-001-14-2, BRD-K18135438-001-16-7	Launched
CHF5074	gamma secretase modulator	PSEN1			MedChemEx	92.25	BRD-K34508702-001-02-4	Phase 2
chicago-sky-blue-6b	glutamate inhibitor, macrophage migration inhibiting factor inhibitor	MIF			Prestwick	76.61	BRD-K56483981-342-06-4	Preclinical
chidamide	HDAC inhibitor	HDAC10, HDAC3			MedChemEx	91.41	BRD-K28537285-001-01-8	Launched
chiniofon	antiprotozoal agent		infectious disease	amebiasis	MicroSource	95.18	BRD-K52284881-236-02-4	Launched
CHIR-124	CHK inhibitor	CHEK1			Selleck	95.19	BRD-K02241333-001-02-7	Preclinical
CHIR-98014	glycogen synthase kinase inhibitor	GSK3A, GSK3B			Selleck	94.71	BRD-K42973005-001-04-0	Preclinical
CHIR-99021	glycogen synthase kinase inhibitor	CDK1, GSK3A, GSK3B, MAPK1			Selleck, Tocris	95.6	BRD-K16189898-003-03-3, BRD-K16189898-001-21-9	Preclinical
chloralose					MicroSource	96.81	BRD-A98174560-001-02-1	Preclinical
chlorambucil	DNA inhibitor		hematologic malignancy	chronic lymphocytic leukemia (CLL), Hodgkin's lymphoma	MicroSource	94.93	BRD-K29458283-001-29-9	Launched
chloramine-t			infectious disease	bacterial gill disease	MicroSource	69.13	BRD-K93546328-236-02-8	Launched
chloramphenicol	bacterial 50S ribosomal subunit inhibitor	CD55	infectious disease, endocrinology	meningitis, fever, cholera	MicroSource, Selleck	99.59	BRD-K08111712-001-16-7, BRD-K08111712-001-14-2	Launched
chloramphenicol-palmitate	protein synthesis inhibitor		infectious disease, endocrinology	meningitis, fever, cholera	MicroSource	89.74	BRD-K96424892-001-02-9	Launched
chloramphenicol-sodium-succinate	protein synthesis inhibitor		infectious disease	gram-negative bacterial infections	MicroSource	31.43	BRD-K25209357-236-01-2	Launched
chlorazanil					MicroSource	98.95	BRD-K21452876-003-01-8	Preclinical
chlorcyclizine	histamine receptor antagonist	HRH1	allergy	allergic rhinitis	Enzo	97.82	BRD-A57133233-003-11-0	Launched
chlorfenson	other antifungal				Sigma	0	BRD-K89409436-001-01-4	Phase 2
chlorhexidine	membrane integrity inhibitor		dermatology, infectious disease, dental	cosmetic, skin infections, gingivitis	MicroSource	97.77	BRD-K52256627-300-06-6	Launched
chlorindanol					MicroSource	93.98	BRD-K01653460-001-01-1	Preclinical
chlorindione					MicroSource	96.83	BRD-K61802864-001-08-8	Preclinical
chlorisondamine-diiodide	acetylcholine receptor antagonist	CHRNA1			Tocris	0	BRD-K18030938-302-02-7	Preclinical
chlormadinone-acetate	5 alpha reductase inhibitor	PGR	endocrinology	hypermenorrhea, amenorrhea, oligomenorrhea, polymenorrhea	MicroSource	99.74	BRD-A01593789-001-03-1	Launched
chlormezanone	GABA receptor modulator	GABRA1, TSPO			MicroSource, Tocris, Selleck	98.9	BRD-A20348246-001-15-8, BRD-A20348246-001-14-1, BRD-A20348246-001-13-3	Withdrawn
chlormidazole	fungal lanosterol demethylase inhibitor		infectious disease	fungal infection	MicroSource	94.26	BRD-K60443845-001-08-6	Launched
chlorobutanol			neurology/psychiatry	anesthetic, sedative	MicroSource, Enamine	0	BRD-K39495750-001-01-2, BRD-K39495750-001-02-0	Launched
chlorocresol	ryanodine receptor activator		infectious disease	first-aid antiseptic	MicroSource, Selleck, Selleck	94.58	BRD-K89056082-001-07-7, BRD-K89056082-001-06-9, BRD-K89056082-001-08-5	Launched
chlorogenic-acid	antioxidant	SLC37A4	neurology/psychiatry, pulmonary, allergy	headache, chest congestion, allergic rhinitis	Selleck, Selleck	95.33	BRD-K47114202-001-14-6, BRD-K47114202-001-15-3	Launched
chlorophyllide-cu-complex-na-salt					MicroSource	0	BRD-A63866086-314-01-7	Preclinical
chlorophyllin			urology	urinary incontinence	Adooq	5.35	BRD-K23728266-001-01-1	Preclinical
chlorophyllin-copper	cytochrome P450 inhibitor				MedChemEx	20.18	BRD-A92960111-314-01-2	Phase 1
chloroprocaine	sodium channel blocker	ATP1A1, CHRNA10, GRIN3A, HTR3A, SCN10A, SLC6A3	neurology/psychiatry	local anesthetic	Enamine	88.33	BRD-K86864073-001-01-1	Launched
chloropyramine	histamine receptor antagonist	HRH1	cardiology, ophthalmology, allergy, pulmonary	edema, conjunctivitis, allergic rhinitis, asthma	MicroSource	95.27	BRD-K83257731-003-23-5	Launched
chloroquine	antimalarial agent	GSTA2, MRGPRX1, TLR9, TNF	infectious disease	malaria, amebiasis	MicroSource, Selleck, Selleck	96.54	BRD-A91699651-316-10-9, BRD-A91699651-316-09-1, BRD-A91699651-316-11-7	Launched
chlorothiazide	diuretic	CA1, CA2, CA4, SLC12A3	cardiology	hypertension	MicroSource, Selleck	95.43	BRD-K88682005-001-16-6, BRD-K88682005-001-15-8	Launched
chlorothymol					Enamine	0	BRD-K04358951-001-01-0	Launched
chlorotrianisene	estrogenic hormone	ESR1, ESR2	endocrinology, oncology	menopause, prostate cancer	Prestwick	98.18	BRD-K27062708-001-23-1	Launched
chloroxine	opioid receptor antagonist	OPRK1	gastroenterology, infectious disease, dermatology	diarrhea, inflammatory bowel disease, giardiasis, dandruff	MicroSource, Selleck, Selleck	99.48	BRD-K17075857-001-17-6, BRD-K17075857-001-18-4, BRD-K17075857-001-16-8	Launched
chloroxoquinoline					Alinda	97.87	BRD-K83335125-001-07-0	Launched
chloroxylenol	ATP synthase inhibitor		infectious disease	skin infections	MicroSource	95.32	BRD-K17223896-001-10-0	Launched
chlorphenamine	histamine receptor antagonist	HRH1, SLC6A2, SLC6A3, SLC6A4	allergy	allergic rhinitis, urticaria	Selleck	96.29	BRD-A04553218-050-16-2	Launched
chlorphenesin	muscle relaxant		neurology/psychiatry	muscle relaxant, sedative	Enamine, Sigma	98.16	BRD-A92262698-001-01-7, BRD-A92262698-001-02-5	Launched
chlorphensin-carbamate	muscle relaxant				Prestwick	98.03	BRD-A39230911-001-10-2	Preclinical
chlorproguanil	dihydrofolate reductase inhibitor	DHFR	infectious disease	malaria	AMS	97.75	BRD-K25494650-003-01-8	Launched
chlorpromazine	dopamine receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CALM1, CHRM1, CHRM3, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HRH4, HTR1A, HTR2A, HTR2B, HTR2C, HTR6, HTR7, KCNH2, ORM1, ORM2, SMPD1, TRPC5	neurology/psychiatry, gastroenterology, hematology, infectious disease	schizophrenia, nausea, vomiting, acute intermittent porphyria (AIP), tetanus	MicroSource, Selleck, Selleck	97.33	BRD-K89997465-001-10-3, BRD-K89997465-003-43-0, BRD-K89997465-003-44-8	Launched
chlorpropamide	ATP channel blocker	ABCC8, KCNJ10, KCNJ11	endocrinology	diabetes mellitus	MicroSource, Selleck	98.37	BRD-K97746869-001-27-0, BRD-K97746869-001-26-2	Launched
chlorpropham	antiviral				Sigma	99.36	BRD-K59590127-001-04-5	Phase 1
chlorprothixene	dopamine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, HRH1, HTR2A, HTR2B, HTR2C	neurology/psychiatry	schizophrenia, bipolar disorder	Selleck, MicroSource, Selleck	97.83	BRD-K36207157-001-07-0, BRD-K36207157-001-09-6, BRD-K36207157-001-08-8	Launched
chlorpyrifos	acetylcholinesterase inhibitor	ACHE			MicroSource	79.39	BRD-K08303368-001-10-0	Launched
chlorquinaldol	other antibiotic		infectious disease	fungal infection	Selleck, MicroSource	96.93	BRD-K90374350-001-09-2, BRD-K90374350-001-10-0	Launched
chlortetracycline	protein synthesis inhibitor		ophthalmology	conjunctivitis	MicroSource, Selleck, Selleck	76.26	BRD-A25492003-003-13-3, BRD-A25492003-003-15-8, BRD-A25492003-003-14-1	Launched
chlorthalidone	carbonic anhydrase inhibitor	CA1, CA12, CA14, CA4, CA7, SLC12A1, SLC12A3	cardiology, gastroenterology, rheumatology, nephrology	hypertension, edema, congestive heart failure, hepatic cirrhosis, nephrotic syndrome, acute glomerulonephritis (AGN), chronic renal failure	MicroSource	98.01	BRD-A26384407-001-25-1	Launched
chlorzoxazone	bacterial 30S ribosomal subunit inhibitor	KCNMA1, KCNN4	neurology/psychiatry	muscle relaxant	MicroSource, Selleck	100	BRD-K98174813-001-18-0, BRD-K98174813-001-17-2	Launched
cholecalciferol		VDR	endocrinology	vitamin D deficiency	MicroSource, Selleck, Selleck	92.35	BRD-K62779383-001-08-9, BRD-K62779383-001-07-1, BRD-K62779383-001-05-5	Launched
cholesterol		RORA			MicroSource	0	BRD-A42883684-001-04-1	Preclinical
cholic-acid	bile acid	ADH1C, CES1, COX4I1, COX5A, COX5B, COX6A2, COX6B1, COX6C, COX7A1, COX7B, COX7C, COX8A, ESRRG, FABP6, FECH, GPBAR1, MT-CO1, MT-CO2, MT-CO3, PLA2G1B	gastroenterology, neurology/psychiatry, genetics	bile acid synthesis disorders, peroxisomal disorders, Zellweger syndrome	Enzo	100	BRD-K43164539-001-11-5	Launched
choline	acetylcholine precursor	ACHE, BCHE, CHRNA2, PCYT1A, PCYT1B, PHOSPHO1, PLD1, PLD2			MicroSource, Selleck	100	BRD-K77300776-001-01-7, BRD-K77300776-001-02-5	Phase 3
choline-alfoscerate	acetylcholine precursor	GM2A			MedChemEx	100	BRD-A72390365-001-15-2	Launched
CHPG	glutamate receptor agonist	GRM5			Tocris	0	BRD-A19381518-001-02-1	Preclinical
CHR-6494	serine/threonine kinase inhibitor	GSG2			MedChemEx, Tocris	99.14	BRD-K76259716-001-01-9, BRD-K76259716-019-01-1	Preclinical
chromanol-(+/-)	potassium channel blocker				Tocris	98.74	BRD-M02075109-001-01-1	Preclinical
chromanol-293B-(-)-[3R,4S]	potassium channel blocker				Tocris	99.19	BRD-K27911943-001-02-8	Preclinical
chromocarb	antispasmodic				MicroSource, Selleck	97.77	BRD-K94720315-001-10-4, BRD-K94720315-001-09-6	Launched
chrysin	breast cancer resistance protein inhibitor	AKR1B1, CDK6, CYP19A1, CYP1B1			Selleck	96.12	BRD-K22861715-001-17-4	Phase 1
chrysophanic-acid	EGFR inhibitor	EGFR, MTOR			Selleck	96.2	BRD-K59284035-001-07-9	Preclinical
chuanxiongzine					Enzo	97.8	BRD-K25691735-001-09-5	Phase 2
CH223191	aryl hydrocarbon receptor antagonist	AHR			Tocris	97.94	BRD-K22314899-001-02-4	Preclinical
CH5132799	PI3K inhibitor	MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG			Selleck, Selleck	93.07	BRD-K28352084-001-02-3, BRD-K28352084-001-03-1	Phase 1
CH55	retinoid receptor binder	RARA, RARB			Tocris, Tocris	92.13	BRD-K71487808-001-03-6, BRD-K71487808-001-02-8	Preclinical
CI-844					ChemImpex	98.44	BRD-K83022601-001-01-0	Phase 2
CI-923	acetylcholine receptor antagonist				Sigma	86.83	BRD-A50016482-001-01-7	Phase 1
CI-966	GAT inhibitor	SLC6A1			Tocris, Tocris	98.04	BRD-K67680372-003-03-4, BRD-K67680372-003-02-6	Phase 1
CI-976	ACAT inhibitor	ACAT1, CES1			Tocris, Tocris	98.32	BRD-K88544581-001-06-1, BRD-K88544581-001-08-7	Phase 1
ciaftalan-zinc	reactive oxygen species stimulant				Sigma	22.93	BRD-K01423020-001-01-2	Phase 1
cianidanol	fatty acid synthase inhibitor	PTGS1			MicroSource	98.72	BRD-K58736316-001-09-5	Withdrawn
cibenzoline	sodium channel blocker				Sigma	98.93	BRD-K34251960-036-01-6	Launched
ciclesonide	glucocorticoid receptor agonist	NR3C1, SERPINA6	allergy	allergic rhinitis	Enzo	98.53	BRD-K35245662-001-01-2	Launched
ciclopirox	membrane integrity inhibitor	ATP1A1	infectious disease	onychomycosis	MicroSource, Selleck, Selleck, Sigma, Selleck, Selleck	84.85	BRD-K13044802-213-21-5, BRD-K13044802-001-02-4, BRD-K13044802-001-03-2, BRD-K13044802-213-25-6, BRD-K13044802-213-24-9, BRD-K13044802-213-20-7	Launched
cicloprofen	cyclooxygenase inhibitor	PTGS1, PTGS2			Enamine	95.97	BRD-A94965935-001-01-6	Preclinical
CID-16020046	G protein-coupled receptor antagonist	GPR55			Tocris	98.4	BRD-A59391172-001-07-7	Preclinical
CID-2011756	protein kinase inhibitor	PKD1			Tocris	98.57	BRD-K92781136-001-08-9	Preclinical
CID-2745687	G protein-coupled receptor antagonist	GPR35			Tocris	90.54	BRD-K06405316-001-03-3	Preclinical
CID-5458317	MAP kinase phosphatase inhibitor	MAPK3			EMDBio	96.86	BRD-A08840375-001-01-3	Preclinical
cidofovir	DNA polymerase inhibitor		infectious disease	acquired immunodeficiency syndrome (AIDS), cytomegalovirus retinitis	Selleck, Selleck	100	BRD-K96153583-001-05-1, BRD-K96153583-001-04-4	Launched
ciglitazone	PPAR receptor agonist	PPARG			Tocris	96.7	BRD-A93000692-001-08-1	Phase 2
cilastatin	dehydropeptidase inhibitor	DPEP1			AvaChem, Tocris	0	BRD-K85518562-236-08-9, BRD-K85518562-236-09-7	Launched
cilazapril	angiotensin converting enzyme inhibitor	ACE	cardiology	hypertension, congestive heart failure	Selleck	97	BRD-K65518078-002-01-1	Launched
cilengitide	integrin antagonist	ITGAV, ITGB3			Selleck	96.22	BRD-K57252450-001-02-5	Phase 3
cilnidipine	calcium channel blocker	CACNA1B	cardiology	hypertension	Selleck, Tocris, Tocris, Selleck	95.59	BRD-A02743701-001-04-4, BRD-A02743701-001-03-6, BRD-A02743701-001-06-9, BRD-A02743701-001-02-8	Launched
cilomilast	phosphodiesterase inhibitor	PDE4A, PDE4B, PDE4D			Selleck	91.79	BRD-K38473998-001-02-0	Phase 3
cilostamide	phosphodiesterase inhibitor	PDE3A, PDE3B			Tocris, Tocris	95.91	BRD-K28578425-001-09-6, BRD-K28578425-001-07-0	Preclinical
cilostazol	phosphodiesterase inhibitor	PDE3A, PDE3B	cardiology	claudication	MicroSource, Tocris, Selleck, Tocris	98.71	BRD-K67017579-001-28-1, BRD-K67017579-001-29-9, BRD-K67017579-001-26-5, BRD-K67017579-001-27-3	Launched
CIM-0216	transient receptor potential channel agonist	TRPM3			Tocris	90.64	BRD-A75514485-001-01-9	Preclinical
cimaterol	adrenergic receptor agonist	ADRB1, ADRB2, ADRB3			Tocris	89.76	BRD-A65440446-001-04-1	Preclinical
cimetidine	histamine receptor antagonist	HRH2, SLC29A4, SLC47A1, SLC47A2	gastroenterology, hematologic malignancy, endocrinology	duodenal ulcer disease, peptic ulcer disease (PUD), gastroesophageal reflux disease (GERD), aggressive systemic mastocytosis (ASM), Zollinger-Ellison syndrome, endocrine adenoma	Tocris, Tocris, Selleck, MicroSource	99.16	BRD-K34157611-001-21-0, BRD-K34157611-001-15-2, BRD-K34157611-001-14-5, BRD-K34157611-001-16-0	Launched
cimetropium	acetylcholine receptor antagonist	CHRM1	gastroenterology	irritable bowel syndrome	Sigma	93.27	BRD-A99899486-004-01-9	Launched
cinacalcet	calcium channel activator	CASR	endocrinology, nephrology, oncology	hyperparathyroidism, chronic kidney disease (CKD), parathyroid carcinoma, hypercalcemia	Selleck	98.6	BRD-K73838513-003-05-5	Launched
cinaciguat	guanylate cyclase activator	GUCY1A3, GUCY1B3			MedChemEx	97.86	BRD-K73440166-001-01-3	Phase 2
cinalukast	leukotriene receptor antagonist	CYSLTR1			Tocris, Tocris, Tocris	92.06	BRD-K53720352-001-05-7, BRD-K53720352-001-04-0, BRD-K53720352-001-03-2	Phase 2
cinanserin	serotonin receptor antagonist	HTR2A			Tocris	96.6	BRD-K40901640-003-01-6	Preclinical
cinchocaine	sodium channel blocker	CALM1, SCN10A, SCN5A	neurology/psychiatry	local anesthetic	MicroSource, Selleck	96.87	BRD-K99121711-003-20-5, BRD-K99121711-003-19-7	Launched
cinchonidine	P glycoprotein inhibitor				MicroSource, Selleck	93.36	BRD-K39079086-001-06-8, BRD-K39079086-001-07-6	Phase 1
cinchonine	P glycoprotein inhibitor	CYP2D6			MicroSource	86.78	BRD-K14693417-001-04-0	Preclinical
cinchophen	analgesic agent		rheumatology	gout	Selleck, MicroSource	99.45	BRD-K72915123-001-17-3, BRD-K72915123-001-18-1	Launched
cinepazet	vasodilator				Sigma	95.1	BRD-K00531707-001-01-3	Launched
cinepazide	calcium channel activator				Selleck, Selleck	99.15	BRD-K46839850-050-04-2, BRD-K46839850-050-05-9	Withdrawn
cinflumide	muscle relaxant				Enamine	89.23	BRD-K25154476-001-01-4	Phase 2
cinnamaldehyde	aldose reductase inhibitor, TRPV agonist	TRPA1			Otava	0	BRD-K38088841-001-01-7	Preclinical
cinnarazine	calcium channel blocker		neurology/psychiatry, gastroenterology, ophthalmology	Meniere's disease, nausea, vomiting, Cogan's syndrome	MicroSource, ChemDiv	98.16	BRD-K07220430-001-19-2, BRD-K07220430-001-18-4	Launched
cinoctramide					MicroSource	0	BRD-K08699567-001-01-9	Preclinical
cinoxacin	topoisomerase inhibitor		infectious disease	urinary tract infections	MicroSource, Selleck	93.53	BRD-K14704277-001-23-4, BRD-K14704277-001-22-6	Launched
cinoxate			dermatology	sunscreen lotion	Enamine	95.2	BRD-K17828029-001-01-5	Launched
CINPA-1	CAR antagonist	NR1H4, NR1I3, PPARG			Tocris	93.64	BRD-K24570280-001-01-8	Preclinical
cinromide					MicroSource	99.12	BRD-K66241279-001-01-8	Phase 3
cintriamide					MicroSource	97.46	BRD-K24507548-001-01-8	Preclinical
cipemastat	metalloproteinase inhibitor	ADAM17, MMP1, MMP13, MMP2, MMP3, MMP8, MMP9			Tocris	86.65	BRD-K95362002-001-01-1	Phase 3
ciprofibrate	PPAR receptor agonist	PPARA	endocrinology	hyperlipidemia	MicroSource, Selleck	96.78	BRD-A49358627-001-14-6, BRD-A49358627-001-13-8	Launched
ciprofloxacin	bacterial DNA gyrase inhibitor	TOP2A	otolaryngology	otitis	MicroSource, Selleck, Selleck	98.2	BRD-K04804440-001-09-5, BRD-K04804440-001-13-7, BRD-K04804440-001-08-7	Launched
ciproxifan	histamine receptor antagonist	ADRA2A, ADRA2C, HRH3, HRH4, HTR3A			Selleck	94.57	BRD-K01767299-050-02-1	Preclinical
CIQ	glutamate receptor potentiator	GRIN2C, GRIN2D			Tocris	98.05	BRD-A35425966-001-02-3	Preclinical
cirazoline	adrenergic receptor agonist	ADRA1A			Tocris, Tocris	92.59	BRD-K54142781-003-13-4, BRD-K54142781-003-11-8	Preclinical
cis-aconitic-acid		ACO2			Enamine	0	BRD-K71756122-001-02-5	Preclinical
cis-ACPD	glutamate receptor agonist	GRM2, GRM3, GRM6, GRM7, GRM8			Tocris	100	BRD-M29936662-001-02-0	Preclinical
cis-exo-camphanediol-2,3	nitric oxide stimulant	NOS3			Sigma	0	BRD-K41962502-001-01-8	Phase 1
cis-urocanic acid	serotonin receptor agonist	HTR2A			Sigma	96.8	BRD-K25146005-001-01-0	Phase 2
cis-urocanic-acid	serotonin receptor agonist	HTR2A			Enamine, Enamine	100	BRD-K52670952-003-02-2, BRD-K52670952-003-01-4	Phase 2
cis-9,trans-11-Conjugated-linoleic-acid					Enzo	96.02	BRD-K80025777-001-01-4	Launched
cisapride	serotonin receptor agonist	HTR2A, HTR3A, HTR4, KCNH2			MicroSource, Tocris, Tocris	98.57	BRD-A12896037-001-04-3, BRD-K06895174-001-03-6, BRD-K06895174-001-02-8	Withdrawn
cisatracurium	acetylcholine receptor antagonist	CHRNA2	neurology/psychiatry, critical care	muscle relaxant, endotracheal intubation	Selleck	64.92	BRD-K17498618-344-03-4	Launched
cisplatin	DNA alkylating agent, DNA synthesis inhibitor	XIAP	oncology	testicular carcinoma, ovarian cancer, bladder cancer	Selleck, Tocris, MicroSource, Selleck	0	BRD-K69172251-001-11-3, BRD-K69172251-001-09-7, BRD-K69172251-001-10-5, BRD-K69172251-001-08-9	Launched
citalopram	selective serotonin reuptake inhibitor (SSRI)	SLC6A2, SLC6A4	neurology/psychiatry	depression	MicroSource, Enamine, Tocris, Selleck	97.27	BRD-A47598013-004-17-8, BRD-A47598013-004-18-6, BRD-A47598013-004-16-0, BRD-A47598013-034-02-7	Launched
CITCO	constitutive androstane receptor (CAR) agonist	NR1I3			Tocris, Tocris	94.15	BRD-K53263234-001-05-2, BRD-K53263234-001-06-0	Preclinical
citicoline	membrane permeability enhancer, glutathione transferase stimulant	ACHE, SLC1A2	neurology/psychiatry, ophthalmology	stroke, Alzheimer's disease, senile dementia, Parkinson's Disease, attention-deficit/hyperactivity disorder (ADHD), glaucoma	TargetMol, MicroSource, Cayman	99.5	BRD-A91728607-001-01-8, BRD-A91728607-396-01-2, BRD-A91728607-236-11-9	Launched
citiolone	lipotropic, mucolytic agent				MicroSource	94.67	BRD-A57957888-001-08-0	Preclinical
citric-acid	coagulation factor inhibitor	AKR1B1, ANG, APRT, BHMT, C8G, CA4, CPB1, CS, CTDSP1, GNMT, HGS, HS3ST3A1, IL4I1, ITPA, LSM6, MDH2, MIF, PDE5A, PKD2L1, PLEKHA1, RNASE1, RNASE3, SRC, TNFSF13B, UCK2			Sigma	0	BRD-K76792669-001-08-1	Preclinical
CJ-033466	serotonin receptor agonist	HTR4			Tocris	87.64	BRD-K21306330-001-01-0	Preclinical
CK-636	actin related protein inhibitor	ACTR2, ACTR3, ARPC1B, ARPC2, ARPC3, ARPC4, ARPC5			Selleck, Selleck	84.46	BRD-K81572616-001-01-9, BRD-K81572616-001-02-7	Preclinical
CKD-712	NFkB pathway inhibitor	JAK2, STAT1			MedChemEx, MedChemEx	93.15	BRD-A26458246-004-02-1, BRD-A26458246-004-01-3	Phase 1
CKI-7	casein kinase inhibitor	CSNK1G2			Tocris	93.33	BRD-K34303607-300-02-2	Preclinical
CL-218872	benzodiazepine receptor agonist	GABRA1, GABRA2, GABRA3, GABRA5, GABRB2, GABRG2			Tocris, Tocris	98.21	BRD-K00662280-001-10-2, BRD-K00662280-001-09-4	Phase 1
CL-225385					Enamine	96.85	BRD-K87573013-001-01-0	Phase 2
cladribine	adenosine deaminase inhibitor, ribonucleotide reductase inhibitor	ADA, PNP, POLA1, POLE, POLE2, POLE3, POLE4, RRM1, RRM2, RRM2B	hematologic malignancy	hairy cell leukemia	Selleck	98.23	BRD-K93034159-001-25-8	Launched
clarithromycin	bacterial 50S ribosomal subunit inhibitor	CYP3A4	otolaryngology, pulmonary, infectious disease	pharyngitis, tonsillitis, sinusitis, bronchitis, pneumonia, skin infections, otitis	MicroSource, Selleck	100	BRD-K49668410-001-16-2, BRD-K49668410-001-18-8	Launched
clavulanate	beta lactamase inhibitor		otolaryngology	otitis	MicroSource, AvaChem	0	BRD-K94250879-235-03-9, BRD-K94250879-001-01-9	Launched
clebopride	dopamine receptor antagonist	ACHE, DRD2	gastroenterology	nausea	Prestwick	99.18	BRD-K17294426-050-12-3	Launched
clemastine	histamine receptor antagonist	HRH1	allergy	allergic rhinitis, urticaria	Tocris, MicroSource, Selleck, Tocris	96.36	BRD-K30240666-051-16-7, BRD-K30240666-051-15-9, BRD-K30240666-051-13-4, BRD-K30240666-051-14-2	Launched
clemizole	HCV inhibitor		allergy	allergic rhinitis	Tocris, MicroSource	97.9	BRD-K04704168-003-15-0, BRD-K04704168-003-14-3	Launched
clenbuterol	adrenergic receptor agonist	ADRB1, ADRB2, ADRB3, NGF, TNF	pulmonary	chronic obstructive pulmonary disease (COPD), asthma	MicroSource	99.02	BRD-A75726477-003-21-3	Launched
cleviprex	calcium channel blocker	CACNA1C, CACNA1D, CACNA1F, CACNA1S	cardiology	hypertension	Selleck	96.26	BRD-A01563671-001-02-7	Launched
clevudine	DNA polymerase inhibitor		infectious disease	hepatitis B	Selleck	94.05	BRD-K18948558-001-01-9	Launched
clidinium	acetylcholine receptor antagonist	CHRM1, CHRM3	gastroenterology	peptic ulcer disease (PUD), irritable bowel syndrome, enterocolitis	MicroSource	99.37	BRD-A46066006-004-22-6	Launched
climbazole	enzyme inducer		dermatology	dandruff, eczema	Selleck, MicroSource	99.56	BRD-A61676498-001-05-8, BRD-A61676498-001-06-6	Launched
clinafloxacin	bacterial DNA gyrase inhibitor				MicroSource, Selleck, Selleck, Selleck	98.71	BRD-A93964801-003-03-3, BRD-A93964801-001-14-4, BRD-A93964801-003-02-5, BRD-A93964801-001-15-1	Phase 3
clindamycin	protein synthesis inhibitor		infectious disease	respiratory tract infections, pneumonia, skin infections, gynecologic infections, intra-abdominal infections, bacterial septicemia, bone and joint infections	MicroSource, Selleck, Selleck	100	BRD-K23586533-003-01-6, BRD-K23586533-001-03-6, BRD-K23586533-003-02-4	Launched
clindamycin-palmitate	bacterial 50S ribosomal subunit inhibitor		infectious disease	intra-abdominal infections, skin infections, pneumonia, peritonitis, gynecologic infections	Selleck	100	BRD-A76672327-003-02-0	Launched
clindamycin-phosphate	protein synthesis inhibitor		obstetrics/gynecology	bacterial vaginosis	Selleck	100	BRD-K27771035-001-02-5	Launched
clinofibrate	lipase clearing factor inhibitor	LPL	endocrinology	hypertriglyceridemia	Selleck	94.72	BRD-A90625545-001-02-0	Launched
clioquinol	chelating agent	OPRK1			MicroSource	91.44	BRD-K09255212-001-16-6	Withdrawn
clobazam	GABA benzodiazepine site receptor agonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ	neurology/psychiatry	seizures	Enzo	98.93	BRD-K52408781-001-02-8	Launched
clobenpropit	histamine receptor antagonist	HRH1, HRH2, HRH3, HRH4			Tocris	96.33	BRD-K71430621-303-02-3	Preclinical
clobetasol-propionate	glucocorticoid receptor agonist	NR3C1, PLA2G1B	dermatology	corticosteroid-responsive dermatoses	Sigma, MicroSource, Selleck	98.73	BRD-K10799896-001-24-7, BRD-K10799896-001-26-2, BRD-K10799896-001-25-4	Launched
clobetasone-butyrate	corticosteroid agonist	NR3C1	dermatology	eczema, psoriasis, dermatitis	Sigma	93.44	BRD-K58810291-001-16-2	Launched
clobutinol	antitussive				Prestwick	96.04	BRD-A43809092-003-02-1	Withdrawn
clocortolone-pivalate	steroid	NR3C1, PLA2G1B	dermatology	corticosteroid-responsive dermatoses	Prestwick	98.68	BRD-K38003476-001-09-1	Launched
clodronic-acid	bone resorption inhibitor	SLC25A4, SLC25A5, SLC25A6	orthopedics, endocrinology, hematologic malignancy	osteoporosis, hyperparathyroidism, hypercalcemia, multiple myeloma	Selleck, Selleck	0	BRD-K72542090-304-02-4, BRD-K72542090-304-03-2	Launched
clofarabine	ribonucleotide reductase inhibitor	POLA1, POLD1, POLE, RRM1, RRM2, RRM2B	hematologic malignancy	acute lymphoblastic leukemia (ALL)	Tocris, Tocris, Selleck	98.71	BRD-K34022604-001-09-0, BRD-K34022604-001-06-6, BRD-K34022604-001-05-8	Launched
clofazimine	GK0582 inhibitor		infectious disease	leprosy	MicroSource, Selleck, Selleck	86.22	BRD-K56614220-001-19-0, BRD-K56614220-001-18-2, BRD-K56614220-001-21-6	Launched
clofedanol	histamine receptor antagonist	HRH1	pulmonary	cough suppressant	Sigma	97.05	BRD-A15687940-001-05-6	Launched
clofibrate	PPAR receptor agonist	LPL, PPARA	endocrinology, cardiology	hyperlipidemia, cholesterol	MicroSource, Selleck, Selleck	99.05	BRD-K45252063-001-13-6, BRD-K45252063-001-14-4, BRD-K45252063-001-12-8	Launched
clofibric-acid	PPAR receptor agonist	PPARA			MicroSource, Tocris, Selleck	98.95	BRD-K19111024-001-20-9, BRD-K19111024-001-19-1, BRD-K19111024-001-18-3	Launched
clofilium	potassium channel blocker	KCNA5, KCNH1			Sigma, Prestwick	46.21	BRD-K02680176-075-12-9, BRD-K02680176-075-11-1	Phase 2
clofoctol	protein synthesis inhibitor		infectious disease	gram-positive bacterial infections	Selleck, MicroSource	97.9	BRD-K02900412-001-11-3, BRD-K02900412-001-12-1	Launched
clomesone	DNA inhibitor				Enamine	0	BRD-K39230570-001-01-1	Phase 1
clomethiazole	GABA receptor antagonist, GABA receptor modulator	GABRA1	neurology/psychiatry	Parkinson's Disease, sedative, muscle relaxant	Tocris, Enamine	94.39	BRD-K50422030-003-02-6, BRD-K50422030-001-05-3	Launched
clomifene	estrogen receptor antagonist	ESR1	obstetrics/gynecology	infertility	MicroSource, Selleck, Selleck	94.27	BRD-K29950728-048-17-4, BRD-K29950728-048-16-6, BRD-K29950728-048-18-2	Launched
clomipramine	serotonin transporter (SERT) inhibitor	GSTP1, HTR2A, HTR2B, HTR2C, SLC6A2, SLC6A3, SLC6A4	neurology/psychiatry	obsessive compulsive disorder (OCD)	MicroSource, Tocris, Selleck	92.56	BRD-K52989797-003-28-0, BRD-K52989797-003-27-2, BRD-K52989797-003-26-4	Launched
clonazepam	GABA benzodiazepine site receptor agonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, TSPO	neurology/psychiatry	seizures, panic disorders	MicroSource	96.01	BRD-K38183498-001-02-0	Launched
clonidine	adrenergic receptor agonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C	cardiology, neurology/psychiatry	hypertension, attention-deficit/hyperactivity disorder (ADHD)	MicroSource, Tocris, Selleck	99.61	BRD-K98530306-003-18-3, BRD-K98530306-003-17-5, BRD-K98530306-003-16-7	Launched
clonixin-lysinate	cyclooxygenase inhibitor		neurology/psychiatry	pain relief	Prestwick, Sigma	86.5	BRD-M63173034-001-02-8, BRD-M63173034-001-03-6	Launched
clopamide	sodium/chloride cotransporter inhibitor		cardiology	hypertension	Selleck	98.21	BRD-A85651701-001-19-7	Launched
cloperastine	antitussive		pulmonary	cough suppressant	MicroSource	97.64	BRD-A80908310-003-13-8	Launched
clopidogrel	purinergic receptor antagonist	P2RY12	cardiology, neurology/psychiatry	myocardial infarction, stroke, peripheral artery disease (PAD), acute coronary syndrome (ACS)	Selleck, MicroSource, Selleck	99.2	BRD-K27721098-065-10-2, BRD-K27721098-065-09-4, BRD-K27721098-065-08-6	Launched
clopidol			infectious disease	coccidiosis	MicroSource	95.89	BRD-K80036624-001-04-0	Launched
cloprostenol-(+/-)	prostaglandin receptor agonist	PTGDR, PTGER1, PTGER3, PTGFR, TBXA2R			Tocris	93.34	BRD-K17850764-236-11-9	Launched
cloranolol	adrenergic receptor antagonist	ADRB1, ADRB2, ADRB3			Sigma	97.23	BRD-A04971881-003-01-3	Launched
clorgiline	monoamine oxidase inhibitor	MAOA			Selleck, MicroSource	97.37	BRD-K73251053-003-21-4, BRD-K73251053-003-22-2	Phase 2
clorotepine	dopamine receptor antagonist, adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, DRD2, HRH1, HTR2C, HTR6	neurology/psychiatry	psychosis	Sigma	99.23	BRD-A19053834-050-09-5	Launched
clorprenaline	adrenergic receptor agonist	ADRB1, ADRB2	pulmonary	asthma	Selleck	95.94	BRD-A29281099-003-03-2	Launched
clorsulon	glycolysis inhibitor		infectious disease	gastrointestinal roundworms, lungworms, liver flukes, lice, mites	MicroSource, Selleck	99.05	BRD-K97521363-001-16-1, BRD-K97521363-001-15-3	Launched
closantel	chitinase inhibitor, NFkB pathway inhibitor		infectious disease	liver flukes	MicroSource, Selleck, Selleck, Selleck	99.14	BRD-A19952358-001-11-3, BRD-A19952358-236-01-6, BRD-A19952358-001-10-5, BRD-A19952358-001-12-1	Launched
clotiapine			neurology/psychiatry	psychosis	Enzo	98.82	BRD-K10990317-001-04-5	Launched
clotrimazole	cytochrome P450 inhibitor, imidazoline receptor ligand	CYP3A4, KCNN4, NR1I2, NR1I3, TRPM2, TRPM4, TRPM8	infectious disease	vulvovaginal candidiasis, oropharyngeal candidiasis	Tocris, MicroSource, Selleck	98.93	BRD-K15916496-001-29-5, BRD-K15916496-001-27-9, BRD-K15916496-001-26-1	Launched
cloxacillin	bacterial cell wall synthesis inhibitor		infectious disease	gram-positive bacterial infections	MicroSource, Selleck, Selleck	94.98	BRD-K01244426-236-12-1, BRD-K01244426-323-07-7, BRD-K01244426-323-08-5	Launched
cloxyquin	potassium channel activator	KCNK18			MicroSource	94.72	BRD-K46982791-001-09-4	Preclinical
clozapine	dopamine receptor antagonist, serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CALY, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR3A, HTR5A, HTR6, HTR7	neurology/psychiatry	schizophrenia	MicroSource, Selleck, Tocris, Selleck	95.42	BRD-K37289225-001-36-4, BRD-K37289225-001-34-9, BRD-K37289225-001-35-6, BRD-K37289225-001-37-2	Launched
CL316243	adrenergic receptor agonist	ADRB3, UCP1, UCP2, UCP3			Tocris	96.36	BRD-K06467130-304-02-7	Phase 2
CMPD-1	p38 MAPK inhibitor	GNRHR, MAPK14			Tocris, Tocris	96.43	BRD-K54095730-001-03-1, BRD-K54095730-001-04-9	Preclinical
CNQX	glutamate receptor antagonist	GRIA1, GRIA2, GRIA3, GRIA4			Tocris, Tocris	97.7	BRD-K19438463-304-01-2, BRD-K19438463-001-05-5	Phase 1
CNX-2006	EGFR inhibitor	EGFR			MedChemEx	88.48	BRD-K24869513-001-02-1	Preclinical
CNX-774	Bruton's tyrosine kinase (BTK) inhibitor	BTK			Selleck	96.11	BRD-K48443249-001-01-0	Preclinical
CO-101244	glutamate receptor antagonist	GRIN2B			Tocris, Tocris	94.77	BRD-K55677650-003-02-9, BRD-K55677650-003-03-7	Preclinical
co-102862		SCN4A, SCN9A			Tocris	97.69	BRD-K70912147-001-01-8	Phase 1
cobicistat	cytochrome P450 inhibitor	CYP3A4, CYP3A43, CYP3A5, CYP3A7	infectious disease	human immunodeficiency virus (HIV-1)	Selleck	95.36	BRD-K51040301-001-02-1	Launched
cobimetinib	MEK inhibitor		oncology	melanoma	MedChemEx	91.15	BRD-K03390685-001-01-7	Launched
coenzyme-a		ACAT2, CRAT, CS, DBI, HMGCR, KAT2A, KAT2B, KAT5			ChemImpex	0	BRD-A67956599-002-01-3	Launched
coenzyme-i		AASS, ACADS, ADH1A, ADH1B, ADH1C, ADH4, ADH5, ADH7, AKR1B1, AKR1C1, AKR1C2, AKR1C3, AKR1C4, ALDH1A1, ALDH1A2, ALDH1A3, ALDH1B1, ALDH2, ALDH3A1, ALDH3A2, ALDH3B1, ALDH3B2, ALDH4A1, ALDH5A1, ALDH6A1, ALDH7A1, ALDH9A1, AMT, BDH1, BLVRA, BLVRB, CDO1, CYB5R3, CYP17A1, CYP4A11, DHCR7, DHFR, DLAT, DLD, EHHADH, GAPDH, GAPDHS, GLUD1, GLUD2, GPD1, GSR, H6PD, HADH, HADHA, HIBADH, HMGCR, HMOX1, HMOX2, HPGD, HSD11B1, HSD11B2, HSD17B1, HSD17B10, HSD17B2, HSD17B3, HSD17B4, HSD17B7, HSD17B8, HSD3B1, HSD3B2, IDH3A, IDH3B, IDH3G, IMPDH1, IMPDH2, LDHA, LDHAL6A, LDHAL6B, LDHB, LDHC, MDH1, MDH2, ME1, ME2, ME3, MSMO1, MT-ND1, MT-ND2, MT-ND3, MT-ND4, MT-ND4L, MT-ND5, MT-ND6, MTHFD1, MTHFD2, NDUFA1, NDUFA10, NDUFA11, NDUFA12, NDUFA13, NDUFA2, NDUFA3, NDUFA4, NDUFA4L2, NDUFA5, NDUFA6, NDUFA7, NDUFA8, NDUFA9, NDUFAB1, NDUFB1, NDUFB10, NDUFB2, NDUFB3, NDUFB4, NDUFB5, NDUFB6, NDUFB7, NDUFB8, NDUFB9, NDUFC1, NDUFC2, NDUFS1, NDUFS2, NDUFS3, NDUFS4, NDUFS5, NDUFS6, NDUFS7, NDUFS8, NDUFV1, NDUFV2, NDUFV3, NNT, NQO2, NSDHL, OGDH, PDHA1, PDHA2, PDHB, PHGDH, PYCR1, PYCR2, QDPR, RDH5, SORD, TSTA3, TYR, UGDH			Apollo, SantaCruz	0	BRD-A84188517-304-01-1, BRD-A84188517-304-02-9	Phase 2
coenzyme-q10					Sigma, Selleck, Selleck	0	BRD-K75043328-001-05-9, BRD-K75043328-001-04-2, BRD-K75043328-001-03-4	Launched
colchicine	microtubule inhibitor	GLRA1, GLRA2, TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8	rheumatology, endocrinology	gout, fever	MicroSource, Tocris	96.57	BRD-K00259736-001-16-4, BRD-K00259736-001-18-0	Launched
colesevalam					MicroSource	0	BRD-U08520523-000-01-0	Preclinical
colforsin	adenylyl cyclase activator	ADCY2, ADCY5			MicroSource	100	BRD-A55416093-001-06-4	Phase 2
colforsin-daproate	adenylyl cyclase activator				EMDBio	100	BRD-K19388745-003-01-7	Launched
colfosceril-palmitate	pulmonary surfactant		pulmonary	respiratory distress syndrome (RDS)	Sigma, Acros	0	BRD-A95886749-001-04-3, BRD-A95886749-001-03-5	Launched
colistimethate	bacterial permeability inducer		infectious disease	gram-negative bacterial infections	MicroSource, Selleck	0	BRD-A13668387-319-04-7, BRD-A44942307-405-01-9	Launched
colistin	bacterial permeability inducer		infectious disease	gram-negative bacterial infections	MedChemEx, MedChemEx	65.4	BRD-A18924964-065-01-5, BRD-A18924964-065-02-3	Launched
colistin-b-sulfate	bacterial permeability inducer		infectious disease	gram-negative bacterial infections	Enzo	46.42	BRD-A36456202-001-01-3	Launched
colistin-sulfate	bacterial permeability inducer		infectious disease	gram-negative bacterial infections	MicroSource, Selleck, Selleck	55.02	BRD-A45201156-315-02-0, BRD-K57773246-001-01-1, BRD-K57773246-001-02-9	Launched
combretastatin-A-4	tubulin polymerization inhibitor				ChemDiv	87.15	BRD-K61195623-001-01-4	Phase 2
compound-w	beta-secretase inhibitor	BACE1			Tocris	98.85	BRD-K98143539-001-02-2	Preclinical
compound-401	DNA dependent protein kinase inhibitor	MTOR, PRKDC			Tocris	99.02	BRD-K19655798-001-01-9	Preclinical
compound-58112					Sigma	97.83	BRD-K76139886-003-01-3	Preclinical
conivaptan	vasopressin receptor antagonist	AVPR1A, AVPR2	endocrinology	hyponatremia	Selleck	98.26	BRD-K37385792-003-02-1	Launched
copanlisib	PI3K inhibitor	PIK3CA, PIK3CB, PIK3CD, PIK3CG	hematologic malignancy	follicular lymphoma	MedChemEx, MedChemEx	97.22	BRD-K24666289-001-02-3, BRD-K24666289-001-04-9	Launched
copper-histidine		HAL, HARS, HDC, SLC15A3, SLC15A4, SLC38A3, SLC38A5			Enzo	93.67	BRD-K36449075-001-01-0	Phase 3
COR-170	cannabinoid receptor inverse agonist	CNR2			Tocris	98.6	BRD-K74965187-001-01-3	Preclinical
cordycepin	DNA inhibitor				Tocris, Tocris	98.83	BRD-K65428967-001-08-4, BRD-K65428967-001-09-2	Phase 1/Phase 2
corosolic-acid	PKC inhibitor, protein tyrosine kinase inhibitor	HSD11B1, PTPN1			MedChemEx	96.17	BRD-K27885593-001-06-8	Phase 2
corticosterone	mineralocorticoid receptor agonist	HSD11B1, NCOA1, NR3C2			Prestwick, Tocris	98.1	BRD-K73589401-001-23-6, BRD-K73589401-001-25-1	Preclinical
cortisone	glucocorticoid receptor agonist	NR3C1	gastroenterology, rheumatology, dermatology	ulcerative colitis, rheumatoid arthritis, psoriasis, joint inflammation, eczema	MicroSource	93.59	BRD-A62731508-001-05-8	Launched
cortisone-acetate	glucocorticoid receptor agonist	NR3C1	pulmonary, rheumatology, allergy, dermatology, ophthalmology, gastroenterology, infectious disease	asthma, rheumatoid arthritis, urticaria, osteoarthritis, psoriasis, allergic rhinitis, conjunctivitis, ulcerative colitis, meningitis	MicroSource, Selleck, Selleck	87.13	BRD-K86161929-001-13-3, BRD-K86161929-001-11-7, BRD-K86161929-001-12-5	Launched
cortodoxone	androgen receptor antagonist	AR			Vitas-M, MedChemEx, Sigma	94.37	BRD-K43736954-001-22-3, BRD-K32891457-001-16-3, BRD-K32891457-001-15-5	Phase 3
costunolide	telomerase inhibitor				Selleck, Tocris, Selleck	89.25	BRD-K26833429-001-04-4, BRD-K26833429-001-03-6, BRD-K26833429-001-02-8	Preclinical
cot-inhibitor-1	MAPK-interacting kinase inhibitor	MAP3K8			MedChemEx	90.4	BRD-K98710228-001-01-6	Preclinical
cot-inhibitor-2	MAPK-interacting kinase inhibitor	MAP3K8			MedChemEx, MedChemEx	93.1	BRD-K49468759-001-05-9, BRD-K49468759-001-04-2	Preclinical
cotinine	nicotine metabolite				MicroSource	97.89	BRD-K94144010-001-13-9	Phase 2
coumarin	vitamin K antagonist	CA1, CA12, CA14, CA2, CA4, CA6, CA9, CYP2A6	gastroenterology, pulmonary	ulcerative colitis, asthma, celiac disease	MicroSource, Selleck	99.45	BRD-K23913458-001-20-7, BRD-K23913458-001-19-9	Launched
coumophos	cholinesterase inhibitor				MicroSource	89.12	BRD-K41567533-001-08-3	Preclinical
CP-316819	glycogen phosphorylase inhibitor	PYGL			Tocris	95.8	BRD-K53913008-001-01-5	Preclinical
CP-339818	potassium channel blocker	KCNA3			Tocris	99.19	BRD-K52113681-003-02-1	Preclinical
CP-376395	corticosteroid releasing factor receptor antagonist	CRHR1			Key, Tocris	98.61	BRD-K31394475-001-01-9, BRD-K31394475-003-01-5	Phase 1
CP-471474	matrix metalloprotease inhibitor	MMP1, MMP13, MMP2, MMP3, MMP9			Tocris	75.47	BRD-K33234937-001-01-7	Preclinical
CP-532623	cholesteryl ester transfer protein inhibitor	CETP			Sigma	98.71	BRD-K36611520-001-01-6	Phase 1
CP-640186	acetyl-CoA carboxylase inhibitor	ACACA, ACACB			MedChemEx	89.9	BRD-K26921335-003-01-2	Preclinical
CP-673451	PDGFR tyrosine kinase receptor inhibitor	KIT, PDGFRA, PDGFRB			Selleck, Selleck	91.79	BRD-K43621685-001-02-5, BRD-K43621685-001-03-3	Preclinical
CP-724714	EGFR inhibitor, protein tyrosine kinase inhibitor	ERBB2			Selleck	97.14	BRD-K76908866-001-07-6	Phase 2
CP-775146	PPAR receptor agonist	PPARA			Tocris	97.47	BRD-K96843359-001-02-6	Preclinical
CP-91149	glycogen phosphorylase inhibitor	PYGL			Selleck	97.92	BRD-K19171642-001-02-3	Preclinical
CP-93129	serotonin receptor agonist	HTR1A			Tocris	87.99	BRD-K81876028-300-02-0	Preclinical
CP-94253	serotonin receptor agonist	HTR1B			Tocris, Tocris	92.31	BRD-K33860217-003-04-0, BRD-K33860217-003-03-2	Preclinical
CP-945,598	cannabinoid receptor antagonist	CNR1			MedChemEx	98.78	BRD-K09090949-001-01-9	Phase 3
CP-99994	tachykinin antagonist	TACR1			Tocris	94.58	BRD-K09946180-300-01-6	Phase 2
CPA-inhibitor	carboxypeptidase inhibitor	CPA1, CPA2			MedChemEx	95.18	BRD-A69126730-001-01-3	Preclinical
CPCCOEt	glutamate receptor antagonist	GRM1			Tocris, Tocris	96.83	BRD-A05729358-001-03-8, BRD-A05729358-001-02-0	Preclinical
CPI-0610	bromodomain inhibitor	BRD4			MedChemEx	97.89	BRD-K19871656-001-01-3	Phase 1
CPI-1189	tumor necrosis factor release inhibitor	TNF			ChemDiv	98.62	BRD-K11073688-001-01-6	Phase 2
CPI-169	histone lysine methyltransferase inhibitor	EZH2			MedChemEx	93.82	BRD-K97181972-001-01-9	Preclinical
CPI-203	bromodomain inhibitor	BRD4			Tocris, MedChemEx	94.7	BRD-K15811707-001-02-0, BRD-K15811707-001-01-2	Preclinical
CPI-360	histone lysine methyltransferase inhibitor	EZH2			MedChemEx	94.64	BRD-K18319422-001-01-7	Preclinical
CPI-613	pyruvate dehydrogenase inhibitor	PDHA1			Selleck	95.51	BRD-A06916187-001-02-9	Phase 2
CPP	glutamate receptor antagonist	GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D			Tocris, EMDBio, AMS	93.04	BRD-K66094457-001-02-3, BRD-K66094457-001-01-5, BRD-A60832661-001-01-8	Phase 2
CPSI-1306-(+/-)	macrophage migration inhibiting factor inhibitor	MIF			Tocris	96.78	BRD-A81603255-001-01-0	Preclinical
creatine		CKB, CKM, CKMT1A, CKMT2, GAMT, SLC6A8			Vitas-M	100	BRD-K19615002-001-02-3	Launched
creatinine					Selleck, MicroSource	100	BRD-K13495773-001-11-4, BRD-K13495773-001-12-2	Preclinical
creatinol-phosphate					CombiBlocks, CombiBlocks	100	BRD-K42991124-001-04-8, BRD-K42991124-001-03-0	Launched
crenolanib	PDGFR tyrosine kinase receptor inhibitor	CSF1R, FLT3, KIT, PDGFRA, PDGFRB			Selleck, Selleck	91.35	BRD-K22127577-001-03-7, BRD-K22127577-001-02-9	Phase 2
cresol					MicroSource	78.99	BRD-K56940914-001-04-2	Launched
cresopirine					MicroSource	94.31	BRD-K58648841-001-04-7	Preclinical
cridanimod	progesterone receptor agonist	PGR			ChemDiv, Sigma	98.36	BRD-K97939847-001-11-2, BRD-K97939847-001-12-0	Launched
crisaborole	phosphodiesterase inhibitor	PDE4B			MedChemEx	93.42	BRD-K43230258-001-01-4	Phase 3
crizotinib	ALK tyrosine kinase receptor inhibitor	ALK, MET	oncology	non-small cell lung cancer (NSCLC)	MedChemEx, Selleck, Selleck	89.1	BRD-K78431006-001-15-1, BRD-K78431006-001-10-2, BRD-K78431006-001-11-0	Launched
crizotinib-(S)	MTH1 inhibitor	NUDT1			Selleck, Selleck	91.61	BRD-K40308497-001-02-0, BRD-K40308497-001-01-2	Preclinical
croconazole	bacterial cell wall synthesis inhibitor				AKSci	0	BRD-K73701464-003-01-3	Launched
cromakalim		KCNJ8			Tocris	99.22	BRD-M89827113-001-01-5	Phase 2
cromoglicic-acid	immunosuppressant	KCNMA1, S100P	pulmonary, ophthalmology, allergy, gastroenterology	asthma, conjunctivitis, urticaria, ulcerative colitis	MicroSource, Selleck	100	BRD-K20920669-304-10-9, BRD-K20920669-304-09-1	Launched
crotamiton	antipruritic		infectious disease	scabies	MicroSource	85.06	BRD-K57179821-001-15-4	Launched
CRT0044876					Selleck	96.56	BRD-K02816415-001-01-9	Preclinical
cryptotanshinone	acetylcholinesterase inhibitor, STAT inhibitor	STAT3			MedChemEx, MedChemEx, Selleck, Selleck	66.48	BRD-K33336844-001-11-1, BRD-K33336844-001-10-3, BRD-K33336844-001-09-5, BRD-K33336844-001-12-9	Preclinical
crystal-violet	other antibiotic				Selleck, Selleck, MicroSource	86.06	BRD-K60025295-003-07-4, BRD-K60025295-003-05-8, BRD-K60025295-003-06-6	Launched
CR8-(R)	CDK inhibitor	CCNA2			Tocris, Tocris	96.87	BRD-K40331046-305-01-5, BRD-K40331046-305-02-3	Preclinical
CS-110266	dopamine receptor agonist	SLC6A3			Tocris, Tocris	94.58	BRD-K15519488-050-02-1, BRD-K15519488-050-01-3	Preclinical
CS-917	fructose biphosphate inhibitor	FBP1			MedChemEx, MedChemEx	92.89	BRD-K35601925-001-01-9, BRD-K35601925-001-02-7	Phase 2
CT-7758	integrin antagonist	ITGA4			MedChemEx	96.91	BRD-K40870905-001-01-7	Phase 2
CTEP	glutamate receptor antagonist	GRM5			Selleck	96.37	BRD-K30572193-001-02-0	Preclinical
CTS-1027	metalloproteinase inhibitor	MMP1, MMP13, MMP2, MMP3, MMP9			MedChemEx, MedChemEx	97.14	BRD-K53508936-001-02-8, BRD-K53508936-001-01-0	Phase 2
CTS21166	beta-secretase inhibitor	BACE1			EMDBio	78.39	BRD-K89071957-001-01-1	Phase 1
CU-CPT-4a	toll-like receptor inhibitor	TLR3			Tocris	91.08	BRD-K58234744-001-01-0	Preclinical
CU-T12-9	toll-like receptor agonist	TLR1, TLR2			Tocris	94.4	BRD-K89462779-001-01-8	Preclinical
CUDC-101	EGFR inhibitor	EGFR, ERBB2			Selleck	94.69	BRD-K41278234-001-03-0	Phase 1
CUDC-427	apoptosis inhibitor	XIAP			MedChemEx, MedChemEx	86.1	BRD-K69351586-001-02-8, BRD-K69351586-001-01-0	Phase 1
CUDC-907	PI3K inhibitor	HDAC2, PIK3R1			Selleck	91.24	BRD-K77638923-001-02-0	Phase 2
CUR-61414	smoothened receptor antagonist	DHH, IHH, SMO			Cayman	97.61	BRD-K69624312-001-01-1	Phase 1
curcumin	cyclooxygenase inhibitor, histone acetyltransferase inhibitor, lipoxygenase inhibitor, NFkB pathway inhibitor	APP, CA1, CA12, CA14, CA2, CA4, CA6, CA9, CYP3A4, DNMT3B, EP300, MMP13, MMP9, NOS2, PTGS1, PTGS2, XDH			Selleck, Selleck, Enzo	91.77	BRD-K07572174-001-39-4, BRD-K07572174-001-38-6, BRD-K07572174-001-43-6	Launched
curcumol	JAK inhibitor	JAK1, JAK2, JAK3			Selleck, Selleck	82.1	BRD-K41933240-001-02-4, BRD-K41933240-001-03-2	Phase 1
cutamesine	sigma receptor agonist	SIGMAR1			MedChemEx, Tocris	95.88	BRD-K90777969-300-01-2, BRD-K90777969-300-02-0	Phase 2
CV-1808	adenosine receptor agonist	ADORA2A			Tocris	95.83	BRD-K49197823-001-09-8	Preclinical
CVT-10216	aldehyde dehydrogenase inhibitor	ALDH2			Sigma, Tocris	96.71	BRD-K60659193-001-01-0, BRD-K60659193-001-02-8	Phase 1
CW-008	PKA activator	PRKACA			Tocris	92.05	BRD-K84068331-001-01-9	Preclinical
CX-4945	casein kinase inhibitor	CSNK2A1, CSNK2A2, DAPK3, HIPK3			Selleck	98.07	BRD-K81458380-001-04-9	Phase 1/Phase 2
CX-516	glutamate receptor modulator				Tocris	98.29	BRD-K25140590-001-03-0	Phase 2/Phase 3
CX-5461	RNA polymerase inhibitor				MedChemEx	96.98	BRD-K12787259-001-04-3	Phase 1
cyacetacide					MicroSource	93.04	BRD-K39371216-001-01-3	Preclinical
cyamemazine	serotonin receptor antagonist	HTR1A, HTR2A, HTR2C, HTR7	neurology/psychiatry	schizophrenia, anxiety	Sigma	87.23	BRD-A42881122-001-01-1	Launched
cyanocobalamin	methylmalonyl CoA mutase stimulant, vitamin B	MMAA, MMACHC, MTHFR, MTR, MTRR, MUT	hematology, infectious disease, gastroenterology	anemia, fish tapeworm infestation, celiac disease	MicroSource, Selleck	97.22	BRD-A18627414-001-05-6, BRD-A18627414-001-04-9	Launched
cyanopindolol	adrenergic receptor antagonist	ADRB1, HTR1A, HTR1D			Tocris	96.81	BRD-A47884604-051-01-2	Phase 2
cyclamic-acid					MicroSource, MicroSource, Selleck	100	BRD-K50785021-001-04-7, BRD-K50785021-001-03-9, BRD-K50785021-001-02-1	Preclinical
cyclandelate	calcium channel blocker	CACNA2D1, CES1	cardiology, rheumatology	claudication, arteriosclerosis, Raynaud's disease	MicroSource, Selleck, Selleck	96.1	BRD-A27370296-001-03-0, BRD-A27370296-001-02-2, BRD-A27370296-001-04-8	Launched
cyclic-AMP		CNGA3, HCN2, PRKAR1A, PRKAR2B, TRPM7			ChemDiv	100	BRD-A41840684-001-01-8	Preclinical
cyclizine	histamine receptor modulator	HRH1, SULT1E1	gastroenterology, neurology/psychiatry	nausea, vomiting, vertigo, motion sickness	MicroSource, Selleck	99.27	BRD-K79501723-001-04-6, BRD-K79501723-300-01-8	Launched
cyclobenzaprine	adrenergic receptor agonist, serotonin receptor agonist	HTR2A	neurology/psychiatry	spasms	MicroSource	97.11	BRD-K42348709-003-13-1	Launched
cyclocreatine	creatine kinase substrate				Sigma	96.8	BRD-K14379200-001-04-7	Phase 1
cyclocytidine	DNA synthesis inhibitor, RNA synthesis inhibitor				MicroSource, Selleck	99.31	BRD-K67536197-003-11-4, BRD-K67536197-003-10-6	Preclinical
cycloheximide	protein synthesis inhibitor	RPL3			Sigma, MicroSource	89.23	BRD-K36055864-001-20-0, BRD-K36055864-001-19-2	Preclinical
cyclopenthiazide	thiazide diuretic		cardiology	hypertension, congestive heart failure	Prestwick	99.7	BRD-A41250306-001-11-7	Launched
cyclopentolate	acetylcholine receptor antagonist	CHRM1	ophthalmology	mydriasis, cycloplegia	MicroSource	94.68	BRD-A77291778-003-22-0	Launched
cyclophosphamide	DNA alkylating agent	CYP2A6, CYP2B6, CYP2C18, CYP2C19, CYP2C8, CYP2C9, CYP2D6, CYP3A4, CYP3A5, CYP3A7	hematologic malignancy, oncology	Hodgkin's lymphoma, small lymphocytic lymphoma (SLL), breast cancer, neuroblastoma, Burkitt's lymphoma, multiple myeloma, chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML), true histiocytic lymphoma (THL), retinoblastoma, ovarian cancer	MicroSource, Selleck, Selleck	93.6	BRD-A09722536-002-18-0, BRD-A09722536-002-19-8, BRD-A09722536-002-17-2	Launched
cyclopiazonic-acid	ATPase inhibitor	ATP2A1			Tocris, Tocris	99.1	BRD-A10420615-001-05-1, BRD-A10420615-001-04-4	Preclinical
cycloserine-(d)	bacterial cell wall synthesis inhibitor	GRIN1	infectious disease	tuberculosis	MedChemEx, MicroSource, Selleck, MedChemEx, Selleck	0	BRD-K87226815-001-21-3, BRD-K87226815-001-17-1, BRD-K87226815-001-18-9, BRD-K87226815-001-20-5, BRD-K87226815-001-19-7	Launched
cyclosporin-a	calcineurin inhibitor	PPP3CA	rheumatology, dermatology	rheumatoid arthritis, psoriasis	Tocris, MicroSource	99.52	BRD-A69815203-001-07-6, BRD-A69815203-001-08-4	Launched
cyclosporine	calcineurin inhibitor	ABCB11, CAMLG, FPR1, PPIA, PPIF, PPP3R2, SLC10A1, SLCO1B1, SLCO1B3	transplant, rheumatology, dermatology	organ rejection, rheumatoid arthritis, psoriasis	Selleck, Selleck	98.93	BRD-K13533483-001-16-2, BRD-K13533483-001-17-0	Launched
cyclothiazide	glutamate receptor modulator	CA1, CA2, CA4, FXYD2, GRIA1, GRIA2, GRIA3, GRIA4, SLC12A3	cardiology	hypertension	Tocris, MicroSource, Sigma, DuPont, Tocris	65.61	BRD-A38675539-001-13-5, BRD-A38675539-001-11-9, BRD-A38675539-001-14-3, BRD-A38675539-001-12-7, BRD-A38675539-001-10-1	Launched
cyclovalone	breast cancer resistance protein inhibitor	ABCG2	gastroenterology	bile stimulation	Enamine, Sigma	97.7	BRD-K59866480-001-08-1, BRD-K59866480-001-07-3	Launched
cyclovirobuxin-d	calcium channel modulator				Selleck, Selleck	100	BRD-K27799744-001-02-8, BRD-K27799744-001-03-6	Preclinical
CYC116	Aurora kinase inhibitor	AURKA, AURKB, KDR			Selleck, Selleck	93.87	BRD-K64866502-001-04-7, BRD-K64866502-001-03-9	Phase 1
CYM-50260	sphingosine 1 phosphate receptor agonist	S1PR4			Tocris	96.41	BRD-K69877120-001-01-7	Preclinical
CYM-50358	sphingosine 1-phosphate receptor antagonist	S1PR4			Tocris	97.71	BRD-K80666802-003-01-0	Preclinical
CYM-50769	neuropeptide receptor antagonist	NPBWR1			Tocris	98.77	BRD-K27732927-001-03-6	Preclinical
CYM-5442	sphingosine 1 phosphate receptor agonist	S1PR1			Tocris	97.43	BRD-A43005764-003-01-5	Preclinical
CYM-5520	sphingosine 1 phosphate receptor agonist	S1PR2			Tocris	96.49	BRD-K29151923-001-01-5	Preclinical
CYM-5541	sphingosine 1 phosphate receptor agonist	S1PR3			Tocris	93.59	BRD-K75940276-001-03-3	Preclinical
cypermethrin					MicroSource	42.23	BRD-A62798249-001-04-4	Launched
cyproheptadine	histamine receptor antagonist	ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, HRH1, HTR2A, HTR2C, HTR6, HTR7	allergy, otolaryngology, ophthalmology, dermatology	allergic rhinitis, vasomotor rhinitis, conjunctivitis, urticaria, dermatographism	MicroSource, Tocris, MicroSource, Selleck	98.68	BRD-K28143534-001-02-2, BRD-K28143534-003-25-9, BRD-K28143534-003-26-7, BRD-K28143534-003-24-2	Launched
cyproterone	androgen receptor antagonist	AR	oncology	prostate cancer	MicroSource	54.15	BRD-A48103086-001-04-2	Launched
cyproterone-acetate	androgen receptor antagonist	ADORA1, AR	oncology	prostate cancer	MicroSource, Sigma, Selleck	94.11	BRD-K41141507-001-17-0, BRD-K41141507-001-15-4, BRD-K41141507-001-16-2	Launched
cyromazine					Selleck, MicroSource	99.31	BRD-K36711084-001-01-2, BRD-K36711084-001-02-0	Launched
cysteamine	tissue transglutaminase inhibitor	NPY2R, SST	metabolism	cystinosis	MicroSource, Selleck, Selleck	0	BRD-K92611362-001-02-6, BRD-M77687198-001-10-6, BRD-M77687198-001-12-2	Launched
CYT-997	tubulin polymerization inhibitor	TUBB			Selleck	96.56	BRD-K23363278-001-02-1	Phase 2
cytarabine	ribonucleotide reductase inhibitor	POLA1, POLB, POLD1, POLE	hematologic malignancy	acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), non-Hodgkin lymphoma (NHL)	MicroSource, Selleck, Selleck	100	BRD-K71847383-001-13-3, BRD-K71847383-001-12-5, BRD-K71847383-001-07-5	Launched
cytisine	acetylcholine receptor agonist	CHRNA2, CHRNA3, CHRNA4, CHRNA6, CHRNA7, CHRNB2, CHRNB4	neurology/psychiatry	nicotinism	MicroSource, Tocris, Selleck, Selleck	98.23	BRD-K74186897-001-13-2, BRD-K74186897-001-11-6, BRD-K74186897-001-10-8, BRD-K74186897-001-12-4	Launched
cytochalasin-b	microtubule inhibitor	ACTB			Enzo	95.57	BRD-K47000838-001-01-6	Phase 2
cytochlor					Berry	100	BRD-K48988407-001-01-2	Phase 1
cyt387		JAK1, JAK2, JAK3			Selleck, Selleck	94.44	BRD-K87737963-001-07-8, BRD-K87737963-001-06-0	Phase 3
CY208-243	dopamine receptor agonist	CALY			Tocris, Tocris	66.95	BRD-K79353516-001-05-0, BRD-K79353516-001-04-3	Phase 2
CZC-54252	leucine rich repeat kinase inhibitor	LRRK2			Tocris	96.05	BRD-K87021635-003-02-2	Preclinical
CZC24832	PI3K inhibitor	PIK3CG			Selleck, Tocris	98.69	BRD-K01377300-001-01-1, BRD-K01377300-001-02-9	Preclinical
C106					Enzo	0	BRD-M12328004-001-01-8	Phase 3
C11-Acetate		ABAT, ACE, AKR1C3, CA2, CELA1, ESR2, FFAR2, FFAR3, HPRT1, LTA4H, MMP12, NOS1, NOS3, PLA2G1B, PTPN1, SOD1, TXN			SantaCruz	0	BRD-K83914624-415-01-3	Phase 3
C34	toll-like receptor inhibitor	TLR4			Tocris	100	BRD-K43167535-001-01-3	Preclinical
C646	histone acetyltransferase inhibitor	EP300			Selleck, Selleck	88.71	BRD-K73383190-001-03-1, BRD-K73383190-001-02-3	Preclinical
D-(+)-maltose		AMY2B, MGAM			MicroSource	100	BRD-K74377520-001-01-7	Preclinical
D-alpha-tocopheryl-succinate					SantaCruz	93.52	BRD-K64636206-001-02-7	Launched
D-delta-Tocopherol					Acros	91.79	BRD-K04657451-001-01-0	Launched
D-limonene					Sigma, MicroSource	0	BRD-K20879694-001-01-7, BRD-K20879694-001-02-5	Phase 1
D-Phenylalanine	enkephalinase inhibitor	CCBL1, CRH, HCAR3			MicroSource, Selleck, Selleck	100	BRD-K00911807-003-01-2, BRD-K00911807-001-03-2, BRD-K00911807-001-04-0	Preclinical
D-Serine	glutamate receptor agonist	GLRA1, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SERPINB3			Enzo	100	BRD-K71822263-001-03-2	Launched
D-4476	TGF beta receptor inhibitor	CSNK1A1, CSNK1D, TGFB1			Tocris, Tocris	96.91	BRD-K09132007-001-07-5, BRD-K09132007-001-11-7	Preclinical
D-64131	microtubule inhibitor	TUBB			Tocris	98.74	BRD-K26997899-001-02-2	Preclinical
D-7193					ChemImpex	0	BRD-K32372024-001-01-0	Phase 2
DAA-1106	benzodiazepine receptor agonist	TSPO			MedChemEx	98.31	BRD-K01080633-001-01-9	Preclinical
dabigatran	thrombin inhibitor	F2	neurology/psychiatry, hematology	stroke, systemic embolism, pulmonary embolism (PE), deep vein thrombosis (DVT)	MedChemEx, Selleck, MedChemEx, Selleck	77.34	BRD-K38168441-001-04-5, BRD-K38168441-001-02-9, BRD-K38168441-001-05-2, BRD-K38168441-001-03-7	Launched
dabigatran-etexilate	thrombin inhibitor	F2	neurology/psychiatry, hematology	stroke, systemic embolism, pulmonary embolism (PE), deep vein thrombosis (DVT)	MicroSource, Selleck	92.78	BRD-K57041787-066-01-1, BRD-K57041787-001-02-6	Launched
dabrafenib	RAF inhibitor	BRAF, LIMK1, NEK11, RAF1, SIK1	oncology	melanoma	Selleck, MedChemEx, Selleck	98.14	BRD-K09951645-001-11-8, BRD-K09951645-001-08-4, BRD-K09951645-001-06-8	Launched
dacarbazine	DNA alkylating agent	PGD, POLA2	oncology, hematologic malignancy	melanoma, Hodgkin's lymphoma	MicroSource, Selleck	98.92	BRD-K35520305-001-17-7, BRD-K35520305-001-16-9	Launched
dacinostat	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9			Selleck, Selleck	87.84	BRD-K56957086-001-09-7, BRD-K56957086-001-06-3	Phase 1
daclatasvir	HCV inhibitor		infectious disease	hepatitis C	Selleck	94.53	BRD-K82861010-001-02-5	Launched
dacomitinib	EGFR inhibitor	EGFR, ERBB2, ERBB4			Selleck	95.48	BRD-K57169635-001-04-5	Phase 3
dactinomycin	RNA polymerase inhibitor	POLR2A	oncology	testicular carcinoma, Wilm's tumor, rhabdomyosarcoma, Ewing's sarcoma, gestational trophoblastic disease (GTD)	MicroSource	77.87	BRD-K70578146-001-06-7	Launched
daidzein	estrogen receptor agonist	ESRRA, ESRRB, ESRRG, TRPC5			Tocris, Selleck, Enzo, Selleck, Tocris	97.99	BRD-K42095107-001-22-1, BRD-K42095107-001-21-3, BRD-K42095107-001-18-9, BRD-K42095107-001-16-3, BRD-K42095107-001-17-1	Phase 2
dalargin	opioid receptor agonist	OPRM1			InterBioScreen	79.63	BRD-A89196962-300-01-7	Phase 2
dalbavancin	bacterial cell wall synthesis inhibitor	PNLIP	infectious disease	skin infections	MedChemEx	68.91	BRD-K30177383-001-01-0	Launched
dalcetrapib	cholesteryl ester transfer protein inhibitor	CETP			Selleck, Selleck	95.55	BRD-K18849474-001-04-4, BRD-K18849474-001-03-6	Phase 3
dalfampridine	potassium channel blocker	KCNA1, KCNA10, KCNA2, KCNA3, KCNA4, KCNA5, KCNA6, KCNA7, KCNB1, KCNB2, KCNC1, KCNC2, KCNC3, KCNC4, KCND1, KCND2, KCND3, KCNF1, KCNG1, KCNG2, KCNG3, KCNG4, KCNH1, KCNH2, KCNH3, KCNH4, KCNH5, KCNH6, KCNH7, KCNH8, KCNJ13, KCNJ5, KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5, KCNS1, KCNS2, KCNS3, KCNV1, KCNV2	neurology/psychiatry	multiple sclerosis	Tocris, MicroSource	97.14	BRD-K22482860-001-20-6, BRD-K22482860-001-21-4	Launched
daltroban	thromboxane receptor antagonist	TBXA2R			Sigma	94.94	BRD-K26813177-001-03-2	Phase 3
daminozide	KDM2A inhibitor	KDM2A, KDM7A, PHF8			Tocris	63.13	BRD-K83452553-001-05-8	Preclinical
danazol	estrogen receptor antagonist, progesterone receptor agonist	AR, CCL2, ESR1, GNRHR, GNRHR2, PGR	obstetrics/gynecology, cardiology	endometriosis, angioedema	MicroSource	98.72	BRD-A92537424-001-04-7	Launched
danegaptide	gap junction modulator				MedChemEx	85.91	BRD-K35589454-003-01-1	Phase 2
danirixin	CC chemokine receptor antagonist	CXCR2			MedChemEx	94.48	BRD-K13769342-001-01-5	Phase 2
danofloxacin	bacterial DNA gyrase inhibitor		pulmonary	bovine respiratory disease (BRD)	Selleck	95.15	BRD-K45916615-066-02-5	Launched
danoprevir	HCV inhibitor				Selleck	94.01	BRD-K08111240-001-02-8	Phase 2
dantrolene	calcium channel blocker	RYR1, RYR3	neurology/psychiatry, endocrinology	spasms, malignant hyperthermia (MH)	MicroSource, Tocris	97.08	BRD-K81272440-236-13-5, BRD-K81272440-236-12-7	Launched
dantron	laxative				MicroSource	95.61	BRD-K10065684-001-07-4	Withdrawn
danusertib	Aurora kinase inhibitor, growth factor receptor inhibitor	AURKA, AURKB, AURKC, FGFR1, NTRK1, RET, SLK			Selleck, Selleck	91.1	BRD-K07881437-001-04-6, BRD-K07881437-001-03-8	Phase 2
dapagliflozin	sodium/glucose cotransporter inhibitor	SLC5A1, SLC5A2	endocrinology	diabetes mellitus	Selleck, MicroSource	98	BRD-K58160573-001-05-4, BRD-K58160573-001-04-7	Launched
daphnetin	protein kinase inhibitor				Selleck	91.06	BRD-K61269089-001-05-5	Preclinical
dapiprazole	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D	ophthalmology	mydriasis	AvaChem	99.76	BRD-K33133047-001-01-8	Launched
dapivirine	non-nucleoside reverse transcriptase inhibitor	CYP3A4, CYP3A5			Selleck	97.99	BRD-K12885236-001-02-7	Phase 3
dapoxetine	selective serotonin reuptake inhibitor (SSRI)	HTR1A, HTR1B, HTR2C, SLC6A4	urology	premature ejaculation (PE)	Selleck	98.79	BRD-K51579475-003-02-4	Launched
daprodustat	hypoxia inducible factor inhibitor	EGLN1			MedChemEx	93.43	BRD-K06455935-001-01-3	Phase 3
dapsone	bacterial antifolate	DHFR	dermatology, infectious disease	dermatitis herpetiformis (DH), leprosy	MicroSource	98.4	BRD-K62363391-001-24-9	Launched
DAPT	gamma secretase inhibitor				Tocris, Selleck, Tocris	96.31	BRD-K47177710-001-03-1, BRD-K47177710-001-02-3, BRD-K47177710-001-04-9	Preclinical
daptomycin	bacterial cell wall synthesis inhibitor		infectious disease	skin infections, endocarditis	Selleck, Selleck	89.99	BRD-K94358652-001-03-9, BRD-K94358652-001-02-1	Launched
darapladib	phospholipase inhibitor	PLA2G7			MedChemEx	93.01	BRD-K19085898-001-01-8	Phase 3
darglitazone	PPAR receptor antagonist	PPARG			Cayman	96.02	BRD-K82908348-001-01-9	Phase 2
darifenacin	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	urology	urinary incontinence	MicroSource, Selleck	95.96	BRD-K95773607-004-04-6, BRD-K95773607-004-03-8	Launched
darunavir	HIV protease inhibitor	CYP3A4	infectious disease	human immunodeficiency virus (HIV-1)	Selleck	98.7	BRD-K84986517-001-01-8	Launched
darusentan	endothelin receptor antagonist	EDNRA			Key	98.96	BRD-K54863166-001-01-9	Phase 3
dasabuvir	HCV inhibitor		infectious disease	hepatitis C	MedChemEx	91.31	BRD-K02943813-001-01-9	Launched
dasatinib	Bcr-Abl kinase inhibitor, ephrin inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor, tyrosine kinase inhibitor	ABL1, ABL2, BLK, EPHA2, FGR, FRK, FYN, HCK, KIT, LCK, LYN, PDGFRB, SRC, SRMS, STAT5B, YES1	hematologic malignancy	chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL)	Selleck, Selleck	88.41	BRD-K49328571-001-19-2, BRD-K49328571-001-15-0	Launched
DAU-5884	acetylcholine receptor antagonist	CHRM3			Tocris, Tocris	97.49	BRD-K31633810-003-03-6, BRD-K31633810-003-02-8	Preclinical
daucosterol	apoptosis stimulant				MedChemEx	89.9	BRD-K14276241-001-01-2	Phase 2
daunorubicin	RNA synthesis inhibitor, topoisomerase inhibitor	TOP2A, TOP2B	hematologic malignancy	acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL)	MicroSource, Tocris, Selleck, Selleck	90.48	BRD-K43389675-001-02-1, BRD-K43389675-003-20-9, BRD-K43389675-003-19-1, BRD-K43389675-003-16-7	Launched
dazmegrel	thromboxane synthase inhibitor	TBXAS1			Vitas-M	98.91	BRD-K20738689-001-01-2	Phase 2
dazoxiben	thromboxane synthase inhibitor	TBXAS1			AKSci	95.24	BRD-K82767007-001-01-1	Phase 2
DBeQ	ATPase inhibitor	CASP3			Tocris, Selleck	96.56	BRD-K59204667-001-05-6, BRD-K59204667-001-03-1	Preclinical
DBPR108	dipeptidyl peptidase inhibitor	DPP4			MedChemEx	95.35	BRD-K83020231-001-01-2	Phase 1
DC-260126	free fatty acid receptor antagonist	FFAR1			Tocris	94.07	BRD-K10596918-001-01-9	Preclinical
DCC-2618	PDGFR tyrosine kinase receptor inhibitor, KIT inhibitor	KIT, PDGFRA			MedChemEx	97.17	BRD-K49246350-001-01-1	Phase 1
DCEBIO	potassium channel activator	KCNN2, KCNN3, KCNN4			Tocris, Tocris, Tocris	99.43	BRD-K89299012-001-08-6, BRD-K89299012-001-07-8, BRD-K89299012-001-06-0	Preclinical
DCPIB	chloride channel blocker, gap junction modulator, glutamate inhibitor	SLC1A2			Tocris	88.14	BRD-A39255369-001-03-1	Preclinical
DDR1-IN-1	discoidin domain receptor inhibitor	DDR1, DDR2			Tocris	92.41	BRD-K61845293-300-01-9	Preclinical
debrisoquin	adrenergic neuron blocker	SLC6A2	cardiology	hypertension	PrincetonBio, MicroSource	80.31	BRD-K80419150-001-02-4, BRD-K80419150-065-03-7	Launched
decamethonium	acetylcholine receptor agonist	ACHE, CHRNA2	neurology/psychiatry	muscle relaxant	MicroSource, Selleck	99.47	BRD-K49783248-303-08-4, BRD-K49783248-303-07-6	Launched
decamethoxine	antiseptic				Innovapharm	0	BRD-A56320380-300-01-6	Phase 2
decernotinib	JAK inhibitor	JAK3			MedChemEx	97.54	BRD-A95300432-001-01-3	Phase 2/Phase 3
decitabine	DNA methyltransferase inhibitor	DNMT1, DNMT3A	hematologic malignancy, hematology	myelodysplastic diseases (MDS), anemia, chronic myeloid leukemia (CML)	Tocris, Tocris, Selleck	100	BRD-K79254416-001-24-2, BRD-K79254416-001-22-6, BRD-K79254416-001-21-8	Launched
decoquinate	antiprotozoal agent		infectious disease	coccidiosis	MicroSource, MedChemEx, Selleck, Selleck	100	BRD-K17641316-213-01-5, BRD-K17641316-001-04-8, BRD-K17641316-001-02-2, BRD-K17641316-001-03-0	Launched
defactinib	focal adhesion kinase inhibitor	PTK2			MedChemEx, MedChemEx	98.24	BRD-K43578482-001-02-2, BRD-K43578482-001-01-4	Phase 2
deferasirox	chelating agent	CYP3A4	hematology	transfusional hemosiderosis, thalassemia, iron overload	Selleck	97.73	BRD-K97010173-001-04-1	Launched
deferiprone	chelating agent	UGT1A6	hematology	transfusional hemosiderosis, thalassemia, iron overload	MicroSource, Selleck	95.65	BRD-K06878038-001-18-6, BRD-K06878038-001-17-8	Launched
deferoxamine-mesylate	chelating agent		hematology	acute iron intoxication, iron overload	Sigma, MicroSource, MedChemEx	95.48	BRD-K09821361-066-24-1, BRD-K09821361-066-23-3, BRD-K09821361-066-25-8	Launched
deflazacort	glucocorticoid receptor agonist	NR3C1	rheumatology	joint inflammation	Selleck	91.86	BRD-K96006502-001-02-6	Launched
deforolimus	mTOR inhibitor	MTOR			Selleck, Selleck	89.39	BRD-K62304154-001-03-4, BRD-K62304154-001-04-2	Phase 3
degarelix	gonadotropin releasing factor hormone receptor antagonist	GNRHR	oncology	prostate cancer	MedChemEx	96.07	BRD-A88562598-001-01-7	Launched
dehydroacetic-acid					MicroSource	86.69	BRD-A17300716-001-01-5	Preclinical
dehydrocholate					MicroSource	85.01	BRD-A64125466-236-04-6	Preclinical
dehydrocholate-acid					MicroSource	91.75	BRD-A11551002-001-04-6	Preclinical
dehydrocorydaline	acetylcholinesterase inhibitor	ACHE			MedChemEx, MedChemEx	91.32	BRD-K67186445-001-01-3, BRD-K67186445-001-02-1	Phase 3
dehydroepiandrosterone	protein synthesis stimulant	ESR1, ESR2, G6PD, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, HSD17B1, NR1I2, NR1I3, PPARA, SIGMAR1, SULT2A1, SULT2B1			MicroSource, Selleck	100	BRD-K41256143-001-13-5, BRD-K41256143-001-12-7	Launched
dehydroepiandrosterone-sulfate	androgen receptor agonist, estrogen receptor agonist	AR, ESR1, ESR2	endocrinology	menopause	Sigma	99.5	BRD-K15360631-325-01-4	Launched
delamanid	bacterial cell wall synthesis inhibitor		infectious disease	tuberculosis	Adooq	97.31	BRD-K17480742-001-01-1	Launched
delanzomib	proteasome inhibitor	CMA1, CTSG, CYP3A4, ELANE			MedChemEx, MedChemEx, Selleck, Selleck	89.99	BRD-K59325863-001-04-4, BRD-K59325863-001-01-0, BRD-K59325863-001-03-6, BRD-K59325863-001-02-8	Phase 1/Phase 2
delapril	angiotensin converting enzyme inhibitor	ACE	cardiology	hypertension	AKSci	94.88	BRD-K00573984-003-01-5	Launched
delavirdine	non-nucleoside reverse transcriptase inhibitor	CYP3A4	infectious disease	human immunodeficiency virus (HIV-1)	Tocris, Sigma, MedChemEx, Enzo	95.35	BRD-K34068325-066-04-5, BRD-K34068325-066-02-9, BRD-K34068325-066-03-7, BRD-K34068325-066-01-1	Launched
delivert	angiotensin receptor agonist	AGTR1, AGTR2			MedChemEx	88.91	BRD-K45503887-001-01-1	Launched
delphinidin	membrane permeability inhibitor	GLO1			Cayman, Cayman	0	BRD-K79107392-003-02-2, BRD-K79107392-003-01-4	Phase 2
delta-Tocotrienol	HMGCR inhibitor	HMGCR			AnalytiCon	0.25	BRD-K85776940-001-01-9	Phase 1
deltarasin	phosphodiesterase inhibitor	KRAS			Tocris	98.28	BRD-K90830492-305-01-4	Preclinical
demecarium	acetylcholinesterase inhibitor	ACHE, BCHE	ophthalmology	intraocular pressure, glaucoma	Prestwick	94.41	BRD-K51471001-303-04-7	Launched
demeclocycline	bacterial 30S ribosomal subunit inhibitor		endocrinology, infectious disease, ophthalmology, urology	fever, respiratory tract infections, psittacosis, trachoma, conjunctivitis, urethritis, chancroid, cholera, syphilis, listeria, anthrax, actinomycosis, tularemia, brucellosis	MicroSource, MedChemEx, MedChemEx, Selleck	63.01	BRD-A34145622-003-22-8, BRD-A34145622-003-23-6, BRD-A34145622-003-24-4, BRD-A34145622-003-25-1	Launched
denatonium-benzoate					MicroSource	81.39	BRD-K34122555-057-11-5	Preclinical
denotivir	antiviral		infectious disease	virus herpes simplex (HSV), skin infections	Vitas-M	98.5	BRD-K01773083-001-01-4	Launched
deoxyarbutin	tyrosinase inhibitor				Selleck, Selleck	62.84	BRD-A62562325-001-03-3, BRD-A62562325-001-02-5	Preclinical
deoxycholic-acid	biliverdin reductase A activator, G protein-coupled receptor agonist	EFTUD1, FPR1, GPBAR1	endocrinology	submental fat	Enzo	100	BRD-K41170226-001-13-8	Launched
deoxycorticosterone-acetate	progestogen hormone	NR3C2			MicroSource, Selleck, Selleck, Selleck	98.53	BRD-K24556098-001-19-1, BRD-K24556098-001-17-5, BRD-K24556098-001-18-3, BRD-K24556098-001-16-7	Preclinical
deoxyepinephrine	adrenergic receptor agonist, dopamine receptor agonist	ADRA1A, DRD1, DRD2			Enzo	83.38	BRD-K33151569-003-09-7	Preclinical
deptropine	histamine receptor antagonist	HRH1			Prestwick	96.68	BRD-A65797496-048-09-3	Preclinical
dequalinium	PKC inhibitor	KCNN1, KCNN3			MicroSource, Selleck	95.31	BRD-K77685957-300-09-1, BRD-K77685957-300-08-3	Launched
deracoxib	cyclooxygenase inhibitor	PTGS2	rheumatology	osteoarthritis	MicroSource	99.74	BRD-K68558722-001-04-0	Launched
deserpidine	angiotensin converting enzyme inhibitor	ACE, SLC18A2	cardiology	hypertension	Key, AKSci	96.99	BRD-K29462201-001-02-7, BRD-K29462201-001-01-9	Launched
desipramine	tricyclic antidepressant	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR1A, HTR2A, HTR2C, SLC6A2, SLC6A4, SMPD1	neurology/psychiatry	depression	MicroSource, Sigma	94.4	BRD-K60762818-003-25-2, BRD-K60762818-003-26-0	Launched
deslanoside	Na/K-ATPase inhibitor	ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP1B1, ATP1B2, ATP1B3, FXYD2	cardiology	congestive heart failure, cardiac arrythmia	AvaChem	98.38	BRD-K99919177-001-01-3	Launched
desloratadine	histamine receptor antagonist	HRH1	allergy	allergic rhinitis, urticaria	MicroSource, Selleck, Selleck	91.35	BRD-K82357231-001-18-3, BRD-K82357231-001-19-1, BRD-K82357231-001-17-5	Launched
desmethylclozapine	acetylcholine receptor agonist	HTR2C			Tocris	67.09	BRD-K10042277-001-05-0	Phase 2
desmopressin-acetate	vasopressin receptor agonist	AVPR1A, AVPR1B, AVPR2, OXTR	endocrinology, urology	central diabetes insipidus, nocturnal enuresis	MedChemEx	90.07	BRD-A49399758-015-01-8	Launched
desogestrel	progesterone receptor agonist	ESR1, PGR	endocrinology	contraceptive	Enzo	97.27	BRD-K46061689-001-01-9	Launched
desonide	glucocorticoid receptor agonist	NR3C1, PLA2G1B	gastroenterology	Crohn's disease	MicroSource, Selleck, Selleck	97.37	BRD-K21528677-001-04-4, BRD-K21528677-001-02-8, BRD-K21528677-001-03-6	Launched
desoximetasone	glucocorticoid receptor agonist	NR3C1, PLA2G1B	dermatology	corticosteroid-responsive dermatoses	MicroSource	98.83	BRD-A49447682-001-02-4	Launched
desoxycorticosterone-pivalate	corticosteroid agonist	NR3C2	endocrinology	Addison's disease	InterBioScreen	98.85	BRD-K26024145-001-01-9	Launched
desoxycortone	mineralocorticoid receptor agonist	NR3C1, NR3C2			Prestwick	98.09	BRD-K98521173-001-19-4	Preclinical
desoxypeganine	acetylcholinesterase inhibitor, monoamine oxidase inhibitor	ACHE			Enzo	93.52	BRD-K13819402-003-10-2	Phase 1
desvenlafaxine	serotoninâ€“norepinephrine reuptake inhibitor (SNRI)	SLC6A2, SLC6A3, SLC6A4	neurology/psychiatry	depression	MicroSource, Tocris, Selleck, Selleck, Selleck, Selleck	97.16	BRD-A98845662-036-03-7, BRD-A98845662-036-05-2, BRD-A98845662-001-02-3, BRD-A98845662-036-02-9, BRD-A98845662-001-03-1, BRD-A98845662-036-04-5	Launched
detomidine	adrenergic receptor agonist	ADRA2A	neurology/psychiatry	sedative	Selleck	98.34	BRD-K77597856-003-02-5	Launched
dexamethasone	glucocorticoid receptor agonist	ANXA1, NOS2, NR0B1, NR3C1, NR3C2	endocrinology, rheumatology, allergy, gastroenterology, hematology, neurology/psychiatry, dermatology	hypercalcemia, rheumatoid arthritis, psoriatic arthritis, osteoarthritis, allergic rhinitis, ulcerative colitis, anemia, multiple sclerosis, enteritis, lupus, dermatitis herpetiformis (DH), nephrotic syndrome, psoriasis	MicroSource, Tocris, Selleck, Tocris	96.19	BRD-A10188456-001-04-9, BRD-K38775274-001-22-1, BRD-K38775274-001-23-9, BRD-K38775274-001-24-7	Launched
dexamethasone-acetate	glucocorticoid receptor agonist		endocrinology, rheumatology, allergy, gastroenterology, hematology, neurology/psychiatry, dermatology	hypercalcemia, rheumatoid arthritis, psoriatic arthritis, osteoarthritis, allergic rhinitis, ulcerative colitis, anemia, multiple sclerosis, enteritis, lupus, dermatitis herpetiformis (DH), nephrotic syndrome, psoriasis	MicroSource, Selleck	97.02	BRD-K47635719-001-21-1, BRD-K47635719-001-20-3	Launched
dexamethasone-sodium-phosphate	glucocorticoid receptor agonist	NR3C1	endocrinology, rheumatology, allergy, gastroenterology, hematology, neurology/psychiatry, dermatology	hypercalcemia, rheumatoid arthritis, psoriatic arthritis, osteoarthritis, allergic rhinitis, ulcerative colitis, anemia, multiple sclerosis, enteritis, lupus, dermatitis herpetiformis (DH), nephrotic syndrome, psoriasis	MicroSource, MicroSource	95.47	BRD-A79380603-304-02-4, BRD-A83802939-304-04-2	Launched
dexchlorpheniramine	histamine receptor antagonist		allergy, cardiology	allergic conjunctivitis, allergic rhinitis, urticaria, angioedema	MicroSource	95.84	BRD-K39462424-050-09-8	Launched
dexfenfluramine	serotonin receptor agonist	HTR2C, SLC6A4			Prestwick	92.42	BRD-K58626373-003-07-8	Withdrawn
dexfosfoserine	membrane integrity inhibitor	CFTR, GRM4, GRM6, GRM7, GRM8, KCNC4, PDPK1, PIM1, PRKACA, PRKCQ, PYGL, PYGM, REG1A, RHO, SERPINB3, SMAD2, TAOK2			Sigma, MicroSource	0	BRD-K30019776-001-01-9, BRD-K30019776-003-01-5	Preclinical
dexlansoprazole	ATPase inhibitor	ATP4A, ATP4B	gastroenterology	gastroesophageal reflux disease (GERD), erosive esophagitis (EE)	MicroSource, Selleck, Selleck	95.4	BRD-K05900209-001-02-6, BRD-K05900209-001-01-8, BRD-K05900209-001-03-4	Launched
dexloxiglumide	CCK receptor antagonist	CCKAR			AdvChemBlocks	96.36	BRD-K07609981-001-01-7	Phase 3
dexmedetomidine	adrenergic receptor agonist	ADRA2A, ADRA2B, ADRA2C			Tocris, Selleck, Selleck	98.01	BRD-K18423410-003-03-3, BRD-K18423410-003-02-5, BRD-K18423410-001-02-9	Launched
dexniguldipine	calmodulin antagonist	ADORA3			Tocris	92.38	BRD-K44309363-003-02-1	Phase 2
dexpanthenol			gastroenterology	paralytic ileus	MicroSource, MicroSource	89.9	BRD-K71210479-001-05-5, BRD-A59413292-001-08-2	Launched
dexrazoxane	chelating agent, topoisomerase inhibitor	TOP2A, TOP2B	cardiology	cardiomyopathy	Selleck, Selleck, Tocris	94.57	BRD-K07265709-003-05-6, BRD-K07265709-003-03-1, BRD-K07265709-003-04-9	Launched
dextran			hematology, critical care	thrombosis, hypovolemia	ANpharma	100	BRD-K67117832-001-01-9	Launched
dextroamphetamine	monoamine oxidase inhibitor	ADRA1A, ADRA1B, SLC18A2, SLC6A2, SLC6A3, TAAR1	neurology/psychiatry	attention-deficit/hyperactivity disorder (ADHD), narcolepsy	MicroSource	85.01	BRD-K21160401-065-01-0	Launched
dextromethorphan	glutamate receptor antagonist, sigma receptor agonist	CHRNA2, CHRNA3, CHRNA4, CHRNA7, CHRNB2, CHRNB4, CYBA, CYBB, GRIN3A, NCF1, NCF2, NCF4, OPRD1, OPRK1, OPRM1, PGRMC1, RAC1, RAC2, SIGMAR1, SLC6A2, SLC6A4	pulmonary	cough suppressant	MicroSource	99.02	BRD-K33211335-004-01-7	Launched
dextrose			endocrinology	hypoglycemia	Selleck	96.3	BRD-K51431759-001-02-9	Launched
DFB	glutamate receptor agonist	GRM5			Tocris	98.04	BRD-K82002057-001-01-2	Preclinical
DG-172	PPAR receptor inverse agonist	PPARD			Tocris	79.69	BRD-K75748943-300-01-3	Preclinical
DH-97	melatonin receptor antagonist	MTNR1B			Tocris, Tocris	96	BRD-K06014311-001-03-8, BRD-K06014311-001-02-0	Preclinical
DHBP	ryanodine receptor blocker				Tocris	0	BRD-K41262162-303-02-2	Preclinical
diacerein	interleukin inhibitor	IL1B	rheumatology	osteoarthritis	MicroSource, Selleck, Selleck	95.35	BRD-K69122748-001-10-1, BRD-K69122748-001-09-3, BRD-K69122748-001-11-9	Launched
diacetamate					MicroSource	98.65	BRD-K93611241-001-02-2	Preclinical
diadenosine-tetraphosphate	adenosine kinase inhibitor	P2RY13, P2RY2			Enzo	99.35	BRD-A15035311-001-01-8	Phase 1
dianhydrogalactitol	DNA alkylating agent				MedChemEx	0	BRD-K68502831-001-01-2	Phase 1
diarylpropionitrile	estrogen receptor agonist	ESR2			Tocris	94.36	BRD-A27143604-001-02-0	Preclinical
diatrizoic-acid			radiology	contrast agent	MicroSource	97.75	BRD-K48247567-001-01-9	Launched
diaveridine	dihydrofolate reductase inhibitor				MicroSource	99.41	BRD-K97464279-001-03-5	Launched
diazepam	benzodiazepine receptor agonist	ADRA1A, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3, TSPO	neurology/psychiatry	generalized anxiety disorder (GAD), abstinence from alcohol, hallucinosis, tremors	Enzo	99.35	BRD-K16508793-001-05-9	Launched
diazooxonorleucine	glutamate receptor antagonist				ChemImpex	0	BRD-K38458514-001-01-8	Phase 2
diazoxide	potassium channel activator	ATP1A1, CA1, CA2, KCNJ11, KCNJ8, KCNMA1, SLC12A3	endocrinology	hypoglycemia	Tocris, MicroSource, Tocris	99.38	BRD-K73109821-001-22-7, BRD-K73109821-001-20-1, BRD-K73109821-001-19-3	Launched
dibekacin	bacterial 30S ribosomal subunit inhibitor		infectious disease	gram-negative bacterial infections	MicroSource	0	BRD-K48427910-001-01-1	Launched
dibenzepine	norepinephrine reputake inhibitor				Selleck	96.96	BRD-K79145749-003-02-2	Preclinical
dibenzothiophene					MicroSource, Selleck, Selleck	99.86	BRD-K46863940-001-05-4, BRD-K46863940-001-04-7, BRD-K46863940-001-06-2	Preclinical
dibutyl-phthalate		TRPA1			MicroSource	99.18	BRD-K73477617-001-08-5	Preclinical
dichlorisone-acetate					MicroSource, Selleck, Selleck	91.61	BRD-K54187111-001-09-2, BRD-K54187111-001-07-6, BRD-K54187111-001-08-4	Phase 2
dichloroacetate	pyruvate dehydrogenase kinase inhibitor	PDK1			Tocris, Sigma	96.5	BRD-M97302542-001-03-6, BRD-M97302542-001-04-4	Phase 3
dichlorophen	anticestodal agent				Sigma, MicroSource	92.97	BRD-K62326629-001-20-8, BRD-K62326629-001-19-0	Launched
dichlorvos	acetylcholinesterase inhibitor				MicroSource	0	BRD-K23779958-001-05-8	Launched
diclazuril	antiprotozoal agent		infectious disease	equine protozoal myeloencephalitis (EPM)	MicroSource, Selleck	98.14	BRD-A06426627-001-04-3, BRD-A06426627-001-03-5	Launched
diclofenac	cyclooxygenase inhibitor	AKR1C3, ALOX5, ASIC1, ASIC3, KCNQ2, KCNQ3, PLA2G2A, PPARG, PTGS1, PTGS2, SCN4A	rheumatology, neurology/psychiatry	rheumatoid arthritis, osteoarthritis, migraine headache	MicroSource, Selleck, Selleck, Selleck	99.61	BRD-K08252256-236-33-8, BRD-K08252256-237-02-1, BRD-K08252256-224-02-9, BRD-K08252256-236-32-0	Launched
diclofenamide	carbonic anhydrase inhibitor	CA1, CA12, CA2, CA4, CA7	ophthalmology, neurology/psychiatry	glaucoma, epilepsy	Selleck	98.21	BRD-K71499074-001-12-9	Launched
diclofensine	dopamine reuptake inhibitor	DRD1, MAOA, MAOB			MedChemEx	97.06	BRD-A51078674-003-01-0	Phase 3
dicloralurea					MicroSource	0	BRD-A41657926-001-03-0	Preclinical
dicloxacillin	bacterial cell wall synthesis inhibitor		infectious disease	gram-positive bacterial infections	MicroSource, Selleck, Selleck	87.83	BRD-K05673000-236-12-1, BRD-K05673000-323-13-5, BRD-K05673000-323-12-7	Launched
dicoumarol	NADPH inhibitor	CRYZ, NQO1, VKORC1	hematology	deep vein thrombosis (DVT)	MicroSource	99.51	BRD-K82236179-213-01-0	Launched
dicyclohexylamine					Vitas-M	96.38	BRD-K57091285-001-07-7	Preclinical
dicycloverine	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3	gastroenterology	irritable bowel syndrome	MicroSource, Selleck	100	BRD-K68507560-003-25-3, BRD-K68507560-003-24-6	Launched
didanosine	nucleoside reverse transcriptase inhibitor	PNP	infectious disease	human immunodeficiency virus (HIV-1)	Selleck, Selleck	99.4	BRD-K99063460-001-13-1, BRD-K99063460-001-12-3	Launched
dideoxyadenosine	nucleoside reverse transcriptase inhibitor				Berry	97.9	BRD-K84794093-001-07-5	Phase 1
didox	ribonucleotide reductase inhibitor	RRM1	oncology	breast cancer	MedChemEx	95.72	BRD-K94146583-001-01-6	Launched
dienestrol	estrogen receptor agonist	ESR1	endocrinology	menopause	MicroSource	90.26	BRD-K95309561-001-24-7	Launched
dienogest	progesterone receptor agonist	PGR	endocrinology, obstetrics/gynecology	contraceptive, endometriosis	Selleck	92.69	BRD-K50853363-001-02-3	Launched
diethylcarbamazine	lipoxygenase inhibitor	ALOX5, PTGS1	infectious disease	filariasis	MicroSource	99.23	BRD-K45542189-048-22-1	Launched
diethylstilbestrol	estrogen receptor agonist	ESR1, ESR2, ESRRB, ESRRG			MicroSource, Selleck	92.99	BRD-K45330754-001-22-5, BRD-K45330754-001-21-7	Withdrawn
diethyltoluamide	ionotropic receptor IR40a activator		dermatology	sunscreen lotion	MicroSource	98.89	BRD-K94080537-001-09-7	Launched
difenpiramide	cyclooxygenase inhibitor, prostaglandin inhibitor				Enamine	85.55	BRD-K96206066-001-07-9	Launched
diflorasone-diacetate	glucocorticoid receptor agonist	NR3C1	dermatology	corticosteroid-responsive dermatoses	MicroSource	97.55	BRD-A66869276-001-02-9	Launched
difloxacin	bacterial DNA gyrase inhibitor		infectious disease	skin infections, urinary tract infections	Selleck, MicroSource	97.01	BRD-K73923631-003-01-1, BRD-K73923631-003-02-9	Launched
diflunisal	prostanoid receptor antagonist	PTGS1, PTGS2	rheumatology	rheumatoid arthritis, osteoarthritis	MicroSource	98.97	BRD-K22031190-001-23-6	Launched
difluprednate	glucocorticoid receptor agonist	NR3C1	ophthalmology	endogenous uveitis	Selleck	95.46	BRD-K33720171-001-01-0	Launched
diftalone	cyclooxygenase inhibitor		endocrinology	thyroiditis	Vitas-M	98.16	BRD-K80076813-001-08-8	Launched
digitoxigenin	ATPase inhibitor	ATP1A1			Prestwick	93.94	BRD-K18518344-001-15-9	Preclinical
digitoxin	ATPase inhibitor	ATP1A1			MicroSource	97.65	BRD-A93236127-001-04-5	Launched
digoxigenin	steroid				Selleck	97.81	BRD-K18619710-001-14-4	Preclinical
digoxin	ATPase inhibitor	ATP1A1	cardiology	congestive heart failure, atrial fibrillation (AF)	MicroSource	96.49	BRD-A94756469-001-04-7	Launched
dihomo-gamma-linolenic-acid	prostanoid receptor agonist	PTGS1, PTGS2			Sigma, Sigma, Enzo	81.2	BRD-K20152659-001-10-3, BRD-K20152659-001-07-9, BRD-K20152659-001-04-6	Phase 2
dihydrexidine	dopamine receptor agonist	DRD1, DRD2, DRD3, DRD4, DRD5			Tocris	67.11	BRD-K31471398-003-01-5	Phase 2
dihydroartemisinin	antimalarial agent		infectious disease	malaria	Selleck, MicroSource	94.91	BRD-K62213621-001-01-6, BRD-K62213621-001-02-4	Launched
dihydroergocristine	adrenergic receptor antagonist, prolactin inhibitor	ADRA1A, ADRB1, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR2A, HTR3A, HTR4, HTR5A, HTR6, HTR7			Tocris, Tocris	96.31	BRD-K97440753-066-19-9, BRD-K97440753-066-18-1	Launched
dihydroergotamine	serotonin receptor agonist	ADRA2A, DRD2, HTR1B, HTR1D, HTR1E, HTR1F, HTR2B, HTR7	neurology/psychiatry	migraine headache	Tocris, MicroSource, Tocris	97.15	BRD-K72166146-066-06-2, BRD-K72166146-066-05-4, BRD-K72166146-066-04-7	Launched
dihydromyricetin					MedChemEx, MedChemEx, Selleck, Selleck	80.78	BRD-K01614093-001-05-9, BRD-K01614093-001-04-2, BRD-K01614093-001-02-6, BRD-K01614093-001-03-4	Preclinical
dihydrostreptomycin	bacterial 30S ribosomal subunit inhibitor				MicroSource	96.53	BRD-A67363467-001-01-3	Withdrawn
dihydrotachysterol	vitamin analog	VDR	orthopedics, endocrinology	rickets, hypocalcemia, osteomalacia	Sigma	0	BRD-A34455052-001-01-8	Launched
dihydrotestosterone	androgen receptor agonist	AR, HSD17B1	neurology/psychiatry, endocrinology	tetany, hypoparathyroidism	MedChemEx	99.31	BRD-K22525962-001-05-0	Launched
dihydroxyacetone			dermatology	skin protectant	Sigma	0	BRD-K18637542-001-01-7	Launched
dihydroxyphenylglycine	glutamate receptor agonist	GRM1, GRM5			Tocris	0	BRD-A20589515-001-02-9	Preclinical
diiodothyropropionic-acid	thyroid hormone stimulant				Sigma	3.17	BRD-K36802417-001-01-7	Phase 2
dilazep	adenosine reuptake inhibitor	SLC29A1			MicroSource, Tocris	92.84	BRD-K48722258-300-11-0, BRD-K48722258-300-10-2	Launched
diloxanide	protein synthesis inhibitor		infectious disease	amebiasis	MicroSource	98.59	BRD-K10974103-001-21-1	Launched
diltiazem	calcium channel blocker	CACNA1C, CACNA1S, CACNA2D1, CACNG1, HTR3A, KCNA5	cardiology	hypertension, angina pectoris	Tocris, MicroSource, Selleck, Tocris	99.25	BRD-K24023109-003-28-6, BRD-A69636825-003-04-7, BRD-K24023109-003-25-2, BRD-K24023109-003-26-0	Launched
dimaprit	histamine receptor agonist	HRH2, HRH3, HRH4			Selleck, Tocris	100	BRD-K23541596-300-07-2, BRD-K23541596-300-08-0	Preclinical
dimemorfan	sigma receptor agonist	SIGMAR1	pulmonary	cough suppressant	Key	98.52	BRD-K29812331-011-01-7	Launched
dimenhydrinate	histamine receptor antagonist	HRH1	neurology/psychiatry, gastroenterology	motion sickness, nausea, vomiting	MicroSource, MedChemEx, MedChemEx	59.15	BRD-M98649031-001-08-6, BRD-M98649031-001-10-2, BRD-M98649031-001-09-4	Launched
dimercaprol	chelating agent		neurology/psychiatry	metal toxicity	Sigma, MicroSource	0	BRD-A56152450-001-03-8, BRD-A56152450-001-02-0	Launched
dimercaptosuccinic-acid	chelating agent	DNMT1	neurology/psychiatry	metal toxicity	AlfaAesar, AlfaAesar	0	BRD-K88701661-001-03-7, BRD-K88701661-001-02-9	Launched
dimesna	tubulin polymerization inhibitor				MicroSource, Selleck	100	BRD-K30126819-304-03-5, BRD-K30126819-304-02-7	Phase 3
dimethadione	oxazolidine antiepileptic				MicroSource	0	BRD-K43687498-001-09-8	Preclinical
dimethicone			dermatology	cosmetic	Sigma	0	BRD-K26674746-001-01-4	Launched
dimethindene-(S)-(+)	acetylcholine receptor antagonist	HRH1			Tocris, Tocris	90.39	BRD-K83192048-050-03-5, BRD-K83192048-050-02-7	Preclinical
dimethisoquin	local anesthetic		neurology/psychiatry	local anesthetic	Prestwick	95.73	BRD-K73391359-003-10-2	Launched
dimethyl-fumarate	nuclear factor erythroid derived, like (NRF2) activator	KEAP1	neurology/psychiatry	multiple sclerosis	MicroSource, Selleck, Selleck	97.66	BRD-K31111078-001-04-2, BRD-K31111078-001-05-9, BRD-K31111078-001-03-4	Launched
dimethyl-isosorbide	cosmetic moisturizer				AMS	0	BRD-A17224697-001-01-0	Preclinical
dimetindene	histamine receptor antagonist, cholinergic receptor antagonist	CHRM2, HRH1	allergy	allergic rhinitis	AMS	52.79	BRD-A54141700-001-01-5	Launched
dimetridazole	bacterial DNA inhibitor				MicroSource	96.89	BRD-K72728560-001-01-4	Launched
diminazene-aceturate	angiotensin converting enzyme activator	AOC1, PRDX5, PRSS1			MicroSource, Selleck, Selleck	87.59	BRD-K92848252-001-01-9, BRD-K92848252-001-02-7, BRD-K92848252-001-03-5	Phase 3
dimpylate	acetylcholinesterase inhibitor	ACHE			MicroSource	89.72	BRD-K60567437-001-10-2	Launched
dinaciclib	CDK inhibitor	CDK1, CDK2, CDK5, CDK9			Selleck	96.78	BRD-K13662825-001-07-5	Phase 3
dinitolmide			infectious disease	coccidiosis	MicroSource	98.55	BRD-K93240442-001-08-4	Launched
dinoprost	prostacyclin analog	PTGDR, PTGDR2, PTGER1, PTGER2, PTGER3, PTGER4, PTGFR, PTGIR, TBXA2R	obstetrics/gynecology	labor induction	Enzo	100	BRD-K81672972-001-03-1	Launched
dinoprostone	prostanoid receptor agonist	CATSPER1, CATSPER2, CATSPER3, CATSPER4, PTGDR, PTGDR2, PTGER1, PTGER2, PTGER3, PTGER4, PTGFR, TBXA2R			Tocris, Cayman	98.3	BRD-K26521938-001-07-2, BRD-K26521938-001-09-8	Withdrawn
dioscin	apoptosis stimulant	CXCR3			Selleck	100	BRD-K37723606-001-01-5	Preclinical
diosgenin	steroid				Selleck	95.08	BRD-K28690501-001-02-1	Preclinical
diosmetin	aryl hydrocarbon receptor agonist	CYP1B1	dermatology	cosmetic	Selleck	96.23	BRD-K26862302-001-05-2	Launched
diosmin	aryl hydrocarbon receptor agonist, capillary stabilizing agent	AHR	cardiology, hematology, dermatology	chronic venous insufficiency (CVI), edema, deep vein thrombosis (DVT), statis dermatitis, heavy leg syndrome	MicroSource, Selleck, Selleck	89.84	BRD-K94436377-001-10-2, BRD-K94436377-001-11-0, BRD-K94436377-001-12-8	Launched
dioxybenzone	topical sunscreen agent				MicroSource	96.11	BRD-K22193694-001-13-6	Preclinical
dipeptamin					ChemImpex, ChemImpex	0	BRD-K11595419-001-02-2, BRD-K11595419-001-01-4	Launched
diperodon	local anesthetic				Selleck, MicroSource	98.2	BRD-A30693873-003-11-0, BRD-A30693873-003-12-8	Preclinical
diphemanil	acetylcholine receptor antagonist	CHRM3	neurology/psychiatry	spasms	Selleck	96.64	BRD-K93441486-067-12-8	Launched
diphencyprone	immunostimulant				Vitas-M, Sigma	98.43	BRD-K51730347-001-05-6, BRD-K51730347-001-06-4	Phase 2
diphenhydramine	histamine receptor antagonist	HRH1	neurology/psychiatry	headache	MicroSource, Selleck	98.11	BRD-K47278471-003-26-3, BRD-K47278471-003-25-5	Launched
diphenidol	acetylcholine receptor agonist	CHRM1, CHRM2, CHRM3, CHRM4	neurology/psychiatry	vertigo	Enamine	99.63	BRD-K01663662-003-20-2	Launched
diphenyleneiodonium	nitric oxide synthase inhibitor	NOS2, NOS3			Tocris	100	BRD-K65814004-003-02-9	Preclinical
diphenylguanidine					Vitas-M	85.15	BRD-K12362304-001-07-3	Preclinical
diphenylpyraline	dopamine uptake inhibitor	HRH1, SLC6A3	allergy	allergic rhinitis	MicroSource, Selleck	97.93	BRD-K22936972-003-23-6, BRD-K22936972-003-22-8	Launched
dipivefrine	adrenergic receptor agonist	ACHE, ADRA1A, ADRA2A, ADRB2, BCHE	ophthalmology	glaucoma, intraocular pressure	Prestwick	94.37	BRD-A47494775-003-11-3	Launched
dipraglurant	glutamate receptor negative allosteric modulator	GRM5			MedChemEx	94.48	BRD-K64838454-001-01-0	Phase 2
DIPT	dopamine reuptake inhibitor, serotonin reuptake inhibitor	HTR1A, HTR2A, HTR2C			Cayman	88.49	BRD-K75385383-001-01-5	Launched
dipyridamole	phosphodiesterase inhibitor	ADA, PDE10A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PDE6A, PDE6B, PDE6C, PDE6D, PDE6G, PDE6H, PDE7A, PDE7B, PDE8A, PDE8B, PDE9A, SLC29A1	cardiology	coronary artery disease (CAD), peripheral artery disease (PAD), hypertension	Selleck, Tocris, MicroSource, Selleck, Tocris	91.41	BRD-K86301799-001-37-1, BRD-K86301799-001-39-7, BRD-K86301799-001-36-3, BRD-K86301799-001-34-8, BRD-K86301799-001-35-5	Launched
dipyrocetyl	chelating agent		endocrinology, neurology/psychiatry	fever, pain relief	MicroSource	46.15	BRD-K47608922-001-04-7	Launched
dirithromycin	bacterial 50S ribosomal subunit inhibitor		pulmonary	bronchitis	AvaChem, MicroSource, Sigma, MedChemEx, MedChemEx, Selleck, Selleck	95.4	BRD-K52756523-001-27-0, BRD-K52756523-001-24-7, BRD-K52756523-001-28-8, BRD-A77786295-001-02-9, BRD-K52756523-001-25-4, BRD-K52756523-001-26-2, BRD-K52756523-001-29-6	Launched
diroximel-fumarate	anti-inflammatory agent				WuXi	97.29	BRD-K87386013-001-01-7	Phase 3
disodium sebacate		HBA1, HBB			Sigma	68.1	BRD-K66672047-304-01-3	Phase 1
disopyramide	sodium channel blocker	CHRM1, CHRM2, CHRM3, KCND2, KCND3, KCNH2, SCN5A	cardiology	ventricular tachycardia (VT), ventricular arrhythmias	MicroSource, Selleck	97.94	BRD-A29734509-011-13-6, BRD-A29734509-011-12-8	Launched
disulfiram	aldehyde dehydrogenase inhibitor, DNA methyltransferase inhibitor, TRPV agonist	ALDH2, DBH	neurology/psychiatry	abstinence from alcohol	MicroSource, Selleck, Selleck	99.04	BRD-K32744045-001-31-2, BRD-K32744045-001-30-4, BRD-K32744045-001-34-6	Launched
dithranol	DNA synthesis inhibitor		dermatology	psoriasis	Sigma	0	BRD-K51807679-001-06-8	Launched
ditiocarb-sodium-trihydrate	immunostimulant	CA1, CA2, CA4			Enamine, Enamine	0	BRD-K40654626-236-02-3, BRD-K40654626-236-01-5	Phase 3
ditolylguanidine	sigma receptor agonist	GRIN1, GRIN2A, GRIN2B, SIGMAR1			Tocris	89.42	BRD-K33459542-001-07-4	Preclinical
divalproex-sodium	benzodiazepine receptor agonist	ALDH5A1	neurology/psychiatry	epilepsy, seizures	Selleck, Selleck, Sigma	65.88	BRD-K41260949-236-20-0, BRD-K41260949-236-19-2, BRD-K41260949-001-18-2	Launched
dixanthogen					MicroSource	0	BRD-K05919151-001-01-6	Preclinical
dizocilpine-(+)	glutamate receptor antagonist	GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D			Tocris, Tocris, Selleck	98.82	BRD-K58930050-050-16-6, BRD-K58930050-050-15-8, BRD-K58930050-001-05-2	Preclinical
dizocilpine-(-)	glutamate receptor antagonist				Tocris, Selleck	99.01	BRD-K23163214-050-15-1, BRD-K23163214-051-01-9	Phase 1
DMAB-anabaseine	adrenergic receptor agonist	CHRNA7			Tocris, Tocris	90.18	BRD-K26573499-300-02-1, BRD-K26573499-300-03-9	Preclinical
DMeOB		GRM5			Tocris	98.09	BRD-K36775483-001-01-4	Preclinical
DMH1	ALK tyrosine kinase receptor inhibitor	ACVR1			Selleck, Tocris	98.8	BRD-K39381259-001-01-0, BRD-K39381259-001-02-8	Preclinical
DMH4	VEGFR inhibitor	KDR			Tocris	96.96	BRD-K40575944-001-01-5	Preclinical
DMNB	DNA dependent protein kinase inhibitor				Tocris	94.25	BRD-K03564313-001-03-3	Preclinical
DMP-543	acetylcholine release enhancer				Tocris, Tocris	98.35	BRD-K89274813-001-02-3, BRD-K89274813-001-03-1	Phase 2
DMP-777	elastase inhibitor	MPO			MedChemEx	85.68	BRD-K54936858-001-01-6	Phase 2
DMPS	chelating agent				Vitas-M	0	BRD-A22971209-001-01-0	Phase 1
DMSO	control vehicle				Sigma	0	BRD-M56212252-001-01-0	Preclinical
DNQX	glutamate receptor antagonist	GRIA1, GRIA2, GRIK1, GRIN1, GRIN2A, GRIN2B			Tocris, Tocris, Tocris	95.86	BRD-K64400208-001-09-1, BRD-K64400208-304-01-6, BRD-K64400208-001-08-3	Preclinical
dobutamine	adrenergic receptor agonist	ADRB1, ADRB2	cardiology	congestive heart failure	Tocris, MedChemEx, Tocris, MedChemEx, Tocris	81.27	BRD-A78322124-003-16-5, BRD-A78322124-003-18-1, BRD-A78322124-003-17-3, BRD-A78322124-003-15-7, BRD-A78322124-003-14-0	Launched
docebenone	lipoxygenase inhibitor	ALOX5			Enzo	62.9	BRD-K08290224-001-14-5	Phase 2
docetaxel	tubulin polymerization inhibitor	BCL2, MAP2, MAP4, MAPT, NR1I2, TUBB, TUBB1	oncology	breast cancer, non-small cell lung cancer (NSCLC), prostate cancer, gastric adenocarcinoma, head and neck squamous cell carcinoma (HNSCC)	Selleck, MicroSource, Selleck	99.62	BRD-K30577245-001-04-3, BRD-K30577245-341-01-9, BRD-K30577245-001-05-0	Launched
doconexent	PPAR receptor agonist	FFAR1, PTGS1, PTGS2			Sigma, MicroSource	56.12	BRD-K39965020-001-12-5, BRD-K39965020-001-09-1	Launched
doconexent-ethyl-ester	omega 3 fatty acid stimulant				Cayman	0	BRD-K61937613-001-01-1	Launched
docosanol	lipase clearing factor inhibitor	TLR7	dental	cold sore	Selleck, Selleck, MicroSource	0	BRD-K50050533-001-04-7, BRD-K50050533-001-02-1, BRD-K50050533-001-03-9	Launched
docusate	laxative		gastroenterology	constipation	MicroSource	60.87	BRD-A00092689-236-03-8	Launched
dodecyl-sulfate		LYZ			Sigma	0	BRD-K05680146-001-01-2	Preclinical
dofequidar	MRP inhibitor, P glycoprotein inhibitor	ABCB1			MedChemEx	98.23	BRD-A14941520-051-01-0	Phase 3
dofetilide	potassium channel blocker	KCNH1, KCNH2, KCNJ12, KCNK2			Tocris, Selleck, Selleck	93.46	BRD-K86887724-001-12-2, BRD-K86887724-001-10-6, BRD-K86887724-001-09-8	Withdrawn
dolasetron	serotonin receptor antagonist	HTR3A	gastroenterology	nausea, vomiting	Tocris, Enzo	99.45	BRD-K28029915-066-03-3, BRD-K28029915-001-02-2	Launched
dolastatin-10	tubulin polymerization inhibitor	TUBB			MedChemEx	94.05	BRD-K78567475-001-01-4	Phase 2
dolutegravir	HIV integrase inhibitor	CYP3A4, CYP3A5, CYP3A7, POU2F2, UGT1A1	infectious disease	human immunodeficiency virus (HIV-1)	Selleck	91.66	BRD-K36386086-001-01-1	Launched
domiphen					Selleck	93.67	BRD-K30431096-004-01-3	Preclinical
domperidone	dopamine receptor antagonist	DRD2, DRD3	infectious disease	fescue toxicosis	Tocris, MicroSource, Selleck	97.24	BRD-K38305202-001-17-4, BRD-K38305202-001-18-2, BRD-K38305202-001-16-6	Launched
donepezil	acetylcholinesterase inhibitor	ACHE, HTR2A	neurology/psychiatry	Alzheimer's disease	MicroSource, Selleck	97.71	BRD-A49160188-003-12-7, BRD-A49160188-003-11-9	Launched
donitriptan	serotonin receptor agonist	HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR5A, HTR6			Tocris	92.52	BRD-K31092604-003-03-5	Phase 2
dopamine	dopamine receptor agonist	DBH, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR7, SLC6A2, SLC6A3, SLC6A4	cardiology, neurology/psychiatry	ventricular arrhythmias, depression, headache, tremors	MicroSource, Selleck, Selleck	100	BRD-K43887077-003-26-3, BRD-K43887077-003-27-1, BRD-K43887077-003-25-5	Launched
doramapimod	p38 MAPK inhibitor	MAPK11, MAPK12, MAPK13, MAPK14			Selleck, Selleck	93.78	BRD-K74065929-001-08-0, BRD-K74065929-001-07-2	Phase 2
doramectin			infectious disease	gastrointestinal roundworms	MicroSource	96.39	BRD-A16350940-001-01-9	Launched
doripenem	bacterial cell wall synthesis inhibitor	DPEP1	infectious disease	intra-abdominal infections, urinary tract infections, pyelonephritis	Sigma, MedChemEx, MedChemEx, Selleck, Selleck	42.28	BRD-K45319714-002-02-7, BRD-K45319714-002-04-3, BRD-K45319714-002-03-5, BRD-K45319714-002-05-0, BRD-K45319714-002-01-9	Launched
dorsomorphin	AMPK inhibitor	ACVR1, BMPR1A, BMPR1B, EPHA2, FKBP1A, FLT1, FLT3, KDR, LCK, MKNK1, PRKAA1, RPS6KA1, SRC			Tocris	91.96	BRD-K54233340-300-05-1	Preclinical
dorzolamide	carbonic anhydrase inhibitor	CA1, CA12, CA14, CA2, CA4, CA7	ophthalmology	intraocular pressure, glaucoma	Selleck	90.38	BRD-K71075609-003-01-0	Launched
dosulepin	norepinephrine reuptake inhibitor, serotoninâ€“norepinephrine reuptake inhibitor (SNRI), tricyclic antidepressant	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1, SLC6A2, SLC6A4	neurology/psychiatry	depression	Prestwick	96.47	BRD-K54759182-003-08-0	Launched
dovitinib	EGFR inhibitor, FGFR inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	CSF1R, EGFR, FGFR1, FGFR2, FGFR3, FLT1, FLT3, FLT4, INSR, KDR, KIT, PDGFRA, PDGFRB			Selleck, Selleck, Selleck, Selleck, Selleck, Selleck	96.83	BRD-K85402309-001-07-4, BRD-K85402309-389-03-2, BRD-K85402309-001-06-6, BRD-K85402309-389-04-0, BRD-K85402309-043-01-9, BRD-K85402309-406-01-8	Phase 3
doxapram	potassium channel blocker	KCNK3, KCNK9	pulmonary, neurology/psychiatry	respiratory depression, central nervous system depression, acute hypercapnia (AHC)	MicroSource, Selleck	97.8	BRD-A46179541-311-03-8, BRD-A46179541-311-02-0	Launched
doxazosin	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, KCNH2, KCNH6, KCNH7	urology, cardiology	benign prostatic hyperplasia (BPH), hypertension	Tocris, MicroSource, Selleck	97.75	BRD-A13188892-066-23-1, BRD-A13188892-066-22-3, BRD-A13188892-066-21-5	Launched
doxepin	histamine receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HRH2, HRH4, HTR1A, HTR2A, HTR2B, HTR2C, HTR6, KCNH2, SLC6A2, SLC6A4	neurology/psychiatry	depression, anxiety	MicroSource, Tocris	98.99	BRD-K37694030-003-12-7, BRD-K37694030-003-11-9	Launched
doxercalciferol	vitamin D receptor agonist	VDR	nephrology, endocrinology	chronic kidney disease (CKD), hyperparathyroidism	Selleck, Selleck	85.38	BRD-K82928892-001-02-5, BRD-K82928892-001-03-3	Launched
doxifluridine	thymidylate synthase inhibitor	TYMS	oncology	colorectal cancer	MicroSource, Selleck	96.4	BRD-K58262659-001-10-5, BRD-K58262659-001-09-7	Launched
doxofylline	adenosine receptor antagonist	ADORA1, PDE4A, PDE4B, PDE4C, PDE4D	pulmonary	asthma	Selleck, MicroSource	99.7	BRD-K70507123-001-08-9, BRD-K70507123-001-09-7	Launched
doxorubicin	topoisomerase inhibitor	TOP2A	hematologic malignancy, oncology	acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), Wilm's tumor, breast cancer, ovarian cancer, Hodgkin's lymphoma, bladder cancer, multiple myeloma	Selleck, Selleck, MicroSource, Tocris, Tocris, Selleck	96.83	BRD-K92093830-003-33-2, BRD-K92093830-003-31-6, BRD-K92093830-001-05-4, BRD-K92093830-003-30-8, BRD-K92093830-003-34-0, BRD-K92093830-003-35-7	Launched
doxycycline	metalloproteinase inhibitor	MMP8	dental	periodontitis	MicroSource, Selleck, Selleck, Selleck, Selleck	99	BRD-A08545410-003-06-0, BRD-A08545410-003-08-6, BRD-A08545410-311-01-8, BRD-A08545410-311-03-4, BRD-A08545410-003-07-8	Launched
doxycycline-hyclate	bacterial 30S ribosomal subunit inhibitor		dental	periodontitis	MedChemEx	0	BRD-M28128163-003-01-7	Launched
doxylamine	histamine receptor antagonist	CHRM1, HRH1	neurology/psychiatry	sedative	MicroSource, Selleck	98.3	BRD-A44008656-036-25-8, BRD-A44008656-036-24-1	Launched
DPC-681	HIV protease inhibitor				MedChemEx	97.55	BRD-K37087535-001-01-1	Phase 1
DPCPX	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3			Tocris	99.02	BRD-K01824921-001-18-5	Phase 1
DPI-201106	sodium channel activator	ADRB2			Enzo	94.82	BRD-A64553394-001-04-4	Phase 2
DPO-1	potassium channel blocker	KCNA5			Tocris	98.66	BRD-K99922388-001-02-0	Preclinical
DPPE	histamine receptor antagonist	ABCB1, HRH1			Tocris	92.86	BRD-K80315159-051-02-0	Phase 3
DQP-1105	glutamate receptor antagonist	GRIN2C, GRIN2D			Tocris	93.59	BRD-A67976398-001-01-6	Preclinical
DR-2313	PARP inhibitor	PARP1, PARP3			Tocris	64.58	BRD-K94920105-001-03-9	Preclinical
DR-4485	serotonin receptor antagonist	HTR7			Tocris	98.04	BRD-A39794701-003-01-6	Preclinical
DRF053-(R)	CDK inhibitor	CSNK1A1			Tocris, Tocris	94.78	BRD-K25486274-300-01-0, BRD-K25486274-300-02-8	Preclinical
drofenine			neurology/psychiatry	spasms	MicroSource	93.04	BRD-A22267103-003-13-1	Launched
droloxifene	selective estrogen receptor modulator (SERM)	ESR1			LKT	82.82	BRD-K38477637-001-01-0	Phase 3
dromostanolone-propionate	androgen receptor modulator	AR	oncology	breast cancer	ANpharma	99.15	BRD-A38706605-001-01-2	Launched
dronedarone	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, KCNA5, KCNH2, KCNK2, SCN1A	cardiology	atrial fibrillation (AF)	Selleck	96.35	BRD-K05524748-003-04-4	Launched
droperidol	dopamine receptor antagonist	ADRA1A, DRD2, DRD3, DRD4, HTR2A	gastroenterology	nausea, vomiting	MicroSource, Selleck	94.72	BRD-K97158071-001-18-1, BRD-K97158071-001-17-3	Launched
dropropizine	antitussive		pulmonary	cough suppressant	MicroSource, Selleck, Selleck	95.27	BRD-A29349577-001-23-0, BRD-A29349577-001-22-2, BRD-A29349577-001-24-8	Launched
drospirenone	mineralocorticoid receptor antagonist	AR, NR3C2, PGR	endocrinology	contraceptive	Selleck, Selleck, MicroSource, Selleck	99.66	BRD-K04394237-001-03-7, BRD-K04394237-001-04-5, BRD-K04394237-001-06-0, BRD-K04394237-001-05-2	Launched
drotaverine	phosphodiesterase inhibitor	CACNA1C, PDE4A	obstetrics/gynecology	labor induction	Vitas-M, Enamine	88.7	BRD-K14658796-001-01-0, BRD-K14658796-003-01-6	Launched
droxicam	cyclooxygenase inhibitor	PTGS1	rheumatology	rheumatoid arthritis, osteoarthritis	Ark, Sigma	0	BRD-K17219082-001-01-1, BRD-K17219082-001-02-9	Launched
droxidopa	norepinephrine precursor	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, PAH	cardiology, neurology/psychiatry	hypertension, Parkinson's Disease	Selleck, Selleck	100	BRD-K20372197-001-02-3, BRD-K20372197-001-03-1	Launched
droxinostat	HDAC inhibitor	HDAC6, HDAC8			Selleck	90.2	BRD-K11558771-001-13-9	Preclinical
DSR-6434	toll-like receptor agonist	TLR7			Tocris	90.78	BRD-K46384285-001-01-3	Preclinical
DS2-(806622)					Tocris, Tocris	89.78	BRD-K09619578-001-01-3, BRD-K09619578-001-02-1	Preclinical
DU-728	structural glycoprotein antagonist	ITGA2B, ITGB3			MedChemEx	100	BRD-K08859203-001-01-9	Phase 1
duloxetine	norepinephrine reuptake inhibitor, serotoninâ€“norepinephrine reuptake inhibitor (SNRI)	HTR2A, HTR2C, HTR6, SLC6A2, SLC6A3, SLC6A4	neurology/psychiatry	depression, generalized anxiety disorder (GAD), muscle pain, peripheral neuropathy	Tocris, MicroSource, Selleck	98.43	BRD-K71103788-003-13-8, BRD-K71103788-003-12-0, BRD-K71103788-003-11-2	Launched
DUP-697	cyclooxygenase inhibitor	PTGS2			Tocris, Tocris	97.02	BRD-K06221026-001-07-6, BRD-K06221026-001-06-8	Phase 1
dutasteride	5 alpha reductase inhibitor	SRD5A1, SRD5A2	urology	benign prostatic hyperplasia (BPH)	Selleck	97.58	BRD-K30373883-001-02-8	Launched
DVD-111					MedChemEx	99.45	BRD-K22520627-001-01-7	Phase 2
dyclonine	sodium channel blocker	SCN10A, SCN5A	neurology/psychiatry	local anesthetic	Selleck, MedChemEx, MicroSource, Selleck, MedChemEx	93.29	BRD-K72259270-003-25-6, BRD-K72259270-003-27-2, BRD-K72259270-003-24-9, BRD-K72259270-003-23-1, BRD-K72259270-003-26-4	Launched
dydrogesterone	progesterone receptor agonist	PGR	obstetrics/gynecology	infertility	MicroSource, Selleck, Selleck	98.97	BRD-K68620903-001-11-4, BRD-K68620903-001-10-6, BRD-K68620903-001-09-8	Launched
dynasore	dynamin inhibitor	DNM1, DNM1L, DNM2			Selleck, Selleck	89.1	BRD-K87718015-001-01-9, BRD-K87718015-001-02-7	Preclinical
dynole-34-2	dynamin inhibitor	DNM1			Tocris	45.25	BRD-K23479488-001-01-3	Preclinical
dyphylline	adenosine receptor antagonist, phosphodiesterase inhibitor	ADORA1, ADORA2A, PDE3A, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B	pulmonary	asthma, bronchitis, emphysema	MicroSource, Selleck	99.68	BRD-A00827783-001-24-6, BRD-A00827783-001-23-8	Launched
DY131	estrogen-related receptor agonist	ESRRB, ESRRG			Tocris, Tocris	88.82	BRD-K58343622-001-01-6, BRD-K58343622-001-02-4	Preclinical
D609	phospholipase inhibitor				MedChemEx, MedChemEx, Tocris, Enzo	86.67	BRD-A77118605-237-09-5, BRD-A77118605-237-08-7, BRD-A77118605-237-06-1, BRD-A77118605-237-07-9	Preclinical
E-2012	gamma secretase modulator	APH1A, APH1B, PSENEN			MedChemEx, Sigma	90.8	BRD-K50564936-001-01-6, BRD-K69144501-001-01-1	Phase 1
E-4031	potassium channel blocker	KCNH1, KCNH2			Tocris, Tocris	96.27	BRD-K41713976-300-03-4, BRD-K41713976-300-02-6	Phase 1
E-64	cysteine protease inhibitor, calpain inhibitor	CTSS			Selleck, Selleck	88.95	BRD-K06273313-001-07-9, BRD-K06273313-001-08-7	Preclinical
eact	calcium-activated chloride channel inhibitor	ANO1			Tocris	96.51	BRD-K53030960-001-01-4	Preclinical
EB-47	PARP inhibitor	PARP1			Tocris	95.65	BRD-K66998413-300-01-6	Preclinical
ebastine	histamine receptor antagonist	CYP3A4, HRH1	allergy	allergic rhinitis, urticaria	Selleck	92.12	BRD-K13314656-001-01-0	Launched
EBPC	aldose reductase inhibitor	AKR1B1			Tocris	91.11	BRD-A96485169-001-14-3	Preclinical
ebrotidine	histamine receptor antagonist	HRH2			MedChemEx, MedChemEx, MedChemEx	83.9	BRD-K22421059-001-03-1, BRD-K22421059-001-01-5, BRD-K22421059-001-02-3	Withdrawn
ebselen	cyclooxygenase inhibitor, glutathione peroxidase agonist, H+/K+-ATPase inhibitor, nitric oxide synthase inhibitor	ALB			MicroSource	90.35	BRD-K29359156-001-30-1	Phase 2/Phase 3
EC-144	HSP inhibitor	HSP90AA1, HSP90AB1			Tocris	96.8	BRD-K41705163-001-01-1	Preclinical
EC-23	retinoid receptor agonist	RARA, RARB, RARG			Sigma, Tocris	98.05	BRD-K81004638-001-01-7, BRD-K81004638-001-02-5	Preclinical
ecabapide					Enamine	87.95	BRD-K47371940-001-01-6	Phase 3
ecabet	gastrin inhibitor, urease inhibitor	NOXO1	ophthalmology	dry eye syndrome	OxChem	98.28	BRD-K03353589-236-01-4	Launched
ecamsule-triethanolamine			dermatology	skin protectant, sunscreen lotion	MicroSource	92.57	BRD-A47953250-001-01-7	Launched
echinomycin	DNA intercalating agent				EMDBio	78.32	BRD-A68969091-001-12-7	Phase 2
econazole	lanosterol demethylase inhibitor, sterol demethylase inhibitor	CYP51A1, NPY1R, NPY2R, TRPM2, TRPV5	infectious disease	tinea pedis, tinea cruris, tinea corporis, tinea versicolor, cutaneous candidiasis	Selleck, MicroSource	99.93	BRD-A51820102-008-27-1, BRD-A51820102-008-28-9	Launched
ectoine-zwitterion					Sigma	98.7	BRD-K60902958-001-01-9	Preclinical
edaglitazone	PPAR receptor agonist	PPARG			Tocris	99.08	BRD-A25182582-001-01-8	Phase 2
edaravone	nootropic agent	BCL2	neurology/psychiatry	stroke	MedChemEx, MedChemEx, MicroSource, Selleck, Tocris, Selleck	65.37	BRD-K35458079-001-34-9, BRD-K35458079-001-33-1, BRD-K35458079-001-29-9, BRD-K35458079-001-31-5, BRD-K35458079-001-28-1, BRD-K35458079-001-27-3	Launched
edelfosine	phospholipase inhibitor				Cayman, Enzo	100	BRD-A30403214-001-04-1, BRD-A30403214-001-03-3	Phase 2
editol					MicroSource	91.55	BRD-A78588743-001-03-4	Preclinical
edoxaban	coagulation factor inhibitor	F10	neurology/psychiatry, hematology, cardiology	stroke, pulmonary embolism (PE), systemic embolism, deep vein thrombosis (DVT), atrial fibrillation (AF)	Selleck	95.16	BRD-K29322660-001-01-9	Launched
edoxudine	DNA directed DNA polymerase inhibitor		infectious disease	virus herpes simplex (HSV)	MicroSource	98.02	BRD-K86892782-001-17-0	Launched
edrophonium	acetylcholinesterase inhibitor	ACHE, BCHE	neurology/psychiatry	myasthenia gravis	MicroSource	98.99	BRD-K81128206-003-24-4	Launched
EDTMP	chelating agent				Vitas-M	0	BRD-K54542929-001-01-7	Preclinical
EED226	polycomb protein inhibitor	EED			MedChemEx	96.75	BRD-K19002914-001-01-3	Preclinical
efaproxiral	haemoglobin oxygen release stimulant	HBA1, HBB			Selleck	97.94	BRD-K37355418-236-01-6	Phase 3
efaroxan	adrenergic receptor antagonist	ADORA2A			Tocris, MicroSource	98.28	BRD-A10739734-003-09-8, BRD-A10739734-003-10-6	Phase 2
efatutazone	PPAR receptor agonist	PPARG			MedChemEx	95.58	BRD-A24560335-300-01-2	Phase 2
efavirenz	HIV protease inhibitor	CYP1A2, CYP2B6, CYP2C19, CYP2C9, CYP2D6, CYP3A4	infectious disease	human immunodeficiency virus (HIV-1)	Enzo	98.9	BRD-K40758068-001-08-2	Launched
efinaconazole	lanosterol demethylase inhibitor	CYP51A1	infectious disease	onychomycosis	MedChemEx	92.45	BRD-A30774155-001-01-2	Launched
eflornithine	ornithine decarboxylase inhibitor	ARG2, ODC1	dermatology	facial hair reduction	Enzo	100	BRD-A96292436-003-16-1	Launched
efloxate	vasodilator				MicroSource	97.67	BRD-K55166090-001-09-0	Preclinical
efonidipine-monoethanolate	L-type calcium channel blocker, T-type calcium channel blocker	CACNA1C, CACNA1G			Tocris, Tocris, Tocris	95.91	BRD-M92675308-003-06-3, BRD-M92675308-003-07-1, BRD-M92675308-003-05-5	Launched
EGF816	EGFR inhibitor	EGFR			MedChemEx, MedChemEx	92.84	BRD-K22514639-001-05-7, BRD-K22514639-001-04-0	Phase 2
eglumetad	glutamate receptor agonist	GRM2, GRM3, GRM6, GRM8			MedChemEx, EMDBio	100	BRD-K65359424-001-02-1, BRD-K65359424-001-01-3	Phase 2
EG00229	neuropilin receptor antagonist	NRP1			MedChemEx, Tocris	96.86	BRD-K50653584-019-01-4, BRD-K50653584-001-01-2	Preclinical
EHop-016	Ras GTPase inhibitor	RAC1, RAC3			Selleck	93.91	BRD-K32289541-001-01-0	Preclinical
EIPA	transient receptor potential polycystic inhibitor, sodium/hydrogen exchanger inhibitor	ADRA2A, ASIC1, PKD2L1			Tocris	65.7	BRD-K88120876-001-09-8	Preclinical
EIT-hydrobromide	nitric oxide synthase inhibitor	NOS2, NOS3			Tocris	90.43	BRD-K81623406-004-08-3	Preclinical
EI1	histone lysine methyltransferase inhibitor	EZH2			MedChemEx	93.04	BRD-K91535048-001-01-2	Preclinical
elacridar	P glycoprotein inhibitor	ABCB1			MedChemEx, MedChemEx, Selleck	94.19	BRD-K88807631-001-03-9, BRD-K88807631-001-01-3, BRD-K88807631-001-02-1	Phase 1
elactocin	exportin antagonist	XPO1			EMDBio	0	BRD-K63876426-001-01-6	Phase 1
elafibranor	PPAR receptor agonist	PPARA, PPARD			MedChemEx	92.97	BRD-K03165895-001-01-9	Phase 3
elagolix	gonadotropin releasing factor hormone receptor antagonist	GNRHR			MedChemEx	81.73	BRD-K55808645-001-01-4	Phase 3
elbasvir	HCV inhibitor		infectious disease	hepatitis C	MedChemEx	95.63	BRD-K09735259-001-01-3	Launched
elemene	VEGFR inhibitor				Enamine	0	BRD-K79565391-001-01-8	Phase 2
elesclomol	oxidative stress inducer	HSPA1A			Selleck	90.7	BRD-K82135108-001-04-3	Phase 3
eletriptan	serotonin receptor agonist	HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2B, HTR7	neurology/psychiatry	migraine headache	Tocris, Selleck, MicroSource, Tocris	97.64	BRD-K30652337-004-03-9, BRD-K30652337-004-01-3, BRD-K30652337-001-01-9, BRD-K30652337-004-02-1	Launched
eliglustat	Glycosyl transferase inhibitor	UGCG	hematology	Gaucher disease, Gaucher disease	MedChemEx, MedChemEx	93.73	BRD-K86410485-001-01-5, BRD-K86410485-046-01-0	Launched
elinogrel	purinergic receptor antagonist	P2RY12			Tocris, Tocris	13.9	BRD-K59271229-001-02-3, BRD-K59271229-001-01-5	Phase 2
eliprodil	glutamate receptor antagonist	GRIN1, GRIN2B			Tocris	87.72	BRD-A61392169-001-02-7	Phase 3
ellagic-acid	glutathione transferase inhibitor, non-nucleoside reverse transcriptase inhibitor	CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, GSK3B, PRKACA, PRKCA, PRKCB, SQLE, SYK			Selleck, MicroSource, Selleck	98.25	BRD-K30466858-001-10-4, BRD-K30466858-001-09-6, BRD-K30466858-001-08-8	Phase 2
ELN-441958	bradykinin receptor antagonist	BDKRB1			MedChemEx	97.7	BRD-K50699835-001-01-2	Preclinical
eltanolone	membrane integrity inhibitor	GABRA1, GABRB2, GABRG2			Enzo	100	BRD-K18172896-001-02-5	Phase 3
eltoprazine	serotonin receptor agonist	HTR1A, HTR1B			MedChemEx, MedChemEx, MedChemEx	97.53	BRD-K86171477-001-01-3, BRD-K86171477-001-03-9, BRD-K86171477-001-02-1	Phase 2
eltrombopag	thrombopoietin receptor agonist	MPL	hematology, infectious disease	anemia, hepatitis C, thrombocytopenia	Selleck, Selleck, Selleck	97.73	BRD-K40496271-396-01-1, BRD-K40496271-001-02-5, BRD-K40496271-001-03-3	Launched
eluxadoline	opioid receptor modulator	OPRD1, OPRK1, OPRM1	gastroenterology	irritable bowel syndrome	MedChemEx	94.62	BRD-K39560679-001-01-1	Launched
elvitegravir	HIV integrase inhibitor		infectious disease	human immunodeficiency virus (HIV-1)	Selleck	94.69	BRD-K54472332-001-03-4	Launched
embelin	HCV inhibitor, XIAP inhibitor	XIAP			Tocris, Selleck, Selleck	94.95	BRD-K86727142-001-12-4, BRD-K86727142-001-11-6, BRD-K86727142-001-13-2	Preclinical
EMD-1214063	hepatocyte growth factor receptor inhibitor	MET			MedChemEx	95.6	BRD-K97963946-001-01-3	Phase 1
EMD-386088	serotonin receptor agonist	HTR6			Tocris, Tocris	90.04	BRD-K47659338-003-02-8, BRD-K47659338-003-03-6	Preclinical
EMD-53998	phosphodiesterase inhibitor	TNNC1			EMDBio	97.01	BRD-A65248799-001-01-7	Phase 1
EMD-66684	angiotensin receptor antagonist	AGTR1			Tocris, Tocris	99.17	BRD-K88759641-003-03-6, BRD-K88759641-003-02-8	Preclinical
emedastine	histamine receptor antagonist	HRH1	ophthalmology	conjunctivitis	Prestwick, TCI	86.56	BRD-K15010214-364-01-9, BRD-K15010214-364-02-7	Launched
emetine	protein synthesis inhibitor	RPS2			MicroSource, Selleck	98.73	BRD-A25687296-300-04-3, BRD-K03067624-001-02-3	Phase 2
emodin	11-beta hydroxysteroid dehydrogenase inhibitor	CSNK2A1			Selleck	92.43	BRD-K58685305-001-20-4	Preclinical
emorfazone	antiinflammatory agent, cyclooxygenase inhibitor		dental	mouth inflammation	Sigma	99.42	BRD-K90629600-001-01-4	Launched
emoxipin					Vitas-M	95.96	BRD-K28982731-001-01-6	Phase 2
empagliflozin	sodium/glucose cotransporter inhibitor	SLC5A1, SLC5A2	endocrinology	diabetes mellitus	Selleck	96.18	BRD-K53765467-001-02-1	Launched
emtricitabine	nucleoside reverse transcriptase inhibitor		infectious disease	human immunodeficiency virus (HIV-1)	Selleck	96.41	BRD-K61452026-001-04-6	Launched
enalapril	angiotensin converting enzyme inhibitor	ACE	cardiology	hypertension, congestive heart failure, left ventricular systolic dysfunction (LVSD)	Selleck, MicroSource	94.83	BRD-K57545991-050-23-1, BRD-K57545991-050-24-9	Launched
enalaprilat	angiotensin converting enzyme inhibitor	ACE	cardiology	hypertension	MicroSource, MedChemEx, Selleck, MedChemEx, Selleck	83.84	BRD-K99447003-335-03-3, BRD-K99447003-335-05-8, BRD-K99447003-335-02-5, BRD-K99447003-335-06-6, BRD-K99447003-335-04-1	Launched
enasidenib	isocitrate dehydrogenase inhibitor	IDH1	hematologic malignancy	acute myeloid leukemia (AML)	MedChemEx	97.55	BRD-K70601687-001-01-3	Launched
enbucrilate			dermatology	skin lacerations, tissue adhesive	Ark	0	BRD-K66918327-001-01-3	Launched
enciprazine	GABA receptor modulator	GABRA1			Key	97.6	BRD-A62197763-001-01-1	Phase 3
endo-IWR-1	PARP inhibitor	TNKS, TNKS2			Tocris, Selleck, Tocris	97.96	BRD-K61314889-001-05-1, BRD-K61314889-001-04-4, BRD-K61314889-001-06-9	Preclinical
endoxifen	estrogen receptor antagonist	ESR1			MedChemEx, Selleck	52.03	BRD-K62752296-003-01-3, BRD-K62752296-003-02-1	Phase 2
enflurane	membrane permeability inhibitor	ATP2C1, ATP5D, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GRIA1, KCNA1, KCNK10, KCNK18, KCNK2, KCNK3, KCNK9, KCNN4			Apollo	0	BRD-A51831848-001-01-7	Launched
enilconazole	sterol demethylase inhibitor	CYP19A1, CYP1A2, CYP2B6, CYP2C9, CYP2J2, CYP3A4, CYP3A5, NR1I2, PPARA, PTGER2	infectious disease	skin infections	MicroSource	98.23	BRD-A11776908-065-01-5	Launched
eniluracil	dihydropyrimidine dehydrogenase inhibitor	AOX1, DPYD, XDH			Sigma	0	BRD-K26425819-001-01-3	Phase 3
enisamium-iodide					Vitas-M	96.66	BRD-K10029415-005-06-9	Launched
ENMD-2076	Aurora kinase inhibitor, FLT3 inhibitor, VEGFR inhibitor	AURKA, FLT3, KDR, PDGFRA, PTK2, SRC			Selleck	96.02	BRD-K68488863-001-04-9	Phase 2
enocitabine	DNA synthesis inhibitor	CMPK1, RRM1, TYMS			AKSci, Carbosynth	97.2	BRD-K32007074-001-02-9, BRD-K32007074-001-01-1	Launched
enoxacin	topoisomerase inhibitor	TOP2A	infectious disease	urinary tract infections, gonorrhea	MicroSource, Selleck, Selleck	89.69	BRD-K78113049-001-16-2, BRD-K78113049-001-15-4, BRD-K78113049-001-17-0	Launched
enoximone	phosphodiesterase inhibitor	PDE3A	cardiology	congestive heart failure	Sigma	92.01	BRD-K21152241-001-07-3	Launched
enoxolone	gap junction modulator	HSD11B1	gastroenterology, otolaryngology	peptic ulcer disease (PUD), common cold	MicroSource, Selleck	99.76	BRD-K96137854-001-18-9, BRD-K96137854-001-17-1	Launched
enprofylline	phosphodiesterase inhibitor	ADORA1, ADORA2A, ADORA2B, ADORA3, PDE4A, PDE4B			Enzo	98.71	BRD-K35007173-001-07-5	Phase 3
enrofloxacin	bacterial DNA gyrase inhibitor		infectious disease	gram-negative bacterial infections, gram-negative bacterial infections	MicroSource, Selleck	96.46	BRD-K76534306-001-22-7, BRD-K76534306-001-21-9	Launched
entacapone	catechol O methyltransferase inhibitor	COMT	neurology/psychiatry	Parkinson's Disease	MicroSource, Selleck, Selleck	97.02	BRD-K83636919-001-04-8, BRD-K83636919-001-05-5, BRD-K83636919-001-03-0	Launched
entecavir	DNA replication inhibitor, nucleoside reverse transcriptase inhibitor		infectious disease	hepatitis B	Selleck	99.22	BRD-K08206212-002-01-0	Launched
entinostat	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC9			Selleck, Selleck	88.78	BRD-K77908580-001-10-4, BRD-K77908580-001-09-6	Phase 3
entrectinib	ALK tyrosine kinase receptor inhibitor, proto-oncogene tyrosine protein kinase inhibitor	ALK, NTRK1, NTRK2, NTRK3, ROS1			Selleck	87.23	BRD-K39009484-001-01-4	Phase 2
enzalutamide	androgen receptor antagonist	AR	oncology	prostate cancer	Selleck	95.96	BRD-K56851771-001-06-8	Launched
enzastaurin	PKC inhibitor	AKT1, GSK3B, PRKCA, PRKCB, PRKCD, PRKCG			Selleck	96.13	BRD-K79404599-001-09-3	Phase 3
EN460	endoplasmic reticulum oxidation inhibitor	ERO1A			MedChemEx, MedChemEx	49.85	BRD-K86063171-001-03-7, BRD-K86063171-001-02-9	Preclinical
EO-1428	p38 MAPK inhibitor	MAPK11, MAPK14			Tocris, Tocris	94.29	BRD-K42452249-001-02-5, BRD-K42452249-001-03-3	Preclinical
epacadostat	indoleamine 2,3-dioxygenase inhibitor	IDO1			MedChemEx, Selleck	97.41	BRD-K79450420-001-03-4, BRD-K79450420-001-02-6	Phase 3
epalrestat	aldose reductase inhibitor	AKR1B1	nephrology	diabetic nephropathy	MedChemEx, MedChemEx, Selleck, Selleck	81.25	BRD-K98054437-001-11-5, BRD-K98054437-001-12-3, BRD-K98054437-001-09-9, BRD-K98054437-001-08-1	Launched
eperezolid	bacterial 30S ribosomal subunit inhibitor				MedChemEx	91.48	BRD-K47554101-001-01-2	Phase 1
eperisone	acetylcholine receptor antagonist	CYP2J2	neurology/psychiatry	amyotrophic lateral sclerosis (ALS), spasms, head injury, spinal injury	CombiBlocks	99	BRD-A04252265-003-01-4	Launched
ephedrine	adrenergic receptor agonist	ACHE, ADRA1A, ADRB2, SLC18A2, SLC6A2	cardiology, pulmonary, neurology/psychiatry, endocrinology	hypotension, asthma, narcolepsy, obesity	MicroSource	97.68	BRD-K45014108-003-01-8	Launched
ephedrine-(racemic)	adrenergic receptor agonist	ADRA1A, ADRA2A	cardiology, pulmonary, neurology/psychiatry, endocrinology	hypotension, asthma, narcolepsy, obesity	MicroSource	97.69	BRD-A54236247-003-04-3	Launched
epiandrosterone	steroid	G6PD			Selleck	100	BRD-K42756753-001-01-9	Preclinical
epicatechin-gallate-(-)	bacterial DNA gyrase inhibitor	BACE1, FASN			AnalytiCon, MedChemEx	96.2	BRD-K50660797-001-04-4, BRD-K50660797-001-05-1	Phase 2
epigallocatechin-gallate-(-)	bacterial DNA gyrase inhibitor	ELANE, EP300, FASN, KAT2B, MMP14, MMP2			MedChemEx, MedChemEx, Selleck, Selleck	81.58	BRD-K55591206-001-20-7, BRD-K55591206-001-22-3, BRD-K55591206-001-19-9, BRD-K55591206-001-18-1	Phase 2/Phase 3
epinastine	histamine receptor antagonist	ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7	ophthalmology	conjunctivitis	Selleck	95.95	BRD-A98990573-003-01-3	Launched
epinephrine	adrenergic receptor agonist, neurotransmitter	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, PAH, TNF	cardiology, allergy, pulmonary	cardiac arrest, anaphylactic shock, asthma	Selleck, Selleck, Selleck, Selleck, Selleck, MicroSource	100	BRD-K63126190-046-03-1, BRD-K63126190-001-05-1, BRD-K63126190-046-02-3, BRD-K63126190-001-03-6, BRD-K63126190-003-01-6, BRD-K63126190-001-04-4	Launched
epinephrine-(racemic)	carbonic anhydrase activator		cardiology, allergy, pulmonary	cardiac arrest, anaphylactic shock, asthma	Selleck, Selleck	0	BRD-A07765530-001-06-4, BRD-A07765530-001-05-6	Launched
epirizole	cyclooxygenase inhibitor	PTGS1, PTGS2	neurology/psychiatry	pain relief	Prestwick	98.14	BRD-K39339537-001-21-0	Launched
epirubicin	topoisomerase inhibitor	CHD1, TOP2A	oncology	breast cancer	MicroSource, Selleck	90.55	BRD-K04548931-003-13-2, BRD-K04548931-003-16-5	Launched
epitiostanol	androgen receptor agonist	AR			Prestwick	90.16	BRD-K02314383-001-01-3	Launched
eplerenone	cytochrome P450 inhibitor	NR3C2	cardiology	congestive heart failure, hypertension	Selleck, Tocris, Selleck	99.75	BRD-K19761926-001-03-6, BRD-K19761926-001-02-8, BRD-K19761926-001-04-4	Launched
epomediol	cholesterol inhibitor	CYP7A1			TimTec	0	BRD-A59329714-001-01-5	Launched
epoprostenol	prostacyclin analog	P2RY12, PTGER1, PTGER4, PTGIR, PTGIS	cardiology	hypertension	Enzo	36.41	BRD-K64054020-001-03-5	Launched
epothilone-a	microtubule stabilizing agent				Selleck	97.44	BRD-K71823332-001-03-7	Preclinical
epothilone-b	microtubule stabilizing agent, tubulin polymerization inhibitor	TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA4A, TUBA8, TUBB, TUBB1, TUBB3, TUBB4A, TUBB4B			Selleck	96.96	BRD-K68164687-001-01-6	Phase 3
epothilone-d	microtubule stabilizing agent, tubulin polymerization inhibitor	TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA4A, TUBA8, TUBB, TUBB1, TUBB3, TUBB4A, TUBB4B			MedChemEx	97.71	BRD-K52762805-001-01-2	Phase 2
EPPTB	trace amine associated receptor antagonist	TAAR1			Tocris	95.64	BRD-K42536037-001-01-3	Preclinical
eprazinone	mucolytic agent		pulmonary	bronchospasm	Selleck, Selleck	94.62	BRD-A72212290-300-01-4, BRD-A72212290-300-02-2	Launched
eprinomectin	benzodiazepine receptor agonist		infectious disease	gastrointestinal roundworms, lungworms	MicroSource	92.46	BRD-A91366704-001-01-9	Launched
eprobemide	monoamine oxidase inhibitor	MAOA	neurology/psychiatry	depression	MicroSource	96.11	BRD-K17979676-001-01-2	Launched
eprodisate	antiamyloidogenic agent, amyloid protein inhibitor	SAA1			MicroSource, MedChemEx, Sigma	95.43	BRD-K11463116-304-01-9, BRD-K11463116-304-03-5, BRD-K11463116-304-02-7	Phase 3
eprosartan	angiotensin receptor antagonist	AGTR1	cardiology	hypertension	Selleck, Selleck	99.15	BRD-K67977190-066-02-3, BRD-K67977190-066-03-1	Launched
eptifibatide	platelet aggregation inhibitor	ITGA2B, ITGB3	cardiology	acute coronary syndrome (ACS), percutaneous coronary intervention (PCI)	Enzo	98.5	BRD-A90547603-001-02-5	Launched
EPZ-5676	histone lysine methyltransferase inhibitor	DOT1L			Selleck, Selleck	95.25	BRD-K26531771-001-01-4, BRD-K26531771-001-02-2	Phase 1
EPZ004777	histone lysine methyltransferase inhibitor	DOT1L			Selleck, Selleck, Selleck	94.61	BRD-K69070623-003-01-7, BRD-K69070623-001-01-1, BRD-K69070623-001-02-9	Preclinical
EPZ005687	histone lysine methyltransferase inhibitor	EZH2			Selleck	95.53	BRD-K57754230-001-02-7	Preclinical
EPZ011989	histone lysine methyltransferase inhibitor	EZH2			MedChemEx	95.82	BRD-K87468701-001-01-0	Preclinical
EPZ015666	protein arginine N-methyltransferase inhibitor	PRMT5			MedChemEx	95.64	BRD-K70446295-001-01-7	Preclinical
EPZ020411	protein arginine N-methyltransferase inhibitor	PRMT6			MedChemEx, MedChemEx	90.26	BRD-K33586289-003-02-8, BRD-K33586289-003-01-0	Preclinical
equilin	estrogen receptor agonist	HSD17B1			MicroSource	86.71	BRD-A88080608-001-04-2	Preclinical
equol	estrogen receptor agonist	ESR1, ESR2			Selleck, Selleck	94.51	BRD-K54847683-001-04-0, BRD-K54847683-001-03-2	Launched
ER-27319	mediator release inhibitor, SYK inhibitor	SYK			Tocris, Tocris, Tocris	95.64	BRD-K11927976-050-04-5, BRD-K11927976-050-02-9, BRD-K11927976-050-03-7	Preclinical
ER-50891	retinoid receptor antagonist	RARA			Tocris	66.53	BRD-K18347943-001-01-8	Preclinical
erastin	ion channel antagonist	VDAC2			Selleck, Selleck	98.74	BRD-A25004090-001-08-4, BRD-A25004090-001-09-2	Preclinical
erbstatin-analog	EGFR inhibitor, tyrosine kinase inhibitor	EGFR			Tocris	63.51	BRD-K35573744-001-06-8	Preclinical
ercalcitriol	vitamin D receptor agonist	VDR			MedChemEx, MedChemEx	92.34	BRD-K84163249-001-03-5, BRD-K84163249-001-01-9	Phase 1
erdafitinib	FGFR inhibitor	FGFR1, FGFR2, FGFR3, FGFR4			MedChemEx	95.96	BRD-K84868168-001-01-0	Phase 2
erdosteine	mucolytic agent		pulmonary, infectious disease	bronchitis, cough suppressant, chronic obstructive pulmonary disease (COPD), respiratory tract infections	MicroSource, Selleck, Selleck	99.06	BRD-A05515753-001-03-2, BRD-A05515753-001-02-4, BRD-A05515753-001-04-0	Launched
ergocalciferol	vitamin analog	VDR	endocrinology, orthopedics	hypoparathyroidism, rickets, hypophosphatemia	MicroSource, Sigma, Selleck, Selleck	79.58	BRD-K56155962-001-15-4, BRD-K56155962-001-12-1, BRD-K56155962-001-16-2, BRD-K56155962-001-11-3	Launched
ergonovine	adrenergic receptor agonist, serotonin receptor agonist	ADRA1A, HTR1E	hematology	postpartum hemorrhage (PPH)	MicroSource	95.17	BRD-A26387268-050-04-4	Launched
ergosterol	vitamin D precursor				Selleck, Selleck	0	BRD-K03039262-001-03-7, BRD-K03039262-001-04-5	Preclinical
ergotamine	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, DRD1, DRD2, DRD5, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, SLC6A2	neurology/psychiatry	migraine headache	MicroSource	25.51	BRD-A43227343-046-01-4	Launched
ERK5-IN-1	MAP kinase inhibitor	MAPK7			MedChemEx	85.1	BRD-K64857848-001-06-4	Preclinical
erlotinib	EGFR inhibitor	EGFR, NR1I2	oncology	non-small cell lung cancer (NSCLC), pancreatic cancer	Selleck, Selleck	99.27	BRD-K70401845-001-15-7, BRD-K70401845-003-09-6	Launched
ertapenem	bacterial cell wall synthesis inhibitor		infectious disease	intra-abdominal infections, skin infections, pneumonia, urinary tract infections, gynecologic infections, postpartum endomyometritis	SantaCruz, SantaCruz	0	BRD-A40472231-304-01-7, BRD-A40472231-304-02-5	Launched
erteberel	estrogen receptor agonist	ESR1, ESR2			Selleck	97.54	BRD-K80608265-001-01-6	Phase 2
ertugliflozin	sodium/glucose cotransporter inhibitor	SLC5A2	endocrinology	diabetes mellitus	MedChemEx	99.59	BRD-K10071630-001-01-0	Launched
erythritol					Selleck, Selleck	92.41	BRD-K79315489-001-07-8, BRD-K79315489-001-08-6	Launched
erythromycin	NFkB pathway inhibitor	MLNR	infectious disease	listeria, respiratory tract infections, skin infections, syphilis, amebiasis, pelvic inflammatory disease, chlamydia, diphtheria, erythrasma	MicroSource, MicroSource, Selleck, Selleck	88.23	BRD-K63550407-001-12-7, BRD-K63550407-028-04-7, BRD-K63550407-001-13-5, BRD-K63550407-001-14-3	Launched
erythromycin-estolate	bacterial 50S ribosomal subunit inhibitor	ABCB1, ALB, CYP3A4, CYP51A1, KCNH2, MLNR, SLC47A1	infectious disease	listeria, respiratory tract infections, skin infections, syphilis, amebiasis, pelvic inflammatory disease, chlamydia, diphtheria, erythrasma	MicroSource	0	BRD-K39746403-084-04-9	Launched
erythromycin-ethylsuccinate	cytochrome P450 inhibitor, protein synthesis inhibitor	ABCB1, ALB, CYP3A4, CYP51A1, KCNH2, MLNR, SLC47A1	infectious disease	listeria, respiratory tract infections, skin infections, syphilis, amebiasis, pelvic inflammatory disease, chlamydia, diphtheria, erythrasma	MicroSource, Selleck, Selleck	93.05	BRD-K51677086-001-12-0, BRD-K51677086-001-13-8, BRD-K51677086-001-14-6	Launched
erythrosine	coloring agent				MicroSource	92.82	BRD-K14920963-304-02-7	Preclinical
esaprazole					Enamine, Enamine	89.47	BRD-K92426617-001-05-5, BRD-K92426617-001-06-3	Phase 2
escin	nitric oxide synthase stimulant		dermatology	varicose veins	MicroSource	34.56	BRD-A90796352-001-04-7	Launched
escitalopram	selective serotonin reuptake inhibitor (SSRI)	ADRA1A, CHRM1, HRH1, SLC6A2, SLC6A3, SLC6A4	neurology/psychiatry	depression, generalized anxiety disorder (GAD)	MicroSource, Tocris	98.5	BRD-K70301876-034-13-7, BRD-K70301876-034-14-5	Launched
esculin	antioxidant				Selleck	90.89	BRD-K36270037-001-01-7	Phase 1
eseroline-(-)	acetylcholinesterase inhibitor	OPRD1, OPRM1			Prestwick	0	BRD-K13629382-051-06-6	Preclinical
ESI-09	EPAC inhibitor	RAPGEF3, RAPGEF4			MedChemEx, Tocris	96.93	BRD-K77139516-001-01-4, BRD-K77139516-001-02-2	Preclinical
eslicarbazepine-acetate	sodium channel blocker	SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	neurology/psychiatry	seizures	MedChemEx	99.86	BRD-K61237927-001-01-7	Launched
esmolol	adrenergic receptor antagonist	ADRB1	cardiology	ventricular tachycardia (VT), hypertension	Selleck	95.59	BRD-A07395371-003-10-0	Launched
esomeprazole	ATPase inhibitor	ATP4A	gastroenterology	gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, peptic ulcer disease (PUD)	Selleck, Selleck, MicroSource	98.67	BRD-K61443506-236-02-0, BRD-K61443506-239-01-6, BRD-K61443506-237-01-0	Launched
estetrol	selective estrogen receptor modulator (SERM)	ESR1			Sigma	86.38	BRD-K75445017-001-01-1	Phase 3
estradiol	estrogen receptor agonist	ESR1, ESR2, GPER1, KCNMA1, NR1I2	endocrinology	contraceptive	Selleck, MicroSource, Selleck	92.44	BRD-K18910433-001-36-6, BRD-K18910433-001-43-2, BRD-K18910433-001-42-4	Launched
estradiol-acetate	estrogen receptor agonist	ESR1	endocrinology, obstetrics/gynecology	menopause, vaginal atrophy	Sigma	96.27	BRD-K53319039-001-01-8	Launched
estradiol-benzoate	contraceptive agent	ESR1			MicroSource	97.72	BRD-A74765037-001-01-1	Preclinical
estradiol-cypionate	estrogen receptor agonist	ESR1	endocrinology	hypoestrogenism, menopause	MicroSource	92.4	BRD-A91452556-001-04-0	Launched
estradiol-valerate	estrogen receptor agonist	ESR1	oncology, endocrinology, obstetrics/gynecology	prostate cancer, hypoestrogenism, menopause, vaginal atrophy	MicroSource, Selleck	96.27	BRD-K66766661-001-19-2, BRD-K66766661-001-20-0	Launched
estramustine	DNA alkylating agent	ESR1, ESR2, MAP1A, MAP2	oncology	prostate cancer	MicroSource	94.83	BRD-A70858459-001-01-7	Launched
estramustine-phosphate	DNA synthesis inhibitor, microtubule inhibitor	ESR1, ESR2, MAP1A, MAP2	oncology	prostate cancer	Enzo	93.37	BRD-K00077635-304-01-2	Launched
estriol	estrogen receptor agonist	ESR1, ESR2	endocrinology, obstetrics/gynecology, infectious disease	menopause, vaginal atrophy, urinary tract infections	MicroSource, Selleck, MicroSource, Selleck	88.19	BRD-K17016787-001-16-7, BRD-K17016787-001-13-4, BRD-A63433173-001-02-1, BRD-K17016787-001-15-9	Launched
estrone	estrogen receptor agonist, estrogenic hormone	ESR1, ESR2			Selleck, MicroSource, Selleck	91.87	BRD-K81839095-001-25-1, BRD-K81839095-001-30-1, BRD-K81839095-001-29-3	Launched
estropipate	estrogen receptor agonist	ESR1, ESR2	orthopedics, endocrinology, obstetrics/gynecology	osteoporosis, menopause, vaginal atrophy, hypoestrogenism	MicroSource	97.6	BRD-A22143024-231-03-8	Launched
eszopiclone	benzodiazepine receptor agonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, TSPO	neurology/psychiatry	insomnia	MicroSource	98.3	BRD-K29220403-001-10-8	Launched
etacrynic-acid	sodium/potassium/chloride transporter inhibitor	ATP1A1, SLC12A1	cardiology, gastroenterology, nephrology, rheumatology	hypertension, congestive heart failure, edema, hepatic cirrhosis, chronic renal failure, nephrotic syndrome	MicroSource	98.7	BRD-K63630713-001-25-8	Launched
etafenone	calcium channel blocker				Vitas-M	98.74	BRD-K84971356-001-01-4	Launched
etamsylate	haemostatic agent		hematology	hemorrhage	Selleck, Selleck	98.66	BRD-K71055333-224-05-8, BRD-K71055333-224-06-6	Launched
etanidazole	bacterial cell wall synthesis inhibitor				Prestwick	97.03	BRD-K96042922-001-09-8	Phase 3
etazolate	phosphodiesterase inhibitor	GABRB3, PDE4A			Tocris	91.67	BRD-K64755930-003-03-2	Phase 2
ETC-1002	AMPK inhibitor	ACLY			MedChemEx	98.6	BRD-K63177377-001-01-8	Phase 3
ETC-159	porcupine inhibitor, beta catenin inhibitor	PORCN			MedChemEx	97.74	BRD-K54264768-001-01-2	Phase 1
etebenecid	uricosuric blocker				MicroSource	98.34	BRD-K24443618-001-10-2	Preclinical
eterobarb	anticonvulsant				Vitas-M	94.62	BRD-K64834129-001-19-6	Phase 2
ethacizin	anticonvulsant		cardiology	ventricular tachycardia (VT), Wolff-Parkinson-White Syndrome (WPW)	Vitas-M	97.41	BRD-K10667240-001-01-7	Launched
ethacridine-lactate-monohydrate	DNA intercalating agent				Selleck, MicroSource, Selleck	87.55	BRD-K24715592-406-01-3, BRD-K24715592-043-02-2, BRD-K24715592-406-02-1	Preclinical
ethambutol	bacterial cell wall synthesis inhibitor		infectious disease	tuberculosis	MicroSource, Selleck	100	BRD-K93231391-300-06-4, BRD-K93231391-300-05-6	Launched
ethamivan	respiratory stimulant				Sigma, MicroSource	87.48	BRD-K38055836-001-22-9, BRD-K38055836-001-21-1	Preclinical
ethanolamine-oleate	immunostimulant	F12, FABP4, FFAR1, FFAR4, PLD2	gastroenterology	esophageal varices	MicroSource	0	BRD-M75061779-001-01-2	Launched
ethaverine	calcium channel blocker		neurology/psychiatry	muscle relaxant, spasms	MicroSource	99.19	BRD-K36756879-003-08-7	Launched
ethenzamide	analgesic agent		neurology/psychiatry, endocrinology, otolaryngology	headache, fever, common cold	MicroSource	99.07	BRD-K88308881-001-06-8	Launched
ethimizol					MedChemEx	99.78	BRD-K19672466-001-02-3	Phase 1
ethinyl-estradiol	estrogen receptor agonist, estrogenic hormone	ESR1, ESR2, NR1I2	endocrinology	contraceptive	Selleck, MicroSource, Selleck	91.77	BRD-K48195008-001-17-3, BRD-K48195008-001-19-9, BRD-K48195008-001-18-1	Launched
ethionamide	mycolic synthesis inhibitor		infectious disease	tuberculosis	MicroSource, Selleck	98.1	BRD-K51207550-001-23-0, BRD-K51207550-001-22-2	Launched
ethisterone	progestogen hormone	TYR			MicroSource, Selleck, Selleck	97.2	BRD-A29111201-001-04-8, BRD-K03981224-001-19-3, BRD-K03981224-001-21-9	Launched
ethopabate	antiprotozoal agent		infectious disease	coccidiosis	MicroSource	97.78	BRD-K02475039-001-01-0	Launched
ethosuximide	succinimide antiepileptic	CACNA1G, CACNA1H, CACNA1I	neurology/psychiatry	epilepsy	Sigma, MicroSource	99.47	BRD-A99633051-001-08-8, BRD-A99633051-001-07-0	Launched
ethotoin	hydantoin antiepileptic	SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	neurology/psychiatry	seizures	MicroSource, AMS	97.23	BRD-A30205217-001-11-2, BRD-A30205217-001-12-0	Launched
ethoxyquin	antioxidant				Prestwick	42.49	BRD-K56792340-001-13-2	Preclinical
ethoxzolamide	carbonic anhydrase inhibitor	CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9	ophthalmology, gastroenterology	glaucoma, duodenal ulcer disease	MicroSource, Selleck	96.7	BRD-K18131774-001-18-4, BRD-K18131774-001-17-6	Launched
ethyl-paraben					MicroSource	99.39	BRD-K02464583-001-02-2	Preclinical
ethyl-pyruvate	tumor necrosis factor production inhibitor	HMGB1, TNF			Sigma	0	BRD-K47738867-001-01-5	Phase 2
ethyl-vanillin					MicroSource	97.9	BRD-K82104468-001-05-0	Preclinical
ethyl-2-(carbamoyloxy)benzoate					Enamine	0	BRD-K21892374-001-01-6	Phase 1
ethylenediaminetetraacetic-acid	PKC inhibitor		neurology/psychiatry	metal toxicity	MicroSource	100	BRD-K82603084-408-01-1	Launched
ethylnorepinephrine	bronchodilator				MicroSource	95.14	BRD-A68509429-003-03-9	Preclinical
ethynodiol-diacetate		ESR1, PGR	endocrinology	contraceptive	Selleck, MicroSource, Selleck	99.51	BRD-K46331928-001-06-6, BRD-K46331928-001-05-8, BRD-K46331928-001-08-2	Launched
eticlopride	dopamine receptor antagonist	DRD2, DRD3, DRD4			Tocris	95.14	BRD-K50417881-003-17-4	Preclinical
etidronic-acid	bone resorption inhibitor	ATP6V1A, PTPRS	endocrinology, orthopedics	Paget's disease, heterotopic ossification	MicroSource, Selleck, Selleck	0	BRD-K37949327-304-06-1, BRD-K37949327-001-07-1, BRD-K37949327-001-06-3	Launched
etifenin	renal function diagnostic agent				Prestwick	46.68	BRD-K63979671-001-10-1	Preclinical
etifoxine	GABA receptor modulator	GABRA1, GABRA2, GABRA3, GABRA5	neurology/psychiatry	anxiety	MedChemEx, MedChemEx, MedChemEx	98.68	BRD-A60821666-003-01-2, BRD-A60821666-003-02-0, BRD-A60821666-001-01-6	Launched
etilefrine	adrenergic receptor agonist	ADRA1A, ADRB1	neurology/psychiatry, otolaryngology, endocrinology, pulmonary	headache, nasal congestion, fever, cough suppressant, common cold	Prestwick	88.17	BRD-A09925278-003-05-6	Launched
etilevodopa	dopamine receptor agonist	DRD3			Enamine, Sigma	95.55	BRD-K90982969-003-01-8, BRD-K90982969-001-01-2	Phase 3
etizolam	benzodiazepine receptor agonist	GABRA1	neurology/psychiatry	insomnia, anxiety	MedChemEx	99.78	BRD-K68232413-001-01-2	Launched
etodolac	cyclooxygenase inhibitor	PTGS1, PTGS2, RXRA	rheumatology	osteoarthritis, rheumatoid arthritis	Selleck, MicroSource	99.16	BRD-A74667430-001-25-1, BRD-A74667430-001-23-6	Launched
etofenamate	cyclooxygenase inhibitor	PTGS1, PTGS2	neurology/psychiatry, rheumatology	muscle pain, joint pain	MedChemEx	97.04	BRD-K73541271-001-03-6	Launched
etofibrate	PPAR receptor agonist	PPARA	endocrinology	hypertriglyceridemia	Selleck	95.38	BRD-K49338325-001-03-4	Launched
etofylline	adenosine receptor antagonist	ADORA1	pulmonary	asthma, bronchitis	Enzo	98.82	BRD-K83064458-001-23-0	Launched
etofylline-clofibrate	platelet aggregation inhibitor	PPARA			Enamine	99.43	BRD-K49840922-001-05-1	Launched
etomidate	GABA receptor modulator	ADRA2B, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ	neurology/psychiatry	general anaesthetic	MicroSource, Selleck, Tocris	95.99	BRD-K55055802-001-09-4, BRD-K55055802-001-10-2, BRD-K55055802-001-08-6	Launched
etomoxir	carnitine palmitoyltransferase inhibitor	CPT1A			MedChemEx	98.66	BRD-K32405725-001-02-8	Phase 2
etonogestrel	progesterone receptor agonist	ESR1, PGR	endocrinology	contraceptive	Enzo	97.58	BRD-A08302182-001-01-7	Launched
etoposide	topoisomerase inhibitor	TOP2A, TOP2B	oncology	non-small cell lung cancer (NSCLC)	Selleck, Tocris, MedChemEx, MicroSource, Selleck, Tocris	99.86	BRD-K37798499-001-18-1, BRD-K37798499-001-24-9, BRD-K37798499-001-25-6, BRD-K37798499-001-27-2, BRD-K37798499-001-22-3, BRD-K37798499-001-21-5	Launched
etoposide-phosphate	topoisomerase inhibitor	TOP2A	oncology	testicular carcinoma, small cell lung cancer	ChemImpex	94.37	BRD-K72533376-001-01-2	Launched
etoricoxib	cyclooxygenase inhibitor	PTGS2	rheumatology	rheumatoid arthritis, psoriatic arthritis, osteoarthritis, gout, ankylosing spondylitis	MedChemEx	99.25	BRD-K54770957-001-04-3	Launched
etosalamide	anti-inflammatory agent				MicroSource	95.92	BRD-K60914966-001-01-4	Preclinical
etoxybamide					Sigma	69.8	BRD-K51364817-001-01-4	Phase 2
ETP-45658	PI3K inhibitor	PIK3CA, PIK3CB, PIK3CD, PIK3CG			Tocris	97.88	BRD-K15858023-001-01-0	Preclinical
ETP-46464	ATR kinase inhibitor				Selleck	97.1	BRD-K24556407-001-02-3	Preclinical
etravirine	non-nucleoside reverse transcriptase inhibitor	CYP2C19, CYP2C9, CYP3A4	infectious disease	human immunodeficiency virus (HIV-1)	Selleck	92.21	BRD-K74717603-001-02-2	Launched
etretinate	protein synthesis inhibitor	RARA, RARB, RARG, RXRA, RXRB, RXRG			MedChemEx, Prestwick, MedChemEx, MedChemEx	87.97	BRD-K49076555-001-05-6, BRD-K49076555-001-01-5, BRD-K49076555-001-03-1, BRD-K49076555-001-04-9	Withdrawn
eucalyptol	acetylcholinesterase inhibitor	ACHE	dental	gingivitis	MicroSource, AMS	0	BRD-K29996876-001-10-1, BRD-K29996876-001-09-3	Launched
eucatropine	acetylcholine receptor antagonist				Prestwick	54.26	BRD-A37942872-003-20-6	Preclinical
eugenol	androgen receptor antagonist	AR	dental	toothache	MicroSource	92.11	BRD-K32977963-001-05-0	Launched
EUK-134	catalase stimulant	APP, SOD2			Selleck, Selleck	0	BRD-K19741031-001-02-2, BRD-K19741031-001-01-4	Preclinical
eupatilin	mucus protecting agent				MedChemEx, Astatech	94.26	BRD-K47031502-001-02-4, BRD-K47031502-001-01-6	Launched
evacetrapib	cholesteryl ester transfer protein inhibitor	CETP			Selleck, Selleck	94.86	BRD-K16551357-001-02-4, BRD-K16551357-001-03-2	Phase 3
evans-blue	glutamate receptor negative allosteric modulator	GRIA1, PTPN1			MicroSource	92.8	BRD-K24548560-342-02-1	Launched
evatanepag	prostaglandin inhibitor	PTGER2, PTGER4			MedChemEx	95.91	BRD-K11452913-001-01-9	Phase 2
everolimus	mTOR inhibitor	MTOR	oncology, neurology/psychiatry, genetics, urology	breast cancer, neuroendocrine tumors of pancreatic origin (PNET), renal cell carcinoma (RCC), subependymal giant cell astrocytoma (SEGA), tuberous sclerosis complex (TSC), renal angiomyolipoma	Selleck, Selleck	95.59	BRD-K13514097-001-04-6, BRD-K13514097-001-05-3	Launched
evodiamine	ATPase inhibitor, TRPV agonist	TRPV1			Selleck, Selleck	98.92	BRD-A68631409-001-05-4, BRD-A68631409-001-06-2	Preclinical
EVP-6124	acetylcholine receptor agonist	CHRNA7			MedChemEx	95.74	BRD-K71603915-003-01-8	Phase 3
EVP4593	NFkB pathway inhibitor				Selleck, MedChemEx, Selleck	87.46	BRD-K68395654-001-03-1, BRD-K68395654-001-06-4, BRD-K68395654-001-05-6	Preclinical
EW-7197	TGF beta receptor inhibitor	ACVR1B, TGFBR1			Selleck	89.86	BRD-K74396648-001-01-4	Phase 1
EX-527	SIRT inhibitor	SIRT1			Selleck, Selleck	94.26	BRD-A73908300-001-09-1, BRD-A73908300-001-06-7	Phase 2
exalamide	membrane permeability inhibitor				MicroSource	98.99	BRD-K12609457-001-03-1	Launched
examorelin	growth hormone releasing factor agonist	GHRHR, GHSR			Sigma	85.7	BRD-K35304636-001-01-0	Phase 2
exatecan-mesylate	topoisomerase inhibitor	TOP1			MedChemEx, MedChemEx	87.61	BRD-K92150287-066-02-0, BRD-K92150287-066-01-2	Phase 3
exemestane	aromatase inhibitor	CYP19A1	oncology	breast cancer	Tocris, MicroSource, Selleck	98.07	BRD-K33425534-001-10-9, BRD-K33425534-001-12-5, BRD-K33425534-001-11-7	Launched
exenatide	GLP receptor agonist	GLP1R	endocrinology	diabetes mellitus	MedChemEx	59.57	BRD-K05505104-001-01-1	Launched
exherin	cadherin antagonist	CDH2			MedChemEx	94.47	BRD-K81795818-019-01-4	Phase 2
exifone	nootropic agent	TYR			Sigma, Enzo	95.11	BRD-K65716359-001-04-7, BRD-K65716359-001-02-1	Withdrawn
exisulind	phosphodiesterase inhibitor	PDE5A			LKT	96.77	BRD-K37708699-001-01-4	Phase 3
exo-IWR-1	WNT signaling inhibitor negative control	TNKS			Tocris	91.1	BRD-K96155658-001-01-5	Preclinical
EXO-1	ARF inhibitor				Tocris, Tocris	99.03	BRD-K78633253-001-11-1, BRD-K78633253-001-10-3	Preclinical
ezatiostat	glutathione transferase inhibitor	GSTP1			MedChemEx, MedChemEx, MedChemEx	88.92	BRD-K98963219-001-03-8, BRD-K98963219-001-02-0, BRD-K98963219-001-01-2	Phase 2
ezetimibe	cholesterol inhibitor, Niemann-Pick C1-like 1 protein antagonist	ANPEP, NPC1L1, SOAT1	endocrinology, metabolism	hyperlipidemia, hypercholesterolemia, sitosterolemia	MicroSource, Adooq, Selleck, Selleck	96.2	BRD-A41519720-001-04-8, BRD-K42260897-001-08-4, BRD-K42260897-001-07-6, BRD-K42260897-001-09-2	Launched
ezutromid	utrophin enhancer	UTRN			Vitas-M	77.14	BRD-K25570267-001-01-4	Phase 2
E7449	PARP inhibitor	PARP1, PARP2, TNKS, TNKS2			MedChemEx, MedChemEx, MedChemEx	94.48	BRD-K05444225-001-03-3, BRD-K05444225-001-02-5, BRD-K05444225-001-01-7	Phase 1/Phase 2
F-11440	serotonin receptor agonist	HTR1A			MedChemEx	92.26	BRD-K87948281-001-01-9	Phase 2
fadrozole	aromatase inhibitor	CYP11B1, CYP19A1	oncology	breast cancer	SantaCruz	98.89	BRD-A25619068-003-03-4	Launched
fagomine	glucosidase inhibitor	GLB1			MedChemEx	99.3	BRD-K61536264-001-01-3	Phase 2
falecalcitriol	vitamin D receptor agonist	VDR	endocrinology	hyperparathyroidism	MedChemEx, MedChemEx	89.51	BRD-K08251020-001-02-8, BRD-K08251020-001-01-0	Launched
famciclovir	DNA polymerase inhibitor		dental, infectious disease	cold sore, genitial herpes, shingles	MicroSource, Selleck	99.1	BRD-K45033733-001-12-2, BRD-K45033733-001-11-4	Launched
famotidine	histamine receptor antagonist	HRH2	gastroenterology	heartburn	Selleck, MicroSource	99.08	BRD-K00673382-001-17-1, BRD-K00673382-001-18-9	Launched
famprofazone	cyclooxygenase inhibitor				Selleck, MicroSource	95.25	BRD-A08255417-001-13-9, BRD-A08255417-001-14-7	Preclinical
fananserin	dopamine receptor antagonist, serotonin receptor antagonist	HTR2A			Tocris, Tocris	93.07	BRD-K08998509-001-02-4, BRD-K08998509-001-03-2	Phase 2
fanetizole	neutrophil superoxide production				Enamine	94.26	BRD-K60798049-001-03-8	Phase 3
farnesyl-thiosalicylic-acid-amide	Ras GTPase inhibitor	HRAS			Cayman	96.81	BRD-K14590126-001-01-6	Phase 1
faropenem	lactamase inhibitor		infectious disease, pulmonary, otolaryngology	pneumonia, bronchitis, skin infections, urinary tract infections, sinusitis	Astatech	98.06	BRD-A49622760-001-01-9	Launched
faropenem-medoxomil	lactamase inhibitor		otolaryngology, infectious disease, pulmonary	sinusitis, pneumonia, bronchitis, skin infections, urinary tract infections	MedChemEx, MedChemEx, MedChemEx	82.42	BRD-K59045783-001-03-7, BRD-K59045783-001-02-9, BRD-K59045783-001-01-1	Launched
fasudil	rho associated kinase inhibitor	PKIA, PRKACA, ROCK1, ROCK2	neurology/psychiatry	cerebral vasospasm	MicroSource, Selleck, Tocris, Tocris	98.59	BRD-K76617868-001-05-5, BRD-K76617868-003-10-1, BRD-K76617868-003-14-3, BRD-K76617868-003-11-9	Launched
favipiravir	RNA polymerase inhibitor				AdvChemBlocks	95.67	BRD-K04264130-001-01-4	Phase 3
FCE-22250	DNA directed DNA polymerase inhibitor				Vitas-M	15.69	BRD-A10991937-001-01-1	Phase 1
fdcyd	DNA methyltransferase inhibitor				SantaCruz	94.9	BRD-K18157228-001-01-7	Phase 2
febuxostat	xanthine oxidase inhibitor	XDH	nephrology	hyperuricemia	Tocris, MicroSource, Selleck	98.36	BRD-K48367671-001-07-5, BRD-K48367671-001-06-7, BRD-K48367671-001-05-9	Launched
felbamate	glutamate receptor antagonist	GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B	neurology/psychiatry	epilepsy	Tocris, Tocris, Selleck, Selleck	94.7	BRD-K99107520-001-27-4, BRD-K99107520-001-24-1, BRD-K99107520-001-25-8, BRD-K99107520-001-23-3	Launched
felbinac	cyclooxygenase inhibitor	CTSL	rheumatology, neurology/psychiatry	rheumatoid arthritis, muscle pain	MicroSource	99.79	BRD-K91740057-001-19-8	Launched
felbinac-ethyl	cyclooxygenase inhibitor	PTGS1, PTGS2			AMS	47.98	BRD-K26404903-001-01-5	Launched
felodipine	calcium channel blocker	CACNA1C, CACNA1D, CACNA1F, CACNA1H, CACNA1S, CACNA2D1, CACNA2D2, CACNB2, CALM1, CFTR, NR3C2, PDE1A, PDE1B, TNNC1, TNNC2	cardiology	hypertension	Tocris, MicroSource, Selleck	98.85	BRD-A30815329-001-12-1, BRD-A30815329-001-10-5, BRD-A30815329-001-08-9	Launched
fenaclon					MicroSource	88.3	BRD-K08791496-001-01-0	Preclinical
fenbendazole	tubulin polymerization inhibitor	TUBB	infectious disease	gastrointestinal parasites, gastrointestinal roundworms	Selleck, MicroSource	98.69	BRD-K51318897-001-14-6, BRD-K51318897-001-15-3	Launched
fenbufen	cyclooxygenase inhibitor	PTGS1, PTGS2			MicroSource	99.5	BRD-K12513978-001-24-1	Launched
fenclonine-(+/-)	tryptophan hydroxylase inhibitor	PAH, TPH1, TPH2			MicroSource	89.42	BRD-A81615860-003-01-7	Preclinical
fendiline	calcium channel blocker	HTR2B			MicroSource	97.49	BRD-A71033472-003-23-9	Preclinical
fenigam	benzodiazepine receptor agonist	GABBR1, GABBR2	neurology/psychiatry	posttraumatic stress disorder, anxiety, depression	Enamine	92.36	BRD-A66920069-001-01-3	Launched
fenipentol	choleretic agent		gastroenterology	bile stimulation	MicroSource	0	BRD-A66284731-001-02-0	Launched
fenobam	glutamate receptor antagonist	GRM5			Tocris, Tocris	94.73	BRD-K41160163-001-06-8, BRD-K41160163-001-07-6	Phase 2
fenofibrate	PPAR receptor agonist	MMP25, PPARA	endocrinology	hypercholesterolemia, hypertriglyceridemia	Tocris, MicroSource, Selleck	99.56	BRD-K50388907-001-32-0, BRD-K50388907-001-30-4, BRD-K50388907-001-29-6	Launched
fenofibric-acid	cytochrome P450 inhibitor	CLCN1, PPARA	cardiology	dyslipidemia	MicroSource	94.36	BRD-K30213273-001-01-6	Launched
fenoldopam	dopamine receptor agonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD4, DRD5	cardiology	hypertension	MicroSource, Tocris	94.55	BRD-A50684349-066-11-7, BRD-A50684349-003-02-9	Launched
fenoprofen	prostaglandin inhibitor	PTGS1, PTGS2, SLC5A8	rheumatology	rheumatoid arthritis, osteoarthritis	Selleck, MicroSource, Selleck	99.05	BRD-A81129465-001-04-6, BRD-A81129465-001-03-8, BRD-A81129465-238-01-0	Launched
fenoterol	adrenergic receptor agonist	ADRB1, ADRB2, ADRB3			MicroSource	92.58	BRD-A97104540-004-15-0	Withdrawn
fenoverine	acetylcholine receptor antagonist		neurology/psychiatry	spasms	Vitas-M	94.91	BRD-K77564118-001-03-1	Launched
fenoxaprop-p-ethyl		NOS2, NOS3			MedChemEx	94.27	BRD-K44777569-001-01-7	Preclinical
fenretinide	apoptosis stimulant, retinoid receptor agonist	RARA			MedChemEx, MedChemEx, Adooq, Tocris	82.51	BRD-K89085489-001-24-0, BRD-K89085489-001-23-2, BRD-K89085489-001-22-4, BRD-K89085489-001-19-0	Phase 3
fenspiride	bronchodilator		pulmonary, otolaryngology	asthma, otitis, sinusitis, rhinopharyngitis, laryngitis	Selleck, MicroSource	98.6	BRD-K26739552-003-14-7, BRD-K26739552-003-15-4	Launched
fenthion	cholinesterase inhibitor				MicroSource	78.04	BRD-K67217586-001-08-0	Launched
fentiazac	cyclooxygenase inhibitor	PTGS1, PTGS2	neurology/psychiatry, rheumatology	muscle pain, joint pain	Prestwick	92.65	BRD-K16077845-001-06-1	Launched
fenticonazole	bacterial cell wall synthesis inhibitor		infectious disease	vulvovaginal candidiasis	Selleck	98.76	BRD-A33697453-008-02-4	Launched
FERb-033	EGFR inhibitor	ERBB2			Tocris, Tocris	94.02	BRD-K61642990-001-01-0, BRD-K61642990-001-02-8	Preclinical
ferrostatin-1	ferroptosis inhibitor				Selleck, Tocris, Selleck	83.4	BRD-K97375133-001-01-3, BRD-K97375133-001-03-9, BRD-K97375133-001-02-1	Preclinical
ferulic-acid	antioxidant	CA1, CA12, CA14, CA2, CA4, CA6, CA9			MedChemEx, MedChemEx, Selleck, Selleck	95.29	BRD-K66295376-236-02-6, BRD-K66295376-236-01-8, BRD-K66295376-001-13-1, BRD-K66295376-001-12-3	Phase 2
fesoterodine	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	urology	urinary incontinence	Selleck, Selleck	88.03	BRD-K46731503-050-01-8, BRD-K46731503-051-04-0	Launched
fexaramine	FXR agonist	NR1H4			Tocris, Tocris	85.86	BRD-K08864679-001-02-2, BRD-K08864679-001-03-0	Preclinical
fexinidazole					Ark	99.04	BRD-K37069697-001-01-3	Phase 2/Phase 3
fexofenadine	histamine receptor antagonist	HRH1	allergy	allergic rhinitis, urticaria	MicroSource, Tocris, Tocris, Selleck	98.09	BRD-A73368467-003-18-4, BRD-A73368467-003-17-6, BRD-A73368467-003-19-2, BRD-A73368467-003-16-8	Launched
FG-2216	hypoxia inducible factor prolyl hydroxylase inhibitor	EGLN1, EGLN2, HIF1A			MedChemEx	96.03	BRD-K56807945-001-01-2	Phase 2
FG-4592	hypoxia inducible factor prolyl hydroxylase inhibitor	EGLN2			Selleck, Selleck	93.33	BRD-K14385366-001-04-4, BRD-K14385366-001-02-8	Phase 3
FG-7142	GABA benzodiazepine site receptor inverse agonist				Tocris, Tocris	97.73	BRD-K61951118-001-08-7, BRD-K61951118-001-07-9	Preclinical
FGIN-1-27	inositol monophosphatase inhibitor	TSPO			Tocris, Tocris	96.53	BRD-K09778810-001-11-4, BRD-K09778810-001-10-6	Preclinical
FGIN-1-43	benzodiazepine receptor agonist	TSPO			Tocris, Tocris	98.62	BRD-K66093087-001-04-9, BRD-K66093087-001-03-1	Preclinical
FH-535	PPAR receptor antagonist, WNT signaling inhibitor	PPARD, PPARG			Tocris	93.75	BRD-K48112880-001-02-3	Preclinical
FH1	hepatocyte function enhancer				Selleck, Tocris	97.97	BRD-K44777625-001-03-5, BRD-K44777625-001-05-0	Preclinical
fiacitabine	DNA synthesis inhibitor				MedChemEx	99.3	BRD-K07160047-001-01-3	Phase 2
fidarestat	aldose reductase inhibitor	AKR1B1			Vitas-M	88.01	BRD-A63752151-001-01-2	Phase 3
fidaxomicin	RNA polymerase inhibitor		gastroenterology	diarrhea	Selleck	91.8	BRD-K57371763-001-01-7	Launched
filanesib	kinesin inhibitor, kinesin-like spindle protein inhibitor	KIF11			MedChemEx, MedChemEx	85.47	BRD-K37379014-001-01-2, BRD-K37379014-001-02-0	Phase 3
filgotinib	JAK inhibitor	JAK1, JAK2, JAK3, TYK2			MedChemEx	96.83	BRD-K16803204-001-01-6	Phase 2
fimasartan	angiotensin receptor antagonist	AGTR1	cardiology	hypertension, congestive heart failure, hypertension, congestive heart failure	MedChemEx, MedChemEx	89.33	BRD-K21586122-001-02-7, BRD-K21586122-001-01-9	Launched
finafloxacin	bacterial DNA gyrase inhibitor		infectious disease, pulmonary	intra-abdominal infections, chronic obstructive pulmonary disease (COPD), cystic fibrosis	SantaCruz	93.21	BRD-K98384930-003-01-5	Launched
finasteride	5 alpha reductase inhibitor	AKR1D1, SRD5A1, SRD5A2	endocrinology	androgenetic alopecia	MicroSource, Selleck	98.24	BRD-K01095011-001-15-9, BRD-K01095011-001-14-2	Launched
fingolimod	immunosuppressant, sphingosine phosphate receptor agonist	S1PR1, S1PR5	neurology/psychiatry	multiple sclerosis	Selleck, Selleck	95.28	BRD-K88025533-003-04-1, BRD-K88025533-003-03-3	Launched
fipexide	psychoactive drug				MicroSource	98.95	BRD-K37688416-003-13-1	Withdrawn
FIPI	phospholipase inhibitor	PLD1, PLD2			Tocris	97.57	BRD-K61560897-003-01-4	Preclinical
fipronil	chloride channel blocker, GABA gated chloride channel blocker				MicroSource	96.39	BRD-A50675702-001-07-1	Launched
firategrast	integrin antagonist	ITGA4			MedChemEx	99.31	BRD-K17513304-001-01-9	Phase 2
firocoxib	cyclooxygenase inhibitor	PTGS2	rheumatology	osteoarthritis	MicroSource	99.46	BRD-K09090523-001-02-1	Launched
fisetin	Aurora kinase inhibitor	CDK6, FASN			Selleck, Selleck	84.91	BRD-K31836715-001-05-0, BRD-K31836715-001-06-8	Preclinical
FIT	opioid receptor agonist	OPRD1			Tocris	8.53	BRD-K17896185-001-02-0	Preclinical
FK-33-824	opioid receptor agonist	OPRM1			Enzo	81.78	BRD-A01907367-001-01-7	Phase 2
FK-3311	cyclooxygenase inhibitor	PTGS2			MedChemEx	94.36	BRD-K38350380-001-01-8	Phase 2
FK-866	niacinamide phosphoribosyltransferase inhibitor	NAMPT			Enzo	92.65	BRD-K58550667-001-08-7	Phase 2
FK-888	tachykinin antagonist	TACR1, TACR2			Tocris, Tocris	97.91	BRD-K83508485-001-02-7, BRD-K83508485-001-03-5	Phase 2
FK-962	somatostatin receptor agonist				Enamine	98.54	BRD-K80607346-001-01-1	Phase 2
flavin-adenine-dinucleotide		ACAD8, ACADM, ACADS, ACOX1, AIFM1, CYB5R1, CYB5R3, DAO, DLD, DPYD, ERO1LB, FDXR, GCDH, GFER, GSR, IL4I1, IVD, MAOA, MAOB, NOS1, NQO1, NQO2, POR, TXNRD1, XDH			Vitas-M	0	BRD-A86545589-001-01-5	Preclinical
flavoxate	acetylcholine receptor antagonist	CHRM1, CHRM2	urology	urinary incontinence, interstitial cystitis (IC), urethritis, prostatitis	Selleck	96.85	BRD-K47639036-003-06-6	Launched
flecainide	sodium channel blocker	KCNA5, KCNA7, SCN4A, SCN5A	cardiology	ventricular tachycardia (VT), atrial fibrillation (AF), ventricular arrhythmias	Tocris, MicroSource, Tocris	96.6	BRD-A09472452-015-26-7, BRD-A09472452-015-23-4, BRD-A09472452-015-22-6	Launched
fleroxacin	topoisomerase inhibitor		infectious disease, gastroenterology	gonorrhea, enteritis, diarrhea, respiratory tract infections	Selleck, Selleck	99.55	BRD-K61717546-001-04-3, BRD-K61717546-001-05-0	Launched
FLI-06	notch signaling inhibitor				Selleck, Tocris, Selleck	97.33	BRD-A44500574-001-01-8, BRD-A44500574-001-03-4, BRD-A44500574-001-02-6	Preclinical
flibanserin	serotonin receptor agonist	DRD4, HTR1A, HTR2A	neurology/psychiatry	hypoactive sexual desire disorder	MedChemEx	96.14	BRD-K33637378-001-01-7	Launched
flindokalner	potassium channel agonist	KCNMA1, KCNN4, KCNQ2, KCNQ4, KCNQ5			Tocris, Sigma	98.77	BRD-K56740996-001-02-1, BRD-K56740996-001-01-3	Phase 3
floctafenine	cyclooxygenase inhibitor	PTGS1, PTGS2	neurology/psychiatry	pain relief	Carbosynth	99.43	BRD-A23418262-001-01-5	Launched
flopropione	serotonin receptor antagonist	HTR1A	neurology/psychiatry	spasms	MicroSource, Selleck	98.95	BRD-K43383936-001-05-2, BRD-K43383936-001-04-5	Launched
florfenicol	protein synthesis inhibitor		pulmonary	bovine respiratory disease (BRD)	MicroSource, Selleck	97.38	BRD-A30886737-001-02-9, BRD-K11298197-001-12-0	Launched
flosequinan	phosphodiesterase inhibitor				Key	99.63	BRD-A79643124-001-01-9	Withdrawn
floxuridine	DNA synthesis inhibitor	TYMS	oncology	colorectal cancer	MicroSource, Selleck	100	BRD-A03757454-001-03-4, BRD-K47832606-001-30-1	Launched
flubendazole	tubulin polymerization inhibitor	TUBB	infectious disease	gastrointestinal parasites	MicroSource, Selleck	97.49	BRD-K86003836-001-10-5, BRD-K86003836-001-09-7	Launched
flucloxacillin	bacterial cell wall synthesis inhibitor		infectious disease, otolaryngology, dermatology, gastroenterology	gram-positive bacterial infections, tonsillitis, sinusitis, pneumonia, eczema, endocarditis, meningitis, enteritis, bacterial septicemia	Prestwick, Sigma	78.07	BRD-K27871792-001-01-8, BRD-K27871792-236-01-0	Launched
fluconazole	sterol demethylase inhibitor	CYP51A1	infectious disease	esophageal candidiasis, meningitis	MicroSource, Sigma, Selleck	97.95	BRD-K05977355-001-19-0, BRD-K05977355-001-23-2, BRD-K05977355-001-18-2	Launched
flucytosine	other antifungal	DNMT1	infectious disease	bacterial septicemia, endocarditis, urinary tract infections, meningitis	MicroSource, Selleck	100	BRD-K82143716-001-20-7, BRD-K82143716-001-19-9	Launched
fludarabine	ribonucleotide reductase inhibitor	ADA, RRM1, RRM2	hematologic malignancy	chronic lymphocytic leukemia (CLL)	Tocris, Selleck, Tocris	98.32	BRD-K66788707-001-14-3, BRD-K66788707-001-17-6, BRD-K66788707-001-15-0	Launched
fludarabine-phosphate	ribonucleotide reductase inhibitor	DCK, POLA1, POLD1, POLE, RRM1, RRM2, RRM2B	hematologic malignancy	chronic lymphocytic leukemia (CLL)	Selleck, MicroSource, Selleck	96.99	BRD-K71106091-001-09-5, BRD-K71106091-001-06-1, BRD-K71106091-001-05-3	Launched
fludrocortisone-acetate		AR, NR3C1, NR3C2	endocrinology	Addison's disease, adrenogenital syndrome	MicroSource, Sigma	92.71	BRD-K06408664-001-03-5, BRD-K06408664-001-02-7	Launched
fludroxycortide	glucocorticoid receptor agonist	NR3C1, SERPINA6	infectious disease, dermatology	skin infections, psoriasis	MicroSource	97.06	BRD-A49765801-001-04-1	Launched
flufenamic-acid	chloride channel blocker	AKR1C3, ANO1, AR, GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1, PANX1, PANX2, PANX3, PKD2L1, PTGS1, PTGS2, TRPC5, TRPM2, TRPM5			MicroSource, Selleck	99.37	BRD-K44067360-001-30-3, BRD-K44067360-001-29-5	Preclinical
flumatinib	Bcr-Abl kinase inhibitor	ABL1, PDGFRB			MedChemEx	94.43	BRD-K68870568-066-01-5	Phase 3
flumazenil	benzodiazepine receptor antagonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ	neurology/psychiatry	sedative	Tocris, MicroSource, Selleck, Tocris	99.3	BRD-K98769987-001-25-2, BRD-K98769987-001-23-7, BRD-K98769987-001-21-1, BRD-K98769987-001-22-9	Launched
flumecinol					Enamine	97.8	BRD-A44181516-001-01-8	Launched
flumequine	topoisomerase inhibitor		infectious disease	urinary tract infections	MicroSource, Selleck	98.1	BRD-A69777949-001-25-9, BRD-A69777949-001-24-2	Launched
flumethasone	glucocorticoid receptor agonist	NR3C1, PLA2G1B	dermatology	corticosteroid-responsive dermatoses	Selleck, MicroSource	97.76	BRD-K61496577-001-19-4, BRD-K61496577-001-20-2	Launched
flumethasone-pivalate	glucocorticoid receptor agonist	NR3C1, SERPINA6			MicroSource	96.12	BRD-A50064262-001-04-7	Launched
flumexadol					Enamine, Enamine	29.46	BRD-A43518428-001-01-9, BRD-A43518428-001-02-7	Preclinical
flunarizine	calcium channel blocker	CACNA1G, CACNA1H, CACNA1I, CALM1, HRH1	neurology/psychiatry, cardiology	migraine headache, vertigo, peripheral artery disease (PAD)	Tocris, Selleck, MicroSource, Tocris	97.81	BRD-K29582677-300-11-4, BRD-K29582677-300-08-0, BRD-K29582677-300-10-6, BRD-K29582677-300-09-8	Launched
flunisolide	cytochrome P450 inhibitor	NR3C1	allergy	allergic rhinitis	MicroSource	93.61	BRD-A65449987-001-10-4	Launched
flunixin-meglumin	prostanoid receptor antagonist				MicroSource, Selleck	99.53	BRD-K99984802-100-13-5, BRD-K99984802-100-12-7	Launched
fluocinolone-acetonide	glucocorticoid receptor agonist	NR3C1, SERPINA6	dermatology	seborrheic dermatitis	MicroSource, MicroSource, Selleck	97.54	BRD-K94353609-001-21-6, BRD-A15297126-001-04-3, BRD-K94353609-001-20-8	Launched
fluocinonide	glucocorticoid receptor agonist	NR3C1, SERPINA6, SMO	dermatology	seborrheic dermatitis, eczema	Selleck	93.28	BRD-K57886322-001-16-6	Launched
fluorescein		SLC22A6	ophthalmology	ophthalmology diagnostic	MicroSource	95.86	BRD-K21913543-001-02-4	Launched
fluorometholone	glucocorticoid receptor agonist	NR3C1	ophthalmology	eye inflammation	MicroSource	98.58	BRD-A13133631-001-04-0	Launched
fluorometholone-acetate		NR3C1	ophthalmology	eye inflammation	Selleck, Selleck	97.54	BRD-K02528732-001-01-6, BRD-K02528732-001-02-4	Launched
fluoromethylcholine					MatrixSci	100	BRD-K51199656-003-01-4	Launched
fluoxetine	selective serotonin reuptake inhibitor (SSRI)	ANO1, HTR2B, SLC6A4	neurology/psychiatry	depression, obsessive compulsive disorder (OCD), bulimia nervosa, panic disorders, bipolar disorder	MicroSource, Selleck, Tocris, Tocris	98.86	BRD-A31159102-003-30-4, BRD-A31159102-003-28-8, BRD-A31159102-003-29-6, BRD-A31159102-003-31-2	Launched
fluoxymesterone	androgen receptor modulator	AR, ESR1, NR3C1, PRLR	endocrinology	hypogonadism	Enzo	96.41	BRD-K24255045-001-05-3	Launched
flupentixol	dopamine receptor antagonist	ADRA1A, CHRM1, DRD1, DRD2, DRD3, DRD5, HTR2A	neurology/psychiatry	schizophrenia, depression	Enzo	93.69	BRD-K70487031-001-02-8	Launched
fluphenazine	dopamine receptor antagonist	CALM1, DRD1, DRD2, DRD5, HRH1, HTR2A, HTR6, HTR7	neurology/psychiatry	schizophrenia	MicroSource	95.33	BRD-K55127134-300-11-2	Launched
fluphenazine-decanoate	dopamine receptor antagonist	DRD2, HTR1B, HTR4	neurology/psychiatry	schizophrenia	AKSci	59.41	BRD-K27898013-001-01-4	Launched
flupirtine	glutamate receptor antagonist	ADRA2A, KCNQ1, KCNQ2	neurology/psychiatry	pain relief	Selleck, Tocris, MedChemEx, MedChemEx, Selleck	85.76	BRD-K50720187-051-03-1, BRD-K50720187-001-02-8, BRD-K50720187-050-09-0, BRD-K50720187-050-08-2, BRD-K50720187-051-02-3	Launched
fluprazine	serotonin receptor agonist	HTR1A, HTR1B			Enamine	92.16	BRD-K44091134-001-01-9	Phase 1
flurbiprofen-(+/-)	cyclooxygenase inhibitor	PTGS1, PTGS2	rheumatology	rheumatoid arthritis, osteoarthritis	Tocris, MicroSource	98.21	BRD-A86044036-001-26-5, BRD-A86044036-001-27-3	Launched
flurbiprofen-(S)-(+)	cyclooxygenase inhibitor	PTGS1, PTGS2	rheumatology	rheumatoid arthritis, osteoarthritis	Selleck, Selleck	99.2	BRD-K69907333-001-07-2, BRD-K69907333-001-10-6	Launched
flurizan	gamma secretase inhibitor	APH1B, BACE1, IKBKG, PSEN1, PSEN2, PTGS1, PTGS2			Tocris	95.1	BRD-K75410565-001-02-9	Phase 3
flurofamide	urease inhibitor				Tocris, Tocris, Tocris	73.24	BRD-K67445247-001-04-7, BRD-K67445247-001-03-9, BRD-K67445247-001-02-1	Preclinical
flurothyl					MicroSource, TCI	0	BRD-K14763542-001-02-3, BRD-K14763542-001-03-1	Preclinical
fluroxene	local anesthetic				MedChemEx, MicroSource	0	BRD-K56908511-001-02-0, BRD-K56908511-001-01-2	Preclinical
fluspirilene	dopamine receptor antagonist	CACNG1, DRD2, HRH1, HTR1A, HTR1D, HTR1E, HTR2A	neurology/psychiatry	schizophrenia	Enzo	91.79	BRD-K77947974-001-16-3	Launched
flutamide	androgen receptor antagonist	AHR, AR	oncology	prostate cancer	Tocris, MicroSource, Selleck	99.28	BRD-K28307902-001-23-3, BRD-K28307902-001-21-7, BRD-K28307902-001-20-9	Launched
fluticasone-propionate	glucocorticoid receptor agonist	NR3C1, NR3C2, PGR, PLA2G4A	dermatology	corticosteroid-responsive dermatoses	Tocris, MicroSource, Selleck, Tocris	96.66	BRD-K62310379-001-12-1, BRD-A45538101-001-01-9, BRD-K62310379-001-13-9, BRD-K62310379-001-10-5	Launched
flutrimazole	sterol demethylase inhibitor		infectious disease	mycosis	SantaCruz	99.39	BRD-A00218260-001-03-4	Launched
fluvastatin	HMGCR inhibitor	HMGCR	endocrinology, cardiology	hypercholesterolemia, congenital heart defects	Selleck, MicroSource, Tocris, Selleck	97.47	BRD-K66296774-236-11-3, BRD-K66296774-001-07-9, BRD-K66296774-236-12-1, BRD-K66296774-236-10-5	Launched
fluvoxamine	selective serotonin reuptake inhibitor (SSRI)	SLC6A4	neurology/psychiatry	obsessive compulsive disorder (OCD)	MicroSource, Tocris, Selleck	93.31	BRD-K53517854-050-21-4, BRD-K53517854-050-20-6, BRD-K53517854-051-01-4	Launched
fmoc-l-leucine	PPAR receptor agonist				Sigma	99.78	BRD-K15327298-001-05-5	Phase 2
folic-acid	folate receptor ligand	FOLR2, FOLR3, SLC19A1, SLC46A1	hematology	megaloblastic anemia	MicroSource	89.21	BRD-K18673820-001-15-5	Launched
fomepizole	alcohol dehydrogenase inhibitor	ADH1A, ADH1B, ADH1C, AKR1A1, CAT	critical care	poison antidote	MicroSource, MicroSource	98.99	BRD-K56810756-003-07-7, BRD-K56810756-001-03-0	Launched
fomocaine	voltage-gated sodium channel modulator		neurology/psychiatry	local anesthetic	ChemDiv	96.22	BRD-K44942188-001-09-1	Launched
foretinib	VEGFR inhibitor	FLT1, FLT4, KDR, MET			Selleck	93.68	BRD-K03449891-001-08-6	Phase 2
formestane	aromatase inhibitor	CYP19A1	oncology	breast cancer	Selleck, MicroSource	100	BRD-A26503646-001-18-2, BRD-A26503646-001-16-6	Launched
formononetin	alcohol dehydrogenase inhibitor	ADH1C, SLC5A2			Selleck	96.93	BRD-K55567017-001-12-3	Preclinical
formoterol	adrenergic receptor agonist	ADRB2	pulmonary	asthma, chronic obstructive pulmonary disease (COPD), bronchospasm	Tocris, Selleck, Selleck, Tocris	98.09	BRD-K54006094-051-06-6, BRD-K54006094-051-01-7, BRD-K54006094-051-03-3, BRD-K54006094-051-02-5	Launched
forodesine	purinergic receptor antagonist	PNP			MedChemEx, MedChemEx	100	BRD-K16505263-003-01-1, BRD-K16505263-003-02-9	Phase 2
foropafant	platelet activating factor receptor antagonist	PTAFR			Sigma	97.36	BRD-K57774929-001-01-3	Phase 3
forskolin	adenylyl cyclase activator	ADCY2, ADCY5, GNAS			Tocris, Selleck, Tocris	100	BRD-K09602097-001-13-6, BRD-K09602097-001-23-5, BRD-K09602097-001-20-1	Launched
fosamprenavir	HIV protease inhibitor		infectious disease	human immunodeficiency virus (HIV-1)	MedChemEx	93.28	BRD-K59110290-238-01-7	Launched
fosaprepitant-dimeglumine	tachykinin antagonist	TACR1	gastroenterology	nausea, vomiting	MedChemEx, MedChemEx, Selleck, Selleck	78.2	BRD-K23848629-401-05-2, BRD-K23848629-401-04-5, BRD-K23848629-401-02-9, BRD-K23848629-401-03-7	Launched
fosbretabulin	tubulin polymerization inhibitor, VE-cadherin antagonist	CDH5			MedChemEx, MedChemEx, MedChemEx, MedChemEx	90.79	BRD-K68399195-304-02-9, BRD-K06814349-304-01-9, BRD-K06814349-304-02-7, BRD-K68399195-304-01-1	Phase 3
foscarnet	DNA polymerase inhibitor		infectious disease	cytomegalovirus retinitis, acquired immunodeficiency syndrome (AIDS), virus herpes simplex (HSV)	Selleck, Selleck, MicroSource	0	BRD-K85146014-314-05-4, BRD-K85146014-314-07-0, BRD-K85146014-314-06-2	Launched
fosfestrol	synthetic estrogen	ESR1, ESR2	oncology	prostate cancer	MatrixSci	0	BRD-K20801936-001-01-9	Launched
fosfomycin	bacterial cell wall synthesis inhibitor		infectious disease	urinary tract infections	Selleck, MicroSource	100	BRD-K81101512-234-01-9, BRD-A10652366-238-04-1	Launched
fosfosal	phosphodiesterase inhibitor	PTGS1, PTGS2			MicroSource, Sigma	84.64	BRD-K28687144-001-07-9, BRD-K28687144-001-08-7	Launched
fosfructose	fructose diphosphate stimulant	PKLR			SantaCruz	0	BRD-A19086570-314-01-0	Phase 3
fosinopril	angiotensin converting enzyme inhibitor	ACE	cardiology	hypertension, congestive heart failure	Selleck, Selleck	97.48	BRD-A51382177-236-03-0, BRD-A51382177-236-04-8	Launched
fosinoprilat	angiotensin converting enzyme inhibitor	ACE			AvaChem	61.88	BRD-A33506612-001-01-2	Launched
fosphenytoin	sodium channel blocker	SCN5A	neurology/psychiatry	epilepsy, seizures	AKSci, CombiBlocks	94.91	BRD-K53809807-304-01-6, BRD-K53809807-304-02-4	Launched
fostamatinib	SYK inhibitor	SYK	hematology	chronic immune thrombocytopenia (ITP)	Selleck, Selleck	92.92	BRD-K85178109-001-03-1, BRD-K85178109-001-02-3	Launched
fotemustine	thioredoxin inhibitor	TXNRD1	oncology	melanoma	MedChemEx, MedChemEx	36.92	BRD-A62893078-001-02-3, BRD-A62893078-001-01-5	Launched
foxy-5	WNT5a peptide mimetic	WNT5A			Tocris	99.26	BRD-K13005598-001-02-3	Phase 1
FPA-124	AKT inhibitor				Tocris, Tocris	0	BRD-M17926088-001-02-1, BRD-M17926088-001-01-3	Preclinical
FPH1-(BRD-6125)	hepatocyte function enhancer				Selleck	96.07	BRD-K61250484-001-02-3	Preclinical
FPL-12495	glutamate receptor antagonist				Enamine	92.23	BRD-A09368919-001-01-7	Phase 1
FPL-55712	leukotriene receptor antagonist				Tocris	97.14	BRD-A96456596-001-02-2	Phase 1
FPL-62064	cyclooxygenase inhibitor, lipoxygenase inhibitor				Astatech	86.14	BRD-K59875992-001-01-8	Phase 2
FPL-64176	calcium channel activator	CACNA1C, CACNA1S			Tocris, Tocris	98.96	BRD-K78959463-001-15-7, BRD-K78959463-001-13-2	Preclinical
FPS-ZM1	RAGE receptor antagonist	AGER			MedChemEx	97.01	BRD-K87691185-001-01-2	Preclinical
FR-122047	cyclooxygenase inhibitor				Tocris	98.1	BRD-K30990140-003-02-4	Preclinical
FR-139317	endothelin receptor antagonist	EDNRA			Tocris, Tocris	97.59	BRD-K19318328-001-02-1, BRD-K19318328-001-01-3	Phase 1
FR-180204	MAP kinase inhibitor	MAPK1, MAPK3			Tocris, Tocris	85.02	BRD-K68756823-001-07-1, BRD-K68756823-001-10-5	Preclinical
FRAX486	serine/threonine kinase inhibitor	PAK1, PAK2, PAK3, PAK4			MedChemEx, Tocris	92.66	BRD-K57243773-001-01-6, BRD-K57243773-001-02-4	Preclinical
frentizole	immunosuppressant				MedChemEx	87.55	BRD-K07202345-001-19-4	Phase 1
frovatriptan	serotonin receptor agonist	HTR1A, HTR1B, HTR1D	neurology/psychiatry	migraine headache	Sigma	91.96	BRD-K08255599-365-01-1	Launched
fruquintinib	VEGFR inhibitor	KDR			MedChemEx	97.88	BRD-K70504253-001-01-3	Phase 3
ftaxilide					MicroSource	66.74	BRD-K05724540-001-08-5	Preclinical
ftorafur	thymidylate synthase inhibitor	TYMS	oncology	colorectal cancer	Selleck, Selleck	100	BRD-K99383816-001-03-5, BRD-K99383816-001-02-7	Launched
fudosteine	mucolytic agent		pulmonary	chest congestion	Selleck, Selleck	100	BRD-K54838207-001-03-8, BRD-K54838207-001-02-0	Launched
fulvestrant	estrogen receptor antagonist	ESR1, ESR2, GPER1	oncology	breast cancer	Tocris, MicroSource, Tocris, Selleck	97.7	BRD-A85667082-001-10-1, BRD-A85667082-001-11-9, BRD-A85667082-001-12-7, BRD-A85667082-001-13-5	Launched
fumagillin	methionine aminopeptidase inhibitor	METAP2	infectious disease	microsporidiosis	MedChemEx, MedChemEx, Enzo	86.8	BRD-A99367815-001-04-9, BRD-A99367815-001-03-1, BRD-A99367815-001-01-5	Launched
furaltadone	bacterial DNA inhibitor				MicroSource, Selleck, Selleck	99.01	BRD-A67514145-001-02-9, BRD-A67514145-003-05-8, BRD-A67514145-003-06-6	Launched
furamidine	protein arginine N-methyltransferase inhibitor	PRMT1			Tocris	76.91	BRD-K77758223-300-01-1	Preclinical
furazolidone	bacterial DNA inhibitor		gastroenterology, infectious disease	diarrhea, enteritis, cholera	MicroSource	91.67	BRD-K11756522-001-09-9	Launched
furegrelate	thromboxane synthase inhibitor	TBXAS1			Cayman	98.91	BRD-K55529781-236-03-8	Phase 1
furosemide	diuretic	CA2, GPR35, SLC12A1, SLC12A2	cardiology, rheumatology	edema, hypertension, congestive heart failure, nephrotic syndrome	Tocris, Selleck, MicroSource	99.55	BRD-K78010432-001-24-9, BRD-K78010432-001-20-7, BRD-K78010432-001-21-5	Launched
fursultiamine	vitamin B				Prestwick	99.61	BRD-A71157293-003-10-0	Launched
fusidic-acid	bacterial 30S ribosomal subunit inhibitor		dermatology	acne vulgaris (AV)	MicroSource	96.62	BRD-A06935312-001-04-3	Launched
F351	TGF beta receptor inhibitor	TGFB1			Carbosynth	95.15	BRD-K41267922-001-01-4	Phase 2
g-caryophyllene	acetylcholinesterase inhibitor	ACHE			Sigma	0	BRD-K26878113-001-01-6	Preclinical
G-1	G protein-coupled receptor agonist	GPER1			Tocris	97.15	BRD-K62696033-001-01-4	Preclinical
G-15	estrogen receptor antagonist	GPER1			Tocris	94.06	BRD-M30288325-001-01-4	Preclinical
GABA-linoleamide	benzodiazepine receptor agonist				Enzo	0	BRD-K46254452-001-01-5	Phase 2
gabapentin	calcium channel blocker	ADORA1, CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1E, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CACNG2, CACNG3, CACNG4, CACNG5, CACNG6, CACNG7, CACNG8, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B	infectious disease, neurology/psychiatry	virus herpes simplex (HSV), shingles, seizures, restless leg syndrome	Selleck, MicroSource, Selleck	100	BRD-K62737565-001-09-5, BRD-K62737565-001-10-3, BRD-K62737565-003-02-6	Launched
gabapentin-enacarbil	adrenergic receptor agonist	CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1E, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CACNG2, CACNG3, CACNG4, CACNG5, CACNG6, CACNG7, CACNG8	neurology/psychiatry	restless leg syndrome, postherpetic neuralgia	AdvChemBlocks	89.16	BRD-A86665761-001-01-1	Launched
gabazine	GABA receptor antagonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRG2			Tocris, Tocris	98.53	BRD-K79905821-004-04-4, BRD-K79905821-004-03-6	Preclinical
gabexate	serine protease inhibitor	PRSS1, TPSAB1	gastroenterology	pancreatitis	MedChemEx, Selleck, MedChemEx, Selleck, Tocris	85.7	BRD-K59256312-066-17-3, BRD-K59256312-066-13-2, BRD-K59256312-066-16-5, BRD-K59256312-066-15-7, BRD-K59256312-066-14-0	Launched
gaboxadol	benzodiazepine receptor agonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRD, GABRR1, GABRR2, GABRR3			Tocris, MicroSource, Tocris	100	BRD-K89104321-003-16-3, BRD-K89104321-003-15-5, BRD-K89104321-003-14-8	Phase 3
gadobutrol	radiopaque medium		radiology	MRI contrast agent	MedChemEx	100	BRD-A67181951-001-01-2	Launched
gadodiamide	radiopaque medium		radiology	MRI contrast agent	Selleck	100	BRD-K38140108-002-01-2	Launched
gadopentetic-acid	contrast agent		radiology	contrast agent	Sigma	0	BRD-K25106841-001-01-2	Launched
gadoterate-meglumine	radiopaque medium		radiology	MRI contrast agent	Sigma, TCI	97.1	BRD-K11099631-001-08-4, BRD-K11099631-001-07-6	Launched
gadoteridol	radiopaque medium		radiology	MRI contrast agent	Kemprotec, MicroSource	86.8	BRD-A72401848-001-02-2, BRD-A72401848-001-01-4	Launched
galantamine	acetylcholinesterase inhibitor	ACHE, BCHE, CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG	neurology/psychiatry	senile dementia	Tocris, MicroSource	98.59	BRD-K49481516-004-18-3, BRD-K49481516-001-01-5	Launched
galeterone	androgen receptor modulator	AR, CYP17A1			Selleck	96.55	BRD-A07986123-001-02-8	Phase 3
gallamine-triethiodide	acetylcholine receptor antagonist	ACHE, CHRM2, CHRNA1, CHRNA2	neurology/psychiatry	muscle relaxant	Selleck, MicroSource, Selleck	98.46	BRD-K43106192-320-09-2, BRD-K43106192-320-10-0, BRD-K43106192-320-11-8	Launched
gallic-acid	beta amyloid protein neurotoxicity inhibitor, PPAR receptor agonist	CA1, CA12, CA14, CA2, CA4, CA6, CA9, SELP			MicroSource	98.82	BRD-K77345217-001-05-0	Preclinical
gallium-triquinolin-8-olate					Sigma	0	BRD-K46648676-001-01-8	Phase 1
gallopamil	L-type calcium channel blocker	ATP2A2	cardiology	hypertension, cardiac arrythmia	Enzo	97.61	BRD-A52922642-001-03-7	Launched
gambogic-acid	caspase activator	BCL2			MedChemEx, MedChemEx, Enzo	81.89	BRD-K08542803-001-01-5, BRD-K08542803-001-02-3, BRD-K08542803-001-03-1	Phase 2
gamma-aminobutyric-acid	benzodiazepine receptor agonist	GABBR1, GABBR2, GABRA1, GABRA2, GABRA3, GABRA5, GABRB2, GABRG2, GATM, KCTD12, KCTD16, KCTD8, SLC6A1			MicroSource	100	BRD-K77245796-003-01-6	Preclinical
gamma-linolenic-acid	cyclooxygenase inhibitor, prostanoid receptor agonist	PTGS1, PTGS2			Sigma, Cayman, Enzo	87.22	BRD-K18059238-001-13-8, BRD-K18059238-001-11-2, BRD-K18059238-001-10-4	Phase 2
ganaxolone	GABA receptor modulator	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6			Tocris	100	BRD-K28217197-001-01-4	Phase 3
ganciclovir	DNA polymerase inhibitor		infectious disease	cytomegalovirus (CMV)	Selleck, Selleck, MicroSource	100	BRD-K22662435-001-17-5, BRD-K22662435-001-19-1, BRD-K22662435-001-18-3	Launched
ganetespib	HSP inhibitor	HSP90AA1			Selleck	97.3	BRD-K38852836-001-02-1	Phase 3
ganglioside-gm1					EMDBio	85.28	BRD-A30703952-201-01-2	Phase 2
GANT-58	GLI antagonist	GLI1			Tocris	96.49	BRD-K64451768-001-05-4	Preclinical
GANT-61	GLI antagonist	GLI1, GLI2			Tocris	89.02	BRD-K09485525-001-03-9	Preclinical
garenoxacin	topoisomerase inhibitor	TOP2A	infectious disease	respiratory tract infections	MedChemEx	96.9	BRD-K77038618-356-01-3	Launched
gastrodin					Selleck	100	BRD-K81613478-001-01-8	Phase 2
gatifloxacin	bacterial DNA gyrase inhibitor				MicroSource, Selleck	93.99	BRD-A74980173-213-01-1, BRD-A74980173-001-11-9	Withdrawn
gavestinel	glutamate receptor antagonist	GLRB			Tocris, Tocris, Tocris	92.51	BRD-K81981783-236-01-1, BRD-K81981783-236-02-9, BRD-K81981783-236-03-7	Phase 3
GBR-12783	dopamine uptake inhibitor				Tocris	97.13	BRD-K92015269-300-01-2	Preclinical
GBR-12935	dopamine uptake inhibitor	AGTR1, SLC6A3			Tocris	97.4	BRD-K50135270-300-02-3	Preclinical
GBR-13069	dopamine uptake inhibitor	SLC6A3			Tocris	95.51	BRD-K92577649-300-01-2	Preclinical
GDC-0068	AKT inhibitor	AKT1, AKT2, AKT3, PRKG1			Selleck	96.67	BRD-K71480163-001-01-4	Phase 2
GDC-0152	XIAP inhibitor	BIRC2, BIRC3, BIRC7, XIAP			Selleck	94.69	BRD-K68938568-001-01-7	Phase 1
GDC-0349	Pim kinase inhibitor	PIK3CA			Selleck, Selleck	89.78	BRD-K43187018-001-02-5, BRD-K43187018-001-03-3	Phase 1
GDC-0623	MEK inhibitor				MedChemEx, MedChemEx, MedChemEx, Selleck	92.75	BRD-K46908090-001-03-0, BRD-K46908090-001-01-4, BRD-K46908090-001-04-8, BRD-K46908090-001-02-2	Phase 1
GDC-0810	selective estrogen receptor destabilizer	ESR1			MedChemEx	96.35	BRD-K61923022-001-02-4	Phase 2
GDC-0834	Bruton's tyrosine kinase (BTK) inhibitor	BTK			MedChemEx, MedChemEx	90.56	BRD-A30984645-001-02-3, BRD-A30984645-001-01-5	Phase 1
GDC-0879	RAF inhibitor	BRAF			Selleck, Selleck, Tocris	97.55	BRD-K67578145-001-09-7, BRD-K67578145-001-12-1, BRD-K67578145-001-10-5	Preclinical
GDC-0941	PI3K inhibitor	PIK3CA, PIK3CB, PIK3CD, PIK3CG			Selleck	95.23	BRD-K52911425-001-09-8	Phase 2
GDC-0980	mTOR inhibitor, PI3K inhibitor	FGR, MAP3K9, MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG, SYK			Selleck, Selleck	94.13	BRD-K23228615-001-02-8, BRD-K23228615-001-03-6	Phase 2
GDC-0994	MAP kinase inhibitor	MAPK1, MAPK3			Selleck	98.7	BRD-A20830788-001-01-9	Phase 1
gedunin	HSP inhibitor	HSP90AA1			Tocris	95.65	BRD-K02703275-001-07-5	Preclinical
gefitinib	EGFR inhibitor	EGFR	oncology	non-small cell lung cancer (NSCLC)	Selleck, Tocris, Selleck, Tocris	99.54	BRD-K64052750-001-22-5, BRD-K64052750-001-17-5, BRD-K64052750-001-16-7, BRD-K64052750-001-23-3	Launched
geldanamycin	HSP inhibitor	HSP90AA1, HSP90AB1			Selleck, Selleck	76.5	BRD-K43570081-001-02-4, BRD-K43570081-001-04-0	Preclinical
gemcadiol	antilipemic				Sigma	92.2	BRD-K43890836-001-01-6	Phase 2
gemcitabine	ribonucleotide reductase inhibitor	CMPK1, RRM1, RRM2, TYMS	oncology	ovarian cancer, breast cancer, non-small cell lung cancer (NSCLC), pancreatic cancer	MedChemEx, Selleck, Tocris, Selleck	100	BRD-K15108141-001-08-2, BRD-K15108141-001-06-6, BRD-K15108141-003-04-7, BRD-K15108141-003-05-4	Launched
gemcitabine-elaidate	DNA synthesis inhibitor, apoptosis inhibitor	CMPK1, RRM1, TYMS			MedChemEx	94.93	BRD-K09456915-001-01-2	Phase 1
gemfibrozil	lipoprotein lipase activator	LPL, PPARA, SLCO1B1, SLCO1B3, SLCO2B1	endocrinology, cardiology	hyperlipidemia, coronary heart disease	Selleck, MicroSource	97.18	BRD-K11129031-001-26-7, BRD-K11129031-001-27-5	Launched
gemifloxacin	bacterial DNA gyrase inhibitor		pulmonary, infectious disease	bronchitis, pneumonia	MicroSource	94.6	BRD-A40787240-066-04-6	Launched
genipin	choleretic agent				MedChemEx, Selleck, Selleck	99.08	BRD-K28824103-001-03-6, BRD-K28824103-001-04-4, BRD-K28824103-001-02-8	Preclinical
geniposide	GLP receptor agonist	GLP1R			Selleck, Selleck	97.9	BRD-K57275767-001-02-4, BRD-K57275767-001-03-2	Preclinical
geniposidic-acid	cyclooxygenase inhibitor				Selleck, Selleck	86.68	BRD-K73771095-001-03-3, BRD-K73771095-001-02-5	Preclinical
genistein	tyrosine kinase inhibitor	CFTR, ESR1, ESR2, ESRRA, ESRRB, ESRRG, NCOA1, NCOA2, PPARG, PTK2B, TOP2A, TRPC5			Selleck, Tocris, Tocris, MicroSource	97.71	BRD-K43797669-001-28-8, BRD-K43797669-001-29-6, BRD-K43797669-001-31-2, BRD-K43797669-001-30-4	Phase 2/Phase 3
gentamycin	bacterial 50S ribosomal subunit inhibitor	HSPA8, LRP2	infectious disease, critical care	bone and joint infections, endocarditis, pelvic inflammatory disease, meningitis, pneumonia, urinary tract infections, sepsis	MicroSource, Sigma	0	BRD-A89445950-001-01-6, BRD-M10279501-065-05-9	Launched
gentiopicrin	glutamate receptor downregulator	GRIN2B			Sigma	97.46	BRD-K33131085-001-07-2	Phase 3
genz-123346	glucosylceramidase inhibitor	UGCG			MedChemEx, MedChemEx	85.93	BRD-K70693421-001-01-1, BRD-K70693421-001-02-9	Preclinical
genz-644282	topoisomerase inhibitor	TOP1			MedChemEx	97.15	BRD-K99475619-001-01-2	Phase 1
gepefrine	adrenergic receptor agonist		cardiology	hypotension	Sigma	84.77	BRD-A04447196-001-01-8	Launched
gepon					InterBioScreen	99.2	BRD-A56754222-001-01-2	Phase 1
geranyl-farnesylacetate	mucin production enhancer				Adooq, AKSci	49.56	BRD-K02780233-001-02-5, BRD-K02780233-001-01-7	Phase 2
gestodene	contraceptive agent		endocrinology	contraceptive	Selleck	95.03	BRD-K97197005-001-03-2	Launched
gestrinone	progesterone receptor antagonist	AR, ESR1, PGR	obstetrics/gynecology	endometriosis	Prestwick	95.29	BRD-K97472745-001-01-8	Launched
GF109203X	PKC inhibitor	PDPK1, PIM1, PRKCI, PRKCZ			Tocris, Tocris	88.34	BRD-K31342827-001-13-8, BRD-K31342827-001-15-3	Preclinical
GGsTop	gamma glutamyltransferase Inhibitors	GGT1			Tocris	15.75	BRD-A25625670-001-01-9	Preclinical
GGTI-298	GGTase inhibitor	CDKN1A			EMDBio	38.97	BRD-K19669037-001-01-1	Preclinical
gidazepam	GABA benzodiazepine site receptor agonist				Enamine	88.96	BRD-K22588750-001-07-0	Launched
gilteritinib	FLT3 inhibitor	FLT3			MedChemEx	90.94	BRD-K72280606-001-01-2	Phase 3
gimeracil	dihydropyrimidine dehydrogenase inhibitor	DPYD	oncology	gastric adenocarcinoma	Selleck, Selleck	98.28	BRD-K35687421-001-02-5, BRD-K35687421-001-03-3	Launched
ginkgolide-a	GABA receptor antagonist	GLRA1, GLRB			Selleck	100	BRD-A95121829-001-08-9	Preclinical
ginkgolide-b	platelet activating factor receptor antagonist	GLRA1, GLRA2, GLRA3, GLRB, HTR3A, HTR3B			Tocris, Selleck, Tocris	100	BRD-A08430411-001-01-9, BRD-A59001851-001-02-1, BRD-A59001851-001-01-3	Phase 3
ginsenoside-c-k	NFkB pathway inhibitor, nitric oxide synthase inhibitor	PTGS2			MedChemEx	99.5	BRD-K01942833-001-01-8	Preclinical
ginsenoside-rd	calcium channel blocker				MedChemEx	100	BRD-A84810646-001-01-6	Phase 3
ginsenoside-rg3	angiogenesis inhibitor, apoptosis stimulant	KCNH2			MedChemEx	99.4	BRD-A44511856-001-01-4	Launched
givinostat	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9			Selleck	92.76	BRD-K13810148-311-03-2	Phase 2
GKA-50	glucokinase activator	GCK			Tocris	93.93	BRD-K03827870-001-01-3	Preclinical
GKT137831	NADPH oxidase inhibitor	NOX1, NOX4			MedChemEx, MedChemEx, Selleck	90	BRD-K79710622-001-03-7, BRD-K79710622-001-01-1, BRD-K79710622-001-02-9	Phase 2
GK921	transglutaminase inhibitor	TGM2			MedChemEx, MedChemEx	94.48	BRD-K38272302-001-02-7, BRD-K38272302-001-01-9	Preclinical
glafenine	DeltaF508-CFTR Correctors	CFTR			MicroSource, Selleck	98.69	BRD-A38076815-001-04-0, BRD-A38076815-003-10-3	Withdrawn
glasdegib	hedgehog pathway inhibitor	SMO			MedChemEx	90.62	BRD-K34341643-001-01-4	Phase 2
gliclazide	ATP channel blocker, insulin secretagogue	ABCC8, VEGFA	endocrinology	diabetes mellitus	MicroSource, Selleck, Selleck	88.04	BRD-A61154809-001-15-9, BRD-A61154809-001-16-7, BRD-A61154809-001-14-2	Launched
glimepiride	insulin secretagogue	ABCC8, KCNJ1, KCNJ11	endocrinology	diabetes mellitus	MicroSource, Tocris, Selleck	96.93	BRD-K34776109-001-16-6, BRD-K34776109-001-15-8, BRD-K34776109-001-14-1	Launched
glipizide	sulfonylurea	ABCC8, KCNJ10, KCNJ11, PPARG	endocrinology	diabetes mellitus, hyperglycemia	MicroSource, Selleck	98.53	BRD-K12219985-001-26-1, BRD-K12219985-001-25-3	Launched
gliquidone	sulfonylurea	ABCC8, KCNJ10, KCNJ8	endocrinology	diabetes mellitus	Selleck	94.47	BRD-K80396088-001-12-0	Launched
GLPG0492	androgen receptor modulator	AR			MedChemEx	95.84	BRD-K15893360-001-01-8	Phase 1
GLPG0492-R-enantiomer	androgen receptor modulator	AR			MedChemEx	90.37	BRD-K04643927-001-01-6	Phase 1
glucaric-acid					Sigma	0	BRD-K60150658-432-01-5	Phase 1
gluconolactone		LCT			MicroSource	0	BRD-K04288422-001-04-4	Launched
glucosamine	glycosylated protein precursor	IFNG, IL1B, MMP9, NFKB2, TNF	neurology/psychiatry, rheumatology	muscle pain, rheumatoid arthritis, joint pain, backache	MicroSource	100	BRD-K29918010-003-04-1	Launched
glutamine-(l)		CTPS1, GLUL, GPRC6A, PPAT	gastroenterology, dental, neurology/psychiatry, rheumatology	diarrhea, mucositis, muscle pain, joint pain, peptic ulcer disease (PUD), ulcerative colitis, Crohn's disease, anxiety, insomnia	Selleck, Selleck	93.22	BRD-K83896451-001-06-7, BRD-K83896451-001-07-5	Launched
glutathione	antioxidant	ESD, GGT1, GLO1, GLRX, GLRX2, GPX1, GPX2, GPX3, GPX4, GPX5, GPX6, GPX7, GPX8, GSR, GSS, GSTA1, GSTA2, GSTA3, GSTA4, GSTA5, GSTK1, GSTM1, GSTM2, GSTM3, GSTM4, GSTM5, GSTO1, GSTO2, GSTP1, GSTT1, GSTZ1, HAGH, HPGDS, LTC4S, MGST1, MGST2, MGST3, TXNDC12			MicroSource	0	BRD-K69346723-001-04-8	Phase 3
glutathione-monoisopropyl-ester	lipid peroxidase inhibitor				ChemImpex, Sigma	79.96	BRD-K58937086-001-01-4, BRD-K58937086-001-02-2	Phase 2
gly-gln					Ark	100	BRD-K85066592-001-01-6	Phase 2
glyburide	ATP channel blocker, insulin secretagogue, sulfonylurea	ABCA1, ABCB11, ABCC8, ABCC9, CFTR, CPT1A, KCNJ1, KCNJ11, KCNJ5, KCNJ8, SLCO2B1	endocrinology	diabetes mellitus, hyperglycemia	Tocris, Selleck, MicroSource, Tocris	97.94	BRD-K36927236-001-36-7, BRD-K36927236-001-30-0, BRD-K36927236-001-32-6, BRD-K36927236-001-31-8	Launched
glycerol-monolaurate	beta lactamase inhibitor				Sigma	98.1	BRD-A10773072-001-03-4	Launched
glycitein	tumor necrosis factor release inhibitor	TNF			Cayman	97.95	BRD-K78303961-001-02-3	Phase 3
glycopyrrolate	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	gastroenterology	peptic ulcer disease (PUD)	MicroSource	98.36	BRD-A81233518-004-16-1	Launched
GMX1778	NAMPT inhibitor	NAMPT			MedChemEx	96.98	BRD-K69832040-001-01-9	Phase 1/Phase 2
GNF-2	Bcr-Abl kinase inhibitor	ABL1, BCR			Selleck, Tocris	96.55	BRD-K97056771-001-13-1, BRD-K97056771-001-14-9	Preclinical
GNF-5	Bcr-Abl kinase inhibitor	ABL1, BCR			Tocris	99.44	BRD-K87632963-001-03-0	Preclinical
GNF-5837	growth factor receptor inhibitor	NTRK1, NTRK2, NTRK3			Tocris	75.24	BRD-K19975102-001-01-2	Preclinical
GNF-7	protein kinase inhibitor, glucokinase inhibitor	GCK, TNK2			Tocris	90.81	BRD-K69075588-001-01-3	Preclinical
GNTI	opioid receptor antagonist	OPRK1, OPRM1			Tocris	0	BRD-K64748124-300-01-7	Preclinical
go-6983	protein kinase inhibitor	PRKCA, PRKCB, PRKCD, PRKCG, PRKCZ			Selleck, Selleck	93.45	BRD-K36984403-001-02-7, BRD-K36984403-001-03-5	Preclinical
golgicide-a	ARF inhibitor	GBF1			Tocris	96.27	BRD-A57886255-001-01-1	Preclinical
golvatinib	VEGFR inhibitor	KDR, MET			Selleck	91.39	BRD-K69001009-001-02-8	Phase 2
gonadorelin	gonadotropin releasing factor hormone receptor agonist	GNRHR, GNRHR2	obstetrics/gynecology	cystic ovaries, reproductive synchrony	MedChemEx	95.93	BRD-K96874295-015-01-0	Launched
goserelin-acetate	gonadotropin releasing factor hormone receptor agonist	GNRHR, LHCGR	oncology, obstetrics/gynecology	prostate cancer, breast cancer, endometriosis	Enzo	97.19	BRD-K99504665-001-01-2	Launched
gossypol	BCL inhibitor, MCL1 inhibitor	BCL2			Selleck, Tocris, Tocris, Selleck, Selleck, Selleck	96.16	BRD-K19295594-015-13-5, BRD-K19295594-001-16-8, BRD-K19295594-001-17-6, BRD-K19295594-001-15-0, BRD-K19295594-015-14-3, BRD-K19295594-015-12-7	Phase 2
GPBAR-A	G protein coupled receptor agonist	GPBAR1			Tocris	96.41	BRD-K67397687-001-01-3	Preclinical
GPI-1046	FKBP inhibitor	FKBP1A			Key	97.78	BRD-K44869961-001-01-6	Preclinical
GPi-688	glycogen phosphorylase inhibitor				Tocris	93.41	BRD-A90201073-001-01-2	Preclinical
GPP-78	NAMPT inhibitor	NAMPT			Tocris	98.04	BRD-K83289131-003-01-0	Preclinical
GPR120-modulator-1	G protein-coupled receptor modulator	FFAR4			MedChemEx	96.16	BRD-K19409553-001-01-6	Preclinical
GP1a	cannabinoid receptor agonist	CNR2			Tocris	97.02	BRD-K65285700-001-02-3	Preclinical
GP2a	cannabinoid receptor agonist	CNR2			Tocris	98.53	BRD-K34608650-001-02-4	Preclinical
GR-103691	dopamine receptor antagonist	DRD3			Tocris	85.45	BRD-K50891186-001-04-4	Preclinical
GR-113808	serotonin receptor antagonist	HTR4			Tocris	94.87	BRD-K49945136-001-10-0	Preclinical
GR-127935	serotonin receptor antagonist	HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR6			Tocris	89.38	BRD-K11911061-003-11-9	Preclinical
GR-135531	melatonin receptor agonist				Tocris	90.72	BRD-K83023055-001-02-7	Preclinical
GR-144053	integrin antagonist	ITGA2B, ITGB3			Tocris	94.59	BRD-K12120659-305-02-2	Preclinical
GR-159897	tachykinin antagonist	TAC1, TACR2			Tocris, Tocris	92.73	BRD-K52394958-001-03-5, BRD-K52394958-001-02-7	Preclinical
GR-235	estrogen receptor agonist, FXR antagonist, progesterone receptor agonist	NR1H4			Tocris	55.9	BRD-K26674531-001-02-1	Launched
GR-79236	adenosine receptor agonist	ADORA1, ADORA2A			Tocris	98.53	BRD-K40578143-001-02-6	Phase 1
gramicidin	bacterial permeability inducer		infectious disease	first-aid antibiotic	MicroSource	65.47	BRD-A52977603-001-01-2	Launched
gramine	norepinephrine reputake inhibitor				Selleck	90.98	BRD-K26005076-001-12-8	Preclinical
granisetron	serotonin receptor antagonist	HTR3A	gastroenterology	nausea, vomiting	MicroSource, Selleck	97.08	BRD-A10967948-003-06-3, BRD-A10967948-003-05-5	Launched
grapiprant	prostaglandin inhibitor	PTGER4	rheumatology	osteoarthritis	MedChemEx	96.45	BRD-K62050508-001-01-0	Launched
grazoprevir	HCV inhibitor				MedChemEx, MedChemEx	98.76	BRD-K24943235-237-01-3, BRD-K24943235-001-01-3	Launched
griseofulvin	tubulin polymerization inhibitor	KRT12	infectious disease	ringworm, tinea pedis	MicroSource, Selleck	95.44	BRD-K08273968-001-16-6, BRD-K08273968-001-19-0	Launched
GR125487	serotonin receptor antagonist	HTR4			Tocris	95.42	BRD-K62594868-082-08-6	Preclinical
GR46611	serotonin receptor agonist	HTR1D			Tocris, Tocris	91.27	BRD-K98155362-001-08-5, BRD-K98155362-001-07-7	Preclinical
GS-143	ubiquitin ligase inhibitor	BTRC, NFKBIA			Tocris	67.28	BRD-K99916169-001-01-9	Preclinical
GS-39783	GABA receptor modulator	GABBR1			Tocris	98.14	BRD-K75478907-001-02-3	Preclinical
GS-6201	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3			Tocris	99.12	BRD-K68453341-001-01-1	Phase 1
GS-9620	toll-like receptor agonist	TLR7			MedChemEx, MedChemEx	86.83	BRD-K73585091-001-02-3, BRD-K73585091-001-01-5	Phase 2
GS-9973	syk inhibitor	SYK			MedChemEx, Selleck, MedChemEx, Selleck	92.11	BRD-K76719364-001-06-6, BRD-K76719364-001-01-7, BRD-K76719364-001-04-1, BRD-K76719364-001-02-5	Phase 2
GSK-J1	histone demethylase inhibitor	KDM6B			MedChemEx, Tocris	94.8	BRD-K32847255-001-01-1, BRD-K32847255-001-02-9	Preclinical
GSK-J2	histone demethylase inhibitor				MedChemEx, Tocris	95.52	BRD-K82484347-001-01-2, BRD-K82484347-001-02-0	Preclinical
GSK-J4	histone lysine demethylase inhibitor	KDM6A, KDM6B			Selleck, Tocris	94.39	BRD-K98203492-003-04-1, BRD-K98203492-001-02-9	Preclinical
GSK-J5	histone demethylase control				Tocris	95.18	BRD-K55438324-001-01-8	Preclinical
GSK-LSD-1	histone lysine demethylase inhibitor	KDM1A			Tocris	37.79	BRD-K33521504-300-02-4	Preclinical
GSK-0660	PPAR receptor antagonist	PPARD			Tocris, Tocris	96.98	BRD-K98684188-001-02-9, BRD-K98684188-001-03-7	Preclinical
GSK-1562590	urotensin receptor antagonist	UTS2R			Tocris	93.97	BRD-K36697397-003-01-1	Preclinical
GSK-2193874	transient receptor potential channel antagonist	TRPV4			Tocris	92.6	BRD-K90737788-001-01-9	Preclinical
GSK-2837808A	lactate dehydrogenase inhibitor	LDHA			Tocris	92.69	BRD-K50679358-001-01-1	Preclinical
GSK-3-inhibitor-IX	glycogen synthase kinase inhibitor, lipoxygenase inhibitor	GSK3A, GSK3B			Tocris, Selleck	95.08	BRD-K04923131-001-15-4, BRD-K04923131-001-14-7	Preclinical
GSK-37647	free fatty acid receptor agonist	FFAR4			Tocris	98.11	BRD-K26514105-001-01-7	Preclinical
GSK1059615	PI3K inhibitor	PIK3CG			Selleck, Selleck	82.73	BRD-K06750613-001-07-3, BRD-K06750613-001-04-0	Phase 1
GSK1070916	Aurora kinase inhibitor	AURKA, AURKB, AURKC, CYP2D6, CYP3A4			Selleck	96.68	BRD-K36740062-001-06-6	Phase 1
GSK1292263	glucose dependent insulinotropic receptor agonist	GRPR			Selleck	97.16	BRD-K60341624-001-02-2	Phase 2
GSK163090	serotonin receptor antagonist	HTR1A, HTR1B, HTR1D			MedChemEx	98.29	BRD-K69669039-001-01-8	Phase 2
GSK1838705A	insulin growth factor receptor inhibitor	ALK, IGF1R, INSR, RPS6KA1			Selleck, Selleck, Tocris	94.21	BRD-K06749501-001-02-1, BRD-K06749501-001-03-9, BRD-K06749501-001-05-4	Preclinical
GSK1904529A	IGF-1 inhibitor, insulin growth factor receptor inhibitor, insulin receptor ligand	IGF1R, INSR			Selleck	93.1	BRD-K04833372-001-06-2	Preclinical
GSK2110183	AKT inhibitor	AKT1, AKT2, AKT3			MedChemEx	86.22	BRD-K25412176-001-01-9	Phase 2
GSK2126458	mTOR inhibitor, PI3K inhibitor	MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG			Selleck	95.25	BRD-K07972848-001-02-0	Phase 1
GSK2190915	lipoxygenase inhibitor	ALOX5AP			MedChemEx	97.5	BRD-K15691453-236-01-6	Phase 2
GSK2194069	fatty acid synthase inhibitor	FASN			Tocris	98.51	BRD-K95123482-001-01-6	Preclinical
GSK2256294A	epoxide hydolase inhibitor	EPHX2			MedChemEx	96.85	BRD-K62738477-001-01-7	Phase 1
GSK2330672	bile acid transporter inhibitor	SLC10A2			MedChemEx	96.72	BRD-K05858796-001-01-7	Phase 2
GSK2334470	phosphoinositide dependent kinase inhibitor	AURKA, AURKB, PDPK1			Tocris	86.72	BRD-K70642949-001-04-5	Preclinical
GSK256066	phosphodiesterase inhibitor	PDE4A			Selleck	92.4	BRD-K37590257-001-02-8	Phase 2
GSK2578215A	leucine rich repeat kinase inhibitor	LRRK2			Tocris	98.57	BRD-K30185465-001-03-0	Preclinical
GSK2606414	protein kinase inhibitor	EIF2AK3, MYLK2			MedChemEx, MedChemEx, Tocris	90.4	BRD-K81689258-001-04-8, BRD-K81689258-001-02-2, BRD-K81689258-001-03-0	Preclinical
GSK2636771	PI3K inhibitor	PIK3CB			Selleck, Selleck	91.39	BRD-K49215523-001-04-2, BRD-K49215523-001-05-9	Phase 2
GSK2656157	PERK inhibitor				Selleck	95.49	BRD-K41104902-001-01-3	Preclinical
GSK269962	rho associated kinase inhibitor	ROCK1, ROCK2			Tocris	98.12	BRD-K89464729-001-03-1	Preclinical
GSK2801	bromodomain inhibitor	BAZ2A, BAZ2B			MedChemEx	97.85	BRD-K48062199-001-01-8	Preclinical
GSK2816126	histone lysine methyltransferase inhibitor	EZH2			MedChemEx, MedChemEx	88.86	BRD-K21867462-001-02-9, BRD-K21867462-001-03-7	Phase 1
GSK2830371	protein phosphatase inhibitor	PPM1D			MedChemEx, Tocris	93.44	BRD-K17472821-001-01-2, BRD-K17472821-001-02-0	Preclinical
GSK2838232	HIV gag inhibitor				MedChemEx, MedChemEx	81.68	BRD-K08398903-001-02-9, BRD-K08398903-001-01-1	Phase 1
GSK2879552	histone lysine demethylase inhibitor	KDM1A			MedChemEx	97.24	BRD-K09223495-001-01-4	Phase 1
GSK3787	PPAR receptor antagonist	PPARD			Tocris, Selleck	95.61	BRD-K03155172-001-03-0, BRD-K03155172-001-02-2	Preclinical
GSK429286A	rho associated kinase inhibitor	ROCK1			MedChemEx, Selleck, Tocris	96.54	BRD-A10523515-001-11-1, BRD-A10523515-001-07-9, BRD-A10523515-001-10-3	Preclinical
GSK461364	PLK inhibitor	PLK1			Selleck	94.3	BRD-K92428232-001-10-6	Phase 1
GSK503	histone lysine methyltransferase inhibitor	EZH2			MedChemEx	94.9	BRD-K72293620-001-01-7	Preclinical
GSK650394	serum/glucocorticoid regulated kinase inhibitor	SGK1, SGK2			MedChemEx, Tocris, Tocris	97.46	BRD-K14991967-001-04-2, BRD-K14991967-001-02-6, BRD-K14991967-001-03-4	Preclinical
GSK690693	AKT inhibitor	AKT1, AKT2, AKT3, PAK4, PAK6, PAK7, PRKCQ, PRKG1, PRKX			Selleck, Selleck, Tocris	94.6	BRD-K25325018-001-05-6, BRD-K25325018-001-02-3, BRD-K25325018-001-06-4	Phase 1
GSK9027	glucocorticoid receptor agonist	NR3C1			Tocris	96.16	BRD-K29328421-001-01-6	Preclinical
GSK923295	centromere associated protein inhibitor	CENPE			MedChemEx	88.45	BRD-K89015388-001-01-7	Phase 1
GTP-14564	FLT3 inhibitor, tyrosine kinase inhibitor	CSF1R, FLT3, KIT, PDGFRB			Tocris, Tocris	98.68	BRD-K16664969-001-04-1, BRD-K16664969-001-03-3	Preclinical
GTS21	cholinergic receptor agonist	CHRNA7			ChemDiv	98.14	BRD-K14235254-001-01-2	Phase 1/Phase 2
guacetisal	immunosuppressant				AvaChem	96.88	BRD-K00739965-001-01-9	Launched
guaiacol	local anesthetic	CA2			MicroSource	0	BRD-K96282009-001-08-8	Launched
guaifenesin	expectorant		pulmonary	cough suppressant	MicroSource, Selleck	98.9	BRD-A90515964-001-16-5, BRD-A90515964-001-15-7	Launched
guanaben-acetate	adrenergic receptor agonist	ADRA2A, ADRA2B, ADRA2C	cardiology	hypertension	Tocris, Selleck, MicroSource, Selleck	95.27	BRD-K62736196-015-10-2, BRD-K62736196-015-09-4, BRD-K62736196-015-13-6, BRD-K62736196-015-11-0	Launched
guanadrel	adrenergic inhibitor	SLC6A2	cardiology	hypertension	MicroSource	100	BRD-A14262390-065-01-8	Launched
guanethidine	adrenergic inhibitor	SLC6A2	cardiology	hypertension	MicroSource, Selleck	100	BRD-K62676709-001-01-9, BRD-K62676709-065-05-5	Launched
guanfacine	adrenergic receptor agonist	ADRA2A, ADRA2B, ADRA2C	cardiology	hypertension	MicroSource, MicroSource, Tocris	100	BRD-K32830106-003-21-2, BRD-K32830106-001-02-6, BRD-K32830106-003-20-4	Launched
guanidine	HSP inhibitor	ALDH2, DLG4, GAMT, RNASE1	neurology/psychiatry	Lambert-Eaton myasthenic syndrome (LEMS)	Selleck, MicroSource	98.46	BRD-K76037122-001-02-5, BRD-K76037122-001-01-7	Launched
guanidinoethyldisulfide-bicarbonate	nitric oxide synthase inhibitor	NOS2			TygerSci	0	BRD-K69191882-065-01-6	Phase 2
guanidinopropionic-acid	creatine kinase inhibitor	CKM			Sigma	0	BRD-K50781608-001-02-1	Phase 2
guanosine		PNP			Selleck	92.38	BRD-K92976206-001-01-5	Preclinical
Gue-1654	oxoeicosanoid receptor modulator	OXER1			Tocris	96.81	BRD-K18745919-001-01-3	Preclinical
guvacine	GABA uptake inhibitor	SLC6A1, SLC6A11, SLC6A12, SLC6A13			Tocris	100	BRD-K01980392-003-11-6	Preclinical
GW-0742	PPAR receptor agonist	PPARD			Tocris, Selleck, Tocris	94.54	BRD-K82983861-001-05-0, BRD-K82983861-001-04-3, BRD-K82983861-001-06-8	Preclinical
GW-1100	G protein-coupled receptor agonist	FFAR1			MedChemEx	93.14	BRD-K23614267-001-01-2	Preclinical
GW-1929	PPAR receptor agonist	PPARG			Tocris	75.23	BRD-A15415227-003-02-9	Preclinical
GW-2580	cFMS kinase inhibitor	CSF1R			Selleck	94.93	BRD-K24242599-001-02-8	Preclinical
GW-311616	leukocyte elastase inhibitor, elastase inhibitor	ELANE			MedChemEx	97.39	BRD-K37864785-001-01-0	Phase 1
GW-3965	LXR agonist	NR1H2, NR1H3			Tocris, Tocris, Selleck	97.64	BRD-K33818169-003-04-6, BRD-K33818169-003-05-3, BRD-K33818169-003-03-8	Preclinical
GW-405833	cannabinoid receptor agonist	CNR2			Tocris	95.83	BRD-K10705233-001-02-2	Preclinical
GW-4064	FXR agonist	NR1H4			Tocris, Selleck	94.31	BRD-K88186167-001-05-5, BRD-K88186167-001-04-8	Preclinical
GW-438014A	neuropeptide receptor antagonist	NPY5R			Tocris	96.45	BRD-K13039700-066-01-2	Preclinical
GW-441756	growth factor receptor inhibitor	NTRK1			Tocris, Selleck	96.24	BRD-K41312087-001-02-7, BRD-K41312087-001-01-9	Preclinical
GW-501516	PPAR receptor agonist	PPARA, PPARD			MedChemEx, MedChemEx	95.38	BRD-K14880289-001-03-0, BRD-K14880289-001-02-2	Phase 2
GW-5074	RAF inhibitor, leucine rich repeat kinase inhibitor	NTRK1, RAF1			Selleck, Tocris, Selleck	58.05	BRD-K39520573-001-03-8, BRD-K39520573-001-04-6, BRD-K39520573-001-02-0	Preclinical
GW-542573X	calcium channel activator	KCNN1			Tocris	91.84	BRD-K36485341-001-01-2	Preclinical
GW-583340	EGFR inhibitor	EGFR, ERBB2			Tocris, Tocris	93.17	BRD-K79930101-300-04-5, BRD-K79930101-300-03-7	Preclinical
GW-627368	prostanoid receptor antagonist	PTGER4			Tocris	99.49	BRD-K50005760-001-01-1	Preclinical
GW-6471	PPAR receptor antagonist	PPARA			Tocris, Tocris	97.24	BRD-K20828910-001-01-2, BRD-K20828910-001-02-0	Preclinical
GW-7647	PPAR receptor agonist	PPARA			Tocris, Tocris	97.97	BRD-K96263742-001-15-5, BRD-K96263742-001-14-8	Preclinical
GW-788388	ALK tyrosine kinase receptor inhibitor	LCK, MAPK14, TGFBR1			Selleck, Tocris	95	BRD-K78086729-001-02-7, BRD-K78086729-001-03-5	Preclinical
GW-803430	melanin inhibitor	KCNH2, MCHR1			Tocris	93.27	BRD-K65576800-001-01-6	Phase 1
GW-842166	cannabinoid receptor agonist	CNR2			Selleck	97.52	BRD-K26823213-001-02-9	Phase 2
GW-843682X	PLK inhibitor	PLK1, PLK3			Tocris, Tocris	98.98	BRD-K90382497-001-10-7, BRD-K90382497-001-13-1	Preclinical
GW-9508	free fatty acid receptor agonist, G protein-coupled receptor agonist	FFAR1, FFAR4			Tocris, Tocris, Selleck	94.14	BRD-K71534238-001-11-8, BRD-K71534238-001-12-6, BRD-K71534238-001-10-0	Preclinical
GW-9662	PPAR receptor antagonist	NCOA2, PPARG, RXRA			Selleck, Tocris	98.73	BRD-K93258693-001-16-5, BRD-K93258693-001-17-3	Preclinical
GYKI-52466	glutamate receptor antagonist	GRIA1, GRIA2, GRIA3, GRIA4			Tocris, Tocris	71.41	BRD-K24240364-003-09-6, BRD-K24240364-003-08-8	Preclinical
gynostemma-extract	calcium channel modulator				Selleck, Selleck	2.21	BRD-K58775955-001-02-4, BRD-K58775955-001-03-2	Preclinical
GZD824	Bcr-Abl kinase inhibitor	ABL1, BCR			Selleck	96.55	BRD-K35329391-334-01-7	Preclinical
G007-LK	tankyrase inhibitor	TNKS, TNKS2			MedChemEx	97.94	BRD-K12198961-001-01-8	Preclinical
H-89	PKA inhibitor	GSG2, PKIA, PRKACA			Tocris, Selleck, Tocris	97.93	BRD-K27737647-300-04-8, BRD-K27737647-300-03-0, BRD-K27737647-300-08-9	Preclinical
HA-1004	calcium channel blocker				Enzo	98.82	BRD-K05434375-001-06-5	Phase 2
HA-130	autotaxin inhibitor	ENPP2			Tocris	90.3	BRD-K64452997-001-01-4	Preclinical
HA-14-1	BCL inhibitor	BCL2			Tocris	0	BRD-A13807286-001-07-0	Preclinical
HA-966-(R)-(+)	glutamate receptor agonist	GRIA1			Tocris	100	BRD-K58046914-001-03-8	Preclinical
HA-966-(S)-(-)	glutamate receptor antagonist	GRIA1			Tocris	100	BRD-K41304947-001-03-2	Preclinical
halazone					MicroSource	0	BRD-K68091065-001-04-7	Launched
halcinonide	glucocorticoid receptor agonist	NR3C1	dermatology	corticosteroid-responsive dermatoses	MicroSource, Selleck	97.7	BRD-A88138582-001-04-8, BRD-K81709173-001-09-5	Launched
halobetasol-propionate	glucocorticoid receptor agonist	NR3C1, PLA2G1B	dermatology	corticosteroid-responsive dermatoses	Selleck	96.13	BRD-K65877271-001-01-8	Launched
halofantrine	antimalarial agent	KCNH2, KCNN4	infectious disease	malaria	Enzo	89.55	BRD-A51964809-003-12-6	Launched
halofuginone	collagenase inhibitor	COL1A1, MMP2	rheumatology	scleroderma	EMDBio	95.58	BRD-K54247840-004-01-3	Launched
halopemide	phospholipase inhibitor	PLD1, PLD2			Sigma	97.2	BRD-K50055394-001-03-6	Phase 2
haloperidol	dopamine receptor antagonist	DRD1, DRD2, DRD3, DRD4, DRD5, GRIN2B, HRH1, HTR1A, HTR1D, HTR2A, HTR2B, HTR7, KCNH1	neurology/psychiatry	schizophrenia, Tourette's disorder	Tocris, Selleck, MicroSource	99.67	BRD-K67783091-003-07-7, BRD-K67783091-001-25-3, BRD-K67783091-001-26-1	Launched
haloperidol-decanoate	psychoactive drug	DRD2, DRD3, DRD4, HTR2A	neurology/psychiatry	schizophrenia	Key	99.05	BRD-K80859331-001-01-5	Launched
haloprogin	other antifungal		infectious disease	tinea pedis	Prestwick	98.19	BRD-K13238168-001-02-0	Launched
halothane	glutamate receptor antagonist	ATP2C1, ATP5D, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GNG2, GRIN2A, GRIN3A, GRIN3B, KCNJ3, KCNJ6, KCNK10, KCNK12, KCNK13, KCNK15, KCNK18, KCNK2, KCNK3, KCNK9, KCNMA1, KCNN4, MT-ND1, NPSR1, RHO	neurology/psychiatry	general anaesthetic	MicroSource, MedChemEx	0	BRD-A20550616-001-02-9, BRD-A20550616-001-03-7	Launched
harmane	monoamine oxidase inhibitor	MAOA, MAOB			Tocris	97.3	BRD-K12630395-001-14-9	Preclinical
harringtonine	protein synthesis inhibitor				Enzo	87.81	BRD-K96358241-001-01-9	Phase 3
HA14-1	BCL inhibitor	BCL2			Selleck, Selleck	95.14	BRD-K18163608-001-02-3, BRD-K18163608-001-05-6	Preclinical
HC-030031	TRPA1 channel blocker	TRPA1			Selleck	98.24	BRD-K73815512-001-02-5	Phase 1
HC-067047	transient receptor potential channel antagonist	TRPV4			Tocris	93.91	BRD-K03391209-001-02-0	Preclinical
heclin	ubiquitin ligase inhibitor	NEDD4, SMURF2, WWP1			Tocris	91.97	BRD-K49788188-001-01-0	Preclinical
HEMADO		ADORA1, ADORA2A, ADORA2B, ADORA3			Tocris, Tocris	96.56	BRD-K34672903-001-02-5, BRD-K34672903-001-01-7	Preclinical
hematoporphyrin			neurology/psychiatry	depression, psychosis, psychosis, depression	MedChemEx, Sigma	16.61	BRD-A44995766-300-03-0, BRD-A44995766-001-02-6	Launched
hematoxylin					Selleck, Selleck	94.58	BRD-K78342372-001-03-2, BRD-K78342372-001-02-4	Preclinical
hemin	enzyme inducer		hematology, cardiology	acute intermittent porphyria (AIP), hypertension, ventricular tachycardia (VT)	InterBioScreen	0	BRD-M75036822-003-01-7	Launched
hemoglobin-modulators-1	hemoglobin modulator				MedChemEx	96.07	BRD-K43639297-001-01-9	Phase 3
hemomex-s		PPARG			MedChemEx	90.75	BRD-K15231341-001-01-5	Launched
heptaminol	vasoconstrictor		cardiology	hypotension	MicroSource	100	BRD-A32988684-003-08-7	Launched
HER2-Inhibitor-1	EGFR inhibitor				Selleck	62.06	BRD-K89709433-001-02-8	Preclinical
hesperadin	Aurora kinase inhibitor	AURKB			Selleck, Tocris	96.66	BRD-K58122457-001-02-2, BRD-K58122457-003-01-0	Preclinical
hesperetin	ACAT inhibitor	DGAT1, MTTP, SOAT1, SOAT2			Selleck	98.16	BRD-K30553453-001-13-2	Launched
hesperidin	flavanone glycoside	CACNA1B			Selleck, Selleck, Selleck	90.46	BRD-K38903228-001-11-9, BRD-K38903228-001-13-5, BRD-K38903228-001-12-7	Launched
hetacillin	bacterial cell wall synthesis inhibitor		obstetrics/gynecology	mastitis	MicroSource	26.47	BRD-A27828834-237-04-4	Launched
hexachlorophene	potassium channel activator	GLUD1, SDHD	infectious disease	gram-positive bacterial infections	MicroSource	98.49	BRD-K99792991-001-34-9	Launched
hexamethonium	cholinergic receptor antagonist	CHRNA2, CHRNA3, CHRNA4, CHRNA6			MicroSource, Selleck, Selleck	96.93	BRD-K10598093-303-06-1, BRD-K10598093-303-05-3, BRD-K10598093-303-07-9	Preclinical
hexamethylenebisacetamide	AKT inhibitor, differentiation inducer, NFKB pathway inhibitor	AKT1			Sigma	87.14	BRD-K04710043-001-17-8	Phase 2
hexaminolevulinate			radiology	diagnostic agent	MedChemEx	100	BRD-K73753850-003-01-6	Launched
hexasodium-phytate					TCI	0	BRD-K70007857-001-01-7	Phase 2
hexestrol	synthetic estrogen	AKR1C1, ESR1, ESR2			MicroSource, Selleck, Selleck	88.97	BRD-A01078468-001-14-8, BRD-K69253806-001-02-0, BRD-K69253806-001-03-8	Launched
hexetidine	local anesthetic		otolaryngology, infectious disease, dental, gastroenterology	pharyngitis, meningitis, laryngitis, gingivitis, ulcerative colitis	MicroSource, MedChemEx, MedChemEx	25.25	BRD-A18605525-001-12-4, BRD-A18605525-001-13-2, BRD-A18605525-001-14-0	Launched
hexonic-acid					Sigma	90.83	BRD-A63267145-001-01-0	Preclinical
hexoprenaline	adrenergic receptor agonist	ADRB2	pulmonary	asthma	Carbosynth	79.95	BRD-A33894669-065-01-9	Launched
hexylcaine	sodium channel blocker	SCN10A, SCN5A	neurology/psychiatry	local anesthetic	Prestwick	96.16	BRD-A97730597-003-11-5	Launched
hexylene-glycol		AKR1C3, CTPS1, DLG4, HSP90AA1, NOS3, PGF, PLA2G1B, PTPN1, SELP			MicroSource	15.17	BRD-A14234430-001-01-4	Preclinical
hexylresorcinol	local anesthetic	TYR	infectious disease	skin infections, first-aid antiseptic	MicroSource	98.8	BRD-K99946902-001-07-5	Launched
higenamine	adrenergic receptor agonist	ADRB2			Accela	94.65	BRD-A55204514-003-01-2	Phase 1
hippuric-acid					CombiBlocks	97.62	BRD-K62914667-001-13-9	Preclinical
histamine	histamine receptor agonist	HRH1, HRH2, HRH3, HRH4	allergy	allergic rhinitis	Tocris, Tocris, Selleck, MicroSource, Selleck, Selleck	100	BRD-K01674964-300-07-1, BRD-K01674964-300-10-5, BRD-K01674964-001-19-0, BRD-K01674964-300-08-9, BRD-K01674964-316-01-0, BRD-K01674964-300-06-3	Launched
HJC-0350	GTPase inhibitor	RAPGEF4			Tocris	95.86	BRD-K34411045-001-01-9	Preclinical
HKI-357	EGFR inhibitor	EGFR			Tocris, Tocris	98.23	BRD-K58811567-001-01-9, BRD-K58811567-001-02-7	Phase 1
HLCL-61	protein arginine N-methyltransferase inhibitor	PRMT5			MedChemEx	95.62	BRD-K73746696-003-01-8	Preclinical
HMN-214	PLK inhibitor	PLK1			Selleck	90.91	BRD-K70511574-001-06-9	Phase 1
homatropine	acetylcholine receptor antagonist	CES1, CHRM1	ophthalmology	pupil dilation	MicroSource, Selleck	93.54	BRD-A74975734-004-10-7, BRD-A74975734-004-09-9	Launched
homatropine-methylbromide	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	ophthalmology	uveal tract inflammation	MicroSource	96.2	BRD-A43999749-004-04-1	Launched
homidium					MicroSource	69.09	BRD-K28354016-004-11-7	Preclinical
homochlorcyclizine	antihistamine	HRH1	allergy	allergic rhinitis	Enzo	96.11	BRD-A22769835-300-05-7	Launched
homoharringtonine	protein synthesis inhibitor	RPL3	hematologic malignancy	chronic myeloid leukemia (CML)	Tocris	87.85	BRD-K76674262-001-03-3	Launched
homoquinolinic-acid	glutamate receptor agonist	GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D			Tocris	100	BRD-K30519779-001-03-1	Preclinical
homosalate	HSP inducer				MicroSource	85.67	BRD-A34751532-001-06-9	Preclinical
homoveratrylamine	dopamine analog				Prestwick	66.18	BRD-K59570838-003-01-9	Preclinical
honokiol	AKT inhibitor	ALOX5, PTGS1, PTGS2			Selleck	97.8	BRD-K98493452-001-14-9	Phase 3
hordenine					Selleck, Selleck	88.33	BRD-K93631643-001-03-2, BRD-K93631643-001-02-4	Preclinical
HQK-1001					Enamine, Enamine	0	BRD-K44963273-001-07-7, BRD-K44963273-001-06-9	Phase 2
HTH-01-015	protein kinase inhibitor	NUAK1			Tocris	86.89	BRD-K58726989-001-01-9	Preclinical
HTMT	histamine receptor agonist	HRH4			Tocris, Tocris	86.57	BRD-A66435872-332-02-6, BRD-A66435872-332-01-8	Preclinical
huperzine-a	acetylcholinesterase inhibitor	ACHE			MedChemEx, Selleck, Selleck	86.35	BRD-K62240499-001-05-9, BRD-K62240499-001-04-2, BRD-K62240499-001-06-7	Phase 2
hyaluronic-acid		C1QBP, CD44, HABP2, HAPLN1, HAPLN3, HAPLN4, HMMR, ICAM1, NCAN, VCAN	rheumatology, urology	osteoarthritis, interstitial cystitis (IC)	Sigma	0	BRD-K59788572-236-01-3	Launched
hycanthone	RNA synthesis inhibitor		infectious disease	schistosomiasis	MicroSource	86.83	BRD-K50406511-001-26-0	Launched
hydralazine	vasodilator	AOC3, P4HA1	cardiology	hypertension	MicroSource, MedChemEx, Selleck, Selleck	87.04	BRD-K82103381-003-07-8, BRD-K82103381-003-09-4, BRD-K82103381-003-06-0, BRD-K82103381-003-08-6	Launched
hydrastine-(1r,-9s)	tyrosine hydroxylase inhibitor				MicroSource	99.03	BRD-K02715688-001-02-1	Preclinical
hydrastinine	haemostatic agent				MicroSource, Selleck	92.64	BRD-A57900429-003-06-6, BRD-A57900429-003-05-8	Preclinical
hydrochlorothiazide	thiazide diuretic	CA1, CA12, CA2, CA4, CA9, KCNMA1, SLC12A3	cardiology	hypertension, congestive heart failure	Selleck, MicroSource	98.34	BRD-K13078532-001-27-6, BRD-K13078532-001-28-4	Launched
hydrocortisone	glucocorticoid receptor agonist		dermatology, neurology/psychiatry	eczema, psoriasis, seborrheic dermatitis, itching	Tocris, MicroSource, Selleck	97.33	BRD-K93568044-001-30-4, BRD-K93568044-001-32-0, BRD-K93568044-001-31-2	Launched
hydrocortisone-acetate	glucocorticoid receptor agonist	NR3C1, NR3C2	dermatology	corticosteroid-responsive dermatoses	MicroSource	88.6	BRD-A65767837-001-04-4	Launched
hydrocortisone-butyrate	glucocorticoid receptor agonist	NR3C1	dermatology	corticosteroid-responsive dermatoses, eczema	MicroSource, Sigma	85.87	BRD-K99199077-001-17-9, BRD-K99199077-001-16-1	Launched
hydrocortisone-hemisuccinate					MicroSource	96.14	BRD-A07000685-001-04-4	Phase 2/Phase 3
hydrocortisone-phosphate		ANXA1, NOS2, NR3C1	pulmonary, gastroenterology, hematologic malignancy, ophthalmology	asthma, nausea, vomiting, multiple myeloma, contact dermatitis, enteritis, colitis	MicroSource	79.61	BRD-A46186775-369-02-0	Launched
hydrocortisone-valerate	glucocorticoid receptor agonist		dermatology	corticosteroid-responsive dermatoses	MicroSource	88.16	BRD-A25143711-001-02-2	Launched
hydroflumethiazide	sodium/potassium/chloride transporter inhibitor	ATP1A1, CA1, CA12, CA2, CA4, CA9, KCNMA1, SLC12A1, SLC12A3	cardiology, gastroenterology, rheumatology, nephrology	edema, congestive heart failure, hepatic cirrhosis, nephrotic syndrome, chronic renal failure, acute glomerulonephritis (AGN), hypertension	MicroSource	97.64	BRD-K36862742-001-25-6	Launched
hydroquinidine	antiarrhythmic		cardiology	cardiac arrythmia	MicroSource	98.92	BRD-A06390036-001-04-6	Launched
hydroquinone	melanin inhibitor	TYR	dermatology	dyschromia	MicroSource, MedChemEx	49.83	BRD-K11227669-001-07-8, BRD-K11227669-001-08-6	Launched
hydroxyamphetamine	trace amine associated receptor agonist	TAAR1	ophthalmology	mydriasis	MicroSource	97.66	BRD-A80871782-004-06-9	Launched
hydroxychloroquine	antimalarial agent	TLR7, TLR9	infectious disease	malaria	MicroSource, Sigma	98.39	BRD-A99117172-065-04-0, BRD-A99117172-065-05-7	Launched
hydroxyfasudil	rho associated kinase inhibitor	PKIA, PRKACA, ROCK1			Tocris	97.11	BRD-K77793136-003-03-0	Preclinical
hydroxyprogesterone	progesterone receptor agonist	PGR	obstetrics/gynecology	spontaneous preterm birth	MicroSource	95.14	BRD-A39791822-001-05-1	Launched
hydroxyprogesterone-acetate	progesterone receptor agonist	PGR			Sigma	94	BRD-K92902018-001-01-9	Launched
hydroxypropyl-beta-cyclodextrin					Cayman	98.32	BRD-A01412266-001-01-0	Phase 2
hydroxystilbamidine					Enzo	93.1	BRD-K62186992-334-02-8	Launched
hydroxytacrine-maleate-(r,s)	cholinesterase inhibitor	ACHE			Prestwick	92.87	BRD-A98299281-050-09-6	Preclinical
hydroxytoluic-acid					MicroSource	99.14	BRD-K75608666-001-08-3	Preclinical
hydroxyurea	ribonucleotide reductase inhibitor	RRM1, RRM2, RRM2B	hematologic malignancy, oncology	chronic myeloid leukemia (CML), head and neck squamous cell carcinoma (HNSCC)	Selleck, Selleck, MicroSource	98.2	BRD-K51747290-001-15-6, BRD-K51747290-001-12-3, BRD-K51747290-001-13-1	Launched
hydroxyzine	antihistamine	HRH1	neurology/psychiatry, allergy, dermatology	anxiety, urticaria, itching, dermatosis, anxiety, urticaria, itching, dermatosis	Selleck, MicroSource	96.59	BRD-A62428732-300-06-3, BRD-A62428732-096-10-9	Launched
hygromycin-b	polypeptide synthesis inhibitor				Selleck	100	BRD-A67101513-001-03-7	Preclinical
hymecromone	monoamine oxidase inhibitor	MAOA, MAOB			MicroSource, Selleck	95.22	BRD-K46424862-001-15-8, BRD-K46424862-001-14-1	Phase 2
hyodeoxycholic-acid	atherosclerosis formation inhibitor				Selleck	96.92	BRD-K44009692-001-02-3	Phase 1
hyoscyamine	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4	gastroenterology, urology, neurology/psychiatry, allergy	peptic ulcer disease (PUD), acute abdominal visceral spasm, ulcerative colitis, interstitial cystitis (IC), enterocolitis, irritable bowel syndrome, tremors, allergic rhinitis	MicroSource, Selleck	97.93	BRD-K40530731-001-11-6, BRD-K40530731-001-10-8	Launched
hypericin	tyrosine kinase inhibitor				Enzo	87.7	BRD-K29673530-001-05-4	Phase 2
hyperin	aldose reductase inhibitor	ACE, AKR1B1			ChemDiv	96.75	BRD-A63780829-001-11-4	Preclinical
hypoestoxide	IKK inhibitor	IKBKB, IL1B, TNF			EMDBio	97.42	BRD-A51571244-001-01-9	Phase 1
hypoxanthine	PARP inhibitor	PNP			Selleck	96.41	BRD-K03739921-001-06-8	Preclinical
H2L-5765834	lysophosphatidic acid receptor antagonist	LPAR1, LPAR3			Tocris	95.78	BRD-K26439554-001-01-3	Preclinical
I-BET-762	bromodomain inhibitor	BRD2, BRD3, BRD4			Selleck	97.76	BRD-K08109215-001-06-4	Phase 2
I-BET151	bromodomain inhibitor	BRD2, BRD3, BRD4			Selleck, Tocris	96.17	BRD-K36363294-001-04-2, BRD-K36363294-300-01-4	Preclinical
I-BRD9	bromodomain inhibitor	BRD9			Tocris, MedChemEx	95.93	BRD-K04972057-001-02-9, BRD-K04972057-001-01-1	Preclinical
I-BZA					Enamine	89.11	BRD-K14762862-001-01-9	Phase 2
I-BZA2					ChemBridge	98.45	BRD-K71698503-003-01-6	Phase 3
I-CBP-112	bromodomain inhibitor	CREBBP, EP300			Tocris	81.05	BRD-K57090026-001-02-4	Preclinical
IB-MECA	adenosine receptor agonist	ADORA1, ADORA2A, ADORA2B, ADORA3			Tocris	96.28	BRD-K31135544-001-07-0	Phase 3
ibandronate	bone resorption inhibitor	FDPS	orthopedics	osteoporosis	MicroSource, Selleck, Selleck	0	BRD-K08681769-323-04-5, BRD-K08681769-323-05-2, BRD-K08681769-323-03-7	Launched
IBC-293	hydroxycarboxylic acid receptor agonist	HCAR3			Tocris	96.09	BRD-K15196155-001-02-3	Preclinical
IBMX	phosphodiesterase inhibitor	ADORA1, PDE2A, PDE3B, PDE4D, PDE5A, PDE6G, PDE7A, PDE8A, PDE9A			Tocris	95.56	BRD-K94979336-001-20-0	Preclinical
ibotenic-acid	glutamate receptor agonist	GRIN1			Tocris	0	BRD-A04628621-001-02-6	Phase 1
ibrolipim	lipoprotein lipase activator	LPL			Sigma	96.6	BRD-K62490786-001-01-1	Phase 2
ibrutinib	Bruton's tyrosine kinase (BTK) inhibitor	BLK, BMX, BTK	hematologic malignancy	chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), Waldenstrom's macroglobulinemia (WM)	Selleck, Selleck	99.58	BRD-K70301465-001-05-9, BRD-K70301465-001-02-6	Launched
ibudilast	leukotriene receptor antagonist, phosphodiesterase inhibitor	IL1B, IL6, PDE3A, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A	pulmonary, neurology/psychiatry	asthma, stroke	Tocris, Tocris	96.95	BRD-K16444452-001-11-7, BRD-K16444452-001-09-1	Launched
ibuprofen	cyclooxygenase inhibitor	PTGS1, PTGS2	neurology/psychiatry, rheumatology, otolaryngology, obstetrics/gynecology, endocrinology, dental	headache, muscle pain, rheumatoid arthritis, backache, common cold, menstrual pain, fever, toothache	MicroSource, Selleck	99.41	BRD-A17655518-001-24-4, BRD-A17655518-001-23-6	Launched
ibuprofen-(s)	cyclooxygenase inhibitor	ASIC1, BCL2, CFTR, FABP2, PLAT, PPARG, PTGS1, PTGS2, SLC5A8, THBD			Tocris, MicroSource	99.44	BRD-K14965640-001-13-2, BRD-K14965640-001-12-4	Preclinical
ibuprofen-lysine	cyclooxygenase inhibitor	PTGS1, PTGS2	cardiology	patent ductus arteriosus (PDA)	Selleck, Selleck	0	BRD-M64062803-001-03-9, BRD-M64062803-001-02-1	Launched
ibuprofen-piconol	cyclooxygenase inhibitor	PTGS1, PTGS2			Enamine, Enamine	95.32	BRD-A75224450-001-01-6, BRD-A75224450-001-02-4	Launched
ibuproxam	cyclooxygenase inhibitor, prostaglandin inhibitor	ALOX5	endocrinology, rheumatology, neurology/psychiatry	fever, joint inflammation, pain relief	Enzo	80.93	BRD-A40940854-001-01-1	Launched
ibutamoren	growth hormone secretagogue receptor agonist	GHR, GHSR			MedChemEx, Tocris	94.74	BRD-K44771174-066-01-0, BRD-K44771174-066-02-8	Phase 2
ibutilide	potassium channel blocker	CACNA1C, CACNA2D1, CACNB1, CACNG1, KCNH2, KCNH6, KCNH7, KCNJ11, KCNK1, KCNK6	cardiology	atrial fibrillation (AF)	Tocris, Selleck, Selleck	96.32	BRD-A74391928-051-03-9, BRD-A74391928-051-01-3, BRD-A74391928-051-02-1	Launched
ICA-069673	voltage-gated potassium channel activator	KCNQ2, KCNQ3			Tocris	87.74	BRD-K59839632-001-01-0	Preclinical
ICA-110381	voltage-gated potassium channel activator	KCNQ2			Tocris	92.75	BRD-K71686520-001-01-4	Preclinical
ICA-121431	sodium channel blocker	SCN1A, SCN3A			Tocris	97.46	BRD-K03149601-001-02-6	Preclinical
icariin	phosphodiesterase inhibitor	PDE5A			Selleck, Selleck	90.67	BRD-K65639003-001-10-8, BRD-K65639003-001-09-0	Phase 3
icaritin	PPAR receptor antagonist	PDE5A			MedChemEx, MedChemEx	88.81	BRD-K24476327-001-02-1, BRD-K24476327-001-01-3	Phase 2
icatibant-acetate	bradykinin receptor antagonist	ANPEP, BDKRB2	cardiology	angioedema	MedChemEx, MedChemEx, MedChemEx	93.99	BRD-K63772874-001-03-0, BRD-K63772874-001-01-4, BRD-K63772874-001-02-2	Launched
ICG-001	beta-catenin inhibitor	CTNNB1			Selleck	95.2	BRD-K94455792-001-01-8	Preclinical
ICI-118,551	adrenergic receptor antagonist	ADRB2, ADRB3			Tocris	97.18	BRD-K74603273-003-01-1	Phase 2
ICI-162846	histamine receptor antagonist	HRH2			Tocris	91.43	BRD-K11071038-001-01-7	Phase 1
ICI-185,282	thromboxane receptor antagonist				Tocris	96.78	BRD-K29133151-001-03-2	Phase 1
ICI-192605	thromboxane receptor antagonist	TBXA2R			Tocris, Tocris	96.71	BRD-K59433843-001-02-5, BRD-K59433843-001-01-7	Phase 2
ICI-199441	opioid receptor agonist	CYP2D6, OPRD1, OPRK1, OPRM1, UTS2R			Tocris, Tocris	97.12	BRD-K73290745-003-03-4, BRD-K73290745-003-02-6	Preclinical
ICI-215,001	adrenergic receptor agonist	ADRB3			Tocris	98.33	BRD-K52487250-003-01-2	Preclinical
ICI-63197	phosphodiesterase inhibitor				Tocris, Tocris	97.43	BRD-K52219182-001-03-2, BRD-K52219182-001-02-4	Preclinical
ICI-89406	adrenergic receptor antagonist	ADRB1, ADRB2			Tocris	88.81	BRD-A03359064-001-02-3	Phase 1
icilin	TRPV agonist	TRPA1, TRPM8			Tocris	10.14	BRD-K48869804-001-09-6	Phase 1
icomucret	mucin production enhancer	LTB4R2			Enzo	44	BRD-K41234004-001-03-1	Phase 3
icosapent	platelet aggregation inhibitor	ACSL3, ACSL4, FADS1, FFAR1, PPARD, PPARG, PTGS1, PTGS2, SLC8A1, TRPV1	endocrinology	hypertriglyceridemia	Enzo	87.46	BRD-K47192521-001-05-4	Launched
icotinib	EGFR inhibitor	EGFR	oncology	non-small cell lung cancer (NSCLC)	Selleck	96.95	BRD-K31698212-001-02-9	Launched
iCRT-14	WNT signaling inhibitor, beta catenin inhibitor	CTNNB1, TCF4			Tocris	89.36	BRD-K18634484-001-01-4	Preclinical
IC261	casein kinase inhibitor	CSNK1A1, CSNK1D, CSNK1E, CSNK1G2			MedChemEx, MedChemEx	74.58	BRD-K09638361-001-02-2, BRD-K09638361-001-03-0	Preclinical
ID-1101	insulin sensitizer	INS			Sigma	78.9	BRD-K90305467-001-01-3	Phase 1
ID-8					Selleck, Tocris	97.87	BRD-K39166528-001-01-0, BRD-K39166528-001-02-8	Preclinical
idalopirdine	serotonin receptor antagonist	HTR6			MedChemEx	95.12	BRD-K79102359-003-01-6	Phase 3
idarubicin	topoisomerase inhibitor	TOP2A	hematologic malignancy	acute myeloid leukemia (AML)	Selleck, Selleck	98.01	BRD-K69650333-003-13-2, BRD-K69650333-003-14-0	Launched
idasanutlin	MDM inhibitor	MDM2, TP53			MedChemEx	97.79	BRD-K62627508-001-01-5	Phase 3
idazoxan	adrenergic receptor antagonist	ADRA2A			Tocris, MicroSource	84.32	BRD-A18696154-003-21-8, BRD-A18696154-003-22-6	Phase 3
idazoxane	adrenergic receptor antagonist	ADRA2A, ADRA2B, ADRA2C			AMS	96.56	BRD-K70759443-001-01-4	Preclinical
idebenone	calcium channel modulator		neurology/psychiatry, ophthalmology	Alzheimer's disease, Friedreich's ataxia, Leber hereditary optic neuropathy (LHON)	Selleck, Selleck, MicroSource	95.71	BRD-K37516142-001-11-3, BRD-K37516142-001-09-7, BRD-K37516142-001-10-5	Launched
idelalisib	PI3K inhibitor	PIK3CA, PIK3CB, PIK3CD, PIK3CG	hematologic malignancy	chronic lymphocytic leukemia (CLL)	Selleck	96.97	BRD-K60866521-001-07-1	Launched
idoxuridine	DNA directed DNA polymerase inhibitor		infectious disease	virus herpes simplex (HSV)	Selleck, MicroSource	98.08	BRD-K76634210-001-12-1, BRD-K76634210-001-14-7	Launched
IDO5L	indoleamine 2,3-dioxygenase inhibitor	IDO1			MedChemEx	88.63	BRD-K22356203-001-01-8	Preclinical
IDRA-21	glutamate receptor positive allosteric modulator	GRIA1, GRIA2, GRIA3, GRIA4			Tocris, Tocris	97.41	BRD-A14344385-001-04-0, BRD-A14344385-001-03-2	Preclinical
idramantone					MicroSource	23.73	BRD-A57877027-001-01-7	Preclinical
idronoxil	XIAP inhibitor	ENOX2, SPHK1			Sigma	81.54	BRD-K74671368-001-01-8	Phase 3
IEM1460	glutamate receptor antagonist	GRIA2			Tocris, Tocris	98.63	BRD-K13829090-303-03-7, BRD-K13829090-303-02-9	Preclinical
IEM1754	glutamate receptor antagonist	GRIA1			Selleck, Selleck	95.33	BRD-K80060353-303-03-9, BRD-K80060353-303-02-1	Preclinical
ifenprodil	adrenergic receptor antagonist, glutamate receptor antagonist	GRIN1, GRIN2B			MicroSource, Selleck, Tocris, Selleck	99	BRD-A24191444-046-01-3, BRD-A24191444-046-02-1, BRD-A24191444-045-10-6, BRD-A24191444-046-03-9	Launched
ifosfamide	DNA alkylating agent	CYP2A6, CYP2B6, CYP2C18, CYP2C19, CYP2C8, CYP2C9, CYP3A4, CYP3A5, CYP3A7, PTGS1	oncology, urology	testicular carcinoma, hemorrhagic cystitis	MicroSource, Selleck	100	BRD-A67097164-001-18-7, BRD-A67097164-001-17-9	Launched
igmesine	sigma receptor agonist	SIGMAR1			Tocris	95.83	BRD-A48376327-003-01-5	Phase 2
iguratimod	cyclooxygenase inhibitor, NFkB pathway inhibitor	PTGS2	rheumatology	rheumatoid arthritis	MedChemEx	96.01	BRD-K15426076-001-01-2	Launched
IKK-16	IKK inhibitor	IKBKB			Tocris, Tocris, Selleck	95.29	BRD-K14618467-003-02-6, BRD-K14618467-003-03-4, BRD-K14618467-001-04-6	Preclinical
IKK-2-inhibitor	IKK inhibitor, SYK inhibitor	IKBKB			Tocris, Selleck, Selleck	93.53	BRD-K26373640-001-06-9, BRD-K26373640-001-05-1, BRD-K26373640-001-07-7	Preclinical
IKK-2-inhibitor-V	IKK inhibitor, NFkB pathway inhibitor	IKBKB			Tocris, Selleck	97.99	BRD-K74305673-001-07-0, BRD-K74305673-001-06-2	Phase 1
ilepcimide	anticonvulsant				Enamine	87.77	BRD-K43873574-001-01-8	Phase 3
ilomastat	matrix metalloprotease inhibitor	ACAN, ADAM28, MMP1, MMP12, MMP13, MMP14, MMP2, MMP3, MMP8, MMP9			Selleck, Selleck	94.49	BRD-K51662849-001-05-4, BRD-K51662849-001-08-8	Phase 3
iloperidone	dopamine receptor antagonist, serotonin receptor antagonist	ADRA1A, ADRA2C, DRD1, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR2A, HTR6, HTR7	neurology/psychiatry	schizophrenia	Selleck	97.56	BRD-K48722833-001-07-6	Launched
iloprost	platelet aggregation inhibitor, prostanoid receptor agonist	PDE4A, PDE4B, PDE4C, PDE4D, PLAT, PTGDR, PTGER1, PTGER2, PTGER3, PTGER4, PTGFR, PTGIR, TBXA2R	pulmonary	pulmonary arterial hypertension (PAH)	MedChemEx	50.79	BRD-A45664787-001-04-8	Launched
imatinib	Bcr-Abl kinase inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor	ABL1, CSF1R, DDR1, KIT, NTRK1, PDGFRA, PDGFRB, RET	hematologic malignancy, oncology	chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL), myelodysplastic diseases (MDS), aggressive systemic mastocytosis (ASM), hypereosinophilic syndrome (HES), chronic eosinophilic leukemia (CEL), dermatofibrosarcoma protuberans (DFSP), gastrointestinal stromal tumors (GIST)	Selleck, Selleck, Selleck	99.23	BRD-K92723993-001-12-5, BRD-K92723993-001-06-7, BRD-K92723993-066-22-7	Launched
imeglimin	gluconeogenesis inhibitor				MedChemEx, MedChemEx	97.85	BRD-K55822903-003-02-6, BRD-K55822903-003-01-8	Phase 2
imetit	histamine receptor agonist	HRH3, HRH4			Tocris	90.26	BRD-K33183200-303-02-4	Preclinical
imexon	apoptosis stimulant, ribonucleotide reductase inhibitor	RRM1, RRM2			MicroSource	100	BRD-A78195072-001-06-2	Phase 2
imidacloprid	acetylcholine receptor antagonist	CHRFAM7A			SantaCruz	99.22	BRD-K76609936-001-08-4	Launched
imidafenacin	acetylcholine receptor antagonist	CHRM1, CHRM3	neurology/psychiatry	spasms, spasms	MedChemEx, MedChemEx	97.97	BRD-K29626940-001-01-5, BRD-K29626940-001-02-3	Launched
imidapril	angiotensin converting enzyme inhibitor	ACE	cardiology	hypertension, congestive heart failure	Selleck	97.71	BRD-K34332569-001-01-3	Launched
imidurea	other antibiotic				Prestwick	0	BRD-A65444648-001-11-4	Preclinical
imiloxan	adrenergic receptor antagonist	ADRA2A, ADRA2B			Tocris	97.18	BRD-A10903566-003-07-7	Phase 1
imipenem	bacterial cell wall synthesis inhibitor		infectious disease	pneumonia, urinary tract infections, intra-abdominal infections, gynecologic infections, bacterial septicemia, bone and joint infections, skin infections, endocarditis	MicroSource, Sigma	0	BRD-K23200955-002-01-5, BRD-K23200955-002-02-3	Launched
imipramine	norepinephrine reputake inhibitor, serotonin reuptake inhibitor	ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD5, HRH1, HTR1A, HTR2A, HTR2C, HTR6, HTR7, KCND2, KCND3, KCNH1, KCNH2, SLC6A2, SLC6A3, SLC6A4	neurology/psychiatry, urology	depression, nocturnal enuresis	Selleck, MicroSource, Selleck	92.52	BRD-K38436528-003-25-3, BRD-K38436528-003-26-1, BRD-K38436528-003-27-9	Launched
imiquimod	interferon inducer, toll-like receptor agonist	TLR7, TLR8	dermatology, infectious disease, oncology	actinic keratosis (AK), genital warts, basal cell carcinoma (BCC)	Selleck, MicroSource, Selleck	98.69	BRD-K26657438-001-17-8, BRD-K26657438-003-01-8, BRD-K26657438-001-15-2	Launched
immepip	histamine receptor agonist	HRH3, HRH4			Tocris	91.38	BRD-K25906698-303-02-7	Preclinical
immethridine	histamine receptor agonist	HRH3			Tocris, Tocris	97.64	BRD-K49519092-303-02-2, BRD-K49519092-303-03-0	Phase 1
impentamine	histamine receptor antagonist	HRH3			Tocris	70.44	BRD-K20049318-303-02-1	Preclinical
IMREG-1					ChemImpex	97.29	BRD-K00926464-001-01-8	Phase 3
INC-280	c-Met inhibitor	MET			Selleck	95.03	BRD-K81016934-001-02-0	Phase 2
INCA-6	calcineurin inhibitor	NFATC1			Tocris, Tocris	58.26	BRD-K33308633-001-02-4, BRD-K33308633-001-03-2	Preclinical
INCB-003284	CC chemokine receptor antagonist				EMDBio	83.66	BRD-K28059174-334-01-2	Phase 2
INCB-024360	indoleamine 2,3-dioxygenase inhibitor	IDO1			MedChemEx	95.87	BRD-K79450420-001-01-8	Phase 2
INCB-3284	CC chemokine receptor antagonist	CCR2			MedChemEx	92.32	BRD-K67628093-001-01-9	Phase 2
indacaterol	adrenergic receptor agonist	ADRB1, ADRB2	pulmonary	chronic obstructive pulmonary disease (COPD)	Selleck	95.34	BRD-K89208535-051-01-5	Launched
indalpine	selective serotonin reuptake inhibitor (SSRI)	SLC6A4			Sigma	90.29	BRD-K64973364-001-01-4	Withdrawn
indapamide	thiazide diuretic	KCNE1, KCNQ1, SLC12A3	cardiology	hypertension, congestive heart failure	MicroSource, Selleck	96.25	BRD-A95869247-001-26-9, BRD-A95869247-001-25-1	Launched
indatraline	norepinephrine transporter inhibitor	MAOA, MAOB			Tocris, Tocris	96.95	BRD-K01649396-003-08-9, BRD-K01649396-003-07-1	Preclinical
indeloxazine	norepinephrine reuptake inhibitor, serotonin reuptake inhibitor				Sigma	99.26	BRD-A59747053-003-01-3	Withdrawn
indibulin	tubulin polymerization inhibitor				Vitas-M	97.78	BRD-K74057757-001-01-9	Phase 1/Phase 2
indinavir	HIV protease inhibitor	CYP3A4, CYP3A5, CYP3A7	infectious disease	human immunodeficiency virus (HIV-1)	Enzo	97.93	BRD-K33226500-001-01-0	Launched
indiplon	benzodiazepine receptor agonist	GABRA1			Tocris, Tocris	99.26	BRD-K90948141-001-01-4, BRD-K90948141-001-02-2	Phase 3
indirubin	CDK inhibitor, glycogen synthase kinase inhibitor	CDK1, CDK5, GSK3A			Selleck	99.41	BRD-K17894950-001-14-3	Phase 2/Phase 3
indirubin-3-monoxime	CDK inhibitor, glycogen synthase kinase inhibitor	CDK1, CDK2, CDK5, CDK5R1, GSK3B			Tocris	97.67	BRD-K19136521-001-08-9	Preclinical
indisulam	CDK inhibitor	CA1, CA12, CA14, CA2, CA6, CA7, CA9			Sigma	98.25	BRD-K17610631-001-03-3	Phase 2
indium(iii)-isopropoxide					AlfaAesar	0	BRD-M08274809-001-01-7	Preclinical
indium-tri(2-propanolate)					AlfaAesar	0	BRD-K42332878-001-01-9	Preclinical
indobufen	cyclooxygenase inhibitor, platelet aggregation inhibitor	PTGS1, PTGS2	hematology	thrombosis	AKSci	99.21	BRD-A16296925-001-01-3	Launched
indocyanine-green	contrast agent	SLCO1B1			MedChemEx, Sigma, MedChemEx	92.75	BRD-K80762071-236-01-7, BRD-K80762071-236-02-5, BRD-K80762071-236-03-3	Launched
indole-3-carbinol	aryl hydrocarbon receptor agonist, indoleamine 2,3-dioxygenase inhibitor	AHR			Selleck	96.69	BRD-K01815685-001-15-5	Phase 2/Phase 3
indole-3-pyrubate	melatonin receptor agonist				Sigma	0	BRD-K09109825-001-07-3	Phase 2
indomethacin	cyclooxygenase inhibitor	GLO1, PLA2G2A, PPARA, PPARG, PTGDR2, PTGR2, PTGS1, PTGS2, SLC46A1	rheumatology, orthopedics	rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, bursitis, tendinitis	Tocris, MicroSource, Selleck	99.45	BRD-K57222227-001-29-3, BRD-K57222227-001-30-1, BRD-K57222227-001-28-5	Launched
indoprofen	cyclooxygenase inhibitor, prostanoid receptor antagonist	CXCR1, CXCR2, PTGS1, PTGS2			MicroSource	99.31	BRD-A44090213-001-25-6	Withdrawn
indoramin	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2B, ADRA2C	urology, cardiology	benign prostatic hyperplasia (BPH), hypertension	Maybridge	92.44	BRD-K76953762-001-08-5	Launched
indoximod	indoleamine 2,3-dioxygenase inhibitor	IDO1			Cayman	98.79	BRD-K93255255-001-02-1	Phase 2
ingenol-mebutate	PKC activator	PRKCA, PRKCB, PRKCD, PRKCE, PRKCG	dermatology	actinic keratosis (AK)	MedChemEx	97.23	BRD-K93779381-001-01-9	Launched
INH1	Hec1 inhibitor	NDC80			Tocris	98.19	BRD-K70177501-003-01-4	Preclinical
inimur	other antifungal				MedChemEx, MedChemEx	86.95	BRD-A71407503-001-01-8, BRD-A71407503-001-02-6	Launched
iniparib	PARP inhibitor	PARP1			Selleck	97.59	BRD-K11153516-001-05-5	Phase 3
inosine	neurotrophic agent	PARP1, PNP			Selleck, Selleck, MicroSource	94.71	BRD-K79612754-001-20-9, BRD-K79612754-001-19-1, BRD-K79612754-001-21-7	Launched
inositol	insulin sensitizer	CDIPT, GBA			MicroSource	98.26	BRD-K52618540-001-09-9	Launched
inositol-hexanicotinate			dermatology, cardiology, rheumatology, neurology/psychiatry	statis dermatitis, claudication, Raynaud's disease, hypertension, insomnia, atherosclerosis, restless leg syndrome, schizophrenia, psoriasis, acne vulgaris (AV)	AKSci	89.29	BRD-K82800842-001-01-9	Launched
INS316	purinergic receptor antagonist				Enzo	0	BRD-A29125379-314-01-7	Phase 2
INT-747	FXR agonist				MedChemEx	98.9	BRD-K30968378-001-01-9	Phase 3
INT-767	FXR agonist	GPBAR1			MedChemEx	98.4	BRD-K33067152-236-01-1	Phase 1
integrin-antagonist-1	integrin antagonist	ITGAV, ITGB6			MedChemEx	93.77	BRD-K88165431-003-01-4	Phase 1
iobenguane	antineoplastic agent		oncology, cardiology, endocrinology	neuroblastoma, congestive heart failure, pheochromocytoma	Prestwick, Axon	98.26	BRD-K43860855-065-10-1, BRD-K43860855-065-11-9	Launched
iocetamic-acid	radiopaque medium		radiology	contrast agent	Prestwick	85.31	BRD-A37492983-001-10-3	Launched
iodipamide	radiopaque medium	ALB	radiology	contrast agent	MicroSource	99.2	BRD-K67261995-001-11-7	Launched
iodixanol	radiopaque medium		radiology	contrast agent	Sigma, MicroSource	79.95	BRD-A08660406-001-06-7, BRD-A08660406-001-05-9	Launched
iodoantipyrine					AlfaAesar	98.81	BRD-K69216798-001-01-9	Preclinical
iododexetimide	acetylcholine receptor antagonist				MedChemEx	96.72	BRD-A46813902-001-01-6	Phase 2
iodophenpropit	histamine receptor antagonist	HRH3, HRH4			Tocris	95.9	BRD-K51918615-303-02-9	Preclinical
iodoquinol	antiseptic		infectious disease	amebiasis	MicroSource	88.89	BRD-K75855670-001-14-2	Launched
iohexol	radiopaque medium		radiology	contrast agent	MicroSource	98.79	BRD-A60217728-001-11-2	Launched
iopamidol	radiopaque medium		radiology	contrast agent	MedChemEx	100	BRD-K75868704-001-05-3	Launched
iopanic-acid	thyroid hormone inhibitor				MicroSource	98.49	BRD-A42628519-001-12-4	Preclinical
iopodic-acid			radiology	contrast agent	Vitas-M	98.86	BRD-K51956333-001-03-8	Launched
iopromide	radiopaque medium		radiology	contrast agent	Prestwick, Sigma	64.8	BRD-A72075775-001-10-4, BRD-A72075775-001-11-2	Launched
iothalamic-acid-d3	radiopaque medium				Toronto	0	BRD-K98250023-001-01-0	Preclinical
ioversol	radiopaque medium		radiology	contrast agent	MicroSource	97.06	BRD-A65818372-001-05-3	Launched
IOWH032	CFTR channel antagonist	CFTR			Selleck	98.44	BRD-K84892605-001-01-1	Phase 2
ioxaglic-acid	radiopaque medium		radiology	contrast agent	Prestwick	92.49	BRD-K79124250-001-08-9	Launched
ioxilan	radiopaque medium		radiology	angiography	MicroSource	85.72	BRD-A09370961-001-01-0	Launched
IOX1	histone demethylase inhibitor	EGLN1, KDM3A, KDM4C, KDM6B			MedChemEx, Tocris	87.15	BRD-K70751730-001-10-4, BRD-K70751730-001-11-2	Preclinical
IOX2	hypoxia inducible factor inhibitor	EGLN1, KDM2A, KDM5C			Selleck, Tocris	97.26	BRD-K98251413-001-04-0, BRD-K98251413-001-06-5	Preclinical
IPA-3	p21 activated kinase inhibitor	PAK1			Tocris, Selleck, Selleck	70.81	BRD-K38727704-001-02-4, BRD-K38727704-001-01-6, BRD-K38727704-001-03-2	Preclinical
IPAG					Tocris	95.16	BRD-K82421491-001-02-6	Preclinical
IPI-145	PI3K inhibitor	PIK3CA, PIK3CB, PIK3CD, PIK3CG			Selleck	95.49	BRD-K93468883-001-02-0	Phase 3
ipidacrine	acetylcholinesterase inhibitor	ACHE			ChemDiv	98.46	BRD-K66896231-001-08-1	Phase 3
ipragliflozin-l-proline	sodium/glucose cotransporter inhibitor	SLC5A2	endocrinology	diabetes mellitus	MedChemEx	98.3	BRD-K51247865-001-01-2	Launched
ipratropium	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	pulmonary	bronchospasm, chronic obstructive pulmonary disease (COPD), bronchitis, emphysema	Tocris, MicroSource, Selleck	93.93	BRD-A47449001-004-12-9, BRD-A47449001-004-13-7, BRD-A47449001-004-14-5	Launched
ipriflavone	bone resorption inhibitor		orthopedics	osteoporosis	MicroSource, Selleck	98.07	BRD-K93618743-001-21-0, BRD-K93618743-001-20-2	Launched
iproniazid	monoamine oxidase inhibitor	MAOA, MAOB			MicroSource	98.08	BRD-K88568253-011-19-9	Withdrawn
ipsapirone	serotonin receptor agonist	HTR1A			Tocris	93.81	BRD-K90574421-001-03-5	Phase 3
irbesartan	angiotensin receptor antagonist	AGTR1, JUN, SLC10A1	cardiology, nephrology	hypertension, diabetic nephropathy	MicroSource, Selleck	98.6	BRD-K60038276-001-09-0, BRD-K60038276-001-08-2	Launched
irinotecan	topoisomerase inhibitor	TOP1, TOP1MT	oncology	colorectal cancer	Selleck, Tocris, MedChemEx, Tocris, MicroSource, Selleck, Selleck	98.48	BRD-K08547377-001-04-4, BRD-K08547377-003-06-5, BRD-K08547377-003-07-3, BRD-K08547377-003-04-0, BRD-K08547377-003-05-7, BRD-K08547377-001-06-9, BRD-K08547377-394-03-5	Launched
IRL-2500	endothelin receptor antagonist	EDNRB			Tocris	94.23	BRD-K98357249-001-02-9	Preclinical
irosustat	steroid sulfatase inhibitor	CA2, STS			Sigma	0	BRD-K87777313-001-02-2	Phase 2
irsogladine	phosphodiesterase inhibitor	PDE4A	gastroenterology	peptic ulcer disease (PUD)	Tocris, Tocris, Selleck	99.31	BRD-K74195153-050-12-1, BRD-K74195153-050-13-9, BRD-K74195153-001-04-1	Launched
isamoltane	adrenergic receptor antagonist	HTR1A, HTR1B			Tocris	89.47	BRD-A26845397-051-01-9	Phase 1
isavuconazole	cytochrome P450 inhibitor	CYP3A4			MedChemEx	98.14	BRD-A17009129-001-01-3	Phase 3
isaxonine	nerve growth factor agonist				MicroSource	81.09	BRD-K95957366-001-02-6	Withdrawn
isbufylline	phosphodiesterase inhibitor				Vitas-M	97.28	BRD-K06762493-001-08-1	Phase 2
isepamicin	protein synthesis inhibitor		infectious disease	pneumonia, peritonitis	Carbosynth, Sigma	95.5	BRD-K74759733-001-01-9, BRD-K74759733-065-01-4	Launched
ISO-1	macrophage migration inhibiting factor inhibitor	MIF			Tocris	83.05	BRD-A94055480-001-01-5	Preclinical
isobutamben	local anesthetic				MicroSource	99.03	BRD-K96714749-001-01-0	Preclinical
isobutyramide	gene expression stimulant	HBE1, HBG1			Otava	0	BRD-K54057105-001-01-2	Phase 2
isocarboxazid	monoamine oxidase inhibitor	MAOA, MAOB	neurology/psychiatry	depression	Sigma, Enzo	64.59	BRD-K93332168-001-11-5, BRD-K93332168-001-10-7	Launched
isoconazole	fungal lanosterol demethylase inhibitor	CYP17A1	infectious disease	gram-positive bacterial infections	Selleck	98.55	BRD-A93353767-008-02-2	Launched
isodibut	aldehyde reductase inhibitor				Enamine, Sigma	99.18	BRD-K60241851-001-10-1, BRD-K60241851-001-11-9	Phase 2
isoetharine	adrenergic receptor agonist	ADRB1, ADRB2	pulmonary	bronchospasm, asthma	Selleck, MicroSource, Selleck	94.7	BRD-A24587114-066-21-7, BRD-A24587114-066-22-5, BRD-A24587114-066-23-3	Launched
isofloxythepin	dopamine receptor antagonist				Specs	85.83	BRD-A07704283-001-01-3	Phase 2
isoflupredone-acetate		NR3C1			Prestwick	91.96	BRD-K29173907-001-09-2	Preclinical
isoflurane	inhaled anaesthetic	ATP2C1, ATP5D, CALM1, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GRIA1, KCNA1, KCNK10, KCNK18, KCNK2, KCNK3, KCNK9	neurology/psychiatry	general anaesthetic	Sigma, Enamine	0	BRD-A31564021-001-02-6, BRD-A31564021-001-01-8	Launched
isoflurophate	cholinesterase inhibitor	ACHE, BCHE	ophthalmology	glaucoma	Sigma, Sigma	0	BRD-K56575995-001-03-0, BRD-K56575995-001-02-2	Launched
isoguvacine	benzodiazepine receptor agonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRR1, GABRR2, GABRR3			Tocris	100	BRD-K66480997-003-10-0	Preclinical
isoleucine		ACADSB, BCAT1, BCAT2, IARS, IARS2			Enamine	89.82	BRD-A02232681-001-01-8	Launched
isoliquiritigenin	guanylate cyclase activator	GABBR1			Selleck	90.32	BRD-K33583600-001-16-1	Preclinical
isometheptene-mucate		ADRA1A, SLC18A2	neurology/psychiatry	headache	Prestwick	81.13	BRD-A64743628-001-01-5	Launched
isoniazid	FABI inhibitor	CYP1A2, CYP2C19, CYP2C8, CYP2E1, CYP3A4	infectious disease	tuberculosis	Selleck, MicroSource	100	BRD-K87202646-001-32-6, BRD-K87202646-001-33-4	Launched
isopentyl-4-methoxycinnamate			dermatology	sunscreen lotion	Enamine	0	BRD-K37851352-001-01-0	Launched
isoprenaline	adrenergic receptor agonist	ADRB1, ADRB2, ADRB3, MAPK1, PIK3R1, PIK3R2, PIK3R3	cardiology, pulmonary	bradycardia, heart block, asthma	Selleck, Selleck, MicroSource, Tocris	94.79	BRD-A04322457-003-18-7, BRD-A04322457-003-15-3, BRD-A04322457-003-17-9, BRD-A04322457-003-16-1	Launched
isopropamide-iodide	acetylcholine receptor antagonist	CHRM3, CHRM4	gastroenterology	peptic ulcer disease (PUD), gastrointestinal acidosis	MicroSource	97.23	BRD-K14127446-005-22-7	Launched
isopropyl-myristate			dermatology	cosmetic	Sigma, Acros	0	BRD-K13409143-001-02-7, BRD-K13409143-001-01-9	Launched
isopropyl-palmitate	cosmetic moisturizer		dermatology	cosmetic	Sigma, TCI	0	BRD-K30758549-001-02-6, BRD-K30758549-001-01-8	Launched
isoquinoline,-6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro,					Prestwick	98.3	BRD-A75140635-003-10-9	Preclinical
isosorbide	nitric oxide stimulant		cardiology	angina pectoris, coronary artery disease (CAD)	MedChemEx, MedChemEx, Selleck, Selleck	0	BRD-K47178855-001-03-4, BRD-K47178855-001-02-6, BRD-K47178855-001-04-2, BRD-K47178855-001-01-8	Launched
isosorbide-dinitrate	nitric oxide stimulant	GUCY1A2, GUCY1A3, GUCY1B2, GUCY1B3, NPR1	cardiology	angina pectoris, coronary artery disease (CAD)	Enamine, MicroSource	0	BRD-K55853390-001-13-2, BRD-K55853390-001-12-4	Launched
isosorbide-mononitrate	nitric oxide stimulant	GUCY1A2, GUCY1A3, GUCY1B2, GUCY1B3	cardiology	angina pectoris, coronary artery disease (CAD)	MicroSource	97.02	BRD-K82225283-001-03-1	Launched
isosteviol					ChemDiv	100	BRD-A96529864-001-01-3	Phase 2
isotiquimide					Enamine	92.3	BRD-A02933148-001-01-8	Phase 1
isotretinoin	retinoid receptor agonist	RARA, RARB, RARG	dermatology	acne vulgaris (AV)	Selleck, MedChemEx, Selleck, MicroSource	51.38	BRD-K76723084-001-25-7, BRD-K76723084-001-24-0, BRD-K76723084-001-22-4, BRD-K76723084-001-23-2	Launched
isovaleramide	alcohol dehydrogenase inhibitor				PrincetonBio, Selleck, MicroSource, Selleck	79.17	BRD-K90069354-001-04-5, BRD-K90069354-001-01-1, BRD-K90069354-001-02-9, BRD-K90069354-001-03-7	Phase 2
isoxepac	anti-inflammatory agent				Ark	99.77	BRD-K92116564-001-01-4	Phase 2
isoxicam	cyclooxygenase inhibitor	PTGS1, PTGS2			MicroSource, Selleck	97.77	BRD-A75552914-001-16-8, BRD-A75552914-001-15-0	Withdrawn
isoxsuprine	adrenergic receptor agonist	ADRB2	rheumatology, cardiology	Raynaud's disease, arteriosclerosis, Buerger's disease	MicroSource	93.61	BRD-A16700644-003-04-4	Launched
ispinesib	kinesin inhibitor	KIF11			Selleck, Tocris, Selleck	88.16	BRD-K64881305-001-05-2, BRD-K64881305-001-06-0, BRD-K64881305-001-03-7	Phase 2
isradipine	calcium channel blocker	CACNA1C, CACNA1D, CACNA1F, CACNA1H, CACNA1S, CACNA2D1, CACNA2D2, CACNB2	cardiology	hypertension	Tocris, MicroSource, Selleck, Tocris	97.4	BRD-A90799790-001-20-7, BRD-A90799790-001-19-9, BRD-A90799790-001-16-5, BRD-A90799790-001-17-3	Launched
ISRIB	eukaryotic translation initiation factor inhibitor, PERK inhibitor	EIF2A, EIF2AK3			MedChemEx	90.08	BRD-K12826175-001-02-4	Preclinical
istaroxime	ATPase inhibitor	ATP1A1			MedChemEx	97.6	BRD-K95412502-003-01-5	Phase 2
istradefylline	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3	neurology/psychiatry	Parkinson's Disease, dyskinesia	MedChemEx, MedChemEx, MedChemEx, Selleck, Selleck	95.36	BRD-K87774949-001-06-2, BRD-K87774949-001-05-4, BRD-K87774949-001-07-0, BRD-K87774949-001-03-9, BRD-K87774949-001-04-7	Launched
ISX-9	neural stem cell inducer	NEUROD1			Tocris	89.11	BRD-K53903639-001-04-7	Preclinical
itacitinib	JAK inhibitor	JAK1			MedChemEx	96.17	BRD-K67482377-001-01-8	Phase 2
ITD-1	TGF beta receptor inhibitor	TGFBR2			Tocris	93.59	BRD-A56690687-001-01-6	Preclinical
ITE	aryl hydrocarbon receptor agonist	AHR			Tocris	97.76	BRD-K60298136-001-03-3	Preclinical
ITI214	phosphodiesterase inhibitor	PDE1A			MedChemEx	95.75	BRD-K77987496-011-01-9	Phase 1
itopride	dopamine receptor antagonist	CHRM3, DRD2	gastroenterology, neurology/psychiatry	dyspepsia, gastroparesis, heartburn, nausea, vomiting, anorexia	MicroSource	96.72	BRD-K96740444-001-02-1	Launched
itraconazole	cytochrome P450 inhibitor	CYP51A1	infectious disease	onychomycosis, histoplasmosis, blastomycosis, aspergillosis	MicroSource, Selleck, Selleck	89.77	BRD-A23067620-300-01-3, BRD-A23067620-001-04-1, BRD-A23067620-001-03-3	Launched
ITX3	GEF inhibitor	TRIO			MedChemEx, MedChemEx	84.43	BRD-K36515744-001-03-5, BRD-K36515744-001-02-7	Preclinical
IT1t	CC chemokine receptor antagonist	CXCR4			Tocris	77.71	BRD-K73499906-300-01-0	Preclinical
IU1	ubiquitin C-terminal hydrolase inhibitor	USP14			Tocris, Selleck, Selleck	87.3	BRD-K45841694-001-12-5, BRD-K45841694-001-11-7, BRD-K45841694-001-10-9	Preclinical
ivabradine	HCN channel antagonist, potassium channel blocker, sodium channel blocker	HCN1, HCN3, HCN4	cardiology	angina pectoris	Selleck	96.65	BRD-K31385749-003-01-3	Launched
ivacaftor	CFTR channel potentiator	CFTR	pulmonary	cystic fibrosis	Selleck	98.82	BRD-K52818472-001-02-2	Launched
ivermectin	benzodiazepine receptor agonist	CHRNA7, GABRB3, GLRA3, P2RX7	infectious disease	gastrointestinal roundworms, lungworms, cattle grubs, mites, lice, horn flies	Tocris, MicroSource, Selleck, Selleck	94.01	BRD-K85554912-001-05-5, BRD-K85554912-001-08-9, BRD-K85554912-001-06-3, BRD-K85554912-001-07-1	Launched
ivosidenib	isocitrate dehydrogenase inhibitor	IDH1	hematologic malignancy	acute myeloid leukemia (AML)	MedChemEx	96.63	BRD-K93073858-001-01-1	Launched
IWP-L6	porcupine inhibitor	PORCN			Selleck	95.25	BRD-K53234107-001-01-6	Preclinical
ixabepilone	microtubule stabilizing agent	TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8	oncology	breast cancer	MedChemEx	98.98	BRD-K03601870-001-01-2	Launched
ixazomib	proteasome inhibitor		hematologic malignancy	multiple myeloma	Selleck	93.99	BRD-K78659596-001-03-9	Launched
ixazomib-citrate	proteasome inhibitor		hematologic malignancy	multiple myeloma	Selleck	92.47	BRD-A66419424-001-02-4	Launched
JAK3-inhibitor-V	JAK inhibitor	JAK3			Tocris	0	BRD-K95676198-001-05-9	Preclinical
JDTic	opioid receptor antagonist	OPRK1			MedChemEx	91.5	BRD-K95837862-300-01-7	Phase 1
JHW-007	dopamine uptake inhibitor	SLC6A3			Tocris	89.23	BRD-K32892871-003-01-7	Preclinical
JIB04	histone lysine demethylase inhibitor	KDM4E			Selleck, Selleck, Tocris	85.22	BRD-K76180386-001-01-6, BRD-K76180386-001-02-4, BRD-K76180386-001-03-2	Preclinical
JK-184	hedgehog pathway inhibitor				Tocris, Tocris, Tocris	81.15	BRD-K38860038-001-03-8, BRD-K38860038-001-01-2, BRD-K38860038-001-02-0	Preclinical
JLK-6	gamma secretase inhibitor	PSEN1			Tocris	0	BRD-K22010301-001-04-6	Preclinical
JNJ-10191584	histamine receptor antagonist	HRH4			Tocris, Tocris	99.26	BRD-K15086322-050-01-3, BRD-K15086322-050-02-1	Preclinical
JNJ-10397049	orexin receptor antagonist	HCRTR1, HCRTR2			Tocris	90.72	BRD-K61721596-001-02-8	Preclinical
JNJ-16259685	glutamate receptor antagonist	GRM1			Tocris, Tocris	97.98	BRD-K25596805-001-01-8, BRD-K25596805-001-02-6	Preclinical
JNJ-1661010	FAAH inhibitor	FAAH			Selleck, Tocris	96.42	BRD-K47376733-001-08-1, BRD-K47376733-001-09-9	Preclinical
JNJ-17203212	TRPV antagonist	TRPV1			Tocris, Tocris	94.57	BRD-K51770398-001-01-9, BRD-K51770398-001-02-7	Preclinical
JNJ-26481585	HDAC inhibitor	HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9, MDM2			Selleck	91.72	BRD-K83837640-001-04-8	Phase 2
JNJ-26990990	anticonvulsant				Enamine	93.07	BRD-K24864897-001-01-0	Phase 2
JNJ-27141491	CC chemokine receptor antagonist	CCR2			Tocris	87.73	BRD-K41895652-001-01-8	Preclinical
JNJ-37822681	dopamine receptor antagonist	DRD2			Enamine	89	BRD-K31802667-001-01-9	Phase 2
JNJ-38877605	tyrosine kinase inhibitor	MET			Selleck	97.35	BRD-K02123250-001-06-7	Phase 1
JNJ-40411813	glutamate receptor positive allosteric modulator	GRM2			MedChemEx	95.69	BRD-K55029398-001-01-6	Phase 2
JNJ-42041935	hypoxia inducible factor prolyl hydroxylase inhibitor	PDK2			MedChemEx	97.43	BRD-K01036220-001-01-0	Preclinical
JNJ-42165279	FAAH inhibitor	FAAH			MedChemEx	94.84	BRD-K70330032-001-01-1	Phase 2
JNJ-47965567	purinergic receptor antagonist	P2RX7			Tocris	93.76	BRD-K83547600-001-01-7	Preclinical
JNJ-63533054	G protein-coupled receptor agonist	GPR139			MedChemEx	98.12	BRD-K19482962-001-01-8	Preclinical
JNJ-7706621	CDK inhibitor	AURKA, AURKB, CDK1, CDK2			Selleck	93.95	BRD-K11636097-001-03-1	Preclinical
JNJ-7777120	histamine receptor antagonist	HRH4			Tocris, Selleck	97.84	BRD-K17774839-001-03-7, BRD-K17774839-001-02-9	Preclinical
josamycin	bacterial 50S ribosomal subunit inhibitor		pulmonary	bronchitis	Prestwick	90.23	BRD-K25837718-001-03-8	Launched
JQ1-(+)	bromodomain inhibitor	BRD4, BRDT			Selleck, Tocris	97.16	BRD-K54606188-001-13-1, BRD-K54606188-001-16-4	Preclinical
JTC-801	opioid receptor antagonist	OPRL1			Tocris, Tocris, Selleck	96.79	BRD-K17705806-003-04-4, BRD-K17705806-003-06-9, BRD-K17705806-003-03-6	Phase 2
JTE-013	lysophospholipid receptor antagonist	P2RY10, S1PR2			Tocris, Tocris	74.8	BRD-K43330982-001-02-3, BRD-K43330982-001-03-1	Preclinical
JTE-607	cytokine production inhibitor	IL10, IL1B, IL6, TNF			Tocris, Tocris	98.12	BRD-K81405859-300-01-4, BRD-K81405859-300-02-2	Phase 2
JTE-907	cannabinoid receptor inverse agonist	CNR2			Tocris, Tocris	98.31	BRD-K63150726-001-02-1, BRD-K63150726-001-03-9	Phase 1
JW-55	tankyrase inhibitor	TNKS, TNKS2			Tocris	96.32	BRD-K53328210-001-04-4	Preclinical
JW-642	monoacylglycerol lipase inhibitor	MGLL			Tocris	92.32	BRD-K48424871-001-03-1	Preclinical
JW-67	Wnt pathway inhibitor	APC, AXIN1, GSK3B			Tocris	96.58	BRD-K24554037-001-08-3	Preclinical
JW-74	WNT signaling inhibitor, tankyrase inhibitor	TNKS, TNKS2			PrincetonBio, Tocris	99.87	BRD-K75664313-001-02-6, BRD-K75664313-001-03-4	Preclinical
JX-401	p38 MAPK inhibitor	MAPK14			Tocris, Tocris	98.22	BRD-K05464208-001-05-7, BRD-K05464208-001-08-1	Preclinical
JZL-184	monoacylglucerol lipase inhibitor	MGLL			Tocris, Selleck	96.24	BRD-K45446451-001-06-8, BRD-K45446451-001-05-0	Preclinical
JZL-195	FAAH inhibitor, monoacylglycerol lipase inhibitor	FAAH, MGLL			Tocris	98.35	BRD-K38875233-001-03-9	Preclinical
K-MAP					ChemBridge	92.13	BRD-A45906415-001-01-9	Phase 2
K-Ras(G12C)-inhibitor-12	K-ras inhibitor	KRAS			MedChemEx, MedChemEx	82.19	BRD-K90756851-001-01-1, BRD-K90756851-001-02-9	Preclinical
K-Ras(G12C)-inhibitor-6	K-ras inhibitor				Selleck, Selleck	94.21	BRD-K26305185-001-01-3, BRD-K26305185-001-02-1	Preclinical
k-strophanthidin	ATPase inhibitor	ATP1A1			Enzo	69.82	BRD-A55312468-001-04-7	Phase 2
K-247					ChemBridge	62.72	BRD-A74648924-001-02-3	Phase 1
K-858	kinesin-like spindle protein inhibitor	KIF11			Tocris	98.42	BRD-A67748489-001-10-0	Preclinical
kaempferol	bone resorption inhibitor, estrogen-related receptor inverse agonist	AKR1B1, ALOX15B, ALOX5, AR, CYP1B1, GLO1, HSD17B1, UGT3A1			Tocris, Selleck, Selleck	97.71	BRD-K12807006-001-18-5, BRD-K12807006-001-17-7, BRD-K12807006-001-19-3	Preclinical
kainic-acid	kainate receptor agonist	GRIA1, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5			Tocris	100	BRD-K52459018-001-09-1	Preclinical
kakonein	GABA receptor antagonist, serotonin receptor antagonist				Vitas-M	97.6	BRD-A07815743-001-01-1	Phase 2
kanamycin	bacterial 30S ribosomal subunit inhibitor		infectious disease	gram-negative bacterial infections	MedChemEx, MedChemEx, MicroSource	0	BRD-K08327065-065-05-0, BRD-K08327065-065-04-3, BRD-K08327065-065-06-8	Launched
kartogenin	chondrocyte differentiation stimulator	FLNA			Tocris	71.07	BRD-K27584835-001-01-6	Preclinical
KB-R7943	sodium/calcium exchange inhibitor	SLC8A1, TRPC3, TRPC5, TRPC6			Tocris, Tocris	92.36	BRD-K17743697-066-04-4, BRD-K17743697-066-03-6	Preclinical
KB-SRC-4	src inhibitor	SRC			Tocris	98.82	BRD-K88154110-001-01-0	Preclinical
KBG	neprilysin inhibitor	MME			SantaCruz	97.5	BRD-A00376169-001-01-6	Phase 2
KD-023	ACAT inhibitor	ACACA, ACACB			EMDBio	100	BRD-K71164191-001-01-0	Phase 2
KD025	rho associated kinase inhibitor	ROCK2			MedChemEx	97.3	BRD-K88506063-001-01-8	Phase 2
kenpaullone	CDK inhibitor, glycogen synthase kinase inhibitor	CCNB1, CDK1, CDK5, GSK3B			Tocris, Tocris	96.42	BRD-K37312348-001-17-6, BRD-K37312348-001-15-0	Preclinical
ketanserin	serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA1D, DRD1, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, SLC18A1, SLC18A2	cardiology	hypertension	MicroSource, Tocris, Selleck	98.5	BRD-K49671696-046-01-8, BRD-K49671696-045-08-5, BRD-K49671696-001-05-4	Launched
ketoconazole	sterol demethylase inhibitor	AR, CYP19A1, CYP21A2, KCNA10	dermatology	seborrheic dermatitis	Selleck, Tocris, Selleck, MicroSource	95.89	BRD-K29113274-001-28-3, BRD-K29113274-001-27-5, BRD-K29113274-001-26-7, BRD-A38350138-001-04-9	Launched
ketoprofen	cyclooxygenase inhibitor	CXCR1, PTGS1, PTGS2, SLC5A8	rheumatology	rheumatoid arthritis, osteoarthritis	Selleck, MicroSource	99.39	BRD-A97739905-001-25-7, BRD-A97739905-001-26-5	Launched
ketorolac	cyclooxygenase inhibitor	PTGS1, PTGS2			MicroSource, Selleck, Selleck	95.72	BRD-A40639672-234-18-0, BRD-A40639672-234-17-2, BRD-A40639672-001-01-9	Launched
ketotifen	histamine receptor agonist, leukotriene receptor antagonist, phosphodiesterase inhibitor	HRH1, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B, PGD	neurology/psychiatry	itching	Tocris, MicroSource, Selleck	98.24	BRD-K28936863-051-32-2, BRD-K28936863-051-33-0, BRD-K28936863-051-31-4	Launched
kevetrin	p53 activator				MedChemEx	95.3	BRD-K61339991-003-01-8	Phase 1
KF-38789	P selectin inhibitor	SELP			Tocris, Tocris	92.1	BRD-A54927599-001-16-9, BRD-A54927599-001-17-7	Preclinical
KG-5	RAF inhibitor	BRAF, FLT3, KIT, PDGFRB			Tocris	96.24	BRD-K90747162-001-01-4	Preclinical
KH-CB19	CDC inhibitor	CLK1, CLK3, DYRK1A			MedChemEx	27.29	BRD-K01673854-001-02-1	Preclinical
khellin	vasodilator				MicroSource, Sigma	99.43	BRD-K80353807-001-24-6, BRD-K80353807-001-25-3	Phase 2
KHK-IN-1	hexokinase inhibitor	KHK			MedChemEx	93.66	BRD-K84605263-003-01-6	Preclinical
KHS-101	neural stem cell inducer	TACC3			Tocris	97.05	BRD-K78978711-003-01-3	Preclinical
KI-16425	lysophosphatidic acid receptor antagonist	LPAR1, LPAR3			Selleck	96.73	BRD-A25569250-001-03-3	Preclinical
KI-20227	c-Fms inhibitor	CSF1R, KDR, KIT, PDGFRB			Tocris	97.77	BRD-A88787317-001-01-0	Preclinical
KI-8751	KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	KDR			Tocris, Selleck, Tocris	96.63	BRD-K47150025-001-06-1, BRD-K47150025-001-05-3, BRD-K47150025-001-09-5	Preclinical
kifunensine	mannosidase inhibitor	MAN1B1, MAN2A1			EMDBio	100	BRD-K02898090-001-02-7	Phase 1
kinetin	cell division inducer		dermatology	sunburn	Selleck	97.88	BRD-K65667145-001-14-0	Launched
ki16198	lipoprotein antagonist	LPA			Selleck	96.6	BRD-A94323479-001-02-8	Preclinical
KL-001	proteasome inhibitor	CRY1, CRY2			Tocris	98.65	BRD-A94580299-001-10-4	Preclinical
KML29	monoacylglucerol lipase inhibitor	MGLL			MedChemEx	96.99	BRD-K46734292-001-03-6	Preclinical
KN-62	calcium/calmodulin dependent protein kinase inhibitor, purinergic receptor antagonist	AKT1, CAMK2A, CHEK1, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, P2RX7, PRKCA, ROCK1, RPS6KB1, SGK1			MedChemEx	96.68	BRD-A81177136-001-12-7	Preclinical
KN-93	calcium/calmodulin dependent protein kinase inhibitor	CAMK2A			MedChemEx, MedChemEx, MedChemEx	98.69	BRD-K93480852-003-01-0, BRD-K93480852-001-06-3, BRD-K93480852-001-05-5	Preclinical
Ko143	BCRP inhibitor	ABCB1, ABCC1			Tocris, MedChemEx	97.42	BRD-K64642496-001-04-0, BRD-K64642496-001-03-2	Preclinical
KP-1212					Berry	100	BRD-K46690591-001-01-2	Phase 2
KPT-185	exportin antagonist	XPO1			Selleck	95.93	BRD-K71467466-001-02-3	Preclinical
KPT-276	exportin antagonist	XPO1			Selleck	95.86	BRD-K75352575-001-01-3	Preclinical
KRCA-0008	ALK inihibitor	ALK			Tocris	89.08	BRD-K40604024-001-01-6	Preclinical
KRN-633	VEGFR inhibitor	FLT1, FLT4, KDR			Selleck	93.55	BRD-K90993449-001-02-7	Preclinical
KS-176	BCRP inhibitor	ABCG2			Tocris	96.94	BRD-K81053848-001-01-0	Preclinical
KT-433	uricosuric agent				Sigma	97.5	BRD-K66437909-001-01-0	Phase 2
ku-0063794	mTOR inhibitor	MTOR			Selleck, Selleck	95.33	BRD-K67566344-001-08-3, BRD-K67566344-001-07-5	Preclinical
KU-55933	ATM kinase inhibitor	ATM, PRKDC			Tocris, Selleck	98.75	BRD-K25311561-001-10-7, BRD-K25311561-001-09-9	Preclinical
KU-60019	ATM kinase inhibitor	ATM			Selleck, Selleck, Tocris	96.77	BRD-K36016295-001-05-2, BRD-K36016295-001-04-5, BRD-K36016295-001-06-0	Preclinical
kuromanin	ribosyl cyclase inhibitor	CD38			MedChemEx	98.1	BRD-K51337109-003-01-3	Preclinical
KU14R	imidazoline receptor antagonist				Tocris, Tocris	98.56	BRD-A38747044-001-03-1, BRD-A38747044-001-02-3	Preclinical
KW-2449	Abl kinase inhibitor, Aurora kinase inhibitor, FLT3 inhibitor	ABL1, AURKA, AURKB, FLT3			Selleck	93.46	BRD-K21718444-001-06-8	Phase 1
KW-2478	HSP inhibitor				Selleck	92.87	BRD-K41213548-001-02-0	Phase 1/Phase 2
KW-3902	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3			Tocris	98.8	BRD-A95683721-001-03-8	Phase 3
KX2-391	src inhibitor, tubulin polymerization inhibitor	SRC			Selleck	96.52	BRD-K29968218-001-03-2	Phase 2
kynurenic-acid	glutamate receptor antagonist	GPR35, GRIN1, GRIN2A, GRIN2B			Tocris, Tocris	98.64	BRD-K85872723-001-17-5, BRD-K85872723-001-15-9	Preclinical
KY02111	Wnt pathway inhibitor	DKK1			Selleck, Tocris	97.58	BRD-K13302470-001-02-7, BRD-K13302470-001-03-5	Preclinical
K02288	bone morphogenic protein inhibitor	BMP1			MedChemEx, Selleck, Tocris	99.48	BRD-K58568447-001-03-7, BRD-K58568447-001-01-1, BRD-K58568447-001-02-9	Preclinical
K145	sphingosine kinase inhibitor	SPHK2			MedChemEx	87.48	BRD-K12106308-003-01-9	Preclinical
L-(+)-Rhamnose-Monohydrate					Selleck	100	BRD-A86354194-002-01-7	Preclinical
L-alanine					Sigma	0	BRD-K25125382-001-02-5	Launched
L-Arginine	nitric oxide precursor	ARG2, ASL, ASS1, AZIN2, GPRC6A, NOS2, NOS3, SLC7A1, SLC7A3, SLC7A4	cardiology, neurology/psychiatry, urology, obstetrics/gynecology, otolaryngology	congestive heart failure, hypertension, coronary artery disease (CAD), claudication, senile dementia, erectile dysfunction, infertility, common cold	Selleck	100	BRD-K76811153-003-01-3	Launched
L-Ascorbyl-6-palmitate					Selleck, MicroSource, Selleck	36.17	BRD-A45419686-001-02-3, BRD-A45419686-001-04-9, BRD-A45419686-001-03-1	Preclinical
L-asparagine		ASNS, ASRGL1, NARS, NARS2, SLC1A5, SLC38A3			Sigma	0	BRD-K06665116-001-02-6	Phase 3
L-asparagine-n-hydroxy					Sigma	98.6	BRD-K82178523-001-01-6	Preclinical
L-Aspartic-Acid	metallic radical formation stimulant	ACY1, ACY3, ADSS, ADSSL1, ASNS, ASPA, ASPH, ASRGL1, ASS1, CAD, DARS, DARS2, GOT1, GOT2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, LYZ, PAICS, RNASE1, SLC1A1, SLC25A12, SLC25A13			Sigma, Enzo	98.1	BRD-K97163964-001-04-1, BRD-K97163964-001-03-3	Launched
L-Citrulline	nitric oxide stimulant	ASS1, DDAH1, DDAH2, GPRC6A, NOS1, NOS2, NOS3, OTC, PADI1, PADI2, PADI3, PADI4, PADI6	cardiology, urology	hypertension, erectile dysfunction	Vitas-M	100	BRD-A12237696-001-04-2	Launched
L-cysteine		CARS, CARS2, CBS, CDO-1, CDO1, CSAD, CTH, GCLC, GCLM, GOT1, GSS, MGMT, NFS1, SLC19A3			Sigma	0	BRD-K00795468-001-02-1	Launched
L-Cysteinesulfinic-acid	glutamate receptor agonist	GRM1, GRM5, GSR, HMGCS2, PAPOLA, PRDX2			Tocris	0	BRD-A25800195-001-02-2	Preclinical
L-Cystine		CTNS, SLC3A1, SLC7A11, SLC7A9			Enamine, Enamine, Sigma	0	BRD-A15397381-001-02-5, BRD-A15397381-001-03-3, BRD-K99679910-001-02-3	Launched
L-ergothioneine	free radical scavenger				Enzo	100	BRD-K26341917-001-01-3	Phase 2
L-glutamic-acid	glutamate receptor agonist	AADAT, AASS, ABAT, ALDH18A1, ASNS, BCAT1, BCAT2, CCBL2, DNPEP, EARS2, ENPEP, EPRS, FOLH1, FPGS, FTCD, GAD1, GAD2, GATB, GCLC, GCLM, GGCX, GLS, GLS2, GLUD1, GLUD2, GLUL, GMPS, GOT1, GOT2, GPT, GPT2, GRIA1, GRIA2, GRIA3, GRIA4, GRID1, GRID2, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, GRM1, GRM2, GRM3, GRM4, GRM6, GRM7, GRM8, LGSN, NADSYN1, NAGS, OPLAH, PFAS, PGCP, PSAT1, SLC1A1, SLC1A2, SLC1A3, SLC1A6, SLC1A7, SLC25A18, SLC25A22, SLC7A11, TAT			Sigma	98.26	BRD-K62309135-001-05-2	Launched
L-Hydroxyproline					Enamine	0	BRD-A12454076-001-01-9	Launched
L-leucine		BCAT1, BCAT2, LARS, LARS2, LCMT1, LCMT2			Sigma	58.9	BRD-K12853841-001-02-2	Phase 3
L-lysine	serotonin receptor agonist	GPRC6A, KARS, SLC7A1, SLC7A2, SLC7A3, SLC7A4			Sigma	0	BRD-K86016185-001-01-3	Phase 2
L-methionine	voltage-gated calcium channel ligand				Sigma	97.7	BRD-K06502269-001-02-6	Launched
L-mimosine	dopamine beta hydroxylase inhibitor, eukaryotic translation initiation factor inhibitor	DBH, EIF5A			Sigma	50.1	BRD-K98151021-001-01-2	Preclinical
L-monomethylarginine	nitric oxide synthase inhibitor	NOS1, NOS2			Tocris	0	BRD-K20946707-001-01-9	Phase 3
L-NAME	nitric oxide synthase inhibitor	NOS3			Tocris, Tocris	96.03	BRD-K33141550-003-06-5, BRD-K33141550-003-05-7	Phase 2/Phase 3
L-NIL	nitric oxide synthase inhibitor	NOS1, NOS2, NOS3			Tocris	97.43	BRD-K60036103-003-01-6	Preclinical
L-proline	glutamate receptor agonist	EPRS, L3HYPDH, P3H1, P3H2, P3H3, P4HA1, P4HA2, PARS2, PPIA, PPIB, PPIC, PPIF, PPIG, PPIH, PRODH, PROSC, PYCR1, PYCR2, PYCRL, SLC6A14, SLC6A7			Sigma	99.2	BRD-K01666412-001-02-0	Launched
L-Quisqualic-acid	glutamate receptor agonist	FOLH1, GRIA2, GRIK1, GRIK2, GRM1, GRM2, GRM3, GRM5, GRM7, GRM8			Tocris	100	BRD-K92404805-001-07-0	Preclinical
L-Theanine	glutamate receptor antagonist				Enzo	100	BRD-A08715367-001-01-7	Launched
L-threonine		TARS, TARS2, THNSL1			Sigma	0	BRD-K75508643-001-02-6	Phase 2
L-152804	neuropeptide receptor antagonist	NPY5R			Tocris, Tocris	92.68	BRD-A42553870-001-15-0, BRD-A42553870-001-14-3	Preclinical
L-161982	prostanoid receptor antagonist	PTGER4			Tocris, Tocris	98.41	BRD-K39733634-001-02-6, BRD-K39733634-001-03-4	Preclinical
L-165041	PPAR receptor agonist	PPARD			Tocris, Tocris	98.7	BRD-K98372770-001-09-0, BRD-K98372770-001-08-2	Preclinical
L-168049	glucagon receptor antagonist	GCGR			Tocris, Tocris	94.42	BRD-K18036262-001-02-8, BRD-K18036262-001-03-6	Preclinical
L-365260	CCK receptor antagonist	CCKAR, CCKBR, KCNQ1			Tocris	98.98	BRD-K34277641-001-01-2	Phase 2
L-368899	oxytocin receptor antagonist	AVPR1A, AVPR2, OXTR			Tocris, Tocris	84.47	BRD-A43930669-003-02-8, BRD-A43930669-003-03-6	Phase 1
L-655,708	GABA receptor inverse agonist	GABRA1, GABRA2, GABRA3, GABRA5, GABRG2			Tocris, Tocris	98.39	BRD-K13474508-001-02-0, BRD-K13474508-001-01-2	Preclinical
L-655240	thromboxane receptor antagonist	PTGES			Tocris, Tocris	98.81	BRD-K89402695-001-03-1, BRD-K89402695-001-02-3	Phase 1
L-670596	prostanoid receptor antagonist				Tocris	98.01	BRD-A85472596-001-02-2	Preclinical
L-689560	glutamate receptor antagonist	GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D			Tocris, Tocris	95.13	BRD-K74284736-001-03-1, BRD-K74284736-001-02-3	Preclinical
L-690330	inositol monophosphatase inhibitor	IMPA1			Tocris	0	BRD-K28470988-001-04-6	Preclinical
L-693403	sigma receptor agonist, sigma receptor antagonist	DRD2, SIGMAR1			Tocris	96.18	BRD-K83322645-050-01-9	Preclinical
L-694247	serotonin receptor agonist	HTR1A, HTR1B, HTR1D			Tocris	29.3	BRD-K18816859-001-02-2	Preclinical
L-701252	glutamate receptor antagonist	GRIN1			Tocris	97.91	BRD-K10176267-001-03-3	Preclinical
L-701324	glutamate receptor antagonist	GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D			Tocris, Tocris	98.44	BRD-K08109516-001-08-6, BRD-K08109516-001-07-8	Preclinical
L-732,138	tachykinin antagonist	TACR1, TACR2			Tocris, Tocris	97.96	BRD-K37952347-001-02-2, BRD-K37952347-001-01-4	Preclinical
L-733060	tachykinin antagonist	TACR1			Tocris	96.09	BRD-K15791587-003-02-5	Preclinical
L-741742	dopamine receptor antagonist	DRD3, DRD4, SCN1A, SCN3A			Tocris	97.25	BRD-K13211965-003-02-8	Preclinical
L-745870	dopamine receptor antagonist	DRD1, DRD2, DRD3, DRD4, HTR1A, HTR2A, HTR6, HTR7			Tocris, Tocris	93.03	BRD-K05528470-305-03-0, BRD-K05528470-305-02-2	Preclinical
L-755507	adrenergic receptor agonist	ADRB1, ADRB2, ADRB3			Tocris, Tocris	76.05	BRD-K39359968-001-01-8, BRD-K39359968-001-02-6	Preclinical
L-760735	tachykinin antagonist	TACR1			Tocris	72.75	BRD-K30425481-003-01-0	Preclinical
L-778123	farnesyltransferase inhibitor	FNTA, FNTB, PGGT1B			MedChemEx	96.05	BRD-K10958118-003-01-5	Phase 1
L-798,106	prostanoid receptor antagonist	PTGER3			Tocris, Tocris	99.28	BRD-K43905307-001-01-2, BRD-K43905307-001-02-0	Preclinical
L-838417	GABA receptor partial agonist	GABRA1, GABRA2, GABRA3, GABRA5			Tocris	97.33	BRD-K46647427-001-02-0	Preclinical
labetalol	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2	cardiology	hypertension	MicroSource	95.95	BRD-A07440155-003-25-4	Launched
lacidipine	calcium channel blocker	CACNA1C	cardiology	hypertension	Selleck	95.57	BRD-K43586850-001-02-9	Launched
lacitol	osmosis stimulant		gastroenterology	constipation	MicroSource, MicroSource	100	BRD-K40787673-001-02-1, BRD-K40787673-001-01-3	Launched
lacosamide	collapsin response mediator protein inhibitor, collapsin response mediator protein stimulant, sodium channel blocker	SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	neurology/psychiatry	seizures	Enzo	98.58	BRD-K68232650-001-02-2	Launched
lactulose	laxative		gastroenterology	portal-systemic encephalopathy (PSE)	MicroSource	100	BRD-K77258318-001-04-6	Launched
lafutidine	histamine receptor antagonist	HRH2	gastroenterology	duodenal ulcer disease, peptic ulcer disease (PUD)	Selleck	96.82	BRD-A67516570-001-02-8	Launched
lamivudine	nucleoside reverse transcriptase inhibitor		infectious disease	human immunodeficiency virus (HIV-1), acquired immunodeficiency syndrome (AIDS), hepatitis B	MicroSource, Selleck	96.67	BRD-A02309928-001-04-1, BRD-K02992638-001-11-8	Launched
lamotrigine	serotonin receptor antagonist, sodium channel blocker	SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	neurology/psychiatry	epilepsy, bipolar disorder	MicroSource, Selleck	99.52	BRD-K93460210-001-23-7, BRD-K93460210-001-22-9	Launched
lanatoside-c	cardiac glycoside				MicroSource	98.52	BRD-A64242993-001-05-6	Preclinical
landiolol	adrenergic receptor antagonist	ADRB1	cardiology	cardiac arrythmia	AKSci	98.94	BRD-K86436199-003-01-3	Launched
lanoconazole	sterol demethylase inhibitor		infectious disease	fungal infection	AKSci	96.68	BRD-A54275602-001-01-0	Launched
lansoprazole	ATPase inhibitor	ATP4A, ATP4B	gastroenterology	heartburn	MicroSource, Tocris, Selleck	98.97	BRD-A49172652-001-28-9, BRD-A49172652-001-27-1, BRD-A49172652-001-26-3	Launched
lapatinib	EGFR inhibitor	EGFR, ERBB2	oncology	breast cancer	Selleck, Selleck, Selleck	97.32	BRD-K19687926-001-10-8, BRD-K19687926-379-07-4, BRD-K19687926-001-04-1	Launched
lappaconite	sodium channel blocker				Selleck	90.14	BRD-A05906449-004-01-1	Phase 2
laquinimod	immunosuppressant	CXCL2			Selleck, Selleck	86.53	BRD-K60918217-001-02-0, BRD-K60918217-001-03-8	Phase 3
laropiprant	prostanoid receptor antagonist	PTGDR, PTGDR2, PTGER1, PTGER2, PTGER3, PTGFR, PTGIR, TBXA2R	cardiology	cholesterol	MedChemEx	98.78	BRD-K48894757-001-01-8	Launched
lasalocid	bacterial permeability inducer		infectious disease	coccidiosis	MicroSource	91.23	BRD-A72711497-236-03-8	Launched
lasofoxifene	selective estrogen receptor modulator (SERM)	ESR1, ESR2	orthopedics, oncology	osteoporosis, breast cancer	MedChemEx, MedChemEx	98.71	BRD-M93148412-001-02-6, BRD-M93148412-001-01-8	Launched
latanoprost	prostanoid receptor agonist	PTGFR	ophthalmology	ocular hypertension, glaucoma	Enzo	98.27	BRD-K10961822-001-05-1	Launched
latrepirdine	glutamate receptor antagonist	HRH1, HTR6			ChemDiv, Tocris, Adooq	95.21	BRD-K55703048-001-07-7, BRD-K55703048-300-02-4, BRD-K55703048-300-01-6	Phase 3
latrunculin-b	actin polymerization inhibitor	ACTA1, MKL1, SPIRE2			EMDBio	31.64	BRD-K61292460-001-02-3	Phase 1
lauric-acid	bacterial permeability inducer	GPR84, HNF4A, LTF, LY96, PLA2G2A, TLR4			Enzo	58.87	BRD-K67375056-001-07-9	Phase 3
lauric-diethanolamide					Enamine	97.68	BRD-K11548689-001-01-6	Preclinical
laurocapram					InterBioScreen	94.26	BRD-K35698076-001-01-2	Phase 3
lazabemide	monoamine oxidase inhibitor	MAOB			Tocris, Tocris	89.6	BRD-K51486818-003-02-8, BRD-K51486818-003-03-6	Phase 3
LB-100	protein phosphatase inhibitor				MedChemEx, MedChemEx, MedChemEx	61.4	BRD-A49767491-001-01-8, BRD-A73709786-001-01-3, BRD-A73709786-001-02-1	Phase 1
LB42708	farnesyltransferase inhibitor				Tocris, Selleck, Selleck	96.49	BRD-K18834913-001-03-7, BRD-K18834913-001-01-1, BRD-K18834913-001-02-9	Preclinical
LCL-161	XIAP inhibitor	BIRC2, XIAP			MedChemEx	95.17	BRD-K08248804-001-01-8	Phase 2
LCQ908	diacylglycerol O acyltransferase inhibitor	DGAT1			MedChemEx	89	BRD-K20008181-001-01-3	Phase 3
LCZ696	angiotensin receptor antagonist		cardiology	angioedema, hypotension	MedChemEx, MedChemEx, MedChemEx, Selleck	61.98	BRD-M31057929-314-01-9, BRD-M31057929-001-01-2, BRD-M31057929-385-01-9, BRD-M31057929-447-01-7	Launched
LDC1267	protein tyrosine kinase inhibitor	AXL, MERTK, TYRO3			MedChemEx	98.38	BRD-K44715996-001-01-0	Preclinical
LDN-209929	haspin kinase inhibitor	GSG2			Tocris	0	BRD-K61795638-300-01-0	Preclinical
LDN-212854	bone morphogenic protein inhibitor	ABL1, ACVR1, RIPK2			Selleck, Selleck	97.26	BRD-K59831625-001-01-6, BRD-K59831625-001-02-4	Preclinical
LDN-27219	tissue transglutaminase inhibitor	TGM2			Tocris	88.89	BRD-K51485109-001-01-4	Preclinical
LDN-57444	ubiquitin C-terminal hydrolase inhibitor				MedChemEx, Selleck, Selleck	99.35	BRD-K94485812-001-03-7, BRD-K94485812-001-01-1, BRD-K94485812-001-02-9	Preclinical
LDN193189	bone morphogenic protein inhibitor	ACVR1, BMPR1A			MedChemEx	85.57	BRD-K04853698-376-01-4	Preclinical
LE-135	retinoid receptor agonist	RARB			Tocris, Tocris	95.85	BRD-K06593056-001-05-5, BRD-K06593056-001-04-8	Preclinical
ledipasvir	HCV inhibitor		infectious disease	hepatitis C	MedChemEx	94.99	BRD-K05446112-001-01-8	Launched
leflunomide	dihydroorotate dehydrogenase inhibitor, PDGFR tyrosine kinase receptor inhibitor	AHR, DHODH, PTK2B	rheumatology	rheumatoid arthritis	MicroSource, Tocris, Selleck	94.48	BRD-K78692225-001-24-5, BRD-K78692225-001-23-7, BRD-K78692225-001-22-9	Launched
lemborexant	orexin receptor antagonist	HCRTR1, HCRTR2			MedChemEx	96.65	BRD-K78666663-001-01-6	Phase 3
lenalidomide	anticancer agent	CDH5, CRBN, PTGS2, TNF, TNFSF11	hematologic malignancy	multiple myeloma, mantle cell lymphoma (MCL), myelodysplastic diseases (MDS)	Selleck	98.9	BRD-A17883755-001-06-1	Launched
lenvatinib	FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	FLT4, KDR	oncology	thyroid cancer	Selleck	98.78	BRD-K39974922-001-04-3	Launched
lercanidipine	calcium channel blocker	CACNA2D1, CACNG1	cardiology	hypertension	Sigma	98.03	BRD-A18992208-003-02-7	Launched
lerisetron	serotonin receptor antagonist	HTR3A			LifeChem	91.67	BRD-K62398570-300-01-2	Phase 3
lersivirine	non-nucleoside reverse transcriptase inhibitor				MedChemEx	96.3	BRD-K03289534-001-01-4	Phase 2
lesinurad	uric acid diuretic	SLC22A12	rheumatology	gout	MedChemEx	85.07	BRD-K75024268-001-01-0	Launched
lestaurtinib	FLT3 inhibitor, growth factor receptor inhibitor, JAK inhibitor	FLT3, NTRK1			EMDBio	97.47	BRD-A27376179-001-01-3	Phase 3
leteprinim	nerve growth factor agonist				Sigma	97.65	BRD-K21612934-001-01-1	Phase 2
letermovir	CMV terminase inhibitor				MedChemEx	96.6	BRD-K94288301-001-01-7	Phase 3
letosteine	mucolytic agent		pulmonary, infectious disease	bronchitis, pneumonia	AKSci	96.97	BRD-A32597168-001-03-6	Launched
letrozole	aromatase inhibitor	CYP19A1	oncology	breast cancer	Tocris, Selleck	96.85	BRD-K88789588-001-16-4, BRD-K88789588-001-14-9	Launched
leucomethylene-blue	nitric oxide production inhibitor, tau aggregation inhibitor	MAPT			MedChemEx	0	BRD-K27460187-334-01-8	Phase 3
leucovorin	folate receptor ligand	TYMS	oncology	osteosarcoma	Selleck, Selleck, MicroSource	97.3	BRD-A75919782-399-02-6, BRD-A75919782-399-03-4, BRD-A75919782-238-08-3	Launched
leucylleucine-methyl-ester					ChemImpex	100	BRD-K81136890-003-01-6	Phase 2
leuprolide	gonadotropin releasing factor hormone receptor agonist	GNRHR	oncology	prostate cancer	Sigma	93.87	BRD-K26323068-001-01-8	Launched
levalbuterol	adrenergic receptor agonist	ADRB2	pulmonary	bronchospasm	MicroSource	97.04	BRD-K34469523-003-03-0	Launched
levallorphan	opioid antagonist	CHRNA2, OPRM1	pulmonary	respiratory depression	Enzo	93.45	BRD-K30634073-046-01-0	Launched
levamisole	acetylcholine receptor agonist	ALPL, ALPPL2, CHRNA3			MicroSource, Selleck	99.45	BRD-K73107279-003-12-5, BRD-K73107279-003-11-7	Withdrawn
levcromakalim	potassium channel activator	KCNJ5			Tocris, Sigma	99.04	BRD-K24526313-001-17-7, BRD-K24526313-001-18-5	Phase 3
levetiracetam	calcium channel blocker	CACNA1B, SCN1A, SV2A	neurology/psychiatry	seizures	Selleck, Tocris, MicroSource, Selleck	95.46	BRD-K49404994-001-11-7, BRD-K49404994-001-13-3, BRD-K49404994-001-10-9, BRD-K49404994-001-09-1	Launched
levo-phencynonate	acetylcholine receptor antagonist	CHRM1			ChemPacific	87.3	BRD-A64698388-003-01-7	Launched
levobetaxolol	adrenergic receptor antagonist	ADRB1, ADRB2	ophthalmology	intraocular pressure, glaucoma	Selleck	94.07	BRD-K43883465-003-01-5	Launched
levobunolol	adrenergic receptor antagonist	ADRB1, ADRB2, ADRB3	ophthalmology	glaucoma, ocular hypertension	Prestwick, Enzo	99.36	BRD-K31812033-003-11-0, BRD-K31812033-003-10-2	Launched
levobunolol-(+)	adrenergic receptor antagonist				Prestwick	99.32	BRD-K73323637-003-10-9	Preclinical
levobunolol-(+/-)	adrenergic receptor antagonist				MicroSource	98.4	BRD-A46876182-003-02-8	Preclinical
levocabastine	histamine receptor antagonist	HRH1, NTSR2	ophthalmology	conjunctivitis	Prestwick	98.8	BRD-K33453211-003-11-5	Launched
levocarnitine			endocrinology	carnitine deficiency	MicroSource, Selleck	100	BRD-K59647213-001-10-5, BRD-K59647213-001-09-7	Launched
levocarnitine-propionate	carnitine palmitoyltransferase inhibitor	CRAT	neurology/psychiatry, endocrinology	peripheral neuropathy, carnitine deficiency	MedChemEx	61.9	BRD-K84366268-003-01-0	Launched
levocetirizine	histamine receptor antagonist	HRH1	allergy	allergic rhinitis, urticaria	MicroSource	94.6	BRD-K27184429-300-01-3	Launched
levodopa	dopamine precursor	DRD1, DRD2, DRD3, DRD4, DRD5, GPR143	neurology/psychiatry	Parkinson's Disease	Selleck, MicroSource, Selleck	92.55	BRD-K34730807-001-17-6, BRD-K34730807-001-16-8, BRD-K34730807-001-15-0	Launched
levodropropizine	antitussive		pulmonary	cough suppressant	Selleck, Selleck	95.16	BRD-K83551379-001-02-6, BRD-K83551379-001-01-8	Launched
levofloxacin	bacterial DNA gyrase inhibitor	TOP2A	infectious disease, otolaryngology, pulmonary, urology	pneumonia, sinusitis, bronchitis, skin infections, prostatitis, urinary tract infections, pyelonephritis, anthrax, plague	MicroSource, Selleck	97.7	BRD-K09471561-001-18-2, BRD-K09471561-001-20-8	Launched
levomenol			neurology/psychiatry, infectious disease	spasms, skin infections	Sigma	0	BRD-K62751771-001-01-3	Launched
levomenthol		OPRK1, TRPA1, TRPM8, TRPV3	neurology/psychiatry	pain relief	MicroSource, Sigma, Sigma	32.51	BRD-K50329370-001-08-2, BRD-A54393207-001-03-6, BRD-K50329370-001-09-0	Launched
levomepromazine	dopamine receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR2A, HTR2C	neurology/psychiatry, gastroenterology	psychosis, schizophrenia, bipolar disorder, nausea, insomnia	Prestwick, Sigma	96.44	BRD-K35559145-050-08-5, BRD-K35559145-001-01-3	Launched
levomequitazine	histamine receptor antagonist	HRH1			Vitas-M	96.71	BRD-A67616246-001-07-9	Phase 2
levonordefrin	vasodilator	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, SLC6A2	hematology	hemorrhage	Sigma, MicroSource	0	BRD-K02976377-001-08-2, BRD-K02976377-001-07-4	Launched
levonorgestrel	estrogen receptor agonist, glucocorticoid receptor antagonist, progesterone receptor agonist, progesterone receptor antagonist	AR, ESR1, PGR, SRD5A1	endocrinology	contraceptive	Tocris, Selleck, Selleck, MicroSource	98.56	BRD-K35189033-001-28-7, BRD-K35189033-001-30-3, BRD-K35189033-001-29-5, BRD-K35189033-001-26-1	Launched
levopropoxyphene	antitussive	OPRD1, OPRK1, OPRM1	pulmonary	cough suppressant	Prestwick	28.74	BRD-A54635441-078-09-1	Launched
levosimendan	calcium sensitizer	KCNJ11, KCNJ8, PDE3A, TNNC1	cardiology	congestive heart failure	Selleck, MicroSource	99.1	BRD-K03095347-001-05-3, BRD-K03095347-001-06-1	Launched
levosulpiride	dopamine receptor antagonist	CA1, CA12, CA7, DRD2, DRD3	neurology/psychiatry, gastroenterology, urology	schizophrenia, psychosis, anxiety, vertigo, dyspepsia, irritable bowel syndrome, premature ejaculation (PE)	Tocris, Selleck, Tocris	98.1	BRD-K51671335-001-12-2, BRD-K51671335-001-09-8, BRD-K51671335-001-10-6	Launched
levothyroxine	thyroid hormone stimulant	THRA, THRB	endocrinology	myxedema coma	Selleck, MicroSource, Selleck, Sigma	96.14	BRD-K30685142-001-16-2, BRD-K30685142-001-15-4, BRD-K30685142-001-14-7, BRD-K30685142-001-17-0	Launched
LFM-A13	Bruton's tyrosine kinase (BTK) inhibitor	BTK			Tocris	94.77	BRD-A30655177-001-14-0	Preclinical
LGK-974	porcupine inhibitor	PORCN			Selleck	97.22	BRD-K16810791-001-01-0	Phase 2
LGX818	RAF inhibitor	BRAF			Selleck	96.4	BRD-A56085258-001-01-8	Phase 3
LH846	casein kinase inhibitor	CSNK1D			MedChemEx, Tocris	97.64	BRD-K47409078-001-01-8, BRD-K47409078-001-02-6	Preclinical
liarozole	cytochrome P450 inhibitor	CYP19A1, CYP26A1			Tocris	88.88	BRD-A57133765-300-01-7	Phase 2/Phase 3
licarbazepine	voltage-gated sodium channel blocker	SCN5A			Tocris, Tocris	98.65	BRD-A22642447-001-02-7, BRD-A22642447-001-01-9	Phase 3
licochalcone-a	topoisomerase inhibitor	PTPN1			Enzo	90.29	BRD-K26011976-001-01-0	Phase 3
licofelone	cyclooxygenase inhibitor, lipoxygenase inhibitor	ALOX5, PLA2G2E, PTGS2			Adooq, Selleck, Selleck	43.46	BRD-K08439945-001-03-9, BRD-K08439945-001-01-3, BRD-K08439945-001-02-1	Phase 3
lidamidine	adrenergic receptor agonist		gastroenterology	diarrhea	ChemDiv	93.96	BRD-K68693535-001-03-4	Launched
lidocaine	histamine receptor agonist	EGFR, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	neurology/psychiatry, dermatology, hematology	itching, eczema, hemorrhage	Selleck, MicroSource	99.22	BRD-K52662033-001-19-0, BRD-K52662033-003-21-2	Launched
lidoflazine	calcium channel blocker	SCN1A, SCN3A, SLC29A1			Prestwick	97.89	BRD-K62996583-001-10-3	Launched
ligustilide	tumor necrosis factor production inhibitor	TNF			MedChemEx	87.42	BRD-K48875051-001-01-0	Preclinical
limaprost-alfadex	prostanoid receptor agonist	PTGER1	cardiology	claudication	MedChemEx, MedChemEx	93.26	BRD-K25015158-001-01-2, BRD-K25015158-001-02-0	Launched
LIMKi-3	LIM kinase inhibitor	LIMK1			Tocris	98.06	BRD-K75373031-001-01-7	Preclinical
limonin	HIV protease inhibitor				Selleck	92.68	BRD-K05906022-001-05-1	Preclinical
linaclotide	guanylate cyclase activator	GUCY2C	gastroenterology	irritable bowel syndrome, constipation	MedChemEx	0	BRD-A55468767-001-01-1	Launched
linagliptin	dipeptidyl peptidase inhibitor	DPP4	endocrinology	diabetes mellitus	MicroSource, MicroSource, Selleck, Selleck	88.62	BRD-K96550715-003-01-4, BRD-K96550715-001-03-4, BRD-K96550715-001-04-2, BRD-K96550715-001-02-6	Launched
linalool	anticonvulsant				InterBioScreen	0	BRD-A43082461-001-06-3	Phase 1
lincomycin	bacterial 30S ribosomal subunit inhibitor		gastroenterology	enteritis	Selleck, MicroSource, Selleck	94.94	BRD-K81447180-003-21-4, BRD-K08033334-003-04-3, BRD-K81447180-001-01-0	Launched
lindane		GABRB1, GLRA1, GLRA2, GLRA3, GLRB	infectious disease	scabies	MedChemEx, MedChemEx, MicroSource	0	BRD-K93814253-001-06-8, BRD-K93814253-001-05-0, BRD-K93814253-001-04-3	Launched
linezolid	bacterial 50S ribosomal subunit inhibitor	MAOA, MAOB	infectious disease	pneumonia, skin infections	Tocris, MicroSource, Selleck	98.39	BRD-K66876909-001-15-9, BRD-K66876909-001-12-6, BRD-K66876909-001-11-8	Launched
linifanib	PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	CSF1, CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRB, RET, TEK			Selleck	90.79	BRD-K99749624-001-07-0	Phase 3
linoleic-acid	oxidative stress inducer	FABP4, FFAR1, FFAR4, HNF4A, KCNB1, PPARG, TRPM8			Sigma	0	BRD-K08973992-001-06-2	Phase 3
linopirdine	potassium channel blocker	KCNQ2, KCNQ3, KCNQ4, KCNQ5			Tocris, Tocris	98.43	BRD-K59332007-300-03-5, BRD-K59332007-300-02-7	Phase 3
linsidomine	nitric oxide donor		urology	erectile dysfunction	EMDBio, Cayman	94.73	BRD-K86344238-003-04-6, BRD-K86344238-003-03-8	Launched
linsitinib	IGF-1 inhibitor	IGF1R, INSR, INSRR			Selleck, Selleck	88.41	BRD-K86118762-001-01-8, BRD-K86118762-001-05-9	Phase 3
liothyronine	thyroid hormone stimulant	THRA, THRB	endocrinology	hypothyroidism, myxedema coma	MicroSource, Selleck, Selleck	87.3	BRD-K89152108-236-06-8, BRD-K89152108-236-05-0, BRD-K89152108-236-07-6	Launched
liothyronine-(isomer)					MicroSource	94.02	BRD-K46428823-001-02-5	Preclinical
lipoamide					MicroSource	70.53	BRD-A14440173-001-03-4	Preclinical
liraglutide	GLP receptor agonist	GLP1R	endocrinology	weight-loss aid, diabetes mellitus	MedChemEx	83.15	BRD-A48274390-001-01-8	Launched
liranaftate	fungal squalene epoxidase inhibitor		infectious disease	fungal infection	Selleck	97.22	BRD-K35775715-001-03-1	Launched
lirimilast	phosphodiesterase inhibitor				Enamine	87.13	BRD-K31339321-001-03-6	Phase 2
lisadimate	topical sunscreen agent		dermatology	sunscreen lotion	Sigma	78.91	BRD-A76533773-001-01-9	Launched
lisinopril	angiotensin converting enzyme inhibitor	ACE, ACE2	cardiology, endocrinology	hypertension, congestive heart failure, diabetes mellitus	Selleck, MicroSource, Selleck	100	BRD-K67966701-001-10-8, BRD-K67966701-001-11-6, BRD-K67966701-001-12-4	Launched
lisofylline	interleukin receptor antagonist, STAT inhibitor				Enzo	99.2	BRD-A05334458-001-02-8	Phase 2
lisuride	dopamine receptor agonist	ADRA1A, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR6	neurology/psychiatry	Parkinson's Disease	Enzo	92.31	BRD-K67943528-050-01-4	Launched
lithium-acetoacetate					SantaCruz	0	BRD-K73234506-235-02-1	Preclinical
lithium-citrate			neurology/psychiatry	bipolar disorder, depression	MicroSource, Selleck, Selleck	0	BRD-M41245765-001-04-2, BRD-M41245765-001-05-9, BRD-M41245765-001-03-4	Launched
lithocholic-acid	FXR antagonist, vitamin D receptor agonist	GPBAR1, NR1H4, NR1I2, VDR			Selleck	95.71	BRD-K04497194-001-02-1	Preclinical
litronesib	kinesin-like spindle protein inhibitor	KIF11			MedChemEx	94.34	BRD-K83029223-001-01-3	Phase 2
lixivaptan	vasopressin receptor antagonist	AVPR2			Carbosynth	89.39	BRD-K59391348-001-01-7	Phase 3
LM-22A4	tropomyosin receptor kinase inhibitor	NTRK2			Tocris	98.29	BRD-K70404782-001-01-6	Preclinical
LMI070	survival motor neuron protein modulator	SMN1			MedChemEx	96.89	BRD-K08532119-001-01-5	Phase 1/Phase 2
LMK-235	HDAC inhibitor	HDAC4, HDAC5			Tocris	82.85	BRD-K49921286-001-02-6	Preclinical
LM11A-31	neurotrophic agent	NGFR			Enamine	94.1	BRD-A04649065-001-01-7	Phase 1
lobeline	acetylcholine receptor antagonist	CHRNA10, CHRNA9, SLC18A2	neurology/psychiatry	smoking cessation	MedChemEx, MicroSource, Tocris, Sigma, MedChemEx	65.76	BRD-K66206289-003-22-1, BRD-A65243462-003-04-4, BRD-K66206289-003-20-5, BRD-K66206289-065-01-4, BRD-K66206289-003-21-3	Launched
lobendazole	anthelmintic agent				MicroSource	93.92	BRD-K15834839-001-02-3	Preclinical
lobenzarit	immunosuppressant		rheumatology	rheumatoid arthritis	AKSci	98.34	BRD-K55847762-304-01-7	Launched
lodoxamide	histamine receptor antagonist		ophthalmology	vernal keratoconjunctivitis (VKC)	Prestwick	94.05	BRD-K66937583-001-01-2	Launched
lofemizole	cyclooxygenase inhibitor				AMS	98.71	BRD-K06388517-001-01-2	Phase 3
lofepramine	norepinephrine reuptake inhibitor, serotoninâ€“norepinephrine reuptake inhibitor (SNRI)	HTR1A, SLC6A2, SLC6A4	neurology/psychiatry	depression	Tocris, Key	46.37	BRD-K82147103-001-02-7, BRD-K82147103-003-05-6	Launched
lofexidine	adrenergic receptor agonist	ADRA2A	neurology/psychiatry	opioid withdrawal	Selleck, MicroSource	97.02	BRD-A02990301-003-05-8, BRD-A02990301-003-06-6	Launched
lomefloxacin	bacterial DNA gyrase inhibitor	TOP2A	infectious disease	respiratory tract infections, urinary tract infections	Selleck, MicroSource	98.31	BRD-A75850590-003-09-8, BRD-A75850590-213-01-0	Launched
lomeguatrib	O6-alkylguanine-DNA alkyltransferase inhibitor	MGMT			Selleck, Tocris	97.23	BRD-K27955832-001-02-9, BRD-K27955832-001-05-2	Phase 2
lomerizine	calcium channel blocker	CACNA1B, SCN5A	neurology/psychiatry	migraine headache	MicroSource, Selleck	97.88	BRD-K62858456-001-01-8, BRD-K62858456-300-01-4	Launched
lometrexol	glycinamide ribonucleotide formyltransferase inhibitor	GART, MTHFD1			Cayman	66.91	BRD-K66036108-001-01-9	Phase 2
lomitapide	microsomal trigylceride transfer protein inhibitor	MTTP	endocrinology	hypercholesterolemia	MedChemEx	91.88	BRD-K92213669-001-01-3	Launched
lomustine	DNA synthesis inhibitor	STMN4	hematologic malignancy, oncology	Hodgkin's lymphoma, brain tumors	MedChemEx, MedChemEx, Selleck, Selleck, MicroSource	0	BRD-K51768138-001-10-9, BRD-K51768138-001-09-1, BRD-K51768138-001-04-2, BRD-K51768138-001-07-5, BRD-K51768138-001-05-9	Launched
lonafarnib	farnesyltransferase inhibitor	FNTA, HRAS, KRAS, NRAS			Selleck	97.47	BRD-K41599323-001-02-3	Phase 3
lonidamine	glucokinase inhibitor	GCK			Tocris, MicroSource, Selleck, Tocris	98.47	BRD-K78513633-001-16-5, BRD-K78513633-001-15-7, BRD-K78513633-001-13-2, BRD-K78513633-001-14-0	Launched
loperamide	opioid receptor agonist	CACNA1A, CALM1, OPRD1, OPRK1, OPRM1, POMC	gastroenterology	diarrhea	Tocris, MicroSource, Selleck	98.87	BRD-K61250553-003-30-6, BRD-K61250553-003-32-2, BRD-K61250553-003-29-8	Launched
lopinavir	HIV protease inhibitor		infectious disease	human immunodeficiency virus (HIV-1)	Selleck	98.22	BRD-K99451608-001-07-3	Launched
loracarbef	bacterial cell wall synthesis inhibitor		infectious disease, otolaryngology, pulmonary	ear infections, laryngitis, bronchitis, pneumonia, urinary tract infections, skin infections	Kemprotec, Prestwick	24.5	BRD-A04915500-002-01-3, BRD-K28935038-001-02-2	Launched
loratadine	histamine receptor antagonist	HRH1	allergy, neurology/psychiatry	allergic rhinitis, itching	Tocris, MicroSource, Selleck, Tocris	99.62	BRD-K82795137-001-28-8, BRD-K82795137-001-26-2, BRD-K82795137-001-24-7, BRD-K82795137-001-25-4	Launched
lorazepam	benzodiazepine receptor agonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, TSPO	neurology/psychiatry	status epilepticus	Enzo	98.57	BRD-A11990600-001-03-4	Launched
lorcaserin	serotonin receptor agonist	HTR2A, HTR2B, HTR2C	endocrinology	obesity	Selleck	95.01	BRD-K55013654-003-02-3	Launched
loreclezole	benzodiazepine receptor agonist	GABRB2, GABRB3			Tocris	98.11	BRD-K09659835-003-01-4	Phase 2
lorediplon	GABA receptor modulator	GABRA1			MedChemEx	97.58	BRD-K42066335-001-01-0	Phase 2
lorglumide	CCK receptor antagonist	CCKAR, CCKBR			MicroSource	99.07	BRD-A29854054-236-12-6	Phase 1
lorlatinib	ALK tyrosine kinase receptor inhibitor	ALK			Tocris, MedChemEx	98.73	BRD-K99879819-001-03-9, BRD-K99879819-001-02-1	Phase 2
lornoxicam	cyclooxygenase inhibitor	PTGS1, PTGS2	rheumatology, neurology/psychiatry	osteoarthritis, sciata	Selleck, MicroSource	97.64	BRD-A90551241-001-09-0, BRD-A90551241-001-10-8	Launched
losartan	angiotensin receptor antagonist	AGTR1	cardiology, nephrology	hypertension, diabetic nephropathy	MicroSource, Tocris, Selleck, Pharmeks	97.85	BRD-K76205745-001-06-6, BRD-K76205745-237-19-9, BRD-K76205745-237-16-5, BRD-K76205745-237-18-1	Launched
losmapimod	p38 MAPK inhibitor	MAPK14			MedChemEx	96.05	BRD-K56195681-001-01-0	Phase 3
loteprednol	glucocorticoid receptor agonist, phospholipase inhibitor	NR3C1	ophthalmology	conjunctivitis	Selleck, Selleck	95.55	BRD-K39983086-001-06-1, BRD-K39983086-001-07-9	Launched
lovastatin	HMGCR inhibitor	HDAC2, HMGCR, ITGAL, NR1I2	cardiology, endocrinology	coronary heart disease, myocardial infarction, hypercholesterolemia	Tocris, MicroSource, Selleck, Selleck, Tocris	89.65	BRD-K09416995-001-43-1, BRD-K09416995-001-39-9, BRD-K09416995-001-44-9, BRD-K09416995-001-40-7, BRD-K09416995-001-38-1	Launched
loxapine	dopamine receptor antagonist, serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, ADRB1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR3A, HTR5A, HTR6, HTR7, SLC6A2, SLC6A3, SLC6A4	neurology/psychiatry	schizophrenia	MicroSource, Selleck	98.55	BRD-K39915878-036-25-1, BRD-K39915878-036-24-4	Launched
loxistatin-acid	cysteine peptidase inhibitor	CTSB			Selleck, Selleck	98.39	BRD-K21937671-001-10-0, BRD-K21937671-001-09-2	Preclinical
LOXO-101	tropomyosin receptor kinase inhibitor	NTRK1, NTRK2, NTRK3			MedChemEx	96.12	BRD-K36574127-001-01-3	Phase 2
loxoprofen	cyclooxygenase inhibitor, prostanoid receptor antagonist	PTGS2	neurology/psychiatry	pain relief	MicroSource, MedChemEx	98.61	BRD-A43082555-001-02-9, BRD-A43082555-001-01-1	Launched
LPA2-antagonist-1	lysophosphatidic acid receptor antagonist	LPAR2			MedChemEx	97.22	BRD-K32322923-001-01-7	Preclinical
LRRK2-IN-1	leucine rich repeat kinase inhibitor	LRRK2			Tocris, MedChemEx	98.57	BRD-K01436366-001-22-2, BRD-K01436366-001-20-6	Preclinical
LSN-2463359	glutamate receptor positive allosteric modulator	GRM5			Tocris	96.1	BRD-K79337272-001-01-6	Preclinical
LTA					Enamine	94.91	BRD-K52914072-001-01-5	Phase 2
LTB4	leukocyte activator	LTB4R, LTB4R2			Enzo	8.37	BRD-K53124401-001-03-8	Phase 2
Lu-AA-47070	adenosine receptor antagonist	ADORA2A			Tocris	88.17	BRD-K83970940-001-01-0	Phase 2
lubiprostone	chloride channel activator	CLCN2	gastroenterology	constipation, irritable bowel syndrome	Selleck, Selleck	98.91	BRD-K33814251-001-01-4, BRD-K33814251-001-02-2	Launched
lucitanib	FGFR inhibitor, VEGFR inhibitor	FGFR1, FLT1, KDR, KIT, PDGFRA, PDGFRB, RET			MedChemEx	91.38	BRD-K31309378-001-01-5	Phase 2
LUF-5834	adenosine receptor agonist	ADORA2A, ADORA2B			Tocris	98.27	BRD-K67079690-001-01-2	Preclinical
lufenuron	chitin inhibitor		infectious disease	flea control	MicroSource	97.07	BRD-A71774530-001-05-9	Launched
luliconazole	sterol demethylase inhibitor		infectious disease	tinea pedis, tinea cruris, tinea corporis	Selleck	92.75	BRD-K71058253-001-01-9	Launched
lumacaftor	CFTR channel agonist	CFTR	pulmonary	cystic fibrosis	Selleck	98.26	BRD-K69236721-001-02-7	Launched
lumateperone	serotonin receptor antagonist, dopamine receptor modulator	DRD2, HTR2A			MedChemEx, MedChemEx	81.32	BRD-K10031916-075-02-1, BRD-K10031916-075-01-3	Phase 3
lumefantrine	antimalarial agent	ATP1A1	infectious disease	malaria	MedChemEx, Enamine, MedChemEx	58.57	BRD-A05926236-001-04-6, BRD-A05926236-001-05-3, BRD-A05926236-001-03-8	Launched
lumiracoxib	cyclooxygenase inhibitor	PTGS1, PTGS2			Selleck, MicroSource	97.35	BRD-K26901728-001-05-4, BRD-K26901728-001-06-2	Withdrawn
lupanine	sodium channel blocker	INS			ChemDiv	97.57	BRD-A92826379-001-01-5	Phase 1
lurasidone	dopamine receptor antagonist, serotonin receptor antagonist	ADRA2A, ADRA2C, DRD2, HTR1A, HTR2A, HTR7	neurology/psychiatry	schizophrenia	Selleck	97.97	BRD-K51143828-003-03-1	Launched
lutein	antioxidant		ophthalmology	macular degeneration, cataracts, retinitis pigmentosa (RP)	Sigma, AKSci	0	BRD-K16742848-001-02-6, BRD-K16742848-001-01-8	Launched
luteolin	glucosidase inhibitor	TOP1			Selleck	92.4	BRD-K05236810-001-19-0	Phase 2
luzindole	melatonin receptor antagonist	MTNR1A, MTNR1B			Tocris, Tocris	89.41	BRD-K67013324-001-04-9, BRD-K67013324-001-03-1	Preclinical
LXR-623	LXR agonist	AR, NR1H2, NR1H3, NR1I2, NR3C1			MedChemEx	99.59	BRD-K54520417-001-01-2	Phase 1
LX1031	tryptophan hydroxylase inhibitor	TPH1			MedChemEx	93.2	BRD-K32101625-001-01-6	Phase 2
LX7101	LIM kinase inhibitor, rho associated kinase inhibitor	LIMK2, ROCK1, ROCK2			MedChemEx, MedChemEx	81.88	BRD-K21038058-001-02-7, BRD-K21038058-001-01-9	Phase 1/Phase 2
LY-404187	glutamate receptor positive allosteric modulator	GRIA1, GRIA2, GRIA3, GRIA4			Tocris	90.87	BRD-A50062753-001-01-3	Preclinical
lycopene	free radical scavenger				AKSci	0	BRD-K37083340-001-02-3	Phase 3
lylamine	cannabinoid receptor agonist	CNR1			Tocris	69.31	BRD-K62289640-003-02-7	Preclinical
lymecycline	bacterial 50S ribosomal subunit inhibitor		dermatology	acne vulgaris (AV)	Prestwick	0	BRD-A15750551-001-01-1	Launched
lynestrenol	progestogen hormone		endocrinology	contraceptive	Prestwick, Sigma	0	BRD-K39707084-001-04-1, BRD-K39707084-001-05-8	Launched
lypressin	vasopressin receptor agonist	AVPR1A, AVPR1B, AVPR2			Apollo	70.31	BRD-K93331255-001-02-0	Launched
LY2090314	glycogen synthase kinase inhibitor	GSK3B			MedChemEx	98.37	BRD-K78055238-001-01-8	Phase 2
LY2109761	TGF beta receptor inhibitor	TGFBR1, TGFBR2			Selleck	98.4	BRD-K47557313-001-02-7	Preclinical
LY2140023	glutamate receptor agonist	GRM3			Selleck, Selleck	100	BRD-K49519144-001-04-6, BRD-K49519144-001-03-8	Phase 3
LY215490	glutamate receptor antagonist	GRIA1, GRIA2, GRIA3, GRIA4, GRIK1			MedChemEx	100	BRD-K34313798-001-01-6	Phase 1
LY2157299	TGF beta receptor inhibitor	TGFBR1			Selleck	97.81	BRD-K78118466-001-03-3	Phase 2/Phase 3
LY2183240	FAAH inhibitor, FAAH reuptake inhibitor	FAAH			Tocris, Tocris	95.78	BRD-K37865504-001-04-1, BRD-K37865504-001-05-8	Preclinical
LY2228820	p38 MAPK inhibitor	MAPK14			Selleck, Selleck	94.21	BRD-K59227464-334-03-2, BRD-K59227464-334-02-4	Phase 2
LY223982	leukotriene receptor antagonist	LTB4R			Cayman	95.19	BRD-K35367061-001-01-1	Phase 2
LY225910	CCK receptor antagonist	CCKBR			Tocris, Tocris	98.13	BRD-K33864865-001-03-3, BRD-K33864865-001-02-5	Preclinical
LY231617	lipid peroxidase inhibitor				Otava	90.52	BRD-K85804405-003-01-3	Preclinical
LY2334737	antitumor agent, ribonucleotide reductase inhibitor				MedChemEx	95.83	BRD-K04993719-001-01-7	Phase 1
LY2365109	Glycine transporter 1 inhibitor	SLC6A9			Tocris, Tocris	97.65	BRD-K13888115-003-02-2, BRD-K13888115-003-03-0	Preclinical
LY2452473	androgen receptor modulator	AR			Sigma	82.38	BRD-K90171280-001-01-4	Phase 2
LY255283	leukotriene receptor antagonist	LTB4R, LTB4R2			Tocris, Tocris	97.51	BRD-K92492521-001-02-9, BRD-K92492521-001-03-7	Preclinical
LY2584702	ribosomal protein inhibitor	RPS6KB1			Adooq, Selleck	98.81	BRD-K21833260-075-02-9, BRD-K21833260-075-01-1	Phase 1
LY2603618	CHK inhibitor	CHEK1			Selleck, Selleck	86.32	BRD-K14109347-001-05-9, BRD-K14109347-001-03-4	Phase 2
LY2606368	CHK inhibitor	CHEK1			MedChemEx, MedChemEx	97.06	BRD-K20463415-300-01-4, BRD-K20463415-001-01-8	Phase 2
LY2608204	glucokinase activator	GCK			MedChemEx, Selleck, Selleck	94.33	BRD-K12068470-001-03-3, BRD-K12068470-001-02-5, BRD-K12068470-001-04-1	Phase 2
LY266097	serotonin receptor antagonist	HTR2B			Tocris	94.79	BRD-A64004759-003-01-9	Preclinical
LY2784544	JAK inhibitor	JAK2, JAK3			Selleck	91.48	BRD-K25630527-001-03-8	Phase 2
LY2801653	MET inhibitor	MET			MedChemEx	99.53	BRD-K18961567-001-01-1	Phase 2
LY2811376	beta-secretase inhibitor	BACE1			Selleck	96.96	BRD-K94534639-001-02-5	Phase 1
LY2857785	CDK inhibitor	CDK9			MedChemEx	91.94	BRD-K15382985-001-01-7	Preclinical
LY2874455	FGFR antagonist	FGFR1, FGFR2, FGFR3, FGFR4, KDR			MedChemEx	90.03	BRD-K17203476-001-01-9	Phase 1
LY288513	CCK receptor antagonist	CCKBR			Tocris	4.58	BRD-K24675965-001-04-1	Preclinical
LY2886721	beta-secretase inhibitor	BACE1			Selleck	97.19	BRD-K17953908-001-01-7	Phase 1/Phase 2
LY294002	mTOR inhibitor, PI3K inhibitor, DNA dependent protein kinase inhibitor, phosphodiesterase inhibitor, PLK inhibitor	AKT1, CHEK1, GSK3B, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PLK1, PRKCA, PRKDC, ROCK1, RPS6KB1, SGK1			Selleck, Tocris, Tocris	96.09	BRD-K27305650-001-16-6, BRD-K27305650-003-03-0, BRD-K27305650-003-02-2	Preclinical
LY2979165	glutamate receptor agonist	GRM2			MedChemEx, MedChemEx	97.2	BRD-K68220839-413-02-8, BRD-K68220839-413-01-0	Phase 1
LY3000328	cathepsin inhibitor	CTSS			MedChemEx	96.06	BRD-K21070437-001-01-4	Phase 1
LY3009120	RAF inhibitor	BRAF, RAF1			MedChemEx, Selleck	95.74	BRD-K38385169-001-04-5, BRD-K38385169-001-03-7	Phase 1
LY3023414	PI3K inhibitor, mTOR inhibitor	MTOR			MedChemEx	96.51	BRD-K82967180-001-01-6	Phase 2
LY303511	casein kinase inhibitor, mTOR inhibitor, PI3K inhibitor	BRD2, BRD3, BRD4			Tocris, Tocris	95.92	BRD-K22385716-001-02-5, BRD-K22385716-001-03-3	Preclinical
LY310762	serotonin receptor antagonist	HTR1D			MedChemEx	97.19	BRD-K41194171-003-09-7	Preclinical
LY320135	cannabinoid receptor antagonist	CNR1			Tocris	98.54	BRD-K78637815-001-02-2	Preclinical
LY344864	serotonin receptor agonist	HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR7			Tocris, Tocris	86.9	BRD-K95899059-003-02-8, BRD-K95899059-003-03-6	Preclinical
LY364947	TGF beta receptor inhibitor, p38 MAPK inhibitor	TGFBR1			Tocris, Selleck, Tocris	96.57	BRD-K06234293-001-04-2, BRD-K06234293-001-03-4, BRD-K06234293-001-05-9	Preclinical
LY393558	serotonin receptor antagonist	HTR1B, HTR1D, HTR2A, HTR2B			Tocris	15.46	BRD-K08534264-001-01-4	Preclinical
LY411575	gamma secretase inhibitor				Selleck	97.33	BRD-K20013301-001-02-6	Preclinical
LY450108	glutamate receptor modulator				MedChemEx	94.81	BRD-K54538117-001-01-7	Phase 1
LY456236	glutamate receptor antagonist	GRM1			Tocris, Tocris	97.15	BRD-K87696786-003-04-4, BRD-K87696786-003-05-1	Preclinical
m-Chlorophenylbiguanide		HTR3A, HTR3B			Tocris	93.77	BRD-K36965586-003-08-8	Preclinical
m-THP					FrontierSci	88.76	BRD-K91147684-001-01-5	Phase 1
M-14157	ATP-sensitive potassium channel antagonist	KCNQ1			Enzo	0	BRD-A96977263-001-03-7	Phase 2
M-25	smoothened receptor antagonist	DHH, IHH, SMO			Tocris	98.33	BRD-K51265828-001-01-0	Preclinical
m-3M3FBS		PLCB2, PLCB3, PLCD1, PLCG1, PLCG2			Tocris, Tocris	98.86	BRD-K09635314-001-04-2, BRD-K09635314-001-03-4	Preclinical
M-344	HDAC inhibitor				Selleck, Selleck, Tocris	97.25	BRD-K45528773-001-07-2, BRD-K45528773-001-06-4, BRD-K45528773-001-08-0	Preclinical
mabuprofen	cyclooxygenase inhibitor		neurology/psychiatry	pain relief	Enamine	91.14	BRD-A93683007-001-01-9	Launched
mabuterol	adrenergic receptor agonist	ADRB2			Sigma	98.26	BRD-A13116749-003-01-6	Launched
macelignan	antioxidant, antiinflammatory agent				MedChemEx	97.67	BRD-K94948151-001-07-4	Preclinical
macitentan	endothelin receptor antagonist	EDNRA, EDNRB	endocrinology	contraceptive	Selleck, Selleck	90.02	BRD-K48812570-001-02-3, BRD-K48812570-001-03-1	Launched
madrasin	cell splicing inhibitor				PrincetonBio	93.78	BRD-K48905682-001-11-1	Preclinical
mafenide	carbonic anhydrase inhibitor	CA12, CA14, CA2, CA4, CA6, CA9	infectious disease	first-aid antibiotic, skin infections	MicroSource	100	BRD-K30649484-003-13-7	Launched
magnolol	PPAR receptor agonist	GABRA1, PPARG			Selleck	93.11	BRD-K26168087-001-09-7	Preclinical
malathion	cholinesterase inhibitor	ACHE, BCHE	infectious disease	lice	MedChemEx, MicroSource, MedChemEx	78.47	BRD-A01976766-001-06-8, BRD-A01976766-001-04-3, BRD-A01976766-001-07-6	Launched
malic-acid		CS, ME2, PKD2L1			Enamine, Enamine	100	BRD-A18396475-001-16-1, BRD-A18396475-001-15-3	Launched
malotilate	protein synthesis stimulant		gastroenterology	hepatic cirrhosis	Selleck	96.64	BRD-K97884852-001-05-4	Launched
maltobionic-acid	matrix metalloprotease inhibitor		dermatology	cosmetic	CombiBlocks	97.5	BRD-K01624185-001-05-7	Launched
mandelic-acid					Enamine	0	BRD-A91448670-001-06-4	Launched
mangafodipir	contrast agent		radiology	contrast agent	MicroSource, MedChemEx	0	BRD-K57365211-314-01-4, BRD-K57365211-314-02-2	Launched
manidipine	calcium channel blocker	CACNA1C, CACNA1D	cardiology	hypertension	MicroSource, Selleck, Selleck, Selleck	98.86	BRD-A90695733-001-07-4, BRD-A90695733-300-02-1, BRD-A90695733-001-06-6, BRD-A90695733-001-08-2	Launched
mannitol-D	diuretic		neurology/psychiatry, ophthalmology, gastroenterology	intracranial pressure, intraocular pressure, constipation	MicroSource, Selleck	100	BRD-K66035042-001-11-9, BRD-K30374899-001-09-3	Launched
maprotiline	norepinephrine reputake inhibitor, tricyclic antidepressant	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A, HTR2C, HTR7, SLC6A2	neurology/psychiatry	depression, dysthymic disorder	Selleck, Tocris, MicroSource	96.89	BRD-K25433859-003-23-9, BRD-K25433859-003-24-7, BRD-K25433859-003-25-4	Launched
maraviroc	CC chemokine receptor antagonist	CCR5	infectious disease	human immunodeficiency virus (HIV-1)	Tocris, Selleck	95.18	BRD-A04352665-001-06-1, BRD-A04352665-001-05-3	Launched
marbofloxacin	bacterial DNA gyrase inhibitor		infectious disease	gram-negative bacterial infections	Selleck, Selleck, MicroSource	99.41	BRD-K71926323-001-14-6, BRD-K71926323-001-12-0, BRD-K71926323-001-13-8	Launched
maribavir	cytomegalovirus inhibitor, protein kinase inhibitor	PYGM			MedChemEx	94.38	BRD-K59524082-001-01-3	Phase 3
marimastat	matrix metalloprotease inhibitor	MMP1, MMP10, MMP11, MMP12, MMP13, MMP14, MMP15, MMP16, MMP17, MMP19, MMP2, MMP20, MMP21, MMP23A, MMP24, MMP25, MMP26, MMP27, MMP28, MMP3, MMP7, MMP8, MMP9			MedChemEx	92.47	BRD-K21396683-001-04-8	Phase 3
maropitant	neurokinin receptor antagonist	TACR1	gastroenterology	vomiting	MedChemEx	97.11	BRD-K76594255-001-01-6	Launched
masitinib	KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor	FGFR3, KIT, PDGFRA, PDGFRB	dermatology	mastocytoma	Selleck, Selleck	92.11	BRD-K71035033-001-08-9, BRD-K71035033-001-07-1	Launched
masoprocol	lipoxygenase inhibitor	ALOX5	dermatology	actinic keratosis (AK)	Enzo	89.52	BRD-A87130939-001-07-9	Launched
matrine	opioid receptor agonist	OPRK1			Selleck	92.78	BRD-K25312248-001-01-5	Phase 2
mavoglurant	glutamate receptor antagonist	GRM5			MedChemEx	93	BRD-K07790550-001-01-6	Phase 2
maxacalcitol	vitamin D receptor agonist	VDR	endocrinology	hyperparathyroidism	MedChemEx	95.36	BRD-K81332461-001-01-4	Launched
maytansinol-isobutyrate					MedChemEx	78.12	BRD-K15898725-001-01-7	Preclinical
mazindol	dopamine reuptake inhibitor, selective serotonin reuptake inhibitor (SSRI)	SLC6A2, SLC6A3, SLC6A4	genetics	duchenne muscular dystrophy (DMD)	MedChemEx	96.3	BRD-A68464583-001-02-5	Launched
MBX-2982	glucose dependent insulinotropic receptor agonist	GPR119			MedChemEx	98.92	BRD-K32218650-001-01-6	Phase 2
MC-1		AADAT, ABAT, AGXT, AGXT2, ALAS1, AZIN2, BCAT1, BCAT2, CBS, CCBL1, CCBL2, CSAD, CTH, DDC, FTCD, GAD1, GAD2, GADL1, GCAT, GLDC, GOT1, GOT2, GPT, GPT2, HDC, IGSF10, KYNU, MOCOS, NFS1, OAT, ODC1, PDXDC1, PDXP, PHYKPL, PNPO, PROSC, PSAT1, PYGB, PYGL, PYGM, SCLY, SDS, SDSL, SEPSECS, SGPL1, SHMT1, SHMT2, SPTLC1, SPTLC2, SPTLC3, SRR, TAT, THNSL1			Vitas-M, Sigma	0	BRD-K50712474-001-02-7, BRD-K50712474-002-02-5	Phase 3
MCC950	NOD like receptor inhibitor	NLRP3			MedChemEx, MedChemEx	37.23	BRD-K55418700-001-03-0, BRD-K55418700-001-02-2	Preclinical
McN-5652-(+/-)	selective serotonin reuptake inhibitor (SSRI)				Tocris	26.5	BRD-K31168993-001-02-8	Preclinical
MCOPPB	nociceptin/orphanin FQ (NOP) receptor agonist	OPRL1			Tocris	96.23	BRD-K73276278-305-01-1	Preclinical
mCPP	serotonin receptor agonist	HTR1A, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR6			Enzo	95.44	BRD-K75844781-003-08-0	Phase 2
MC1568	HDAC inhibitor	HDAC2			Selleck, MedChemEx, Selleck	89.02	BRD-K24031866-001-02-1, BRD-K24031866-001-03-9, BRD-K24031866-001-01-3	Preclinical
MD-920	NFkB pathway inhibitor	AADACL2			Enzo	96.77	BRD-K92758126-001-18-8	Phase 1
mdivi-1	dynamin inhibitor	DNM1			Selleck, Selleck	97.44	BRD-K61128465-001-09-9, BRD-K61128465-001-10-7	Preclinical
MDL-11939	serotonin receptor antagonist	HTR2A, HTR2B, HTR2C			Tocris, Tocris	98.53	BRD-A62057054-001-04-9, BRD-A62057054-001-03-1	Phase 2
MDL-27531	glycine receptor agonist				Otava	84.16	BRD-K50888640-001-01-6	Preclinical
MDL-29951	glutamate receptor antagonist	FBP1			MedChemEx	96.68	BRD-K59753853-001-02-3	Preclinical
MDL-72832	serotonin receptor agonist	HTR1A			Tocris	96.3	BRD-A17453586-003-02-3	Preclinical
MDL-73005EF	serotonin receptor antagonist	HTR1A			Tocris	96.76	BRD-A50764878-003-02-8	Phase 1
MDMS	DNA inhibitor				Enamine	0	BRD-K70840370-001-01-9	Phase 2
ME-0328	PPAR receptor antagonist	PARP3			Tocris	97.84	BRD-K24283677-001-01-9	Preclinical
mebendazole	tubulin polymerization inhibitor	TUBA1A, TUBB, TUBB4B	infectious disease	pinworm, whipworm, hookworm, ascariasis	MicroSource	96.72	BRD-K77987382-001-13-2	Launched
mebeverine	acetylcholine receptor antagonist	CHRM1	gastroenterology	irritable bowel syndrome	MicroSource	95.24	BRD-A09467419-003-22-4	Launched
mebhydrolin	antihistamine		allergy	allergic rhinitis, urticaria	MicroSource	90.08	BRD-K29713308-001-01-7	Launched
mebhydroline-1,5-naphtalenedisulfonate					Prestwick	93.45	BRD-K29713308-077-04-1	Preclinical
mebicar	anxiolytic		neurology/psychiatry	anxiety	ChemDiv	94.75	BRD-K76606751-001-01-7	Launched
mebrofenin			radiology	diagnostic agent	Sigma	69.8	BRD-K96691275-001-01-2	Launched
mecamylamine	acetylcholine receptor antagonist	CHRNA1, CHRNA2, CHRNA3, CHRNA4, CHRNA6, CHRNA7	cardiology	hypertension	MicroSource	100	BRD-A20119038-003-07-8	Launched
mecarbinate					Selleck	97.97	BRD-K28405228-001-06-7	Preclinical
mechlorethamine	DNA inhibitor		hematologic malignancy, hematology, infectious disease, oncology	Hodgkin's lymphoma, chronic myeloid leukemia (CML), chronic lymphocytic leukemia (CLL), polycythemia vera, mycosis, bronchogenic carcinoma	MedChemEx, Selleck, MedChemEx, MicroSource, Selleck	21.94	BRD-K12829205-003-05-1, BRD-K12829205-003-02-8, BRD-K12829205-003-04-4, BRD-K12829205-001-04-8, BRD-K12829205-003-03-6	Launched
meclinertant	neurotensin receptor antagonist	NTSR1, NTSR2			Sigma	98.44	BRD-K25075681-001-02-0	Phase 2/Phase 3
meclizine	constitutive androstane receptor (CAR) agonist	HRH1, NR1I3	gastroenterology, neurology/psychiatry	nausea, vomiting, motion sickness	Tocris, Selleck, MicroSource	97.63	BRD-A50311610-300-11-2, BRD-A50311610-300-09-6, BRD-A50311610-300-10-4	Launched
meclocycline-sulfosalicylate	bacterial 50S ribosomal subunit inhibitor		dermatology, infectious disease	acne vulgaris (AV), skin infections	MicroSource, DuPont, Selleck	82.79	BRD-A07600638-060-05-2, BRD-A07600638-060-06-0, BRD-A07600638-060-04-5	Launched
meclofenamic-acid	cyclooxygenase inhibitor, prostanoid receptor antagonist	ALOX5, CNR1, KCNQ2, KCNQ3, PTGS1, PTGS2	rheumatology, neurology/psychiatry, endocrinology	joint pain, muscle pain, rheumatoid arthritis, primary dysmenorrhea (PD)	MicroSource	98.55	BRD-K50398167-236-22-7	Launched
meclofenoxate	nootropic agent		neurology/psychiatry	senile dementia, Alzheimer's disease	MicroSource	87.92	BRD-K10314788-003-12-7	Launched
mecysteine	analgesic agent		pulmonary	chest congestion	MicroSource	12.39	BRD-A77473570-003-04-2	Launched
medetomidine	adrenergic receptor agonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C	neurology/psychiatry	sedative	Selleck, Tocris, Tocris	98.61	BRD-A21607826-003-04-4, BRD-A21607826-003-06-9, BRD-A21607826-003-05-1	Launched
medica-16	ATP citrase lyase inhibitor	FFAR1			Cayman	98.1	BRD-K92908289-001-01-8	Phase 2
medorinone					Key	97.74	BRD-K40715924-001-01-1	Phase 1
medronic-acid	bone resorption inhibitor		radiology	skeletal imaging agent	Sigma	98.4	BRD-K94072573-001-09-9	Launched
medroxyprogesterone	progesterone receptor agonist	ESR1, PGR	endocrinology	contraceptive	MedChemEx	95.16	BRD-K99615199-001-18-5	Launched
medroxyprogesterone-acetate	progesterone receptor agonist		endocrinology	contraceptive	Selleck, MicroSource	95.9	BRD-A61221616-001-05-0, BRD-A61221616-001-04-3	Launched
medrysone	glucocorticoid receptor agonist	NR3C1	ophthalmology	conjunctivitis, episcleritis	Selleck, MicroSource	95.45	BRD-A59014912-001-01-3, BRD-K56515112-001-21-6	Launched
mefenamic-acid	cyclooxygenase inhibitor	KCNQ1, PTGS1, PTGS2, TRPM3	endocrinology	primary dysmenorrhea (PD)	MicroSource, Selleck	99.01	BRD-K92778217-001-32-7, BRD-K92778217-001-31-9	Launched
mefexamide	psychoactive drug				MicroSource	99.12	BRD-K20655524-003-12-0	Preclinical
mefloquine	adenosine receptor antagonist, hemoglobin antagonist	ADORA2A, HBA1	infectious disease	malaria	MicroSource	88.97	BRD-A89585551-003-16-6	Launched
megestrol-acetate	progesterone receptor agonist	NR3C1, PGR	neurology/psychiatry, endocrinology	anorexia, cachexia	Selleck, Selleck, MicroSource	98.58	BRD-K19507340-001-22-1, BRD-K19507340-001-25-4, BRD-A35989968-001-04-2	Launched
meglitinide	potassium channel blocker	CCR2			Enamine	99.32	BRD-K51324732-001-01-0	Phase 2
meglumine	excipient				MicroSource, Selleck, Selleck	100	BRD-K28595280-001-04-5, BRD-K28595280-001-03-7, BRD-K28595280-001-05-2	Launched
meglutol	HMGCR inhibitor	HMGCR			MicroSource	0	BRD-K00495673-001-05-2	Launched
meisoindigo	STAT inhibitor	STAT3			MedChemEx	97.04	BRD-K14529030-001-01-9	Phase 3
MEK1-2-inhibitor	MEK inhibitor	MAP2K2			Tocris, Selleck	95.74	BRD-K12244279-001-05-8, BRD-K12244279-001-04-1	Preclinical
MEK162	MEK inhibitor	MAP2K1, MAP2K2			Selleck	94.6	BRD-K82244583-001-01-3	Phase 3
melatonin	melatonin receptor agonist, nitric oxide synthase inhibitor	ASMT, CALM1, CALR, EPX, ESR1, HTR2B, MPO, MTNR1A, MTNR1B, NQO2, RORB	neurology/psychiatry	sleep cycle support	Tocris, Tocris, Selleck	95.68	BRD-K97530723-001-20-9, BRD-K97530723-001-24-1, BRD-K97530723-001-19-1	Launched
meldonium	gamma butyrobetaine hydroxylase inhibitor	BBOX1	cardiology	coronary artery disease (CAD)	LifeChem	60.9	BRD-K79392608-335-01-8	Launched
melengestrol-acetate	progesterone receptor agonist				MicroSource	86.88	BRD-A42746051-001-02-9	Preclinical
melevodopa	dopamine precursor, dopamine receptor agonist	DDC	neurology/psychiatry	Parkinson's Disease	Vitas-M, Sigma	88.63	BRD-A25827085-001-01-0, BRD-K18749874-003-08-9	Launched
meloxicam	cyclooxygenase inhibitor	PTGS1, PTGS2	rheumatology	osteoarthritis, rheumatoid arthritis	MicroSource, Sigma, Selleck	99.09	BRD-A84174393-236-07-1, BRD-A84174393-323-07-7, BRD-A84174393-001-34-3	Launched
melperone	dopamine receptor antagonist, serotonin receptor antagonist	DRD2, HTR2A	neurology/psychiatry	psychosis	Tocris, Tocris	96.46	BRD-K92984783-003-05-7, BRD-K92984783-003-06-5	Launched
melphalan	DNA alkylating agent, DNA inhibitor		hematologic malignancy	multiple myeloma	MicroSource, MicroSource	93.38	BRD-K87827419-001-16-8, BRD-K87827419-001-14-3	Launched
melphalan-n-oxide	hypoxia inducible factor inhibitor	HIF1A			Adooq	67.76	BRD-K36394566-300-01-0	Phase 1
meluadrine					MedChemEx	98.2	BRD-A07164067-001-01-2	Preclinical
memantine	glutamate receptor antagonist	CHRFAM7A, DRD2, GRIN1, GRIN2A, GRIN2B, GRIN3A, HTR3A	neurology/psychiatry	Alzheimer's disease, senile dementia	Selleck, Tocris, MicroSource	100	BRD-A79803969-003-16-1, BRD-A79803969-003-17-9, BRD-A79803969-003-18-7	Launched
menadione	mitochondrial DNA polymerase inhibitor, phosphatase inhibitor	AOX1, BGLAP, F10, F2, F7, F9, GGCX, NQO1, NQO2, PROC, PROS1, PROZ, VKORC1, VKORC1L1	gastroenterology, neurology/psychiatry, dermatology, rheumatology	ulcerative colitis, diarrhea, headache, varicose veins, rheumatoid arthritis	Selleck, Selleck, MicroSource	98.17	BRD-K78126613-001-27-7, BRD-K78126613-001-29-3, BRD-K78126613-001-28-5	Launched
menadione-bisulfite	vitamin K	GGCX, VKORC1, VKORC1L1			Sigma	98.12	BRD-A19777893-236-01-9	Phase 2
menatetrenone	bone resorption inhibitor		orthopedics	osteoporosis	Sigma	48.49	BRD-K75864342-001-14-2	Launched
menbutone			gastroenterology	bile stimulation	MicroSource	93.68	BRD-K53852914-001-01-8	Launched
mepacrine	cytokine production inhibitor, NFkB pathway inhibitor, TP53 activator	PLA2G1B, PLA2G4A, PLA2G6, PLCL1	infectious disease	giardiasis	Selleck, MicroSource, Selleck	95.48	BRD-A45889380-300-06-3, BRD-A45889380-300-07-1, BRD-A45889380-300-08-9	Launched
meparfylon					MicroSource	0	BRD-A11662333-001-03-3	Preclinical
mepazine	MALT1 inhibitor (JH)	MALT1			ChemDiv	90.48	BRD-A82772293-001-03-2	Phase 2
mepenzolate	acetylcholine receptor antagonist	CHRM1, CHRM3	gastroenterology	peptic ulcer disease (PUD)	MicroSource, Selleck	99.17	BRD-A62421304-004-18-9, BRD-A62421304-004-17-1	Launched
mephenesin	muscle relaxant		neurology/psychiatry	muscle relaxant	MicroSource	99.05	BRD-A55469827-001-07-4	Launched
mephentermine	adrenergic receptor agonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3	cardiology	hypotension	MicroSource	93.01	BRD-K18194590-065-08-0	Launched
mephenytoin	hydantoin antiepileptic	SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	neurology/psychiatry	seizures	MicroSource	98.67	BRD-A83937277-001-10-5	Launched
mepiroxol					Selleck, MicroSource	98.37	BRD-K78299798-001-02-2, BRD-K78299798-001-03-0	Preclinical
mepivacaine	potassium channel blocker, sodium channel blocker	SCN10A	neurology/psychiatry	local anesthetic	MicroSource, Selleck	97.82	BRD-A03216249-003-24-3, BRD-A03216249-003-23-5	Launched
meprednisone		NR3C1			Selleck, Selleck	0.53	BRD-K18207669-001-02-4, BRD-K81190290-001-01-3	Launched
meprobamate		GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ	neurology/psychiatry	anxiety	Enzo	91.41	BRD-K19180152-001-02-6	Launched
meprylcaine	local anesthetic				MicroSource	83.5	BRD-K65417056-003-10-1	Preclinical
meptazinol	opioid receptor agonist	BCHE	neurology/psychiatry	pain relief	Tocris, Selleck, Selleck	94.08	BRD-A02710418-003-13-4, BRD-A02710418-003-12-6, BRD-A02710418-003-11-8	Launched
mepyramine	histamine receptor antagonist	HRH1	otolaryngology, obstetrics/gynecology	common cold, menstrual pain	Selleck, MicroSource, Tocris	99.13	BRD-K97564742-051-02-8, BRD-K97564742-050-32-7, BRD-K97564742-050-31-9	Launched
mequinol		TYR	dermatology	skin depigmentation	MicroSource, Selleck, Selleck	99.23	BRD-K45216060-001-10-0, BRD-K45216060-001-09-2, BRD-K45216060-001-11-8	Launched
merbarone	topoisomerase inhibitor	TOP2A			EMDBio	100	BRD-K45152786-001-08-4	Phase 2
merbromin	antiseptic		infectious disease	first-aid antiseptic	MicroSource	0	BRD-K21771665-304-04-2	Launched
mercaptopurine	immunosuppressant, protein synthesis inhibitor, purine antagonist	HPRT1, IMPDH1, IMPDH2, PPAT	hematologic malignancy	acute lymphoblastic leukemia (ALL)	Selleck, MicroSource	100	BRD-K91601245-001-12-0, BRD-K91601245-001-13-8	Launched
mercaptosuccinic-acid					Enamine, Enamine	100	BRD-A43435802-001-01-2, BRD-A43435802-001-02-0	Launched
mericitabine	HCV inhibitor				MedChemEx	98	BRD-K69726595-001-01-2	Phase 2
merimepodib	inosine monophosphate dehydrogenase inhibitor	IMPDH1			MedChemEx	98.21	BRD-K09372874-001-01-0	Phase 2
meropenem	bacterial cell wall synthesis inhibitor		infectious disease	skin infections, intra-abdominal infections, meningitis	Selleck, Key, Selleck, MicroSource	23.73	BRD-K01612348-001-12-2, BRD-K01612348-001-11-4, BRD-K01612348-001-13-0, BRD-K01612348-001-14-8	Launched
mesalazine	cyclooxygenase inhibitor, lipoxygenase inhibitor, prostanoid receptor antagonist	ALOX5, CHUK, IKBKB, MPO, PPARG, PTGS1, PTGS2	gastroenterology	ulcerative colitis, inflammatory bowel disease	Selleck, MicroSource, Selleck	90.1	BRD-K28849549-001-13-4, BRD-K28849549-001-12-6, BRD-K28849549-001-11-8	Launched
mesna	antioxidant		urology	hemorrhagic cystitis	Selleck, Selleck, MicroSource	92.74	BRD-K49954789-001-03-7, BRD-K49954789-001-01-1, BRD-K49954789-001-02-9	Launched
mesoridazine	dopamine receptor antagonist	DRD2, HTR2A	neurology/psychiatry	schizophrenia	MicroSource, Selleck, Selleck	90.35	BRD-A14395271-074-17-8, BRD-A14395271-074-16-0, BRD-A14395271-074-18-6	Launched
mestinon	cholinesterase inhibitor	ACHE, BCHE	neurology/psychiatry	myasthenia gravis	MicroSource, Selleck	98.82	BRD-K69688083-004-23-1, BRD-K69688083-004-22-3	Launched
mestranol	estrogen receptor agonist	ESR1	endocrinology	contraceptive	Selleck, MicroSource	98.35	BRD-K31920458-001-22-8, BRD-K31920458-001-23-6	Launched
mesulergine	dopamine receptor agonist	HTR2A, HTR2B, HTR2C, HTR3A, HTR3B, HTR6, HTR7			Enzo	94.81	BRD-K91336023-003-01-0	Phase 2
meta-cresyl-acetate					MicroSource	0	BRD-K33442414-001-02-6	Preclinical
metacetamol	analgesic agent				MicroSource	99.02	BRD-K16474819-001-09-6	Preclinical
metacresol		INS			MicroSource	96.37	BRD-K22518984-001-01-8	Launched
metafolin		AMT			MedChemEx, MedChemEx, MedChemEx	67.8	BRD-K28580965-238-03-9, BRD-K28580965-238-01-3, BRD-K28580965-238-02-1	Launched
metamizole	cyclooxygenase inhibitor, opioid receptor agonist	PTGS1			MicroSource	93.08	BRD-K76812510-236-14-8	Withdrawn
metaphit	phencyclidine receptor acylator				Tocris	12.3	BRD-K95701999-001-02-3	Preclinical
metaproterenol	adrenergic receptor agonist	ADRB2	pulmonary	bronchospasm, asthma, bronchitis, emphysema	Selleck, MicroSource, Selleck	90.17	BRD-A07780951-065-09-2, BRD-A07780951-001-08-9, BRD-A07780951-065-10-0	Launched
metaraminol	adrenergic receptor agonist	ADRA1A	cardiology	hypotension	MicroSource, Selleck, Selleck	95.01	BRD-K96253961-046-04-9, BRD-K96253961-046-05-6, BRD-K96253961-046-03-1	Launched
metatinib	Bcr-Abl kinase inhibitor	ABL1, BCR			Selleck	98.07	BRD-K27182532-001-02-3	Phase 1
metaxalone	muscle relaxant		neurology/psychiatry	muscle pain	MicroSource	99.54	BRD-A94709349-001-08-3	Launched
metazosin	adrenergic receptor antagonist	ADRA1A			Sigma	98.7	BRD-A78277353-001-01-9	Phase 2
metenkephalin	immunostimulant	OPRD1			MPBio	91.27	BRD-A38218502-001-01-2	Phase 2
metergoline	dopamine receptor agonist, serotonin receptor antagonist	HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7			Tocris, MicroSource, Tocris	94	BRD-K56699285-001-24-3, BRD-A72309220-001-04-1, BRD-K56699285-001-23-5	Launched
metformin	insulin sensitizer	ACACB, PRKAB1	endocrinology	diabetes mellitus	Selleck, MicroSource, Tocris	93.76	BRD-K79602928-003-18-1, BRD-K79602928-003-19-9, BRD-K79602928-003-21-5	Launched
methacholine	acetylcholine receptor agonist	CHRM2, CHRM3, CHRM4	pulmonary	bronchial hyperresponsiveness diagnostic	MicroSource	98.32	BRD-A18056626-003-22-3	Launched
methacycline	protein synthesis inhibitor		pulmonary	bronchitis	MedChemEx, Selleck, Selleck, MicroSource	90.63	BRD-A49035384-003-29-7, BRD-A49035384-003-28-9, BRD-A49035384-003-30-5, BRD-A49035384-003-27-1	Launched
methanesulfonyl-fluoride	acetylcholinesterase inhibitor	ACHE			Sigma	0	BRD-K53896891-001-01-2	Phase 2
methantheline	acetylcholine receptor antagonist	CHRM1, HRH2	gastroenterology, neurology/psychiatry, urology	peptic ulcer disease (PUD), irritable bowel syndrome, pancreatitis, dyskinesia, neurogenic bladder	Prestwick	53.05	BRD-K09859624-004-10-4	Launched
methapyrilene	histamine receptor antagonist	HRH1			MicroSource, Selleck	93.74	BRD-K47323024-003-25-1, BRD-K47323024-003-24-4	Withdrawn
metharbital	GABA receptor modulator	CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2	neurology/psychiatry	epilepsy	Enamine	99.64	BRD-K88143662-001-01-5	Launched
methazolamide	carbonic anhydrase inhibitor	CA1, CA12, CA14, CA2, CA4, CA7	ophthalmology	glaucoma, intraocular pressure	MicroSource, Selleck, Selleck	98.57	BRD-K13356952-001-26-9, BRD-K13356952-001-25-1, BRD-K13356952-001-27-7	Launched
methenamine	bacterial DNA inhibitor		infectious disease	urinary tract infections	Selleck, MicroSource	100	BRD-K30114692-001-15-9, BRD-K30114692-001-16-7	Launched
methiazole	anthelmintic agent				Prestwick	95.06	BRD-K02764365-001-13-6	Preclinical
methicillin	bacterial cell wall synthesis inhibitor				Sigma, MicroSource	85.33	BRD-K34388247-236-09-0, BRD-K34388247-236-08-2	Launched
methimazole	antithyroid agent	TPO	endocrinology	hyperthyroidism	Selleck, MicroSource	100	BRD-K54416256-001-18-1, BRD-K54416256-001-19-9	Launched
methionine		BHMT, BHMT2, METAP2, MTR, MTRR			Sigma	47.29	BRD-A39515206-001-01-9	Launched
methiopril	angiotensin converting enzyme inhibitor	ACE			ChemDiv	97.96	BRD-A32172948-001-07-6	Phase 2
methocarbamol	muscle relaxant	CA1	neurology/psychiatry	muscle relaxant	Selleck, MicroSource	99.36	BRD-A31521121-001-25-6, BRD-A31521121-001-26-4	Launched
methoprene-(s)					MicroSource	86.73	BRD-K34591242-001-04-3	Preclinical
methotrexate	dihydrofolate reductase inhibitor	DHFR	oncology, hematologic malignancy, dermatology, rheumatology	gestational choriocarcinoma, hydatidiform mole, acute lymphoblastic leukemia (ALL), psoriasis, rheumatoid arthritis	Selleck, Selleck, Tocris, MicroSource	98.9	BRD-K59456551-001-22-6, BRD-K59456551-001-19-2, BRD-K59456551-001-20-0, BRD-A55424491-001-19-9	Launched
methoxamine	adrenergic receptor agonist	ADRA1A, ADRA1B, ADRA1D	cardiology	hypotension	Selleck, MicroSource	97.81	BRD-A39189014-003-21-9, BRD-A39189014-003-22-7	Launched
methoxsalen	DNA synthesis inhibitor	CYP1A1, CYP1A2, CYP2A13, CYP2A6, CYP3A4	dermatology	psoriasis	Selleck, MicroSource	99.46	BRD-K63430059-001-16-4, BRD-K63430059-001-17-2	Launched
methoxyamine	DNA repair enzyme inhibitor	APEX1			Otava	0	BRD-K79277568-003-04-7	Phase 2
methoxyflurane	membrane permeability inhibitor	ATP2C1, ATP5D, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GRIA1, KCNA1, MT-ND1	neurology/psychiatry	general anaesthetic	Sigma, MatrixSci	0	BRD-K06152156-001-02-6, BRD-K06152156-001-01-8	Launched
methoxyphenamine	adrenergic receptor agonist		pulmonary	asthma	Sigma	98.67	BRD-A21474126-001-01-6	Launched
methscopolamine	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3	gastroenterology	peptic ulcer disease (PUD)	Selleck, MicroSource, Selleck	98.54	BRD-K48619321-004-16-8, BRD-A03932035-004-04-3, BRD-K48619321-004-17-6	Launched
methsuximide	T-type calcium channel binder	CACNA1G, CACNA1H, CACNA1I	neurology/psychiatry	seizures	MicroSource	99.54	BRD-A57592049-001-01-6	Launched
methyclothiazide	chloride reabsorption inhibitor	CA1, CA2, CA4, SLC12A1, SLC12A3	cardiology	hypertension, edema	Selleck	97.93	BRD-A95340155-001-09-7	Launched
methyl-aminolevulinate	oxidizing agent	FCGR1A, FECH	dermatology	actinic keratosis (AK)	Enzo	0	BRD-K01292611-003-17-8	Launched
methyl-nicotinate					Vitas-M, Sigma	0	BRD-K10132944-001-01-1, BRD-K10132944-001-02-9	Phase 2
methyl-salicylate			endocrinology, neurology/psychiatry	fever, pain relief	Enamine	0	BRD-K10103010-001-01-1	Launched
methylatropine-nitrate	acetylcholine receptor antagonist	CHRM1			MicroSource	96.89	BRD-A52460047-001-01-3	Preclinical
methylbenzethonium-chloride	other antibiotic				MicroSource	64.12	BRD-K46531780-003-18-9	Preclinical
methyldopa	adrenergic receptor agonist	ADRA2A, ADRA2B, ADRA2C, DDC	cardiology	hypertension	Selleck, Selleck, Tocris, MicroSource	100	BRD-K48578705-001-17-6, BRD-K48578705-001-14-3, BRD-K48578705-001-15-0, BRD-K48578705-001-16-8	Launched
methyldopate			cardiology	hypertension	Prestwick	0	BRD-K82259334-003-02-7	Launched
methylene-blue	guanylyl cyclase inhibitor, nitric oxide production inhibitor	ACHE	hematology	methemoglobinemia	MicroSource, MedChemEx	47.14	BRD-K16406336-311-02-0, BRD-K54770538-003-14-6	Launched
methylergometrine	dopamine receptor antagonist, serotonin receptor antagonist	DRD1, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C	hematology, neurology/psychiatry	postpartum hemorrhage (PPH), migraine headache	Tocris, MicroSource	91.71	BRD-K34685430-050-11-7, BRD-K34685430-050-12-5	Launched
methyllycaconitine	acetylcholine receptor antagonist	CHRNA7			Tocris, Tocris, Tocris	93.67	BRD-K43192255-048-02-8, BRD-K43192255-048-01-0, BRD-K43192255-048-03-6	Preclinical
methylnaltrexone	opioid receptor antagonist	OPRD1, OPRK1, OPRM1	gastroenterology	constipation	MedChemEx	96.91	BRD-K33732501-004-01-0	Launched
methylparaben	other antifungal		dermatology	cosmetic	Enamine	0	BRD-K78321730-001-10-8	Launched
methylphenidate	dopamine-norepinephrine reuptake inhibitor	SLC6A2, SLC6A3, SLC6A4	neurology/psychiatry	attention-deficit/hyperactivity disorder (ADHD), narcolepsy	MicroSource	96.03	BRD-A19585813-003-03-3	Launched
methylprednisolone	glucocorticoid receptor agonist	NR3C1	endocrinology, rheumatology, dermatology, infectious disease, allergy, hematology, neurology/psychiatry, gastroenterology	hypercalcemia, thyroiditis, ankylosing spondylitis, bursitis, osteoarthritis, psoriatic arthritis, seborrheic dermatitis, mycosis, allergic rhinitis, psoriasis, anemia, multiple sclerosis, ulcerative colitis, enteritis	Tocris, Selleck, MicroSource	95.49	BRD-K35240538-001-24-7, BRD-K35240538-001-25-4, BRD-K35240538-001-26-2	Launched
methylprednisolone-aceponate	anti-inflammatory agent, glucocorticoid receptor agonist	NR3C1	endocrinology, rheumatology, infectious disease, allergy, pulmonary, gastroenterology, dermatology, neurology/psychiatry, hematology	congenital adrenal hyperplasia, thyroiditis, hypercalcemia, rheumatoid arthritis, bursitis, epicondylitis, allergic rhinitis, asthma, ulcerative colitis, enteritis, osteoarthritis, psoriasis, multiple sclerosis, anemia	Alinda	97.13	BRD-K24452555-001-01-7	Launched
methylprednisolone-sodium-succinate	glucocorticoid receptor agonist		endocrinology, rheumatology, dermatology, pulmonary, allergy, infectious disease, ophthalmology, gastroenterology, hematology, neurology/psychiatry	hypercalcemia, thyroiditis, osteoarthritis, rheumatoid arthritis, seborrheic dermatitis, asthma, allergic rhinitis, shingles, conjunctivitis, ulcerative colitis, enteritis, anemia, multiple sclerosis, mycosis	MicroSource	85.4	BRD-A45044890-236-02-3	Launched
methylthiouracil			endocrinology	hyperthyroidism	MicroSource, Selleck	100	BRD-K11900042-001-14-4, BRD-K11900042-001-13-6	Launched
methysergide	serotonin receptor antagonist	HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7	neurology/psychiatry	headache	Tocris	61.35	BRD-K35941380-050-27-9	Launched
meticrane	diuretic		cardiology	edema	Selleck, MicroSource	97.99	BRD-K58265391-001-11-9, BRD-K58265391-001-12-7	Launched
metipranolol	adrenergic receptor antagonist	ADRB1, ADRB2			Aronis	96.55	BRD-A99388803-001-01-5	Withdrawn
metirosine	tyrosine hydroxylase inhibitor	TH	cardiology	hypertension	Enamine	85.79	BRD-K83766205-001-03-8	Launched
metitepine	anti-HCVE2	HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7			Tocris, MicroSource, Tocris	98.47	BRD-A07932845-050-16-6, BRD-A07932845-066-11-3, BRD-A07932845-050-15-8	Preclinical
metixene	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	neurology/psychiatry	Parkinson's Disease	Prestwick	97.52	BRD-A33711280-003-03-1	Launched
metoclopramide	dopamine receptor antagonist, serotonin receptor antagonist	CHRM1, DRD2, HTR3A, HTR3B, HTR4	gastroenterology	gastroparesis, nausea, vomiting	MicroSource	98.56	BRD-K75641298-003-25-0	Launched
metocurine	acetylcholine receptor antagonist	CHRM2, CHRNA2	neurology/psychiatry	muscle relaxant	Specs	96.67	BRD-K16484091-001-01-1	Launched
metolazone	carbonic anhydrase inhibitor	SLC12A3	cardiology	edema, hypertension	Selleck, MicroSource, Selleck	97.53	BRD-A61793559-001-16-4, BRD-A61793559-001-15-6, BRD-A61793559-001-14-9	Launched
metoprolol	adrenergic receptor antagonist	ADRB1, ADRB2	cardiology	hypertension, angina pectoris, myocardial infarction	Tocris, MicroSource, Selleck	98.88	BRD-A03623303-046-15-0, BRD-A03623303-045-09-5, BRD-A03623303-046-14-3	Launched
metoxibutropate	cyclooxygenase inhibitor	PTGS1, PTGS2			Specs	96.65	BRD-A71725768-001-01-3	Launched
metrifonate	acetylcholinesterase inhibitor	ACHE			MedChemEx, MicroSource, MedChemEx	58.32	BRD-A22101059-001-15-5, BRD-A22101059-001-13-0, BRD-A22101059-001-14-8	Phase 3
metrizamide	radiopaque medium		radiology	contrast agent	Selleck	91.39	BRD-A45543382-001-10-0	Launched
metrizoic-acid	radiopaque medium		radiology	contrast agent	Sigma, TCI	89.37	BRD-K99241550-001-04-3, BRD-K99241550-001-03-5	Launched
metronidazole	DNA inhibitor	CYP2C9, CYP3A4	dermatology	rosacea	Selleck, MicroSource	99.43	BRD-K52020312-001-25-0, BRD-K52020312-001-26-8	Launched
metyrapone	cytochrome P450 inhibitor	CYP11B1	nephrology	adrenal diagnostic agent	Tocris, MicroSource, MedChemEx	92.16	BRD-K46862739-001-15-0, BRD-K46862739-001-13-5, BRD-K46862739-001-14-3	Launched
mevalonic-d,-l-acid-lactone					Prestwick	0	BRD-A05674712-001-06-0	Preclinical
mevastatin	HMGCR inhibitor	HMGCR			Tocris, MicroSource, Selleck, Selleck, Tocris	93.53	BRD-K94441233-001-15-5, BRD-K94441233-001-17-1, BRD-K94441233-001-16-3, BRD-K94441233-001-13-0, BRD-K94441233-001-12-2	Preclinical
mexeneone					MicroSource	97.2	BRD-K18613660-001-05-5	Preclinical
mexiletine	sodium channel blocker	AHR, SCN4A, SCN5A	cardiology	ventricular arrhythmias, ventricular tachycardia (VT)	MicroSource, Tocris, Tocris, Selleck	98.76	BRD-A64092382-003-18-3, BRD-A64092382-003-17-5, BRD-A64092382-003-19-1, BRD-A64092382-003-16-7	Launched
mezlocillin	bacterial cell wall synthesis inhibitor		infectious disease	gram-negative bacterial infections, gram-positive bacterial infections	Selleck, Selleck	88.63	BRD-K45114938-236-02-6, BRD-K45114938-236-01-8	Launched
ME0328	PARP inhibitor	PARP3			Selleck	99.08	BRD-A63444178-001-01-5	Preclinical
MF-101	estrogen receptor agonist	CYP19A1, XDH			InterBioScreen	98	BRD-K34328244-001-01-4	Phase 3
MG-132	proteasome inhibitor	PSMB1			Selleck, Selleck, Selleck	86.03	BRD-K60230970-001-17-5, BRD-K60230970-001-13-4, BRD-K60230970-001-16-7	Preclinical
MG-624	acetylcholine receptor antagonist	CHRNA7			Tocris, Tocris	93.43	BRD-K03128577-005-07-0, BRD-K03128577-005-06-2	Preclinical
MGCD-265	VEGFR inhibitor	AXL, MET			Selleck	92.2	BRD-K56277358-001-07-5	Preclinical
MI-14	PI4K inhibitor	PI4KB			Tocris	92.97	BRD-K26726854-001-01-0	Preclinical
mianserin	serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD5, HRH1, HRH2, HRH4, HTR1A, HTR1F, HTR2A, HTR2B, HTR2C, HTR6, HTR7, OPRK1, SLC6A2, SLC6A3, SLC6A4	neurology/psychiatry	depression	Selleck, MicroSource, Tocris, Selleck	98.04	BRD-A19661776-003-28-4, BRD-A19661776-003-27-6, BRD-A19661776-003-26-8, BRD-A19661776-003-25-0	Launched
mibampator	glutamate receptor modulator	GRIA1			MedChemEx	99.84	BRD-K42981054-001-01-9	Phase 2
mibefradil	T-type calcium channel blocker	ANO1, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, CATSPER1, CATSPER2, CATSPER3, CATSPER4			Tocris, Tocris	97.32	BRD-K09549677-300-03-4, BRD-K09549677-300-04-2	Withdrawn
micafungin	fungal 1,3-beta-D-glucan synthase inhibitor		infectious disease	candidemia, peritonitis, esophageal candidiasis	MedChemEx, MedChemEx, MedChemEx, Enzo	83.81	BRD-K40407248-236-01-6, BRD-A06596811-236-03-3, BRD-K40407248-236-02-4, BRD-A11207520-001-01-4	Launched
miconazole	bacterial cell wall synthesis inhibitor	KCNH2, KCNH6, KCNH7, KCNMA1, KCNMB1, KCNMB2, KCNMB3, KCNMB4, KCNN1, KCNN2, KCNN3, KCNN4, NOS2, NOS3, TRPM2, TRPV5	infectious disease, neurology/psychiatry	yeast infection, itching	Tocris, Selleck, Selleck, MicroSource	99.92	BRD-A82396632-008-30-8, BRD-A82396632-001-16-2, BRD-A82396632-008-28-2, BRD-A82396632-008-29-0	Launched
micronomicin	protein synthesis inhibitor		infectious disease	gram-negative bacterial infections	AvaChem	0	BRD-K18552138-001-01-8	Launched
midafotel	glutamate receptor antagonist	GRIN2A, GRIN2B, GRIN2C, GRIN2D			Tocris, EMDBio	100	BRD-K45163704-001-02-3, BRD-K45163704-001-01-5	Phase 3
midecamycin	protein synthesis inhibitor		infectious disease	respiratory tract infections, ear infections, skin infections	AvaChem	0	BRD-K68822425-001-01-6	Launched
midodrine	adrenergic receptor agonist	ADRA1A, ADRA1B, ADRA1D	cardiology	hypotension	MicroSource	96.09	BRD-A79981887-003-16-4	Launched
midostaurin	FLT3 inhibitor, KIT inhibitor, PKC inhibitor	FLT3, PRKCG	hematologic malignancy	acute myeloid leukemia (AML)	Enzo	95.95	BRD-K13646352-001-03-8	Launched
mifepristone	glucocorticoid receptor antagonist, progesterone receptor antagonist	AR, NR1I2, NR3C1, PGR	endocrinology	hyperglycemia, diabetes mellitus	Tocris, MicroSource, Selleck, Selleck, Tocris	90.12	BRD-K37270826-001-29-2, BRD-K37270826-001-31-8, BRD-K37270826-001-27-6, BRD-K37270826-001-30-0, BRD-K37270826-001-26-8	Launched
mifobate	PPAR receptor antagonist	PPARG			Tocris	92.75	BRD-A72066420-001-04-5	Phase 2
miglitol	glucosidase inhibitor	GAA, GANAB, GANC, MGAM	endocrinology	diabetes mellitus	Tocris, MicroSource, Selleck	100	BRD-K44779798-001-10-7, BRD-A63310107-001-04-8, BRD-K44779798-001-11-5	Launched
miglustat	Glycosyl transferase inhibitor	UGCG	hematology	Gaucher disease	Enzo	100	BRD-K33251802-001-01-3	Launched
milacemide	monoamine oxidase inhibitor	MAOB			Enamine	92.25	BRD-K64338723-001-01-6	Phase 3
milnacipran	serotoninâ€“norepinephrine reuptake inhibitor (SNRI)	GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, SLC6A2, SLC6A4	rheumatology	fibromyalgia	MicroSource, Selleck	97.86	BRD-A15202882-003-02-7, BRD-K02227374-003-07-1	Launched
milrinone	phosphodiesterase inhibitor	PDE2A, PDE3A, PDE3B, PDE5A	cardiology	congestive heart failure	MicroSource, Selleck	100	BRD-K67080878-001-16-2, BRD-K67080878-001-15-4	Launched
miltefosine	membrane integrity inhibitor	PLA2G1B	infectious disease	leishmaniasis	MicroSource	92.47	BRD-A31811760-001-06-7	Launched
mimosine	DNA replication inhibitor	CCL2, SHMT1, SHMT2, TYR			Enzo	0	BRD-K67642028-001-03-6	Preclinical
minaprine	serotonin reuptake inhibitor	ACHE, CHRM1, DRD1, DRD2, HTR2A, HTR2B, HTR2C, MAOA, SLC6A4			MicroSource	99.62	BRD-K02867583-300-08-9	Withdrawn
minerval	FAAH inhibitor				Sigma	98.8	BRD-A74347210-001-01-7	Phase 1/Phase 2
minocycline	bacterial 30S ribosomal subunit inhibitor	ALOX5, CASP1, CASP3, CYCS, IL1B, MMP9, VEGFA	endocrinology, infectious disease, ophthalmology, urology	fever, respiratory tract infections, psittacosis, trachoma, conjunctivitis, urethritis, chancroid, tularemia, cholera, brucellosis	MedChemEx, Sigma, MicroSource, Selleck, Selleck	93.08	BRD-A69651145-003-11-4, BRD-A69651145-003-10-6, BRD-A69651145-003-07-2, BRD-A69651145-003-08-0, BRD-A69651145-003-09-8	Launched
minodronic-acid	bone resorption inhibitor	FDPS, GGPS1	orthopedics	osteoporosis	AKSci, AvaChem	0	BRD-K89337853-001-01-1, BRD-K89337853-001-02-9	Launched
minoxidil	KATP activator, Kir6 channel (KATP) activator, vasodilator	ABCC9, KCNJ1, KCNJ10, KCNJ11, KCNJ8, PTGS1	endocrinology	androgenetic alopecia	Tocris, MicroSource, Selleck, Sigma, Tocris	96.36	BRD-K06902185-001-21-9, BRD-K06902185-003-01-7, BRD-K06902185-001-16-9, BRD-K06902185-001-22-7, BRD-K06902185-001-17-7	Launched
miocamycin	other antibiotic		infectious disease	urinary tract infections, chlamydia	AvaChem	92.27	BRD-K30764557-001-01-5	Launched
MIRA-1	apoptosis stimulant				Tocris	0	BRD-K39706510-001-03-9	Preclinical
mirabegron	adrenergic receptor agonist	ADRB1, ADRB2, ADRB3	urology	urinary incontinence	Selleck, Selleck	95.25	BRD-K47949423-001-02-3, BRD-K47949423-001-03-1	Launched
mirin	MRE11A exonuclease inhibitor	MRE11A			Tocris	89.76	BRD-K55420858-001-02-8	Preclinical
miriplatin	DNA synthesis inhibitor		oncology	hepatocellular carcinoma (HCC)	MedChemEx, MedChemEx	0	BRD-M78068755-001-02-0, BRD-M78068755-001-01-2	Launched
mirodenafil	phosphodiesterase inhibitor	PDE5A	urology	erectile dysfunction	MedChemEx	97.2	BRD-K82967685-300-01-2	Launched
mirtazapine	adrenergic receptor antagonist, serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD5, HRH1, HRH3, HTR2A, HTR2B, HTR2C, HTR3A, HTR7, OPRK1, SLC6A2, SLC6A3, SLC6A4	neurology/psychiatry	depression	Tocris, MicroSource, Selleck, Tocris	98.93	BRD-A64977602-001-16-7, BRD-A64977602-001-15-9, BRD-A64977602-001-13-4, BRD-A64977602-001-14-2	Launched
misonidazole					Cayman	96.47	BRD-A16263897-001-06-6	Phase 3
misoprostol	prostanoid receptor agonist	PTGER2, PTGER3, PTGER4, PTGIR	gastroenterology	duodenal ulcer disease	Sigma	99.4	BRD-A72351335-001-04-5	Launched
mitiglinide	insulin secretagogue	ABCC8, KCNJ10, PPARG	endocrinology	diabetes mellitus	Selleck	98.47	BRD-K52959329-238-01-9	Launched
mitoflaxone	antitumor agent	VWF			Specs	98.8	BRD-K35882976-001-04-7	Phase 2
mitomycin-c	DNA alkylating agent, DNA synthesis inhibitor		oncology	pancreatic cancer, gastric adenocarcinoma	MicroSource	99.49	BRD-A48237631-001-04-8	Launched
mitotane	antineoplastic agent	CYP11A1, CYP11B1, ESR1, FDX1	oncology	adrenal cortical carcinoma	MedChemEx, MicroSource, MedChemEx, Selleck, Selleck	0	BRD-A31204924-001-18-3, BRD-A31204924-001-14-2, BRD-A31204924-001-17-5, BRD-A31204924-001-16-7, BRD-A31204924-001-13-4	Launched
mitoxantrone	topoisomerase inhibitor	TOP2A	neurology/psychiatry, oncology, hematologic malignancy	multiple sclerosis, prostate cancer, acute myeloid leukemia (AML)	MicroSource, Selleck, Selleck	96.64	BRD-K21680192-300-15-1, BRD-K21680192-300-16-9, BRD-K21680192-300-14-4	Launched
mivacurium	acetylcholine receptor antagonist	BCHE, CHRM2, CHRM3, CHRNA2	critical care, neurology/psychiatry	endotracheal intubation, muscle relaxant	AKSci	47.83	BRD-A48465967-300-01-1	Launched
mivobulin	microtubule inhibitor				Sigma	80.61	BRD-K39576764-071-01-6	Preclinical
mizolastine	histamine receptor antagonist	HRH1	allergy	urticaria, allergic rhinitis	Selleck	98.43	BRD-K21884483-001-03-7	Launched
mizoribine	immunosuppressant, inosine monophosphate dehydrogenase inhibitor	IMPDH1			Selleck, MicroSource, Selleck	100	BRD-K88061624-001-21-4, BRD-K88061624-001-20-6, BRD-K88061624-001-22-2	Launched
MJ-15	cannabinoid receptor antagonist	CNR1			Tocris	92.68	BRD-K71315565-001-01-6	Preclinical
MK-0354	niacin receptor agonist	HCAR2, HCAR3			MedChemEx	94.22	BRD-K91405252-001-01-9	Phase 2
MK-0752	gamma secretase inhibitor				Selleck	93.39	BRD-K18850819-001-04-6	Phase 1/Phase 2
MK-0773	androgen receptor modulator	AR			MedChemEx	97.69	BRD-K38868394-001-01-3	Phase 2
MK-0812	CC chemokine receptor antagonist	CCR2			MedChemEx	97.78	BRD-K14175878-001-01-6	Phase 2
MK-0893	glucagon receptor antagonist	GCGR			MedChemEx	98.42	BRD-K16732600-001-01-7	Phase 2
MK-1775	WEE1 kinase inhibitor	WEE1			Selleck	91.74	BRD-K54256913-001-08-7	Phase 2
MK-2048	HIV integrase inhibitor				Selleck, Selleck	61.42	BRD-K03128512-001-03-6, BRD-K03128512-001-02-8	Preclinical
MK-2206	AKT inhibitor	AKT1, AKT2, AKT3			Selleck	97.67	BRD-K68065987-300-09-1	Phase 2
MK-2295	TRPV antagonist	TRPV1			DuPont	97.5	BRD-K43316319-001-01-8	Phase 2
MK-2461	FGFR inhibitor, VEGFR inhibitor	FGFR1, FGFR2, FGFR3, FLT1, FLT3, FLT4, KDR, MERTK, MET, MST1R, NTRK1, NTRK2, PDGFRB			Selleck	93.34	BRD-K56405753-001-02-4	Phase 1/Phase 2
MK-2894	prostaglandin inhibitor	PTGER4			MedChemEx	92.79	BRD-K27983781-001-01-4	Preclinical
MK-3207	calcitonin antagonist	CALCA			MedChemEx	98.79	BRD-K66911501-003-01-2	Phase 2
MK-3697	orexin receptor antagonist	HCRTR2			MedChemEx	97.36	BRD-K95828359-001-01-0	Phase 2
MK-5046	bombesin receptor agonist	BRS3, GRPR, NMBR			MedChemEx	90.83	BRD-K03886848-001-01-8	Preclinical
MK-5108	Aurora kinase inhibitor	AURKA, AURKB, AURKC			Selleck	92.91	BRD-K53665955-001-03-0	Phase 1
MK-571	leukotriene receptor antagonist	ABCC2, CYSLTR1			MedChemEx	94.07	BRD-A73679382-236-01-8	Phase 2
MK-6096	orexin receptor antagonist	HCRTR1, HCRTR2			MedChemEx	97.98	BRD-K03894385-001-01-1	Phase 2
MK-8033	c-Met inhibitor	MET			MedChemEx	91.91	BRD-K55512740-001-01-6	Phase 1
MK-8245	stearoyl-CoA desaturase inhibitor	SCD			Selleck	96.51	BRD-K29656036-001-02-5	Phase 2
MK-8745	Aurora kinase inhibitor	AURKA			Selleck	93.7	BRD-K25279140-001-01-5	Preclinical
MKT-077	HSP inhibitor				Tocris, Cayman	49.21	BRD-K61695967-003-02-1, BRD-K61695967-003-01-3	Phase 1
MK2-IN-1	MAP kinase inhibitor	MAPKAPK2			MedChemEx	91.11	BRD-K90316462-003-01-1	Preclinical
ML-10302	serotonin receptor partial agonist	HTR3A, HTR3B, HTR4			Tocris	94.1	BRD-K69343602-003-01-3	Preclinical
ML-141	GTPase inhibitor	CDC42			Tocris	88.19	BRD-A28422330-001-10-1	Preclinical
ML-179	liver receptor homolog inverse agonist	NR5A2			Tocris	96.66	BRD-K77547509-001-03-3	Preclinical
ML-193	G protein-coupled receptor antagonist	GPR55			Tocris	99.09	BRD-K27539181-001-08-5	Preclinical
ML-213	potassium channel activator	KCNQ4			Tocris	97.46	BRD-A12633378-001-07-0	Preclinical
ML-218	T-type calcium channel binder	CACNA1G, CACNA1H, CACNA1I			Tocris	93.41	BRD-K92995792-003-02-9	Preclinical
ML-228	hypoxia inducible factor activator	HIF1A			Tocris	97.16	BRD-K44432556-001-05-5	Preclinical
ML-277	potassium channel activator	KCNQ1			Tocris	97.08	BRD-K60020910-001-02-5	Preclinical
ML-281	serine/threonine kinase inhibitor	STK33			Tocris	98.78	BRD-K48188942-001-03-7	Preclinical
ML-297	inward rectifier potassium channel activator	KCNJ3			Tocris	72.69	BRD-K51137250-001-02-6	Preclinical
ML-298	phospholipase inhibitor	PLD2			Tocris	86.04	BRD-K24600306-003-01-9	Preclinical
ML-323	ubiquitin specific protease inhibitor	USP1			MedChemEx	96.64	BRD-K93942811-001-01-3	Preclinical
ML-3403	MAP kinase inhibitor	CYP3A4, MAPK11, MAPK12, MAPK14			Tocris	96.63	BRD-A29014990-001-02-3	Preclinical
ML-348	lysophospholipase inhibitor	LYPLA1			Tocris	97.3	BRD-K81044214-001-06-4	Preclinical
ML-365	potassium channel blocker	KCNK3, KCNK9			Tocris	98.91	BRD-K02160913-001-02-7	Preclinical
ML-786	RAF inhibitor	BRAF, RAF1			Tocris	91.56	BRD-K52644305-300-01-3	Preclinical
ML-9	myosin light chain kinase inhibitor	TRPC6			Tocris, Tocris	98.37	BRD-K68402494-003-03-5, BRD-K68402494-003-04-3	Preclinical
MLN-8054	Aurora kinase inhibitor	AURKA			Selleck	93.63	BRD-K83963101-001-06-9	Phase 1
MLN0128	mTOR inhibitor	MTOR, PIK3CA, PIK3CD, PIK3CG			Selleck	97.29	BRD-K59317601-001-05-5	Phase 2
MLN1117	PI3K inhibitor	PIK3CA			MedChemEx	97.33	BRD-K73877023-001-01-9	Phase 1/Phase 2
MLN2480	RAF inhibitor				MedChemEx	94.36	BRD-K43410529-001-02-3	Phase 1
MLN9708	proteasome inhibitor				MedChemEx, MedChemEx	17.51	BRD-K15203492-001-01-1, BRD-K15203492-001-02-9	Phase 3
ML130	NOD1 inhibitor				Tocris, Selleck	96.19	BRD-K89306950-001-13-3, BRD-K89306950-001-12-5	Preclinical
ML133	potassium channel blocker				Selleck	97.57	BRD-K33743361-003-02-6	Preclinical
ML161	protease-activated receptor inhibitor				Tocris, Selleck	98.28	BRD-K59036917-001-17-5, BRD-K59036917-001-16-7	Preclinical
ML167	CLK inhibitor, DYRK inhibitor	CLK4, DYRK1B			Selleck	90.04	BRD-K64835161-001-02-8	Preclinical
ML204	transient receptor potential channel antagonist	TRPC4, TRPC5			MedChemEx	97.27	BRD-K80021413-001-08-8	Preclinical
ML314	neurotensin agonist	NTSR1			MedChemEx	96.62	BRD-K92606079-001-02-0	Preclinical
ML324	histone lysine demethylase inhibitor	KDM4A			MedChemEx	86.85	BRD-K25611237-001-02-1	Preclinical
ML347	ALK tyrosine kinase receptor inhibitor	ACVR1, ACVRL1, BMPR1A			Selleck, Tocris	99.36	BRD-K33892651-001-02-4, BRD-K33892651-001-03-2	Preclinical
MM-102	WDR5/MLL interaction inhibitor				Selleck	91.66	BRD-K68474068-001-01-8	Preclinical
MM-11253	retinoid receptor antagonist	RARG			Tocris	98.06	BRD-K98353094-001-01-6	Preclinical
MMPX	phosphodiesterase inhibitor				Tocris	99.04	BRD-K56077740-001-09-2	Preclinical
MM77	serotonin receptor antagonist	HTR1A			Tocris	75.74	BRD-K50293352-300-02-1	Preclinical
MN-64	tankyrase inhibitor	TNKS			MedChemEx	96.16	BRD-K16183658-001-01-4	Preclinical
MNITMT	lymphocyte inhibitor				Tocris	98.32	BRD-K63151507-001-02-4	Preclinical
MNS-(3,4-Methylenedioxy-nitrostyrene)	src inhibitor, syk inhibitor	SRC, SYK			Selleck, Selleck	93.21	BRD-K42205652-001-02-7, BRD-K42205652-001-05-0	Preclinical
mocetinostat	HDAC inhibitor	HDAC1, HDAC11, HDAC2, HDAC3			Selleck, MedChemEx, Selleck	96.2	BRD-K16485616-001-12-1, BRD-K16485616-001-13-9, BRD-K16485616-001-08-9	Phase 2
moclobemide	monoamine oxidase inhibitor	MAOA, MAOB	neurology/psychiatry	depression, anxiety	Tocris, Selleck	94.41	BRD-K07237224-001-20-4, BRD-K07237224-001-19-6	Launched
modafinil	adrenergic receptor agonist	ADRA1B, SLC6A3	pulmonary, neurology/psychiatry	obstructive sleep apnea, shift work disorder (SWD)	MicroSource	48.32	BRD-A16332958-001-09-9	Launched
modaline					MicroSource	98.29	BRD-K25317177-065-01-4	Preclinical
moexipril	angiotensin converting enzyme inhibitor	ACE, ACE2	cardiology	hypertension	Tocris, Selleck, Selleck	93.18	BRD-K34441861-003-06-2, BRD-K34441861-003-05-4, BRD-K34441861-003-07-0	Launched
mofegiline	monoamine oxidase inhibitor	MAOA, MAOB			MedChemEx, MedChemEx	88.73	BRD-K52598503-003-01-1, BRD-K52598503-003-02-9	Phase 1
mofezolac	cyclooxygenase inhibitor	PTGS1	rheumatology, orthopedics	rheumatoid arthritis, osteoporosis	Sigma	99.58	BRD-K49372556-001-04-1	Launched
moguisteine	ATP-sensitive potassium channel inhibitor				Selleck	97.02	BRD-A87673115-001-04-1	Phase 2
molidustat	hypoxia inducible factor inhibitor	EGLN2			MedChemEx, MedChemEx	90.41	BRD-K01291782-001-02-9, BRD-K01291782-001-01-1	Phase 2
molindone	dopamine receptor antagonist	CHRM1, DRD2, HRH1, HTR1A, HTR2A	neurology/psychiatry	schizophrenia	MicroSource	98.2	BRD-A65280694-003-13-7	Launched
molsidomine	guanylate cyclase stimulant	GUCY1A3	cardiology	coronary artery disease (CAD)	MicroSource	98.74	BRD-K63861289-001-19-6	Launched
mometasone	glucocorticoid receptor agonist	NR3C1	dermatology	corticosteroid-responsive dermatoses	Sigma	0	BRD-K50265942-001-01-2	Launched
mometasone-furoate	glucocorticoid receptor agonist	NR3C1	dermatology	corticosteroid-responsive dermatoses	MicroSource, Selleck	94.31	BRD-K60640630-001-11-0, BRD-K60640630-001-10-2	Launched
monastrol	kinesin inhibitor	KIF11			Tocris, Tocris	97.94	BRD-A78377521-001-06-3, BRD-A78377521-001-05-5	Preclinical
monensin	bacterial permeability inducer				Selleck, MicroSource, Selleck	83.47	BRD-A06627858-236-01-4, BRD-A06627858-236-03-0, BRD-A06627858-236-02-2	Launched
monobenzone	melanin inhibitor	TYR	dermatology	skin depigmentation	Selleck, MicroSource, Sigma, Selleck	77.12	BRD-K54262262-001-11-6, BRD-K54262262-001-10-8, BRD-K54262262-001-12-4, BRD-K54262262-001-09-0	Launched
monoctanoin			gastroenterology	gallstones	Sigma, Sigma	84.6	BRD-A48938994-001-15-8, BRD-A48938994-001-14-1	Launched
monosodium-alpha-luminol					Enamine, MedChemEx	97.04	BRD-K52559566-001-01-1, BRD-K52559566-001-02-9	Launched
monostearin					TCI	92.85	BRD-A31454688-001-01-6	Preclinical
montelukast	leukotriene receptor antagonist	ALOX5, CYSLTR1	pulmonary, allergy	asthma, allergic rhinitis, exercise-induced bronchoconstriction (EIB)	Selleck, MicroSource, Selleck	98.68	BRD-K69470111-236-08-9, BRD-K69470111-001-01-2, BRD-K69470111-236-09-7	Launched
moprolol	adrenergic receptor antagonist		cardiology, ophthalmology, neurology/psychiatry	hypertension, glaucoma, anxiety	LifeChem	95.27	BRD-A51747092-003-03-0	Launched
moracizine	sodium channel blocker	SCN5A	cardiology	ventricular arrhythmias	Prestwick	99.39	BRD-K21548250-003-19-1	Launched
morantel	acetylcholine receptor agonist		infectious disease	tapeworm	MicroSource	55.48	BRD-K71454870-048-06-3	Launched
morin	cytochrome P450 inhibitor	ADORA2A, ESR2, FASN, MCL1, SLC22A12			Selleck, Selleck	100	BRD-K11590034-002-02-6, BRD-K11590034-002-03-4	Preclinical
morinidazole	other antibiotic	CYP51A1			MedChemEx	85.47	BRD-A40546373-001-01-8	Launched
morniflumate	anti-inflammatory agent		neurology/psychiatry	pain relief	AKSci	97.89	BRD-K38938675-001-01-4	Launched
moroxydine	antiviral		infectious disease	influenza A virus infection	MicroSource, Selleck	100	BRD-K57291914-003-10-2, BRD-K57291914-003-09-4	Launched
mosapride	serotonin receptor agonist	HTR4	gastroenterology	hypertrophic gastritis (GHG), gastroesophageal reflux disease (GERD), dyspepsia, irritable bowel syndrome	Tocris, Selleck	98.7	BRD-A39052811-048-12-8, BRD-A39052811-048-11-0	Launched
motesanib	KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	FLT1, FLT4, KDR, KIT			Selleck, MedChemEx, MedChemEx, Selleck, MedChemEx	95.52	BRD-K99616396-316-05-3, BRD-K99616396-001-06-9, BRD-K99616396-001-05-1, BRD-K99616396-316-04-6, BRD-K99616396-316-06-1	Phase 3
motolimod	toll-like receptor agonist	TLR8			MedChemEx	87.75	BRD-K11785681-001-01-2	Phase 1/Phase 2
moxalactam	bacterial cell wall synthesis inhibitor		infectious disease	skin infections, bone and joint infections, pneumonia, urinary tract infections, meningitis	MedChemEx, MicroSource, Selleck, Selleck	0	BRD-K40831222-304-06-2, BRD-A08899266-304-05-0, BRD-K40831222-304-05-4, BRD-K40831222-304-04-7	Launched
moxaverine	phosphodiesterase inhibitor		neurology/psychiatry	spasms	Innovapharm	99.2	BRD-K12742203-003-01-7	Launched
moxidectin	chloride channel antagonist		infectious disease	gastrointestinal parasites	MicroSource	92.02	BRD-K61988078-001-01-2	Launched
moxifloxacin	bacterial DNA gyrase inhibitor	TOP2A	otolaryngology, pulmonary, infectious disease	sinusitis, bronchitis, pneumonia, skin infections, intra-abdominal infections	MicroSource, Selleck	92.59	BRD-K66615216-003-14-8, BRD-K66615216-003-13-0	Launched
moxisylyte	adrenergic receptor antagonist				MicroSource	95.95	BRD-K81144366-003-19-7	Withdrawn
moxonidine	imidazoline receptor agonist	ADRA2A, ADRA2B, ADRA2C	cardiology	hypertension	Tocris, Tocris, Selleck	96.96	BRD-K77771411-003-10-7, BRD-K77771411-003-12-3, BRD-K77771411-001-12-7	Launched
mozavaptan	vasopressin receptor antagonist	AVPR1A, AVPR1B, AVPR2	endocrinology	hyponatremia	Selleck	97.07	BRD-A31095847-001-02-3	Launched
MPEP	glutamate receptor antagonist	GRM1, GRM4, GRM5			Tocris, Selleck, Tocris	97.59	BRD-K60690191-003-11-2, BRD-K60690191-001-03-3, BRD-K60690191-003-09-6	Preclinical
MPI-0479605	mitotic kinase inhibitor	TTK			MedChemEx, Selleck, MedChemEx, Selleck	94.28	BRD-K45551181-001-03-9, BRD-K45551181-001-01-3, BRD-K45551181-001-04-7, BRD-K45551181-001-02-1	Preclinical
Mps-BAY-2a	monopolar spindle 1 kinase inhibitor	TTK			Tocris	94.23	BRD-K18530250-001-01-6	Preclinical
Mps1-IN-1	monopolar spindle 1 kinase inhibitor	TTK			Tocris	85.19	BRD-K94853001-300-01-7	Preclinical
Mps1-IN-5	protein kinase inhibitor				MedChemEx	94.51	BRD-K43812936-001-01-9	Preclinical
MR-16728	acetylcholine release enhancer				Tocris	93.83	BRD-A30590053-003-02-9	Preclinical
MR-948	thromboxane synthase inhibitor	TBXAS1			Enamine	98.9	BRD-K84883208-001-01-1	Phase 1
MRK-016	GABA receptor inverse agonist	GABRA1, GABRA2, GABRA3, GABRA5			Tocris, Tocris	98.16	BRD-K44022883-001-01-7, BRD-K44022883-001-02-5	Phase 1
MRK-409	benzodiazepine receptor agonist				Tocris, Sigma	99.45	BRD-K57416838-001-02-9, BRD-K57416838-001-01-1	Phase 1
MRK-560	gamma secretase inhibitor	APP			Tocris	90.05	BRD-K68795758-001-01-1	Preclinical
MRS-1220	adenosine receptor antagonist	ADORA2B, ADORA3			Tocris, Tocris	92.13	BRD-K37618799-001-04-8, BRD-K37618799-001-03-0	Preclinical
MRS-3777	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3			Tocris	96.4	BRD-M86143595-034-03-4	Preclinical
MRS1334	adenosine receptor antagonist	ADORA3			Tocris	83.79	BRD-A06784547-001-02-6	Preclinical
MRS1845	calcium channel blocker				Tocris	95.21	BRD-A78093359-001-06-3	Preclinical
MRS2578	purinergic receptor antagonist	P2RY6			Selleck, Selleck	21.98	BRD-K91135178-001-03-9, BRD-K91135178-001-02-1	Preclinical
MRS3777	adenosine receptor antagonist	ADORA2A			Tocris	97.24	BRD-K10575656-034-01-0	Preclinical
MSX-122	CC chemokine receptor antagonist	CXCR4			MedChemEx	93.92	BRD-K25143390-001-01-0	Phase 1
MTPG	glutamate receptor antagonist	GRM2, GRM3			Tocris	93.8	BRD-A28329383-001-02-1	Preclinical
mubritinib	protein tyrosine kinase inhibitor	EGFR, ERBB2			Tocris, Tocris, Selleck	96.61	BRD-K19061412-001-03-2, BRD-K19061412-001-04-0, BRD-K19061412-001-02-4	Phase 1
mupirocin	isoleucyl-tRNA synthetase inhibitor		infectious disease	impetigo	MicroSource, MedChemEx, Selleck	93.41	BRD-K15262564-001-14-3, BRD-K15262564-001-15-0, BRD-K15262564-001-16-8	Launched
muscimol	benzodiazepine receptor agonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRR1, GABRR2, GABRR3			Tocris	97.75	BRD-K60441002-001-04-8	Phase 1
MUT056399	FABI inhibitor				MedChemEx	93.76	BRD-K72078047-001-01-7	Phase 1
MY-5445	phosphodiesterase inhibitor, platelet aggregation inhibitor	PDE5A			Tocris, Tocris	99.38	BRD-K90524085-001-08-6, BRD-K90524085-001-07-8	Preclinical
mycophenolate-mofetil	dehydrogenase inhibitor, inositol monophosphatase inhibitor	IMPDH1, IMPDH2	transplant	organ rejection	Tocris, MicroSource, Selleck	95.21	BRD-K92428153-001-07-7, BRD-K92428153-001-05-1, BRD-K92428153-001-04-4	Launched
mycophenolic-acid	dehydrogenase inhibitor, inositol monophosphatase inhibitor	IMPDH1, IMPDH2	transplant	organ rejection	Tocris, MicroSource, Selleck, Tocris	98.39	BRD-K63750851-001-22-3, BRD-K63750851-001-20-7, BRD-K63750851-001-18-1, BRD-K63750851-001-19-9	Launched
myricetin	androgen receptor agonist, cytochrome P450 inhibitor	PIK3CG			Selleck, Selleck	94.44	BRD-K43149758-001-22-7, BRD-K43149758-001-23-5	Preclinical
myricitrin	PKC inhibitor	NOS1, PRKCA			Selleck	94.75	BRD-K29834313-001-01-4	Preclinical
myristyl-nicotinate	topical sunscreen agent				Accela	0	BRD-K88153212-001-01-9	Phase 1
M8-B	transient receptor potential channel antagonist	TRPM8			Tocris	93.81	BRD-K90410034-003-01-1	Preclinical
N-(2-chlorophenyl)-2-({(2E)-2-[1-(2-pyridinyl)ethylidene]hydrazino}carbothioyl)hydrazinecarbothioamide					Key	20.21	BRD-K57027742-001-01-1	Preclinical
N-[2-(Piperidinylamino)ethyl]-4-iodobenzamide	sigma receptor ligand				Tocris	98.14	BRD-K78844995-001-02-6	Preclinical
N-acetyl-D-glucosamine		B4GALT1, B4GALT2, B4GALT3, B4GALT4, NAGK, NAGLU, NAGPA, RENBP			Vitas-M	100	BRD-K80653534-001-01-7	Phase 2/Phase 3
N-acetyl-tyrosine					Enamine	96.39	BRD-A24857382-001-03-4	Launched
N-acetylcarnosine					AKSci	100	BRD-K52523550-001-01-5	Phase 2
N-acetylglycyl-D-glutamic-acid	glutamate receptor agonist				Tocris, Tocris	100	BRD-K28121004-001-02-9, BRD-K28121004-001-01-1	Preclinical
N-acetylmannosamine		CHIT1			Vitas-M	100	BRD-A92872453-001-01-8	Phase 1
N-acetyltryptamine	melatonin receptor agonist				Tocris, Tocris	98.63	BRD-K73700643-001-13-8, BRD-K73700643-001-11-2	Preclinical
N-alpha-Methylhistamine-dihydrochloride	histamine receptor agonist	HRH4			Tocris	100	BRD-K64422603-300-02-7	Phase 3
N-benzylnaltrindole	opioid receptor antagonist				Tocris	92.01	BRD-A33514596-003-01-2	Preclinical
N-cyanopyrrolidine		CTSK			Maybridge	0	BRD-K90042229-001-01-1	Preclinical
N-demethylantipyrine					Sigma	26.35	BRD-K84517077-001-01-3	Preclinical
N-hydroxynicotinamide					Sigma	96.8	BRD-K28030264-001-02-7	Preclinical
N-methyl-(-)ephedrine-[1r,2s]					MicroSource	82.42	BRD-K82236108-001-04-9	Preclinical
N-methylformamide					Sigma	0	BRD-K33445938-001-01-8	Phase 2
N-methyllidocaine-iodide	antiarrhythmic medication				Tocris	98.14	BRD-K60060639-005-02-2	Preclinical
N-methylpyrrolidone					Sigma	0	BRD-K52732207-001-01-9	Phase 1
N-methylquipazine	serotonin receptor agonist	HTR1A, HTR1D, HTR2A, HTR2B, HTR2C, HTR3A, HTR3B, HTR6, SLC6A4			Tocris	98.26	BRD-K62056274-332-01-8	Preclinical
N-MPPP	opioid receptor agonist				Tocris	97.35	BRD-K93806173-003-01-8	Preclinical
N-oxydiethylenebenzothiazole-2-sulfenamide					Enamine	3.71	BRD-K97360717-001-09-2	Preclinical
N-salicoylaminophenol	ribonucleotide reductase inhibitor				CombiBlocks	99.07	BRD-K39693230-001-01-2	Preclinical
NAB-2	ubiquitin ligase transport promoter	NEDD4			Tocris	97.08	BRD-K36804890-001-01-9	Preclinical
nabumetone	cyclooxygenase inhibitor	PTGS1, PTGS2	rheumatology	rheumatoid arthritis, osteoarthritis	MicroSource, Selleck	99.57	BRD-K65146499-001-27-9, BRD-K65146499-001-26-1	Launched
nadide	electron acceptor	AHCY, AKR1A1, ALDH2, BLVRA, DHPS, DLD, GALE, HMGCR, HSD17B1, HSD17B4, IMPDH2, MGAM, P2RY11, SORD, TRPM2			MicroSource	86.18	BRD-A11132253-001-08-2	Launched
nadifloxacin	bacterial DNA gyrase inhibitor		dermatology, infectious disease	acne vulgaris (AV), skin infections	MicroSource, Selleck	99.02	BRD-A24397426-001-10-4, BRD-A24397426-001-09-6	Launched
nadolol	adrenergic receptor antagonist	ADRB1, ADRB2, ADRB3	cardiology	angina pectoris, hypertension	MicroSource, Sigma	63.89	BRD-A87606379-001-22-4, BRD-A87606379-001-23-2	Launched
NADPH		AASS, DPYD, GHSR, TXNRD1			MedChemEx, MedChemEx	70	BRD-M06409173-001-02-7, BRD-M06409173-001-01-9	Preclinical
nafadotride	dopamine receptor antagonist	DRD2, DRD3, HTR1A			Tocris	86.99	BRD-A71262238-001-08-4	Preclinical
nafamostat	serine protease inhibitor	ASIC1, ASIC2, ASIC3, C1R, PRSS1, TPSAB1, TRPM7			Selleck, Tocris, Selleck	89.75	BRD-K06674495-334-04-0, BRD-K06674495-334-05-7, BRD-K06674495-334-03-2	Launched
nafcillin	bacterial cell wall synthesis inhibitor	CYP1A2, CYP3A4, SLC22A6	infectious disease	gram-positive bacterial infections	Selleck, MicroSource, Selleck	96.54	BRD-K18574842-323-11-6, BRD-K18574842-236-17-7, BRD-K18574842-323-10-8	Launched
naftidrofuryl	adrenergic receptor antagonist		cardiology	claudication	MicroSource	92.27	BRD-A67862938-034-14-9	Launched
naftifine	fungal squalene epoxidase inhibitor	SQLE	infectious disease	tinea pedis, tinea cruris, tinea corporis	MicroSource, Selleck	98.83	BRD-K74141488-003-11-2, BRD-K74141488-003-10-4	Launched
naftopidil	adrenergic receptor antagonist	ADRA1A	urology	benign prostatic hyperplasia (BPH)	Selleck, Tocris, Selleck, Selleck, Selleck, Tocris, MicroSource	99.08	BRD-A01787639-300-09-4, BRD-A01787639-003-17-7, BRD-A01787639-300-08-6, BRD-A01787639-001-06-4, BRD-A01787639-001-08-0, BRD-A01787639-003-16-9, BRD-A01787639-001-07-2	Launched
nalbuphine	opioid receptor agonist, opioid receptor antagonist	OPRD1, OPRK1, OPRM1	neurology/psychiatry	pain relief	MicroSource, Enzo	91.8	BRD-K66404838-001-02-4, BRD-K66404838-310-01-1	Launched
nalfurafine	opioid receptor agonist	OPRK1, OPRM1	nephrology	uremic pruritus	MedChemEx	97.5	BRD-K89272869-003-01-8	Launched
nalidixic-acid	bacterial DNA gyrase inhibitor		infectious disease	urinary tract infections	MicroSource, Selleck	97.94	BRD-K47886988-001-22-2, BRD-K47886988-001-21-4	Launched
nalmefene	opioid receptor antagonist	OPRD1, OPRK1, OPRM1	pulmonary	respiratory depression	Tocris, Selleck	96.81	BRD-K68407436-003-02-7, BRD-A72767275-003-01-6	Launched
naloxegol	opioid receptor antagonist	OPRM1	gastroenterology	constipation	MedChemEx	88.98	BRD-K41458421-034-01-6	Launched
naloxone	opioid receptor antagonist	CREB1, ESR1, OPRD1, OPRK1, OPRM1, TLR4	pulmonary	respiratory depression	Selleck, Selleck, Tocris, MicroSource	87.7	BRD-K67511046-003-16-9, BRD-K67511046-003-14-4, BRD-K67511046-003-15-1, BRD-K67511046-001-02-3	Launched
naloxone-benzoylhydrazone	opioid receptor antagonist	OPRK1, OPRM1			Tocris, Tocris, Tocris	80.29	BRD-K70898774-001-05-0, BRD-K70898774-001-04-3, BRD-K70898774-001-03-5	Preclinical
naltrexone	opioid receptor antagonist	OPRD1, OPRK1, OPRM1, SIGMAR1	neurology/psychiatry	abstinence from alcohol	MicroSource, Selleck, Selleck	93.54	BRD-K88172511-003-21-1, BRD-K88172511-003-19-5, BRD-K88172511-003-20-3	Launched
naltriben	opioid receptor antagonist	OPRD1, OPRK1, OPRM1			Tocris, Tocris	94.38	BRD-A19102171-066-02-2, BRD-A19102171-066-01-4	Preclinical
naltrindole	opioid receptor antagonist	OPRD1, OPRK1, OPRM1			Tocris, Tocris	97.6	BRD-A47342814-003-02-6, BRD-A47342814-003-01-8	Preclinical
Nampt-IN-1					MedChemEx	97.45	BRD-K18280217-001-01-0	Preclinical
NAN-190	serotonin receptor agonist	ADRA1A, ADRA1B, ADRA1D, HTR1A, HTR1F			Tocris	91.6	BRD-K69195780-004-08-4	Preclinical
nanchangmycin	other antibiotic				Selleck	98.79	BRD-A73871920-236-03-6	Preclinical
nandrolone	imidazoline receptor agonist	AR, CYP19A1, MAOA, MAOB	hematology	anemia	MedChemEx, MedChemEx	95.76	BRD-K52080565-001-09-2, BRD-K52080565-001-10-0	Launched
nandrolone-decanoate	androgenic steroid	AR			MedChemEx, MedChemEx	89	BRD-K78352627-001-02-6, BRD-K78352627-001-01-8	Phase 1
napabucasin	STAT inhibitor	STAT3			MedChemEx, Tocris	89.62	BRD-K22064724-001-01-8, BRD-K22064724-001-02-6	Phase 3
naphazoline	adrenergic receptor agonist	ADRA1A, ADRA2A	ophthalmology	eye irritation	Selleck, MicroSource	98.84	BRD-K77641333-003-26-3, BRD-K77641333-003-27-1	Launched
naphthoquine-phosphate	antimalarial agent				MedChemEx, MedChemEx, MedChemEx	79.04	BRD-K13664493-316-02-5, BRD-K13664493-316-01-7, BRD-K13664493-316-03-3	Launched
napirimus	immunosuppressant				Enamine	98.99	BRD-K91234829-001-01-7	Phase 1
naproxen	cyclooxygenase inhibitor	PTGS1, PTGS2	neurology/psychiatry, rheumatology, dental, otolaryngology, endocrinology	pain relief, rheumatoid arthritis, headache, toothache, backache, muscle pain, common cold, fever	Selleck, Tocris, Selleck, MicroSource	99.66	BRD-K59197931-236-22-9, BRD-K59197931-236-21-1, BRD-K59197931-236-20-3, BRD-K59197931-001-04-5	Launched
narasin	antiprotozoal agent		infectious disease	coccidiosis	MicroSource	100	BRD-A25608658-001-01-1	Launched
naratriptan	serotonin receptor agonist	HTR1A, HTR1B, HTR1D, HTR1E, HTR1F	neurology/psychiatry	migraine headache	Selleck, Selleck	88.86	BRD-K61337602-003-03-9, BRD-K61337602-003-02-1	Launched
naringenin	aromatase inhibitor, TRPV antagonist	CYP19A1, CYP1B1, ESR2, GLO1, HSD17B1			Selleck	96.02	BRD-K08832567-001-11-5	Phase 1
naringeninic-acid		HCAR2, PTGR1			Vitas-M, Sigma	97.59	BRD-K87122641-001-08-1, BRD-K87122641-001-10-7	Phase 1
naringin	cytochrome P450 inhibitor	SLCO1A2			Selleck	92.64	BRD-K02953697-001-09-2	Preclinical
naringin-dihydrochalcone	cytochrome P450 inhibitor				Selleck	91.24	BRD-K13511380-001-01-4	Preclinical
narlaprevir	HCV inhibitor				MedChemEx	95.2	BRD-K38287497-001-01-2	Phase 2/Phase 3
nastorazepide	CCK receptor antagonist	CCKBR			MedChemEx	97.38	BRD-K17295893-001-01-0	Phase 2
natamycin	fungal ergosterol inhibitor		ophthalmology, infectious disease	conjunctivitis, fungal keratosis, blepharitis	MicroSource, MedChemEx, MedChemEx, Sigma, Selleck, Selleck	91.43	BRD-K90563805-213-01-9, BRD-K90563805-001-03-4, BRD-K90563805-001-04-2, BRD-K90563805-001-02-6, BRD-K90563805-001-05-9, BRD-K90563805-001-06-7	Launched
nateglinide	insulin secretagogue	ABCC8, KCNJ10, KCNJ11, PPARG	endocrinology	diabetes mellitus	Tocris, MicroSource, Tocris, Selleck	98.07	BRD-K44353683-001-10-9, BRD-K84658672-001-04-8, BRD-K44353683-001-08-3, BRD-K44353683-001-07-5	Launched
NAV-26	voltage-gated sodium channel blocker	SCN9A			Tocris	97.97	BRD-A84202322-001-01-7	Preclinical
navarixin	CC chemokine receptor antagonist	CXCR1, CXCR2			MedChemEx	93.85	BRD-K82850175-001-01-1	Phase 2
navitoclax	BCL inhibitor	BCL2, BCL2L1, BCL2L2			Selleck, Selleck	94.7	BRD-K82746043-001-19-3, BRD-K82746043-001-15-1	Phase 2
NBI-27914	corticosteroid releasing factor receptor antagonist	CRHR1			Tocris, Tocris	97.59	BRD-K61177364-003-03-7, BRD-K61177364-003-02-9	Preclinical
NBI-74330-(+/-)	CC chemokine receptor antagonist	CXCR3			Tocris	98.26	BRD-A86523169-001-01-0	Preclinical
NBQX	glutamate receptor antagonist	GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIN1, GRIN2A, GRIN2B			Tocris, Tocris, Tocris	98.85	BRD-K11796549-001-05-2, BRD-K11796549-304-01-9, BRD-K11796549-001-04-5	Preclinical
NCS-382	GABA receptor antagonist	GABBR1, GABBR2, SLC52A2			Tocris	97.2	BRD-A85025557-001-02-5	Preclinical
NDT-9513727	complement antagonist	C5AR1			Tocris	91.92	BRD-K17539220-001-01-5	Preclinical
NE-100	sigma receptor antagonist	SIGMAR1			Tocris, Tocris	92.52	BRD-K11443721-003-01-6, BRD-K11443721-003-02-4	Phase 2
nebivolol	adrenergic receptor antagonist	ADRB1, ADRB2	cardiology	hypertension	Tocris, Tocris, Selleck, MicroSource	94.76	BRD-K04956647-003-03-3, BRD-K04956647-003-04-1, BRD-K04956647-003-02-5, BRD-A53597562-003-01-2	Launched
nebracetam	acetylcholine receptor agonist	CHRM1			Enamine	98.57	BRD-A51355958-003-01-9	Phase 3
NECA	adenosine receptor agonist	ADORA1, ADORA2A, ADORA2B, ADORA3, HSP90B1			Tocris, Tocris	98.69	BRD-K14395568-001-17-1, BRD-K14395568-001-16-3	Launched
necrostatin-1	RIPK inhibitor	RIPK1			Tocris, Tocris, Selleck, Selleck	94.54	BRD-A36318220-001-09-6, BRD-A36318220-001-12-0, BRD-A36318220-001-08-8, BRD-A36318220-001-11-2	Preclinical
necrostatin-2	necroptosis inhibitor, RIPK inhibitor	RIPK2			MedChemEx	98.11	BRD-K68851986-001-01-6	Preclinical
nedaplatin	DNA inhibitor				MedChemEx, MedChemEx	0	BRD-K38820178-001-01-6, BRD-K73469236-001-01-8	Launched
nedocromil	histamine receptor antagonist	CYSLTR1, CYSLTR2, FPR1, HSP90AA1, PTGDR	neurology/psychiatry, ophthalmology	itching, conjunctivitis	MedChemEx, MedChemEx, MedChemEx	91.97	BRD-K64716392-001-02-1, BRD-K64716392-001-01-3, BRD-K64716392-001-03-9	Launched
nefazodone	adrenergic inhibitor, norepinephrine reuptake inhibitor, serotonin receptor antagonist, serotonin reuptake inhibitor	ADRA1A, ADRA1B, ADRA2A, CYP3A4, HTR1A, HTR2A, HTR2C, SLC6A2, SLC6A3, SLC6A4			Tocris, MicroSource	97.09	BRD-K90789829-003-12-4, BRD-K90789829-001-07-8	Withdrawn
nefiracetam	acetylcholine receptor agonist, benzodiazepine receptor agonist	CHRM1			Tocris, MicroSource, Selleck	99.27	BRD-K65678996-001-09-7, BRD-K65678996-001-05-5, BRD-K65678996-001-04-8	Phase 3
nefopam	cyclooxygenase inhibitor		neurology/psychiatry	pain relief	Selleck, MicroSource	98.6	BRD-A78877355-003-11-9, BRD-A78877355-001-03-0	Launched
nelarabine	DNA synthesis inhibitor, T cell inhibitor	POLA1	hematologic malignancy	acute lymphoblastic leukemia (ALL), acute lymphoblastic leukemia (ALL)	Selleck	98.35	BRD-K84466663-001-05-4	Launched
nelfinavir	HIV protease inhibitor	CYP1A2, CYP2B6, CYP2C19, CYP2C9, CYP2D6, CYP3A4, CYP3A7	infectious disease	human immunodeficiency virus (HIV-1)	Enzo	98.14	BRD-K74117820-066-10-8	Launched
nemonapride	dopamine receptor antagonist	DRD2, DRD3, DRD4	neurology/psychiatry	schizophrenia	Tocris, Tocris	96.75	BRD-M80207679-001-02-3, BRD-M80207679-001-01-5	Launched
nemorubicin	topoisomerase inhibitor	TOP1, TOP2A			MedChemEx	90.61	BRD-K51911221-001-01-2	Phase 2
neo-gilurytmal					InterBioScreen	83.33	BRD-A53539450-004-01-7	Launched
neohesperidin					Selleck	95.17	BRD-K96299080-001-02-7	Preclinical
neohesperidin-dihydrochalcone					Selleck	94.52	BRD-K61032563-001-02-9	Preclinical
neomycin	bacterial 30S ribosomal subunit inhibitor	CXCR4	gastroenterology, infectious disease	hepatic encephalopathy (HE), intra-abdominal infections	MedChemEx, Sigma, MedChemEx, Selleck	0	BRD-K71013094-326-02-6, BRD-K71013094-001-02-5, BRD-K71013094-326-01-8, BRD-K71013094-065-04-6	Launched
neomycin-sulfate	bacterial 30S ribosomal subunit inhibitor		infectious disease	first-aid antibiotic	Selleck, MicroSource	0	BRD-K71013094-065-05-3, BRD-K71013094-326-03-4	Launched
neostigmine	acetylcholinesterase inhibitor	ACHE	neurology/psychiatry	myasthenia gravis	Selleck, Selleck, MicroSource	95.35	BRD-K18922609-004-24-9, BRD-K18922609-004-22-3, BRD-K18922609-004-23-1	Launched
nepafenac	cyclooxygenase inhibitor	PTGS1, PTGS2	ophthalmology	eye inflammation	Selleck	97.8	BRD-K04112579-001-07-0	Launched
nepicastat	dopamine beta hydroxylase inhibitor	DBH			MedChemEx, Sigma, MedChemEx	91.33	BRD-K09126848-003-03-5, BRD-K09126848-003-02-7, BRD-K09126848-003-01-9	Phase 2
neratinib	EGFR inhibitor	EGFR, ERBB2, KDR			Selleck	90.19	BRD-K85606544-001-09-1	Phase 3
nerbacadol	cyclooxygenase inhibitor				Enamine	85.08	BRD-K43647122-001-01-3	Phase 3
neridronic-acid	bone resorption inhibitor	FDPS	endocrinology	brittle bone disease, Paget's disease	Toronto	0	BRD-K60212747-236-01-1	Launched
nesbuvir	RNA polymerase inhibitor				MedChemEx	98.31	BRD-K79989959-001-01-4	Phase 2
netilmicin	protein synthesis inhibitor		infectious disease	gram-negative bacterial infections	MicroSource, MedChemEx, Selleck, Selleck	100	BRD-A59825838-315-02-5, BRD-A59825838-326-01-4, BRD-A59825838-315-03-3, BRD-A59825838-315-04-1	Launched
netupitant	tachykinin antagonist	TACR1	gastroenterology	nausea, vomiting	MedChemEx	97.52	BRD-K97428065-001-01-2	Launched
neurodazine	neurogenesis of non-pluripotent C2C12 myoblast inducer				Tocris, Tocris	85.65	BRD-K22631935-001-02-7, BRD-K22631935-001-03-5	Preclinical
neuropathiazol	neural stem cell inducer	BMP2, LIF			Tocris	83.16	BRD-K28567778-001-02-7	Preclinical
nevirapine	non-nucleoside reverse transcriptase inhibitor	CYP1A2, CYP2A6, CYP2B6, CYP2C9, CYP2D6, CYP3A4, CYP3A5	infectious disease	human immunodeficiency virus (HIV-1)	MicroSource, Selleck	99.37	BRD-K15502390-001-20-9, BRD-K15502390-001-19-1	Launched
nexturastat-a	HDAC inhibitor	HDAC1, HDAC6			Selleck	91.37	BRD-K70402238-001-02-8	Preclinical
NFKB-activation-inhibitor-II	NFkB pathway inhibitor	RELA			Selleck, Selleck	76.84	BRD-K83354763-001-03-7, BRD-K83354763-001-06-0	Preclinical
NG-nitro-arginine	nitric oxide synthase inhibitor	NOS1, NOS2, NOS3			ChemDiv, Sigma	98.3	BRD-K89223384-001-04-5, BRD-K89223384-001-05-2	Phase 1
NGB-2904	dopamine receptor antagonist	DRD3			Tocris, Tocris	96.62	BRD-K05181084-003-03-7, BRD-K05181084-003-04-5	Preclinical
NGD-94-1	dopamine receptor antagonist	DRD4			Tocris	97.29	BRD-K28639661-001-01-6	Phase 1
NGD-98-2	corticosteroid releasing factor receptor antagonist	CRHR1			Tocris	69.89	BRD-K81779590-003-01-6	Preclinical
NHI-2	lactate dehydrogenase inhibitor	LDHA			Tocris	81.23	BRD-K05653025-001-01-5	Preclinical
NH125	eukaryotic translation elongation factor 2 inhibitor				Tocris, Selleck	97.8	BRD-K31086665-005-01-2, BRD-K31086665-005-04-6	Preclinical
NI-57	bromodomain inhibitor	BRD1, BRPF1, BRPF3			Tocris	97.87	BRD-K03042257-001-01-2	Preclinical
niacin	NAD precursor, vitamin B	DGAT2, HCAR1, HCAR2, HCAR3, NNMT, QPRT	endocrinology	hypertriglyceridemia	Selleck, Selleck, MicroSource	91.85	BRD-K60237333-001-28-9, BRD-K60237333-001-26-3, BRD-K60237333-001-27-1	Launched
nialamide	monoamine oxidase inhibitor	COMT, MAOA, MAOB			MicroSource, Selleck	95.02	BRD-K12102668-001-25-5, BRD-K12102668-001-24-8	Withdrawn
nibentan	potassium channel blocker				Vitas-M	96.69	BRD-A85876464-001-01-5	Phase 2
nicaraven	free radical scavenger				Selleck	96.43	BRD-A86871940-001-01-9	Phase 3
nicardipine	calcium channel blocker	ADORA3, ADRA1A, ADRA1B, ADRA1D, CACNA1C, CACNA1D, CACNA2D1, CACNB2, CALM1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, PDE1A, PDE1B	cardiology	chronic stable angina, hypertension	Selleck, MicroSource	97.24	BRD-A26711594-003-08-0, BRD-A26711594-003-10-6	Launched
nicergoline	adrenergic receptor antagonist	ADRA1A	rheumatology, neurology/psychiatry, cardiology, hematology	Raynaud's disease, migraine headache, atherosclerosis, thrombosis, Raynaud's disease, migraine headache, atherosclerosis, thrombosis	Tocris, MicroSource	96.16	BRD-K76810206-001-08-1, BRD-K76810206-001-07-3	Launched
niceritrol	NAD precursor		endocrinology	hyperlipidemia	Kemprotec	97.86	BRD-K11256763-001-01-5	Launched
niclosamide	DNA replication inhibitor, STAT inhibitor	STAT3	infectious disease	tapeworm	MicroSource, Selleck	97.63	BRD-K35960502-001-20-0, BRD-K35960502-001-19-2	Launched
nicorandil	nitric oxide donor, potassium channel activator	KCNJ11	cardiology	angina pectoris	Tocris, MicroSource, Selleck, Selleck	93	BRD-K97752965-001-14-9, BRD-K97752965-001-15-6, BRD-K97752965-001-13-1, BRD-K97752965-001-16-4	Launched
nicotinamide	protein synthesis stimulant	BST1, LDHA, PARP1, SIRT5	dermatology	acne vulgaris (AV)	MicroSource, Selleck, Selleck	96.39	BRD-K28912512-001-24-0, BRD-K28912512-001-25-7, BRD-K28912512-001-23-2	Launched
nicotine	acetylcholine receptor agonist	CHAT, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB2, CHRNB3, CHRNB4, CYP19A1, TBXAS1, TRPA1	neurology/psychiatry	smoking cessation	Selleck, MicroSource, Selleck	98.55	BRD-A93695607-322-01-7, BRD-K05395900-322-05-4, BRD-A93695607-322-02-5	Launched
nicotinyl-alcohol-tartrate					MicroSource	88.02	BRD-K76600340-045-04-9	Launched
NIDA-41020	cannabinoid receptor antagonist	CNR1			Tocris	97.58	BRD-K17617556-001-01-3	Preclinical
nifedipine	calcium channel blocker	CACNA1C, CACNA1D, CACNA1F, CACNA1H, CACNA1S, CACNA2D1, CACNB2, CALM1, GLRA1, GLRA3, GLRB, KCNA1, KCNA5, NR1I2, TRPM3	cardiology	vasospastic angina, chronic stable angina	MedChemEx, MedChemEx, Tocris, Selleck, MicroSource, Selleck	96.3	BRD-K96354014-001-29-4, BRD-K96354014-001-27-8, BRD-K96354014-001-15-3, BRD-K96354014-001-21-1, BRD-K96354014-001-17-9, BRD-K96354014-001-14-6	Launched
nifekalant	potassium channel blocker		cardiology	ventricular arrhythmias, ventricular tachycardia (VT)	Prestwick	94.25	BRD-K32311154-001-01-0	Launched
nifenalol	adrenergic receptor antagonist	ADRB1, ADRB2			Enamine	87.38	BRD-A21280314-001-06-8	Launched
nifenazone	analgesic agent		neurology/psychiatry	pain relief	Selleck, MicroSource	99.25	BRD-K47407372-001-16-3, BRD-K47407372-001-17-1	Launched
niflumic-acid	cyclooxygenase inhibitor	ANO1, CLCN1, CLCNKA, CLCNKB, KCNQ1, PLA2G1B, PLA2G4A, PTGS1, PTGS2, UGT1A9	rheumatology, neurology/psychiatry	joint pain, muscle pain	MicroSource, Selleck	97.55	BRD-K98763141-001-30-8, BRD-K98763141-001-29-0	Launched
nifuroxazide	bacterial DNA inhibitor		gastroenterology	colitis, diarrhea	MicroSource, Selleck, Selleck	98.14	BRD-K68188368-001-09-4, BRD-K68188368-001-08-6, BRD-K68188368-001-11-0	Launched
nifursol	bacterial DNA inhibitor				MicroSource	96.23	BRD-K85757157-001-01-7	Launched
nifurtimox	DNA inhibitor		infectious disease	Chagas disease, African trypanosomiasis	Prestwick	95.98	BRD-A00100033-001-08-9	Launched
niguldipine-(S)-(+)	adrenergic receptor antagonist	ADRA1A			Tocris, Tocris	94.55	BRD-K59333713-003-03-8, BRD-K59333713-003-02-0	Preclinical
nikethamide	immunostimulant				MicroSource	96.18	BRD-K91544578-001-03-8	Withdrawn
nilotinib	Abl kinase inhibitor, Bcr-Abl kinase inhibitor	ABL1, KIT	hematologic malignancy	chronic myeloid leukemia (CML)	Selleck	98.71	BRD-K81528515-001-13-8	Launched
nilutamide	androgen receptor antagonist	AR	oncology	prostate cancer	MicroSource, Tocris	99.22	BRD-K23566484-001-15-1, BRD-K23566484-001-14-4	Launched
nilvadipine	calcium channel blocker	CACNA1C, CACNA1D, CACNA1S, CACNA2D1, CACNA2D3, CACNB2	cardiology	hypertension, cerebral artery occlusion	Selleck, Selleck	90.2	BRD-A84687895-001-03-2, BRD-A84687895-001-04-0	Launched
nimesulide	cyclooxygenase inhibitor	LTF, PLA2G2E, PTGS1, PTGS2	rheumatology, obstetrics/gynecology	osteoarthritis, menstrual pain	MicroSource, Tocris, Selleck	99.29	BRD-K76775527-001-30-2, BRD-K76775527-001-29-4, BRD-K76775527-001-28-6	Launched
nimodipine	calcium channel blocker	AHR, CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, CFTR, NR3C2	hematology	hemorrhage	MicroSource, Selleck, Tocris	93.03	BRD-A58048407-001-20-4, BRD-A58048407-001-17-0, BRD-A58048407-001-18-8	Launched
nimorazole	bacterial DNA inhibitor		oncology	head and neck squamous cell carcinoma (HNSCC)	MedChemEx	96.86	BRD-K79145628-001-05-5	Launched
nimustine	DNA alkylating agent				MicroSource, Sigma	37.86	BRD-K13240081-001-06-1, BRD-K13240081-003-06-7	Launched
nintedanib	FGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	FGFR1, FGFR2, FGFR3, FGFR4, FLT1, FLT4, KDR, PDGFRA, PDGFRB	pulmonary	idiopathic pulmonary fibrosis (IPF)	Selleck, Selleck	90.8	BRD-K49075727-001-09-3, BRD-K49075727-001-08-5	Launched
niraparib	PARP inhibitor	PARP1	oncology	primary peritoneal cancer (PPC)	MedChemEx, MedChemEx	95.87	BRD-K54955827-001-02-2, BRD-K54955827-001-01-4	Launched
niridazole	phosphofructokinase inhibitor		infectious disease	schistosomiasis	Prestwick	94.95	BRD-K53123955-001-10-5	Launched
nisin	bacterial cell wall synthesis inhibitor				Cayman	0	BRD-A41063939-001-01-0	Phase 1
nisoldipine	calcium channel blocker	CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNA2D1, CACNB2	cardiology	hypertension	MicroSource, MedChemEx, MedChemEx, Selleck, Selleck	86.15	BRD-A84465106-001-05-3, BRD-A84465106-001-09-5, BRD-A84465106-001-08-7, BRD-A84465106-001-03-8, BRD-A84465106-001-06-1	Launched
nisoxetine	norepinephrine reuptake inhibitor	SLC6A2, SLC6A3, SLC6A4			Tocris	98.12	BRD-A95696066-003-13-8	Phase 1
nitarsone			dermatology	blackhead disease	MicroSource, Selleck	89.7	BRD-K56707426-001-02-0, BRD-K56707426-001-01-2	Launched
nitazoxanide	pyruvate ferredoxin oxidoreductase inhibitor		gastroenterology	diarrhea	Selleck, MicroSource, MedChemEx, MedChemEx, Selleck	87.36	BRD-K96471533-001-09-0, BRD-K96471533-001-08-2, BRD-K96471533-001-10-8, BRD-K96471533-001-11-6, BRD-K96471533-001-07-4	Launched
nitecapone	catechol O methyltransferase inhibitor	COMT			Cayman	31.32	BRD-K75551531-001-01-3	Phase 2
nitenpyram			infectious disease	flea control	Selleck	93.18	BRD-K47887731-001-01-4	Launched
nithiamide	bacterial DNA inhibitor				MicroSource, Selleck, Selleck	100	BRD-K39467894-001-05-9, BRD-K39467894-001-04-2, BRD-K39467894-001-06-7	Preclinical
nitisinone	hydroxyphenylpyruvate dioxygenase inhibitor	HPD	metabolism	tyrosinemia	MedChemEx, Enzo	87.67	BRD-K01109406-001-04-5, BRD-K01109406-001-03-7	Launched
nitrendipine	calcium channel blocker	CACNA1C, CACNA1D, CACNA1H, CACNA1S, CACNA2D1, CACNA2D2, CACNB2, CACNG1, KCNN4	cardiology	hypertension	Tocris, MicroSource, Selleck, Tocris	97.81	BRD-A02006392-001-19-8, BRD-A02006392-001-17-2, BRD-A02006392-001-15-6, BRD-A02006392-001-16-4	Launched
nitrocaramiphen	cholinergic receptor antagonist	CHRM1			Tocris	92.79	BRD-K28453807-003-11-2	Preclinical
nitrofurantoin	DNA inhibitor		infectious disease	urinary tract infections, pyelonephritis	MedChemEx, MedChemEx, MicroSource	83.96	BRD-K76927775-001-13-4, BRD-K76927775-001-11-8, BRD-K76927775-001-10-0	Launched
nitrofurazone	bacterial DNA inhibitor		infectious disease	first-aid antibiotic	Selleck, MicroSource	98.77	BRD-K79092138-001-10-2, BRD-K79092138-001-11-0	Launched
nitromide					MicroSource	99.72	BRD-K76381435-001-08-6	Launched
nitrosodimethylurea	DNA synthesis inhibitor				Enamine	0	BRD-K08927448-001-01-9	Preclinical
nitroxoline	cathepsin inhibitor	METAP2	infectious disease	urinary tract infections	MedChemEx, MicroSource	62.54	BRD-K97534525-001-24-3, BRD-K97534525-001-23-5	Launched
nizatidine	histamine receptor antagonist	HRH2	gastroenterology	duodenal ulcer disease, erosive esophagitis (EE), ulcerative esophagitis (UE), gastroesophageal reflux disease (GERD)	Selleck, MicroSource	93.08	BRD-K73589491-001-12-0, BRD-K73589491-001-11-2	Launched
nizofenone	ion channel antagonist		neurology/psychiatry	stroke	AKSci	99.4	BRD-K84011460-051-01-7	Launched
NK-252	NRF2 activator	NFE2L2			Tocris	71.07	BRD-K47441935-001-01-4	Preclinical
NKP-1339	HSP inhibitor				MedChemEx, MedChemEx	76.7	BRD-K74796838-236-01-7, BRD-K81645297-236-01-1	Phase 1
NKY-80	adenylyl cyclase inhibitor	ADCY5			Tocris	92.62	BRD-A75015151-001-07-7	Preclinical
NLG919	indoleamine 2,3-dioxygenase inhibitor	IDO1			MedChemEx, MedChemEx, Selleck, Selleck	79.93	BRD-A62133859-001-03-7, BRD-A62133859-001-04-5, BRD-A62133859-001-01-1, BRD-A62133859-001-02-9	Phase 1
NMDA	glutamate receptor agonist	GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D			Tocris, Selleck	100	BRD-K62414032-001-13-8, BRD-K62414032-001-12-0	Preclinical
NMS-E973	HSP inhibitor				Selleck	96.76	BRD-K58770988-001-01-8	Preclinical
NMS-P715	protein kinase inhibitor				MedChemEx	96.6	BRD-K54170555-001-01-8	Preclinical
NMS-1286937	PLK inhibitor	FLT3, PLK1, PLK2, PLK3			MedChemEx	96.61	BRD-K83699324-001-01-1	Phase 1
NMS-873	ATPase inhibitor	VCP			MedChemEx, Selleck	98.64	BRD-K26253904-001-03-1, BRD-K26253904-001-01-5	Preclinical
NM107	RNA polymerase inhibitor				LifeChem	100	BRD-A66966115-001-01-0	Phase 2
NNC-05-2090	GABA uptake inhibitor, GAT inhibitor	SLC6A12			Tocris, Tocris	98.12	BRD-K85015012-003-02-9, BRD-K85015012-003-03-7	Preclinical
NNC-55-0396	T-type calcium channel blocker	CATSPER1, CATSPER2, CATSPER3, CATSPER4			Tocris, Tocris	97.64	BRD-K78122587-300-04-3, BRD-K78122587-300-02-7	Preclinical
NNC-63-0532	opioid receptor agonist	OPRL1			Tocris, Tocris	97.28	BRD-K72904818-001-02-9, BRD-K72904818-001-01-1	Preclinical
NNC-711	GABA uptake inhibitor	SIGMAR1, SLC6A1			Tocris, Tocris	99.12	BRD-K42221274-003-08-5, BRD-K42221274-003-07-7	Preclinical
NO-ASA	cyclooxygenase inhibitor	PTGS2			Enzo	2.28	BRD-K08807999-001-02-4	Phase 2
nobiletin	MEK inhibitor	MAP2K1			Selleck	97.88	BRD-K06753942-001-14-5	Preclinical
nocodazole	tubulin polymerization inhibitor	HPGDS			Tocris, MicroSource, Selleck, Tocris	95.61	BRD-K12539581-001-25-2, BRD-K12539581-001-23-7, BRD-K12539581-001-21-1, BRD-K12539581-001-22-9	Preclinical
nolatrexed	thymidylate synthase inhibitor	TYMS			AvaChem	95.58	BRD-K36636143-001-01-0	Phase 3
nomegestrol-acetate	progesterone receptor agonist	PGR	endocrinology	contraceptive	Prestwick	96.56	BRD-K27351809-001-09-5	Launched
nomifensine	dopamine uptake inhibitor, noradrenaline uptake inhibitor	DRD2, MAOA, MAOB, MPO, SLC6A2, SLC6A3			Selleck, MicroSource, Selleck	97.52	BRD-A29644307-050-16-2, BRD-A29644307-050-17-0, BRD-A29644307-050-18-8	Withdrawn
nonivamide	TRPV agonist	TRPV1	rheumatology, neurology/psychiatry	rheumatoid arthritis, muscle pain	MicroSource	92	BRD-K05907307-001-07-1	Launched
nonoxynol-9	membrane integrity inhibitor		endocrinology	contraceptive	MicroSource, LKT, MedChemEx	82.85	BRD-K88625236-001-04-2, BRD-K88625236-001-07-5, BRD-K88625236-001-05-9	Launched
nor-Binaltorphimine-dihydrochloride	opioid receptor antagonist	OPRD1, OPRK1, OPRM1			Tocris, Tocris	77.38	BRD-K36381762-300-03-5, BRD-K36381762-300-02-7	Preclinical
norcyclobenzaprine	adrenergic receptor agonist, serotonin receptor antagonist				Prestwick	97.82	BRD-K63165456-001-10-8	Preclinical
norelgestromin		PGR	endocrinology	contraceptive	MedChemEx	88.48	BRD-K42504537-001-01-6	Launched
norepinephrine	adrenergic receptor agonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, PAH, SLC18A1, SLC18A2	cardiology, allergy, neurology/psychiatry	hypertension, urticaria, headache, seasonal affective disorder	Selleck, Selleck, MicroSource	100	BRD-K87349682-347-02-0, BRD-K87349682-347-03-8, BRD-K87349682-001-04-9	Launched
norethindrone	progesterone receptor agonist	PGR	obstetrics/gynecology	endometriosis	Selleck, MicroSource, Selleck	98.2	BRD-K92073408-001-15-7, BRD-K92073408-001-16-5, BRD-K92073408-001-14-0	Launched
norethindrone-acetate	progesterone receptor agonist		endocrinology, orthopedics, obstetrics/gynecology	menopause, osteoporosis, vaginal atrophy	MicroSource	98.25	BRD-A09349126-001-10-7	Launched
norethisterone-enanthate	contraceptive agent		endocrinology	contraceptive	AvaChem	96.7	BRD-K07625016-001-01-2	Launched
noretynodrel	progestogen hormone	PGR	endocrinology	contraceptive	MicroSource	81.73	BRD-A00758722-001-04-9	Launched
norfloxacin	bacterial DNA gyrase inhibitor	TOP2A	infectious disease, urology	urinary tract infections, gonorrhea, prostatitis	Selleck, Selleck, MicroSource	98.57	BRD-K11196887-001-22-0, BRD-K11196887-001-20-4, BRD-K11196887-001-21-2	Launched
norfluoxetine	selective serotonin reuptake inhibitor (SSRI)	HTR2B			Cayman	95.93	BRD-A79769222-001-01-3	Phase 1
norgestimate	progesterone receptor agonist	ESR1, PGR	endocrinology	contraceptive	MicroSource, Sigma	61.05	BRD-K38041788-001-02-9, BRD-K38041788-001-01-1	Launched
norgestrel	progesterone receptor agonist	PGR	endocrinology	contraceptive	MicroSource	98.29	BRD-A14886633-001-01-6	Launched
nornicotine	acetylcholine receptor agonist				Enzo	83.34	BRD-A24543851-001-05-7	Preclinical
nortriptyline	tricyclic antidepressant	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR1A, HTR2A, HTR2C, HTR6, KCNJ10, PGRMC1, SIGMAR1, SLC6A2, SLC6A4	neurology/psychiatry	depression	MicroSource	98.98	BRD-K91263825-003-21-4	Launched
norvancomycin					MedChemEx	65.08	BRD-A08791201-003-01-4	Preclinical
noscapine	bradykinin receptor antagonist, tubulin polymerization inhibitor	SIGMAR1	pulmonary	cough suppressant	Selleck, MicroSource, Tocris	99.38	BRD-K89237706-003-02-6, BRD-K91301684-003-05-5, BRD-K89237706-003-03-4	Launched
NOV-002		GSR, GSTM2			InterBioScreen	94.9	BRD-K11411329-001-01-3	Phase 3
novobiocin	bacterial DNA gyrase inhibitor		obstetrics/gynecology	mastitis	Selleck, MicroSource, Selleck	89.03	BRD-K85307935-236-10-3, BRD-K85307935-236-09-5, BRD-K85307935-236-08-7	Launched
NPC-01	steroid				Sigma	93.36	BRD-K58277159-001-01-7	Phase 3
NPC-15199	ICAM1 antagonist	PPARG			Tocris	78.5	BRD-K65275554-001-04-7	Phase 2
NPPB	chloride channel blocker	ANO1, CLCN2, CLCN7, TRPA1			Tocris, Tocris	98.44	BRD-K89272762-001-13-5, BRD-K89272762-001-12-7	Preclinical
NPS-2143	calcium receptor antagonist	CASR			Tocris, Selleck	98.14	BRD-K75506300-003-01-2, BRD-K75506300-001-01-6	Preclinical
NPY-5RA972	neuropeptide receptor antagonist	NPY5R			Tocris, Tocris	95.24	BRD-K95600043-001-01-5, BRD-K95600043-001-02-3	Preclinical
NQDI-1	caspase inhibitor	CASP3			MedChemEx	96.79	BRD-K61918008-001-07-1	Preclinical
NS-018	JAK inhibitor	JAK1, JAK2, JAK3, TYK2			MedChemEx	92.62	BRD-K21865955-003-01-5	Phase 1/Phase 2
NS-11021	calcium-activated potassium channel activator	KCNMA1			Tocris	0	BRD-K94342292-001-01-3	Preclinical
NS-1643	voltage-gated potassium channel activator	KCNH2, KCNH6, KCNMA1			Tocris	91.34	BRD-K73738482-001-02-5	Preclinical
NS-19504	calcium-activated potassium channel activator	KCNMA1			Tocris	84.54	BRD-K03808106-001-01-9	Preclinical
NS-309	calcium-activated potassium channel activator	KCNN1, KCNN2, KCNN3, KCNN4			Tocris	92.67	BRD-K37602296-001-01-6	Preclinical
NS-3623	voltage-gated potassium channel activator	KCNH2			Tocris	86.42	BRD-K24434292-001-02-1	Preclinical
NS-3861	acetylcholine receptor agonist	CHRNA3, CHRNB4			Tocris	89.71	BRD-A23155040-051-01-7	Preclinical
NS-5806	voltage-gated potassium channel activator	KCND3			Tocris	85.92	BRD-K93314017-001-01-7	Preclinical
NS-8	potassium channel agonist	KCNMA1			Enamine	40.47	BRD-K22667752-001-01-3	Phase 2
NS-8593	calcium-activated potassium channel modulator	KCNN1, KCNN2, KCNN3			Tocris	97.22	BRD-K34624869-003-01-6	Preclinical
NS-9283	acetylcholine receptor allosteric modulator	CHRNA4			Tocris	97.98	BRD-K40176866-001-01-6	Preclinical
NSC-23766	Ras GTPase inhibitor				Tocris, Tocris, Selleck, Selleck	95.29	BRD-A80213327-305-08-3, BRD-A80213327-305-13-3, BRD-A80213327-305-07-5, BRD-A80213327-305-11-7	Preclinical
NSC-319726	p53 activator				Selleck, Tocris, Selleck	84.67	BRD-K99170882-001-04-3, BRD-K99170882-001-06-8, BRD-K99170882-001-05-0	Preclinical
NSC-3852	HDAC inhibitor	HDAC1			Tocris	96.22	BRD-K13169950-001-14-4	Preclinical
NSC-405020	matrix metalloprotease inhibitor	MMP1			Tocris, Selleck	97.07	BRD-A67975844-001-02-6, BRD-A67975844-001-01-8	Preclinical
NSC-4644	ACAT inhibitor, sterol regulatory element binding protein (SREBP) inhibitor	PYGM			Enzo	100	BRD-K64874225-001-04-7	Phase 2
NSC-625987	CDK inhibitor	CDK2, CDK4			Tocris	0.34	BRD-K62949423-001-03-1	Preclinical
NSC-632839	ubiquitin specific protease inhibitor	SENP2, USP1, USP2, USP7			Tocris, Tocris	90.63	BRD-K81197548-003-01-4, BRD-K81197548-003-02-2	Preclinical
NSC-663284	CDC inhibitor	CDC25A, CDC25B, CDC25C			Tocris, Tocris	96.21	BRD-K03109492-001-03-0, BRD-K03109492-001-02-2	Preclinical
NSC-697923	ubiquitin-conjugating enzyme inhibitor	UBE2N			Selleck, Tocris	92.89	BRD-K20605374-001-05-4, BRD-K20605374-001-06-2	Preclinical
NSC-95397	CDC inhibitor	CDC25A, CDC25B			Tocris	9.25	BRD-K68143200-001-11-7	Preclinical
NSC-9965	acetylcholine receptor antagonist	CHRNA4, CHRNB2			Enzo	95.89	BRD-K49811169-004-06-6	Preclinical
NSC5844	CC chemokine receptor agonist	CCR1			MedChemEx	96.41	BRD-K73799155-001-01-5	Preclinical
NSC636819	histone demethylase inhibitor	KDM4A, KDM4B			Tocris	90.48	BRD-K61120504-001-01-6	Preclinical
NSI-189	neurotrophic agent				MedChemEx	99.38	BRD-K74371986-001-01-7	Phase 2
NTNCB	neuropeptide receptor antagonist	NPY5R			Tocris	97.68	BRD-A40413915-003-01-2	Preclinical
NTRC-824	neurotensin receptor antagonist	NTSR2			Tocris	93.63	BRD-K07788774-001-01-0	Preclinical
nTZDpa	PPAR receptor agonist	PPARG			Tocris, Tocris	98	BRD-K54708045-001-03-9, BRD-K54708045-001-02-1	Preclinical
NT157	IGF-1 inhibitor	IGF1R			MedChemEx, MedChemEx	66.42	BRD-K54098378-001-02-4, BRD-K54098378-001-01-6	Preclinical
NU-1025	PARP inhibitor	PARP1			Tocris, Tocris	95.84	BRD-K48692744-001-02-0, BRD-K48692744-001-03-8	Preclinical
NU-2058	cyclin D inhibitor	CCNA2, CDK2			Tocris	91.61	BRD-K20976221-001-12-0	Preclinical
NU-7026	DNA dependent protein kinase inhibitor, mTOR inhibitor, PI3K inhibitor	PRKDC			MedChemEx, Tocris, Selleck	99.72	BRD-K09537769-001-06-5, BRD-K09537769-001-04-0, BRD-K09537769-001-03-2	Preclinical
NU-7441	DNA dependent protein kinase inhibitor	PRKDC			Selleck	98.03	BRD-K00337317-001-06-6	Preclinical
nuclomedone	immunosuppressant				InterBioScreen	93.86	BRD-A96466199-001-01-4	Phase 3
nutlin-3	MDM inhibitor	MDM2, TP53			Selleck, Selleck, Tocris	95.55	BRD-A12230535-001-11-7, BRD-A12230535-001-06-7, BRD-K73255294-001-02-8	Preclinical
NU6027	CDK inhibitor	CCNA2, CDK2			Selleck	93.48	BRD-K03294269-001-08-0	Preclinical
NVP-ADW742	insulin growth factor receptor inhibitor	IGF1R			Selleck, Selleck, Tocris	96.14	BRD-K15179513-001-04-2, BRD-K15179513-001-03-4, BRD-K15179513-001-05-9	Preclinical
NVP-AEW541	IGF-1 inhibitor	IGF1R, INSR			Selleck	94.66	BRD-K24696047-001-02-3	Preclinical
NVP-AUY922	HSP inhibitor	HSP90AA1, HSP90AB1			Selleck, MedChemEx, Selleck	96.22	BRD-K41859756-001-08-4, BRD-K41859756-001-09-2, BRD-K41859756-001-06-8	Phase 2
NVP-BEZ235	mTOR inhibitor, PI3K inhibitor	ATR, MTOR, PIK3CA, PIK3CD, PIK3CG			Selleck, Selleck	98.67	BRD-K12184916-001-19-6, BRD-K12184916-001-15-4	Phase 2
NVP-BGJ398	FGFR inhibitor	FGFR1, FGFR2, FGFR3, FGFR4, KDR			LCLabs, MedChemEx, Selleck, MedChemEx, Selleck	89.82	BRD-K42728290-001-09-1, BRD-K42728290-001-11-7, BRD-K42728290-001-06-7, BRD-K42728290-001-08-3, BRD-K42728290-001-07-5	Phase 2
NVP-BHG712	ephrin inhibitor	EPHB4			Selleck	98.2	BRD-K79259477-001-04-9	Preclinical
NVP-BSK805	JAK inhibitor	JAK2			Selleck, Selleck	92.69	BRD-K02017404-300-07-0, BRD-K02017404-300-06-2	Preclinical
NVP-BVU972	MET inhibitor	MET			Selleck	98.35	BRD-K77943374-001-02-8	Preclinical
NVP-DPP728	dipeptidyl peptidase inhibitor	DPP4			Tocris	92.57	BRD-K77396579-300-01-0	Phase 2
NVP-HSP990	HSP inhibitor	HSP90AA1, HSP90AB1			MedChemEx	94.87	BRD-K67915505-001-01-2	Phase 1
NVP-TAE226	protein tyrosine kinase inhibitor	PTK2			Selleck, Selleck	95.2	BRD-K21025364-001-04-9, BRD-K21025364-001-05-6	Preclinical
NVP-TAE684	ALK tyrosine kinase receptor inhibitor	ALK, INSR			Selleck	90.97	BRD-K50140147-001-10-1	Preclinical
NVP-TNKS656	tankyrase inhibitor	TNKS2			MedChemEx	93.82	BRD-K87454346-001-01-1	Preclinical
NVP-231	ceramidase inhibitor	CERK			Tocris, MedChemEx	96.82	BRD-K01573278-001-03-9, BRD-K01573278-001-02-1	Preclinical
NVS-PAK1-1	p21 activated kinase inhibitor	PAK1			MedChemEx	99.03	BRD-K28132190-001-02-0	Preclinical
NXY-059	free radical scavenger				Tocris, Selleck	91.94	BRD-K46133855-304-03-8, BRD-K46133855-304-02-0	Phase 3
nystatin	fungal ergosterol inhibitor		infectious disease	esophageal candidiasis, skin infections, yeast infection	Sigma, MedChemEx, Selleck, MicroSource, Selleck	61.91	BRD-K21656326-001-01-4, BRD-K21656326-001-02-2, BRD-K25770965-001-01-5, BRD-A78080706-001-04-5, BRD-K45107378-001-01-7	Launched
N20C	glutamate receptor antagonist				Tocris	95.35	BRD-K41143549-003-02-4	Preclinical
N6-cyclopentyladenosine	adenosine receptor agonist	ADORA1, ADORA2A, ADORA2B, ADORA3, SLC29A1			Tocris	97.75	BRD-K60150510-001-15-6	Preclinical
N6-methyladenosine					Selleck	97.73	BRD-K81807412-001-10-6	Preclinical
N6022	alcohol dehydrogenase inhibitor	ADH5			MedChemEx	96.42	BRD-K82522873-001-01-1	Phase 1/Phase 2
o-acetyl-L-serine		PTGS1			Astatech	96.8	BRD-K63247785-001-01-5	Preclinical
o-mercapto-benzoic-acid					Enamine	97.04	BRD-K36998189-001-03-5	Preclinical
O-1918	cannabinoid receptor antagonist				Tocris, Tocris	95.81	BRD-K18316707-001-02-7, BRD-K18316707-001-03-5	Preclinical
o-3M3FBS	phospholipase activator				Tocris, Tocris	98.98	BRD-K46384212-001-03-7, BRD-K46384212-001-02-9	Preclinical
OAC1	Oct activator				Selleck, Tocris	94.83	BRD-K10878147-001-02-2, BRD-K10878147-001-03-0	Preclinical
OAC2	Oct activator	POU5F1			MedChemEx	96.28	BRD-K18305454-001-07-4	Preclinical
obatoclax	BCL inhibitor	BCL2			Selleck, Selleck	89.43	BRD-K15600710-066-05-8, BRD-K15600710-066-04-1	Phase 3
obeticholic-acid	FXR agonist	NR1H4	gastroenterology	primary biliary cholangitis	Selleck	67.62	BRD-A75838038-001-01-4	Launched
obidoxime	cholinesterase reactivator	ACHE	critical care, neurology/psychiatry	poison antidote, nerve gas poisoning	Vitas-M	100	BRD-K33588785-001-01-9	Launched
ochromycinone	STAT inhibitor	STAT3			AnalytiCon	0	BRD-K92524032-001-02-1	Phase 1
ocinaplon	GABA receptor modulator	GABRA1, GABRA2, GABRA3, GABRA5			Tocris	99.66	BRD-K92581468-001-01-6	Phase 3
OCO-1112	cholesterol inhibitor				Enamine	98.74	BRD-K22097830-001-01-9	Phase 2
octadecan-1-ol					Ark	0	BRD-K20501889-001-02-0	Preclinical
octamethyltrisiloxane					Sigma	0	BRD-K73201113-001-01-3	Preclinical
octenidine	membrane integrity inhibitor				TCI	99.2	BRD-K04568635-300-01-4	Launched
octinoxate			dermatology	sunscreen lotion	MicroSource	95.81	BRD-K19972289-001-01-4	Launched
octisalate			dermatology	sunscreen lotion	MicroSource	98.81	BRD-K95161686-001-02-8	Launched
octocrylene			dermatology	sunscreen lotion	MicroSource	98.2	BRD-K39023557-001-01-7	Launched
octodrine	antitumor agent				MicroSource	21.54	BRD-A37873789-001-01-9	Preclinical
octopamine	trace amine associated receptor agonist	F10, TAAR1			Tocris, MicroSource, Selleck, Selleck	100	BRD-A14240607-003-25-3, BRD-A14240607-003-26-1, BRD-A14240607-003-27-9, BRD-A14240607-003-24-6	Preclinical
octreotide	somatostatin receptor agonist	SSTR1, SSTR2, SSTR3, SSTR5	gastroenterology, endocrinology, oncology	diarrhea, acromegaly, carcinoid tumors	MedChemEx, MedChemEx, MedChemEx	91	BRD-A64173453-015-03-1, BRD-A64173453-015-02-3, BRD-A64173453-015-01-5	Launched
OC000459	CRTH receptor antagonist	PTGDR2			MedChemEx, Selleck, Selleck	93.19	BRD-K36463073-001-03-9, BRD-K36463073-001-01-3, BRD-K36463073-001-02-1	Phase 2
odanacatib	cathepsin inhibitor	CTSK			Selleck	97.87	BRD-K22822991-001-02-3	Phase 3
ODM-201	androgen receptor antagonist	AR			MedChemEx, Selleck	98.62	BRD-A44971162-001-01-9, BRD-A44971162-001-02-7	Phase 3
ODQ	guanylyl cyclase inhibitor	GUCY1A2, GUCY1A3, GUCY1B3			Tocris, Tocris	70.01	BRD-K26015241-001-04-4, BRD-K26015241-001-03-6	Preclinical
OF-1	bromodomain inhibitor	BRD1			Tocris	86.25	BRD-K92658264-001-01-8	Preclinical
ofloxacin	bacterial DNA gyrase inhibitor	TOP2A	infectious disease, otolaryngology, gastroenterology, endocrinology	respiratory tract infections, sinusitis, skin infections, bone and joint infections, intra-abdominal infections, diarrhea, fever, urinary tract infections	MicroSource, Selleck	98.67	BRD-A24228527-213-01-9, BRD-A24228527-001-31-5	Launched
OG-L002	histone lysine demethylase inhibitor	KDM1A			Selleck, Selleck	85.35	BRD-K26349472-001-02-1, BRD-K26349472-001-01-3	Preclinical
oglemilast	phosphodiesterase inhibitor				MedChemEx	96.52	BRD-K92303087-001-01-6	Phase 2
OICR-9429	WDR5/MLL interaction inhibitor	WDR5			Tocris	93.82	BRD-K94083718-001-01-9	Preclinical
olanzapine	dopamine receptor antagonist, serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH1, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR3A, HTR5A, HTR6, HTR7	neurology/psychiatry	schizophrenia, bipolar disorder	MicroSource, Tocris, Selleck, Selleck	95.27	BRD-K18895904-001-16-1, BRD-K18895904-001-19-5, BRD-K18895904-001-15-3, BRD-K18895904-001-17-9	Launched
olaparib	PARP inhibitor	PARP1, PARP2	oncology	ovarian cancer	Selleck, Selleck	98.64	BRD-K02113016-001-19-6, BRD-K02113016-001-15-4	Launched
OLDA	TRPV agonist	GPR119			Tocris	96.21	BRD-K95523387-001-09-6	Preclinical
oleamide	cannabinoid receptor agonist	HTR7, PLA2G2A			Tocris	100	BRD-K06644925-001-03-0	Preclinical
oleandrin	Na/K-ATPase inhibitor				MedChemEx	94.48	BRD-K98006098-001-01-6	Phase 1
oleanolic-acid	G protein-coupled receptor agonist	GPBAR1			Selleck, Selleck	90.67	BRD-K90647725-001-07-3, BRD-K90647725-001-06-5	Preclinical
oleoylethanolamide	cannabinoid receptor agonist, glucose dependent insulinotropic receptor agonist, potassium channel blocker, PPAR receptor agonist	CNR1, GPR119, GPR55, PPARA			Tocris	97.64	BRD-K66956375-001-11-3	Preclinical
olesoxime	apoptosis stimulant				MedChemEx, MedChemEx, MedChemEx	69.73	BRD-K18210059-001-01-8, BRD-A33931310-001-02-5, BRD-K18210059-001-02-6	Phase 2/Phase 3
oleuropein	estrogen receptor agonist	GPER1			Selleck	85.99	BRD-A00842753-001-01-9	Phase 2
oligomycin-a	ATP synthase inhibitor, ATPase inhibitor	ATP5A1			Selleck	94.2	BRD-A81541225-001-06-8	Preclinical
olmesartan	angiotensin receptor antagonist	AGTR1	cardiology	hypertension	Tocris, MedChemEx, MicroSource, MedChemEx	95.2	BRD-K83144676-001-09-5, BRD-K83144676-001-08-7, BRD-K83144676-001-06-1, BRD-K83144676-001-07-9	Launched
olmesartan-medoxomil	angiotensin receptor antagonist	AGTR1	cardiology	hypertension	MicroSource, Tocris, Selleck	95.9	BRD-K78485176-001-07-8, BRD-K78485176-001-09-4, BRD-K78485176-001-06-0	Launched
olmutinib	EGFR inhibitor, Bruton's tyrosine kinase (BTK) inhibitor	BTK, EGFR			MedChemEx, MedChemEx	91.76	BRD-K60421517-001-02-2, BRD-K60421517-001-01-4	Launched
olomoucine	CDK inhibitor	CDK1, CDK2, CDK5, MAPK1			Tocris	97.73	BRD-K82731415-001-07-0	Preclinical
olopatadine	histamine receptor antagonist	HRH1, S100A1, S100A12, S100A13, S100A2, S100B	ophthalmology	conjunctivitis	Tocris, Selleck	98.6	BRD-K67637637-003-11-8, BRD-K67637637-003-12-6	Launched
olprinone	phosphodiesterase inhibitor	PDE3A	cardiology	congestive heart failure	MedChemEx	99.86	BRD-K20745393-003-01-0	Launched
olsalazine	cyclooxygenase inhibitor	IFNG, TPMT	gastroenterology	ulcerative colitis	Selleck, MicroSource	98.41	BRD-K57853941-304-02-5, BRD-K57853941-304-03-3	Launched
oltipraz	nuclear factor erythroid derived, like (NRF2) activator	ANG			MicroSource, MicroSource	97.51	BRD-K86972824-001-01-4, BRD-K86972824-001-02-2	Phase 3
olvanil	TRPV agonist	CNR1, GPR119, TRPV1			Tocris, Tocris	94.57	BRD-K31560319-001-02-3, BRD-K31560319-001-01-5	Preclinical
omadacycline	bacterial 30S ribosomal subunit inhibitor				MedChemEx	59.45	BRD-A72591750-066-01-1	Phase 3
omarigliptin	dipeptidyl peptidase inhibitor	DPP4			MedChemEx, MedChemEx	94.52	BRD-K14171291-001-01-4, BRD-K14171291-001-02-2	Launched
ombitasvir	HCV inhibitor		infectious disease	hepatitis C	MedChemEx, MedChemEx	96.54	BRD-K11072003-001-02-4, BRD-K11072003-001-01-6	Launched
OMDM-2	FAAH inhibitor	GPR119			Tocris	92.27	BRD-K48830578-001-01-9	Preclinical
omecamtiv-mecarbil	cardiac myosin activator	MYBPC3			Selleck	94.66	BRD-K36680103-001-01-6	Phase 2
omega-(4-Iodophenyl)pentadecanoic acid					Sigma	13.69	BRD-K53156781-001-01-4	Preclinical
omega-3-acid-esters	cholesterol inhibitor				MicroSource, MedChemEx, MedChemEx	71.9	BRD-K31139048-001-02-4, BRD-K31139048-001-03-2, BRD-K31139048-001-04-0	Launched
omeprazole	ATPase inhibitor	ATP4A, CLCN2	gastroenterology	heartburn	Selleck, MicroSource, Tocris, Selleck	99.07	BRD-A55962179-001-24-7, BRD-A55962179-001-23-9, BRD-A55962179-001-22-1, BRD-A55962179-001-21-3	Launched
omeprazole-magnesium	proton pump inhibitor	ATP4A, ATP4B	gastroenterology	gastroesophageal reflux disease (GERD), heartburn	Vitas-M	98.99	BRD-A56892734-001-09-4	Launched
omeprazole-sulfide	ATPase inhibitor				AKSci	92.79	BRD-K69035426-001-01-3	Phase 1
ON-01500	apoptosis stimulant				Enamine	74.35	BRD-K55790047-001-01-8	Preclinical
oncrasin-1	apoptosis stimulant				Tocris	99.67	BRD-K43449605-001-01-0	Preclinical
ONC201	AKT inhibitor, MAP kinase inhibitor	TNFSF10			Cayman	96.29	BRD-K58529924-001-01-5	Phase 2
ondansetron	serotonin receptor antagonist	HTR1A, HTR1B, HTR3A, HTR3B, HTR4, OPRM1	gastroenterology	nausea, vomiting	Selleck, Selleck, MicroSource	99.41	BRD-A19736161-003-14-7, BRD-A19736161-001-05-9, BRD-A19736161-001-06-7	Launched
ONO-AE3-208	prostanoid receptor antagonist	PTGER4			Tocris	96.3	BRD-A80567330-001-01-7	Preclinical
ONO-4059	Bruton's tyrosine kinase (BTK) inhibitor	BTK			Selleck	97.08	BRD-A13689093-001-01-8	Phase 1
ONO-4817	matrix metalloprotease inhibitor	MMP8			Sigma	97.35	BRD-K58894520-001-01-1	Phase 1
ONO-8130	prostanoid receptor antagonist	PTGER1			Tocris	92	BRD-K76725781-001-01-9	Preclinical
ONX-0914	proteasome inhibitor				Selleck	93.85	BRD-K60446698-001-01-2	Preclinical
ON123300	CDK inhibitor	CDK4, NUAK1, PDGFRB			MedChemEx, MedChemEx	91.24	BRD-K88554883-001-01-6, BRD-K88554883-001-03-2	Preclinical
OPC-21268	vasopressin receptor antagonist	AVPR1A, AVPR2, OXTR			Tocris, Sigma	96.93	BRD-K19426040-001-02-9, BRD-K19426040-001-01-1	Phase 1
opicapone	catechol O methyltransferase inhibitor	COMT			MedChemEx, MedChemEx	94.71	BRD-K66192203-001-01-4, BRD-K66192203-001-02-2	Phase 3
opipramol	sigma receptor agonist		neurology/psychiatry	generalized anxiety disorder (GAD)	Prestwick	97.22	BRD-K43786866-300-02-3	Launched
oprozomib	proteasome inhibitor				Selleck	94.08	BRD-A36331462-001-02-1	Phase 1/Phase 2
OR-486	catechol O methyltransferase inhibitor	COMT			Tocris	0	BRD-K18602506-001-08-0	Preclinical
orantinib	FGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	AURKA, AURKB, EGFR, FGFR1, FGFR2, KDR, PDGFRA, PDGFRB			Selleck, Tocris, Tocris, Selleck	92.22	BRD-K55966568-001-09-6, BRD-K55966568-001-06-2, BRD-K55966568-001-10-4, BRD-K55966568-001-05-4	Phase 3
orbifloxacin	bacterial DNA gyrase inhibitor		infectious disease	urinary tract infections	MicroSource, Selleck, Selleck	99.48	BRD-K63001556-001-08-8, BRD-K63001556-001-10-4, BRD-K63001556-001-09-6	Launched
ORE1001	angiotensin converting enzyme inhibitor	ACE2			EMDBio	94.22	BRD-K67068943-001-01-0	Phase 1/Phase 2
Org-12962	serotonin receptor agonist	HTR2A, HTR2B, HTR2C			Key	91.07	BRD-K07409305-001-01-1	Phase 2
Org-25543	glycine transporter inhibitor	GLRB, SLC6A5			Tocris	97.69	BRD-K32853922-003-01-8	Preclinical
org-26576	glutamate receptor modulator				AMS	98.64	BRD-K40002998-001-01-5	Phase 2
org-27569	cannabinoid receptor modulator	CNR1			Selleck	90.91	BRD-K57597776-001-01-2	Preclinical
org-9768	adrenergic receptor antagonist	ADRA2A			Enamine	93.42	BRD-K41434598-003-01-9	Phase 1
oridonin	BCL inhibitor	BCL2			Selleck, Selleck	92.98	BRD-K23925186-001-02-8, BRD-K23925186-001-01-0	Preclinical
oritavancin	bacterial cell wall synthesis inhibitor		infectious disease	skin infections	MedChemEx	92.37	BRD-A33352494-316-01-6	Launched
orlistat	lipase inhibitor	CNR1, DAGLA, DAGLB, FASN, LIPF, PNLIP	endocrinology	weight-loss aid	MicroSource, Tocris, Selleck	100	BRD-K94062100-001-04-3, BRD-K63343048-001-13-0, BRD-K63343048-001-12-2	Launched
ornidazole	antiprotozoal agent		infectious disease	protozoan infection	MicroSource, Selleck, Selleck	92.96	BRD-A42759514-001-20-5, BRD-A42759514-001-21-3, BRD-A42759514-001-19-7	Launched
ornithine	NFkB pathway modulator	ARG1, ARG2, GATM, GPRC6A, OAT, OAZ1, OAZ2, OAZ3, OTC, SLC25A15, SLC25A2, SLC7A1, SLC7A2, SLC7A3, SLC7A4			MicroSource	0	BRD-A13561534-003-02-0	Launched
orotic-acid		DHODH			MicroSource, Selleck	100	BRD-K32572029-001-05-1, BRD-K32572029-001-04-4	Phase 2
orphanin-fq	opioid receptor agonist	OPRL1, OPRM1			Enzo	63.03	BRD-K05717154-001-01-1	Phase 1
orphenadrine	acetylcholine receptor antagonist	GRIN1, GRIN2D, GRIN3A, GRIN3B, HRH1, SCN10A, SLC6A2	neurology/psychiatry	muscle pain	MicroSource, Selleck	98.55	BRD-A53576514-048-14-3, BRD-A53576514-048-13-5	Launched
orteronel	androgen biosynthesis inhibitor, androgen receptor antagonist, cytochrome P450 inhibitor	CYP17A1			Selleck	97.87	BRD-K00674894-001-01-4	Phase 3
ORY-1001	histone lysine demethylase inhibitor	KDM1A			MedChemEx, Selleck	92.83	BRD-K59711701-300-02-1, BRD-K59711701-300-01-3	Phase 1/Phase 2
oseltamivir-carboxylate	neuraminidase inhibitor		infectious disease	influenza A virus infection	MedChemEx	85.81	BRD-K93767137-001-01-1	Launched
oseltamivir-phosphate	neuraminidase inhibitor	CES1, NEU1, NEU2	infectious disease	influenza A virus infection	Selleck, Selleck, MicroSource	93.88	BRD-K76011241-011-02-5, BRD-K76011241-001-02-6, BRD-K76011241-001-01-8	Launched
osemozotan	serotonin receptor agonist	HTR1A			Sigma	98.16	BRD-K60371362-001-01-7	Phase 2/Phase 3
OSI-027	mTOR inhibitor	MTOR			Selleck, Selleck	91.53	BRD-K87124298-001-03-4, BRD-K87124298-001-04-2	Phase 1
OSI-420	EGFR inhibitor	EGFR			Selleck	96.28	BRD-K73309154-003-02-8	Preclinical
OSI-930	KIT inhibitor, VEGFR inhibitor	KDR, KIT			Selleck, Selleck	86.5	BRD-K25340465-001-11-1, BRD-K25340465-001-07-9	Phase 1
osimertinib	EGFR inhibitor	EGFR	oncology	non-small cell lung cancer (NSCLC)	MedChemEx	87.75	BRD-K42805893-001-04-9	Launched
ospemifene	selective estrogen receptor modulator (SERM)	ESR1, ESR2	obstetrics/gynecology, endocrinology	vaginal atrophy, dyspareunia, menopause	Selleck	99.9	BRD-K44184170-001-01-7	Launched
ostarine	androgen receptor modulator	AR			Selleck	97.85	BRD-K29735307-001-02-9	Phase 3
osthol	calcium channel blocker				Selleck	98.35	BRD-K78294846-001-12-4	Preclinical
OT-R-antagonist-1	oxytocin receptor antagonist	AVPR1A, OXTR			MedChemEx	98.05	BRD-K42009284-001-01-1	Preclinical
otamixaban	coagulation factor inhibitor	F10			MedChemEx	95.95	BRD-K80082640-001-01-0	Phase 3
otenzepad	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5			Tocris, Tocris	92.55	BRD-A00520476-001-08-2, BRD-A00520476-001-07-4	Phase 3
otilonium	acetylcholine receptor antagonist	CACNA1C	gastroenterology	irritable bowel syndrome	Selleck	98.47	BRD-K85337334-004-02-6	Launched
OTS167	maternal embryonic leucine zipper kinase inhibitor	MELK			MedChemEx	93.78	BRD-K53417444-003-03-1	Phase 1
OTS514	TOPK inhibitor				MedChemEx	93.47	BRD-K38018935-001-01-1	Preclinical
OTX015	bromodomain inhibitor	BRD2, BRD3, BRD4			Selleck, Selleck	98.65	BRD-K43471985-001-05-5, BRD-K43471985-001-03-0	Phase 1/Phase 2
ouabain	ATPase inhibitor	ATP1A1	cardiology	hypertension, cardiac arrythmia	Tocris, MicroSource, Selleck	96.12	BRD-K33277808-001-01-2, BRD-K33277808-331-01-3, BRD-K33277808-001-02-0	Launched
OXA-06	rho associated kinase inhibitor	ROCK1, ROCK2			Tocris	96.59	BRD-K98736329-300-01-5	Preclinical
oxacillin	bacterial cell wall synthesis inhibitor		infectious disease	staphylococcal infections	Selleck, Selleck, MicroSource	98.27	BRD-K96786677-323-02-0, BRD-K96786677-323-03-8, BRD-K96786677-236-02-4	Launched
oxacyclohexadecan-2-one	protein kinase inhibitor				Sigma	0	BRD-K36982194-001-01-6	Preclinical
oxaliplatin	DNA inhibitor		oncology	colorectal cancer	Selleck, Tocris, MicroSource, Selleck	98.79	BRD-K78960041-001-05-7, BRD-K78960041-001-03-2, BRD-K78960041-001-07-3, BRD-K78960041-001-02-4	Launched
oxaloacetate	glutamate release inhibitor	CS, SPR			Sigma, Enamine	0	BRD-K61279411-001-03-8, BRD-K61279411-001-02-0	Phase 2/Phase 3
oxandrolone	androgen receptor agonist	AR	endocrinology	weight-gain aid	MedChemEx	100	BRD-K92467929-001-01-1	Launched
oxantel	anthelmintic agent				MicroSource	36.2	BRD-K66019333-096-02-0	Phase 3
oxaprozin	cyclooxygenase inhibitor	PTGS1, PTGS2	rheumatology	osteoarthritis, rheumatoid arthritis	MicroSource, Selleck	99.41	BRD-K25394294-001-14-9, BRD-K25394294-001-13-1	Launched
oxatomide	histamine receptor antagonist	HRH1	allergy	allergic rhinitis	Vitas-M	95.48	BRD-K02079473-001-01-3	Launched
oxazepam	GABA benzodiazepine site receptor agonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3	neurology/psychiatry	anxiety	Enzo	98.7	BRD-A50049929-001-01-9	Launched
oxcarbazepine	sodium channel blocker	SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	neurology/psychiatry	seizures	MicroSource, Selleck, Selleck	95.44	BRD-K04196797-001-24-4, BRD-K04196797-001-23-6, BRD-K04196797-001-25-1	Launched
oxelaidin	antitussive		pulmonary	cough suppressant	Selleck, MicroSource, Selleck	91.86	BRD-K17977438-048-03-2, BRD-K17977438-048-02-4, BRD-K17977438-048-04-0	Launched
oxethazaine	local anesthetic		neurology/psychiatry	local anesthetic	MicroSource, Selleck	94.7	BRD-K56940463-001-14-6, BRD-K56940463-001-13-8	Launched
OXF-BD-02	bromodomain inhibitor	BRD4			Tocris	93.12	BRD-A73891132-001-01-0	Preclinical
oxfendazole	anthelmintic agent		infectious disease	lungworms, tapeworm, gastrointestinal roundworms	MicroSource, Selleck	97.28	BRD-A33447119-001-11-6, BRD-A33447119-001-10-8	Launched
oxfenicine	carnitine palmitoyltransferase inhibitor	CPT1A, CPT1B			Enamine, Vitas-M	98	BRD-K30373577-001-01-1, BRD-A86525947-001-01-4	Phase 1
oxibendazole	tubulin polymerization inhibitor	TUBB, TUBB4B	infectious disease	strongyles	MicroSource, Selleck	96.34	BRD-K52075715-001-07-5, BRD-K52075715-001-06-7	Launched
oxiconazole	bacterial cell wall synthesis inhibitor		infectious disease	tinea pedis, tinea cruris, tinea corporis	MicroSource	98.63	BRD-K56104152-008-04-1	Launched
oxidopamine	neurotoxin				MicroSource	0	BRD-K41809988-003-09-3	Preclinical
oxiniacic-acid					Vitas-M, MicroSource	100	BRD-K20417253-001-02-7, BRD-K20417253-001-01-9	Preclinical
oxiperomide	dopamine receptor antagonist				Enamine	86.05	BRD-K78096648-001-05-7	Phase 2
oxiracetam	acetylcholine receptor agonist				MedChemEx	100	BRD-K50677762-001-01-5	Launched
oxolamine	antitussive		pulmonary	cough suppressant	MicroSource	43.12	BRD-K42596464-048-11-9	Launched
oxolinic-acid	bacterial DNA gyrase inhibitor				MicroSource	95.97	BRD-K73394555-237-01-1	Preclinical
oxonic-acid	uricase inhibitor				AKSci, Sigma	0	BRD-K31468676-237-01-8, BRD-K31468676-237-02-6	Preclinical
oxotremorine-m	acetylcholine receptor agonist	CHRM1, CHRM2, CHRM3, CHRM4			Tocris, Tocris	97.04	BRD-K01942991-005-09-0, BRD-K01942991-005-08-2	Preclinical
oxotremorine-sesquifumarate	cholinergic receptor agonist	CHRM1, CHRM2, CHRM3, CHRM4			Tocris, Tocris	69.87	BRD-K21936341-051-04-0, BRD-K21936341-051-03-2	Preclinical
oxprenolol	adrenergic receptor antagonist	ADRB1, ADRB2	cardiology	angina pectoris, hypertension, cardiac arrythmia	Selleck	95.83	BRD-A43671941-003-11-9	Launched
oxtriphylline	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3, HDAC2, PDE3A, PDE4A, PDE4B, PDE5A	pulmonary	asthma, chronic obstructive pulmonary disease (COPD), bronchospasm	MicroSource	60.29	BRD-K97799481-205-01-9	Launched
oxybenzone	lipase inhibitor	LIPE	dermatology	sunscreen lotion	MicroSource	98.13	BRD-K59037100-001-14-7	Launched
oxybuprocaine	local anesthetic	SCN10A	neurology/psychiatry	local anesthetic	MicroSource, Selleck, Selleck	94.35	BRD-K04185004-003-12-7, BRD-K04185004-003-11-9, BRD-K04185004-003-13-5	Launched
oxybutynin	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3	urology	urinary incontinence	MicroSource, Selleck, Selleck	95.56	BRD-A65013509-003-24-4, BRD-A65013509-001-02-4, BRD-A65013509-003-23-6	Launched
oxyclozanide			infectious disease	fascioliasis	MicroSource	95.82	BRD-K07283971-001-01-3	Launched
oxyfedrine	adrenergic receptor agonist		cardiology	angina pectoris	Kemprotec	94.49	BRD-K73027814-003-01-0	Launched
oxymatrine					Selleck	90.8	BRD-A57833392-001-01-7	Launched
oxymetazoline	adrenergic receptor agonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, HTR1B, HTR1D, HTR2C	otolaryngology	nasal congestion	Tocris, MicroSource, Selleck	99.39	BRD-K16195444-003-25-2, BRD-K16195444-003-26-0, BRD-K16195444-003-24-5	Launched
oxymetholone	androgen receptor agonist	AR	hematology	anemia	Selleck, Selleck	35.22	BRD-A93291428-001-02-0, BRD-A23637604-001-04-1	Launched
oxyphenbutazone	cyclooxygenase inhibitor	PLA2G2E, PTGS1, PTGS2			MicroSource	69.64	BRD-A33749298-001-18-3	Withdrawn
oxyphencyclimine	cholinergic receptor antagonist	CHRM1, CHRM2, CHRM3	gastroenterology	peptic ulcer disease (PUD)	MicroSource	97.02	BRD-A58193911-003-18-7	Launched
oxyphenonium	cholinergic receptor antagonist	CHRM1	gastroenterology	peptic ulcer disease (PUD)	MicroSource	92.38	BRD-A14208071-004-19-8	Launched
oxypurinol	xanthine oxidase inhibitor	XDH			AlfaAesar	95	BRD-K31841515-001-07-8	Phase 2/Phase 3
oxyquinoline	chelating agent	METAP2	dermatology	cosmetic	MicroSource	97.72	BRD-K66808046-065-03-7	Launched
oxytetracycline	bacterial 30S ribosomal subunit inhibitor		infectious disease, urology	chlamydia, urinary tract infections, skin infections, ear infections, gonorrhea, urethritis, Lyme disease	Selleck, MedChemEx, Selleck, Sigma, MedChemEx, Selleck, MicroSource, Selleck	51.7	BRD-A22740840-001-09-7, BRD-A56621826-001-02-1, BRD-A22740840-001-10-5, BRD-A22740840-002-07-9, BRD-A22740840-001-11-3, BRD-A22740840-335-06-5, BRD-A22740840-003-06-9, BRD-A22740840-001-08-9	Launched
oxytocin	oxytocin receptor agonist	AVPR1A, AVPR1B, AVPR2, OXTR	obstetrics/gynecology	labor induction	Sigma, MedChemEx	84.04	BRD-K25243230-001-01-2, BRD-K25243230-001-02-0	Launched
ozagrel	thromboxane synthase inhibitor	TBXAS1	neurology/psychiatry	stroke	Selleck, Selleck, Tocris	96.99	BRD-K53061490-003-13-9, BRD-K53061490-001-02-6, BRD-K53061490-003-14-7	Launched
ozanimod	sphingosine 1 phosphate receptor agonist	S1PR1			MedChemEx	98.03	BRD-K46625559-001-01-8	Phase 3
ozolinone	diuretic				Sigma	78.8	BRD-A72297358-001-01-8	Phase 3
O4I1	Oct inducer	POU5F1			Tocris	0	BRD-K53849769-001-01-0	Preclinical
O6-Benzylguanine	O6-alkylguanine-DNA alkyltransferase inhibitor	MGMT			CombiBlocks	98.19	BRD-K92041145-001-09-5	Phase 3
p-dimethylinamyl-benzoate					Enamine	26.63	BRD-K42336459-001-01-7	Preclinical
PA-452	retinoid receptor antagonist	RXRA			Tocris	96.7	BRD-K11428250-001-01-0	Preclinical
PA-824	nitric oxide donor	FASN			Selleck	96.87	BRD-K96671969-001-03-1	Phase 3
PAC-1	caspase activator	CASP3			Tocris, Tocris, Selleck	96.8	BRD-K92991072-001-05-6, BRD-K92991072-001-06-4, BRD-K92991072-001-04-9	Phase 1
paclitaxel	tubulin polymerization inhibitor	BCL2, MAP2, MAP4, MAPT, NR1I2, TLR4, TUBB, TUBB1	oncology	ovarian cancer, breast cancer, non-small cell lung cancer (NSCLC)	Tocris, MicroSource, Selleck, Selleck, Tocris	98.1	BRD-K62008436-001-25-4, BRD-K62008436-001-22-1, BRD-K62008436-001-18-9, BRD-K62008436-001-23-9, BRD-K62008436-001-24-7	Launched
PACOCF3	phospholipase inhibitor	PLA2G4A			Tocris	0	BRD-K05677083-001-05-4	Preclinical
pacritinib	FLT3 inhibitor, JAK inhibitor	FLT3, JAK1, JAK2, JAK3			MedChemEx, Selleck, Selleck	90.7	BRD-K19034817-001-04-8, BRD-K19034817-001-01-4, BRD-K19034817-001-02-2	Phase 3
paeoniflorin	anticonvulsant				Selleck, Selleck	80.79	BRD-K83631119-001-02-1, BRD-K83631119-001-03-9	Preclinical
paeonol	anti-inflammatory agent				Selleck	94.76	BRD-K94239562-001-05-5	Preclinical
pafuramidine	DNA synthesis inhibitor				MedChemEx	94.73	BRD-K68805147-001-01-8	Phase 3
palbociclib	CDK inhibitor	CDK4, CDK6	oncology	breast cancer	Selleck, Selleck	94.04	BRD-K51313569-001-07-8, BRD-K51313569-003-03-3	Launched
palifosfamide	DNA alkylating agent				MedChemEx, MedChemEx	0	BRD-K12047401-001-01-5, BRD-K12047401-001-02-3	Phase 3
paliperidone	dopamine receptor antagonist, serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CYP2D6, CYP3A4, CYP3A5, DRD1, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1D, HTR2A, HTR2C	neurology/psychiatry	schizophrenia	Selleck, Selleck, MicroSource	96.4	BRD-A99888680-001-05-3, BRD-A99888680-001-03-8, BRD-A99888680-001-04-6	Launched
palmatine-chloride	dopamine synthesis inhibitor	CYP3A4			Selleck	92.35	BRD-K58466253-003-14-0	Preclinical
palmitoleic-acid					Sigma	97.5	BRD-K91356052-001-04-0	Preclinical
palmitoylcarnitine	protein kinase inhibitor				Tocris	100	BRD-A77577770-003-08-9	Preclinical
palmitoylethanolamide	cannabinoid receptor agonist	CNR2, GPR119, GPR55			MicroSource, Tocris	96.53	BRD-K68095457-001-11-9, BRD-K68095457-001-10-1	Launched
palomid-529	AKT inhibitor, mTOR inhibitor	MTOR			Selleck	94.07	BRD-A50998626-001-02-1	Phase 1
palonosetron	serotonin receptor antagonist	HTR3A	gastroenterology	nausea, vomiting	Selleck	97.7	BRD-K08924299-003-06-1	Launched
palosuran	urotensin receptor antagonist	UTS2R			MedChemEx	98.46	BRD-K07682953-001-01-8	Phase 2
palovarotene	retinoid receptor agonist	RARG			MedChemEx	85.97	BRD-K83794243-001-01-8	Phase 2
pamabrom	diuretic		gastroenterology	bloating	MicroSource	0	BRD-M67659203-001-01-9	Launched
pamidronate	bone resorption inhibitor	FDPS	endocrinology, oncology, hematologic malignancy	hypercalcemia, Paget's disease, breast cancer, multiple myeloma	Selleck, Selleck	0	BRD-K58513245-304-03-5, BRD-K58513245-304-02-7	Launched
pancuronium	acetylcholine receptor antagonist	CHRM2, CHRM3, CHRNA1, CHRNA2	critical care, neurology/psychiatry	endotracheal intubation, muscle relaxant	Selleck, Selleck	100	BRD-K50817623-303-05-7, BRD-K50817623-303-06-5	Launched
panobinostat	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC4, HDAC6, HDAC7, HDAC8, HDAC9	hematologic malignancy	multiple myeloma	Selleck, MedChemEx, MedChemEx, Selleck	81.65	BRD-K02130563-001-12-2, BRD-K02130563-001-15-5, BRD-K02130563-001-14-8, BRD-K02130563-001-11-4	Launched
pantethine	coenzyme A precursor				Sigma, MedChemEx, MedChemEx, MicroSource	97.01	BRD-K68764924-001-03-2, BRD-K68764924-001-05-7, BRD-K68764924-001-04-0, BRD-A76244192-001-02-4	Launched
pantoprazole	ATPase inhibitor	ATP4A	gastroenterology	gastroesophageal reflux disease (GERD), erosive esophagitis (EE), Zollinger-Ellison syndrome	MicroSource, MedChemEx, SantaCruz	99.89	BRD-A22380646-001-05-6, BRD-A22380646-236-06-6, BRD-A22380646-236-05-8	Launched
pantothenic-acid	coenzyme A precursor				Selleck, MicroSource, Selleck	86.63	BRD-K29392254-001-02-2, BRD-K29392254-236-01-6, BRD-K29392254-001-03-0	Launched
PAOPA	dopamine receptor modulator	DRD2			Tocris	69.39	BRD-K18573821-001-02-4	Preclinical
papaverine	phosphodiesterase inhibitor	PDE10A, PDE4B, PDE5A	cardiology, hematology, gastroenterology	myocardial infarction, angina pectoris, pulmonary embolism (PE), colitis, vascular spasm	MicroSource	99.78	BRD-K15567136-003-27-2	Launched
para-toluenesulfonamide		CA12, CA2, CA6, CA9			Enamine	97.72	BRD-K62412084-001-07-1	Phase 3
paracetamol	cyclooxygenase inhibitor	FAAH, PTGS1, PTGS2, TRPV1	neurology/psychiatry, endocrinology	pain relief, fever	Tocris, MicroSource, Tocris	95	BRD-K41524689-001-25-0, BRD-K41524689-001-23-5, BRD-K41524689-001-22-7	Launched
parachlorophenol	antiinfective drug				MicroSource	89.27	BRD-K40992116-001-09-7	Launched
paramethadione	anticonvulsant	CACNA1G, CACNA1H, CACNA1I	neurology/psychiatry	seizures	MicroSource, Enamine	15	BRD-A22128695-001-02-6, BRD-A22128695-001-03-4	Launched
paraxanthine	adenosine receptor antagonist				Enzo	97.98	BRD-K24084088-001-11-3	Phase 1
parbendazole	tubulin polymerization inhibitor	TUBB			Prestwick	98.82	BRD-K02407574-001-09-7	Preclinical
pardoprunox	serotonin receptor agonist, dopamine receptor agonist	DRD2, DRD3, DRD4, HTR1A, HTR7			MedChemEx	95.88	BRD-K11851476-003-01-7	Phase 3
parecoxib	cyclooxygenase inhibitor	LTF	neurology/psychiatry	pain relief	MedChemEx	99.02	BRD-K13800121-001-01-5	Launched
parethoxycaine	local anesthetic				ChemBridge	91.8	BRD-K54799382-003-08-4	Preclinical
pargyline	monoamine oxidase inhibitor	MAOA, MAOB	cardiology	hypertension	MicroSource	99.36	BRD-K83597974-003-22-2	Launched
paricalcitol	vitamin D receptor agonist	VDR	nephrology, endocrinology	chronic kidney disease (CKD), hyperthyroidism	MedChemEx	98.6	BRD-K60585088-001-01-5	Launched
paritaprevir	HCV inhibitor		infectious disease	hepatitis C	MedChemEx	97.16	BRD-K89920762-001-01-4	Launched
paromomycin	bacterial 30S ribosomal subunit inhibitor		infectious disease	amebiasis	MicroSource, MedChemEx, Sigma, Selleck, Selleck	97.2	BRD-K36524108-065-06-5, BRD-K36524108-065-04-0, BRD-K36524108-065-07-3, BRD-K36524108-065-05-7, BRD-K36524108-065-03-2	Launched
paroxetine	selective serotonin reuptake inhibitor (SSRI)	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HTR2A, SLC6A2, SLC6A4	neurology/psychiatry	depression, obsessive compulsive disorder (OCD), generalized anxiety disorder (GAD), panic disorders, posttraumatic stress disorder, social anxiety disorder	MicroSource, Tocris, Selleck	94.73	BRD-K37991163-003-14-2, BRD-K37991163-050-18-4, BRD-K37991163-003-13-4	Launched
paroxypropione	gonadotropin inhibitor				MicroSource	93.24	BRD-K07441213-001-18-9	Launched
parthenolide	NFkB pathway inhibitor				Tocris, Tocris	96.19	BRD-K98548675-001-06-7, BRD-K98548675-001-05-9	Phase 1
parthenolide-(-)	NFkB pathway inhibitor	HDAC1			Selleck	96.2	BRD-K34851558-001-02-3	Preclinical
parthenolide-(alternate-stereo)	NFkB pathway inhibitor	IKBKB, RELA			Prestwick	97.8	BRD-K28120222-001-08-4	Preclinical
pasiniazid	cyclooxygenase inhibitor		infectious disease	tuberculosis	MicroSource, Selleck	93.93	BRD-K87202646-061-05-6, BRD-K87202646-061-04-9	Launched
pasireotide	somatostatin receptor agonist	SSTR1, SSTR2, SSTR3, SSTR5	endocrinology	Cushing's syndrome, acromegaly	MedChemEx	87.58	BRD-K59715032-362-01-4	Launched
pazopanib	KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	CSF1R, FGF1, FGFR1, FGFR3, FLT1, FLT4, ITK, KDR, KIT, PDGFRA, PDGFRB, SH2B3	oncology	renal cell carcinoma (RCC), soft tissue sarcoma (STS)	Selleck, Selleck	98.32	BRD-K74514084-003-09-2, BRD-K74514084-001-03-9	Launched
pazufloxacin	topoisomerase inhibitor		infectious disease	pneumonia, peritonitis, bacterial septicemia	MicroSource	97.79	BRD-K66412701-066-01-6	Launched
PCA-4248	platelet activating factor receptor antagonist	PTAFR			Tocris, Tocris	91.88	BRD-A29289453-001-05-4, BRD-A29289453-001-04-7	Phase 1
PCI-24781	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC6			Selleck	90.76	BRD-K12867552-001-04-7	Phase 1/Phase 2
PCI-29732	Bruton's tyrosine kinase (BTK) inhibitor	BTK			Tocris	0	BRD-K71223042-001-01-5	Preclinical
PCI-34051	HDAC inhibitor	HDAC1, HDAC10, HDAC6, HDAC8			Selleck, Selleck, Tocris	88.28	BRD-K88742110-001-07-9, BRD-K88742110-001-08-7, BRD-K88742110-001-09-5	Preclinical
PCO-400	potassium channel activator	KCNJ8			Enzo	32.31	BRD-K52721684-001-03-0	Phase 1
PD-0325901	MEK inhibitor	MAP2K1			Selleck	95.2	BRD-K49865102-001-08-4	Phase 2
PD-102807	acetylcholine receptor antagonist	CHRM4			Tocris, Tocris	88.27	BRD-A89337244-001-03-7, BRD-A89337244-001-02-9	Preclinical
PD-118057	potassium channel activator	KCNH2			Sigma	94.44	BRD-K34657753-001-01-9	Preclinical
PD-123319	angiotensin antagonist	AGTR2			Selleck, Tocris	95.92	BRD-K34713073-001-01-3, BRD-K34713073-362-01-9	Phase 1
PD-128907	dopamine receptor agonist	DRD2, DRD3			Selleck, Selleck, Tocris	91.59	BRD-K20260086-001-01-6, BRD-K38797369-003-01-1, BRD-K62456038-003-07-1	Preclinical
PD-153035	EGFR inhibitor	EGFR, KDR			MedChemEx	98.35	BRD-K26603252-003-04-9	Phase 1
PD-156707	endothelin receptor antagonist	EDNRA, EDNRB			Sigma	71.03	BRD-K13826399-236-01-7	Preclinical
PD-158780	EGFR inhibitor	EGFR			Tocris, Tocris	69.87	BRD-K48735772-001-03-0, BRD-K48735772-001-04-8	Preclinical
PD-160170	neuropeptide receptor antagonist	NPY1R			Tocris, Tocris	97.6	BRD-K12079898-001-02-6, BRD-K12079898-001-03-4	Preclinical
PD-161570	FGFR inhibitor	FGFR1			Tocris, Tocris	86.49	BRD-K97152684-001-01-9, BRD-K97152684-001-02-7	Preclinical
PD-166285	src inhibitor	EGFR, FGFR1, PDGFRB, PKMYT1, SRC, WEE1			Tocris	93.87	BRD-K93217218-300-01-5	Preclinical
PD-166793	collagenase inhibitor, metalloproteinase inhibitor	MMP13, MMP2, MMP3			Tocris, Tocris	98.52	BRD-K60984070-001-01-0, BRD-K60984070-001-02-8	Preclinical
PD-168077	dopamine receptor agonist	DRD2			Tocris	20.24	BRD-K47761761-050-07-8	Preclinical
PD-168393	EGFR inhibitor	EGFR, ERBB2, SRC			Selleck	96.19	BRD-K17702546-001-03-2	Preclinical
PD-168568	dopamine receptor antagonist	DRD2, DRD4			Tocris	96.65	BRD-A82013137-300-01-1	Preclinical
PD-173074	FGFR inhibitor, VEGFR inhibitor	FGFR1, FGFR2, FGFR3, FGFR4, FLT1, FLT4, KDR, PDGFRA, PDGFRB			Selleck, Selleck, Tocris	94.27	BRD-K97764662-001-20-7, BRD-K97764662-001-17-3, BRD-K97764662-001-21-5	Preclinical
PD-173212	calcium channel blocker	CACNA1B			Tocris	91.84	BRD-K04426574-001-02-0	Preclinical
PD-184352	MEK inhibitor	MAP2K1, MAP3K1, MAP3K2			Selleck	96.78	BRD-K05104363-001-10-0	Phase 2
PD-198306	MAP kinase inhibitor, MEK inhibitor	MAP2K1, MAP2K2			Tocris	93.92	BRD-K88677950-001-03-9	Preclinical
PD-318088	MEK inhibitor	MAP2K1			Selleck	95.69	BRD-A57798112-001-03-7	Preclinical
PD-407824	PKC inhibitor	WEE1			Tocris, Tocris	92.11	BRD-K82823804-001-04-1, BRD-K82823804-001-05-8	Preclinical
PD-81723	adenosine receptor agonist	ADORA1			Tocris	10.23	BRD-K77951111-001-04-5	Preclinical
PD-98059	MEK inhibitor	AKT1, CHEK1, GSK3B, LCK, MAP2K1, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1			Selleck, Tocris, Tocris	94.02	BRD-K62810658-001-11-4, BRD-K62810658-001-15-5, BRD-K62810658-001-12-2	Preclinical
PDE10-IN-1	phosphodiesterase inhibitor	PDE10A			MedChemEx	96.99	BRD-K38145871-001-01-8	Preclinical
PDP-EA	FAAH activator	FAAH			Tocris	96.07	BRD-K26358347-001-01-7	Preclinical
PD1-PDL-inhibitor-1	programmed death ligand inhibitor	CD274			MedChemEx	97.25	BRD-K04032780-001-01-8	Preclinical
peficitinib	JAK inhibitor	JAK1, JAK2, JAK3			MedChemEx, Selleck	98.78	BRD-K21225231-001-01-2, BRD-A14577621-001-01-5	Phase 3
pefloxacin	bacterial DNA gyrase inhibitor	TOP2A	infectious disease, urology	gastrointestinal infections, urethritis, gonorrhea, urinary tract infections	MicroSource, Selleck	98.47	BRD-K55034111-066-17-1, BRD-K55034111-066-16-3	Launched
pelanserin	serotonin receptor antagonist	HTR2A			Enamine	91.31	BRD-K96436774-001-01-8	Phase 2
pelitinib	EGFR inhibitor	EGFR			Selleck	92.07	BRD-K08799216-001-05-3	Phase 2
pemetrexed	dihydrofolate reductase inhibitor, thymidylate synthase inhibitor	ATIC, DHFR, GART, TYMS	oncology	non-small cell lung cancer (NSCLC), mesothelioma	Key, Selleck, MedChemEx, MedChemEx, Selleck, MicroSource	87.62	BRD-K32842773-434-01-8, BRD-K32842773-304-04-7, BRD-K32842773-304-05-4, BRD-K32842773-380-01-3, BRD-K32842773-304-06-2, BRD-K32842773-304-03-9	Launched
pemirolast	mediator release inhibitor	HRH1	pulmonary	asthma	MedChemEx, Selleck	97.42	BRD-K31731454-237-03-3, BRD-K31731454-237-02-5	Launched
pempidine	ganglionic blocker		cardiology	hypertension	MicroSource	52.72	BRD-K71075093-045-14-7	Launched
penbutolol	adrenergic receptor antagonist	ADRB1, ADRB2, HTR1A, HTR1B	cardiology	hypertension	MicroSource	90.41	BRD-K55705469-065-01-0	Launched
penciclovir	DNA directed DNA polymerase inhibitor		dental	cold sore	Selleck, MicroSource, Selleck	94.53	BRD-K47780086-001-06-1, BRD-K47780086-001-07-9, BRD-K47780086-001-08-7	Launched
penfluridol	T-type calcium channel blocker	CACNA1G	neurology/psychiatry	schizophrenia	MicroSource, Selleck	93.21	BRD-K15409150-001-07-4, BRD-K15409150-001-05-8	Launched
penicillamine-(D)	chelating agent		metabolism, rheumatology, nephrology	Wilson's disease, rheumatoid arthritis, cystinuria	Selleck, Selleck	0	BRD-K17518951-001-03-0, BRD-K17518951-001-04-8	Launched
penicillamine-(racemic)					MicroSource	0	BRD-A16376407-213-01-1	Preclinical
penicillin-v-potassium	bacterial cell wall synthesis inhibitor		infectious disease	pneumonia, ear infections, skin infections, throat infections, cholera, scarlet fever	MicroSource	90.16	BRD-K43966364-237-04-8	Launched
pentacosanoic-acid					Cayman	100	BRD-K48996094-001-01-3	Preclinical
pentagastrin	CCK receptor agonist	CCKBR	gastroenterology	anacidity diagnostic, gastric hypersecretion diagnostic, anacidity diagnostic, gastric hypersecretion diagnostic	MicroSource, Abblis	84.88	BRD-K78789465-001-02-4, BRD-K78789465-001-01-6	Launched
pentamidine	anti-pneumocystis agent	TRDMT1	infectious disease	pneumonia	MicroSource, Selleck	98.99	BRD-K13183738-317-10-2, BRD-K13183738-300-02-5	Launched
pentetic-acid	chelating agent	PGD			MicroSource	99.18	BRD-K40621224-001-06-7	Phase 2
pentobarbital	barbiturate antiepileptic, GABA receptor modulator	CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B			Prestwick	91.76	BRD-A44448661-001-04-8	Withdrawn
pentolinium	cholinergic receptor antagonist	CHRNA10, CHRNA3, CHRNA4, CHRNB4	cardiology	hypertension	Prestwick, Acros	97.01	BRD-K44942604-346-04-7, BRD-K44942604-346-05-4	Launched
pentostatin	adenosine deaminase inhibitor, ribonucleotide reductase inhibitor	ADA	hematologic malignancy	hairy cell leukemia	MedChemEx, Enzo	86.61	BRD-K91543828-001-02-0, BRD-A17154931-001-01-5	Launched
pentoxifylline	phosphodiesterase inhibitor	ADORA1, ADORA2A, ADORA2B, ADRA2B, NT5E, PDE10A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PDE6A, PDE6B, PDE6C, PDE6D, PDE6G, PDE6H, PDE7A, PDE7B, PDE8A, PDE8B, PDE9A, TNF	cardiology	claudication	MicroSource, Selleck	99.53	BRD-K57569181-001-27-5, BRD-K57569181-001-26-7	Launched
pentylenetetrazol	GABA receptor antagonist				MedChemEx, Tocris, MicroSource	76.62	BRD-K57718010-001-12-7, BRD-K57718010-001-10-1, BRD-K57718010-001-11-9	Withdrawn
pepstatin	aspartic protease inhibitor	CTSB, CTSD, CTSL, REN			Enzo	94.54	BRD-K13571841-001-14-4	Preclinical
peramivir	neuraminidase inhibitor		infectious disease	influenza A virus infection	Selleck, Selleck	85.33	BRD-K00519864-341-02-5, BRD-K00519864-341-03-3	Launched
perampanel	glutamate receptor antagonist	GRIA1, GRIA2, GRIA3, GRIA4	neurology/psychiatry	seizures	MedChemEx	99.4	BRD-K41438959-001-01-7	Launched
perchlozone			infectious disease	tuberculosis	Vitas-M	99.35	BRD-K86435560-001-01-0	Launched
peretinoin	retinoid receptor agonist	RXRA			MedChemEx, MedChemEx	85.75	BRD-K99431849-001-01-7, BRD-K99431849-001-02-5	Phase 3
perfluamine					Oakwood	0	BRD-K16758059-001-01-8	Launched
perflubron	contrast agent		radiology	contrast agent	Sigma, Oakwood	0	BRD-K92988025-001-02-7, BRD-K92988025-001-01-9	Launched
perfluorodecalin			dermatology	cosmetic	Sigma	0	BRD-K55401595-001-01-8	Launched
pergolide	dopamine receptor agonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C			Selleck, Selleck	93	BRD-K60770992-066-26-8, BRD-K60770992-066-25-0	Withdrawn
perhexiline	carnitine palmitoyltransferase inhibitor	CPT1A, CPT2	cardiology	angina pectoris	MicroSource	97.96	BRD-A19633847-050-32-1	Launched
perifosine	AKT inhibitor	AKT1			MedChemEx, MedChemEx, MedChemEx	98.4	BRD-A89082344-001-07-9, BRD-A89082344-001-06-1, BRD-A89082344-001-08-7	Phase 3
perillyl-alcohol	apoptosis stimulant, farnesyltransferase inhibitor	FNTA			Enamine, Enamine	0	BRD-A13323580-001-05-5, BRD-A13323580-001-04-8	Phase 2
perindopril	angiotensin converting enzyme inhibitor	ACE	cardiology	hypertension, myocardial infarction, coronary artery disease (CAD)	MicroSource, Selleck	95.89	BRD-K92731339-227-04-9, BRD-K92731339-227-05-6	Launched
perindoprilat	angiotensin converting enzyme inhibitor	ACE			MicroSource	3.67	BRD-K00768353-001-01-8	Phase 2
permethrin		SCN1A	infectious disease	lice	MedChemEx, MicroSource, Sigma	0	BRD-A25366096-001-09-9, BRD-A25366096-001-07-3, BRD-A25366096-001-08-1	Launched
perospirone	dopamine receptor antagonist, serotonin receptor antagonist	DRD2, DRD3, DRD4	neurology/psychiatry	schizophrenia, bipolar disorder	Prestwick, AKSci	98.77	BRD-K85503079-001-01-0, BRD-K85503079-001-02-8	Launched
perphenazine	dopamine receptor antagonist	CALM1, DRD1, DRD2, HRH1, HTR2A, HTR2C, HTR6, HTR7	neurology/psychiatry, gastroenterology	schizophrenia, nausea, vomiting	MicroSource, MedChemEx, Sigma	87.72	BRD-K10995081-001-26-1, BRD-K10995081-001-28-7, BRD-K10995081-001-27-9	Launched
peruvoside	cardiac glycoside				Enzo	70.11	BRD-A72716251-001-01-5	Phase 1
perzinfotel	glutamate receptor antagonist	GRIN1, GRIN2A, GRIN2B			Sigma	97	BRD-K04643877-001-03-2	Phase 2
PETCM	caspase activator	CASP3			Tocris	93.77	BRD-A93477898-001-04-2	Preclinical
pevonedistat	nedd activating enzyme inhibitor	NAE1, UBA3			MedChemEx	94.15	BRD-K67844266-003-01-9	Phase 2
pexidartinib	tyrosine kinase inhibitor	CSF1R, FLT3, KIT			MedChemEx	94.45	BRD-K54519451-001-02-9	Phase 3
pexmetinib	TIE tyrosine kinase inhibitor, MAP kinase inhibitor	MAPK14, TEK			Selleck, Selleck	99.4	BRD-K53405000-001-02-8, BRD-K53405000-001-01-0	Phase 1
PF-02545920	phosphodiesterase inhibitor	PDE10A			Selleck	95.3	BRD-K31519811-001-02-2	Phase 2
PF-03049423	phosphodiesterase inhibitor	PDE5A			Key	97.3	BRD-K07070922-001-01-4	Phase 2
PF-03084014	gamma secretase inhibitor				MedChemEx	91.79	BRD-K61691541-001-01-1	Phase 2
PF-03758309	p21 activated kinase inhibitor	PAK4			MedChemEx	95.43	BRD-K37764012-001-04-1	Phase 1
PF-03814735	Aurora kinase inhibitor	AURKA, AURKB			MedChemEx, Tocris	99.4	BRD-K68747584-001-02-0, BRD-K68747584-001-03-8	Phase 1
PF-03882845					Sigma	87.47	BRD-K51041191-001-01-4	Phase 1
PF-04136309	CC chemokine receptor antagonist				MedChemEx	97.35	BRD-K94420399-001-01-9	Phase 2
PF-04217903	c-Met inhibitor	MET			Selleck	97.26	BRD-K73319509-001-08-0	Phase 1
PF-04418948	prostaglandin inhibitor	PTGER2			Tocris, Selleck	99.27	BRD-K54871792-001-02-2, BRD-K54871792-001-01-4	Phase 1
PF-04447943	phosphodiesterase inhibitor	PDE9A			MedChemEx	97.37	BRD-K50031829-001-01-6	Phase 2
PF-04457845	FAAH inhibitor	FAAH			MedChemEx	99.1	BRD-K86816506-001-01-8	Phase 2
PF-04620110	diacylglycerol O acyltransferase inhibitor	DGAT1			MedChemEx	99.59	BRD-K30550578-001-01-3	Phase 1
PF-04691502	mTOR inhibitor, PI3K inhibitor	MTOR, PIK3CA			Selleck	96.68	BRD-K07310275-001-02-5	Phase 2
PF-04885614	voltage-gated sodium channel blocker	SCN10A			Tocris	84.39	BRD-K92435527-001-01-4	Preclinical
PF-04937319	glucokinase activator	GCK			Sigma	97.36	BRD-K27755542-001-01-6	Phase 2
PF-05190457	growth hormone secretagogue receptor inverse agonist	GHSR			Sigma	87.74	BRD-K02554563-001-01-6	Phase 2
PF-05212384	mTOR inhibitor, PI3K inhibitor	MTOR, PIK3CA			Key, Selleck, Selleck	97.48	BRD-K07955840-001-04-9, BRD-K07955840-001-02-3, BRD-K07955840-001-03-1	Phase 2
PF-06447475	serine/threonine kinase inhibitor	LRRK2			MedChemEx, Tocris	99.15	BRD-K83114366-001-01-0, BRD-K83114366-001-02-8	Preclinical
PF-06463922	ALK tyrosine kinase receptor inhibitor	ALK, FES, ROS1			Selleck	98.98	BRD-A23124853-001-01-4	Phase 2
PF-3274167	oxytocin receptor antagonist	AVPR1A, OXTR			MedChemEx	96.73	BRD-K31417912-001-01-9	Phase 2
PF-3845	FAAH inhibitor	FAAH			Tocris, Selleck	96.31	BRD-K68997413-001-06-9, BRD-K68997413-001-05-1	Preclinical
PF-429242	SREBP inhibitor	MBTPS1			Tocris	91.17	BRD-K11821338-300-01-8	Preclinical
PF-431396	focal adhesion kinase inhibitor	PTK2, PTK2B			Tocris	97.24	BRD-K93788137-001-04-1	Preclinical
PF-4708671	ribosomal protein inhibitor	RPS6KB1			Selleck, Tocris	98.79	BRD-K14711741-001-02-1, BRD-K14711741-001-05-4	Preclinical
PF-477736	CHK inhibitor	CHEK1, CHEK2			Selleck, Tocris, Selleck	91.23	BRD-K03063480-001-06-6, BRD-K03063480-001-07-4, BRD-K03063480-001-05-8	Phase 1
PF-4800567	casein kinase inhibitor	CSNK1D, CSNK1E			Tocris	98.53	BRD-K43428468-003-04-0	Preclinical
PF-4981517	cytochrome P450 inhibitor	CYP3A4			Selleck	96.16	BRD-K78318619-001-02-7	Preclinical
PF-5274857	smoothened receptor antagonist	SMO			Selleck, Tocris	93.06	BRD-K40302533-001-02-9, BRD-K40302533-003-01-7	Preclinical
PF-562271	focal adhesion kinase inhibitor	PTK2, PTK2B			Selleck, Selleck, Selleck, Selleck	93.6	BRD-K99545815-003-01-0, BRD-K99545815-074-02-9, BRD-K99545815-074-03-7, BRD-K99545815-001-06-3	Phase 1
PF-573228	focal adhesion kinase inhibitor	CDK1, CDK2, CDK7, GSK3B, IKBKB			Selleck, Tocris	96.83	BRD-K79239947-001-06-8, BRD-K79239947-001-07-6	Preclinical
PF-670462	casein kinase inhibitor	CSNK1D, CSNK1E			MedChemEx, Tocris	97.92	BRD-K96295391-300-01-7, BRD-K96295391-300-02-5	Preclinical
PF-750	FAAH inhibitor	FAAH			Tocris	92.71	BRD-K83213911-001-07-7	Preclinical
PF-8380	autotaxin inhibitor	ENPP2			MedChemEx, MedChemEx	87.86	BRD-K50865540-001-02-3, BRD-K50865540-001-01-5	Preclinical
PF-915275	11-beta hydroxysteroid dehydrogenase inhibitor	HSD11B1			Tocris, MedChemEx	98.29	BRD-K18289362-001-02-2, BRD-K18289362-001-01-4	Phase 1
PFI-1	bromodomain inhibitor	BRD4			Selleck, Selleck, Tocris	91.99	BRD-K13094524-001-04-2, BRD-K13094524-001-07-5, BRD-K13094524-001-09-1	Preclinical
PFI-3	bromodomain inhibitor	PBRM1, SMARCA4			Tocris	90.87	BRD-K61524559-001-01-3	Preclinical
PFI-4	bromodomain inhibitor	BRPF1			Tocris	83.46	BRD-K13106865-001-01-7	Preclinical
PFK-015	phosphofructokinase inhibitor	PFKFB3			MedChemEx, MedChemEx	94.52	BRD-K95573441-001-02-0, BRD-K95573441-001-01-2	Phase 1
PFK-158	phosphofructokinase inhibitor	PFKFB3			MedChemEx	90.57	BRD-K28010364-001-01-0	Phase 1
PG-9	acetylcholine receptor agonist				Tocris	92.7	BRD-A70268693-050-01-2	Preclinical
PGL5001	JNK inhibitor	MAPK10, MAPK8, MAPK9			MedChemEx, MedChemEx, MedChemEx	90.93	BRD-A53813595-001-01-8, BRD-A53813595-001-03-4, BRD-A53813595-001-02-6	Phase 2
PH-797804	p38 MAPK inhibitor	MAPK11, MAPK14			Selleck	97.63	BRD-K95880107-001-02-4	Phase 2
PHA-568487	nicotinic receptor agonist	CHRNA7			Tocris	79.3	BRD-K48053228-051-01-7	Preclinical
PHA-665752	c-Met inhibitor	MET			Tocris, Selleck, Selleck, Tocris	97.63	BRD-K95435023-001-07-7, BRD-K95435023-001-08-5, BRD-K95435023-001-10-1, BRD-K95435023-001-09-3	Preclinical
PHA-680632	Aurora kinase inhibitor	AURKA, AURKB, AURKC			Selleck	90.32	BRD-K09443272-001-03-3	Preclinical
PHA-767491	CDC inhibitor	CDK1, RPS6KB1			Selleck, Tocris	96.2	BRD-K50000283-001-04-4, BRD-K50000283-003-02-4	Preclinical
PHA-793887	CDK inhibitor	CDK1, CDK2, CDK4, CDK5, CDK7, CDK9			Selleck, Selleck	91.57	BRD-K64800655-001-09-0, BRD-K64800655-001-07-4	Phase 1
PHA-848125	CDK inhibitor, growth factor receptor inhibitor	CDK2, CDK4, CDK7, NTRK1			Selleck	96.58	BRD-K60997853-001-02-3	Phase 2
PHCCC	glutamate receptor agonist	GRM1, GRM4			Tocris, Tocris	96.49	BRD-A59709458-001-02-6, BRD-A59709458-001-01-8	Preclinical
phenacaine	local anesthetic		neurology/psychiatry	local anesthetic	MPBio	99.16	BRD-K81092066-311-01-6	Launched
phenacemide	sodium channel blocker	SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	neurology/psychiatry	epilepsy, seizures	MicroSource	99.38	BRD-K40905133-001-04-9	Launched
phenacetin	cyclooxygenase inhibitor	PTGS1			MicroSource, Selleck	99.33	BRD-K38323065-001-19-9, BRD-K38323065-001-18-1	Withdrawn
phenazone	cyclooxygenase inhibitor	PTGS1, PTGS2	neurology/psychiatry	pain relief	MicroSource, Selleck	99.14	BRD-K46937689-001-15-0, BRD-K46937689-001-14-3	Launched
phenazopyridine	local anesthetic	SCN1A	infectious disease	urinary tract infections	Selleck, MicroSource, Selleck	96.12	BRD-K76304753-003-19-5, BRD-K76304753-003-20-3, BRD-K76304753-003-21-1	Launched
phenelzine	monoamine oxidase inhibitor	ABAT, AOC3, GAD2, GPT, GPT2, MAOA, MAOB, SLC6A2, SLC6A3, SLC6A4	neurology/psychiatry	depression	Sigma, MicroSource, Sigma	80.24	BRD-K87024524-001-04-0, BRD-K87024524-065-17-7, BRD-K87024524-065-18-5	Launched
phenethicillin	bacterial cell wall synthesis inhibitor				Prestwick	55.17	BRD-A66025870-237-06-9	Launched
phenethyl-isothiocyanate	anticancer agent	CYP2E1			Sigma	0	BRD-K56700933-001-03-9	Phase 2
phenformin	AMPK activator	KCNJ8, PRKAA1			MicroSource, MicroSource, Selleck	97.99	BRD-K11399644-003-10-5, BRD-K11399644-003-11-3, BRD-K11399644-003-09-7	Withdrawn
phenindamine	histamine receptor antagonist	HRH1	allergy, otolaryngology	allergic rhinitis, common cold	AMS, AMS	47.35	BRD-A33178345-001-02-2, BRD-A33178345-001-01-4	Launched
phenindione	vitamin K antagonist	VKORC1	hematology	deep vein thrombosis (DVT)	Selleck, MedChemEx, Selleck, MedChemEx, MicroSource, Sigma	95.63	BRD-K70592963-001-29-0, BRD-K70592963-001-33-2, BRD-K70592963-001-27-4, BRD-K70592963-001-32-4, BRD-K70592963-001-28-2, BRD-K70592963-001-31-6	Launched
pheniramine	histamine receptor antagonist	HRH1	allergy	allergic rhinitis, urticaria	Selleck, MicroSource	98.32	BRD-A23072235-050-17-7, BRD-A23072235-050-18-5	Launched
phenol		CA1, CA12, CA14, CA2, CA4, CA9	otolaryngology	pharyngitis	Sigma	0	BRD-K76549667-001-04-6	Preclinical
phenolphthalein	indicator dye	UGT1A9			MicroSource	98.24	BRD-K19227686-001-18-6	Withdrawn
phenolsulfonphthalein					MicroSource	91.1	BRD-K79892937-001-02-5	Launched
phenothiazine	dopamine receptor antagonist				MicroSource, Selleck, Selleck	88.33	BRD-K59597909-001-19-2, BRD-K59597909-001-17-6, BRD-K59597909-001-20-0	Preclinical
phenothrin			infectious disease	lice	MicroSource, Selleck	76.28	BRD-A22106989-001-06-8, BRD-A22106989-001-05-0	Launched
phenoxybenzamine	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB2, CALM1	cardiology, endocrinology	hypertension, pheochromocytoma	MedChemEx, Selleck, MedChemEx, Selleck	0	BRD-A67799922-003-28-6, BRD-A67799922-003-26-0, BRD-A67799922-003-29-4, BRD-A67799922-003-27-8	Launched
phenprobamate	muscle relaxant		neurology/psychiatry	anxiety, muscle relaxant	Prestwick	98.85	BRD-K22009844-001-12-5	Launched
phenprocoumon	vitamin K antagonist	VKORC1	hematology	thrombosis, pulmonary embolism (PE)	Abblis	97.47	BRD-A49838158-001-01-1	Launched
phenserine	acetylcholinesterase inhibitor, beta amyloid synthesis inhibitor	ACHE, BCHE			Sigma, Enzo	83.49	BRD-K46580984-001-03-6, BRD-K46580984-001-02-8	Phase 3
phensuximide	succinimide antiepileptic	CACNA1G, CACNA1H, CACNA1I	neurology/psychiatry	seizures	MicroSource	98.87	BRD-A18043272-001-09-9	Launched
phentermine	dopamine uptake inhibitor, serotonin reuptake inhibitor	MAOA, MAOB, SLC6A2, SLC6A3, SLC6A4	endocrinology	weight-loss aid	Prestwick	96.96	BRD-K96319534-003-03-9	Launched
phentolamine	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C	endocrinology, cardiology	pheochromocytoma, hypertension	Selleck, MicroSource, Selleck, Enzo	99.38	BRD-K90333595-066-17-9, BRD-K90333595-003-21-4, BRD-K90333595-066-16-1, BRD-K90333595-003-22-2	Launched
phenyl-aminosalicylate			infectious disease	tuberculosis	MicroSource	99.55	BRD-K73157543-001-04-1	Launched
phenyl-salicylate	antiseptic		urology	interstitial cystitis (IC)	Enamine	0	BRD-K44091963-001-01-5	Launched
phenylacetylglutamine	DNA methylase inhibitor, protein synthesis inhibitor				Cayman	89.95	BRD-K70592483-001-01-0	Phase 2
phenylbenzimidazole-sulfonic-acid			dermatology	sunscreen lotion	Vitas-M	92.52	BRD-K02729857-001-01-9	Launched
phenylbutazone	cyclooxygenase inhibitor, prostanoid receptor antagonist	PTGIS, PTGS1, PTGS2			Selleck, Selleck, MicroSource	98.14	BRD-K10843433-001-23-5, BRD-K10843433-001-21-9, BRD-K10843433-001-22-7	Withdrawn
phenylbutyrate	HDAC inhibitor	HDAC1	metabolism	urea cycle disorders	MicroSource, Tocris, Selleck, Tocris	97.03	BRD-K67102207-236-08-5, BRD-K67102207-236-07-7, BRD-K67102207-236-06-9, BRD-K67102207-236-10-1	Launched
phenylephrine	adrenergic receptor agonist	ADRA1A, ADRA1B, ADRA1D	otolaryngology, gastroenterology, cardiology	nasal congestion, hemorrhoids, hypotension	Selleck, Selleck, MicroSource	93.38	BRD-K73381542-003-22-6, BRD-K73381542-003-24-2, BRD-K73381542-003-23-4	Launched
phenylethyl-alcohol					MicroSource	0	BRD-K42371134-001-06-6	Preclinical
phenylmercuric-acetate	other antifungal				MicroSource	0	BRD-K74193284-001-04-8	Preclinical
phenylmethylsulfonyl-fluoride	serine protease inhibitor				Selleck, Selleck	0	BRD-K33422401-001-06-4, BRD-K33422401-001-05-6	Preclinical
phenylpiracetam	noradrenaline uptake inhibitor		neurology/psychiatry	anxiety, fatigue, depression	MedChemEx	91.32	BRD-A65683612-001-07-7	Launched
phenytoin	hydantoin antiepileptic	SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	neurology/psychiatry	seizures	Selleck, MicroSource, Selleck	99.77	BRD-K55930204-236-23-5, BRD-K55930204-236-24-3, BRD-K55930204-001-20-9	Launched
PhiKan-083	p53 stabilizing agent	TP53			Tocris	85.55	BRD-K44400149-003-01-1	Preclinical
phloretin	sodium/glucose cotransporter inhibitor	AQP9, CLCN3, SLC23A1			Selleck	95.59	BRD-K15563106-001-18-0	Launched
phlorizin	sodium/glucose cotransporter inhibitor	SLC5A1, SLC5A11, SLC5A2, SLC5A3			Selleck	97.41	BRD-K24601397-001-01-1	Preclinical
phloroglucin					Vitas-M	98.67	BRD-K00405906-001-01-9	Launched
phortress	aryl hydrocarbon receptor ligand	AHR			Key	92.95	BRD-K74558903-300-01-5	Phase 1
phosphatidylcholine		PCTP	infectious disease, dermatology, gastroenterology, cardiology, obstetrics/gynecology	hepatitis B, hepatitis C, eczema, gallbladder disease, cholesterol, premenstrual syndrome	Selleck, Selleck	0	BRD-U51753822-000-01-1, BRD-A10131665-001-02-0	Launched
PHP-501	GABA receptor antagonist	GABRA1, GABRB2, GABRG2			Tocris	79.59	BRD-K07460388-019-01-6	Preclinical
PHT-427	AKT inhibitor, pyruvate dehydrogenase inhibitor	AKT2, PDPK1			Selleck, Tocris, Selleck	96.76	BRD-K59745944-001-03-8, BRD-K59745944-001-04-6, BRD-K59745944-001-02-0	Preclinical
phthalylsulfacetamide					MedChemEx, Selleck, MicroSource, Selleck	94.32	BRD-K77115421-001-05-9, BRD-K77115421-001-02-6, BRD-K77115421-001-03-4, BRD-K77115421-001-04-2	Preclinical
phthalylsulfathiazole	dihydropteroate synthetase inhibitor		infectious disease, gastroenterology	dysentry, colitis	MedChemEx, MicroSource	83.45	BRD-K64659768-001-13-6, BRD-K64659768-001-12-8	Launched
PHTPP	estrogen receptor antagonist	ESR2			Tocris, Tocris	93.41	BRD-K76568384-001-02-2, BRD-K76568384-001-03-0	Preclinical
physostigmine	cholinesterase inhibitor	ACHE, BCHE	cardiology, neurology/psychiatry, ophthalmology, gastroenterology	hypotension, Alzheimer's disease, glaucoma, gastroparesis	MicroSource	86.09	BRD-K25650355-065-02-0	Launched
physostigmine-salicylate	acetylcholinesterase inhibitor				Selleck, Selleck	93.77	BRD-K25650355-059-19-7, BRD-K25650355-059-18-9	Phase 3
phytonadione		BGLAP, GGCX	hematology	vitamin K deficiency, anticoagulation reversal	MicroSource, Sigma	2.14	BRD-K76661572-001-07-6, BRD-K76661572-001-08-4	Launched
phytosphingosine					Enzo	77.82	BRD-K05048137-001-03-9	Phase 1
PI-103	mTOR inhibitor, PI3K inhibitor	MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PRKDC			Tocris, Selleck	96.2	BRD-K67868012-003-02-3, BRD-K67868012-001-07-6	Preclinical
PI-828	PI3K inhibitor				Tocris, Tocris, Tocris	93.17	BRD-K97365803-001-04-7, BRD-K97365803-001-02-1, BRD-K97365803-001-03-9	Preclinical
pibenzimol	DNA inhibitor				Vitas-M, MedChemEx	93.13	BRD-K79132813-001-09-0, BRD-K17026858-001-01-2	Phase 2
piboserod	serotonin receptor antagonist	HTR2B, HTR4			MedChemEx, MedChemEx	96.02	BRD-K02750403-001-02-2, BRD-K02750403-001-01-4	Phase 2
picartamide	H+/K+-ATPase inhibitor	ATP4A			Enamine	98.26	BRD-A71765060-001-01-4	Phase 2
piceatannol	SYK inhibitor	ATP5A1, ATP5B, ATP5C1, IRF3			Selleck, Selleck, Tocris	88.28	BRD-K91509126-001-25-1, BRD-K91509126-001-23-6, BRD-K91509126-001-24-4	Preclinical
piclamilast	phosphodiesterase inhibitor	PDE4A, PDE4B, PDE4C, PDE4D			Enamine, Tocris	99.07	BRD-K47642186-001-01-3, BRD-K47642186-001-02-1	Phase 2
picolamine					MicroSource	98.78	BRD-K68653965-001-01-1	Preclinical
picolinic-acid	chelating agent				Vitas-M, Enamine, Enamine	99.23	BRD-K01029106-001-01-4, BRD-K60612034-001-07-9, BRD-K60612034-001-08-7	Phase 2
piconol					MicroSource	88.45	BRD-K28492574-001-01-6	Preclinical
picotamide	thromboxane receptor antagonist, thromboxane synthase inhibitor	TBXA2R	hematology	thrombosis	Prestwick	99.78	BRD-K67277431-002-10-5	Launched
picrotin	GABA receptor antagonist	GABRA1, GABRR1, GLRA1, GLRA2, GLRA3, GLRB			SantaCruz	100	BRD-A91822151-001-05-0	Phase 2
picrotoxinin	GABA receptor antagonist	GLRA1, GLRA2, GLRA3, GLRB, HTR3A, HTR3B			Selleck	100	BRD-K36461289-001-05-8	Preclinical
pidolic-acid		ADAM28, AMY1A, AMY2A, AMY2B, ANG, CCL8, HCRT, IGLC1, KRTAP5-2, TFF2, VEGFA	dermatology	xerosis cutis	MicroSource	92.71	BRD-K57313110-001-06-8	Launched
pidotimod	interferon receptor agonist, interleukin receptor agonist		infectious disease	immune adjuvant	MicroSource, Selleck	92.63	BRD-K44442813-001-12-9, BRD-K44442813-001-11-1	Launched
pifithrin-alpha	TP53 inhibitor	TP53			Selleck, Selleck, Tocris	29.69	BRD-K66874953-004-07-0, BRD-K66874953-004-09-6, BRD-K66874953-004-08-8	Preclinical
pifithrin-cyclic	TP53 inhibitor	TP53			Tocris	94.97	BRD-K31792052-004-02-7	Preclinical
pifithrin-mu	HSP inhibitor	HSPA1A, TP53			Tocris, Selleck, Selleck	95.11	BRD-K96799727-001-06-6, BRD-K96799727-001-05-8, BRD-K96799727-001-07-4	Preclinical
PIK-293	PI3K inhibitor	PIK3CA, PIK3CB, PIK3CD, PIK3CG			Selleck	96.54	BRD-K30977212-001-02-8	Preclinical
PIK-294	PI3K inhibitor	PIK3CB, PIK3CD, PIK3CG			Selleck	97.97	BRD-K50631926-001-02-3	Preclinical
PIK-75	DNA protein kinase inhibitor, PI3K inhibitor	PIK3CA, PIK3CB, PIK3CD, PIK3CG, PRKDC			Selleck	98	BRD-K49371609-003-03-8	Preclinical
PIK-93	PI3K inhibitor	PI4KB, PIK3C3, PIK3CG			Selleck	91.02	BRD-K29395450-001-06-8	Preclinical
pikamilone					Enamine	98.59	BRD-K56691760-001-01-2	Phase 1
piketoprofen	cyclooxygenase inhibitor		neurology/psychiatry	pain relief	Enamine	93.58	BRD-A85548292-001-01-8	Launched
pilaralisib	PI3K inhibitor				MedChemEx	95.08	BRD-K49456274-001-01-9	Phase 2
pilocarpine	acetylcholine receptor agonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	ophthalmology, cardiology	glaucoma, hypertension	Tocris, MicroSource, Tocris, Selleck	99.14	BRD-K85090592-003-20-2, BRD-K85090592-008-22-7, BRD-K85090592-003-19-4, BRD-K85090592-003-18-6	Launched
pilsicainide	sodium channel blocker	SCN5A	cardiology	cardiac arrythmia	AKSci	99.35	BRD-K83245588-001-01-4	Launched
PIM-1-Inhibitor-2	Pim kinase inhibitor	PIM1			Tocris, Tocris	86.98	BRD-K48832421-001-01-4, BRD-K48832421-001-02-2	Preclinical
pimavanserin	serotonin receptor inverse agonist	DRD2, HTR2A			MedChemEx	88.73	BRD-K83405785-001-01-5	Launched
pimecrolimus	calcineurin inhibitor	FKBP1A, MTOR	dermatology	eczema	Selleck	90.71	BRD-K92107055-001-01-9	Launched
pimethixene	antihistamine		neurology/psychiatry, allergy	attention-deficit/hyperactivity disorder (ADHD), anxiety, sleep cycle support, allergic rhinitis	MicroSource	97.82	BRD-K88090157-050-10-8	Launched
pimobendan	calcium sensitizer, phosphodiesterase inhibitor	PDE3A	cardiology	congestive heart failure	Selleck	97.63	BRD-A84575140-001-02-4	Launched
pimonidazole					Cayman	94.99	BRD-A67521319-001-01-6	Phase 3
pimozide	dopamine receptor antagonist	CACNA1I, CALM1, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR2A, KCNA10, KCNH2	neurology/psychiatry	Tourette's disorder	Tocris, Selleck, Tocris, MicroSource	97.81	BRD-K01292756-001-27-6, BRD-K01292756-001-23-5, BRD-K01292756-001-24-3, BRD-K01292756-001-25-0	Launched
pinacidil	ATP channel activator, potassium channel activator	ABCC8, ABCC9	cardiology	hypertension	Selleck, MicroSource	98.87	BRD-A43882281-001-14-8, BRD-A43882281-001-15-5	Launched
pinanediol					Sigma	0	BRD-K69885552-001-01-7	Preclinical
pinaverium	T-type calcium channel blocker	CACNA1C	gastroenterology	irritable bowel syndrome	Prestwick	98.24	BRD-A70998768-004-01-1	Launched
pincainide	antiarrhythmic				Enamine	96.6	BRD-K90727284-001-05-0	Phase 1
pindolol	adrenergic receptor antagonist	ADRB1, ADRB2, HTR1A, HTR1B, HTR2A, HTR2B	cardiology	hypertension	Selleck, Tocris, MicroSource	97.25	BRD-A97701745-001-14-5, BRD-A97701745-001-15-2, BRD-A97701745-001-16-0	Launched
pindolol-(-)	adrenergic receptor antagonist, serotonin receptor antagonist	HTR1A			Tocris	71.68	BRD-K95598440-001-09-3	Preclinical
pinitol	gamma secretase inhibitor				InterBioScreen	100	BRD-A69275535-001-01-5	Phase 2
pinocembrin	cytochrome P450 inhibitor	CYP1B1			Enzo	0	BRD-K94689771-001-09-0	Phase 2
pioglitazone	insulin sensitizer, PPAR receptor agonist	PPARG, TRPM3	endocrinology	diabetes mellitus	MicroSource, Tocris, Selleck, Selleck	99.54	BRD-A48430263-003-17-2, BRD-A48430263-003-19-8, BRD-A48430263-003-16-4, BRD-A48430263-001-07-7	Launched
pipamperone	dopamine receptor antagonist	DRD2, HRH1, HTR1A, HTR1B, HTR1D, HTR2A	neurology/psychiatry	schizophrenia	MicroSource	89.65	BRD-K26801045-001-02-9	Launched
pipecuronium	neuromuscular blocker	CHRM2, CHRM3, CHRNA2	neurology/psychiatry	anesthetic	Kemprotec	98.54	BRD-A21544762-303-01-5	Launched
pipemidic-acid	topoisomerase inhibitor		infectious disease	gram-negative bacterial infections	MicroSource	90.96	BRD-K08999871-213-01-5	Launched
pipenzolate	cholinergic receptor antagonist	CHRM1	neurology/psychiatry	spasms	Selleck, MicroSource	97.76	BRD-A53561827-004-22-3, BRD-A53561827-004-23-1	Launched
piperacetazine	dopamine receptor antagonist		neurology/psychiatry	schizophrenia	MicroSource	94.04	BRD-K16277217-001-10-9	Launched
piperacillin	bacterial cell wall synthesis inhibitor		infectious disease	intra-abdominal infections, skin infections, pelvic inflammatory disease, pneumonia	MedChemEx, MedChemEx, Sigma, MicroSource, Selleck, Selleck	96.3	BRD-K86873305-236-17-0, BRD-K86873305-236-16-2, BRD-K86873305-236-15-4, BRD-A99949740-236-04-6, BRD-K86873305-236-18-8, BRD-K86873305-236-14-7	Launched
piperaquine-phosphate	antimalarial agent		infectious disease	malaria	AKSci	96.15	BRD-K27382019-418-01-9	Launched
piperazine	benzodiazepine receptor agonist	GABRB3	infectious disease	gastrointestinal roundworms	MicroSource	100	BRD-K13249881-001-02-3	Launched
piperazinedione	DNA synthesis inhibitor				Enamine	97.3	BRD-K95941975-001-01-5	Phase 2
piperidolate	acetylcholine receptor antagonist	CHRM1	neurology/psychiatry	spasms	MicroSource	98.09	BRD-A97479839-003-13-3	Launched
piperine	monoamine oxidase inhibitor	MAOA, MAOB, TRPV1			Selleck, MicroSource, Selleck	97.26	BRD-K59522102-001-13-8, BRD-K59522102-001-14-6, BRD-K59522102-001-15-3	Phase 1
piperonyl-butoxide	cytochrome P450 inhibitor		infectious disease	lice	MicroSource	88.86	BRD-K76452401-001-03-6	Launched
pipobroman	DNA alkylating agent		hematology	polycythemia vera, thrombocythemia	MicroSource, MedChemEx, MedChemEx	81.16	BRD-K15656090-001-04-0, BRD-K15656090-001-06-5, BRD-K15656090-001-07-3	Launched
pipotiazine-palmitate	dopamine receptor antagonist, serotonin receptor antagonist	DRD1, DRD2, HTR1A, HTR2A			Sigma	75.11	BRD-K48429278-001-01-3	Launched
piracetam	acetylcholine receptor agonist	GRIA1, GRIA2, GRIA3, GRIA4	neurology/psychiatry	senile dementia	Selleck, MicroSource	100	BRD-K19456237-001-26-8, BRD-K19456237-001-27-6	Launched
pirarubicin	topoisomerase inhibitor	TOP2A	oncology	breast cancer	MedChemEx, MedChemEx, Selleck, Selleck	71.82	BRD-K83794624-003-02-1, BRD-K83794624-003-01-3, BRD-K83794624-001-02-5, BRD-K83794624-001-03-3	Launched
pirenoxine	AGE inhibitor		ophthalmology	cataracts	AKSci	94.2	BRD-K65992024-001-01-5	Launched
pirenperone	serotonin receptor antagonist	HTR2A, HTR7			Prestwick	98.26	BRD-K25224017-001-25-0	Preclinical
pirenzepine	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	gastroenterology	peptic ulcer disease (PUD)	MicroSource	98.27	BRD-K89375097-300-08-8	Launched
piretanide	glucocorticoid receptor agonist	SLC12A1, SLC12A2	cardiology	hypertension, edema	Prestwick	99.31	BRD-K87990216-001-10-2	Launched
pirfenidone	TGF beta receptor inhibitor	FURIN, TNF	pulmonary	idiopathic pulmonary fibrosis (IPF)	Selleck, Tocris	97.6	BRD-K96862998-001-14-8, BRD-K96862998-001-15-5	Launched
piribedil	dopamine receptor agonist	ADRA1A, ADRA2A, ADRA2C, DRD2, DRD3, DRD4, HTR1A, HTR2B	neurology/psychiatry	Parkinson's Disease, dizziness	Tocris	87.35	BRD-K47936004-003-11-4	Launched
piricapiron	dopamine receptor antagonist, serotonin receptor antagonist	HTR2A			Vitas-M	93.51	BRD-A04203391-001-08-3	Phase 2
pirinixic-acid	PPAR receptor agonist	PPARA			Tocris, Selleck, Tocris	97.87	BRD-K01902415-001-13-3, BRD-K01902415-001-10-9, BRD-K01902415-001-11-7	Preclinical
pirlindole	monoamine oxidase inhibitor	MAOA	neurology/psychiatry	depression	Tocris	90	BRD-A54490543-066-11-9	Launched
piroctone-olamine			infectious disease	fungal infection	MicroSource	0	BRD-A96510685-213-03-7	Launched
pirodavir					MedChemEx	98.34	BRD-K22261391-001-01-2	Phase 2
piromidic-acid	bacterial DNA gyrase inhibitor				MicroSource, Selleck, Selleck	96.79	BRD-K37682401-213-01-1, BRD-K37682401-001-08-5, BRD-K37682401-001-09-3	Phase 2
piroxicam	cyclooxygenase inhibitor	PTGS1, PTGS2	rheumatology	osteoarthritis, rheumatoid arthritis	Tocris, Selleck, MicroSource	99.2	BRD-A57382968-001-28-2, BRD-A57382968-001-27-4, BRD-A57382968-001-29-0	Launched
piroximone	phosphodiesterase inhibitor	PDE3A			Enamine	99.6	BRD-K71977764-001-01-2	Phase 2
pirquinozol	histamine release inhibitor				Enamine	98.69	BRD-K63651590-001-01-3	Phase 1
PIT	purinergic receptor antagonist	P2RY1			Tocris	24.71	BRD-K43978949-075-02-5	Preclinical
pitavastatin	HMGCR inhibitor	HMGCR	endocrinology	hyperlipidemia	Tocris, Selleck	96.25	BRD-K75958547-238-02-8, BRD-K75958547-238-01-0	Launched
pivagabine	corticosteroid releasing factor receptor antagonist	CRHR1, CRHR2	neurology/psychiatry	depression	Enamine, Enamine	53.16	BRD-K62264492-001-01-5, BRD-K62264492-001-02-3	Launched
pivampicillin	bacterial cell wall synthesis inhibitor		pulmonary, infectious disease	bronchitis, pneumonia, gynecologic infections	Prestwick	38.24	BRD-K32791151-001-04-0	Launched
pivanex	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC8			Sigma	0	BRD-K20504455-001-01-0	Phase 2
pivmecillinam	bacterial cell wall synthesis inhibitor		infectious disease	urinary tract infections, gram-negative bacterial infections	Sigma, Prestwick, MedChemEx	95.37	BRD-K67100011-001-01-8, BRD-K67100011-003-06-3, BRD-K67100011-003-07-1	Launched
pixantrone	topoisomerase inhibitor	TOP2A	hematologic malignancy	non-Hodgkin lymphoma (NHL)	MedChemEx, MedChemEx	53.02	BRD-K48304345-332-02-4, BRD-K48304345-332-01-6	Launched
pizotifen	serotonin receptor antagonist	HTR1A, HTR2A, HTR2C	neurology/psychiatry	migraine headache	Selleck, MicroSource	98.76	BRD-K75958195-037-08-6, BRD-K75958195-037-09-4	Launched
PI3K-IN-2	PI3K inhibitor				MedChemEx	94.14	BRD-K62374002-001-01-5	Phase 2
PI4KIII-beta-inhibitor-1	PI4K inhibitor	PI4K2B			MedChemEx	94.57	BRD-K75528696-001-01-2	Preclinical
PJ-34	PARP inhibitor	EEF2, PARP1, PARP15, PARP3			Selleck, Selleck, Tocris	95.18	BRD-K11853856-001-01-7, BRD-K11853856-001-02-5, BRD-K11853856-003-02-1	Preclinical
PK-THPP	potassium channel blocker	KCNK9			Tocris	97.46	BRD-K44043890-001-01-4	Preclinical
PK-11195	benzodiazepine receptor antagonist	TSPO			Tocris, Tocris	98.79	BRD-A41451487-001-12-0, BRD-A41451487-001-11-2	Phase 1
PK-44	dipeptidyl peptidase inhibitor	DPP4			Tocris	84.96	BRD-K04035716-011-01-9	Preclinical
PKI-166	EGFR inhibitor	EGFR			Sigma	90.82	BRD-K10115470-001-01-8	Phase 1
PKI-179	mTOR inhibitor, PI3K inhibitor	MTOR			EMDBio	97.09	BRD-A28467416-002-01-0	Phase 1
pleconaril					MedChemEx, SantaCruz	91.31	BRD-K27625831-001-02-9, BRD-K27625831-001-01-1	Phase 3
plerixafor	CC chemokine receptor antagonist	ACKR3, CCR4, CXCR4	hematologic malignancy	non-Hodgkin lymphoma (NHL), multiple myeloma	MedChemEx, Selleck, MedChemEx, Selleck	97.85	BRD-K33240821-001-06-2, BRD-K33240821-001-03-9, BRD-K33240821-400-02-5, BRD-K33240821-001-05-4	Launched
plicamycin	alcohol dehydrogenase inhibitor		oncology, endocrinology	testicular carcinoma, Paget's disease, hypercalcemia	Enzo	59.72	BRD-K36368047-001-01-7	Launched
plinabulin	tubulin polymerization inhibitor				MedChemEx, MedChemEx, Adooq	78.21	BRD-K99498722-001-02-6, BRD-K99498722-001-04-2, BRD-K99498722-001-03-4	Phase 3
plovamer-acetate		TAT, TH, YARS, YARS2			Sigma, EMDBio	98.02	BRD-A20781140-001-02-5, BRD-A20781140-001-01-7	Phase 2
plurisin-#1	stearoyl-CoA desaturase inhibitor	SCD			Selleck, Tocris, Selleck	85.97	BRD-K99149715-001-01-6, BRD-K99149715-001-03-2, BRD-K99149715-001-02-4	Preclinical
PLX-4720	RAF inhibitor	BRAF, KDR			Selleck	97.49	BRD-K16478699-001-09-2	Preclinical
PLX-647	receptor tyrosine protein kinase inhibitor	CSF1R, KIT			Tocris	71.86	BRD-K79294107-300-01-6	Preclinical
PLX8394	serine/threonine kinase inhibitor	BRAF			MedChemEx	96.23	BRD-K53723268-001-01-3	Phase 1/Phase 2
PMPA	glutamate receptor antagonist	FOLH1			Tocris	0	BRD-A74387232-001-02-5	Preclinical
PNU-120596	acetylcholine receptor agonist	CHRNA7			Tocris, Tocris, Selleck	98.45	BRD-K71731651-001-04-3, BRD-K71731651-001-05-0, BRD-K71731651-001-03-5	Preclinical
PNU-142633	serotonin receptor agonist	HTR1D			Tocris	97.37	BRD-K81616657-001-01-4	Phase 2
PNU-177864	dopamine receptor antagonist	DRD3			Tocris	92.27	BRD-K04635846-003-01-6	Preclinical
PNU-22394	serotonin receptor agonist	HTR2A, HTR2B, HTR2C, MAOA, MAOB			Tocris	87.68	BRD-K16551401-003-03-4	Phase 2
PNU-282987	cholinergic receptor agonist	CHRNA7			Tocris, Tocris	95.1	BRD-K28863208-001-02-0, BRD-K28863208-001-03-8	Preclinical
PNU-37883	ATP-sensitive potassium channel antagonist				Tocris, Tocris	97.78	BRD-K12769093-003-02-1, BRD-K12769093-003-01-3	Preclinical
PNU-74654	beta-catenin inhibitor	CTNNB1, TCF4			Tocris, Tocris	96.85	BRD-K30707190-001-04-1, BRD-K30707190-001-05-8	Preclinical
PNU-89843	benzodiazepine receptor agonist	GABBR1			Tocris	7.39	BRD-K84507776-003-01-4	Preclinical
podophyllotoxin	microtubule inhibitor, tubulin polymerization inhibitor	IGF1R, TOP2A, TUBA4A, TUBB	infectious disease	genital warts	MicroSource	94.65	BRD-K47869605-001-32-0	Launched
polidocanol	local anesthetic		dermatology	varicose veins	Sigma	97.44	BRD-K35798650-001-01-4	Launched
polydatin	ICAM1 expression inhibitor	ICAM1			Selleck, Selleck	93.06	BRD-K43236057-001-07-1, BRD-K43236057-001-09-7	Phase 2
polyinosine	immunostimulant	ADSSL1, HPRT1, IMPDH2, PYGM			Sigma	98.8	BRD-A67531813-001-01-6	Preclinical
polymyxin-b-sulfate	bacterial permeability inducer		ophthalmology	eye infection	MicroSource	59.7	BRD-A08641215-065-04-8	Launched
polythiazide	sodium/chloride cotransporter inhibitor	SLC12A3	cardiology, gastroenterology, rheumatology, nephrology	edema, congestive heart failure, hepatic cirrhosis, nephrotic syndrome, acute glomerulonephritis (AGN), chronic renal failure, hypertension	Kemprotec	98.56	BRD-A15739803-001-01-0	Launched
pomalidomide	angiogenesis inhibitor, tumor necrosis factor production inhibitor	CRBN, PTGS2, TNF	hematologic malignancy	multiple myeloma	Selleck	96.64	BRD-A12994259-001-02-1	Launched
ponatinib	Bcr-Abl kinase inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor	ABL1, BCR, FGFR1, FGFR2, FGFR3, FGFR4, FLT3, KDR, KIT, LCK, LYN, PDGFRA, RET, SRC, TEK	hematologic malignancy	chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL)	Selleck, Selleck	90.52	BRD-K44227013-001-08-0, BRD-K44227013-001-06-4	Launched
ponesimod	sphingosine 1 phosphate receptor agonist	S1PR1			MedChemEx	95	BRD-K44030614-001-01-6	Phase 3
posaconazole	sterol demethylase inhibitor	CYP3A4	infectious disease	oropharyngeal candidiasis	Selleck, Selleck	87.29	BRD-K06222852-001-05-7, BRD-K06222852-001-03-2	Launched
potassium-canrenoate	mineralocorticoid receptor antagonist	NR3C2	cardiology	edema	MicroSource, Selleck, Selleck	98.01	BRD-K46556543-001-01-4, BRD-K46556543-237-09-7, BRD-K46556543-237-10-5	Launched
potassium-iodide			pulmonary	asthma, bronchitis, emphysema	Selleck, Selleck	0	BRD-M55321172-001-03-3, BRD-M55321172-001-02-5	Launched
potassium-p-aminobenzoate			rheumatology, urology	scleroderma, dermatomyositis, Peyronie's disease	MicroSource	92.96	BRD-K58497451-237-10-7	Launched
pozanicline	acetylcholine receptor antagonist	CHRNA4, CHRNB2			Sigma	98.79	BRD-K79803033-300-01-3	Phase 2
poziotinib	EGFR inhibitor	EGFR, ERBB2, ERBB4			Adooq, Selleck	99.66	BRD-K50010139-001-02-3, BRD-K50010139-001-01-5	Phase 2
PP-1	src inhibitor	HCK, RET			Selleck, Tocris	99.39	BRD-K47598052-001-14-1, BRD-K47598052-001-15-8	Preclinical
PP-121	protein tyrosine kinase inhibitor	ABL1, EGFR, HCK, KDR, MTOR, PDGFRA, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PRKDC, SRC			Selleck, Tocris	97.69	BRD-K81801188-001-02-8, BRD-K81801188-001-05-1	Preclinical
PP-2	src inhibitor	ABL1, LCK, LYN, RIPK2, SRC			Selleck, Tocris, Tocris	99.23	BRD-K95785537-001-22-3, BRD-K95785537-001-24-9, BRD-K95785537-001-23-1	Preclinical
PPT	estrogen receptor agonist	ESR1			Tocris, Tocris	96.1	BRD-K00312224-001-10-3, BRD-K00312224-001-09-5	Preclinical
PPY-A	Abl kinase inhibitor	ABL1, BCR			Tocris	99.07	BRD-K72514671-001-01-4	Preclinical
PP242	mTOR inhibitor	MTOR, PASK			Selleck, Tocris, Selleck	89.25	BRD-K87112191-001-04-5, BRD-K87112191-001-06-0, BRD-K87112191-001-05-2	Preclinical
PQ-401	IGF-1 inhibitor	IGF1R			Selleck, Tocris, Tocris	97.12	BRD-K67537649-001-03-7, BRD-K67537649-001-04-5, BRD-K67537649-001-05-2	Preclinical
PR-619	DUB inhibitor				Selleck, Selleck	93	BRD-K54395039-001-01-7, BRD-K54395039-001-02-5	Preclinical
practolol	adrenergic receptor antagonist	ADRB1			Prestwick, Sigma	87.63	BRD-A41304429-001-14-8, BRD-A41304429-001-17-1	Withdrawn
pralatrexate	dihydrofolate reductase inhibitor	DHFR, TYMS	hematologic malignancy	peripheral T-cell lymphoma (PTCL)	Selleck	94.33	BRD-A74914197-001-02-9	Launched
pralidoxime	acetylcholinesterase inhibitor	ACHE, BCHE	critical care	organophosphate poisoning	MicroSource, MicroSource, MedChemEx	96.7	BRD-K84281997-003-09-2, BRD-K84281997-066-03-2, BRD-K84281997-003-08-4	Launched
pralidoxime-chloride	acetylcholinesterase inhibitor	ACHE, BCHE	pulmonary	respiratory depression	Sigma	97.1	BRD-K24221957-003-01-6	Launched
pramipexole	dopamine receptor agonist	ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C	neurology/psychiatry	Parkinson's Disease	Tocris, Selleck, Selleck	100	BRD-K06388322-300-01-3, BRD-K06388322-001-07-4, BRD-K06388322-312-02-6	Launched
pramiracetam	acetylcholine receptor agonist				Selleck	91.48	BRD-K21123171-001-02-9	Launched
pramoxine	topical anesthetic		dermatology	corticosteroid-responsive dermatoses	Selleck, MicroSource	95.87	BRD-K46523383-003-21-1, BRD-K46523383-003-22-9	Launched
pranidipine	calcium channel blocker	CACNA1C			AKSci	98.76	BRD-A68083442-001-01-6	Phase 2
pranlukast	leukotriene receptor antagonist	CYSLTR1, CYSLTR2, IL5, MUC2, NFKB1, RNASE3, TNF	pulmonary	bronchospasm, asthma, bronchospasm, asthma	MedChemEx, Selleck	99.8	BRD-K97045029-001-02-7, BRD-K97045029-001-04-3	Launched
pranoprofen	cyclooxygenase inhibitor		neurology/psychiatry	pain relief	MicroSource, Selleck, Selleck	98.99	BRD-A64610707-001-04-4, BRD-A64610707-001-03-6, BRD-A64610707-001-05-1	Launched
prasterone-acetate					MicroSource	83.3	BRD-A20758144-001-04-5	Preclinical
prasugrel	purinergic receptor antagonist	P2RY12	cardiology	myocardial infarction, acute coronary syndrome (ACS)	Selleck, MedChemEx, Selleck, MedChemEx	83.3	BRD-A83029242-001-06-1, BRD-A83029242-001-08-7, BRD-A83029242-001-05-3, BRD-A83029242-001-07-9	Launched
pravadoline	cyclooxygenase inhibitor	CNR1, CNR2			Cayman	99.34	BRD-K46209126-001-06-4	Preclinical
pravastatin	HMGCR inhibitor	HMGCR, SLCO1B1	endocrinology, cardiology	hypercholesterolemia, myocardial infarction, hyperlipidemia	Tocris, MicroSource, Tocris, Selleck	95.56	BRD-K60511616-236-06-3, BRD-A71816415-236-04-3, BRD-K60511616-236-07-1, BRD-K60511616-236-08-9	Launched
praziquantel	anthelmintic agent		infectious disease	gastrointestinal parasites, cystic hydatid disease, schistosomiasis	Selleck, MicroSource	99.62	BRD-A21858158-001-22-7, BRD-A21858158-001-23-5	Launched
prazosin	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, KCNH2, KCNH6, KCNH7	cardiology	hypertension	Tocris, MicroSource, Selleck, Tocris	98.79	BRD-K49111258-003-30-5, BRD-K49111258-003-29-7, BRD-K49111258-003-27-1, BRD-K49111258-003-28-9	Launched
PRE-084	sigma receptor agonist	SIGMAR1			Tocris, Tocris	97.96	BRD-K57304726-003-07-7, BRD-K57304726-003-06-9	Preclinical
preclamol	dopamine receptor agonist	DRD2			SantaCruz	91.07	BRD-K02908048-003-06-4	Phase 2
prednicarbate	phospholipase activator	NR3C1, PLA2G1B	dermatology, ophthalmology, neurology/psychiatry	eczema, contact dermatitis, itching	MicroSource	0	BRD-A93963402-001-01-6	Launched
prednisolone	glucocorticoid receptor agonist	NR3C1, NR3C2, SERPINA6	ophthalmology, dermatology, infectious disease	conjunctivitis, rosacea, punctate keratitis, shingles, iritis, cyclitis	MicroSource, Selleck	96.97	BRD-A27887842-001-04-0, BRD-A27887842-001-05-7	Launched
prednisolone-acetate	glucocorticoid receptor agonist	NR3C1	ophthalmology, dermatology, infectious disease	conjunctivitis, rosacea, punctate keratitis, shingles, iritis, cyclitis	Selleck, MicroSource, Selleck	93.2	BRD-K45664306-001-19-6, BRD-A01643550-001-04-9, BRD-K45664306-001-20-4	Launched
prednisolone-hemisuccinate	glucocorticoid receptor agonist	NR3C1			MicroSource	95.56	BRD-A78391468-001-02-8	Preclinical
prednisolone-sodium-phosphate	glucocorticoid receptor agonist	NR3C1	allergy, pulmonary, ophthalmology, infectious disease, rheumatology, endocrinology, neurology/psychiatry, gastroenterology, hematology	allergic rhinitis, asthma, contact dermatitis, mycosis, lupus, hypercalcemia, thyroiditis, congenital adrenal hyperplasia, multiple sclerosis, ulcerative colitis, enteritis, thrombocythemia, pneumonia, asthma, meningitis, psoriatic arthritis, rheumatoid arthritis	MicroSource	84.46	BRD-A94523291-304-02-7	Launched
prednisolone-tebutate	anti-inflammatory agent				MicroSource	96.64	BRD-A53151380-001-01-2	Launched
prednisone	glucocorticoid receptor agonist	HSD11B1, NR3C1	endocrinology, rheumatology, infectious disease, dermatology, ophthalmology, hematology, gastroenterology, neurology/psychiatry	congenital adrenal hyperplasia, hypercalcemia, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, bursitis, osteoarthritis, epicondylitis, dermatomyositis, psoriasis, mycosis, conjunctivitis, anemia, ulcerative colitis, enteritis, multiple sclerosis, meningitis	Selleck, MicroSource, Selleck	95.73	BRD-K85883481-001-22-4, BRD-K85883481-001-25-7, BRD-K85883481-001-24-0	Launched
pregabalin	voltage-gated calcium channel ligand	CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1E, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CACNG2, CACNG3, CACNG4, CACNG5, CACNG6, CACNG7, CACNG8	neurology/psychiatry, rheumatology	peripheral neuropathy, seizures, fibromyalgia, postherpetic neuralgia	MicroSource, MedChemEx	97.97	BRD-K66786476-003-01-9, BRD-K66786476-001-01-3	Launched
pregnanolone	GABA receptor positive allosteric modulator				Tocris	97.4	BRD-A03204438-001-01-2	Phase 2
pregnenolone	glutamate receptor modulator	CYP17A1, SULT2B1			MicroSource, Selleck	98.34	BRD-K43880410-001-15-1, BRD-K43880410-001-14-4	Launched
pregnenolone-succinate	GABA receptor negative allosteric modulator				MicroSource	99.33	BRD-A35912562-001-02-8	Preclinical
preladenant	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3			MedChemEx	94.31	BRD-K46290096-001-01-1	Phase 3
prenylamine	calcium channel blocker	CALM1, MYLK2			Prestwick	98.19	BRD-A10662413-043-11-2	Withdrawn
presatovir	RSV fusion inhibitor				MedChemEx	95.26	BRD-K45906612-001-01-8	Phase 2
pridinol	muscle relaxant		neurology/psychiatry	muscle relaxant	Selleck, MicroSource	98.23	BRD-K17565903-066-22-3, BRD-K17565903-066-23-1	Launched
prilocaine	local anesthetic	SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	neurology/psychiatry	anesthetic	MicroSource, Selleck	98.67	BRD-A53952395-003-25-1, BRD-A53952395-001-02-4	Launched
primaquine	antimalarial agent, DNA inhibitor	KRT7, NQO2	infectious disease	malaria	Selleck, MicroSource	89.83	BRD-A55913614-316-08-8, BRD-A55913614-316-09-6	Launched
PRIMA1	TP53 inhibitor	ACHE			Tocris, Tocris	100	BRD-K15318909-001-12-1, BRD-K15318909-001-10-5	Preclinical
primidone	GABA receptor antagonist	CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	neurology/psychiatry	seizures	Selleck, Tocris, MicroSource	99.02	BRD-K32247306-001-27-8, BRD-K32247306-001-28-6, BRD-K32247306-001-29-4	Launched
prinaberel	estrogen receptor agonist	ESR2, NCOA1			MedChemEx	94.73	BRD-K87316765-001-01-4	Phase 2
priralfinamide	sodium channel blocker	CACNA1B			Tocris, AMS	98.67	BRD-K01662324-066-01-1, BRD-K01662324-001-01-8	Phase 3
pritelivir	helicase primase inhibitor				MedChemEx	98.06	BRD-K25204779-001-01-1	Phase 2
proacipimox	cholesterol inhibitor				Enamine	97.66	BRD-K53605365-001-01-4	Phase 1
proadifen	nitric oxide synthase inhibitor	NOS1			Selleck, Selleck, MicroSource	93.97	BRD-K46317332-003-16-0, BRD-K46317332-003-18-6, BRD-K46317332-003-17-8	Preclinical
probenecid	uricosuric blocker	PANX1, SLC22A11, SLC22A6, SLC22A8, SLCO1C1	nephrology, rheumatology	hyperuricemia, gout	Tocris, MicroSource, Selleck	98.66	BRD-K95237249-001-27-3, BRD-K95237249-001-26-5, BRD-K95237249-001-25-7	Launched
probucol	atherogenesis inhibitor	ABCA1, ABCB11, CES1	cardiology	coronary artery disease (CAD)	MicroSource, Selleck	93.74	BRD-K72029282-001-23-8, BRD-K72029282-001-22-0	Launched
procainamide	sodium channel blocker	DNMT1, SCN5A	cardiology	ventricular arrhythmias, ventricular tachycardia (VT)	MicroSource	97.98	BRD-K75089421-003-24-5	Launched
procaine	HMGCR inhibitor	CHRNA2, GRIN3A, HTR3A, KCNMA1, KCNMB1, KCNMB2, KCNMB3, KCNMB4, KCNN1, KCNN2, KCNN3, KCNN4, MAOA, MAOB, RYR1, RYR2, SCN10A, SLC6A3	neurology/psychiatry	anesthetic	MicroSource, Selleck	99.21	BRD-K24616672-003-20-1, BRD-K24616672-003-19-3	Launched
procarbazine	monoamine oxidase inhibitor		hematologic malignancy	Hodgkin's lymphoma	Selleck, Selleck, MedChemEx, MicroSource	47.77	BRD-K13032584-003-19-3, BRD-K13032584-003-18-5, BRD-K13032584-003-21-9, BRD-K13032584-001-01-5	Launched
procaterol	adrenergic receptor agonist	ADRB2	pulmonary	asthma	Tocris, Tocris	96.33	BRD-K78666826-003-02-4, BRD-K78666826-003-01-6	Launched
prochlorperazine	dopamine receptor antagonist	DRD1, DRD2, DRD3, DRD4	gastroenterology	nausea, vomiting	Tocris, Selleck, MicroSource, Selleck	93	BRD-K19352500-332-09-4, BRD-K19352500-332-07-8, BRD-K19352500-070-12-4, BRD-K19352500-332-08-6	Launched
procodazole	immunostimulant				Selleck, MicroSource	98.53	BRD-K54824716-001-03-2, BRD-K54824716-001-04-0	Preclinical
procyanidin-b-2					SantaCruz, SantaCruz	81.99	BRD-K72093555-001-02-8, BRD-K72093555-001-01-0	Phase 2
procyclidine	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4	neurology/psychiatry	parkinsonism, Parkinson's Disease, akathisia, dystonia	Selleck, MicroSource	96.66	BRD-A31800922-003-24-4, BRD-A31800922-003-25-1	Launched
procysteine	glutathione synthase stimulant				Sigma	93.1	BRD-K92413528-001-06-9	Phase 3
profenamine	butyrylcholinesterase inhibitor, cholinergic receptor antagonist	CHRM1, CHRM2, GRIN3A	neurology/psychiatry	Parkinson's Disease	MicroSource, Sigma	45.81	BRD-A16311756-003-08-5, BRD-A16311756-003-09-3	Launched
proflavine-hemisulfate	topical anesthetic	F2			MicroSource	87.04	BRD-K68408467-065-01-8	Phase 2
progesterone	progesterone receptor agonist	CATSPER1, CATSPER2, CATSPER3, CATSPER4, CYP17A1, ESR1, NR3C2, OPRK1, PGR, TRPC5	obstetrics/gynecology, endocrinology	infertility, amenorrhea	MicroSource, Selleck	97.71	BRD-K64994968-001-32-5, BRD-K64994968-001-33-3	Launched
proglumetacin	cyclooxygenase inhibitor	PTGS1, PTGS2	neurology/psychiatry	pain relief	AKSci	0	BRD-A19458515-001-01-2	Launched
proglumide	CCK receptor antagonist	CCKAR, CCKBR			MicroSource	99.55	BRD-A44863528-001-13-2	Withdrawn
proguanil	dihydrofolate reductase inhibitor	DHFR	infectious disease	malaria	MicroSource	92.08	BRD-K28183345-003-11-4	Launched
prolylleucylglycinamide	melanocyte-stimulating hormone release inhibitor				Pharmeks	32.9	BRD-A09911125-001-01-4	Phase 2
promazine	dopamine receptor antagonist	ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, HRH1, HTR2A, HTR2C	neurology/psychiatry	schizophrenia	MedChemEx, MicroSource	94.85	BRD-K06980535-003-26-7, BRD-K06980535-003-25-9	Launched
promestriene	estrogen receptor agonist	ESR1	endocrinology	androgenetic alopecia	Carbosynth	0	BRD-K75097983-001-01-0	Launched
promethazine	histamine receptor antagonist	ADRA1A, CALM1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A	neurology/psychiatry, allergy	sedative, allergic rhinitis	MedChemEx, MicroSource	88.98	BRD-A46335897-003-27-8, BRD-A46335897-003-26-0	Launched
pronethalol	adrenergic receptor antagonist				MicroSource, Tocris	98.15	BRD-A87715314-003-15-1, BRD-A87715314-003-14-4	Withdrawn
propacetamol	cyclooxygenase inhibitor	PTGS2	endocrinology, neurology/psychiatry	fever, pain relief	AKSci	94.37	BRD-K54496168-003-01-2	Launched
propafenone	antiarrhythmic	ADRB1, ADRB2, KCNA5, KCNH2, SCN5A	cardiology	atrial fibrillation (AF), ventricular tachycardia (VT), ventricular arrhythmias	MicroSource, Selleck	96.58	BRD-A26334849-003-23-3, BRD-A26334849-001-06-2	Launched
propagermanium	interferon receptor agonist, CCR agonist	CCR2	infectious disease	hepatitis B	Sigma	0	BRD-K53382462-001-02-0	Launched
propantheline	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4	gastroenterology	peptic ulcer disease (PUD)	MicroSource	80.23	BRD-K90885812-004-24-2	Launched
propatylnitrate			cardiology	angina pectoris	Sigma	0	BRD-K56276053-001-01-8	Launched
propentofylline	adenosine reuptake inhibitor, phosphodiesterase inhibitor	PDE1A	neurology/psychiatry	stroke	Enzo	95.57	BRD-K59273480-001-10-6	Launched
propidium-iodide		ACHE			Prestwick	37.12	BRD-K14821965-302-05-2	Preclinical
propiolactone					MicroSource	1.17	BRD-K76867903-001-03-8	Launched
propiverine	acetylcholine receptor antagonist	CHRM1	urology	urinary incontinence	Sigma	97.84	BRD-K91244729-003-01-3	Launched
propofol	benzodiazepine receptor agonist	FAAH, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, SCN2A, SCN4A	neurology/psychiatry	anesthetic	MicroSource, Enamine	76.91	BRD-K82255054-001-15-9, BRD-K82255054-001-17-5	Launched
propoxur					MicroSource	93.11	BRD-K08231299-001-08-1	Launched
propoxycaine	local anesthetic		neurology/psychiatry	anesthetic	MicroSource	98.96	BRD-K18250272-003-11-0	Launched
propranolol	adrenergic receptor antagonist		cardiology, neurology/psychiatry	hypertension, angina pectoris, migraine headache	MicroSource, Selleck, Tocris	97.75	BRD-A10070317-003-30-9, BRD-A10070317-003-28-3, BRD-A10070317-003-29-1	Launched
propranolol-(R)	adrenergic receptor antagonist	ADRB2, ADRB3			Tocris	98.07	BRD-K92830582-003-10-5	Preclinical
propranolol-(S)	adrenergic receptor antagonist	ADRB1, ADRB2, ADRB3, HTR1A, HTR1B, HTR5A, SLC10A1			Tocris, MicroSource	97.96	BRD-K13994703-003-15-8, BRD-K13994703-003-16-6	Preclinical
propyl-benzoate					Enamine	0	BRD-K15329706-001-01-6	Launched
propylene-glycol		F13A1			Sigma	0	BRD-A19232309-001-08-6	Launched
propylhexedrine	adrenergic receptor agonist	SLC18A2, TAAR1	otolaryngology, endocrinology, allergy	nasal congestion, fever, allergic rhinitis	PrincetonBio	76.33	BRD-A35667010-001-01-8	Launched
propylparaben					ChemDiv	0	BRD-K60783397-001-09-5	Launched
propylthiouracil	thyroid peroxidase inhibitor	DIO1, TPO	endocrinology	hyperthyroidism, Grave's disease, goiter	MicroSource, Selleck	97.48	BRD-K48168960-001-19-2, BRD-K48168960-001-18-4	Launched
proquazone	cyclooxygenase inhibitor	PTGS1, PTGS2			AMS	97	BRD-K54339150-001-01-8	Launched
proscillaridin-a			cardiology	congestive heart failure, cardiac arrythmia	MicroSource	91.74	BRD-A11815689-001-01-1	Launched
protionamide			infectious disease	tuberculosis	MicroSource, Selleck	94.39	BRD-K75360161-001-18-0, BRD-K75360161-001-17-2	Launched
protirelin	thyrotropin releasing hormone receptor agonist	TRHR	radiology	thyroid function diagnostic	MicroSource	96.18	BRD-A16997652-001-02-3	Launched
protoporphyrin-ix	heme oxygenase inhibitor	HMOX1			MicroSource	18.86	BRD-K26813314-001-08-5	Preclinical
protriptyline	tricyclic antidepressant	SLC6A2, SLC6A4	neurology/psychiatry	depression	MicroSource	97	BRD-K42098891-003-20-5	Launched
proxodolol	adrenergic receptor antagonist				InterBioScreen	97.24	BRD-A29944538-003-08-3	Launched
proxyfan	histamine receptor modulator	HRH3			Tocris, Tocris	97.13	BRD-K77171813-034-01-8, BRD-K77171813-034-02-6	Preclinical
proxymetacaine	sodium channel blocker	SCN10A, SCN5A	neurology/psychiatry	anesthetic	MicroSource, Selleck	97.7	BRD-K79116891-003-15-1, BRD-K79116891-003-14-4	Launched
proxyphylline			pulmonary	asthma	MicroSource	97.93	BRD-A28887267-001-19-3	Launched
PRT062070	JAK inhibitor, syk inhibitor	SYK			MedChemEx, MedChemEx, MedChemEx	89.15	BRD-K25835157-001-02-2, BRD-K25835157-001-04-8, BRD-K25835157-001-01-4	Phase 1
PRT062607	syk inhibitor	FGR, MAP3K9, SYK			Selleck, Selleck	94.89	BRD-K53734668-003-04-6, BRD-K53734668-003-02-0	Phase 2
PRT4165	polycomb repressive complex inhibitor	PRC1			MedChemEx, MedChemEx, Tocris	62.32	BRD-K32456483-001-02-3, BRD-K32456483-001-04-9, BRD-K32456483-001-03-1	Preclinical
prucalopride	serotonin receptor agonist	HTR4	gastroenterology	constipation	Selleck, Selleck	97.6	BRD-K33681278-036-01-2, BRD-K33681278-001-02-4	Launched
prulifloxacin	bacterial DNA gyrase inhibitor		infectious disease, pulmonary, gastroenterology	urinary tract infections, bronchitis, diarrhea	MicroSource, MedChemEx	79.74	BRD-A92341659-001-03-2, BRD-A92341659-001-04-0	Launched
pruvanserin	serotonin receptor antagonist	HTR2A, HTR2C			Tocris, Sigma	98.48	BRD-K43837174-003-02-1, BRD-K43837174-003-01-3	Phase 2
PRX-08066	serotonin receptor antagonist	HTR2B			Selleck	97.22	BRD-K16757695-050-02-5	Phase 2
PSB-06126	NTPDase inhibitor	ENTPD3			Tocris	97.04	BRD-K71266197-236-02-7	Preclinical
PSB-11	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA3			Tocris, Tocris	97.61	BRD-K10177585-003-03-2, BRD-K10177585-003-02-4	Preclinical
PSB-1115	adenosine receptor antagonist	ADORA1, ADORA2B, ADORA3			Tocris, Tocris	96.91	BRD-K49027941-001-02-9, BRD-K49027941-001-01-1	Preclinical
PSB-36	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3			Tocris, Tocris	98.41	BRD-A70407468-001-03-8, BRD-A70407468-001-02-0	Preclinical
PSB-603	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3			Tocris	98.46	BRD-K05419687-001-01-0	Preclinical
PSI-6130	RNA polymerase inhibitor				MedChemEx	100	BRD-K07798980-001-01-9	Phase 1
PSI-7976	HCV inhibitor				MedChemEx	98.58	BRD-K05674516-001-01-7	Preclinical
PSN-375963	glucose dependent insulinotropic receptor agonist	GPR119			Tocris, Tocris	65.92	BRD-K25524093-003-01-7, BRD-K25524093-003-02-5	Preclinical
PSNCBAM-1	cannabinoid receptor modulator	CNR1			Tocris	88.92	BRD-K33502629-001-01-0	Preclinical
psoralen		MAOA, MAOB	dermatology	psoriasis, eczema, vitiligo	Specs	91.19	BRD-K47264279-001-08-9	Launched
PS178990	androgen receptor modulator	AR			MedChemEx	98.09	BRD-K99092662-001-01-1	Phase 1
PT-2385	hypoxia inducible factor inhibitor	EPAS1			MedChemEx	96.9	BRD-K20850787-001-01-6	Phase 1
PTC-209	BMI-1 inhibitor				MedChemEx, Selleck, Selleck	85.87	BRD-K83834509-001-03-7, BRD-K83834509-001-01-1, BRD-K83834509-001-02-9	Preclinical
pterostilbene	cyclooxygenase inhibitor, PPAR receptor agonist	PTGS2			Enzo	85.05	BRD-K53097745-001-01-5	Phase 2/Phase 3
PU-H71	HSP inhibitor	HSP90AA1			MedChemEx	95.73	BRD-K36529613-001-02-6	Phase 1
puerarin	serotonin receptor antagonist				Selleck	97.51	BRD-K89048337-001-06-9	Phase 2
pumosetrag	serotonin receptor agonist	HTR3A, HTR4			Sigma	98.08	BRD-K44164034-003-01-1	Phase 2
purmorphamine	smoothened receptor agonist	SMO			Selleck, Tocris, Selleck	94.09	BRD-K73397362-001-06-6, BRD-K73397362-001-08-2, BRD-K73397362-001-07-4	Preclinical
puromycin	protein synthesis inhibitor	NHP2L1, RPL10L, RPL11, RPL13A, RPL15, RPL19, RPL23, RPL23A, RPL26L1, RPL3, RPL37, RPL8, RSL24D1			MicroSource	96.37	BRD-A28970875-300-04-9	Preclinical
purvalanol-a	CDK inhibitor	CDK1, CDK2, CDK4, CDK5, CSNK1G3, RPS6KA1, SRC			Tocris, Tocris	95.85	BRD-K50836978-001-03-3, BRD-K50836978-001-02-5	Preclinical
purvalanol-b	tyrosine kinase inhibitor	CDK2, CDK4, CDK5, MAPK1, MAPK3, SRPK2			Tocris, Tocris	97.82	BRD-K41564320-001-03-8, BRD-K41564320-001-02-0	Preclinical
putrescine	tissue transglutaminase inhibitor	AMD1, KCNJ4, ODC1			Sigma	0	BRD-K75282878-300-05-3	Phase 2
PX-12	thioredoxin inhibitor	TXN, TXNRD1			MedChemEx	95.68	BRD-A56592690-001-04-3	Phase 2
PX-478	hypoxia inducible factor inhibitor				Selleck	88.15	BRD-A26835809-300-01-3	Phase 1
PYM50028	neurotrophic agent				Enzo	100	BRD-K62277907-001-01-6	Phase 2
PYR-41	ubiquitin activating enzyme inhibitor				Selleck, Selleck	33.17	BRD-K66101666-001-01-5, BRD-K66101666-001-02-3	Preclinical
pyrantel	nicotinic receptor agonist		infectious disease	gastrointestinal roundworms, gastrointestinal roundworms	Sigma	97.74	BRD-K82118441-001-03-7	Launched
pyrantel-pamoate	neuromuscular blocker		infectious disease	hookworm, tapeworm	MedChemEx, MedChemEx, MicroSource	94.32	BRD-K20672254-096-06-7, BRD-K20672254-046-05-4, BRD-K20672254-096-03-4	Launched
pyrantel-tartrate	acetylcholine receptor agonist	CHRNA1			Prestwick, MedChemEx, MedChemEx	79.67	BRD-K20672254-046-03-9, BRD-K20672254-096-05-9, BRD-K20672254-046-04-7	Preclinical
pyrazinamide	fatty acid synthase inhibitor	FASN	infectious disease	tuberculosis	Selleck, MicroSource	98.54	BRD-K28667793-001-27-3, BRD-K28667793-001-28-1	Launched
pyrazinoylguanidine	diuretic				Enamine	95.97	BRD-K61693562-300-01-7	Phase 1
pyrazolanthrone	JNK inhibitor	MAPK10, MAPK8, MAPK8IP1, MAPK9, TTK			Selleck, Tocris	97.4	BRD-K01567962-001-23-0, BRD-K01567962-001-24-8	Preclinical
pyrazoloacridine	topoisomerase inhibitor	TOP1, TOP2A			Sigma	13.26	BRD-K42607789-001-01-2	Phase 2
pyrethrins					MicroSource	0	BRD-K79856453-001-01-6	Launched
pyridoxal		PDXK	neurology/psychiatry	epilepsy	Vitas-M	92.3	BRD-K76204040-001-03-8	Launched
pyridoxal-isonicotinoyl-hydrazone	apoptosis stimulant				Cayman	93.7	BRD-K42019693-001-01-5	Phase 2
pyridoxamine	AGE inhibitor				Sigma	98.7	BRD-K96669468-300-01-1	Phase 3
pyridoxine	vitamin B	DDC, PDXK	metabolism	vitamin B6 deficiency	MicroSource, Selleck	100	BRD-K14349461-001-04-4, BRD-K14349461-003-13-1	Launched
pyrimethamine	dihydrofolate reductase inhibitor	DHFR, SLC47A1	infectious disease	malaria	Tocris, Selleck, Tocris, MicroSource	99.69	BRD-K88429204-001-38-5, BRD-K88429204-001-33-6, BRD-K88429204-001-34-4, BRD-K88429204-001-35-1	Launched
pyrintegrin	integrin signaling activator				Tocris	89.51	BRD-K94659840-001-01-7	Preclinical
pyrithione-zinc	ATP synthase inhibitor	KCNQ1, KCNQ2, KCNQ4, KCNQ5	dermatology	dandruff	Selleck, MicroSource, Selleck	0	BRD-K16136380-001-03-3, BRD-K16136380-001-01-7, BRD-K16136380-001-02-5	Launched
pyrithyldione	psychoactive drug				MicroSource	97.73	BRD-K36116267-001-15-3	Withdrawn
pyritinol			rheumatology, neurology/psychiatry	rheumatoid arthritis, senile dementia	MicroSource	96.46	BRD-K82181219-001-04-3	Launched
pyronaridine	antimalarial agent				MicroSource, Vitas-M	86.56	BRD-K73132780-411-01-3, BRD-K73132780-001-01-2	Phase 3
pyroxamide	HDAC inhibitor	HDAC1			Cayman, Cayman, Tocris	95.74	BRD-K11663430-001-04-9, BRD-K11663430-001-02-3, BRD-K11663430-001-03-1	Phase 1
pyrrolidine-dithiocarbamate	NFkB pathway inhibitor	HSD11B1, RELA			Tocris	0	BRD-K80970344-201-08-6	Preclinical
pyrvinium	androgen receptor antagonist				Enamine	63.11	BRD-M55114534-096-01-9	Launched
pyrvinium-pamoate	androgen receptor antagonist	AR			Sigma, MicroSource	64.19	BRD-M55114534-373-01-2, BRD-K39479472-096-04-7	Launched
P22077	ubiquitin specific protease inhibitor	USP7			Tocris, Selleck	97.13	BRD-K97714174-001-02-1, BRD-K97714174-001-01-3	Preclinical
P276-00	CDK inhibitor	CDK1, CDK4, CDK9			Selleck	91.42	BRD-K51791723-003-01-7	Phase 2
P5091	ubiquitin specific protease inhibitor	USP7			Selleck	97.85	BRD-K13606314-001-01-3	Preclinical
P7C3	NAMPT inhibitor	NAMPT			Tocris	88.39	BRD-A09487507-001-02-1	Preclinical
Q-203	ATP synthase inhibitor				Enamine	89.92	BRD-K59853741-001-01-9	Phase 1
quazinone	phosphodiesterase inhibitor	PDE3A, PDE3B			AMS	96.97	BRD-K63631219-001-01-6	Phase 2
quercetin	polar auxin transport inhibitor	ATP5A1, ATP5B, ATP5C1, HCK, HIBCH, PIK3CG, PIM1, STK17B, UGT3A1	neurology/psychiatry, allergy	fatigue, allergic rhinitis, drowsiness	Tocris, Selleck, Selleck, Selleck, Selleck	93.07	BRD-K97399794-001-15-3, BRD-K97399794-001-14-6, BRD-K97399794-335-05-6, BRD-K97399794-001-16-1, BRD-K97399794-335-06-4	Launched
quetiapine	dopamine receptor antagonist, serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2C, HTR3A, HTR6, HTR7, SLC6A2	neurology/psychiatry	schizophrenia, bipolar disorder	MicroSource, Tocris, Selleck	98.67	BRD-K68867920-001-11-0, BRD-K68867920-051-12-3, BRD-K68867920-051-11-5	Launched
quiflapon	leukotriene synthesis inhibitor	ALOX5, ALOX5AP			MedChemEx	97.94	BRD-K39503511-001-03-9	Phase 2
quinagolide	dopamine receptor agonist	DRD2	endocrinology	hyperprolactinemia	MedChemEx	90.35	BRD-K02995728-003-01-9	Launched
quinapril	angiotensin converting enzyme inhibitor	ACE	cardiology	hypertension, congestive heart failure, angioedema	MicroSource, Selleck, Selleck	93.01	BRD-K72222507-003-16-8, BRD-K72222507-003-15-0, BRD-K72222507-003-17-6	Launched
quinaprilat	angiotensin converting enzyme inhibitor	ACE	cardiology	hypertension, angioedema	MicroSource	0	BRD-K42317111-001-01-7	Launched
quinelorane	dopamine receptor agonist	DRD2, DRD3			Enzo	97.42	BRD-K13261168-300-01-0	Phase 3
quinestrol	estrogen receptor agonist	ESR1	endocrinology	menopause	MicroSource	99.34	BRD-A16439188-001-01-1	Launched
quinethazone	thiazide diuretic	CA1, CA2, SLC12A1, SLC12A2, SLC12A3	cardiology	hypertension	MicroSource	98.85	BRD-A59303141-001-10-4	Launched
quinidine	sodium channel blocker	KCNA5, KCNA7, KCNH1, KCNH2, KCNH5, KCNK1, KCNK6, SCN5A, SLC29A4	infectious disease, cardiology	malaria, atrial fibrillation (AF), ventricular arrhythmias	MicroSource	87.9	BRD-K59632282-052-03-1	Launched
quinine	hemozoin biocrystallization inhibitor	GP9, KCNB2, KCNN4, SLC29A4	infectious disease	malaria	Selleck, MicroSource	93.42	BRD-K07940445-310-02-9, BRD-K48278478-001-01-2	Launched
quinine-ethyl-carbonate			infectious disease	malaria	MicroSource	92.37	BRD-K97028990-001-04-4	Launched
quinolinic-acid	glutamate receptor agonist				Tocris	94.44	BRD-K51885093-001-11-2	Preclinical
quinpirol-(-)	dopamine receptor agonist	DRD1, DRD2, DRD3, DRD4, HTR1A, HTR2A, HTR2B, HTR2C			Tocris, Tocris	94.33	BRD-K26548821-003-11-3, BRD-K26548821-003-10-5	Phase 2
quipazine	serotonin receptor agonist				MicroSource, Selleck, Tocris	92.6	BRD-K77925998-050-14-3, BRD-K77925998-364-01-5, BRD-K77925998-332-04-6	Preclinical
quizartinib	FLT3 inhibitor	CSF1R, FLT3, KIT, PDGFRA, PDGFRB, RET			Selleck	95.17	BRD-K93918653-001-08-9	Phase 3
QX-222	sodium channel blocker				Tocris	98.05	BRD-K40782193-003-02-9	Preclinical
QX-314	sodium channel blocker	MAPK14, TGFBR1			Tocris, Tocris	97.7	BRD-K56596464-003-02-6, BRD-K56596464-004-10-7	Preclinical
r(-)-apomorphine	dopamine receptor agonist	DRD2, HTR5A	neurology/psychiatry	Parkinson's Disease	MicroSource, Tocris, Selleck	97.34	BRD-A35931254-003-04-3, BRD-K76022557-003-02-7, BRD-K76022557-001-03-9	Launched
R-1479	HCV inhibitor				MedChemEx	96.79	BRD-K28442028-001-01-3	Phase 1
R-1485	serotonin receptor antagonist	HTR6			Tocris	95.77	BRD-K96418224-300-01-8	Phase 1
R-268712	serine/threonine kinase inhibitor	TGFBR1			Tocris	91.85	BRD-K83904070-001-01-1	Preclinical
R-428	AXL kinase inhibitor	AXL			MedChemEx	88.26	BRD-K14870255-001-02-3	Phase 1
R-59022	diacylglycerol kinase inhibitor, protein kinase inhibitor	DGKA			Tocris, Tocris	97.41	BRD-K54665485-001-07-9, BRD-K54665485-001-08-7	Preclinical
R-96544	serotonin receptor antagonist	HTR2A			Tocris, Tocris	96.58	BRD-K15588452-003-03-5, BRD-K15588452-003-02-7	Preclinical
rabeprazole	ATPase inhibitor, gastrin inhibitor	ATP4A	gastroenterology	gastroesophageal reflux disease (GERD), duodenal ulcer disease, Zollinger-Ellison syndrome	MicroSource, MedChemEx, Sigma, Sigma	98.9	BRD-A39390670-236-09-9, BRD-A39390670-236-10-7, BRD-A39390670-236-12-3, BRD-A39390670-236-11-5	Launched
rac-BHFF	GABA receptor positive allosteric modulator	GABBR1			Tocris	0	BRD-A11069678-001-01-8	Preclinical
racecadotril	enkephalinase inhibitor	MME	gastroenterology	diarrhea	MicroSource, Selleck	98	BRD-A08187463-001-12-9, BRD-A08187463-001-11-1	Launched
raclopride	dopamine receptor antagonist	DRD2, DRD3, HTR1A			Tocris, Tocris	96.6	BRD-K04111260-001-12-6, BRD-K04111260-001-10-0	Launched
ractopamine	adrenergic receptor agonist				Selleck, MicroSource	93.48	BRD-A86414188-003-01-5, BRD-A86414188-003-02-3	Launched
radafaxine	dopamine-norepinephrine reuptake inhibitor	SLC6A3			MedChemEx	92.33	BRD-K13394247-003-01-4	Phase 2
radezolid	bacterial 30S ribosomal subunit inhibitor, bacterial 50S ribosomal subunit inhibitor				MedChemEx	94.62	BRD-K84683831-001-01-0	Phase 2
RAF265	RAF inhibitor, VEGFR inhibitor	BRAF			Selleck	94.35	BRD-K93123848-001-04-1	Phase 2
raloxifene	estrogen receptor antagonist, selective estrogen receptor modulator (SERM)	ESR1, ESR2	orthopedics, oncology	osteoporosis, breast cancer	MicroSource, Tocris, Tocris, Selleck	98.21	BRD-K63828191-003-34-7, BRD-K63828191-003-33-9, BRD-K63828191-003-35-4, BRD-K63828191-003-32-1	Launched
raltegravir	HIV integrase inhibitor		infectious disease	human immunodeficiency virus (HIV-1)	Selleck, Selleck	94.8	BRD-K05658747-001-02-9, BRD-K05658747-001-03-7	Launched
raltitrexed	thymidylate synthase inhibitor	FPGS, TYMS	oncology	mesothelioma	Selleck, Selleck	93.68	BRD-K89839824-001-06-1, BRD-K89839824-001-05-3	Launched
ramatroban	prostanoid receptor antagonist	PTGDR2, TBXA2R	cardiology, pulmonary	coronary artery disease (CAD), asthma	MedChemEx	97.83	BRD-K08586861-001-01-1	Launched
ramelteon	melatonin receptor agonist	MTNR1A, MTNR1B	neurology/psychiatry	insomnia	MicroSource, Selleck	98.49	BRD-K28761891-001-10-1, BRD-K28761891-001-09-3	Launched
ramifenazone	cyclooxygenase inhibitor		neurology/psychiatry, endocrinology	pain relief, fever	Key, MicroSource	80.52	BRD-K85333151-001-01-3, BRD-K85333151-003-13-4	Launched
ramipril	angiotensin converting enzyme inhibitor	ACE	cardiology	hypertension	MicroSource, Tocris, Selleck	98.06	BRD-K89348303-001-14-7, BRD-K89348303-001-16-2, BRD-K89348303-001-17-0	Launched
ramosetron	serotonin receptor antagonist	HTR3A	gastroenterology	nausea, vomiting, irritable bowel syndrome	MedChemEx	99.58	BRD-K85046107-003-01-2	Launched
ranirestat	aldose reductase inhibitor	AKR1B1			MedChemEx	96.29	BRD-K50489389-001-01-8	Phase 3
ranitidine	histamine receptor antagonist	HRH2	gastroenterology	heartburn	Selleck, Selleck, Tocris, MicroSource	97.81	BRD-K70505054-003-11-6, BRD-K70505054-003-13-2, BRD-K70505054-003-14-0, BRD-K70505054-003-12-4	Launched
ranolazine	sodium channel blocker	SCN10A, SCN4A, SCN5A, SCN9A	cardiology	chronic stable angina	MicroSource, Tocris, Selleck, Selleck	98.48	BRD-A97674275-001-11-8, BRD-A97674275-300-04-9, BRD-A97674275-001-10-0, BRD-A97674275-300-03-1	Launched
rapastinel	glutamate receptor agonist				MedChemEx	0	BRD-K02206208-001-01-4	Phase 2
rasagiline	monoamine oxidase inhibitor	BCL2, MAOB	neurology/psychiatry	Parkinson's Disease	Tocris, Selleck, MicroSource, Selleck	98.6	BRD-K58114536-066-03-5, BRD-K58114536-066-04-3, BRD-K58114536-001-01-6, BRD-K58114536-066-02-7	Launched
rauwolscine	adrenergic receptor antagonist	ADRA2A, ADRA2B, ADRA2C, HTR1B, HTR1D, HTR1E, HTR2B			Tocris, Tocris	88.44	BRD-K77474816-003-14-1, BRD-K77474816-003-13-3	Preclinical
ravoxertinib	ERK1 and ERK2 phosphorylation inhibitor	MAPK1, MAPK3			Adooq	98.38	BRD-K86309810-001-01-5	Phase 1
ravuconazole	sterol demethylase inhibitor				Cayman	98.93	BRD-K03503561-001-01-4	Phase 2
RBC8	Ral GTPase inhibitor	RALA, RALB			Tocris, MedChemEx, MedChemEx	84.72	BRD-A67036568-001-02-1, BRD-A67036568-001-03-9, BRD-A67036568-001-01-3	Preclinical
rebamipide	free radical scavenger	FPR1	gastroenterology	peptic ulcer disease (PUD), gastritis	MicroSource, Selleck	98.72	BRD-A15909516-001-07-4, BRD-A15909516-001-06-6	Launched
rebastinib	Bcr-Abl kinase inhibitor, TIE tyrosine kinase inhibitor, VEGFR inhibitor	ABL1, BCR, FGR, FLT3, HCK, LYN, SRC			Selleck, MedChemEx, MedChemEx, Selleck	96.77	BRD-K76694128-001-05-0, BRD-K76694128-001-06-8, BRD-K76694128-001-07-6, BRD-K76694128-001-04-3	Phase 1
reboxetine	adrenergic receptor antagonist	SLC6A2	neurology/psychiatry	depression	Tocris, Selleck, Cayman, Tocris	98.89	BRD-M39350793-334-02-9, BRD-K77224738-066-02-7, BRD-A43974499-066-02-9, BRD-M39350793-334-01-1	Launched
Rec-15/2615	adrenergic receptor antagonist	ADRA1A			Tocris	58.81	BRD-K84924479-300-01-1	Phase 2
refametinib	MEK inhibitor	MAP2K1, MAP2K2			MedChemEx	95.47	BRD-K85751432-001-03-3	Phase 2
regadenoson	adenosine receptor agonist	ADORA1, ADORA2A, ADORA2B, ADORA3	radiology	myocardial perfusion imaging (MPI)	Enzo	98.94	BRD-A78341343-001-01-6	Launched
regorafenib	FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RAF inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor	ABL1, BRAF, DDR2, EPHA2, FGFR1, FGFR2, FLT1, FLT4, FRK, KDR, KIT, MAPK11, NTRK1, PDGFRA, PDGFRB, RAF1, RET, TEK	oncology	colorectal cancer, gastrointestinal stromal tumors (GIST)	Selleck	97.53	BRD-K16730910-001-07-3	Launched
relcovaptan	vasopressin receptor antagonist	AVPR1A, AVPR1B, AVPR2, OXTR			Tocris, Tocris	98.48	BRD-K96720755-001-02-6, BRD-K96720755-001-03-4	Phase 2
relebactam	beta lactamase inhibitor				MedChemEx	86.36	BRD-K63018010-001-01-7	Phase 3
remacemide	glutamate receptor antagonist	GRIN1			Tocris	97.95	BRD-A36074203-003-07-6	Phase 3
remimazolam	benzodiazepine receptor agonist	GABBR1			MedChemEx	92.64	BRD-K89413285-074-01-5	Phase 3
remodelin	transferase inhibitor	NAT10			Tocris	76.13	BRD-K75349868-001-01-5	Preclinical
remoxipride	dopamine receptor antagonist	DRD2, DRD3, DRD4, HTR2A, SIGMAR1			Tocris	98.31	BRD-K54094468-003-11-1	Withdrawn
repaglinide	insulin secretagogue	ABCC8, KCNJ11, PPARG	endocrinology	diabetes mellitus	Tocris, Tocris, MicroSource, Selleck	99.06	BRD-K82846253-001-17-0, BRD-K82846253-001-15-4, BRD-K82846253-001-16-2, BRD-K82846253-001-14-7	Launched
reparixin	CC chemokine receptor antagonist	CXCR1, CXCR2			MedChemEx	99.13	BRD-K58486055-001-02-7	Phase 3
repsox	TGF beta receptor inhibitor	TGFBR1			Selleck, Tocris	98.05	BRD-K80480517-001-02-4, BRD-K80480517-001-04-0	Preclinical
resatorvid	toll-like receptor antagonist	TLR4			MedChemEx, MedChemEx	96.53	BRD-K61567297-001-02-7, BRD-K61567297-001-01-9	Phase 3
reserpine	vesicular monoamine transporter inhibitor	SLC18A1, SLC18A2	cardiology	hypertension	Selleck, Tocris, Selleck, MicroSource	88.29	BRD-K95921201-001-15-3, BRD-K95921201-001-13-8, BRD-K95921201-001-12-0, BRD-K95921201-001-14-6	Launched
resibufogenin	Na/K-ATPase inhibitor				MedChemEx	87.34	BRD-K25970317-001-01-6	Phase 2
resiquimod	toll-like receptor agonist	TLR7, TLR8			MedChemEx, Tocris	99.64	BRD-K76210423-001-01-6, BRD-K76210423-001-02-4	Phase 3
resminostat	HDAC inhibitor	HDAC1, HDAC3, HDAC6, HDAC8			Selleck, Selleck	91.59	BRD-K28822270-001-01-1, BRD-K28822270-001-03-7	Phase 2
resorcinol	phosphodiesterase inhibitor	CA12, CA14, CA2, PTGS1	dermatology	acne vulgaris (AV), eczema, psoriasis, seborrheic dermatitis	MicroSource	99.52	BRD-K74190368-001-04-3	Launched
resorcinol-monoacetate	antiseptic				MicroSource, MedChemEx	70.52	BRD-K85603128-001-03-5, BRD-K85603128-001-04-3	Launched
resveratrol	cytochrome P450 inhibitor, SIRT activator	CSNK2A1, NQO2, PTGS1, PTGS2			Selleck, MedChemEx, Selleck, Tocris, Tocris	95.03	BRD-K80738081-001-44-3, BRD-K80738081-001-46-8, BRD-K80738081-001-42-7, BRD-K80738081-001-43-5, BRD-K80738081-001-47-6	Launched
retapamulin	protein synthesis inhibitor		infectious disease	impetigo	Selleck	100	BRD-K33082088-001-03-3	Launched
retaspimycin	HSP inhibitor	HSP90AA1			MedChemEx, MedChemEx	0	BRD-K67935717-003-02-8, BRD-K67935717-003-01-0	Phase 3
retigabine	potassium channel activator	KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5	neurology/psychiatry	epilepsy	MedChemEx	90.38	BRD-K89917372-001-01-2	Launched
retinaldehyde			dermatology	cosmetic	SantaCruz	96.68	BRD-K79884267-001-01-4	Launched
retinol	retinoid receptor ligand	ALDH1A1, ALDH1A2, ALDH1A3, DHRS3, DHRS4, LRAT, NR2C2, RBP1, RBP3, RDH11, RDH12, RDH13, RDH14, RDH5, RDH8, RETSAT, RHO, RLBP1, RXRA, RXRB, RXRG	dermatology	cosmetic, acne vulgaris (AV), keratosis	Sigma, MicroSource	0	BRD-K22429181-001-15-9, BRD-K22429181-001-14-2	Launched
retinyl-acetate					MicroSource, Sigma	0	BRD-K65331431-001-06-2, BRD-K65331431-001-08-8	Launched
retinyl-palmitate					MicroSource, Sigma	0	BRD-K80595380-001-07-2, BRD-K80595380-001-09-8	Launched
REV-5901	leukotriene receptor antagonist, lipoxygenase inhibitor	ALOX5			Enzo	94.05	BRD-A68281735-001-18-6	Phase 2
revaprazan	potassium-competitive acid antagonist	ATP4A	gastroenterology	gastritis	AvaChem	0	BRD-A51497544-001-01-4	Launched
reversan	MRP inhibitor	ABCC1			Tocris	96.72	BRD-K79700588-001-09-7	Preclinical
reversine	Aurora kinase inhibitor	AURKB, INCENP, MAP2K1			MedChemEx, MedChemEx	83.16	BRD-K77286328-001-03-7, BRD-K77286328-001-06-0	Preclinical
RGB-286638	CDK inhibitor	CDK1, CDK2, CDK3, CDK4, CDK5, CDK6, CDK7, CDK9, FLT3, GSK3B, JAK2, MAP3K7, MAPK9			MedChemEx, MedChemEx	93.17	BRD-K20986415-001-02-6, BRD-K20986415-001-01-8	Phase 1
RGFP966	HDAC inhibitor	HDAC3			Selleck	91.29	BRD-K61688984-001-02-9	Preclinical
RG108	DNA methyltransferase inhibitor	DNMT1, DNMT3B			Selleck, Tocris	98.82	BRD-K89391146-001-08-0, BRD-K89391146-001-09-8	Preclinical
RG1530	FGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	FGFR1, FGFR2			MedChemEx, MedChemEx, MedChemEx, Tocris	58.63	BRD-K32942258-001-04-1, BRD-K32942258-001-02-5, BRD-K32942258-001-01-7, BRD-K32942258-001-03-3	Phase 1
RG2833	HDAC inhibitor	HDAC1, HDAC3			MedChemEx, Selleck	95.29	BRD-K02389548-001-04-1, BRD-K02389548-001-02-5	Phase 1
RG4733	gamma secretase inhibitor	PSEN1			MedChemEx	98.56	BRD-K22024824-001-03-7	Phase 2
RG7112	MDM inhibitor	MDM2			Selleck	99.27	BRD-A78210457-001-01-5	Phase 1
RHC-80267	triacylglycerol lipase inhibitor	DAGLA, DAGLB			Tocris, Tocris	95.7	BRD-K56047318-001-07-1, BRD-K56047318-001-06-3	Preclinical
rhein		HSP90AA1			Selleck	97.12	BRD-K27335680-001-10-0	Phase 1
rheochrysidin	protein tyrosine kinase inhibitor	PTPN1			Selleck	86.96	BRD-K67772619-001-05-1	Preclinical
rhodamine-123					Cayman	93.16	BRD-K47169076-003-01-6	Phase 1
RI-1		RAD51			Selleck	90.39	BRD-K79555887-001-01-0	Preclinical
ribavirin	antiviral	ADK, ENPP1, IMPDH1, IMPDH2, NT5C2	infectious disease	hepatitis C	Tocris, Selleck, MicroSource	100	BRD-K60369935-001-17-5, BRD-K60369935-001-18-3, BRD-K60369935-001-15-9	Launched
ribitol					Selleck	100	BRD-K49313711-001-05-4	Preclinical
ribociclib	CDK inhibitor	CDK4, CDK6	oncology	breast cancer	MedChemEx, Selleck, Selleck	93.42	BRD-K36788280-001-04-6, BRD-K36788280-001-01-2, BRD-K36788280-001-03-8	Launched
riboflavin	vitamin B2	BLVRB, RFK	gastroenterology	jaundice	MicroSource, Selleck, Selleck	91.09	BRD-K70246307-001-04-1, BRD-K92760278-001-07-3, BRD-K92760278-001-06-5	Launched
riboflavin-5-phosphate-sodium		BLVRB, DHODH, DPYD, HAO1, HAO2, MT-ND1, NOS1, PNPO, POR, PPCDC, RFK, RPS6KA4, SGK1			MedChemEx, MicroSource, Sigma	10.28	BRD-K09229706-236-02-6, BRD-K58734774-236-02-2, BRD-K09229706-236-01-8	Launched
ribostamycin	bacterial 30S ribosomal subunit inhibitor		infectious disease	human immunodeficiency virus (HIV-1), human immunodeficiency virus (HIV-1)	MedChemEx, Bosche	73.8	BRD-K55188888-065-01-2, BRD-A86073102-001-01-6	Launched
ribostamycin-sulfate	bacterial 30S ribosomal subunit inhibitor	P4HB	infectious disease	gram-negative bacterial infections	MicroSource	0	BRD-A03826781-065-03-6	Launched
ricinoleic-acid	prostanoid receptor agonist	PTGER3			TCI	51.56	BRD-K33682646-001-02-7	Launched
rifabutin	protein synthesis inhibitor	HSP90AA1, HSP90B1	infectious disease	human immunodeficiency virus (HIV-1)	Selleck	94.51	BRD-K30563334-001-02-9	Launched
rifampin	RNA polymerase inhibitor	NR1I2, SLCO1A2, SLCO1B1, SLCO1B3	infectious disease	tuberculosis, meningitis	Selleck, MicroSource, Selleck	89.01	BRD-K01507359-001-23-7, BRD-A23603052-001-03-2, BRD-K01507359-001-22-9	Launched
rifamycin	DNA directed RNA polymerase inhibitor	SLCO1A2, SLCO1B1, SLCO1B3, SLCO2B1	infectious disease	tuberculosis, leprosy	AvaChem	2.86	BRD-K38512030-001-01-7	Launched
rifamycin-sv	RNA synthesis inhibitor				Enzo	77.86	BRD-K13277760-001-01-2	Phase 3
rifapentine	RNA polymerase inhibitor	CYP2C8, CYP2C9, CYP3A4	infectious disease	tuberculosis	Selleck, MedChemEx, Selleck	71.91	BRD-K28346421-001-08-4, BRD-K28346421-001-07-6, BRD-K28346421-001-06-8	Launched
rifaximin	RNA synthesis inhibitor	NR1I2	gastroenterology	diarrhea, irritable bowel syndrome, hepatic encephalopathy (HE)	MicroSource, Selleck	94.32	BRD-K92838188-001-01-9, BRD-K92838188-001-02-7	Launched
rigosertib	cell cycle inhibitor, PLK inhibitor	PLK1			Selleck, MedChemEx, Selleck	94.32	BRD-K55187425-236-06-0, BRD-K55187425-236-07-8, BRD-K55187425-236-05-2	Phase 3
rilmenidine	adrenergic receptor agonist, imidazoline receptor agonist	ADRA2A	cardiology	hypertension	Tocris, Selleck	88.74	BRD-K01638814-051-16-8, BRD-K01638814-011-01-4	Launched
rilpivirine	non-nucleoside reverse transcriptase inhibitor	NR1I2, SCN10A	infectious disease	human immunodeficiency virus (HIV-1)	Selleck	93.71	BRD-K06240250-001-01-6	Launched
riluzole	glutamate inhibitor	KCNK10, KCNK2, KCNK4, KCNN4, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A, SLC7A11	neurology/psychiatry	amyotrophic lateral sclerosis (ALS)	Tocris, MicroSource, Selleck	99.88	BRD-K21283037-003-11-2, BRD-K21283037-001-21-5, BRD-K21283037-001-20-7	Launched
rimantadine	antiviral, RNA synthesis inhibitor		infectious disease	influenza A virus infection	MicroSource, Selleck	100	BRD-A75479906-003-11-1, BRD-A75479906-001-02-4	Launched
rimcazole	sigma receptor antagonist	SIGMAR1			Tocris	96.68	BRD-K70490179-300-01-2	Phase 1
rimexolone	glucocorticoid receptor agonist	NR3C1, SERPINA6	ophthalmology	anterior uveitis	Prestwick	97.27	BRD-K31627533-001-09-5	Launched
rimonabant	cannabinoid receptor antagonist	CNR1, GPR55			Selleck	96.88	BRD-K13296708-001-05-8	Withdrawn
riociguat	guanylate cyclase stimulant	GUCY1A2, GUCY1A3, GUCY1B2, GUCY1B3	cardiology	hypertension	MedChemEx	99.03	BRD-K84783599-001-01-0	Launched
riodipine	calcium channel blocker				Sigma	97.87	BRD-K36379990-001-01-1	Phase 2
riodoxol	other antibiotic				Vitas-M, Vitas-M	31.26	BRD-K48963429-001-01-9, BRD-K48963429-001-02-7	Launched
ripasudil	rho associated kinase inhibitor	ROCK1, ROCK2	ophthalmology	glaucoma, ocular hypertension	MedChemEx	98.73	BRD-K53814070-310-01-3	Launched
ripazepam	benzodiazepine receptor agonist	GABRA1			Sigma	99.45	BRD-K57427145-001-01-6	Phase 2
risedronate	osteoclast inhibitor	FDPS	orthopedics, endocrinology	osteoporosis, Paget's disease	Selleck, MicroSource, Selleck, Selleck, Selleck	0	BRD-K05185389-236-05-1, BRD-K05185389-236-04-4, BRD-K05185389-001-02-6, BRD-K05185389-001-03-4, BRD-K05185389-236-03-6	Launched
risperidone	dopamine receptor antagonist, serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2C, HTR6, HTR7	neurology/psychiatry	schizophrenia, bipolar disorder, irritability	MicroSource, Selleck	98.34	BRD-K53857191-001-22-7, BRD-K53857191-001-21-9	Launched
RITA	MDM inhibitor	MDM2			Selleck, Selleck	87.3	BRD-K00317371-001-05-3, BRD-K00317371-001-06-1	Preclinical
ritanserin	serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA1D, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7			Tocris, MicroSource, Tocris	98.51	BRD-K40887525-001-23-5, BRD-K40887525-001-22-7, BRD-K40887525-001-21-9	Phase 3
ritodrine	adrenergic receptor agonist	ADRB2	obstetrics/gynecology	premature labor	Selleck, Selleck, MicroSource	98.11	BRD-K14003026-003-09-0, BRD-K14003026-003-08-2, BRD-A59174698-003-18-5	Launched
ritonavir	HIV protease inhibitor	CYP1A2, CYP2B6, CYP2C19, CYP2C8, CYP2C9, CYP2D6, CYP2E1, CYP3A4, CYP3A5, CYP3A7	infectious disease	human immunodeficiency virus (HIV-1)	Selleck	98.16	BRD-K51485625-001-08-4	Launched
rivanicline	acetylcholine receptor agonist	CHRNA4, CHRNB2, CXCL8			Enzo	94.98	BRD-K79966802-034-01-2	Phase 2
rivaroxaban	coagulation factor inhibitor	F10	neurology/psychiatry, hematology, cardiology	stroke, systemic embolism, atrial fibrillation (AF), deep vein thrombosis (DVT), pulmonary embolism (PE)	MicroSource, Selleck	96.48	BRD-K37130656-001-03-8, BRD-K37130656-001-04-6	Launched
rivastigmine	acetylcholinesterase inhibitor	ACHE, BCHE	neurology/psychiatry	Alzheimer's disease, Parkinson's Disease, senile dementia	MicroSource, Tocris, Tocris, Selleck	97.89	BRD-K10706131-046-04-4, BRD-K10706131-046-05-1, BRD-K10706131-046-03-6, BRD-K10706131-046-02-8	Launched
rizatriptan	serotonin receptor agonist	HTR1A, HTR1B, HTR1D, HTR1E, HTR1F	neurology/psychiatry	migraine headache	Selleck, Tocris, MicroSource, Selleck	93.99	BRD-K75699339-057-09-9, BRD-K75699339-057-10-7, BRD-K75699339-057-08-1, BRD-K75699339-057-07-3	Launched
RKI-1447	rho associated kinase inhibitor	CDC42BPA, DMPK, LIMK1, MYLK, PAK1, PKN1, ROCK1, ROCK2			Selleck, Tocris	98.46	BRD-K19333160-001-01-3, BRD-K19333160-300-01-9	Preclinical
RLX					Vitas-M	0	BRD-K28773847-001-07-7	Preclinical
RN-1	histone demethylase inhibitor	KDM1A			Tocris	85.64	BRD-K41415459-300-01-6	Preclinical
RN-1734	TRPV antagonist	TRPV4			Tocris, Tocris	91.99	BRD-K95581532-001-02-3, BRD-K95581532-001-01-5	Preclinical
RN-1747	TRPV agonist	TRPV4			Tocris, Tocris	96.27	BRD-K45519571-001-02-6, BRD-K45519571-001-01-8	Preclinical
Ro-04-5595		GRIN2B			Tocris, Tocris	90.63	BRD-A63546914-003-03-8, BRD-A63546914-003-02-0	Preclinical
Ro-08-2750		NGF			Tocris	93.42	BRD-K00486786-001-02-2	Preclinical
Ro-10-5824	dopamine receptor agonist	DRD4			Tocris, Tocris	88.47	BRD-K79684402-300-02-8, BRD-K79684402-300-03-6	Preclinical
Ro-106-9920	NFkB pathway inhibitor				Tocris, Tocris	94.47	BRD-A53134341-001-04-0, BRD-A53134341-001-03-2	Preclinical
Ro-1138452	prostanoid receptor antagonist	PTGIR			Tocris	95.11	BRD-K77220725-003-01-5	Preclinical
Ro-15-4513		GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB2, GABRG2			Tocris	87.5	BRD-K82823076-001-02-6	Preclinical
Ro-19-4605		GABRA1, GABRA2, GABRA3, GABRA5			Tocris, Tocris	98.3	BRD-K80778372-001-03-3, BRD-K80778372-001-02-5	Preclinical
Ro-20-1724	phosphodiesterase inhibitor	PDE3A, PDE4A, PDE4B, PDE4C, PDE4D			Tocris, Tocris	98.13	BRD-A07207424-001-14-0, BRD-A07207424-001-13-2	Preclinical
Ro-25-6981		GRIN2B			Tocris, Tocris	97.03	BRD-K51541829-050-02-8, BRD-K51541829-050-01-0	Preclinical
Ro-28-1675	glucokinase activator	GCK			MedChemEx	99.65	BRD-K21672174-001-03-0	Preclinical
RO-3	purinergic receptor antagonist	P2RX3			Tocris	96.35	BRD-K00354853-001-01-2	Preclinical
Ro-3306	CDK inhibitor	CDK1			Tocris	94.61	BRD-K78373679-001-03-7	Preclinical
Ro-48-8071	oxidosqualene cyclase inhibitor	LSS			Tocris, MedChemEx	96.64	BRD-K55192287-051-02-9, BRD-K55192287-051-01-1	Preclinical
Ro-4987655	MEK inhibitor	MAP2K1			MedChemEx	96.87	BRD-K64538373-001-01-4	Phase 1
Ro-5126766	RAF inhibitor, MEK inhibitor	BRAF, MAP2K1, MAP2K2, RAF1			MedChemEx, MedChemEx, Selleck	96.39	BRD-K82804538-001-03-6, BRD-K82804538-001-02-8, BRD-K82804538-001-01-0	Phase 1
Ro-60-0175		HTR2A, HTR2B, HTR2C			Tocris, Tocris	88.51	BRD-K28007504-051-02-0, BRD-K28007504-051-01-2	Preclinical
Ro-61-8048	kynurenine 3-monooxygenase inhibitor	KMO			Tocris, MedChemEx	98.09	BRD-K12639498-001-02-1, BRD-K12639498-001-01-3	Preclinical
Ro-67-7476	glutamate receptor positive allosteric modulator	GRM1			Tocris	90.92	BRD-K91333421-001-01-9	Preclinical
Ro-90-7501		APP			Tocris, Tocris	90.66	BRD-K58299615-001-03-5, BRD-K58299615-001-04-3	Preclinical
Ro-9187	HCV inhibitor				MedChemEx	98.79	BRD-K57284066-001-01-6	Preclinical
robalzotan	serotonin receptor antagonist	HTR1A			Tocris	90.01	BRD-K26169680-003-01-9	Phase 2
rociletinib	EGFR inhibitor	EGFR			Selleck	98.26	BRD-K33610132-001-02-9	Phase 3
rocuronium	acetylcholine receptor antagonist	CHRM2, CHRNA2, HTR3A	neurology/psychiatry	anesthetic	MicroSource, Selleck	100	BRD-K43305603-004-03-6, BRD-K43305603-004-02-8	Launched
rofecoxib	cyclooxygenase inhibitor	ELN, PTGS2			MicroSource, MedChemEx, Sigma, Selleck, Selleck	98.36	BRD-K21733600-001-15-8, BRD-K21733600-001-24-0, BRD-K21733600-001-23-2, BRD-K21733600-001-19-0, BRD-K21733600-001-14-1	Withdrawn
roflumilast	phosphodiesterase inhibitor	PDE4A, PDE4B, PDE4C, PDE4D	pulmonary	chronic obstructive pulmonary disease (COPD), bronchitis	Selleck	99.14	BRD-K03194791-001-04-8	Launched
rolipram	phosphodiesterase inhibitor				Tocris, MicroSource, Tocris, Selleck	98.11	BRD-A34255068-001-38-6, BRD-A34255068-001-34-5, BRD-A34255068-001-33-7, BRD-A34255068-001-32-9	Phase 3
rolipram-R(-)	phosphodiesterase inhibitor	PDE4A, PDE4B, PDE4C, PDE4D, PDE5A			Tocris, Tocris	97.48	BRD-K75516118-001-04-1, BRD-K75516118-001-03-3	Preclinical
rolipram-S(+)	phosphodiesterase inhibitor				Selleck, Tocris	98.17	BRD-K65856711-001-03-6, BRD-K65856711-001-04-4	Preclinical
rolitetracycline	bacterial 30S ribosomal subunit inhibitor				MicroSource, Selleck, Selleck	2.99	BRD-A62336573-001-03-1, BRD-A62336573-001-04-9, BRD-A62336573-001-02-3	Launched
rolziracetam					Sigma	97.8	BRD-K38564664-001-01-1	Phase 2
romidepsin	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9	hematologic malignancy	cutaneous T-cell lymphoma (CTCL)	MedChemEx	98.84	BRD-K61397605-001-03-4	Launched
ronidazole	antiprotozoal agent		infectious disease	histomoniasis, dysentry	MicroSource, Selleck	99.46	BRD-K94266545-001-24-1, BRD-K94266545-001-23-3	Launched
ropinirole	dopamine receptor agonist	ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C	neurology/psychiatry	Parkinson's Disease, restless leg syndrome	MicroSource, Selleck	97.67	BRD-K15933101-003-07-9, BRD-K15933101-003-06-1	Launched
ropivacaine	sodium channel blocker	SCN10A	neurology/psychiatry	anesthetic	Selleck	97.16	BRD-K50938786-003-11-8	Launched
roquinimex	angiogenesis inhibitor, tumor necrosis factor production inhibitor				Tocris	96.21	BRD-K03384561-001-02-7	Phase 3
rosamicin	protein synthesis inhibitor				Vitas-M	58.91	BRD-A38799180-001-01-0	Phase 2
roscovitine	CDK inhibitor	CDK2, CDK9			Selleck, Selleck	97.94	BRD-K07691486-001-19-7, BRD-K07691486-001-15-5	Phase 2
rose-bengal	contrast agent		radiology	diagnostic agent	SantaCruz, Acros	57.93	BRD-K33623053-304-02-5, BRD-K33623053-304-01-7	Launched
rose-bengal-lactone	coloring agent		ophthalmology	staining agent	CombiBlocks	73.73	BRD-K36163066-304-02-4	Launched
rosiglitazone	insulin sensitizer, PPAR receptor agonist	ACSL4, FFAR1, PPARG, TRPC5, TRPM3			Selleck, Selleck, Selleck, MicroSource, Tocris	98.94	BRD-A97437073-050-13-7, BRD-A97437073-003-14-4, BRD-A97437073-001-08-0, BRD-A97437073-050-14-5, BRD-A97437073-001-09-8	Withdrawn
rosmarinic-acid	GABA transaminase inhibitor	MCL1, TYR			Tocris	94.08	BRD-K20313525-001-04-6	Launched
rosoxacin	topoisomerase inhibitor		infectious disease	urinary tract infections	Accela	98.05	BRD-K49841478-001-01-6	Launched
rostafuroxine	ATPase inhibitor	ATP1A1			Tocris, MedChemEx	98.28	BRD-K11672787-001-02-3, BRD-K11672787-001-01-5	Phase 2
rosuvastatin	HMGCR inhibitor	HMGCR	endocrinology, cardiology	hyperlipidemia, dyslipidemia, hypertriglyceridemia, hypercholesterolemia, atherosclerosis	MicroSource, Selleck	93.46	BRD-K82941592-238-03-7, BRD-K82941592-238-04-5	Launched
rotigotine	dopamine receptor agonist	ADRA2B, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A	neurology/psychiatry	Parkinson's Disease, restless leg syndrome	Tocris, MedChemEx	98.62	BRD-K91111634-003-01-8, BRD-K91111634-001-01-2	Launched
rotundine	serotonin receptor agonist	DRD1, DRD2, DRD3, HTR1A			Selleck	90.41	BRD-K35719256-001-02-6	Launched
roxarsone	antiprotozoal agent		endocrinology	weight-gain aid	MicroSource	98.02	BRD-K22685337-001-13-4	Launched
roxatidine-acetate	histamine receptor antagonist	HRH2	gastroenterology	Zollinger-Ellison syndrome, erosive esophagitis (EE), gastroesophageal reflux disease (GERD), gastritis	MedChemEx, Selleck, MicroSource	97.97	BRD-K81855038-003-14-7, BRD-K81855038-003-12-1, BRD-K81855038-003-13-9	Launched
roxithromycin	bacterial 50S ribosomal subunit inhibitor	ABCB1, MLNR	infectious disease	respiratory tract infections, urinary tract infections, skin infections	MicroSource, Selleck	99.06	BRD-K38684403-001-04-7, BRD-K38684403-001-05-4	Launched
RP-001	sphingosine 1 phosphate receptor agonist	S1PR1			Tocris	94.54	BRD-A29148886-003-01-4	Preclinical
RP67580					Tocris	44.82	BRD-K40767677-001-01-1	Preclinical
RQ-00203078	transient receptor potential channel antagonist	TRPM8			Tocris	93.37	BRD-K87973152-001-01-3	Preclinical
RRx-001	glucose 6-phosphate dehydrogenase inhibitor	G6PD			MedChemEx, MedChemEx	0	BRD-K06894065-001-02-3, BRD-K06894065-001-01-5	Phase 2
RS-0481	immunostimulant				Enamine	94.07	BRD-A00055058-001-01-0	Phase 2
RS-100329	adrenergic receptor antagonist	ADRA1A, ADRA1D			Tocris	97.46	BRD-K08640512-003-02-3	Preclinical
RS-102221	serotonin receptor antagonist	HTR2A, HTR2B, HTR2C			Tocris, Tocris, Tocris	97.64	BRD-K87048468-003-03-5, BRD-K87048468-003-04-3, BRD-K87048468-003-02-7	Preclinical
RS-102895	CCR antagonist	CCR2			Tocris, Tocris	97.44	BRD-K83063356-003-03-3, BRD-K83063356-003-02-5	Preclinical
RS-127445	serotonin receptor antagonist	HTR2A, HTR2B, HTR2C			Selleck	95.44	BRD-K90825648-001-02-0	Phase 1
RS-16566	serotonin receptor antagonist				Tocris	98.66	BRD-K80725821-300-02-9	Preclinical
RS-17053	adrenergic receptor antagonist	ADRA1A, ADRA1D			Tocris, Tocris	96.88	BRD-K76840893-003-03-3, BRD-K76840893-003-02-5	Preclinical
RS-23597-190	serotonin receptor antagonist	HTR4			Tocris	98.28	BRD-K01868942-003-02-7	Preclinical
RS-39604	serotonin receptor antagonist	HTR4			Tocris	98.29	BRD-K20742498-003-02-9	Preclinical
RS-45041-190	imidazoline receptor agonist				Tocris	96.87	BRD-K26160755-003-02-6	Preclinical
RS-504393	CC chemokine receptor antagonist	CCL2, CCR2			Tocris	96.5	BRD-K87510569-001-02-8	Preclinical
RS-56812	serotonin receptor partial agonist	HTR3A			Tocris	98.66	BRD-K20714604-003-02-9	Preclinical
RS-67333	serotonin receptor partial agonist	HTR4			Tocris	97.37	BRD-K46142322-003-02-4	Preclinical
RS-67506	serotonin receptor partial agonist	HTR4			Tocris	96.93	BRD-K50018155-003-02-1	Preclinical
RS-79948	adrenergic receptor antagonist	ADRA2A			Tocris	97.72	BRD-K86600316-003-02-0	Preclinical
RSV604	RSV replication inhibitor				MedChemEx	98.22	BRD-K30159788-001-01-9	Phase 2
RTA-408	nitric oxide production inhibitor	NFE2L2			MedChemEx, MedChemEx, Selleck	90.95	BRD-K56211775-001-02-0, BRD-K56211775-001-01-2, BRD-K56211775-001-03-8	Phase 2
RU-SKI-43	hedgehog pathway inhibitor	HHAT			Tocris	92.1	BRD-A33603104-003-01-8	Preclinical
RU-24969	serotonin receptor agonist	HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, HTR6			MedChemEx, MedChemEx, Tocris	64.03	BRD-K00234327-001-04-8, BRD-K00234327-001-03-0, BRD-K00234327-036-05-1	Phase 1
RU-28318	cytochrome P450 inhibitor	NR3C2			Tocris	92.75	BRD-K37687387-237-01-7	Phase 2
RU-42173	adrenergic receptor agonist	ADRB2			Enzo	9.01	BRD-K85285268-003-01-1	Phase 2
RU-58841	androgen receptor antagonist	AR			MedChemEx	97.49	BRD-K62762455-001-01-3	Phase 2
rubitecan	topoisomerase inhibitor	TOP1			Sigma	94.03	BRD-K79821389-001-03-5	Phase 3
rucaparib	PARP inhibitor	PARP1, PARP2			Selleck, Selleck	94.42	BRD-K88560311-011-07-1, BRD-K88560311-011-06-3	Phase 3
rucinol	tyrosinase inhibitor	TYR			TCI	98.99	BRD-K61036791-001-01-6	Phase 1
rufinamide	voltage-gated sodium channel blocker	GRM5, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	neurology/psychiatry	seizures	Selleck	98.35	BRD-K20079257-001-09-6	Launched
rufloxacin	bacterial DNA gyrase inhibitor		infectious disease	gram-negative bacterial infections	MicroSource	97.36	BRD-K62374253-001-07-8	Launched
rupatadine	histamine receptor antagonist, platelet activating factor receptor antagonist	HRH1, PTAFR	allergy	allergic rhinitis, urticaria	Selleck	91.72	BRD-K98004573-051-02-8	Launched
rutaecarpine	cyclooxygenase inhibitor	PTGS2			Selleck	97.45	BRD-K94723713-001-10-6	Preclinical
rutin	antioxidant, capillary stabilizing agent, nitric oxide scavenger	AKR1C3	rheumatology, otolaryngology, gastroenterology, neurology/psychiatry, allergy	joint pain, nasal congestion, constipation, irritability, allergic rhinitis	MicroSource, Selleck, Selleck	91.2	BRD-K20482099-001-11-0, BRD-K20482099-001-09-4, BRD-K20482099-001-10-2	Launched
ruxolitinib	JAK inhibitor	JAK1, JAK2, JAK3, TYK2	hematologic malignancy, hematology	myelofibrosis, polycythemia vera	Selleck	96.54	BRD-K53972329-001-07-0	Launched
ruxolitinib-(S)	JAK inhibitor	JAK1, JAK2			Selleck	97.97	BRD-K19601669-001-03-5	Preclinical
RWJ-21757	toll-like receptor agonist	TLR7			Tocris, Tocris, Sigma	84.99	BRD-K00091711-001-01-2, BRD-K00091711-001-03-8, BRD-K00091711-001-02-0	Phase 1
RWJ-50271	integrin inhibitor	ICAM1			Tocris	97.8	BRD-K94623186-001-01-5	Preclinical
RWJ-67657	MAP kinase inhibitor	MAPK14, PTGS2			Cayman, Tocris	93.32	BRD-K07074923-001-01-5, BRD-K07074923-001-02-3	Phase 1
RX-3117	DNA synthesis inhibitor, CDK inhibitor	CDK2, DNMT1			MedChemEx, MedChemEx	83.1	BRD-K66213167-001-02-0, BRD-K66213167-001-01-2	Phase 1/Phase 2
RX-821002	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C			Tocris, Tocris	97.1	BRD-A65597028-003-08-1, BRD-A65597028-003-07-3	Preclinical
ryuvidine	histone lysine methyltransferase inhibitor	CDK2, CDK4			Tocris, Tocris	95.12	BRD-K06426971-001-02-7, BRD-K06426971-001-03-5	Preclinical
R112	syk inhibitor	SYK			MedChemEx	94.95	BRD-K23902832-001-01-7	Preclinical
R306465	HDAC inhibitor				AdvChemBlocks	82.42	BRD-K86687746-001-01-3	Phase 1
R406	SYK inhibitor	RET, SYK			Selleck, Selleck, Selleck	97.72	BRD-K20285085-074-04-5, BRD-K20285085-074-03-7, BRD-K20285085-001-07-1	Phase 1
R547	CDK inhibitor	CDK1, CDK2, CDK4, CDK7			Selleck	95.54	BRD-K52233191-001-02-4	Phase 1
S-Isopropylisothiourea	nitric oxide synthase inhibitor	NOS3			Tocris	94.16	BRD-K10673031-004-02-0	Preclinical
S-methylcysteine		CTSD, MGMT			Ark, Ark	100	BRD-K63123526-001-02-0, BRD-K63123526-001-01-2	Phase 1
S-Nitrosoglutathione	nitric oxide stimulant	PTPN1			Cayman, Cayman	0	BRD-K94780074-001-07-5, BRD-K94780074-001-06-7	Phase 1
S-Sulfo-L-cysteine-sodium-salt	glutamate receptor agonist				Tocris	90.28	BRD-K59527975-236-01-8	Preclinical
S-Trityl-L-cysteine	mitotic kinesin inhibitor				Tocris	18.45	BRD-K09774593-001-01-7	Preclinical
S-07662	CAR antagonist	NR1I3			Tocris	94.26	BRD-K37635256-001-01-4	Preclinical
S-111	PARP inhibitor	PARP1			MedChemEx	100	BRD-K60005752-001-01-9	Phase 2
S-14506	serotonin receptor agonist	HTR1A			Tocris, Tocris	99.32	BRD-K46766488-003-03-8, BRD-K46766488-003-02-0	Preclinical
SA-47	FAAH inhibitor	FAAH			Tocris	93.41	BRD-K99819791-001-01-1	Preclinical
saccharin	DNA polymerase inhibitor	CA1, CA12, CA2, CA9			MicroSource	98.63	BRD-K46493214-001-06-7	Launched
saclofen	GABA receptor antagonist	GABBR1, GABBR2, KCTD12, KCTD16, KCTD8			Tocris	97.13	BRD-A24122750-001-03-7	Preclinical
sacubitril	neprilysin inhibitor	MME	cardiology	congestive heart failure	MedChemEx, MedChemEx	99.59	BRD-K91456750-001-01-9, BRD-K91456750-238-01-7	Launched
safflower-yellow	anti-inflammatory agent				MedChemEx	0	BRD-A96503329-001-01-7	Preclinical
safinamide	dopamine uptake inhibitor, glutamate inhibitor, monoamine oxidase inhibitor	MAOB	neurology/psychiatry	Parkinson's Disease	Selleck	97.9	BRD-K92613113-066-02-7	Launched
safingol	PKC inhibitor	TRPM3			Enzo	100	BRD-K93944989-001-08-0	Phase 1
safranal	benzodiazepine receptor agonist	GABBR1			Sigma	0	BRD-K90582192-001-01-9	Phase 2
SAG	smoothened receptor agonist	SMO, TRPC6			Tocris	90.09	BRD-K99433989-001-01-3	Preclinical
salazodine					Aronis	90.31	BRD-K15045219-001-01-8	Phase 2
salicin	anti-inflammatory agent				MicroSource, Selleck	99.21	BRD-K64614248-001-12-3, BRD-K64614248-001-11-5	Phase 1
salicyl-alcohol					MicroSource	94.96	BRD-K08493205-001-04-9	Preclinical
salicylamide	analgesic agent		neurology/psychiatry, endocrinology	pain relief, fever	MicroSource	98.74	BRD-K81130846-001-17-4	Launched
salicylanilide	other antibiotic				MicroSource, Selleck	99.27	BRD-K83036479-001-09-2, BRD-K83036479-001-08-4	Preclinical
salicylic-acid	cyclooxygenase inhibitor	AKR1C1, PTGS1, PTGS2	dermatology	acne vulgaris (AV)	MicroSource	98.29	BRD-K93632104-001-17-2	Launched
salidroside	beta amyloid protein neurotoxicity inhibitor	APP			Selleck, Selleck	97.85	BRD-K66030860-001-04-4, BRD-K66030860-001-03-6	Preclinical
salinomycin			infectious disease	coccidiosis	MicroSource, Selleck, Selleck	94.17	BRD-A28301258-236-01-6, BRD-A28301258-001-03-0, BRD-A28301258-001-04-8	Launched
salirasib	mTOR inhibitor	TRPA1			MedChemEx	91.85	BRD-K98453471-001-01-7	Phase 2
salmeterol	adrenergic receptor agonist	ADRB2	pulmonary	asthma, chronic obstructive pulmonary disease (COPD), bronchospasm	MedChemEx, Tocris, Sigma, MedChemEx, Tocris	67.68	BRD-A01320529-104-14-3, BRD-A01320529-104-13-5, BRD-A01320529-104-11-9, BRD-A01320529-104-12-7, BRD-A01320529-104-10-1	Launched
salsolinol-1-carboxylic-acid					Tocris	0	BRD-A49952467-001-02-4	Preclinical
salubrinal	eukaryotic translation initiation factor inhibitor	EIF2S1			Tocris, Tocris, Selleck, Selleck	97.81	BRD-A45107007-001-03-4, BRD-A45107007-001-06-7, BRD-A45107007-001-05-9, BRD-A45107007-001-02-6	Preclinical
salvianolic-acid-B	metalloproteinase inhibitor, EGFR inhibitor	MMP9			AvaChem	95.4	BRD-K18898553-001-01-1	Phase 2
salvinorin-a	opioid receptor agonist	OPRD1, OPRK1, OPRM1			Enzo	96.14	BRD-K19284129-001-02-6	Phase 1
sal003	eukaryotic translation initiation factor inhibitor	EIF2A			Tocris, Tocris, Selleck	95.48	BRD-A45869167-001-11-8, BRD-A45869167-001-12-6, BRD-A45869167-001-10-0	Preclinical
sanazole					Asinex	98.04	BRD-K37747025-001-08-2	Phase 1
sangivamycin	DNA inhibitor				EMDBio	99.32	BRD-A64064900-001-02-3	Phase 1
sanguinarium-chloride	apoptosis stimulant	CASP3			MicroSource, Sigma	92.68	BRD-K66898851-003-02-5, BRD-K66898851-003-03-3	Phase 1
SANT-1	smoothened receptor antagonist	SHH, SMO			Selleck, Tocris, Tocris	96.37	BRD-K99741577-001-01-7, BRD-K99741577-001-02-5, BRD-K99741577-001-03-3	Preclinical
SANT-2	smoothened receptor antagonist	SHH, SMO			Tocris, Tocris	98.44	BRD-K35781423-001-01-6, BRD-K35781423-001-02-4	Preclinical
sapropterin	phenylalanine 4-hydroxylase stimulant	NOS3, PAH, TH, TPH1	metabolism	hyperphenylalaninemia (HPA)	Cayman, Cayman, Cayman	84.77	BRD-K36859431-300-04-9, BRD-K36859431-300-03-1, BRD-K36859431-300-02-3	Launched
saquinavir	HIV protease inhibitor	CYP3A4	infectious disease	human immunodeficiency virus (HIV-1)	Tocris, Enzo	98.75	BRD-K09963420-066-12-5, BRD-A26690767-066-01-9	Launched
SAR-245409	PI3K inhibitor	MTOR, PIK3CG			Selleck	95.59	BRD-K75308783-001-07-0	Phase 1/Phase 2
saracatinib	src inhibitor	ABL1, LCK, SRC, YES1			Selleck	93.33	BRD-K19540840-001-09-4	Phase 2/Phase 3
sarafloxacin	bacterial DNA gyrase inhibitor				MicroSource, Selleck	92.94	BRD-K08525451-003-06-0, BRD-K08525451-003-05-2	Launched
sarcosine	Glycine transporter 1 inhibitor	SLC6A9			Enamine	86.26	BRD-K51263939-001-08-6	Phase 2
sari-59-801					Sigma	93.49	BRD-A92448440-001-01-3	Phase 1
saroglitazar	PPAR receptor agonist	PPARA, PPARG			Synnovator	51.78	BRD-K79878800-001-01-0	Phase 3
sarpogrelate	serotonin receptor antagonist	HTR2A, HTR2B, HTR2C	endocrinology, cardiology, rheumatology	diabetes mellitus, angina pectoris, Raynaud's disease, atherosclerosis, Buerger's disease	Tocris, MedChemEx	93.14	BRD-A34358106-003-02-4, BRD-A34358106-003-01-6	Launched
SAR131675	VEGFR inhibitor	FLT4			Selleck	94.88	BRD-K38904395-001-02-3	Preclinical
SAR405	PI3K inhibitor	PIK3C3			MedChemEx	93.1	BRD-K72868067-001-02-4	Preclinical
SAR405838	MDM inhibitor	MDM2			MedChemEx, MedChemEx, Selleck	87.15	BRD-K86736469-001-02-1, BRD-K86736469-001-01-3, BRD-A16035238-001-01-7	Phase 1
SAR407899	rho associated kinase inhibitor	ROCK1			MedChemEx, MedChemEx	94.32	BRD-K56912469-003-02-0, BRD-K56912469-003-01-2	Phase 2
sasapyrine	NFkB pathway inhibitor	PTGS1, PTGS2	rheumatology	osteoarthritis, rheumatoid arthritis	MicroSource, Selleck	97.73	BRD-K48892307-001-05-8, BRD-K48892307-001-04-1	Launched
satraplatin	DNA alkylating agent				MedChemEx, MedChemEx	98.12	BRD-M31395033-201-01-5, BRD-K42497885-001-01-1	Phase 3
savolitinib	c-Met inhibitor	MET			MedChemEx, MedChemEx	97.52	BRD-K98028353-001-02-8, BRD-K98028353-001-01-0	Phase 2
saxagliptin	dipeptidyl peptidase inhibitor	DPP4	endocrinology	diabetes mellitus	Selleck	91.2	BRD-A81513827-001-03-6	Launched
SB-200646	serotonin receptor antagonist	HTR2B, HTR2C			Tocris, Tocris	94.81	BRD-K77677632-003-03-4, BRD-K77677632-003-02-6	Preclinical
SB-202190	p38 MAPK inhibitor	AKT1, ALOX5, CHEK1, GSK3B, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, ROCK1, RPS6KB1, SGK1			Tocris, Tocris, Selleck	94.52	BRD-K54330070-001-19-6, BRD-K54330070-001-16-2, BRD-K54330070-001-15-4	Preclinical
SB-203186	serotonin receptor antagonist	HTR4			Tocris	98.69	BRD-K27141178-003-07-3	Preclinical
SB-203580	p38 MAPK inhibitor	AKT1, ALOX5, CHEK1, CYP2D6, CYP3A4, GAK, GSK3B, LCK, MAPK1, MAPK10, MAPK11, MAPK12, MAPK14, MAPK8, MAPK9, PRKCA, RAF1, RIPK2, ROCK1, RPS6KB1, SGK1, SRC, TNF			Selleck, Selleck, Selleck, Tocris, Tocris, Tocris	98.22	BRD-A37704979-001-12-3, BRD-A37704979-001-13-1, BRD-A37704979-001-09-9, BRD-A37704979-001-15-6, BRD-A37704979-001-10-7, BRD-A37704979-003-02-0	Preclinical
SB-205384	GABA receptor modulator	GABRA3, GABRA5, GABRA6			Tocris, Tocris	96.8	BRD-A22707317-001-11-6, BRD-A22707317-001-10-8	Preclinical
SB-206553	serotonin receptor antagonist	HTR2A, HTR2B, HTR2C			Tocris, Tocris	94.17	BRD-K36395411-003-03-0, BRD-K36395411-003-02-2	Preclinical
SB-216641	serotonin receptor antagonist	HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C			Tocris	92.18	BRD-K30867024-003-03-3	Preclinical
SB-216763	glycogen synthase kinase inhibitor	CCNA2, CDK2, GSK3A, GSK3B			Selleck, Tocris	98.45	BRD-K59184148-001-21-6, BRD-K59184148-001-22-4	Preclinical
SB-218078	CHK inhibitor	CHEK1			Tocris, Tocris	96.54	BRD-A06352508-001-03-7, BRD-A06352508-001-05-2	Preclinical
SB-218795	tachykinin antagonist	TACR3			Tocris, Tocris	95.63	BRD-K61097567-001-09-3, BRD-K61097567-001-08-5	Preclinical
SB-221284	serotonin receptor antagonist	HTR2A, HTR2B, HTR2C			Tocris	96.67	BRD-K14807180-001-02-5	Preclinical
SB-222200	tachykinin antagonist	TACR3			Tocris, Tocris	99.49	BRD-K04414442-001-09-1, BRD-K04414442-001-08-3	Preclinical
SB-225002	CC chemokine receptor antagonist	CXCR2			Tocris, Tocris	97.9	BRD-K61323504-001-04-0, BRD-K61323504-001-06-5	Preclinical
SB-228357	serotonin receptor antagonist	HTR2A, HTR2B, HTR2C			Tocris, Tocris	97.89	BRD-K15424032-001-04-4, BRD-K15424032-001-03-6	Preclinical
SB-2343	mTOR inhibitor, PI3K inhibitor	MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG			MedChemEx	96.34	BRD-K98795921-001-01-7	Phase 1
SB-239063	p38 MAPK inhibitor	MAPK11, MAPK14, PTGS2			Tocris	94.91	BRD-K82091397-001-03-0	Preclinical
SB-242235	p38 MAPK inhibitor	HSPB1, MAPK14			MedChemEx	88.4	BRD-K19412355-001-01-0	Phase 1
SB-243213	serotonin receptor inverse agonist	HTR2A, HTR2B, HTR2C, HTR6			Tocris	94.92	BRD-K99968849-300-01-4	Phase 1
SB-258585	serotonin receptor antagonist	HTR6			Tocris	94	BRD-K80639402-003-02-9	Preclinical
SB-268262	calcitonin antagonist	CALCA			Tocris	95.7	BRD-A91031770-001-01-8	Preclinical
SB-269970	serotonin receptor antagonist	HTR7			Tocris, Selleck, Tocris	97.96	BRD-K24201553-003-12-3, BRD-K24201553-003-10-7, BRD-K24201553-003-11-5	Preclinical
SB-271046	serotonin receptor antagonist	HTR6			Tocris, Selleck	94.47	BRD-K82467063-003-01-5, BRD-K82467063-001-02-7	Phase 1
SB-297006	CC chemokine receptor antagonist	CCR3			Tocris	91	BRD-K16107558-001-01-4	Preclinical
SB-328437	CCR antagonist				Tocris, Tocris	97.21	BRD-K78720403-001-01-6, BRD-K78720403-001-02-4	Preclinical
SB-334867	orexin receptor antagonist	HCRTR1, HCRTR2			Tocris, Tocris	99.08	BRD-K41567364-001-05-3, BRD-K41567364-001-04-6	Preclinical
SB-366791	TRPV antagonist	TRPV1			Tocris, Tocris	99.59	BRD-K61536336-001-02-5, BRD-K61536336-001-01-7	Preclinical
SB-399885	serotonin receptor antagonist	HTR6			Tocris	96.08	BRD-K03988082-001-01-7	Preclinical
SB-408124	orexin receptor antagonist	HCRTR1, HCRTR2			Tocris, Selleck, Tocris, Selleck	95.35	BRD-K53913732-001-07-5, BRD-K53913732-001-06-7, BRD-K53913732-001-05-9, BRD-K53913732-001-04-2	Preclinical
SB-415286	glycogen synthase kinase inhibitor	GSK3A, GSK3B, RPS6KB1			Selleck, Selleck, Tocris	91.95	BRD-K76805682-001-17-5, BRD-K76805682-001-15-9, BRD-K76805682-001-16-7	Preclinical
SB-431542	TGF beta receptor inhibitor	ACVR1C, TGFBR1			Selleck, Tocris, Tocris	98.92	BRD-K67298865-001-08-2, BRD-K67298865-001-10-8, BRD-K67298865-001-09-0	Preclinical
SB-452533	TRPV antagonist	TRPV1			Tocris	91.86	BRD-K03665769-001-01-1	Preclinical
SB-505124	ALK tyrosine kinase receptor inhibitor	TGFBR1			Selleck	98.07	BRD-K40109029-001-02-9	Preclinical
SB-525334	TGF beta receptor inhibitor	TGFBR1			Selleck, Tocris	95.92	BRD-K37720887-001-07-8, BRD-K37720887-001-08-6	Preclinical
SB-590885	RAF inhibitor	BRAF			Selleck, Selleck, Selleck	87.33	BRD-K78809024-001-03-2, BRD-K78809024-001-05-7, BRD-K78809024-001-02-4	Preclinical
SB-612111	nociceptin/orphanin FQ (NOP) receptor antagonist	OPRL1			Tocris	88.92	BRD-K08333979-003-01-3	Preclinical
SB-657510	urotensin receptor antagonist	UTS2R			Tocris, Tocris	95.89	BRD-K95292280-001-01-3, BRD-K95292280-001-02-1	Preclinical
SB-683698	integrin antagonist	ITGA4, ITGAV, ITGB1, ITGB7			MedChemEx	95.84	BRD-K24968862-001-01-0	Phase 1
SB-705498	TRPV antagonist	TRPV1			Selleck	98.38	BRD-K65991129-001-02-9	Phase 2
SB-706375	urotensin receptor antagonist	UTS2R			Tocris	98.2	BRD-K68633027-001-01-9	Preclinical
SB-742457	serotonin receptor antagonist	HTR6			Selleck, Selleck	89.14	BRD-K78941306-001-03-2, BRD-K78941306-001-02-4	Phase 3
SB-743921	kinesin-like spindle protein inhibitor	KIF11			Selleck, Tocris	95.39	BRD-K68532323-003-02-8, BRD-K68532323-003-05-1	Phase 1/Phase 2
SB-747651A	kinase inhibitor	AKT1, AKT3, ROCK1, RPS6KA5, RPS6KB1			Tocris	97.46	BRD-K49597925-300-01-9	Preclinical
SB-756050	G protein-coupled receptor agonist	GPBAR1			Enamine	99.59	BRD-K45168550-001-01-9	Phase 1
SB-772077B	rho associated kinase inhibitor	ROCK1, ROCK2			Tocris	96.19	BRD-K49110935-300-01-9	Preclinical
SB-939	HDAC inhibitor	HDAC1, HDAC10, HDAC3, HDAC4, HDAC5, HDAC9			Selleck, Selleck	96.34	BRD-K86797399-001-05-1, BRD-K86797399-001-04-4	Phase 2
SBE-13	PLK inhibitor	PLK1			Tocris	98.45	BRD-K71667152-003-09-8	Preclinical
SBHA	HDAC inhibitor	HDAC1, HDAC3			Tocris	63.62	BRD-K54729176-001-02-8	Preclinical
SC-10	protein kinase activator	PRKCA			Tocris	97.54	BRD-K05361803-001-03-9	Preclinical
SC-12267	dihydroorotate dehydrogenase inhibitor	IL17A			MedChemEx	98.78	BRD-K40797222-001-01-8	Phase 2
SC-144	P glycoprotein inhibitor				Selleck, Tocris, Selleck	98.43	BRD-K55305701-001-01-2, BRD-K55305701-003-01-8, BRD-K55305701-001-02-0	Preclinical
SC-19220	prostanoid receptor antagonist	PTGER1			Tocris, Tocris	95.92	BRD-K52512893-001-09-7, BRD-K52512893-001-08-9	Preclinical
SC-236	cyclooxygenase inhibitor	PTGS2			Tocris	98.26	BRD-K76365178-001-01-5	Preclinical
SC-51089	prostanoid receptor antagonist	PTGER1			Tocris	88.12	BRD-K62715847-003-01-4	Preclinical
SC-560	cyclooxygenase inhibitor	PTGS1			Tocris, Tocris	98.01	BRD-K14767410-001-03-1, BRD-K14767410-001-02-3	Preclinical
SC-9	protein tyrosine kinase activator	PRKCA			Tocris, Tocris	98.46	BRD-K25875056-001-03-8, BRD-K25875056-001-02-0	Preclinical
SCH-202676	G protein-coupled receptor modulator	CHRM1, CHRM2, DRD1, DRD2			Tocris, Tocris	46.4	BRD-K29562203-004-09-1, BRD-K29562203-004-08-3	Preclinical
SCH-221510	nociceptin/orphanin FQ (NOP) receptor agonist	OPRL1			Tocris	92.09	BRD-A06700447-001-01-5	Preclinical
SCH-23390	dopamine receptor antagonist	DRD1, DRD5, HTR2C, KCNJ4, KCNJ6			Tocris	96.81	BRD-K45435259-003-11-1	Preclinical
SCH-28080	ATPase inhibitor	ATP4A			Tocris	95.57	BRD-K55748775-001-02-2	Phase 1
SCH-51344	MTH1 inhibitor	NUDT1			Tocris	83.63	BRD-K02460719-001-01-9	Preclinical
SCH-58261	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3			Tocris, Tocris	99.01	BRD-K81225797-001-02-3, BRD-K81225797-001-03-1	Preclinical
SCH-900776	CHK inhibitor	CDK2, CHEK1			Selleck, Selleck	85.42	BRD-K75009076-001-02-1, BRD-K75009076-001-01-3	Phase 2
schisandrin-b	antioxidant	ATR			Selleck	97.81	BRD-K86294588-001-01-9	Preclinical
schisandrol-b	lipid peroxidase inhibitor				MedChemEx, MedChemEx	97.81	BRD-K18878288-001-06-4, BRD-K18878288-001-07-2	Phase 3
sclareol					Selleck	98.63	BRD-A23127772-001-02-3	Preclinical
sclareolide	other antifungal				Selleck, Selleck	83.52	BRD-K72925150-001-10-3, BRD-K72925150-001-11-1	Launched
SCMC-Lys	mucolytic agent	GSTP1			ChemImpex, ChemImpex	83.3	BRD-K33809398-001-02-6, BRD-K33809398-001-01-8	Launched
scopine					Selleck, Selleck	100	BRD-K75923785-003-02-1, BRD-K75923785-001-02-5	Launched
scopolamine	acetylcholine receptor antagonist		neurology/psychiatry, gastroenterology	motion sickness, vomiting, nausea	Selleck, MicroSource, Tocris	98.87	BRD-K89923877-004-15-4, BRD-K64990126-004-01-1, BRD-K89923877-004-16-2	Launched
scopolamine-n-oxide	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, SI			Prestwick	93.9	BRD-A49906757-004-09-8	Preclinical
SCP-1	analgesic agent				Vitas-M	88.92	BRD-K20548681-001-01-3	Phase 1
scriptaid	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9			Tocris, Selleck	94.21	BRD-K22503835-001-12-8, BRD-K22503835-001-11-0	Preclinical
SCS					Tocris, Tocris	95.27	BRD-K78496197-001-04-7, BRD-K78496197-001-03-9	Preclinical
SD-169	p38 MAPK inhibitor	MAPK14			EMDBio	97.83	BRD-K91904471-001-02-4	Preclinical
SD-208	TGF beta receptor inhibitor	TGFBR1			Tocris, Tocris	97.15	BRD-K24566386-001-01-9, BRD-K24566386-001-03-5	Preclinical
SD-2590	matrix metalloprotease inhibitor	MMP1, MMP13, MMP2			Tocris	93.08	BRD-K51102532-003-01-8	Preclinical
SDM25N	opioid receptor antagonist	OPRD1			Tocris, Tocris, Tocris	93.48	BRD-A75769826-003-04-7, BRD-A75769826-003-03-9, BRD-A75769826-003-02-1	Preclinical
SDZ-NKT-343	tachykinin antagonist	TACR1			Tocris, Tocris	97.81	BRD-K65820248-001-01-8, BRD-K65820248-001-02-6	Phase 1
SDZ-SER-082	serotonin receptor antagonist	HTR2A, HTR2B, HTR2C			Tocris	13.89	BRD-K31339597-051-02-0	Preclinical
SDZ-WAG-994	adenosine receptor agonist	ADORA1			Tocris, Tocris	89.51	BRD-K39558284-001-01-2, BRD-K39558284-001-02-0	Phase 2
SDZ-205-557	serotonin receptor antagonist	HTR3A, HTR3B			Tocris	97.71	BRD-K15868788-003-07-7	Preclinical
SDZ-21009	adrenergic receptor antagonist, serotonin receptor antagonist	HTR1A, HTR1B			Tocris	91.78	BRD-A15530910-001-02-1	Preclinical
SDZ-220-040	glutamate receptor antagonist	GRIN1			Tocris	0	BRD-K82266792-001-02-1	Preclinical
SDZ-220-581	glutamate receptor antagonist	GRIN1			Tocris, Tocris	98.62	BRD-K27168049-001-03-6, BRD-K27168049-001-02-8	Preclinical
se-methylselenocysteine					Sigma, Acros	100	BRD-K74227499-001-02-9, BRD-K74227499-001-01-1	Phase 2
secalciferol	vitamin D receptor agonist	VDR	critical care	bone fracture	Enzo	81.1	BRD-K02965577-001-03-4	Launched
seclazone	anti-inflammatory agent				Enamine	99.72	BRD-A53472930-001-01-7	Phase 1
secnidazole	acetylcholinesterase inhibitor, microtubule inhibitor		infectious disease	protozoan infection	Selleck, Selleck, MicroSource	99.58	BRD-A70083328-001-22-7, BRD-A70083328-001-24-3, BRD-A70083328-001-23-5	Launched
secoisolariciresinol-(-)					Sigma	97.1	BRD-K91733562-001-05-0	Preclinical
secoisolariciresinol-diglucoside	antioxidant				AvaChem	94.67	BRD-K77320845-001-01-2	Phase 2
securinine	GABA receptor antagonist, TP53 activator	GABRA1			MicroSource	94.32	BRD-K49071277-001-04-7	Preclinical
selamectin	nematocide		infectious disease	flea control	MicroSource	95.85	BRD-A58564983-001-04-6	Launched
selegiline	monoamine oxidase inhibitor	MAOA, MAOB	neurology/psychiatry	Parkinson's Disease	MicroSource	98.41	BRD-A28545468-003-16-6	Launched
selenomethionine					Sigma, Ark, MicroSource	100	BRD-A18774709-001-01-9, BRD-K74664543-001-01-1, BRD-K74664543-213-01-2	Launched
selexipag	platelet aggregation inhibitor, IP1 prostacyclin receptor agonist	PTGIR			Tocris, MedChemEx	95.84	BRD-K21191422-001-02-3, BRD-K21191422-001-01-5	Phase 3
selfotel	glutamate receptor antagonist	GRIN2A, GRIN2B, GRIN2C, GRIN2D			Enzo	56.69	BRD-K48738253-001-02-4	Phase 3
selinexor	exportin antagonist	XPO1			Selleck	91.58	BRD-K21361524-001-01-1	Phase 2/Phase 3
selumetinib	MEK inhibitor	MAP2K1			Selleck, Selleck	97.15	BRD-K57080016-001-19-1, BRD-K57080016-001-15-9	Phase 3
semagacestat	gamma secretase inhibitor	PSEN1			Selleck	94.1	BRD-K81957469-001-01-0	Phase 3
semapimod	cytokine production inhibitor, p38 MAPK inhibitor	MAPK14			Enamine	86.13	BRD-K21237892-376-01-3	Phase 2
semaxanib	VEGFR inhibitor	FGFR1, FLT1, KDR, KIT, PDGFRA, PDGFRB, RET			Tocris, Selleck, Selleck, Tocris	96.75	BRD-K63504947-001-15-4, BRD-K63504947-001-14-7, BRD-K63504947-001-16-2, BRD-K63504947-001-17-0	Phase 3
semustine	DNA alkylating agent				MicroSource, Sigma	0	BRD-K13281575-001-13-4, BRD-K13281575-001-14-2	Phase 3
SEN-1269	beta amyloid inhibitor	APP			Tocris	97.39	BRD-K70614402-001-01-0	Preclinical
senicapoc	intermediate conductance potassium channel blocker	KCNN4			MedChemEx	99.76	BRD-K21295289-001-01-6	Phase 3
sennoside-a	glycoside agonist		gastroenterology	constipation	MicroSource	98.1	BRD-A30370660-001-04-1	Launched
sennoside-protonated					Vitas-M	40	BRD-A53504839-001-01-9	Preclinical
seocalcitol	vitamin D receptor agonist	VDR			MedChemEx, MedChemEx	92.75	BRD-K28456624-001-02-9, BRD-K28456624-001-01-1	Phase 3
SEP-227900	D-Amino Acid Oxidase Inhibitor	DAO			Enamine	94.51	BRD-K49504902-001-01-6	Phase 1
seratrodast	prostanoid receptor antagonist	TBXA2R	pulmonary	asthma	MedChemEx, MedChemEx, MicroSource	87.19	BRD-A60765580-001-03-4, BRD-A60765580-001-02-6, BRD-A60765580-001-01-8	Launched
serdemetan	MDM inhibitor	MDM2			Selleck, Selleck	94.54	BRD-K65924316-001-07-2, BRD-K65924316-001-03-1	Phase 1
serotonin	growth factor receptor activator	DRD1, DRD5, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR3A, HTR3B, HTR4, HTR5A, HTR6, HTR7, SLC36A1	neurology/psychiatry	anxiety, depression, sleeplessness	Tocris, Selleck, Selleck	80.69	BRD-K38580127-003-16-2, BRD-K38580127-003-15-4, BRD-K38580127-003-17-0	Launched
sertaconazole	sterol demethylase inhibitor		infectious disease	tinea pedis	Selleck	98.39	BRD-A95939040-001-01-2	Launched
sertindole	dopamine receptor antagonist, serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA1D, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2C, HTR6, KCNH2			Prestwick	93.27	BRD-K69116396-001-04-1	Withdrawn
sertraline	selective serotonin reuptake inhibitor (SSRI)	SLC6A3, SLC6A4	neurology/psychiatry, obstetrics/gynecology	depression, obsessive compulsive disorder (OCD), panic disorders, posttraumatic stress disorder, premenstrual syndrome, social anxiety disorder	MicroSource, Tocris, Tocris, Selleck	97.77	BRD-K82036761-003-17-9, BRD-K82036761-003-16-1, BRD-K82036761-003-19-5, BRD-K82036761-003-20-3	Launched
sesamin	NFkB pathway inhibitor				Selleck, Selleck	99.85	BRD-K11631773-001-11-6, BRD-K11631773-001-10-8	Preclinical
setipiprant	prostaglandin inhibitor	PTGDR2			MedChemEx	96.5	BRD-K24497734-001-01-6	Phase 3
setiptiline	adrenergic receptor antagonist	HRH1, HTR2A, HTR2C	neurology/psychiatry	depression	MedChemEx	96.01	BRD-K36732695-001-01-9	Launched
sevelamer	phosphate antagonist		nephrology	chronic kidney disease (CKD)	Selleck, Selleck	0	BRD-U45393375-000-01-6, BRD-M22581557-003-02-5	Launched
sevoflurane	membrane integrity inhibitor	ATP2C1, ATP5D, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GRIA1, KCNA1, KCNK10, KCNK18, KCNK2, KCNK3, KCNK9, MT-ND1	neurology/psychiatry	anesthetic	Enamine, Enamine	0	BRD-K05638300-001-02-0, BRD-K05638300-001-01-2	Launched
SEW-2871	lysophospholipid receptor agonist	S1PR1			Tocris	98.71	BRD-K15601958-001-03-9	Preclinical
SF-11	neuropeptide receptor antagonist	MCOLN3, NPY2R			Tocris	88.14	BRD-K42629487-001-08-6	Preclinical
SGC-CBP30	bromodomain inhibitor	CREBBP, EP300			Selleck, Tocris	97.84	BRD-K24821794-001-01-4, BRD-K24821794-001-04-8	Preclinical
SGC-0946	histone lysine methyltransferase inhibitor				Selleck, Tocris	95.72	BRD-K69577666-001-01-3, BRD-K69577666-001-03-9	Preclinical
SGC-707	protein arginine N-methyltransferase inhibitor	PRMT3			Tocris	85.34	BRD-K86718786-001-01-7	Preclinical
SGI-1027	DNA methyltransferase inhibitor	DNMT1, DNMT3A, DNMT3B			Selleck	90.51	BRD-K61228301-001-01-2	Preclinical
SGI-1776	Pim kinase inhibitor	FLT3, PIM1, PIM2, PIM3			Selleck	96.84	BRD-K80700417-001-04-2	Phase 1
SGX523	hepatocyte growth factor receptor inhibitor	MET			Selleck	98.41	BRD-K19477839-001-07-6	Phase 1
SHA-68	neuropeptide receptor antagonist	NPSR1			Tocris	96.69	BRD-A63344375-001-01-8	Preclinical
shikimic-acid					Selleck	94.86	BRD-A92096630-001-02-8	Preclinical
SHP099	protein tyrosine kinase inhibitor	PTPN11			MedChemEx	50.02	BRD-K00818915-003-01-8	Preclinical
SIB-1553A	acetylcholine receptor agonist	CHRNB4			Tocris	94.8	BRD-A79052425-003-01-5	Phase 2
SIB-1757	glutamate receptor antagonist	GRM5			Tocris	89.43	BRD-K98157055-001-10-9	Preclinical
SIB-1893	glutamate receptor antagonist	GRM4, GRM5			Tocris	0	BRD-K14561059-001-05-9	Preclinical
sibutramine	serotoninâ€“norepinephrine reuptake inhibitor (SNRI)	SLC6A2, SLC6A3, SLC6A4			MicroSource, MedChemEx	82.55	BRD-A23359898-003-10-0, BRD-A23359898-003-11-8	Withdrawn
SID-7969543	steroidogenic factor antagonist	NR5A1			Tocris, Tocris	96.71	BRD-A43885598-001-08-1, BRD-A43885598-001-09-9	Preclinical
siguazodan	phosphodiesterase inhibitor	PDE3A			Tocris, Tocris	97.8	BRD-A62071884-001-06-1, BRD-A62071884-001-04-6	Phase 1
sildenafil	phosphodiesterase inhibitor	PDE5A, PDE6G, PDE6H, SLCO1B1, SLCO1B3	cardiology	hypertension	Tocris, MicroSource, Selleck	99.19	BRD-K79759585-048-07-1, BRD-K79759585-048-04-8, BRD-K79759585-048-03-0	Launched
silibinin	cytochrome P450 inhibitor	ALOX5	gastroenterology	hepatic cirrhosis	Selleck, MicroSource, Selleck	97.75	BRD-K80353138-001-13-9, BRD-K80353138-001-12-1, BRD-K80353138-001-16-2	Launched
silodosin	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D	urology	benign prostatic hyperplasia (BPH)	Selleck, Selleck	93.88	BRD-K10906636-001-01-1, BRD-K10906636-001-02-9	Launched
silver-sulfadiazine	PABA antagonist		critical care	sepsis	Sigma, Enzo	99.7	BRD-K68379918-001-01-1, BRD-K68379918-001-02-9	Launched
silymarin					Selleck, Selleck	50.9	BRD-A06629414-001-02-3, BRD-A06629414-001-03-1	Launched
simeprevir	HCV inhibitor	CYP1A2, CYP3A4	infectious disease	hepatitis C	MedChemEx	98.75	BRD-A68493689-001-01-9	Launched
simvastatin	HMGCR inhibitor	HMGCR, ITGB2	endocrinology, cardiology, neurology/psychiatry	hypercholesterolemia, coronary heart disease, myocardial infarction, stroke, hyperlipidemia	Tocris, Selleck, MicroSource, Tocris, Selleck	91.31	BRD-K22134346-001-28-0, BRD-K22134346-001-24-9, BRD-K22134346-001-22-3, BRD-K22134346-001-21-5, BRD-K22134346-001-30-6	Launched
sinefungin	DNA methyltransferase inhibitor, RNA synthesis inhibitor	CARM1			Sigma	94.6	BRD-K91100918-001-03-8	Preclinical
sinomenine	angiogenesis inhibitor				Selleck	92.76	BRD-K83459933-001-05-4	Preclinical
sipatrigine	voltage-gated sodium channel blocker	CACNA1D, SCN10A, SCN1A, SCN3A, SCN4A, SCN5A, SCN9A			Tocris, Tocris	98.09	BRD-K53195974-001-02-7, BRD-K53195974-001-01-9	Phase 2
siponimod	sphingosine phosphate receptor modulator	S1PR1			MedChemEx, Selleck	95.03	BRD-K62384160-001-02-0, BRD-K62384160-001-01-2	Phase 3
siramesine	sigma receptor antagonist	ADRA1A, ADRA1B, ADRA1D			MedChemEx	87.3	BRD-K51333959-003-01-3	Phase 2
sirolimus	mTOR inhibitor	FGF2, FKBP1A, MTOR	transplant, pulmonary	organ rejection, lymphangioleiomyomatosis	Selleck, MedChemEx, MicroSource, Selleck	95.67	BRD-K84937637-001-09-9, BRD-K84937637-001-13-1, BRD-A79768653-001-12-0, BRD-K84937637-001-11-5	Launched
SirReal-2	SIRT inhibitor	SIRT2			Tocris	97.17	BRD-K16472653-001-01-6	Preclinical
sirtinol	SIRT inhibitor	SIRT1, SIRT2			Tocris, Selleck, Selleck	11.06	BRD-A23747351-001-06-8, BRD-A23747351-001-07-6, BRD-A23747351-001-05-0	Preclinical
sisomicin	protein synthesis inhibitor		ophthalmology	conjunctivitis, punctate keratitis, conjunctivitis, punctate keratitis	MedChemEx, MedChemEx, AvaChem	11.93	BRD-K71772032-001-01-3, BRD-K71772032-315-02-5, BRD-K71772032-315-01-7	Launched
sisomicin-sulfate	bacterial 30S ribosomal subunit inhibitor		infectious disease	gram-negative bacterial infections	MicroSource	0	BRD-A68997559-065-04-5	Launched
SIS3	serine/threonine kinase inhibitor	SMAD3, TGFBR1			Tocris	85.23	BRD-K38905597-003-01-4	Preclinical
sitafloxacin	bacterial DNA gyrase inhibitor		infectious disease	buruli ulcer	Selleck	93.27	BRD-K10836013-001-01-3	Launched
sitagliptin	dipeptidyl peptidase inhibitor	DPP4	endocrinology	diabetes mellitus	MicroSource, Selleck	92.63	BRD-K19416115-366-02-7, BRD-K19416115-001-05-3	Launched
sitaxentan	endothelin receptor antagonist	EDNRA			MedChemEx, MedChemEx, Selleck, Selleck	93.75	BRD-K63806092-236-05-9, BRD-K63806092-236-03-4, BRD-K63806092-236-02-6, BRD-K63806092-236-04-2	Withdrawn
sitosterol					Selleck, Selleck	0	BRD-K79402892-001-06-7, BRD-K79402892-001-07-5	Preclinical
sivelestat	elastase inhibitor	CELA1, ELANE	pulmonary	acute lung injury	Tocris, MedChemEx, MedChemEx	97.49	BRD-K02152879-236-01-0, BRD-K02152879-414-02-1, BRD-K02152879-414-01-3	Launched
SJ-172550	MDM inhibitor	MDM4			MedChemEx, Tocris, MedChemEx	6.12	BRD-K35945299-001-04-2, BRD-K35945299-001-03-4, BRD-K35945299-001-02-6	Preclinical
SK&F-10047-(+)	sigma receptor agonist	SIGMAR1			Tocris	95.87	BRD-A47364545-003-02-6	Phase 1
SKA-31	potassium channel activator	KCNN4			Tocris, Tocris	92.73	BRD-K67304264-001-08-5, BRD-K67304264-001-10-1	Preclinical
skepinone-l	p38 MAPK inhibitor	MAPK14			Selleck	97.68	BRD-K83607951-001-02-2	Preclinical
SKF-38393	dopamine receptor agonist	CALY, DRD1, DRD5			Tocris	90.13	BRD-A88548664-004-02-7	Preclinical
SKF-77434	dopamine receptor agonist	DRD1			Tocris	89	BRD-A64227845-004-09-3	Preclinical
SKF-81297	dopamine receptor agonist	DRD1, DRD5			Tocris, Tocris	94.79	BRD-A09828896-004-12-8, BRD-A09828896-004-11-0	Preclinical
SKF-83566	dopamine receptor antagonist	DRD1, DRD5			Tocris, Tocris	97.41	BRD-A52588987-004-09-0, BRD-A52588987-004-08-2	Preclinical
SKF-86002	p38 MAPK inhibitor	ALOX5, MAPK14			Tocris	93.26	BRD-K96809896-300-02-3	Preclinical
SKF-89976A	GABA uptake inhibitor	SLC6A1			Tocris, Tocris	97.09	BRD-A49046702-003-09-1, BRD-A49046702-003-08-3	Preclinical
SKF-91488	histamine N-methyltransferase inhibitor	HNMT			Tocris, Tocris	74.58	BRD-K49776472-300-03-2, BRD-K49776472-300-02-4	Preclinical
SKF-96365	calcium channel blocker	CYP3A4, PKD2, TRPC1, TRPC3, TRPC4, TRPC5, TRPV2			Tocris	98.58	BRD-A72703248-003-04-9	Preclinical
SKI-II	sphingosine kinase inhibitor	SPHK1			Tocris, Selleck, Selleck	94.83	BRD-K20755323-001-06-7, BRD-K20755323-001-05-9, BRD-K20755323-001-07-5	Preclinical
SKLB1002	VEGFR inhibitor	KDR			Selleck	97.72	BRD-K29895144-001-01-0	Preclinical
SLV-319-(+/-)	cannabinoid receptor antagonist	CNR1, DRD2, HTR1A			Tocris	98.47	BRD-A54228901-001-01-7	Phase 2
SLV-320	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3			Tocris, Tocris	91.33	BRD-K34445261-001-02-2, BRD-K34445261-001-01-4	Phase 2
SM-108					Ark, Ark	100	BRD-K70053378-001-02-9, BRD-K70053378-001-01-1	Phase 2
SM-164	XIAP inhibitor	BIRC2, BIRC3, XIAP			MedChemEx, MedChemEx	85.5	BRD-K06191411-001-02-5, BRD-K06191411-001-01-7	Preclinical
SM-21	sigma receptor antagonist	PGRMC1			Tocris	93.13	BRD-A92933783-050-01-6	Preclinical
SMER-28	autophagy inducer	SNCA			Tocris	96.8	BRD-K08478539-001-13-8	Preclinical
SMI-4a	Pim kinase inhibitor	PIM1			Selleck	95.67	BRD-K70159787-001-01-1	Preclinical
SN-2	transient receptor potential channel agonist	MCOLN3			Tocris	97.71	BRD-A64319165-001-07-0	Preclinical
SN-38	topoisomerase inhibitor	TOP1	oncology	colorectal cancer	Tocris, Tocris, Selleck	98.53	BRD-K89561498-001-02-5, BRD-K89561498-001-03-3, BRD-K89561498-001-01-7	Launched
SN-6	sodium/calcium exchange inhibitor				Tocris, Tocris	92.27	BRD-A14316475-001-02-3, BRD-A14316475-001-03-1	Preclinical
SNAP	nitric oxide donor	PTPN1			Cayman, Cayman	40.86	BRD-A67006024-001-05-5, BRD-A67006024-001-04-8	Phase 2
SNAP-5089	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CACNA1C, CACNA1D			Tocris	64.33	BRD-A21428877-003-02-7	Preclinical
SNAP-94847		ADRA1A, DRD2			Tocris, Tocris	97.3	BRD-K49702221-003-01-6, BRD-K49702221-003-02-4	Preclinical
SNC-80		OPRD1			Tocris, Tocris	96.73	BRD-K29546239-001-04-9, BRD-K29546239-001-02-3	Preclinical
SNG-1153	selective estrogen receptor modulator (SERM)	ESR1			MedChemEx	93.39	BRD-K75016267-001-01-7	Preclinical
SNS-314	Aurora kinase inhibitor	AURKA, AURKB, AURKC			Selleck, Tocris	96.75	BRD-K71512533-066-02-8, BRD-K71512533-066-03-6	Phase 1
SNX-2112	HSP inhibitor				Selleck	97.02	BRD-K71281111-001-04-3	Phase 1
SNX-5422	HSP inhibitor	HSP90AA1			MedChemEx, Selleck, Selleck	89.48	BRD-K73197500-001-04-8, BRD-K73197500-001-02-2, BRD-K73197500-001-03-0	Phase 1/Phase 2
sobetirome	thyroid hormone receptor agonist	THRA, THRB			MedChemEx, Tocris	96.15	BRD-K85406984-001-01-0, BRD-K85406984-001-02-8	Phase 1
sobrepin	mucolytic agent		pulmonary	chest congestion	TCI	0	BRD-K58262380-001-01-0	Launched
sodium-ascorbate					Selleck, Selleck	0	BRD-A67265925-236-01-8, BRD-A67265925-236-02-6	Launched
sodium-butyrate	HDAC inhibitor	BCHE, FFAR2, FFAR3, HDAC1, HDAC2, HDAC3, HDAC8			Selleck, Selleck	0	BRD-K05878375-236-05-7, BRD-K05878375-236-06-5	Phase 2
sodium-danshensu					Selleck, Selleck	100	BRD-A93699261-236-02-6, BRD-A93699261-236-03-4	Preclinical
sodium-dodecyl-sulfate		ALB, LYZ			Enamine, Sigma	98.3	BRD-M58433298-001-01-6, BRD-M58433298-001-02-4	Preclinical
sodium-glucoheptonate					TCI	100	BRD-K35952844-236-01-6	Launched
sodium-gluconate					MicroSource, Selleck, Selleck	0	BRD-K93201765-001-01-0, BRD-M54096567-001-01-9, BRD-M54096567-001-03-5	Launched
sodium-gualenate	antacid				AKSci	99.62	BRD-K80043866-236-01-1	Launched
sodium-monofluorophosphate		PYGM	dental	cavities	Selleck, MicroSource, Selleck	0	BRD-K99308954-304-02-4, BRD-K99308954-304-03-2, BRD-K99308954-304-04-0	Launched
sodium-nitrite	nitric oxide donor		critical care	poison antidote, cyanide poisoning	Selleck, Selleck	0	BRD-K61230716-236-02-7, BRD-K61230716-236-03-5	Launched
sodium-nitroprusside	nitric oxide donor		cardiology	hypertension, congestive heart failure	MicroSource, Selleck, Selleck	0	BRD-K48526231-304-02-8, BRD-K48526231-304-03-6, BRD-K48526231-236-01-4	Launched
sodium-orthovanadate					Selleck, Selleck	5.51	BRD-K60600693-314-02-4, BRD-K60600693-314-03-2	Preclinical
sodium-oxybate	benzodiazepine receptor agonist	GABRB1, HCAR1, SLC52A2	neurology/psychiatry	narcolepsy	MicroSource	90.06	BRD-K82166906-236-02-8	Launched
sodium-picosulfate			gastroenterology	constipation	Selleck	91.14	BRD-K77251551-304-02-9	Launched
sodium-salicylate	prostanoid receptor antagonist	ASIC3, PTGS1, PTGS2	endocrinology, neurology/psychiatry	fever, pain relief	Selleck, MicroSource	98.74	BRD-K93632104-001-19-8, BRD-K93632104-001-18-0	Launched
sodium-stibogluconate	tyrosine phosphatase inhibitor	PTPN6, TOP1	infectious disease	leishmaniasis	Enzo	0	BRD-A60786380-412-01-5	Launched
sodium-tanshinone-ii-a-sulfonate	potassium channel activator				Ark	93.63	BRD-K84798689-236-02-9	Phase 2
sodium-tetradecyl-sulfate		PROC, PROS1	dermatology	varicose veins, varicose veins	MicroSource, AlfaAesar	100	BRD-A55664972-236-02-6, BRD-K84544951-236-01-0	Launched
sofalcone	mucus protecting agent	CBR1	gastroenterology	peptic ulcer disease (PUD)	Cayman	97.31	BRD-K01039503-001-01-2	Launched
sofosbuvir	RNA polymerase inhibitor		infectious disease	hepatitis C	MedChemEx	98.52	BRD-K05674516-001-02-5	Launched
solamargine	apoptosis inhibitor				MedChemEx	99.5	BRD-A65562236-001-01-2	Phase 3
solcitinib	JAK inhibitor	JAK1			MedChemEx	97.64	BRD-K69215269-001-01-1	Phase 1
solifenacin-succinate	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	urology	urinary incontinence, urinary frequency	MicroSource, Selleck	97.36	BRD-K24723746-001-01-1, BRD-K24723746-036-02-5	Launched
solithromycin	protein synthesis inhibitor				MedChemEx	96.7	BRD-K32256160-001-01-9	Phase 3
somantadine	antiviral				ChemBridge	97.8	BRD-K85764479-003-01-0	Phase 1
somatostatin	somatostatin receptor agonist	OPRD1, OPRM1, SSTR1, SSTR2, SSTR3, SSTR4, SSTR5	hematology	hemorrhage	Key	82.44	BRD-K14681867-001-01-6	Launched
sonidegib	smoothened receptor antagonist	SMO	oncology	basal cell carcinoma (BCC)	Selleck, Selleck	95.51	BRD-K19796430-001-05-6, BRD-K19796430-001-09-8	Launched
sophocarpine					Vitas-M, Selleck, Selleck	96.27	BRD-K66845263-001-03-0, BRD-K66845263-001-04-8, BRD-K66845263-001-02-2	Phase 3
sorafenib	FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RAF inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor	BRAF, DDR2, FGFR1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET	oncology	renal cell carcinoma (RCC), thyroid cancer, hepatocellular carcinoma (HCC)	Selleck, Selleck	98.3	BRD-K23984367-075-15-2, BRD-K23984367-001-07-5	Launched
sorbic-acid					Enamine	0	BRD-K55892330-001-01-8	Preclinical
sorbinil	aldose reductase inhibitor	AKR1B1			Key	98.08	BRD-A89164055-001-03-3	Phase 3
sorbitan-monostearate					InterBioScreen	0	BRD-A70197423-001-01-3	Preclinical
sorbitol	mucolytic agent				Selleck, MicroSource	100	BRD-K66035042-001-10-1, BRD-K36513555-001-02-0	Launched
sotagliflozin	sodium/glucose cotransporter inhibitor	SLC5A1, SLC5A2			MedChemEx	95.58	BRD-K05850076-001-01-5	Phase 3
sotalol	adrenergic receptor antagonist	ADRB1, ADRB2, KCNH2	cardiology	atrial fibrillation (AF), ventricular arrhythmias	MicroSource, Selleck, Tocris	98.92	BRD-A33168282-003-18-0, BRD-A33168282-003-16-4, BRD-A33168282-003-17-2	Launched
sotrastaurin	PKC inhibitor	PRKCA, PRKCB, PRKCD, PRKCE, PRKCH, PRKCQ			Selleck	96.57	BRD-K16761703-001-03-8	Phase 2
SP-100030	NFkB pathway inhibitor	JUN, NFKB1			Tocris	62.11	BRD-K71900389-001-01-9	Preclinical
SP-141	ubiquitin ligase inhibitor	MDM2			Tocris	96.64	BRD-K28571773-001-01-6	Preclinical
SP-420					MedChemEx	85.18	BRD-K23005288-001-01-8	Phase 1
spaglumic-acid	glutamate receptor antagonist	GRM3	allergy	allergic conjunctivitis, allergic rhinitis	Prestwick, Tocris	98.11	BRD-K68405354-001-07-2, BRD-K68405354-001-06-4	Launched
sparfloxacin	bacterial DNA gyrase inhibitor	TOP2A			Selleck, MicroSource, Selleck	91.61	BRD-K07612980-001-04-6, BRD-K07612980-001-07-9, BRD-K07612980-001-05-3	Withdrawn
sparfosate	aspartate carbamoyltransferase inhibitor	CA2, CA4, CAD			AMS	0	BRD-A81539525-433-01-5	Phase 3
sparteine-sulfate					MicroSource	100	BRD-K32847234-065-04-6	Launched
spautin-1	deubiquitinase inhibitor	USP10, USP13			Tocris	93.94	BRD-K84964099-001-02-9	Preclinical
spectinomycin	bacterial 30S ribosomal subunit inhibitor		pulmonary	airsacculitis, chronic respiratory disease	MedChemEx, MedChemEx, Selleck, MicroSource, Selleck	68.33	BRD-K11905747-300-11-3, BRD-K11905747-300-10-5, BRD-K11905747-300-09-7, BRD-K11905747-300-08-9, BRD-K11905747-300-12-1	Launched
spermidine	glutamate receptor modulator	KCNJ4, TXNRD1			Tocris	100	BRD-K40438880-305-06-6	Preclinical
spermine		CA14, CA4, CA6, CA9, CASR, GRIN1, GRIN2A, KCNJ4, ODC1, SMOX, SMS, TRPM4, TRPM5			Enzo	100	BRD-K18375018-376-02-3	Preclinical
sphingosylphosphorylcholine	gene expression stimulant	GPR12			EMDBio	100	BRD-A35379661-001-04-6	Preclinical
spiperone	dopamine receptor antagonist	ADRA1A, ADRA1B, ADRA1D, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1D, HTR2A, HTR2B, HTR2C, HTR6, HTR7	neurology/psychiatry	schizophrenia	Tocris, MicroSource	96.07	BRD-K55468218-003-02-8, BRD-K55468218-001-26-1	Launched
spiradoline	opioid receptor agonist	OPRK1			Enzo	97.66	BRD-K28192623-066-08-1	Phase 2
spiramycin	bacterial 50S ribosomal subunit inhibitor		infectious disease	toxoplasmosis, soft tissue infection	MicroSource, Selleck, Selleck	84.38	BRD-A67305656-001-03-1, BRD-A67305656-001-02-3, BRD-A67305656-001-01-5	Launched
spirobromin					MatrixSci	0	BRD-K96684644-300-01-7	Phase 1
spironolactone	mineralocorticoid receptor antagonist	AR, CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CYP11B2, NR3C1, NR3C2, PGR, SHBG	endocrinology, cardiology, gastroenterology, rheumatology	hyperaldosteronism, congestive heart failure, hepatic cirrhosis, nephrotic syndrome, hypertension, hypokalemia	Tocris, MicroSource, Selleck, Selleck	98.19	BRD-K90027355-001-16-6, BRD-K90027355-001-19-0, BRD-K90027355-001-20-8, BRD-K90027355-001-13-3	Launched
spiroxatrine	serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, HTR1A, HTR2B			Tocris	91.05	BRD-A72483914-001-03-7	Preclinical
spizofurone					Sigma	97.9	BRD-K94934625-001-01-5	Withdrawn
splitomycin	SIRT inhibitor	SIRT1			Tocris	38.94	BRD-K27710560-001-07-5	Preclinical
SPP-86	receptor tyrosine protein kinase inhibitor	RET			Tocris	98.51	BRD-K63253858-001-01-5	Preclinical
SPP301	endothelin receptor antagonist	EDNRA			MedChemEx	99.69	BRD-K19203487-001-01-4	Phase 3
SQ-109	bacterial cell wall synthesis inhibitor	FDFT1			MedChemEx, MedChemEx	97.97	BRD-A08772153-001-01-6, BRD-A08772153-001-02-4	Phase 3
SQ-22536	adenylyl cyclase inhibitor	ADCY1			Tocris, Tocris	98.05	BRD-A56987319-001-12-9, BRD-A56987319-001-13-7	Preclinical
SR-1078	retinoid receptor agonist	RORA, RORC			Tocris	90.05	BRD-K26501486-001-01-3	Preclinical
SR-11302					Tocris	0	BRD-K16229414-001-01-0	Preclinical
SR-140333	neurokinin receptor antagonist	TACR1			Tocris	94.45	BRD-K60931454-003-01-3	Phase 2
SR-1664	PPAR receptor ligand	PPARG			Tocris	94.36	BRD-K62814487-001-03-0	Preclinical
SR-2211	retinoid receptor inverse agonist	RORC			Tocris	92.59	BRD-K11641193-001-02-6	Preclinical
SR-2640	leukotriene receptor antagonist	CYSLTR1			Tocris, Tocris	94.07	BRD-K62562723-003-03-5, BRD-K62562723-003-02-7	Phase 2
SR-27897	CCK receptor antagonist	CCKAR			Tocris, Tocris	99.12	BRD-K35629949-001-02-0, BRD-K35629949-001-03-8	Phase 2
SR-3306	JNK inhibitor	MAPK10, MAPK8, MAPK9			MedChemEx	95.06	BRD-K60952143-001-01-0	Preclinical
SR-33805	calcium channel blocker				Tocris, Tocris	97.8	BRD-K43002771-034-02-4, BRD-K43002771-034-01-6	Phase 1
SR-3576	JNK inhibitor	MAPK10			Tocris	99.49	BRD-K50378376-001-01-8	Preclinical
SR-3677	rho associated kinase inhibitor	ROCK2			Tocris	79.6	BRD-A86468475-300-01-3	Preclinical
SR-57227A	serotonin receptor agonist	HTR3A			Tocris	95.89	BRD-K09397065-003-06-1	Phase 2
SR-59230A	adrenergic receptor antagonist	ADRB1, ADRB2, ADRB3			Tocris, Tocris	95.68	BRD-K35430135-003-03-1, BRD-K35430135-003-02-3	Preclinical
SR-95639A	acetylcholine receptor agonist	CHRM1			Prestwick	98.78	BRD-K19309090-300-05-5	Preclinical
SRC-kinase-inhibitor-I	src inhibitor	CSK, LCK, RIPK2			Tocris, Tocris	98.18	BRD-K50495309-001-02-0, BRD-K50495309-001-03-8	Preclinical
SRPIN340	serine arginine protein kinase inhibitor	SRPK1, SRPK2			Tocris, Selleck	98.5	BRD-K62621335-001-02-5, BRD-K62621335-001-01-7	Preclinical
SRT1720	SIRT activator	SIRT1			Selleck	93.47	BRD-K95926480-003-03-6	Preclinical
SRT2104	SIRT activator	SIRT1			MedChemEx, Selleck	99.71	BRD-K48452630-001-02-6, BRD-K48452630-001-01-8	Phase 2
SSR-180711	acetylcholine receptor agonist	CHRNA7			Tocris	94.22	BRD-K02782351-003-01-5	Phase 2
SSR128129E					Selleck	95.43	BRD-K65890018-236-01-1	Preclinical
ST-1859	antiamyloidogenic agent				Enamine	94.72	BRD-K73524797-001-01-1	Phase 1
ST-2825	myeloid differentiation primary response inhibitor	MYD88			MedChemEx	97.03	BRD-K68470841-001-01-0	Preclinical
ST-91	adrenergic receptor agonist				Tocris, Tocris	93.75	BRD-K18905250-003-02-4, BRD-K18905250-003-03-2	Preclinical
STA-5326	interleukin synthesis inhibitor	IL12A			MedChemEx	98.13	BRD-K41783120-001-02-8	Phase 2
stanozolol	androgen receptor agonist	AR	hematology	anemia	Prestwick	97.25	BRD-K46791647-001-01-2	Launched
stattic					Selleck	95.9	BRD-K17061841-001-03-5	Preclinical
STAT3-inhibitor-VI	STAT inhibitor	STAT3			Selleck, MedChemEx, Tocris, Selleck, MedChemEx	96.39	BRD-K40853697-001-17-1, BRD-K40853697-001-20-5, BRD-K40853697-001-19-7, BRD-K40853697-001-12-2, BRD-K40853697-001-18-9	Preclinical
stavudine	DNA directed DNA polymerase inhibitor, nucleoside reverse transcriptase inhibitor		infectious disease	human immunodeficiency virus (HIV-1)	Tocris, Selleck, MicroSource	98.42	BRD-K93880783-001-27-4, BRD-K93880783-001-28-2, BRD-K93880783-001-26-6	Launched
stemregenin-1	aryl hydrocarbon receptor antagonist	AHR			Selleck	95.36	BRD-K36739687-001-03-0	Preclinical
stepronin	mucolytic agent				AKSci	98.87	BRD-A04506385-001-01-2	Launched
stetaderm					Sigma	96.74	BRD-K93900986-001-15-0	Launched
STF-083010	serine/threonine kinase inhibitor	ERN1			MedChemEx, MedChemEx	1.02	BRD-K13049524-001-04-6, BRD-K13049524-001-03-8	Preclinical
STF-118804	NAMPT inhibitor	NAMPT			Selleck, Tocris	96.03	BRD-K39171998-001-01-1, BRD-K39171998-001-04-5	Preclinical
STF-31	NAMPT inhibitor	NAMPT, SLC2A1			Tocris	95.84	BRD-K22477529-001-02-7	Preclinical
STF-62247	autophagy inducer				Selleck, Selleck	89.5	BRD-K85479953-001-12-1, BRD-K85479953-001-11-3	Preclinical
stigmasterol					Selleck, Selleck	0	BRD-K41422683-001-02-2, BRD-K41422683-001-05-5	Preclinical
stiripentol	GABA uptake inhibitor	GABRA3	neurology/psychiatry	epilepsy	Sigma	0	BRD-A72441487-001-05-7	Launched
stobadine	adrenergic receptor antagonist	ADRA1A			Enamine, ChemBridge, Enamine	67.37	BRD-A85069489-300-01-4, BRD-A85069489-001-01-8, BRD-K33839500-001-01-0	Phase 2
streptomycin	bacterial 30S ribosomal subunit inhibitor		infectious disease	tuberculosis	Selleck, Selleck, MicroSource	94.3	BRD-K07166362-330-01-0, BRD-K07166362-330-02-8, BRD-A98954669-065-04-7	Launched
streptozotocin	DNA alkylating agent	SLC2A2	oncology	pancreatic cancer	Sigma, Selleck, MedChemEx, MedChemEx, MicroSource, Selleck, Tocris	83.34	BRD-K34411947-001-14-1, BRD-K34411947-001-13-3, BRD-A94713674-001-02-3, BRD-K34411947-001-15-8, BRD-K34411947-001-12-5, BRD-K34411947-001-11-7, BRD-K34411947-001-17-4	Launched
strontium-ranelate	bone formation stimulant, bone resorption inhibitor	CASR	orthopedics, rheumatology	osteoporosis, osteoarthritis	MedChemEx, Selleck, LKT, Selleck	0	BRD-K83146339-001-02-4, BRD-K83146339-001-03-2, BRD-K83146339-001-04-0, BRD-K83146339-001-05-7	Launched
strychnine	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA10, CHRNA9, GLRA1, GLRA2, GLRA3, GLRB			MicroSource	97.36	BRD-A09094913-065-01-0	Preclinical
SU-11274	hepatocyte growth factor receptor inhibitor, tyrosine kinase inhibitor	MET			Selleck, Tocris	96.9	BRD-K02965346-001-07-5, BRD-K02965346-001-06-7	Preclinical
SU-16f	PDGFR tyrosine kinase receptor inhibitor	PDGFRB			Tocris	89.66	BRD-K91106808-001-02-0	Preclinical
SU-4312	PDGFR tyrosine kinase receptor inhibitor, tyrosine kinase inhibitor, VEGFR inhibitor	KDR, PDGFRB			Tocris	67.6	BRD-K20287671-001-06-9	Preclinical
substance-p	neurokinin receptor antagonist	TACR1, TACR2, TACR3			Tocris	87.35	BRD-K23106423-001-01-0	Phase 1
succinic-acid		ALDH5A1, ASPH, BBOX1, HSD17B6, OXCT1, OXCT2, P3H1, P3H2, P3H3, P4HA1, P4HA2, PLOD1, PLOD3, SDHA, SDHB, SDHC, SDHD, SLC13A1, SLC13A2, SLC13A3, SLC25A10, SUCLA2, SUCLG1, SUCLG2, SUCNR1, TMLHE			Enamine	100	BRD-K45238818-001-02-6	Launched
succinylcholine-chloride		CHRFAM7A, CHRM1, CHRM2, CHRM3, CHRNA1, CHRNA10	neurology/psychiatry	muscle relaxant	Sigma, DuPont, Selleck, Selleck	66.78	BRD-K45497762-336-03-2, BRD-K45497762-300-01-2, BRD-K45497762-336-01-6, BRD-K45497762-336-02-4	Launched
succinylsulfathiazole	dihydrofolate reductase inhibitor	DHFR			MicroSource	96.18	BRD-K01950558-001-14-7	Phase 2
sucralfate	antacid	EGF, FGA, FGB, FGF2, FGG	gastroenterology	duodenal ulcer disease	MicroSource	0	BRD-M71167108-001-01-3	Launched
sucralose					MicroSource, Selleck	100	BRD-K58968598-001-02-8, BRD-K58968598-001-03-6	Launched
sucrose		ACTA1, ATOX1, C22orf28, LYZ			Sigma	99.8	BRD-K74724920-001-02-4	Launched
sucrose-octaacetate					Acros	100	BRD-K01294196-001-01-5	Preclinical
sudan-iv					Vitas-M	79.18	BRD-K65989725-001-01-3	Preclinical
sufentanil	opioid receptor modulator	OPRD1, OPRK1, OPRM1	neurology/psychiatry	anesthetic	MedChemEx	94.14	BRD-K21547160-001-01-4	Launched
sulbactam	beta lactamase inhibitor		infectious disease	skin infections, intra-abdominal infections, gynecologic infections	Selleck, Selleck, MicroSource, Selleck	98.41	BRD-K44133266-001-10-0, BRD-K44133266-236-03-7, BRD-A12490291-001-01-2, BRD-K44133266-236-02-9	Launched
sulbactam-pivoxil	beta lactamase inhibitor		infectious disease	skin infections	AvaChem	85.23	BRD-A63431791-001-01-9	Launched
sulbentine	other antifungal				MicroSource	94.5	BRD-K72384124-001-08-0	Preclinical
sulbutiamine	acetylcholine receptor antagonist		neurology/psychiatry	asthenia	AKSci	97.93	BRD-K12539416-001-01-4	Launched
sulconazole	sterol demethylase inhibitor		infectious disease	tinea pedis, tinea cruris, tinea corporis	Selleck, MicroSource	99.7	BRD-A70649075-008-29-0, BRD-A70649075-008-30-8	Launched
sulfabenzamide	bacterial antifolate				MicroSource	98.4	BRD-K59983611-001-21-9	Launched
sulfacarbamide					MicroSource	91.78	BRD-K13486660-001-01-0	Withdrawn
sulfacetamide	PABA antagonist		ophthalmology	conjunctivitis	Selleck, MicroSource	94.36	BRD-K21520694-236-02-6, BRD-K21520694-001-21-4	Launched
sulfachlorpyridazine	bacterial antifolate		infectious disease	urinary tract infections	MicroSource	98.26	BRD-K32021043-001-14-3	Launched
sulfadiazine	bacterial antifolate		infectious disease, ophthalmology	malaria, meningitis, urinary tract infections, conjunctivitis, trachoma, chancroid	Enamine, Selleck, MicroSource	99.24	BRD-K32273377-001-17-9, BRD-K32273377-001-15-3, BRD-K32273377-001-16-1	Launched
sulfadoxine	dihydropteroate synthase inhibitor		infectious disease	malaria	MicroSource, Selleck	96.8	BRD-K55250441-001-13-0, BRD-K55250441-001-12-2	Launched
sulfafurazole	bacterial antifolate		infectious disease	urinary tract infections	Tocris, MicroSource, Selleck	97.76	BRD-K50859149-001-18-7, BRD-K50859149-001-19-5, BRD-K50859149-001-17-9	Launched
sulfaguanidine	bacterial antifolate		infectious disease	urinary tract infections	MicroSource, Selleck, Selleck	100	BRD-K45086103-001-15-5, BRD-K45086103-001-14-8, BRD-K45086103-001-16-3	Launched
sulfamerazine	bacterial antifolate		infectious disease	coccidiosis, cholera	MicroSource, Selleck	98.63	BRD-K93524252-001-24-7, BRD-K93524252-001-23-9	Launched
sulfameter	dihydrofolate reductase inhibitor	DHFR	infectious disease	urinary tract infections	Selleck, MicroSource	98.75	BRD-K87492696-001-15-7, BRD-K87492696-001-16-5	Launched
sulfamethazine	PABA antagonist		gastroenterology	enteritis, enteritis	Prestwick, MicroSource, Selleck	99.35	BRD-K11640013-236-10-1, BRD-K11640013-001-15-8, BRD-K11640013-001-14-1	Launched
sulfamethizole	bacterial antifolate		infectious disease	urinary tract infections	MicroSource, Selleck	93.08	BRD-K31682896-001-24-0, BRD-K31682896-001-23-2	Launched
sulfamethoxazole	PABA antagonist		infectious disease, gastroenterology	pneumonia, enteritis, urinary tract infections	MicroSource, Selleck	98.94	BRD-K28494619-001-28-2, BRD-K28494619-001-27-4	Launched
sulfamethoxypyridazine	bacterial antifolate				Selleck, MicroSource	97.84	BRD-K00938507-001-16-0, BRD-K00938507-001-17-8	Withdrawn
sulfametopyrazine	PABA antagonist		infectious disease	malaria, urinary tract infections, respiratory tract infections	Enamine	96.63	BRD-K17205817-001-06-1	Launched
sulfamonomethoxine	bacterial antifolate		infectious disease	urinary tract infections	MicroSource	97.68	BRD-K14116214-001-09-6	Launched
sulfamoxole	PABA antagonist		infectious disease	urinary tract infections	Sigma, SantaCruz	70.9	BRD-K19742012-001-02-3, BRD-K19742012-001-01-5	Launched
sulfanilamide	carbonic anhydrase inhibitor	CYP2C19, CYP2C9, CYP2D6, CYP2E1, CYP3A4	infectious disease	vulvovaginal candidiasis	MicroSource, Selleck	100	BRD-K02594908-001-16-4, BRD-K02594908-001-15-6	Launched
sulfanilate-zinc					MicroSource	0	BRD-K04254814-001-01-8	Preclinical
sulfanitran					MicroSource	78.09	BRD-K76845197-001-05-4	Launched
sulfaphenazole	dihydropteroate synthetase inhibitor	DHPS	infectious disease	urinary tract infections	MicroSource	90.33	BRD-K10671814-001-14-8	Launched
sulfapyridine	PABA antagonist				Selleck, MicroSource	98.64	BRD-K41406082-001-15-4, BRD-K41406082-001-16-2	Launched
sulfaquinoxaline	vitamin K antagonist		infectious disease	coccidiosis	MicroSource	92.12	BRD-K71133585-236-14-4	Launched
sulfasalazine	cyclooxygenase inhibitor	ACAT1, ALOX5, CHUK, IKBKB, PLA2G1B, PPARG, PTGS1, PTGS2, SLC46A1, SLC7A11, TBXAS1	gastroenterology	ulcerative colitis	Tocris, MicroSource, Selleck	97.78	BRD-K10670311-001-17-1, BRD-K10670311-001-15-5, BRD-K10670311-001-14-8	Launched
sulfathiazole	dihydropteroate synthase inhibitor				MicroSource, Selleck	98.28	BRD-K14705039-001-16-4, BRD-K14705039-001-15-6	Launched
sulfinpyrazone	uricosuric blocker	ABCC1, ABCC2, FPR1, SLC22A12	rheumatology	gout	MicroSource	97.57	BRD-A36217750-001-16-3	Launched
sulfisoxazole-acetyl	folic acid antagonist		infectious disease, otolaryngology	meningitis, urinary tract infections, otitis, trachoma	MicroSource	56.69	BRD-K84810336-001-01-9	Launched
sulforaphane	anticancer agent, aryl hydrocarbon receptor antagonist	NFE2L2			EMDBio	95.09	BRD-A58955223-001-03-8	Phase 2
sulindac	cyclooxygenase inhibitor	AKR1B1, MAPK3, PPARD, PTGDR2, PTGS1, PTGS2	rheumatology	osteoarthritis, rheumatoid arthritis, ankylosing spondylitis	Tocris, Selleck, MicroSource, Selleck	95.9	BRD-A13946108-001-17-1, BRD-A13946108-001-16-3, BRD-A13946108-001-18-9, BRD-A13946108-001-19-7	Launched
sulisobenzone			dermatology	sunscreen lotion	MicroSource, ChemBridge	98.83	BRD-K38602774-001-03-2, BRD-K38602774-002-01-4	Launched
sulmazole	adenosine receptor antagonist				Prestwick	98.4	BRD-A22081593-001-11-1	Phase 1
sulmetozine	gastrin inhibitor	GAST	gastroenterology	peptic ulcer disease (PUD)	Vitas-M	96.89	BRD-K29570907-001-07-3	Launched
suloctidil	adrenergic receptor antagonist				MicroSource	95.54	BRD-A34205397-001-04-5	Withdrawn
sulphadimethoxine	dihydropteroate synthetase inhibitor				Selleck, MicroSource	97.65	BRD-K71125014-001-26-3, BRD-K71125014-001-27-1	Launched
sulpiride	dopamine receptor antagonist		neurology/psychiatry	schizophrenia, schizophrenia	Tocris, Tocris, MicroSource	98.91	BRD-A55272860-001-16-1, BRD-A55272860-001-14-6, BRD-A55272860-001-15-3	Launched
sumanirole	dopamine receptor agonist	DRD2			Sigma	82.4	BRD-K30485548-050-01-6	Phase 3
sumatriptan	serotonin receptor agonist	HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR5A, HTR6, HTR7	neurology/psychiatry	migraine headache	MicroSource, Tocris, Tocris, Selleck	95.83	BRD-K50938287-001-09-0, BRD-K50938287-036-13-8, BRD-K50938287-036-16-1, BRD-K50938287-036-12-0	Launched
SUN-B-8155	calcitonin agonist	CALCR			Tocris, Tocris	52.27	BRD-K36274133-001-02-0, BRD-K36274133-001-01-2	Preclinical
SUN-11602	fibroblast growth factor mimetic	FGFR1			Tocris	49.28	BRD-K71250460-001-01-1	Preclinical
sunitinib	FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor	CSF1R, FGFR1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB, RET	oncology	gastrointestinal stromal tumors (GIST), renal cell carcinoma (RCC), neuroendocrine tumors of pancreatic origin (PNET)	Selleck, MedChemEx, Selleck, Tocris	94.01	BRD-K42828737-044-10-8, BRD-K42828737-001-03-3, BRD-K42828737-044-09-0, BRD-K42828737-044-12-4	Launched
suplatast	histamine release inhibitor, immunoglobulin inhibitor		rheumatology	Kimura's disease	MedChemEx, Tocris, Selleck, MedChemEx, Selleck	36.74	BRD-A98427211-075-06-1, BRD-A98427211-075-03-8, BRD-A98427211-075-04-6, BRD-A98427211-075-05-3, BRD-A98427211-075-02-0	Launched
suprofen	cyclooxygenase inhibitor	PTGS1, PTGS2			MicroSource, Selleck	97.91	BRD-A34006693-001-15-4, BRD-A34006693-001-14-7	Withdrawn
suramin	DNA synthesis inhibitor	F2, FSHR, P2RY1, P2RY11, P2RY13, P2RY2, PLA2G2A, RYR1, RYR2, SIRT5	infectious disease	African trypanosomiasis, onchocerciasis	MicroSource, Tocris	96.4	BRD-K70327167-348-13-4, BRD-K70327167-348-12-6	Launched
suritozole	GABA receptor inverse agonist	GABBR1			Enamine	91.89	BRD-K98557884-001-01-6	Phase 2
sutezolid	protein synthesis inhibitor				MedChemEx	91.81	BRD-K86670086-001-02-5	Phase 2
suvorexant	orexin receptor antagonist	HCRTR1, HCRTR2	neurology/psychiatry	insomnia	Selleck	99.04	BRD-K94293891-001-01-3	Launched
suxibuzone	cyclooxygenase inhibitor		rheumatology, neurology/psychiatry	joint pain, muscle pain	Selleck, MicroSource	97.83	BRD-K78815826-001-13-8, BRD-K78815826-001-14-6	Launched
SU014813	PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	KDR			MedChemEx	94.85	BRD-K75911534-001-01-6	Phase 2
SU3327	JNK inhibitor	MAPK8			Tocris, Tocris	94.58	BRD-K32730239-001-01-0, BRD-K32730239-001-02-8	Preclinical
SU9516	CDK inhibitor	CDK1, CDK2, CDK4, CDK5			MedChemEx, Tocris	87.43	BRD-K94883909-001-17-7, BRD-K94883909-001-18-5	Preclinical
swainsonine	alpha mannosidase inhibitor	MAN2A1			Enzo	97.53	BRD-K15170068-001-03-2	Phase 2
SX-011	MAP kinase inhibitor	MAPK14			Tocris, Tocris	97.88	BRD-K45385835-001-03-2, BRD-K45385835-001-02-4	Preclinical
SYM-2081	kainate receptor antagonist	GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SLC1A2			Enzo	0	BRD-K72106461-001-02-1	Preclinical
SYM-2206	glutamate receptor antagonist	GRIA1, GRIA2, GRIA3, GRIA4			Tocris, Tocris	95.25	BRD-A77218119-001-04-3, BRD-A77218119-001-03-5	Preclinical
symclosene					MicroSource	0	BRD-K33642804-001-01-1	Preclinical
synephrine	adrenergic receptor agonist	ADRA1A			Selleck, Selleck, Selleck, MicroSource, Selleck	100	BRD-A04327189-003-02-5, BRD-A04327189-003-03-3, BRD-A04327189-001-16-9, BRD-A04327189-001-15-1, BRD-A04327189-001-14-4	Launched
S1P1-agonist-III	sphingosine kinase inhibitor	S1PR1			Tocris, MedChemEx, MedChemEx	94.83	BRD-K12745498-001-02-6, BRD-K12745498-001-03-4, BRD-K12745498-001-01-8	Preclinical
S18986	glutamate receptor modulator	GRIA1, GRIA2, GRIA3, GRIA4			EMDBio	93.79	BRD-K02501528-001-01-1	Phase 2
S26948	PPAR receptor agonist	PPARG			Tocris, Tocris	98.35	BRD-K48826825-001-01-8, BRD-K48826825-001-02-6	Preclinical
S4	carbonic anhydrase inhibitor	CA12, CA9			Tocris	26.89	BRD-K96798615-001-01-4	Preclinical
T-0070907	PPAR receptor antagonist	PPARG			Tocris, Tocris, Selleck	98.04	BRD-K31843556-001-04-1, BRD-K31843556-001-05-8, BRD-K31843556-001-03-3	Preclinical
T-0156	phosphodiesterase inhibitor	PDE5A			Tocris, Tocris	98.39	BRD-K63516691-003-03-8, BRD-K63516691-003-02-0	Preclinical
T-0901317	LXR agonist	NCOA1, NCOA2, NR1H2, NR1H3, NR1I2, RXRB			Tocris, Tocris, Selleck	96.75	BRD-K23383398-001-09-9, BRD-K23383398-001-10-7, BRD-K23383398-001-08-1	Preclinical
T-5224	AP inhibitor	JUN			MedChemEx	92.03	BRD-K84925803-001-01-9	Phase 2
T-5601640	LIM kinase inhibitor	LIMK2			Tocris	99.12	BRD-K83492904-001-01-9	Preclinical
T-62	adenosine receptor modulator	ADORA2A			Enamine, Enamine	63.41	BRD-K09001147-001-02-4, BRD-K09001147-001-01-6	Phase 2
TA-01	casein kinase inhibitor, MAP kinase inhibitor	CSNK1D, CSNK1E, MAPK14			MedChemEx	96.68	BRD-K79856806-001-01-0	Preclinical
tabimorelin	growth hormone secretagogue receptor agonist	GHSR			Tocris	92.38	BRD-K53600683-051-01-5	Phase 2
tacalcitol	vitamin D receptor agonist	VDR	dermatology	psoriasis, chapped lips	MedChemEx	93.56	BRD-K73237276-001-01-0	Launched
tacedinaline	HDAC inhibitor	HDAC1			Selleck, Tocris	96.91	BRD-K52313696-001-12-3, BRD-K52313696-001-14-9	Phase 3
tacrine	acetylcholinesterase inhibitor	ACHE, BCHE	neurology/psychiatry	Alzheimer's disease	Selleck, Tocris, MicroSource	99.35	BRD-K81473089-003-24-6, BRD-K81473089-003-25-3, BRD-K81473089-003-26-1	Launched
tacrolimus	calcineurin inhibitor	FKBP1A	transplant	organ rejection	MedChemEx, MicroSource, Selleck	97.24	BRD-K69608737-001-08-6, BRD-K69608737-001-10-2, BRD-K69608737-001-09-4	Launched
tadalafil	phosphodiesterase inhibitor	PDE11A, PDE5A	cardiology	hypertension	MicroSource, Selleck	98.74	BRD-K93645900-001-12-1, BRD-K93645900-001-11-3	Launched
tafamidis-meglumine	transthyretin amyloid inhibitor	TTR	neurology/psychiatry	familial amyloid polyneuropathy (FAP)	MedChemEx	99.69	BRD-K23728141-001-01-2	Launched
tafenoquine	antimalarial agent				Sigma	82.25	BRD-A78965079-036-01-8	Phase 3
tagatose	phosphorylase inhibitor	PYGL			Enamine, Sigma, TCI, EMDBio, Sigma	100	BRD-A73556557-001-07-2, BRD-K42064204-001-01-3, BRD-K89588135-001-01-9, BRD-A73556557-001-06-4, BRD-K18320600-001-01-9	Phase 3
TAK-063	phosphodiesterase inhibitor	PDE10A			MedChemEx	96.14	BRD-K57155378-001-01-1	Phase 2
TAK-220	CC chemokine receptor antagonist	CCR5			MedChemEx	96.9	BRD-K38793468-001-01-4	Phase 1
TAK-285	EGFR inhibitor	ERBB2			Selleck	92.87	BRD-K80343549-001-02-6	Phase 1
TAK-593	VEGFR inhibitor	PDGFRA			MedChemEx	94.1	BRD-K67262033-001-01-0	Phase 1
TAK-632	RAF inhibitor	BRAF			Selleck	97.83	BRD-K31866293-001-01-6	Preclinical
TAK-715	p38 MAPK inhibitor	MAPK14			Tocris, Selleck	98.88	BRD-K52751261-001-08-7, BRD-K52751261-001-06-1	Phase 2
TAK-733	MEK inhibitor	MAP2K1			Selleck, Selleck	91.47	BRD-K26667523-001-02-5, BRD-K26667523-001-03-3	Phase 1
TAK-875	insulin secretagogue	FFAR1			Selleck	97.03	BRD-K58501140-002-01-0	Phase 3
TAK-901	Aurora kinase inhibitor	AURKB			Selleck	94.01	BRD-K01683783-001-02-6	Phase 1
TAK-960	PLK inhibitor	PLK1			MedChemEx, Tocris	98.58	BRD-K48059512-001-01-4, BRD-K48059512-003-01-0	Phase 1
talabostat	dipeptidyl peptidase inhibitor, fibroblast activation protein inhibitor	DPP4			MedChemEx, MedChemEx, MedChemEx	67.55	BRD-K37419961-066-03-8, BRD-K37419961-066-02-0, BRD-K37419961-066-01-2	Phase 3
taladegib	smoothened receptor antagonist	DHH, IHH, SMO			MedChemEx	98.77	BRD-K50498985-001-03-3	Phase 2
talampanel	glutamate receptor antagonist	GRIA1, GRIA2, GRIA3, GRIA4			MedChemEx, Tocris	93	BRD-K80359953-001-01-3, BRD-K80359953-001-02-1	Phase 2
talarozole	cytochrome P450 inhibitor	CYP26A1			MedChemEx	94.65	BRD-A95755460-001-01-3	Phase 2
talazoparib	PARP inhibitor	PARP2			Selleck	97.61	BRD-K95142244-001-01-5	Phase 3
talc					Selleck, Selleck	0	BRD-M92352362-002-02-3, BRD-M92352362-002-03-1	Launched
talinolol	adrenergic receptor antagonist	ADRB1	cardiology	hypertension	Cayman	90.03	BRD-A94276798-001-01-4	Launched
talipexole	adrenergic receptor agonist, dopamine receptor agonist	ADRA2A, DRD2, HTR3A	infectious disease	genitial herpes	MedChemEx, MedChemEx, MedChemEx, Enzo	84.52	BRD-K75615183-300-04-7, BRD-K75615183-300-05-4, BRD-K75615183-300-06-2, BRD-K75615183-300-03-9	Launched
talmapimod	p38 MAPK inhibitor	MAPK11, MAPK14			Tocris, Tocris, MedChemEx	98.07	BRD-K17555800-003-01-5, BRD-K17555800-003-02-3, BRD-K17555800-001-01-9	Phase 2
talnetant	tachykinin antagonist	TACR2, TACR3			MedChemEx	98.57	BRD-K47095176-001-01-6	Phase 2
talniflumate	cyclooxygenase inhibitor	CLCA1	neurology/psychiatry	pain relief	Tocris, Tocris	93.24	BRD-A98378129-001-02-2, BRD-A98378129-001-03-0	Launched
talopram	adrenergic inhibitor	SLC6A2			Tocris	92.77	BRD-A02532772-003-01-7	Phase 2
taltirelin	thyrotropin releasing hormone receptor agonist	TRHR	neurology/psychiatry	spinocerebellar ataxia	MedChemEx	86.52	BRD-K93869735-001-01-1	Launched
taltobulin	tubulin polymerization inhibitor				MedChemEx	96.83	BRD-K87512222-019-01-7	Phase 1
TAME					Selleck	91.82	BRD-K72231366-001-02-3	Preclinical
tamibarotene	retinoid receptor agonist	RARA, RARB	hematologic malignancy	acute promyelocytic leukemia (APL)	Selleck	97.33	BRD-K36627727-001-05-4	Launched
tamoxifen	estrogen receptor antagonist, selective estrogen receptor modulator (SERM)	EBP, ESR1, ESR2, GPER1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PRKCI, PRKCQ, PRKCZ	oncology	breast cancer	Tocris, Selleck, Tocris, MicroSource, Selleck	97.31	BRD-K93754473-048-23-6, BRD-K93754473-048-18-6, BRD-K93754473-048-19-4, BRD-K93754473-048-20-2, BRD-K93754473-048-21-0	Launched
tamsulosin	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D	urology	benign prostatic hyperplasia (BPH)	Tocris, Enzo	99.03	BRD-K74339692-003-03-1, BRD-K74339692-001-01-9	Launched
tanaproget	progesterone receptor agonist	PGR			MedChemEx, MedChemEx	97.58	BRD-K99604664-001-02-9, BRD-K99604664-001-01-1	Phase 2
tandospirone	serotonin receptor agonist	HTR1A	neurology/psychiatry	generalized anxiety disorder (GAD), dysthymic disorder	Tocris, MedChemEx	98.71	BRD-K65904673-003-01-0, BRD-K65904673-001-01-4	Launched
tandutinib	FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor	CSF1R, FLT3, KIT, PDGFD, PDGFRB			MicroSource, Selleck	94.36	BRD-K89162000-001-07-2, BRD-K89162000-001-06-4	Phase 2
tanespimycin	HSP inhibitor	HSP90AA1			Selleck, Selleck	97.71	BRD-K81473043-001-14-6, BRD-K81473043-001-19-5	Phase 3
tangeritin	cell cycle inhibitor				Selleck	97.49	BRD-K25186396-001-09-6	Preclinical
tannic-acid	PARG inhibitor	ANO1	gastroenterology	constipation	MicroSource	0	BRD-K67392463-001-04-8	Launched
tanshinone-i	AP inhibitor	IFNG			Selleck, Selleck	87.49	BRD-K34073885-001-07-7, BRD-K34073885-001-09-3	Phase 2
tanshinone-iia	anti-inflammatory agent, interleukin inhibitor	IL1B, NR1I2, TNF			Selleck, Selleck	78.69	BRD-K00141480-001-15-4, BRD-K00141480-001-14-7	Phase 2/Phase 3
tapentadol	opioid receptor agonist	HTR3A, OPRD1, OPRK1, OPRM1, SLC6A2, SLC6A4	neurology/psychiatry	acute pain, muscle pain	MicroSource, MedChemEx, MedChemEx	91.75	BRD-K25699529-003-01-1, BRD-K04283354-003-01-9, BRD-K04283354-003-02-7	Launched
taprenepag	prostaglandin receptor agonist	PTGER2			MedChemEx	96.08	BRD-K88854110-001-01-5	Phase 2
tarafenacin	acetylcholine receptor antagonist	CHRM3			MedChemEx	99.28	BRD-K59390331-045-01-5	Phase 2
taranabant	cannabinoid receptor inverse agonist	CNR1			MedChemEx	98.67	BRD-K35169477-001-01-9	Phase 3
targinine	nitric oxide synthase inhibitor	NOS3			Cayman	100	BRD-K59506194-015-04-9	Phase 3
tariquidar	P glycoprotein inhibitor	ABCB1			Selleck, Selleck	95.08	BRD-K09353376-001-02-1, BRD-K09353376-001-03-9	Phase 3
tartaric-acid	antioxidant	ATP6V1C1, B3GAT1, DDX6, HIF1AN, TREM1			MicroSource	0	BRD-K36474365-001-06-6	Launched
TAS-103	topoisomerase inhibitor	TOP1			MedChemEx	91.54	BRD-K09426783-300-01-0	Phase 1
taselisib	PI3K inhibitor	PIK3CA			MedChemEx	98.4	BRD-K44844162-001-01-6	Phase 3
tasimelteon	melatonin receptor agonist	MTNR1A, MTNR1B	neurology/psychiatry	Non-24-Hour Sleep-Wake Disorder	Synnovator	98.42	BRD-K62971431-001-01-9	Launched
tasisulam	apoptosis stimulant				Selleck	97.55	BRD-K42495768-001-01-7	Phase 3
tasquinimod	angiogenesis inhibitor, S100A9 inhibitor	HDAC4			MedChemEx	99.3	BRD-K14653796-001-01-1	Phase 3
tasuldine	mucolytic agent				Vitas-M, Labotest	98.77	BRD-K10415035-001-03-6, BRD-K10415035-001-04-4	Phase 3
taurine	antioxidant		neurology/psychiatry	anxiety, irritability, sleeplessness	MicroSource, Selleck	100	BRD-K51474575-001-11-2, BRD-K51474575-001-10-4	Launched
taurocholate	G protein-coupled receptor agonist	CEL, FABP6, SLCO1C1			Enzo	100	BRD-K81062487-001-05-8	Phase 1
taurolidine	apoptosis stimulant		infectious disease	catheter-related bloodstream infection	Sigma	0	BRD-K98765504-001-01-5	Launched
tavaborole	leucyl-tRNA synthetase inhibitor		infectious disease	onychomycosis	MedChemEx, MedChemEx	91.53	BRD-K76713213-001-02-1, BRD-K76713213-001-01-3	Launched
taxifolin	opioid receptor antagonist	ADIPOR2			Selleck, Selleck	97.48	BRD-K94649603-001-10-6, BRD-K94649603-001-11-4	Phase 2
tazarotene	retinoid receptor agonist	RARA, RARB, RARG, RXRB	dermatology	cosmetic, sunscreen lotion	Selleck	97.04	BRD-K76841105-001-04-7	Launched
tazemetostat	histone lysine methyltransferase inhibitor	EZH2			Selleck, Selleck	93.46	BRD-K11215326-001-02-9, BRD-K11215326-001-03-7	Phase 2
tazobactam	beta lactamase inhibitor		infectious disease	pneumonia	MicroSource	96.32	BRD-A18611368-001-01-5	Launched
TBA-354					MedChemEx	96.43	BRD-K56405978-001-01-5	Phase 1
TBOA-(DL)	excitatory amino acid transporter inhibitor	SLC1A1, SLC1A2, SLC1A3, SLC1A6, SLC1A7			Tocris, Tocris, Tocris	91	BRD-M77041484-001-03-4, BRD-M77041484-001-02-6, BRD-M77041484-001-01-8	Preclinical
TC-A-2317	Aurora kinase inhibitor	AURKA			Tocris	86.6	BRD-A12147465-003-01-4	Preclinical
TC-ASK-10	MAP kinase inhibitor	MAP3K5, MAP3K6			Tocris	95.66	BRD-K29660062-300-01-2	Preclinical
TC-E-5002	histone demethylase inhibitor	KDM2A, KDM4A, KDM4C, KDM5A, KDM6A, KDM7A, PHF8			Tocris, Tocris	96.52	BRD-K15256258-001-01-3, BRD-K15256258-001-02-1	Preclinical
TC-E-5006	gamma secretase modulator	APP			Tocris	96.44	BRD-A66521565-001-01-8	Preclinical
TC-F-2	FAAH inhibitor	FAAH			Tocris	96.64	BRD-K26041695-001-02-5	Preclinical
TC-FPR-43	formyl peptide receptor agonist	FPR2			Tocris	97.83	BRD-K16497916-001-01-6	Preclinical
TC-G-1000	adrenergic receptor agonist	ADRA2A, ADRA2B, ADRA2C			Tocris	77.34	BRD-K27010807-050-01-3	Preclinical
TC-G-1004	adenosine receptor antagonist	ADORA2A			Tocris	90.59	BRD-K76989898-001-01-1	Preclinical
TC-G-1005	G protein-coupled receptor agonist	GPBAR1			Tocris	87.66	BRD-K16939217-001-01-3	Preclinical
TC-G-1008	G protein-coupled receptor agonist	GPR39			Tocris	98.28	BRD-K87199310-001-01-4	Preclinical
TC-H-106	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC8			Tocris	89.32	BRD-K45044657-001-02-2	Preclinical
TC-I-15	integrin inhibitor	ITGA2, ITGB1			Tocris	96.07	BRD-K17621556-001-01-5	Preclinical
TC-I-2000	transient receptor potential channel antagonist	TRPM8			Tocris	96.49	BRD-A83792282-001-01-6	Preclinical
TC-I-2014	transient receptor potential channel antagonist	TRPM8			Tocris	94.45	BRD-K05262258-001-01-3	Preclinical
TC-LPA5-4	lysophosphatidic acid receptor antagonist	LPAR5			Tocris	96.94	BRD-K32031961-001-01-7	Preclinical
TC-Mps1-12	monopolar spindle 1 kinase inhibitor	TTK			Tocris	98.5	BRD-K76792630-001-01-2	Preclinical
TC-N-1752	sodium channel blocker	SCN9A			Tocris	98.27	BRD-K78161388-001-01-2	Preclinical
TC-NTR1-17	neurotensin agonist	NTSR1			Tocris	98.19	BRD-K79608170-001-02-1	Preclinical
TC-O-9311	G protein-coupled receptor agonist	GPR139			Tocris	86.77	BRD-K54297077-001-01-8	Preclinical
TC-OT-39	oxytocin receptor agonist, vasopressin receptor agonist	AVPR1A, OXT			Tocris	96.28	BRD-K55013981-001-01-3	Preclinical
TC-S-7003	src inhibitor	LCK			Tocris	94.27	BRD-K34362291-001-01-5	Preclinical
TC-S-7004	DYRK inhibitor	DYRK1A, DYRK1B			Tocris	95.75	BRD-K89517477-001-01-4	Preclinical
TC-S-7005	PLK inhibitor	PLK2			Tocris	99.07	BRD-K89584803-001-01-9	Preclinical
TC-S-7006	MAP kinase inhibitor	MAP3K8			Tocris	88.42	BRD-K51776215-001-02-5	Preclinical
TC-S-7009	hypoxia inducible factor inhibitor	EPAS1			Tocris	96.72	BRD-K21894922-001-01-9	Preclinical
TC-SP-14	sphingosine 1 phosphate receptor agonist	S1PR1			Tocris	86.12	BRD-K87461578-001-01-5	Preclinical
TCID					Selleck, Selleck	55.04	BRD-K27536248-001-01-7, BRD-K27536248-001-02-5	Preclinical
TCN-238	glutamate receptor positive allosteric modulator	GRM4			Tocris	90.73	BRD-K77915400-001-01-6	Preclinical
TCN201	glutamate receptor antagonist	GRIN2A			Tocris, Tocris	97.03	BRD-K09787262-001-02-7, BRD-K09787262-001-01-9	Preclinical
TCS-HDAC6-20b	HDAC inhibitor	HDAC6			Tocris	100	BRD-K68358632-001-01-0	Preclinical
TCS-OX2-29	orexin receptor antagonist	HCRTR2			Tocris	84.85	BRD-K29424831-003-02-1	Preclinical
TCS-PIM-1-1	Pim kinase inhibitor	PIM1			Tocris	96.33	BRD-K08902330-001-01-3	Preclinical
TCS-21311	JAK inhibitor	JAK3			Tocris	94.18	BRD-K49461364-001-02-8	Preclinical
TCS-2210	neural stem cell inducer				Tocris	87.06	BRD-K19958299-001-01-1	Preclinical
TCS-2314	integrin inhibitor	ITGA4, ITGB1			Tocris	97.08	BRD-K55216666-001-01-4	Preclinical
TCS-3035	G protein-coupled receptor agonist	GPR35			Tocris	58.4	BRD-K81935556-001-01-0	Preclinical
TCS-359	FLT3 inhibitor	FLT3			Tocris, Selleck, Tocris, Selleck	93.25	BRD-K81376179-001-04-8, BRD-K81376179-001-03-0, BRD-K81376179-001-06-3, BRD-K81376179-001-05-5	Preclinical
TCS-5861528	transient receptor potential channel antagonist	TRPA1			Tocris	97.49	BRD-A16560607-001-02-5	Preclinical
TCS2002	glycogen synthase kinase inhibitor	GSK3B			Tocris, Tocris	98.33	BRD-A50028488-001-01-6, BRD-A50028488-001-02-4	Preclinical
TC1	beta-secretase inhibitor	BACE1			Tocris	95.78	BRD-A13964793-001-02-6	Preclinical
TC2559	acetylcholine receptor agonist	CHRNA4			Tocris, Tocris	75.02	BRD-K24227647-364-02-3, BRD-K24227647-364-01-5	Preclinical
tebipenem	bacterial cell wall synthesis inhibitor	CNR1	infectious disease, otolaryngology	pneumonia, otitis	Selleck	94.38	BRD-K06900071-001-01-2	Launched
tecalcet	calcium-sensing receptor agonist	CASR			Tocris, Cayman	96	BRD-K41662846-003-02-3, BRD-K41662846-003-01-5	Phase 2
tecastemizole	histamine receptor antagonist	KCNH2			ChemPacific	91.7	BRD-K48195801-001-01-6	Phase 3
tecovirimat	orthopoxvirus egress inhibitor				MedChemEx	98.79	BRD-K24312986-001-01-2	Phase 3
tedizolid	bacterial 50S ribosomal subunit inhibitor		infectious disease	skin infections	MedChemEx	98.73	BRD-K59436580-001-01-7	Launched
tedizolid-phosphate	protein synthesis inhibitor		infectious disease	skin infections	MedChemEx, Annova, MedChemEx	94.69	BRD-K89121095-001-02-5, BRD-K89121095-304-01-5, BRD-K89121095-001-01-7	Launched
tegaserod	serotonin receptor partial agonist	HTR2A, HTR2B, HTR2C, HTR4			MicroSource, MedChemEx, Tocris	95.01	BRD-K88743730-050-03-3, BRD-K88743730-050-04-1, BRD-K88743730-050-05-8	Withdrawn
tegobuvir	HCV inhibitor, protease inhibitor				MedChemEx	95.88	BRD-K26701552-001-01-8	Phase 3
teicoplanin	bacterial cell wall synthesis inhibitor				MedChemEx	56.59	BRD-K07712545-001-01-8	Launched
teicoplanin-A2-1	bacterial cell wall synthesis inhibitor				MicroSource	46.55	BRD-A09761158-001-02-1	Launched
teicoplanin-a2-3	bacterial cell wall synthesis inhibitor		infectious disease	gram-positive bacterial infections	Selleck, Selleck	9.36	BRD-K96571715-001-01-4, BRD-U59360347-000-01-3	Launched
Teijin-compound-1	CC chemokine receptor antagonist	CCR2			Tocris	98.07	BRD-K51528698-003-01-4	Preclinical
telaprevir	HCV inhibitor	CTSA, PGR	infectious disease	hepatitis C	Selleck, Selleck	85.93	BRD-K72912098-001-03-1, BRD-K72912098-001-02-3	Launched
telatinib	KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	KDR			Selleck	93.51	BRD-K84564571-001-02-4	Phase 2
telbivudine	DNA polymerase inhibitor	TK2	infectious disease	hepatitis B	Selleck	93.99	BRD-K15976406-001-03-3	Launched
telcagepant	calcitonin antagonist	CALCRL, RAMP1			MedChemEx	96.64	BRD-K91159026-001-01-7	Phase 3
telenzepine	acetylcholine receptor antagonist	CHRM1			MicroSource, Tocris	98.14	BRD-K06147391-003-03-5, BRD-K06147391-300-06-8	Phase 3
telithromycin	bacterial 30S ribosomal subunit inhibitor, bacterial 50S ribosomal subunit inhibitor	CYP1A2, CYP2D6, CYP3A4, CYP3A5, CYP3A7	infectious disease	pneumonia	MicroSource, Cayman	81.67	BRD-A94008949-001-01-9, BRD-K82240271-001-01-8	Launched
telmesteine	mucolytic agent				TCI	96.9	BRD-A05523972-001-01-5	Launched
telmisartan	angiotensin receptor antagonist	AGTR1, PPARG	cardiology	hypertension	MicroSource, Tocris, Selleck	99.08	BRD-K73999723-001-11-3, BRD-K73999723-001-13-9, BRD-K73999723-001-10-5	Launched
telotristat	tryptophan hydroxylase inhibitor	TPH1			MedChemEx	94.93	BRD-K63178091-001-01-1	Launched
telotristat-ethyl	tryptophan hydroxylase inhibitor	TPH1	gastroenterology	diarrhea	MedChemEx, MedChemEx, Selleck	99.27	BRD-K94559059-091-03-2, BRD-K94559059-091-01-6, BRD-K94559059-091-02-4	Launched
temazepam	benzodiazepine receptor agonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3, TSPO			MicroSource	98.97	BRD-A93093700-001-02-9	Withdrawn
temefos	cholinesterase inhibitor				MicroSource	46.31	BRD-K51805276-001-09-3	Launched
temocapril	angiotensin converting enzyme inhibitor	ACE	cardiology, nephrology	hypertension, congestive heart failure, diabetic nephropathy, coronary artery disease (CAD)	Selleck	97.25	BRD-K10784860-003-02-3	Launched
temoporfin	radical formation stimulant		oncology	head and neck squamous cell carcinoma (HNSCC)	MedChemEx	85.6	BRD-K63712959-001-01-8	Launched
temozolomide	DNA alkylating agent	MGMT	oncology	glioblastoma, astrocytoma	Tocris, Tocris, Selleck, MicroSource	97.56	BRD-K32107296-001-20-1, BRD-K32107296-001-15-1, BRD-K32107296-001-14-4, BRD-K32107296-001-16-9	Launched
tempol	free radical scavenger				Selleck, Acros, Selleck	100	BRD-K95053546-001-03-5, BRD-K95053546-001-02-7, BRD-K95053546-001-01-9	Phase 2
temsirolimus	mTOR inhibitor	MTOR	oncology	renal cell carcinoma (RCC)	Selleck	90.63	BRD-K42898655-001-01-8	Launched
tenatoprazole	ATPase inhibitor	IDO1			MicroSource	95.62	BRD-A42270467-001-04-4	Phase 2
teneligliptin	dipeptidyl peptidase inhibitor	DPP4	endocrinology	diabetes mellitus	MedChemEx	96.62	BRD-K48068743-001-01-6	Launched
tenidap	cyclooxygenase inhibitor	KCNJ4, PTGS1			Tocris, Tocris	95.02	BRD-A87479750-001-02-7, BRD-A87479750-001-03-5	Phase 3
tenilsetam	AGE inhibitor				LifeChem, Enamine	59.54	BRD-A41835910-001-01-4, BRD-A41835910-001-02-2	Phase 3
teniposide	topoisomerase inhibitor	TOP2A, TOP2B	hematologic malignancy	acute lymphoblastic leukemia (ALL)	Selleck, MicroSource, Selleck	91.09	BRD-K10362825-001-03-4, BRD-A35588707-001-05-5, BRD-K10362825-001-04-2	Launched
tenofovir	HIV integrase inhibitor, nucleoside reverse transcriptase inhibitor		infectious disease	human immunodeficiency virus (HIV-1), hepatitis B	Selleck, MicroSource, Selleck	100	BRD-K15891719-001-05-1, BRD-K15891719-213-01-1, BRD-K15891719-001-04-4	Launched
tenofovir-alafenamide	nucleoside reverse transcriptase inhibitor				Selleck	93.68	BRD-A25988899-001-01-6	Preclinical
tenofovir-disoproxil	nucleoside reverse transcriptase inhibitor	CYP1A2	infectious disease	human immunodeficiency virus (HIV-1), hepatitis B	Selleck, Selleck	95.24	BRD-K61868322-051-06-4, BRD-K61868322-050-01-7	Launched
tenovin-1	SIRT inhibitor, TP53 activator	SIRT1			Selleck, Selleck, Tocris	95.56	BRD-K05977823-001-04-6, BRD-K05977823-001-03-8, BRD-K05977823-001-05-3	Preclinical
tenovin-6	SIRT inhibitor	SIRT1, SIRT2, SIRT3			Selleck, Selleck	93	BRD-K13949769-001-01-7, BRD-K13949769-003-01-3	Preclinical
tenoxicam	cyclooxygenase inhibitor	PTGS1, PTGS2	rheumatology, orthopedics	rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis, periarthritis	MicroSource, Selleck	98.19	BRD-A22844106-001-26-0, BRD-A22844106-001-25-2	Launched
tenylidone					MicroSource	71.2	BRD-K91298281-001-01-3	Preclinical
tepoxalin	cyclooxygenase inhibitor, lipoxygenase inhibitor	ALOX5	rheumatology, orthopedics	rheumatoid arthritis, hip dysplasia	MicroSource, Toronto	97.32	BRD-K89714990-001-01-5, BRD-K89714990-001-02-3	Launched
TEPP-46	pyruvate kinase isozyme activator	PKM			MedChemEx, MedChemEx	97.55	BRD-A18279961-001-02-0, BRD-A18279961-001-01-2	Preclinical
teprenone	mucus protecting agent		dermatology	cosmetic	MedChemEx, MedChemEx, SantaCruz, SantaCruz	82.34	BRD-K11510141-001-04-2, BRD-K11510141-001-03-4, BRD-K11510141-001-02-6, BRD-K11510141-001-01-8	Launched
terameprocol	lipoxygenase inhibitor	BIRC5, CDK1			Sigma	99.1	BRD-K76788410-001-01-6	Phase 1/Phase 2
terazosin	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, KCNH2, KCNH6, KCNH7	urology, cardiology	benign prostatic hyperplasia (BPH), hypertension	Selleck, Tocris	98.12	BRD-A22256192-310-02-8, BRD-A22256192-003-22-7	Launched
terbinafine	fungal squalene epoxidase inhibitor	SQLE	infectious disease	tinea pedis, tinea cruris, tinea corporis	MicroSource, Selleck, Selleck	98.49	BRD-K68132782-003-14-6, BRD-K68132782-003-13-8, BRD-K68132782-001-03-3	Launched
terbutaline	adrenergic receptor agonist	ADRB2	pulmonary	bronchospasm, bronchitis, emphysema	MedChemEx, MicroSource	93.35	BRD-A50157456-065-21-4, BRD-A50157456-065-20-6	Launched
terciprazine					PrincetonBio	94.14	BRD-A11725667-001-01-8	Phase 1
terconazole	sterol demethylase inhibitor		infectious disease	vulvovaginal candidiasis	MicroSource, Kemprotec	94.91	BRD-K86204871-001-16-2, BRD-K07400595-001-02-7	Launched
terfenadine	histamine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1, KCNH1, KCNH2			MicroSource, Tocris, Selleck	97.86	BRD-A06352418-001-25-9, BRD-A06352418-001-27-5, BRD-A06352418-001-24-2	Withdrawn
terguride	dopamine receptor agonist, serotonin receptor antagonist	ADRA1A, ADRA2A, ADRA2B, ADRA2C, DRD2, DRD3, DRD4, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C			Kemprotec	94.68	BRD-A89207210-001-01-6	Launched
teriflunomide	dihydroorotate dehydrogenase inhibitor	DHODH	neurology/psychiatry	multiple sclerosis	Selleck, Tocris, Selleck	99.84	BRD-A42699921-001-02-8, BRD-A42699921-001-04-4, BRD-A42699921-001-03-6	Launched
terlipressin	vasopressin receptor agonist	AVPR1A, AVPR1B, AVPR2	cardiology	hypotension	Key	86.38	BRD-K73451719-001-01-2	Launched
terodiline	cholinergic receptor antagonist				Sigma	97.58	BRD-A33479817-003-03-7	Phase 3
teroxirone	DNA inhibitor				ChemDiv	100	BRD-A39935389-001-05-9	Phase 1
terpene					MicroSource	0	BRD-K93396439-002-01-2	Preclinical
terreic-acid-(-)	Bruton's tyrosine kinase (BTK) inhibitor	BTK			Tocris	0	BRD-A64228451-001-08-4	Preclinical
terutroban	prostanoid receptor antagonist	TBXA2R			MedChemEx	95.89	BRD-K43975632-001-01-1	Phase 3
tesaglitazar	insulin sensitizer, PPAR receptor agonist	PPARA, PPARG			Tocris, Cayman	96.97	BRD-K15507868-001-04-5, BRD-K15507868-001-03-7	Phase 3
testolactone	aromatase inhibitor	CYP19A1	oncology	breast cancer	MedChemEx	90.38	BRD-K69636617-001-01-7	Launched
testosterone	androgen receptor agonist	AR	endocrinology	hypogonadism	MicroSource	86.8	BRD-A55393291-001-09-9	Launched
testosterone-enanthate	androgen receptor agonist	AR	endocrinology	hypogonadism	Enzo	84.92	BRD-K89657519-001-01-8	Launched
testosterone-propionate	androgen receptor agonist	AR			MicroSource	96.91	BRD-A48720949-001-04-0	Launched
testosterone-undecanoate	androgen receptor agonist	AR	endocrinology	hypogonadism	MedChemEx	88.78	BRD-K70650177-001-01-7	Launched
tetrabenazine	vesicular monoamine transporter inhibitor	DRD2, SLC18A1, SLC18A2	infectious disease, neurology/psychiatry	cholera, Huntington's disease	Tocris, Tocris	93.02	BRD-K95739795-001-04-5, BRD-K95739795-001-03-7	Launched
tetracaine	membrane integrity inhibitor	SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	neurology/psychiatry	anesthetic	Selleck, MicroSource	98.82	BRD-K45071273-003-24-9, BRD-K45071273-003-25-6	Launched
tetracycline	bacterial 30S ribosomal subunit inhibitor	PRNP	infectious disease, dermatology	respiratory tract infections, pneumonia, skin infections, urinary tract infections, acne vulgaris (AV), plague, psittacosis	MedChemEx, Selleck, Selleck, MedChemEx, MicroSource, Sigma	76.62	BRD-A34788695-003-13-6, BRD-A34788695-003-08-6, BRD-A34788695-003-10-2, BRD-A34788695-003-14-4, BRD-A34788695-003-09-4, BRD-A34788695-003-12-8	Launched
tetradecylthioacetic-acid	lipid peroxidase inhibitor				Enzo	97.74	BRD-K47539947-001-03-7	Phase 2
tetraethylenepentamine	superoxide dismutase inhibitor	SOD1, SOD2			Selleck, Selleck	99.86	BRD-K41298358-395-02-6, BRD-K41298358-395-03-4	Phase 2/Phase 3
tetrahydrofolic-acid		ALDH1L1, AMT, ATIC, FOLR2, FTCD, MTFMT, MTHFD1, MTHFD2, MTHFR, MTR, SHMT1, SHMT2			Sigma	0	BRD-A36978621-001-01-9	Launched
tetrahydropapaverine					Selleck	97.58	BRD-A91831168-003-02-5	Preclinical
tetrahydrouridine	cytidine deaminase inhibitor	CDA			EMDBio	100	BRD-A86248581-001-01-4	Phase 2
tetrahydrozoline	adrenergic receptor agonist		ophthalmology	eye irritation	Selleck, MicroSource	97.32	BRD-A28856712-003-25-2, BRD-A28856712-003-26-0	Launched
tetramethylthiuram-monosulfide					AKSci	94.7	BRD-K36889451-001-01-1	Preclinical
tetramisole	immunostimulant		infectious disease	gastrointestinal parasites	MicroSource, Selleck	99.58	BRD-A46393198-003-16-6, BRD-A46393198-003-15-8	Launched
tetrandrine	calcium channel blocker	SLC6A3			Selleck, Selleck	97.19	BRD-K08078237-001-19-8, BRD-K08078237-001-20-6	Preclinical
tetrazol-5-yl-glycine-(RS)	glutamate receptor agonist	GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D			Tocris	0	BRD-A14757586-001-03-2	Preclinical
tetrindole	monoamine oxidase inhibitor	MAOA			Tocris, Tocris	93.92	BRD-A52660433-066-03-9, BRD-A52660433-066-02-1	Phase 3
tetroquinone					MicroSource	0	BRD-K90177246-001-05-5	Preclinical
tezacaftor	CFTR channel agonist		pulmonary	cystic fibrosis	Selleck	96.27	BRD-K97101532-001-02-8	Launched
TFC-007	prostaglandin inhibitor	HPGDS			Tocris	95.55	BRD-K57708067-001-01-3	Preclinical
TG-003	CLK inhibitor	CLK1, CLK4, DYRK1A, DYRK1B			Selleck	96.35	BRD-K97072811-001-11-4	Preclinical
TG-02	CDK inhibitor, FLT3 inhibitor, JAK inhibitor	CDK1, CDK2, CDK7, CDK9, FLT3, JAK2			MedChemEx	96.17	BRD-K14560436-001-01-4	Phase 1
TG-100572	src inhibitor, VEGFR inhibitor	KDR, SRC			MedChemEx	89.41	BRD-K18424115-003-01-3	Preclinical
TG-100713	PI3K inhibitor				Selleck	92.96	BRD-K46392623-001-02-5	Preclinical
TG-100801	src inhibitor, VEGFR inhibitor	FGFR1, FLT1, KDR, SRC			MedChemEx	89.33	BRD-K12735121-001-01-4	Phase 2
TG-101209	JAK inhibitor	JAK2, JAK3			Selleck	94.67	BRD-K39841531-001-02-1	Preclinical
TG-101348	FLT3 inhibitor, JAK inhibitor	BRD4, JAK1, JAK2, JAK3, TYK2			Selleck, Selleck	91.26	BRD-K12502280-001-11-4, BRD-K12502280-001-08-0	Phase 3
TGR-1202	PI3K inhibitor				MedChemEx	94.1	BRD-K52579889-001-01-9	Phase 3
TGX-221	PI3K inhibitor	PIK3CB, PIK3CD			Selleck, Selleck	91.18	BRD-A41692738-001-10-0, BRD-A41692738-001-07-6	Preclinical
TG100-115	PI3K inhibitor	PIK3CA, PIK3CB, PIK3CD, PIK3CG			Selleck	94.74	BRD-K64785675-001-04-0	Phase 1/Phase 2
TH-302	DNA alkylating agent				MedChemEx	88.37	BRD-K20958582-001-01-4	Phase 3
thaliblastine	DNA inhibitor				InterBioScreen	0	BRD-K87548127-300-01-1	Phase 2
thalidomide	tumor necrosis factor production inhibitor	CRBN, FGFR2, NFKB1, ORM1, ORM2, PTGS2, TNF			Tocris, Selleck	99	BRD-A93255169-001-28-3, BRD-A93255169-001-27-5	Launched
theobromine	phosphodiesterase inhibitor	ADORA1, ADORA2A, PDE4B			Selleck, MicroSource	98.78	BRD-K34888156-001-11-2, BRD-K34888156-213-01-4	Launched
theophylline	adenosine receptor antagonist		pulmonary	asthma, emphysema, bronchitis	MicroSource	98.81	BRD-K97799481-001-16-0	Launched
thiamet-g	GLCNAC phosphotransferase inhibitor	MGEA5			Tocris, Selleck	95.3	BRD-K38380126-001-02-2, BRD-K38380126-001-01-4	Preclinical
thiamine	vitamin B	SLC19A2, SLC19A3, TPK1	metabolism	thiamine deficiency	Selleck, MicroSource	96.41	BRD-K95785345-300-14-8, BRD-K95785345-300-15-5	Launched
thiamine-pyrophosphate					ChemImpex	0	BRD-A09994331-003-02-4	Launched
thiamphenicol	bacterial 50S ribosomal subunit inhibitor		infectious disease	pelvic inflammatory disease	MicroSource, Selleck	98.69	BRD-K79711234-001-18-3, BRD-K79711234-001-17-5	Launched
thiamylal	glutamate receptor antagonist	GABRA1, KCNJ11, KCNJ8	neurology/psychiatry	sedative	MicroSource	52.77	BRD-A23970436-236-04-2	Launched
thiazovivin	rho associated kinase inhibitor				Selleck	96.94	BRD-K03164761-001-02-1	Preclinical
thiethylperazine	dopamine receptor antagonist	DRD1, DRD2, DRD4	gastroenterology	nausea	Prestwick	91.84	BRD-K69600043-328-05-5	Launched
thiocolchicoside	GABA receptor antagonist	GABRA1, GABRB2, GABRG2, GLRA1, GLRB	neurology/psychiatry	muscle relaxant	Prestwick	96.58	BRD-K26619122-001-02-1	Launched
thioctic-acid	reducing agent	ACHE, LIAS, LIPT1, PTGS2, SLC5A6			MicroSource	94.83	BRD-A16347691-001-13-1	Launched
thiodiglycol					MicroSource	95.75	BRD-K54521836-001-02-1	Preclinical
thioguanine	purine antagonist	IMPDH1, IMPDH2	hematologic malignancy	acute myeloid leukemia (AML)	Selleck, MicroSource, MicroSource	100	BRD-K49350383-001-13-7, BRD-K49350383-001-14-5, BRD-K49350383-001-15-2	Launched
thiomersal	other antibiotic	OXCT1			MicroSource	95.81	BRD-K61443650-236-13-1	Launched
thiopental	GABA receptor antagonist	CHRNA4, CHRNA7, FAAH, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GRIA2, GRIK2	neurology/psychiatry	anesthetic	Key, MicroSource	63.17	BRD-A72603112-236-05-7, BRD-A72603112-236-04-0	Launched
thioperamide	histamine receptor antagonist	HRH3, HRH4			Tocris, Tocris	98.59	BRD-K63874012-001-03-7, BRD-K63874012-001-02-9	Preclinical
thiophanate					Sigma, MicroSource	94.28	BRD-K90168339-001-09-4, BRD-K90168339-001-08-6	Preclinical
thioproperazine	dopamine receptor antagonist	ADRA1A, ADRA1B, DRD1, DRD2, HTR1A, HTR2A	neurology/psychiatry	schizophrenia	Prestwick	77.82	BRD-K08619574-334-05-4	Launched
thioridazine	dopamine receptor antagonist	ADRA1A, ADRA1B, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR2A, HTR2C, HTR6, HTR7, KCNH2			Selleck, MicroSource	91.42	BRD-A84481105-003-31-3, BRD-A84481105-003-32-1	Withdrawn
thiorphan	membrane metalloendopeptidase inhibitor	MME			Sigma, Enzo	38.61	BRD-A56012032-001-15-5, BRD-A56012032-001-14-8	Phase 1
thiostrepton	FOXM1 inhibitor, protein synthesis inhibitor	FOXM1	obstetrics/gynecology	mastitis	MicroSource, MedChemEx, MedChemEx, Selleck, Selleck	96.6	BRD-A20697603-001-07-2, BRD-K58049875-001-03-9, BRD-K58049875-001-01-3, BRD-K58049875-001-02-1, BRD-K58049875-001-04-7	Launched
thiotepa	cytochrome P450 inhibitor	CYP2B6, CYP3A4	oncology	breast cancer, ovarian cancer, bladder cancer	MedChemEx, MicroSource, MedChemEx	77.41	BRD-K09631521-001-12-3, BRD-K09631521-001-09-9, BRD-K09631521-001-11-5	Launched
thiothixene	dopamine receptor antagonist	DRD1, DRD2, HRH1, HTR2A	neurology/psychiatry	schizophrenia	MicroSource	92.31	BRD-K97309399-001-09-4	Launched
thiram		JAK2	ophthalmology	contact dermatitis	MicroSource	97.98	BRD-K29254801-001-14-7	Launched
thonzonium	ATPase inhibitor				MicroSource, Selleck	94.95	BRD-K13387373-004-15-2, BRD-K13387373-004-14-5	Launched
thonzylamine	antihistamine		neurology/psychiatry	itching	MicroSource	91.69	BRD-K88405679-003-03-1	Launched
threo-2-methylisocitrate-(DL)	isocitrate lyase substrate				MedChemEx	93.35	BRD-M01344114-348-01-0	Preclinical
thymol	GABA receptor positive allosteric modulator	TRPA1			Enamine	0	BRD-K17458574-001-07-7	Launched
thymol-iodide					SantaCruz	50.02	BRD-K36617478-001-01-5	Preclinical
THZ1	CDK inhibitor	CDK7			MedChemEx	90.84	BRD-K66401437-001-03-3	Preclinical
THZ1-R	CDK inhibitor	CDK7			MedChemEx	90.43	BRD-K02135007-001-01-8	Preclinical
THZ2	CDK inhibitor	CDK7			MedChemEx	90.03	BRD-K95902121-001-01-0	Preclinical
TH588	MTH1 inhibitor	NUDT1			MedChemEx	97.39	BRD-K01054709-001-01-3	Preclinical
tiabendazole	angiogenesis inhibitor		infectious disease	gastrointestinal roundworms, hookworm	Selleck, MicroSource	99.12	BRD-K77695569-001-29-2, BRD-K77695569-001-30-0	Launched
tiagabine	GABA uptake inhibitor	SLC6A1	neurology/psychiatry	seizures	Tocris, Enzo	95.06	BRD-K60160658-003-12-0, BRD-K60160658-003-11-2	Launched
tianeptine	selective serotonin reuptake enhancer (SSRE)	OPRD1, OPRK1, OPRM1	neurology/psychiatry, pulmonary, gastroenterology	depression, asthma, irritable bowel syndrome	Selleck, MedChemEx, MedChemEx, MedChemEx, Selleck, Tocris	98.15	BRD-A53077924-236-07-1, BRD-A53077924-001-02-0, BRD-A53077924-236-09-7, BRD-A53077924-001-01-2, BRD-A53077924-236-05-5, BRD-A53077924-236-06-3	Launched
tiapride	dopamine receptor antagonist	DRD2, DRD3	neurology/psychiatry	dyskinesia, abstinence from alcohol, psychosis	MicroSource	98.27	BRD-K57432881-003-21-8	Launched
tiaprofenic-acid	cyclooxygenase inhibitor	PTGS1, PTGS2	rheumatology	rheumatoid arthritis	Prestwick, Sigma	94.01	BRD-A72988804-001-10-3, BRD-A72988804-001-11-1	Launched
tiaramide	anti-inflammatory agent		pulmonary	asthma	Sigma	99.54	BRD-K27293958-001-01-5	Launched
tibolone	androgen receptor agonist, estrogen receptor agonist, progesterone receptor agonist	ESR1	obstetrics/gynecology	endometriosis	MicroSource	85	BRD-A82522119-001-01-7	Launched
ticagrelor	purinergic receptor antagonist	P2RY12	cardiology	acute coronary syndrome (ACS), myocardial infarction	Selleck	97.56	BRD-K44974079-001-01-3	Launched
ticarcillin	lactamase inhibitor		infectious disease	gram-negative bacterial infections	Selleck, Selleck, MedChemEx, MicroSource	0	BRD-K29229654-304-02-0, BRD-K29229654-304-03-8, BRD-A55051145-304-03-2, BRD-K29229654-304-04-6	Launched
ticlopidine	purinergic receptor antagonist	P2RY12	hematology, neurology/psychiatry	thrombosis, stroke	MicroSource, Selleck	98.54	BRD-K00603606-003-24-0, BRD-K00603606-003-23-2	Launched
TIC10	AKT inhibitor, TRAIL modulator	AKT1, MAPK1			Selleck, Selleck	98.82	BRD-K01115818-001-01-0, BRD-K19939891-001-05-4	Phase 2
tideglusib	glycogen synthase kinase inhibitor	GSK3B			Selleck, Selleck	96.84	BRD-K81330143-001-02-2, BRD-K81330143-001-04-8	Phase 2
tienilic-acid	sodium/potassium/chloride transporter inhibitor, cytochrome P450 inhibitor	CYP2C9, SLC12A1			Sigma	99.16	BRD-K34098590-001-02-1	Withdrawn
tie2-kinase-inhibitor	TIE tyrosine kinase inhibitor	KDR, MAPK14			Selleck	93.18	BRD-A92800748-001-05-5	Preclinical
tifenazoxide	ATP-sensitive potassium channel agonist	ABCC8, KCNJ11			Sigma	94.29	BRD-K20568871-001-01-1	Phase 1
tigecycline	bacterial 30S ribosomal subunit inhibitor		infectious disease	skin infections, pneumonia, intra-abdominal infections	Selleck, MedChemEx, MedChemEx, Selleck, Sigma, MedChemEx, MicroSource	26.42	BRD-A34462049-001-09-3, BRD-A34462049-001-14-3, BRD-A34462049-001-13-5, BRD-A34462049-001-15-0, BRD-A34462049-001-11-9, BRD-A34462049-001-12-7, BRD-A34462049-001-08-5	Launched
tiletamine	glutamate receptor antagonist		neurology/psychiatry	anesthetic	MicroSource	96.29	BRD-A30582499-003-05-1	Launched
tilmicosin	bacterial 50S ribosomal subunit inhibitor		pulmonary	bovine respiratory disease (BRD)	MicroSource, Selleck	98.67	BRD-K26634012-001-03-1, BRD-K26634012-001-04-9	Launched
tilorone	interferon inducer		infectious disease, gastroenterology, neurology/psychiatry	influenza A virus infection, diarrhea, hepatitis B, multiple sclerosis, urinary tract infections, virus herpes simplex (HSV), hepatitis C	MicroSource	86.28	BRD-K34568562-001-04-3	Launched
tiludronate	bone resorption inhibitor, osteoclast inhibitor	ATP6V1A, MMP2, PTPN1	orthopedics	navicular syndrome	Enzo	100	BRD-K10845183-304-01-6	Launched
timofibrate	cholesterol inhibitor, lipase clearing factor inhibitor	LPL			Enamine	98.06	BRD-A64406146-001-01-2	Phase 2
timolol	adrenergic receptor antagonist	ADRB1, ADRB2	ophthalmology	ocular hypertension, glaucoma	MicroSource, Tocris, Selleck	97.45	BRD-K30421593-050-04-9, BRD-K08806317-050-29-1, BRD-K08806317-051-01-8	Launched
timonacic	antioxidant	ANXA5			MicroSource	100	BRD-A38592941-001-02-7	Launched
tinidazole	antiprotozoal agent		infectious disease, obstetrics/gynecology	giardiasis, amebiasis, bacterial vaginosis, trichomoniasis	Selleck, MicroSource, Selleck	98.57	BRD-K89125793-001-25-2, BRD-K89125793-001-26-0, BRD-K89125793-001-27-8	Launched
tioconazole	sterol demethylase inhibitor	CYP51A1	infectious disease	yeast infection	MicroSource, Selleck	98.01	BRD-A33084557-001-07-4, BRD-A33084557-001-06-6	Launched
tioguanine	purine antagonist				Prestwick	100	BRD-K75649340-001-13-1	Phase 2
tiopronin	chelating agent, reducing agent		urology	kidney stones	MedChemEx, Sigma, Selleck, MicroSource, Selleck	91.45	BRD-A85295731-001-06-4, BRD-A85295731-001-05-6, BRD-A85295731-001-02-3, BRD-A85295731-001-03-1, BRD-A85295731-001-04-9	Launched
tiotidine	histamine receptor antagonist	HRH2			Tocris, Tocris	97.92	BRD-K15071410-001-03-7, BRD-K15071410-001-01-1	Phase 2
tiotropium	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3	pulmonary	chronic obstructive pulmonary disease (COPD), bronchitis, emphysema	Selleck	90.47	BRD-K62782754-337-02-5	Launched
tioxolone	carbonic anhydrase inhibitor	CA2			MicroSource, Selleck	93.15	BRD-K41876534-001-13-7, BRD-K41876534-001-12-9	Preclinical
tipifarnib	farnesyltransferase inhibitor	FNTA, FNTB			Selleck	96.02	BRD-K62965247-001-04-9	Phase 3
tipiracil	thymidine phosphorylase inhibitor	TYMP	oncology	colorectal cancer	MedChemEx	92.57	BRD-K11973162-003-01-8	Launched
tiplaxtinin	plasminogen activator inhibitor	SERPINE1			Tocris, MedChemEx	91.15	BRD-K30882994-001-02-4, BRD-K30882994-001-01-6	Phase 1
tipranavir	HIV protease inhibitor		infectious disease	human immunodeficiency virus (HIV-1)	MedChemEx, MedChemEx	88.06	BRD-A10039652-001-02-0, BRD-A10039652-001-01-2	Launched
tiprenolol	adrenergic receptor antagonist	ADRB1, ADRB2, ADRB3			Enamine	96.46	BRD-A73566563-001-01-6	Phase 2
tiquizium	acetylcholine receptor antagonist		neurology/psychiatry	spasms	AKSci	97.14	BRD-K77552740-004-01-0	Launched
tiracizine	sodium channel blocker	SCN5A			ChemDiv	98.01	BRD-K75250001-001-01-3	Withdrawn
tirapazamine	DNA inhibitor				Adooq, MedChemEx	95.16	BRD-K92968657-001-02-4, BRD-K92968657-001-01-6	Phase 3
tirasemtiv	troponin activator				MedChemEx	99.62	BRD-K51087630-001-01-6	Phase 2
tiratricol	thyroid hormone stimulant	THRA, THRB	endocrinology	Refetoff syndrome	Selleck, MicroSource	92.5	BRD-K61236135-001-08-2, BRD-K61236135-001-09-0	Launched
tirofiban	platelet aggregation inhibitor, structural glycoprotein antagonist	ITGA2B, ITGB3	cardiology	myocardial infarction, refactory angina	Enzo	97.97	BRD-K37872686-003-01-9	Launched
titanocene-dichloride	apoptosis stimulant				Oakwood	98.9	BRD-K60284353-001-01-3	Phase 2
tivantinib	tyrosine kinase inhibitor	MET			MedChemEx	98.79	BRD-K33379087-001-07-5	Phase 3
tivozanib	VEGFR inhibitor	FLT1, FLT4, KDR, KIT, PDGFRA, PDGFRB			Selleck	97.41	BRD-K53414658-001-08-2	Phase 3
tizanidine	adrenergic receptor agonist	ADRA2A, ADRA2B, ADRA2C, NISCH	neurology/psychiatry	spasms	Tocris, Tocris, Selleck	98.81	BRD-K06335600-003-20-7, BRD-K06335600-003-22-3, BRD-K06335600-003-19-9	Launched
TMC-353121	RSV fusion inhibitor				MedChemEx	93.17	BRD-K66097663-001-01-8	Phase 2
TMC647055	RNA polymerase inhibitor				MedChemEx	97.37	BRD-K49659468-436-01-2	Phase 2
TMN-355	cyclophilin inhibitor	PPIA			Tocris	94.31	BRD-K24527118-001-01-6	Preclinical
TMPH					Tocris, Tocris	100	BRD-K49119234-003-02-6, BRD-K49119234-003-03-4	Preclinical
TMS					Tocris, Tocris	89.41	BRD-K96233303-001-02-7, BRD-K96233303-001-01-9	Preclinical
TNP-470	methionine aminopeptidase inhibitor				Sigma	75.74	BRD-K53597484-001-02-7	Phase 2
tobramycin	bacterial 30S ribosomal subunit inhibitor		infectious disease	bacterial septicemia, respiratory tract infections, meningitis, skin infections, urinary tract infections	MicroSource, Selleck	100	BRD-K05619559-001-10-1, BRD-K05619559-001-12-7	Launched
tocainide	sodium channel blocker	SCN5A	cardiology	cardiac arrythmia	MicroSource	96.83	BRD-A92670106-003-05-4	Launched
toceranib	protein tyrosine kinase inhibitor	FLT1, FLT3, KDR, PDGFRA, PDGFRB	oncology	cutaneous mast cell tumors, cutaneous mast cell tumors	MedChemEx, MedChemEx, MedChemEx	92.31	BRD-K62040061-001-01-0, BRD-K62040061-011-02-7, BRD-K62040061-011-01-9	Launched
tocofersolan	antioxidant		cardiology	cerebral cholesterosis	MedChemEx, MedChemEx	0	BRD-A39830855-001-01-6, BRD-K57305459-001-01-4	Launched
todralazine	antihypertensive agent				MicroSource	89.59	BRD-K68553471-003-12-3	Launched
tofacitinib	JAK inhibitor	JAK1, JAK2, JAK3, TYK2	rheumatology	rheumatoid arthritis	Selleck, Selleck, Tocris	98.2	BRD-K31283835-001-08-4, BRD-K31283835-048-04-4, BRD-K31283835-048-03-6	Launched
tofisopam	phosphodiesterase inhibitor, cytochrome P450 inhibitor	CYP3A4, PDE10A, PDE2A, PDE3A, PDE4A	neurology/psychiatry	anxiety, abstinence from alcohol	Sigma	80.14	BRD-K94830213-001-01-3	Launched
tofogliflozin	sodium/glucose cotransporter inhibitor	GCK	endocrinology	diabetes mellitus, diabetes mellitus	MedChemEx, MedChemEx	95.64	BRD-K96344439-002-02-7, BRD-K96344439-002-01-9	Launched
tolamolol	adrenergic receptor antagonist	ADRB1, ADRB2, ADRB3			Sigma	94.9	BRD-A60498477-001-01-2	Phase 3
tolazamide	ATP channel blocker	ABCC8, KCNJ1, KCNJ10, KCNJ11	endocrinology	diabetes mellitus	Selleck, Selleck, MicroSource	97.65	BRD-K32164935-001-29-0, BRD-K32164935-001-31-6, BRD-K32164935-001-30-8	Launched
tolazoline	adrenergic receptor antagonist	ADRA1A, ADRA2A, ADRA2B, ADRA2C, HRH1, HRH2	neurology/psychiatry	reverse sedative	MicroSource, Selleck	98.11	BRD-K46211610-003-26-7, BRD-K46211610-003-25-9	Launched
tolbutamide	ATP channel blocker	ABCC8, KCNJ1, KCNJ11, KCNJ8	endocrinology	diabetes mellitus	MicroSource, Selleck	98.93	BRD-K85119730-001-28-9, BRD-K85119730-001-27-1	Launched
tolcapone	catechol O methyltransferase inhibitor	COMT			Selleck, Selleck	99.4	BRD-K10852020-001-04-5, BRD-K10852020-001-05-2	Withdrawn
tolfenamic-acid	cyclooxygenase inhibitor, prostanoid receptor antagonist		neurology/psychiatry	migraine headache	MicroSource, Selleck	98.71	BRD-K50133271-001-18-7, BRD-K50133271-001-17-9	Launched
tolimidone	src activator	LYN, SRC			Axon, Tocris	99.28	BRD-K41772907-001-01-2, BRD-K41772907-001-02-0	Phase 2
tolmetin	cyclooxygenase inhibitor	PTGS1, PTGS2	rheumatology	rheumatoid arthritis, osteoarthritis	Selleck, MicroSource	98.68	BRD-K82562631-325-04-7, BRD-K82562631-236-04-6	Launched
tolnaftate	fungal squalene epoxidase inhibitor		infectious disease	tinea pedis, tinea corporis	MicroSource, Selleck	99.91	BRD-K44273375-001-25-0, BRD-K44273375-001-24-3	Launched
tolonidine	adrenergic receptor antagonist	ADRA2A			Enamine	98.87	BRD-K82687598-001-01-6	Launched
tolonium			hematology	methemoglobinemia	MicroSource	48.61	BRD-K94882685-003-09-2	Launched
toloxatone	monoamine oxidase inhibitor	MAOA, MAOB	neurology/psychiatry	depression	Sigma	99.02	BRD-A67182178-001-01-7	Launched
tolperisone	voltage-gated sodium channel blocker	CYP2C19, CYP2D6	neurology/psychiatry, infectious disease, rheumatology, cardiology	muscle relaxant, multiple sclerosis, encephalomyelitis, ankylosing spondylitis, atherosclerosis, Raynaud's disease	MicroSource, Selleck	97.96	BRD-A27732521-003-08-3, BRD-A27732521-003-07-5	Launched
tolrestat	aldose reductase inhibitor	AKR1A1, AKR1B1, AKR1B10			MedChemEx, MedChemEx, MedChemEx	89.37	BRD-K85693895-001-01-1, BRD-K85693895-001-02-9, BRD-K85693895-001-03-7	Withdrawn
tolterodine	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	urology	urinary incontinence, urinary frequency	Tocris, Selleck, Selleck	90.63	BRD-K54316499-046-06-0, BRD-K54316499-046-05-2, BRD-K54316499-046-04-5	Launched
toltrazuril	antiprotozoal agent		infectious disease	coccidiosis	MicroSource, Selleck	99.46	BRD-K64514229-001-05-2, BRD-K64514229-001-04-5	Launched
tolvaptan	vasopressin receptor antagonist	AVPR1A, AVPR2	endocrinology, cardiology, gastroenterology	hyponatremia, congestive heart failure, hepatic cirrhosis	Tocris, Selleck	98.54	BRD-A82035391-001-03-5, BRD-A82035391-001-02-7	Launched
tomelukast	leukotriene receptor antagonist	CYSLTR1			Enzo	94.74	BRD-K74765201-001-16-7	Phase 3
tonabersat	gap junction modulator, nitric oxide production inhibitor				MedChemEx	99.82	BRD-K36970462-001-01-6	Phase 2
topiramate	carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist	CA1, CA12, CA2, CA4, CA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	neurology/psychiatry	epilepsy, migraine headache	Tocris, Tocris, MicroSource, Selleck	100	BRD-K29653726-001-16-7, BRD-K29653726-001-14-2, BRD-K29653726-001-15-9, BRD-K29653726-001-13-4	Launched
topiroxostat	xanthine oxidase inhibitor	XDH	rheumatology, nephrology	gout, hyperuricemia	MedChemEx	99.78	BRD-K77561571-001-01-1	Launched
topotecan	topoisomerase inhibitor	TOP1, TOP1MT	oncology	small cell lung cancer, cervical cancer	Selleck, MedChemEx, MicroSource, Key, MedChemEx, Selleck	76.92	BRD-K55696337-003-22-8, BRD-K55696337-003-25-1, BRD-K55696337-003-21-0, BRD-K55696337-003-23-6, BRD-K55696337-003-24-4, BRD-K55696337-003-20-2	Launched
torasemide	electrolyte reabsorption inhibitor, thromboxane receptor antagonist	SLC12A1	cardiology	edema, congestive heart failure, hypertension	MicroSource, Selleck	99.36	BRD-K30480208-001-18-5, BRD-K30480208-001-17-7	Launched
torcetrapib	cholesteryl ester transfer protein inhibitor	CETP			Tocris, Selleck	96.12	BRD-K55675242-001-02-2, BRD-K55675242-001-03-0	Phase 3
torcitabine	DNA polymerase inhibitor	DCK, TK2			MedChemEx	100	BRD-K91822704-003-07-2	Phase 2
toremifene	estrogen receptor antagonist, selective estrogen receptor modulator (SERM)	ESR1	oncology	breast cancer	MicroSource, Selleck, Selleck	97.25	BRD-K51350053-048-16-5, BRD-K51350053-048-17-3, BRD-K51350053-048-15-7	Launched
torin-1	mTOR inhibitor	MTOR			Selleck, Selleck	95.98	BRD-K40175214-001-11-6, BRD-K40175214-001-13-2	Preclinical
torin-2	mTOR inhibitor	MTOR			Selleck, Tocris	97.22	BRD-K68174511-001-06-6, BRD-K68174511-001-08-2	Preclinical
tosedostat	peptidase inhibitor	ANPEP, LAP3, NPEPPS			Selleck, Tocris, Tocris, Selleck	93.96	BRD-K92241597-001-09-4, BRD-K92241597-001-06-0, BRD-K92241597-001-11-0, BRD-K92241597-001-05-2	Phase 2
tosufloxacin	bacterial DNA gyrase inhibitor		infectious disease	gram-negative bacterial infections	Prestwick, TCI	98.13	BRD-A41450521-003-02-7, BRD-A41450521-075-10-8	Launched
toyocamycin	serine/threonine kinase inhibitor	ERN1			Sigma	99.13	BRD-K26420709-001-01-7	Phase 1
tozadenant	adenosine receptor antagonist	ADORA2A			MedChemEx	96.14	BRD-K93045741-001-01-0	Phase 3
tozasertib	Aurora kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, JAK inhibitor	AURKA, AURKB, AURKC, LCK			Selleck, Selleck	97.69	BRD-K59369769-001-23-7, BRD-K59369769-001-20-3	Phase 2
TP-003	GABA receptor inverse agonist	GABRA1, GABRA2, GABRA3, GABRA5			Tocris	94.29	BRD-K87941707-001-01-0	Preclinical
TP-0903	AXL kinase inhibitor	AXL			MedChemEx	96.12	BRD-K84034737-001-01-1	Preclinical
TPCA-1	IKK inhibitor	IKBKB			Tocris, Tocris, Selleck	98.3	BRD-K51575138-001-15-7, BRD-K51575138-001-13-2, BRD-K51575138-001-12-4	Preclinical
TPPS4					Vitas-M	82.5	BRD-K39805756-001-01-6	Phase 1
tracazolate	GABA receptor modulator	GABRA1			Tocris	98.96	BRD-K34154330-003-06-4	Phase 2
TRAM-34	potassium channel antagonist	KCNN4			MedChemEx, MedChemEx	0	BRD-K30071764-001-03-0, BRD-K30071764-001-02-2	Preclinical
TRAM-39	calcium-activated potassium channel activator	KCNN4			Tocris	93.57	BRD-K81341251-001-01-9	Preclinical
tramadol	norepinephrine reputake inhibitor, opioid receptor agonist, serotonin reuptake inhibitor	CHRFAM7A, CHRM3, GRIN3A, HTR2C, OPRD1, OPRK1, OPRM1, SLC6A2, SLC6A4	neurology/psychiatry	acute pain, chronic pain	MicroSource	96.17	BRD-K51033547-003-02-6	Launched
trametinib	MEK inhibitor	MAP2K1, MAP2K2	oncology	melanoma	Selleck, MedChemEx, Selleck, Selleck	94.67	BRD-K12343256-001-18-8, BRD-K12343256-001-14-7, BRD-K12343256-001-11-3, BRD-K12343256-001-08-9	Launched
tramiprosate	beta amyloid protein neurotoxicity inhibitor	APP			MicroSource	100	BRD-K82234479-001-09-4	Phase 3
trandolapril	angiotensin converting enzyme inhibitor	ACE	cardiology	hypertension, myocardial infarction	MicroSource	96.92	BRD-A32505112-001-04-4	Launched
tranexamic-acid	antifibrinolytic, plasminogen activator inhibitor	PLG	hematology	hemophilia	MedChemEx, MedChemEx, MicroSource, Selleck, Selleck	97	BRD-K15014948-001-11-1, BRD-K15014948-001-10-3, BRD-K15014948-213-01-3, BRD-K15014948-001-09-5, BRD-K15014948-001-12-9	Launched
tranilast	angiogenesis inhibitor	HPGDS, HRH1	pulmonary	asthma	Selleck, Tocris, MicroSource, Selleck, Tocris	99.75	BRD-K17849083-001-32-9, BRD-K17849083-001-34-5, BRD-K17849083-001-31-1, BRD-K17849083-001-29-5, BRD-K17849083-001-30-3	Launched
trans-10,cis-12-Conjugated-linoleic-acid					Cayman	95.61	BRD-K26222048-001-01-7	Launched
trans-2-Undecenoic-acid					AlfaAesar	90.54	BRD-K42959922-001-01-5	Preclinical
trans-4-[8-(3-Fluorophenyl)-1,7-naphthyridin-6-yl]cyclohexanecarboxylic-acid					Key	94.05	BRD-K75080769-001-01-6	Preclinical
trans-4-Hydroxycrotonic-acid	gamma hydroxybutyric acid ligand				Tocris	0	BRD-K91614056-001-02-2	Preclinical
trans-4-Methoxycinnamic-acid					Vitas-M	96.49	BRD-K26273521-001-07-3	Preclinical
tranylcypromine	monoamine oxidase inhibitor	KDM1A, MAOA, MAOB	neurology/psychiatry	depression	Selleck, Tocris, MicroSource, Tocris, Selleck	95.92	BRD-K88809146-003-04-7, BRD-K47029922-003-10-9, BRD-A43974575-065-05-1, BRD-K47029922-003-12-5, BRD-K47029922-003-11-7	Launched
trap-101	nociceptin/orphanin FQ receptor antagonist, opioid receptor antagonist	OPRL1			Tocris, Tocris	97.83	BRD-K69837166-003-02-0, BRD-K69837166-003-03-8	Preclinical
trapidil	PDGFR tyrosine kinase receptor inhibitor	PDGFRA	cardiology	coronary artery disease (CAD)	Prestwick	97.83	BRD-K95763993-001-19-3	Launched
travoprost	prostanoid receptor agonist	PTGFR	ophthalmology	ocular hypertension, glaucoma	Enzo	95.41	BRD-K23976833-001-01-0	Launched
traxoprodil	glutamate receptor antagonist	GRIN2B			EMDBio	93.36	BRD-K38158531-001-02-1	Phase 2
trazodone	adrenergic receptor antagonist, serotonin receptor antagonist, serotonin reuptake inhibitor	ADRA1A, ADRA2A, HRH1, HTR1A, HTR2A, HTR2B, HTR2C, SLC6A4	neurology/psychiatry	depression	MicroSource, Selleck	97.98	BRD-K70778732-003-27-5, BRD-K70778732-003-26-7	Launched
trebenzomine					Sigma	53.54	BRD-A20686268-001-01-4	Phase 2
trelagliptin	dipeptidyl peptidase inhibitor	DPP4	endocrinology	diabetes mellitus	Selleck	94.03	BRD-A88369366-001-01-7	Launched
tremorine	acetylcholine receptor agonist				Prestwick	100	BRD-K08619838-300-05-7	Preclinical
treosulfan	DNA synthesis inhibitor		oncology	ovarian cancer	MedChemEx, MedChemEx	0	BRD-K20902145-001-01-2, BRD-K20902145-001-02-0	Launched
trepibutone	cholinergic receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4	gastroenterology	irritable bowel syndrome	AvaChem	97.79	BRD-K37543758-001-01-3	Launched
trequinsin	phosphodiesterase inhibitor	PDE5A			Tocris, Tocris	96.03	BRD-K84663978-003-02-9, BRD-K84663978-003-03-7	Phase 1
tretazicar	DNA replication inhibitor	NQO2			Sigma	92.47	BRD-K08748705-001-08-2	Phase 2
tretinoin	retinoid receptor agonist, retinoid receptor ligand	ALDH1A1, ALDH1A2, GPRC5A, NR0B1, NR2C2, PPARD, RARA, RARB, RARG, RARRES1, RORB, RORC, RXRB, RXRG	hematologic malignancy	acute promyelocytic leukemia (APL)	MedChemEx, Selleck, Sigma, MedChemEx, Tocris, Selleck, MicroSource	64.55	BRD-K71879491-001-51-5, BRD-K71879491-001-44-0, BRD-K71879491-001-47-3, BRD-K71879491-001-48-1, BRD-K71879491-001-38-2, BRD-K71879491-001-37-4, BRD-K71879491-001-39-0	Launched
triacetin					MicroSource	85.32	BRD-K92844263-001-09-8	Launched
triamcinolone	glucocorticoid receptor agonist	NR3C1, SERPINA6	dermatology	corticosteroid-responsive dermatoses	Selleck, MicroSource, Selleck	94.01	BRD-K77554836-001-11-6, BRD-K77554836-001-14-0, BRD-K77554836-001-13-2	Launched
triamcinolone-acetonide	glucocorticoid receptor agonist, immunosuppressant	NR3C1	dermatology	corticosteroid-responsive dermatoses	MicroSource, Selleck	95.27	BRD-A92439610-001-04-0, BRD-A92439610-001-05-7	Launched
triamterene	sodium channel blocker	SCNN1A, SCNN1B, SCNN1D, SCNN1G	endocrinology, cardiology	hypokalemia, hypertension, edema	MicroSource, Selleck	99.47	BRD-K92049597-001-20-8, BRD-K92049597-001-19-0	Launched
triapine	ribonucleotide reductase inhibitor	RRM1, RRM2			MedChemEx, Selleck, Selleck	99.17	BRD-K01669786-001-03-0, BRD-K01669786-001-01-4, BRD-K01669786-001-02-2	Phase 2
triazolam	GABA benzodiazepine site receptor agonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3, TSPO			Enzo	99.47	BRD-K76890464-001-02-3	Withdrawn
tribenoside	anti-inflammatory agent, capillary stabilizing agent				Prestwick	63.93	BRD-A60294240-001-03-7	Launched
tribomsalan					Vitas-M	97.22	BRD-K09118247-001-03-3	Preclinical
tribromoethanol	analgesic agent				MicroSource	0	BRD-K69632891-001-01-3	Preclinical
tributyrin	HDAC inhibitor				Sigma	0	BRD-K38969488-001-01-6	Phase 1
tricaprylin			dermatology	cosmetic	MicroSource	85.71	BRD-K24790130-001-07-1	Launched
trichlormethiazide	chloride channel blocker	ATP1A1, CA1, CA2, CA4, SLC12A1, SLC12A3	cardiology	hypertension, edema	Selleck, MicroSource, Selleck	100	BRD-A28940325-001-23-2, BRD-A28940325-001-24-0, BRD-A28940325-001-25-7	Launched
trichlormethine	DNA alkylating agent				MicroSource	0	BRD-K29888499-003-03-8	Preclinical
trichloroacetic-acid			dermatology	warts	Enamine, Enamine	0	BRD-K42090719-001-07-3, BRD-K42090719-001-06-5	Launched
trichloroethylene					Sigma, MicroSource	0	BRD-K46435528-001-05-1, BRD-K46435528-001-04-4	Preclinical
trichostatin-a	HDAC inhibitor	HDAC1, HDAC10, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9			Selleck, Selleck	98.67	BRD-K68202742-001-16-5, BRD-K68202742-001-13-2	Preclinical
triciribine	AKT inhibitor	AKT1, AKT2, AKT3			Tocris, Tocris, Selleck, Selleck	93.15	BRD-K80431395-001-04-0, BRD-K80431395-001-08-1, BRD-K80431395-001-09-9, BRD-K80431395-001-07-3	Phase 1/Phase 2
triclabendazole	microtubule inhibitor	DNMT1	infectious disease	tapeworm	MicroSource, Selleck	97.58	BRD-K81916719-001-14-7, BRD-K81916719-001-13-9	Launched
triclocarban	other antibiotic				ChemDiv	97.9	BRD-K25029121-001-05-8	Launched
triclosan	antibacterial agent	DNMT1			MicroSource	99.42	BRD-K41731458-001-15-1	Launched
tridihexethyl	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3	gastroenterology, ophthalmology	peptic ulcer disease (PUD), nystagmus	Prestwick	94	BRD-A22152765-003-10-0	Launched
trientine	chelating agent	CA14	metabolism	Wilson's disease	MicroSource	100	BRD-K37111771-300-02-6	Launched
trifluoperazine	dopamine receptor antagonist	ADRA1A, CALM1, CALY, DRD2, DRD4, HRH1, HTR2A, HTR2C, S100A4, TNNC1	neurology/psychiatry	schizophrenia	Selleck, MicroSource, Selleck	96.64	BRD-K89732114-300-15-4, BRD-K89732114-300-14-7, BRD-K89732114-300-13-9	Launched
triflupromazine	dopamine receptor antagonist	CHRM1, CHRM2, DRD1, DRD2, HTR2B	neurology/psychiatry, gastroenterology	psychosis, nausea, vomiting	MicroSource, Selleck	96.33	BRD-K63675182-003-23-6, BRD-K63675182-003-22-8	Launched
trifluridine	DNA directed DNA polymerase inhibitor, thymidylate synthase inhibitor	TYMS	infectious disease	virus herpes simplex (HSV)	Selleck, Tocris, MicroSource, Selleck	96.52	BRD-K03243820-001-23-8, BRD-K03243820-001-24-6, BRD-K03243820-001-25-3, BRD-K03243820-001-22-0	Launched
triflusal	cyclooxygenase inhibitor, platelet aggregation inhibitor, thromboxane synthase inhibitor	NFKB1, NOS2, PDE10A, PTGS1	neurology/psychiatry, cardiology	stroke, myocardial infarction, atrial fibrillation (AF)	MedChemEx, MedChemEx, Selleck, MedChemEx, Selleck	94.75	BRD-K71696703-001-08-7, BRD-K71696703-001-11-1, BRD-K71696703-001-07-9, BRD-K71696703-001-09-5, BRD-K71696703-001-06-1	Launched
trigonelline					Enzo	100	BRD-K69231085-003-05-7	Phase 1
trihexyphenidyl	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	neurology/psychiatry	parkinsonism	MicroSource	96.17	BRD-A48180038-003-24-3	Launched
trilostane	3beta-hydroxy-delta5-steroid dehydrogenase inhibitor	ESR1, ESR2, HSD3B1, HSD3B2	endocrinology	Cushing's syndrome	MicroSource, MedChemEx, Selleck	99.44	BRD-A04497688-001-05-9, BRD-A04497688-001-03-4, BRD-A04497688-001-04-2	Launched
TRIM					Tocris	0	BRD-K36851334-001-12-1	Preclinical
trimebutine	opioid receptor agonist	OPRD1, OPRK1, OPRM1	gastroenterology	irritable bowel syndrome	MicroSource, Selleck	93.92	BRD-A92630576-050-24-1, BRD-A92630576-001-02-0	Launched
trimeprazine	histamine receptor ligand, histamine receptor antagonist	HRH1	allergy, neurology/psychiatry, pulmonary	urticaria, itching, cough suppressant	Sigma	0	BRD-M58473998-046-01-0	Launched
trimetazidine	3-ketoacyl CoA thiolase inhibitor	ACAA2	cardiology	angina pectoris	MicroSource	93.14	BRD-K88366685-300-06-0	Launched
trimethadione	oxazolidine antiepileptic	CACNA1G, CACNA1H, CACNA1I	neurology/psychiatry	seizures	MicroSource, MedChemEx, MedChemEx, Sigma	12.34	BRD-K16606819-001-10-1, BRD-K16606819-001-13-5, BRD-K16606819-001-12-7, BRD-K16606819-001-11-9	Launched
trimethobenzamide	histamine receptor antagonist	DRD2	gastroenterology	vomiting, nausea, gastroenteritis	MicroSource	98.53	BRD-K34415467-003-13-0	Launched
trimethoprim	dihydrofolate reductase inhibitor	DHFR, TYMS	infectious disease, gastroenterology	urinary tract infections, ear infections, diarrhea	MicroSource, Selleck	98.69	BRD-K07208025-001-31-3, BRD-K07208025-001-29-7	Launched
trimethoquinol	adrenergic receptor antagonist	ADRB2, ADRB3			Sigma	85.22	BRD-A56241705-003-01-2	Launched
trimethylolpropane-triacrylate					Sigma	75.72	BRD-K24483849-001-01-8	Preclinical
trimetozine	sedative		neurology/psychiatry	sedative	MicroSource	99.51	BRD-K53220666-001-02-6	Launched
trimipramine	norepinephrine reputake inhibitor, tricyclic antidepressant	ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD5, HRH1, HTR1A, HTR1D, HTR2A, HTR2C, HTR3A, SLC6A2, SLC6A3, SLC6A4	neurology/psychiatry	depression	MicroSource, Selleck	98.04	BRD-A19195498-050-14-1, BRD-A19195498-050-13-3	Launched
trioxsalen	DNA synthesis inhibitor		dermatology	vitiligo, eczema	MicroSource	97.99	BRD-K54790157-001-15-5	Launched
tripelennamine	histamine receptor antagonist	HRH1	pulmonary, allergy	asthma, allergic rhinitis, urticaria	MicroSource, Selleck	96.93	BRD-K57033106-048-04-4, BRD-K57033106-003-19-7	Launched
triprolidine	histamine receptor antagonist	HRH1	allergy	allergic rhinitis	MicroSource, Tocris	98.84	BRD-K11742128-003-23-4, BRD-K11742128-003-22-6	Launched
triptan	serotonin receptor agonist	HTR1B, HTR1D			Sigma	0	BRD-K19427720-001-01-6	Phase 1
triptolide	RNA polymerase inhibitor	RELA			Selleck, Tocris	97.24	BRD-K39484304-001-16-5, BRD-K39484304-001-14-0	Phase 3
triptorelin	gonadotropin releasing factor hormone receptor agonist	GNRHR	oncology, endocrinology, obstetrics/gynecology	prostate cancer, breast cancer, precocious puberty, endometriosis, myoma, gender dysphoria	Enzo	93.55	BRD-K62685538-001-01-7	Launched
troclosene					MicroSource	0	BRD-K76375510-237-01-1	Launched
trofinetide	cytokine production inhibitor	IFNG, IL6, TNF			Sigma	44.1	BRD-K83502127-001-01-6	Phase 2
troglitazone	insulin sensitizer, PPAR receptor agonist	ACSL4, ESRRA, ESRRG, PPARG, SERPINE1, SLC29A1, TRPM3			Tocris, Enzo	87.12	BRD-A13084692-001-20-7, BRD-A13084692-001-17-3	Withdrawn
troleandomycin	protein synthesis inhibitor		infectious disease, pulmonary, otolaryngology	pneumonia, bronchitis, tonsillitis, sinusitis	MicroSource	100	BRD-A24297246-001-03-9	Launched
trolox	antioxidant				Enzo	76.18	BRD-A17846016-001-13-9	Launched
tromaril	prostanoid receptor antagonist				Enamine	99.33	BRD-K91422571-001-01-8	Launched
trometamol		AMD1, CANT1, DCN, NEIL1, VEGFA			MicroSource, Selleck	100	BRD-K47978074-001-03-2, BRD-K47978074-001-02-4	Launched
tropanyl-3,5-dimethylbenzoate	serotonin receptor antagonist	HTR3A, HTR3B			Tocris	94.98	BRD-A84389633-001-05-7	Preclinical
tropesin	cyclooxygenase inhibitor	PTGS1, PTGS2			Sigma	99.27	BRD-A34603619-001-01-9	Launched
tropicamide	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4	ophthalmology	mydriasis diagnostic, cycloplegia diagnostic	Tocris, Tocris, MicroSource, Selleck	99.63	BRD-A79672927-001-22-3, BRD-A79672927-001-19-9, BRD-A79672927-001-20-7, BRD-A79672927-001-18-1	Launched
tropisetron	serotonin receptor antagonist	GLRA1, GLRA2, GLRB, HTR3A, HTR4	gastroenterology	nausea, vomiting, nausea, vomiting	Tocris, Selleck	98.6	BRD-K50866992-003-09-5, BRD-K50866992-003-10-3	Launched
trospium	acetylcholine receptor antagonist	CHRM1	urology	urinary incontinence, urinary frequency	Selleck	97.42	BRD-K69469734-003-02-5	Launched
trovafloxacin	bacterial DNA gyrase inhibitor	TOP2A			Tocris, Enzo	97.94	BRD-K00494077-066-02-7, BRD-K00494077-066-01-9	Withdrawn
troventol					MatrixSci	95.22	BRD-A35868371-005-01-6	Phase 1
trovirdine	non-nucleoside reverse transcriptase inhibitor				MedChemEx	96.15	BRD-K00989047-001-01-2	Phase 1
troxerutin	antioxidant				Selleck, MicroSource, Selleck	90.3	BRD-K73529671-001-02-9, BRD-K73529671-001-04-5, BRD-K73529671-001-03-7	Launched
troxipide	glucosamine synthetase stimulant		gastroenterology	gastroesophageal reflux disease (GERD)	Selleck, Selleck	91.33	BRD-A68589262-001-04-3, BRD-A68589262-001-05-0	Launched
TRV130	opioid receptor agonist	OPRM1			MedChemEx	90.27	BRD-K35626314-003-01-1	Phase 3
tryptanthrin	cyclooxygenase inhibitor	IDO1			Enzo	99.15	BRD-K76973696-001-12-6	Preclinical
tryptophan	serotonin receptor partial agonist	CASR, IDO1, SLC36A1, WARS, WARS2	neurology/psychiatry, gastroenterology	anxiety, bloating, constipation, fatigue, sleeplessness	MicroSource, Sigma	98.59	BRD-K83776863-001-05-5, BRD-K83776863-001-08-9	Launched
TTNPB	retinoid receptor agonist	RARA, RARB, RARG			Tocris, Selleck, Selleck	91.34	BRD-K49685476-001-15-9, BRD-K49685476-001-14-2, BRD-K49685476-001-16-7	Phase 1
TTP-22	casein kinase inhibitor	CSNK2A1			Tocris	98.64	BRD-K64852730-001-01-7	Preclinical
TU-2100					Vitas-M	98.81	BRD-K44590731-001-01-7	Phase 2
tuaminoheptane			otolaryngology	nasal congestion	MicroSource	100	BRD-A19958636-065-04-4	Launched
tubastatin-a	HDAC inhibitor	HDAC6			Selleck, Selleck, Selleck	91.9	BRD-K00627859-003-03-7, BRD-K00627859-001-07-2, BRD-K00627859-001-06-4	Preclinical
tubocurarine	acetylcholine receptor antagonist	ACHE, CHRNA2, HTR3A, HTR3B, KCNN1, KCNN2, KCNN3, ZACN	neurology/psychiatry	anesthetic	MicroSource	93.49	BRD-K99621550-300-01-8	Launched
tucatinib	EGFR inhibitor	ERBB2			MedChemEx	94.53	BRD-K26026438-001-01-0	Phase 2
TUG-770	free fatty acid receptor agonist	FFAR1			MedChemEx	96.74	BRD-K56086081-001-01-7	Preclinical
TUG-891	free fatty acid receptor agonist	FFAR4			Tocris	97.49	BRD-K24282351-001-01-4	Preclinical
tulobuterol	adrenergic receptor agonist	ADRB2	pulmonary	asthma	MicroSource	97.79	BRD-A37441042-003-04-8	Launched
TW-37	BCL inhibitor	BCL2, BCL2L1, MCL1			Selleck, Selleck	91.58	BRD-K28360340-001-08-3, BRD-K28360340-001-05-9	Preclinical
TWS-119	glycogen synthase kinase inhibitor	GSK3B, JUN, MYC			Selleck, Tocris	96.31	BRD-K94176593-001-09-4, BRD-K94176593-362-01-7	Preclinical
TXA127	angiotensin receptor agonist				MedChemEx, MedChemEx	94.47	BRD-K36040345-001-02-9, BRD-K36040345-001-01-1	Phase 2
TY-52156	sphingosine 1-phosphate receptor antagonist	S1PR3			Tocris, MedChemEx, MedChemEx	88.43	BRD-K66584608-001-02-1, BRD-K66584608-001-03-9, BRD-K66584608-001-01-3	Preclinical
tylosin	protein synthesis inhibitor		infectious disease, gastroenterology	gram-positive bacterial infections, colitis	MicroSource, Selleck	94.95	BRD-K37753391-046-02-4, BRD-K37753391-046-03-2	Launched
tyloxapol	NFkB pathway inhibitor	LPL, NFKB2			MedChemEx, Prestwick, MicroSource, MedChemEx	0	BRD-M08959712-001-02-7, BRD-U25960968-000-01-9, BRD-U48018661-000-01-9, BRD-M08959712-001-01-9	Launched
tymazoline			allergy	allergic rhinitis	Sigma	53.77	BRD-K64414150-001-01-7	Launched
tyrphostin-AG-1296	FLT3 inhibitor	FLT3			Selleck, Selleck	99.83	BRD-K76064317-001-08-1, BRD-K76064317-001-07-3	Preclinical
tyrphostin-AG-1478	EGFR inhibitor	EGFR, MAPK14			Selleck	98.06	BRD-K68336408-001-10-9	Preclinical
tyrphostin-AG-18	EGFR inhibitor, tyrosine kinase inhibitor	EGFR			Tocris, Selleck, Selleck	87.88	BRD-K49657628-001-14-8, BRD-K49657628-001-13-0, BRD-K49657628-001-15-5	Preclinical
tyrphostin-AG-494	EGFR inhibitor	EGFR			Tocris	87.72	BRD-K34533029-001-08-5	Preclinical
tyrphostin-AG-825	protein tyrosine kinase inhibitor	ERBB2			Tocris	67.33	BRD-K87919739-001-07-5	Preclinical
tyrphostin-AG-835	protein tyrosine kinase inhibitor	EGFR			Tocris	93.78	BRD-K17415526-001-03-5	Preclinical
tyrphostin-AG-879	tyrosine kinase inhibitor	ERBB2, KDR, NTRK1			Selleck, Selleck	95.85	BRD-K59469039-001-09-8, BRD-K59469039-001-08-0	Preclinical
tyrphostin-AG-99	tyrosine kinase inhibitor	EGFR			Tocris	96.88	BRD-K60184833-001-05-6	Preclinical
tyrphostin-A9	protein tyrosine kinase inhibitor, tyrosine kinase inhibitor				Selleck	94.87	BRD-K40255344-001-17-6	Preclinical
U-0124	MEK inhibitor				Tocris	94.09	BRD-K63169195-001-01-5	Preclinical
U-0126	MEK inhibitor	AKT1, CHEK1, GSK3B, LCK, MAP2K1, MAP2K2, MAP2K7, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1			Selleck, Tocris, Selleck	93.15	BRD-K91701654-001-03-1, BRD-K18787491-001-08-6, BRD-K91701654-001-02-3	Preclinical
U-0521	catechol O methyltransferase inhibitor	COMT			SantaCruz	98.18	BRD-K08953028-001-09-6	Preclinical
U-104	carbonic anhydrase inhibitor	CA1, CA12, CA2, CA9			Selleck, Tocris	96.73	BRD-K77867004-001-02-7, BRD-K77867004-001-03-5	Preclinical
U-18666A	oxidosqualene cyclase inhibitor				Tocris	99.54	BRD-K22025381-003-01-9	Preclinical
U-50488-(-)	opioid receptor agonist	OPRK1			Tocris, Tocris, Tocris	97.11	BRD-K53532120-003-10-3, BRD-K53532120-003-11-1, BRD-K53532120-003-09-5	Preclinical
U-54494A	opioid receptor agonist	OPRK1			Tocris	96.38	BRD-K20995441-001-02-5	Preclinical
U-75799E	growth hormone releasing factor agonist	GHSR			Adooq	86.33	BRD-K77070363-001-01-5	Phase 1
U-99194	dopamine receptor antagonist	DRD3			Tocris	94.8	BRD-K70281171-050-08-9	Preclinical
UAMC-00039	dipeptidyl peptidase inhibitor	DPP4, DPP7			Tocris	84.99	BRD-K38966689-300-01-5	Preclinical
UB-165	acetylcholine receptor agonist	CHRNA3, CHRNA4, CHRNB2			Tocris, Tocris	90.79	BRD-A14574269-051-03-0, BRD-A14574269-051-02-2	Preclinical
ubenimex	leukotriene synthesis inhibitor	LTA4H, RNPEP	hematologic malignancy	acute myeloid leukemia (AML)	Selleck, Tocris	91.72	BRD-K59574735-001-11-8, BRD-K59574735-001-12-6	Launched
UBP-296	glutamate receptor antagonist	GRIK1			Tocris	76.19	BRD-A45499626-001-03-6	Preclinical
UBP-302	glutamate receptor antagonist	GRIK1			Tocris, Tocris, Tocris	96.2	BRD-K79753741-001-02-5, BRD-K79753741-001-03-3, BRD-K79753741-001-01-7	Preclinical
UBP-310	glutamate receptor antagonist	GRIK1, GRIK5			Tocris	66.8	BRD-K09597601-001-01-2	Preclinical
UC-112	XIAP inhibitor	XIAP			Tocris	85.21	BRD-K73610817-001-09-7	Preclinical
UCL-2077	slow afterhyperpolarization channel blocker				Tocris, Tocris	99.33	BRD-K50325075-001-02-1, BRD-K50325075-001-03-9	Preclinical
UF-010	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC8			Tocris	76.99	BRD-K20480395-001-01-6	Preclinical
ufenamate	cyclooxygenase inhibitor	PTGS1, PTGS2	dermatology	eczema, dermatitis	AvaChem	98.96	BRD-K84173274-001-01-6	Launched
UH-232-(+)	dopamine receptor antagonist	DRD2, DRD3, DRD4, HTR1A			Tocris	90.44	BRD-K66715657-050-01-0	Preclinical
UK-356618	metalloproteinase inhibitor	MMP13, MMP14, MMP2, MMP3, MMP9			Tocris	89.38	BRD-K57011718-001-02-3	Preclinical
UK-383367	Procollagen C-Endopeptidase Inhibitors	BMP1			Tocris, Selleck, Selleck	95.33	BRD-K06294530-001-03-1, BRD-K06294530-001-01-5, BRD-K06294530-001-02-3	Phase 1
UK-5099	monocarboxylate transporter inhibitor	SLC16A1			Tocris	90.92	BRD-K19558579-001-01-0	Preclinical
ulifloxacin					AKSci, Ark	79.96	BRD-A61633223-001-01-0, BRD-A61633223-001-02-8	Launched
ulipristal	progesterone receptor antagonist	PGR	endocrinology	contraceptive	Selleck, Selleck	91	BRD-K64381438-001-02-0, BRD-K64381438-001-03-8	Launched
umeclidinium	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3	pulmonary	chronic obstructive pulmonary disease (COPD), bronchitis, emphysema	MedChemEx	98.3	BRD-K46692793-004-01-8	Launched
UNBS-5162	CC chemokine receptor antagonist				MedChemEx	97.44	BRD-K30933884-001-01-0	Phase 1
UNC-2327	protein arginine N-methyltransferase inhibitor	PRMT3			Tocris	97.06	BRD-K60635008-001-01-5	Preclinical
UNC-3230	phosphatidyl-inositol activator	PIP5K1C			Tocris	96.42	BRD-K46344388-001-01-3	Preclinical
UNC-926	MBT inhibitor	L3MBTL1			Tocris	95.92	BRD-K22229656-003-01-5	Preclinical
UNC0224	histone lysine methyltransferase inhibitor	EHMT1, EHMT2			Tocris, Tocris	93.47	BRD-K77428767-001-01-7, BRD-K77428767-001-02-5	Preclinical
UNC0321	histone lysine methyltransferase inhibitor	EHMT2			MedChemEx, MedChemEx	91.24	BRD-K74236984-001-04-8, BRD-K74236984-001-05-5	Preclinical
UNC0631	histone lysine methyltransferase inhibitor	EHMT2			MedChemEx, MedChemEx	96.26	BRD-K13060017-001-01-3, BRD-K13060017-001-02-1	Preclinical
UNC0638	histone lysine methyltransferase inhibitor	EHMT1, EHMT2			MedChemEx, MedChemEx, Tocris	94.36	BRD-K86856088-001-06-9, BRD-K86856088-001-07-7, BRD-K86856088-001-08-5	Preclinical
UNC0642	histone lysine methyltransferase inhibitor	EHMT1, EHMT2			MedChemEx, MedChemEx, Tocris	97.06	BRD-K60130390-001-02-1, BRD-K60130390-001-03-9, BRD-K60130390-001-04-7	Preclinical
UNC0646	histone lysine methyltransferase inhibitor	EHMT2			MedChemEx, MedChemEx, Tocris	90.65	BRD-K87465484-001-02-7, BRD-K87465484-001-03-5, BRD-K87465484-001-04-3	Preclinical
UNC0737	histone lysine methyltransferase inhibitor	EHMT1, EHMT2			SGC	82.62	BRD-K02988401-001-01-2	Preclinical
UNC1215	L3MBTL antagonist	L3MBTL3			Selleck, Selleck	93.94	BRD-K83189926-001-03-1, BRD-K83189926-001-04-9	Preclinical
UNC1999	histone lysine methyltransferase inhibitor	EZH2			Selleck, Selleck, Tocris	96.39	BRD-K26989966-001-04-3, BRD-K26989966-001-03-5, BRD-K26989966-001-05-0	Preclinical
UNC2025	MER tyrosine kinase inhibitor, FLT3 inhibitor	FLT3, MERTK			MedChemEx	96.41	BRD-K91283740-003-01-6	Preclinical
UNC2250	MER tyrosine kinase inhibitor	MERTK			Selleck, Selleck	95.44	BRD-K01773560-001-01-6, BRD-K01773560-001-02-4	Preclinical
UNC669	L3MBTL antagonist	L3MBTL1			Selleck, Selleck	95.32	BRD-K21906513-001-03-2, BRD-K21906513-001-04-0	Preclinical
undecylenic-acid	other antifungal		infectious disease	tinea pedis, tinea corporis	MicroSource, MedChemEx	25.82	BRD-K19189338-001-03-2, BRD-K19189338-001-05-7	Launched
UPF-1069	PARP inhibitor	PARP2			Tocris, Tocris, Selleck	97.99	BRD-K77950083-001-03-3, BRD-K77950083-001-04-1, BRD-K77950083-001-02-5	Preclinical
uprosertib	AKT inhibitor	AKT1, AKT2, AKT3			MedChemEx	87.27	BRD-K38332599-001-01-3	Phase 2
uracil		DPYD, UCKL1			Selleck, MicroSource	100	BRD-K80129304-001-08-1, BRD-K80129304-001-09-9	Launched
uracil-mustard	DNA synthesis inhibitor		hematologic malignancy	non-Hodgkin lymphoma (NHL)	MedChemEx, MedChemEx, Sigma	69.59	BRD-K10180294-001-07-3, BRD-K10180294-001-06-5, BRD-K10180294-001-04-0	Launched
urapidil	adrenergic receptor antagonist	HTR1A	cardiology	hypertension	MicroSource, Selleck, Tocris	97.01	BRD-K73196317-003-15-5, BRD-K73196317-003-13-0, BRD-K73196317-003-14-8	Launched
URB597	FAAH inhibitor	FAAH, FAAH2, TRPA1			Tocris, Selleck, Selleck	80.92	BRD-K92169341-001-12-0, BRD-K92169341-001-11-2, BRD-K92169341-001-10-4	Phase 1
urea	hydroxy radical formation stimulant	ARG1, CA2, CTNNB1	dermatology	psoriasis, xerosis cutis, ichthyosis vulgaris, eczema, keratosis, dermatitis	MicroSource	97.73	BRD-K88052444-001-08-8	Launched
urethane	local anesthetic				MicroSource	0	BRD-K24297741-001-05-2	Preclinical
uric-acid		PYGL			Enamine	100	BRD-K01295354-001-02-8	Phase 3
uridine	dopamine receptor agonist	LSM6, TYMP			Selleck, Selleck	97.91	BRD-K13050303-001-18-1, BRD-K13050303-001-17-3	Phase 2
uridine-triacetate			nephrology	orotic aciduria	Bepharm	96.02	BRD-K18323388-001-01-1	Launched
uridine-5'-triphosphate	purinergic receptor activator	P2RY11, P2RY2, P2RY4, P2RY6, UCK2			Sigma	0	BRD-A89637065-001-01-0	Launched
URMC-099	mixed lineage kinase inhibitor	CDKL2, DAPK3, FLT3, LRRK2, MAP3K10, MAP3K11, MAP3K2, MAP3K9, SRPK2			MedChemEx	91.98	BRD-K66908976-001-01-8	Preclinical
ursodeoxycholyltaurine	cholesterol inhibitor				Enzo	100	BRD-K45245728-335-01-4	Phase 2
ursodiol	nuclear factor erythroid derived, like (NRF2) activator	NR1H4	gastroenterology	gallstones	MicroSource, Selleck	100	BRD-K15697815-001-15-4, BRD-K15697815-001-16-2	Launched
ursolic-acid	ATPase inhibitor, NFkB pathway inhibitor, STAT inhibitor	HSD11B1, PLA2G1B, PTPN1, PYGM			Sigma, Selleck	90.07	BRD-K68185022-001-12-2, BRD-K68185022-001-14-8	Phase 1
usniacin-(+)	MAP kinase activator	PTPN1			Selleck, Selleck	92.95	BRD-A12417644-001-07-6, BRD-A12417644-001-06-8	Preclinical
V-51	adrenergic receptor antagonist				ChemBridge	98.78	BRD-K75052463-001-01-4	Phase 1
val		BCAT1, PCCB, VARS			Enzo	100	BRD-K59424860-001-01-4	Phase 2
valaciclovir	DNA polymerase inhibitor		infectious disease	shingles, virus herpes simplex (HSV)	MicroSource, Selleck	97.83	BRD-K46435977-003-12-9, BRD-K46435977-003-11-1	Launched
valdecoxib	cyclooxygenase inhibitor	CA12, PTGS2			Tocris, Selleck	98.16	BRD-K12994359-001-19-2, BRD-K12994359-001-18-4	Withdrawn
valethamate	acetylcholine receptor antagonist	CHRM1, CHRM4, CHRM5	obstetrics/gynecology	labor induction	Sigma	90.39	BRD-A56613951-004-01-1	Launched
valganciclovir	DNA synthesis inhibitor		infectious disease	cytomegalovirus (CMV)	MicroSource, Selleck	100	BRD-A50922295-003-05-0, BRD-A50922295-001-01-3	Launched
valnemulin	bacterial 50S ribosomal subunit inhibitor		infectious disease, gastroenterology	dysentry, colitis, pneumonia	Selleck	100	BRD-K33813875-003-01-8	Launched
valnoctamide	arachidonic acid acylation inhibitor, benzodiazepine receptor agonist				Sigma	61.43	BRD-A96644976-001-01-5	Phase 3
valproic-acid	HDAC inhibitor	ABAT, ACADSB, ALDH5A1, HDAC1, HDAC2, HDAC9, OGDH, SCN10A, SCN11A, SCN1A, SCN1B, SCN2A, SCN2B, SCN3A, SCN3B, SCN4A, SCN4B, SCN5A, SCN7A, SCN8A, SCN9A	neurology/psychiatry	seizures	Selleck, EMDBio, MicroSource, Enzo, Tocris	96.83	BRD-K41260949-236-15-0, BRD-K41260949-236-18-4, BRD-K41260949-236-16-8, BRD-K41260949-236-17-6, BRD-K41260949-236-21-8	Launched
valpromide	epoxide hydolase inhibitor		neurology/psychiatry	epilepsy	Sigma	60.96	BRD-K54698528-001-01-2	Launched
valrocemide					Enamine	99	BRD-K32804101-001-01-8	Phase 2
valrubicin	DNA inhibitor, topoisomerase inhibitor	TOP2A	oncology	bladder cancer	MedChemEx	97.11	BRD-K72951360-001-01-4	Launched
valsartan	angiotensin receptor antagonist	AGTR1	cardiology	hypertension, congestive heart failure	MicroSource, Tocris, Selleck	99.42	BRD-K45158365-001-11-4, BRD-K45158365-001-12-2, BRD-K45158365-001-10-6	Launched
valspodar	P glycoprotein inhibitor	ABCB1			MedChemEx, MedChemEx	43.76	BRD-K19412342-001-01-6, BRD-K19412342-001-02-4	Phase 3
vancomycin	bacterial cell wall synthesis inhibitor		infectious disease	endocarditis	MicroSource, Selleck, Selleck	88.61	BRD-K91065602-001-01-8, BRD-K91065602-003-05-5, BRD-K91065602-003-04-8	Launched
vandetanib	EGFR inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor	EGFR, EPHA1, EPHA10, EPHA2, EPHA3, EPHA4, EPHA5, EPHA6, EPHA7, EPHA8, EPHB1, EPHB2, EPHB3, EPHB4, EPHB6, ERBB2, ERBB3, ERBB4, FLT1, FLT4, KDR, PTK6, RET, SRC, TEK, VEGFA	oncology	medullary thyroid cancer (MTC)	Selleck	97.69	BRD-K77625799-001-07-7	Launched
vanillin		ABAT, ALDH5A1			Selleck	93.59	BRD-K24258499-001-05-8	Preclinical
vanillylacetone					Selleck, Selleck	98.97	BRD-K33510429-001-03-1, BRD-K33510429-001-02-3	Preclinical
vanitiolide					MicroSource	92.27	BRD-K26502378-001-07-9	Preclinical
vanoxerine	dopamine uptake inhibitor	SLC6A3			Tocris, Tocris	96.73	BRD-K32501161-300-07-0, BRD-K32501161-300-06-2	Phase 3
vardenafil	phosphodiesterase inhibitor	PDE5A, PDE6G, PDE6H	urology	erectile dysfunction	MicroSource, Selleck	99.24	BRD-K13926615-003-03-3, BRD-K13926615-394-02-8	Launched
varenicline	acetylcholine receptor agonist	CHRNA3, CHRNA4, CHRNA6, CHRNA7	neurology/psychiatry	smoking cessation	Selleck	91.17	BRD-A86216746-046-02-6	Launched
varespladib	secretory phospholipase inhibitor	PLA2G2A			Selleck	98.89	BRD-K09711437-001-04-3	Phase 3
vasopressin	vasopressin receptor agonist	AVPR1A, AVPR1B, AVPR2, OXTR	gastroenterology	abdominal distension	Sigma	85.73	BRD-K73028949-001-02-8	Launched
vatalanib	KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	EGFR, FLT1, FLT4, KDR, PDGFRB			Selleck, Selleck, Tocris	99.48	BRD-K70163715-300-05-7, BRD-K70163715-300-04-0, BRD-K70163715-036-01-6	Phase 3
VBY-825	cathepsin inhibitor	CTSB, CTSL, CTSS			MedChemEx, MedChemEx	83.23	BRD-K36338614-001-01-3, BRD-K36338614-001-02-1	Preclinical
VCH-916	HCV inhibitor				MedChemEx	98.31	BRD-K75956464-237-01-5	Phase 1
VE-821	ATR kinase inhibitor	ATR			Selleck	97.3	BRD-K26756394-001-02-2	Preclinical
VE-822	ATR kinase inhibitor	ATM, ATR, MTOR, PIK3CG			MedChemEx, Selleck, Selleck	88.53	BRD-K04701033-001-04-7, BRD-K04701033-001-01-3, BRD-K04701033-001-03-9	Phase 2
vecuronium	acetylcholine receptor antagonist	CHRNA2	neurology/psychiatry	muscle relaxant	MicroSource, Selleck	96.73	BRD-K20168442-004-07-1, BRD-K20168442-004-06-3	Launched
veliflapon	leukotriene synthesis inhibitor	ALOX5AP			Sigma	99.55	BRD-K12852738-001-01-2	Phase 3
veliparib	PARP inhibitor	PARP1, PARP2			Selleck	96.52	BRD-K12737986-001-01-4	Phase 3
velneperit	neuropeptide receptor antagonist	NPY5R			MedChemEx, MedChemEx	84.28	BRD-K06357403-001-02-2, BRD-K06357403-001-01-4	Phase 2
vemurafenib	RAF inhibitor	BRAF, RAF1	oncology	melanoma	Selleck, MedChemEx, Selleck	98.74	BRD-K56343971-001-14-8, BRD-K56343971-001-12-2, BRD-K56343971-001-10-6	Launched
venetoclax	BCL inhibitor	BCL2	hematologic malignancy	chronic lymphocytic leukemia (CLL)	Selleck, Adooq, Selleck	97.4	BRD-K62391742-001-08-9, BRD-K62391742-001-09-7, BRD-K62391742-001-03-0	Launched
venlafaxine	adrenergic inhibitor, norepinephrine reuptake inhibitor, serotoninâ€“norepinephrine reuptake inhibitor (SNRI)	SLC6A2, SLC6A3, SLC6A4	neurology/psychiatry	depression, generalized anxiety disorder (GAD), panic disorders, social anxiety disorder	Tocris, MicroSource, Selleck	96.92	BRD-A51714012-003-14-4, BRD-A51714012-003-13-6, BRD-A51714012-003-12-8	Launched
VER-155008	HSP inhibitor	HSPA1A			Tocris	92.19	BRD-K32330832-001-02-8	Preclinical
VER-49009	HSP inhibitor	HSP90AA1			Selleck	97.34	BRD-K38548312-001-01-0	Preclinical
verapamil	calcium channel blocker	CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1I, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, CYP3A4, KCNA10, KCNA7, KCNH2, KCNJ11, NALCN, SCN5A, SLC29A4, SLC6A4	cardiology	hypertension	Selleck, MicroSource	97.04	BRD-A09533288-003-29-6, BRD-A09533288-003-31-2	Launched
verbascoside	PKC inhibitor, NFkB pathway inhibitor				MedChemEx	79.95	BRD-K36201510-001-06-7	Phase 2/Phase 3
vercirnon	CC chemokine receptor antagonist	CCR9			MedChemEx	95.9	BRD-K47929404-001-01-0	Phase 3
verinurad	urate transporter inhibitor	SLC22A12			MedChemEx	98.04	BRD-K36741660-001-01-1	Phase 2
vernakalant	potassium channel blocker	KCNA5	cardiology	atrial fibrillation (AF)	MedChemEx	97.82	BRD-K19741547-003-01-7	Launched
verteporfin	photosensitizing agent		ophthalmology	macular degeneration	MedChemEx, Tocris, Selleck, Cayman, Selleck	69.27	BRD-K81849500-001-07-7, BRD-K81849500-001-06-9, BRD-K81849500-001-02-8, BRD-K81849500-001-05-1, BRD-K81849500-001-01-0	Launched
verubulin	tubulin polymerization inhibitor	TUBB			Key, Tocris	99.3	BRD-K42673188-001-01-1, BRD-K42673188-003-01-7	Phase 2
vesamicol	acetylcholinesterase inhibitor	SLC18A3			Tocris, Tocris	97.14	BRD-K14765469-003-13-0, BRD-K14765469-003-12-2	Preclinical
vesnarinone	phosphodiesterase inhibitor	KCNH2, PDE3A	cardiology	congestive heart failure	MedChemEx	88.52	BRD-K13414800-001-01-3	Launched
VGX-1027	tumor necrosis factor receptor antagonist	TLR4			Selleck	97.76	BRD-A32269193-001-01-5	Phase 1
vicriviroc	CC chemokine receptor antagonist	CCR5			MedChemEx	97.42	BRD-K84748119-050-01-1	Phase 3
vidarabine	antiviral	ADA	infectious disease	virus herpes simplex (HSV), varicella-zoster virus (VZV)	MicroSource, Selleck	98.16	BRD-K72093121-001-17-1, BRD-K72093121-001-16-3	Launched
vigabatrin	GABA aminotransferase inhibitor	ABAT, GABBR1, SLC32A1	neurology/psychiatry	seizures, spasms	MicroSource	0	BRD-A07893380-213-01-7	Launched
vilanterol	adrenergic receptor agonist	ADRB2	pulmonary	chronic obstructive pulmonary disease (COPD)	MedChemEx, MedChemEx, MedChemEx, MedChemEx	54.71	BRD-M36487418-001-05-5, BRD-M36487418-001-03-0, BRD-M36487418-001-01-4, BRD-M36487418-001-02-2	Launched
vilazodone	serotonin reuptake inhibitor	DRD2, DRD3, HRH1, HTR1A, HTR4, SLC6A4	neurology/psychiatry	depression	MicroSource, Selleck, Selleck	98.4	BRD-K58010567-003-02-2, BRD-K58010567-003-01-4, BRD-K58010567-003-03-0	Launched
vildagliptin	dipeptidyl peptidase inhibitor	DPP4	endocrinology	diabetes mellitus	Selleck, Selleck	99.32	BRD-A94993966-001-04-4, BRD-A94993966-001-05-1	Launched
viloxazine	norepinephrine reuptake inhibitor	SLC6A2	neurology/psychiatry	depression	Prestwick	98.75	BRD-A59198242-003-02-9	Launched
vinblastine	microtubule inhibitor, tubulin polymerization inhibitor	JUN, TUBA1A, TUBB, TUBD1, TUBE1, TUBG1	hematologic malignancy, infectious disease, oncology	Hodgkin's lymphoma, true histiocytic lymphoma (THL), mycosis, small lymphocytic lymphoma (SLL), testicular carcinoma, Kaposi sarcoma	MedChemEx, MedChemEx, MedChemEx, MicroSource, Selleck, Selleck, Tocris	96.33	BRD-K06519765-065-01-6, BRD-K06519765-065-02-4, BRD-K06519765-001-03-7, BRD-K06519765-065-04-0, BRD-K06519765-001-02-9, BRD-K06519765-001-01-1, BRD-K06519765-065-03-2	Launched
vinburnine	adrenergic receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4	neurology/psychiatry	stroke	Enzo	98.61	BRD-K40227168-001-12-9	Launched
vincamine	adrenergic receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4			MicroSource	93.79	BRD-K89704198-001-12-3	Withdrawn
vincristine	tubulin polymerization inhibitor	TUBA4A, TUBB	hematologic malignancy	acute lymphoblastic leukemia (ALL)	MicroSource, MedChemEx, Tocris, Selleck, MedChemEx, Selleck	90.52	BRD-K12251893-065-06-2, BRD-K12251893-065-01-3, BRD-K12251893-065-04-7, BRD-K12251893-065-05-4, BRD-K12251893-065-02-1, BRD-K12251893-065-03-9	Launched
vindesine	tubulin polymerization inhibitor	TUBB, TUBB1	oncology	breast cancer, non-small cell lung cancer (NSCLC), melanoma	AvaChem	78.54	BRD-K59753975-001-02-6	Launched
vinflunine	microtubule inhibitor		oncology	bladder cancer	AvaChem, Selleck	95.66	BRD-K64120610-001-01-4, BRD-K64120610-046-01-9	Launched
vinorelbine	tubulin polymerization inhibitor	TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8	oncology	non-small cell lung cancer (NSCLC)	MedChemEx, MedChemEx, Enzo	77.38	BRD-K04269837-346-01-8, BRD-K69280563-346-01-7, BRD-K69280563-001-01-8	Launched
vinpocetine	phosphodiesterase inhibitor, sodium channel blocker	PDE1A, PDE1C			MicroSource, Tocris, Selleck	98.68	BRD-K53318339-001-24-9, BRD-K53318339-001-23-1, BRD-K53318339-001-26-4	Launched
viomycin	protein synthesis inhibitor		infectious disease	tuberculosis	Prestwick	39.8	BRD-A42379279-065-03-8	Launched
vipadenant	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3			MedChemEx	94.33	BRD-K56565215-001-01-9	Phase 1
vismodegib	hedgehog pathway inhibitor, smoothened receptor antagonist	SMO	oncology	basal cell carcinoma (BCC)	Selleck	98.12	BRD-K44827188-001-06-0	Launched
vitamin-b12			hematology	megaloblastic anemia	AKSci	97.81	BRD-A75369945-001-01-2	Launched
vitamin-E	PKC inhibitor, LDL oxidation inhibitor	ALOX5, DGKA, NR1I2, PPP2CA, PPP2CB, PRKCA, PRKCB, SEC14L2, SEC14L3, SEC14L4			CombiBlocks	0	BRD-K97091514-001-11-4	Phase 2/Phase 3
VLX-600	antitumor agent	TP53			Enamine	87.51	BRD-K26122255-001-01-7	Phase 1
VLX600	ubiquitin C-terminal hydrolase inhibitor	USP14			ChemDiv	86.93	BRD-K89053832-001-01-0	Phase 1
voglibose	glucosidase inhibitor	MGAM	endocrinology	diabetes mellitus, hyperglycemia	Tocris, Tocris, Selleck	100	BRD-K66850609-001-05-8, BRD-K66850609-001-06-6, BRD-K66850609-001-07-4	Launched
volasertib	PLK inhibitor	PLK1			MedChemEx, Selleck	95.76	BRD-K69776681-001-06-1, BRD-K69776681-001-03-8	Phase 3
volinanserin	serotonin receptor antagonist	HTR2A, HTR2B, HTR2C, KCNH2			Tocris, Cayman	98.59	BRD-K23647661-001-03-0, BRD-K23647661-001-02-2	Phase 3
vonoprazan	potassium-competitive acid antagonist	ATP4A	gastroenterology	peptic ulcer disease (PUD)	Selleck, Selleck	88.52	BRD-K32768103-051-02-6, BRD-K32768103-051-03-4	Launched
vorapaxar	thrombin receptor antagonist	F2R	cardiology	myocardial infarction, peripheral artery disease (PAD)	Adooq	98.32	BRD-K93442924-001-03-4	Launched
voreloxin	topoisomerase inhibitor	TOP2A			MedChemEx	93.26	BRD-K23677682-003-01-2	Phase 3
voriconazole	cytochrome P450 inhibitor	CYP2C19, CYP2C9, CYP3A4, CYP3A5, PTGS1	infectious disease	esophageal candidiasis, aspergillosis, skin infections	Selleck, MicroSource, Selleck	99.42	BRD-K06557128-001-08-8, BRD-K06557128-001-07-0, BRD-K06557128-001-06-2	Launched
vorinostat	HDAC inhibitor	HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC5, HDAC6, HDAC8, HDAC9	hematologic malignancy	cutaneous T-cell lymphoma (CTCL)	Selleck, Selleck, Tocris	99.7	BRD-K81418486-001-47-5, BRD-K81418486-001-44-2, BRD-K81418486-001-51-7	Launched
vortioxetine	serotonin receptor agonist, serotonin receptor antagonist	HTR1A, HTR1B, HTR2A, HTR2C, HTR3A, HTR5A, HTR6, HTR7, SLC6A4	neurology/psychiatry	depression	MicroSource, Selleck	95.12	BRD-K53963539-001-01-8, BRD-K53963539-004-02-0	Launched
voxtalisib	mTOR inhibitor, PI3K inhibitor	MTOR, PIK3CA			MedChemEx	99.19	BRD-K56291712-001-01-0	Phase 2
VP-20629	beta amyloid antagonist	PLA2G2E, SLC36A1			ChemDiv	99.13	BRD-K21071223-001-02-8	Phase 1
VS-4718	focal adhesion kinase inhibitor				MedChemEx	98.41	BRD-K09877029-001-01-2	Phase 1
VT-464	cytochrome P450 inhibitor	CYP17A1			MedChemEx	98.44	BRD-K72005722-001-01-2	Phase 2
VTP-27999	renin inhibitor	REN			MedChemEx	92.33	BRD-K81694556-003-01-9	Phase 1
VU-0240551	potassium/chloride cotransporter inhibitor	SLC12A5			MedChemEx	97.16	BRD-K27074404-001-08-4	Preclinical
VU-0364739	phospholipase inhibitor	PLD2			Tocris	95.98	BRD-K93317811-003-02-2	Preclinical
VU-0422288	glutamate receptor allosteric modulator	GRM3			Tocris	96.47	BRD-K68674163-001-01-7	Preclinical
VU-152100	acetylcholine receptor allosteric modulator	CHRM4			Tocris	93.58	BRD-K87727457-001-01-5	Preclinical
VUF10166	serotonin receptor antagonist	HTR3A, HTR3B			Selleck	94.56	BRD-K11046126-001-02-0	Preclinical
VUF10460	histamine receptor agonist	HRH4			Tocris	96.93	BRD-K90082312-001-01-5	Preclinical
VUF11207	CC chemokine receptor agonist	ACKR3			Tocris	97.09	BRD-A93717708-051-01-2	Preclinical
VU0155069	phospholipase inhibitor	PLD1			Tocris, Tocris	97.48	BRD-K48535733-003-01-2, BRD-K48535733-003-02-0	Preclinical
VU0238429	acetylcholine receptor allosteric modulator	CHRM5			Tocris, Tocris	95.11	BRD-K24187789-001-01-7, BRD-K24187789-001-02-5	Preclinical
VU0357121	glutamate receptor positive allosteric modulator	GRM5			Selleck	97.46	BRD-K86109159-001-02-6	Preclinical
VU0360172	glutamate receptor positive allosteric modulator	GRM5			Tocris	77.87	BRD-K83649660-003-03-0	Preclinical
VU0361737	glutamate receptor positive allosteric modulator	GRM4			Tocris, Tocris, Selleck	98.82	BRD-K45462423-001-03-7, BRD-K45462423-001-04-5, BRD-K45462423-001-02-9	Preclinical
VU0364439	glutamate receptor positive allosteric modulator	GRM4			Tocris, Selleck	96.29	BRD-K72687424-001-03-4, BRD-K72687424-001-02-6	Preclinical
VU0364770	glutamate receptor positive allosteric modulator	GRM4			Selleck	96.96	BRD-K66527818-001-02-6	Preclinical
VU10010	acetylcholine receptor allosteric modulator	CHRM4			Tocris	92.95	BRD-K12483104-001-01-2	Preclinical
VU1545	glutamate receptor positive allosteric modulator	GRM5			Tocris	96.37	BRD-K48371964-001-06-5	Preclinical
VU29	glutamate receptor potentiator	GRM5			Tocris	98.04	BRD-K54783522-001-01-8	Preclinical
VU591	potassium channel blocker	KCNJ1			Tocris	87.5	BRD-K72063794-003-01-0	Preclinical
VX-11e	MAP kinase inhibitor	MAPK1			MedChemEx	97.32	BRD-K93725829-001-03-8	Preclinical
VX-222	HCV inhibitor				Selleck	97.92	BRD-K70610771-001-02-9	Phase 2
VX-702	p38 MAPK inhibitor	MAPK11, MAPK12, MAPK14			Selleck, Selleck	93.86	BRD-K07736136-001-04-6, BRD-K07736136-001-03-8	Phase 2
VX-745	p38 MAPK inhibitor	MAPK11, MAPK12, MAPK14			MedChemEx, MedChemEx, Selleck, Selleck	78.69	BRD-K91900765-001-08-4, BRD-K91900765-001-07-6, BRD-K91900765-001-05-0, BRD-K91900765-001-06-8	Phase 2
VX-765	caspase inhibitor	CASP1			Selleck	94.98	BRD-K26712974-001-01-5	Phase 2
W-54011	anaphylatoxin chemotactic receptor antagonist	C5AR1			Tocris, MedChemEx	89.3	BRD-A00559310-003-02-9, BRD-A00559310-003-01-1	Preclinical
walrycin-b	transcriptional regulatory protein WalR				MedChemEx	88.74	BRD-K01129913-001-01-5	Preclinical
warfarin	vitamin K antagonist	VKORC1	hematology, cardiology	deep vein thrombosis (DVT), pulmonary embolism (PE), atrial fibrillation (AF), myocardial infarction	MicroSource	99.85	BRD-A24514565-001-09-7	Launched
WAY-100635	serotonin receptor antagonist	HTR1A			Selleck	95.59	BRD-K69812556-305-02-0	Phase 1
WAY-161503	serotonin receptor agonist	HTR2C			Tocris, Tocris	94.85	BRD-A62021152-003-04-2, BRD-A62021152-003-03-4	Preclinical
WAY-170523	metalloproteinase inhibitor	MMP13			Tocris, Tocris	97.03	BRD-K36198571-001-02-0, BRD-K36198571-001-03-8	Preclinical
WAY-200070	estrogen receptor agonist	ERBB2, ERBB3, ERBB4, ESR2			Tocris, Tocris	93.82	BRD-K08223200-001-01-1, BRD-K08223200-001-02-9	Preclinical
WAY-207024	gonadotropin releasing factor hormone receptor antagonist	GNRHR, HRH2, TACR2			Tocris	95.82	BRD-K08657056-300-01-1	Preclinical
WAY-208466	serotonin receptor agonist	DRD2, HTR2A, HTR2C, HTR6, HTR7			Tocris	96.89	BRD-K63483542-300-01-6	Preclinical
WAY-213613	glutamate inhibitor	SLC1A2			Tocris, Tocris	97.19	BRD-K96758128-001-01-8, BRD-K96758128-001-02-6	Preclinical
WAY-316606	secreted frizzled related protein inhibitor	SFRP1			MedChemEx, Tocris	94.21	BRD-K61871885-001-01-3, BRD-K61871885-003-01-9	Preclinical
WAY-362450	FXR agonist	NR1H4			Selleck	91.54	BRD-K54640016-001-04-7	Phase 1
WAY-600	mTOR inhibitor	MTOR			Selleck	93.96	BRD-K85920262-001-02-1	Preclinical
WAY-629	serotonin receptor agonist	HTR2C			Tocris	66.92	BRD-K55430733-003-02-4	Preclinical
WB-4101	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, HTR1A			Tocris	96.8	BRD-A01493904-003-12-1	Preclinical
WDR5-0103	histone lysine methyltransferase inhibitor	WDR5			Tocris	97.86	BRD-K47726410-001-01-2	Preclinical
WEHI-345-analog	src inhibitor				MedChemEx	95.92	BRD-K55487946-001-01-3	Preclinical
WH-4-023	src inhibitor	LCK, SRC			Tocris	81.92	BRD-K50199947-001-03-4	Preclinical
WHI-P154	JAK inhibitor	EGFR, JAK1, JAK2, JAK3			Selleck, Selleck, Tocris	90.22	BRD-K07487750-001-03-3, BRD-K07487750-001-04-1, BRD-K07487750-001-05-8	Preclinical
WIKI4	Wnt pathway inhibitor, tankyrase inhibitor	TNKS2			MedChemEx	98.16	BRD-K19316653-001-02-0	Preclinical
WIN-18446	aldehyde dehydrogenase inhibitor	ALDH1A2			DuPont	97.79	BRD-K30930903-001-01-3	Preclinical
WIN-64338	bradykinin receptor antagonist	BDKRB2			Tocris, Tocris	95.81	BRD-K22662557-300-02-5, BRD-K22662557-300-01-7	Preclinical
wiskostatin	neural Wiskott-Aldrich syndrome protein inhibitor, actin related protein inhibitor	WAS, WASL			Tocris	91.47	BRD-A18579359-001-04-9	Preclinical
wnt-c59	porcupine inhibitor	PORCN			Selleck, Tocris	98.11	BRD-K78455053-001-01-2, BRD-K78455053-001-02-0	Preclinical
wortmannin	PI3K inhibitor	PI4KA, PI4KB, PIK3CA, PIK3CD, PIK3CG, PIK3R1, PLK1, PRKDC			Selleck, Selleck	56.11	BRD-K87343924-001-12-3, BRD-K87343924-001-15-6	Preclinical
WP1066	STAT inhibitor	STAT3			Selleck, Selleck	87.63	BRD-K05445342-001-05-3, BRD-K05445342-001-02-0	Phase 1
WP1130	deubiquitinase inhibitor	JAK2, UCHL5, USP14, USP9X			Selleck, Selleck	88.88	BRD-K43644456-001-03-2, BRD-K43644456-001-04-0	Preclinical
WR99210	dihydrofolate reductase inhibitor	TYMS	infectious disease	malaria	Sigma	98.92	BRD-K45973863-001-01-4	Preclinical
WWL-113	carboxylesterase inhibitor	CES3			Tocris	97.33	BRD-K49389158-001-01-3	Preclinical
WWL-123	monoacylglycerol lipase inhibitor	ABHD6			Tocris	95.05	BRD-K83176916-001-01-4	Preclinical
Wy-16922	histamine release inhibitor				Sigma	96.26	BRD-K43419711-001-01-4	Phase 1
WYE-125132	mTOR inhibitor	MTOR			Selleck	97.73	BRD-A45498368-001-07-1	Preclinical
WYE-354	mTOR inhibitor	MTOR			Selleck	93.46	BRD-K77008974-001-03-2	Preclinical
WYE-687	mTOR inhibitor	MTOR			Tocris	94.1	BRD-K49900195-300-01-8	Preclinical
WZ-3146	EGFR inhibitor	EGFR			Selleck	91.78	BRD-K73293050-001-03-1	Preclinical
WZ-4002	EGFR inhibitor	EGFR, ERBB2			Selleck, Selleck	92.97	BRD-K72420232-001-13-1, BRD-K72420232-001-12-3	Preclinical
WZ4003	AMPK inhibitor	NUAK1, NUAK2			Selleck	92.13	BRD-K45909031-001-01-5	Preclinical
WZ8040	EGFR inhibitor	EGFR			Selleck	91.07	BRD-K81728688-001-04-4	Preclinical
WZ811	CC chemokine receptor antagonist	CXCR4			Selleck	93.63	BRD-K25359048-001-02-6	Preclinical
xaliproden	serotonin receptor agonist	HTR1A			Tocris, Tocris	99.44	BRD-K88358234-003-04-8, BRD-K88358234-003-05-5	Phase 3
xamoterol	adrenergic receptor agonist	ADRB1			Tocris, Tocris, Tocris	87.58	BRD-A59337442-051-07-9, BRD-A59337442-051-06-1, BRD-A59337442-051-05-3	Phase 3
xanomeline	acetylcholine receptor agonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR6, HTR7			Tocris, MedChemEx	97.8	BRD-K72815923-034-02-0, BRD-K72815923-034-01-2	Phase 3
xanthone	antimalarial agent				Selleck	97.15	BRD-K27135764-001-08-7	Preclinical
XAV-939	tankyrase inhibitor	TNKS, TNKS2			Tocris, Selleck, Tocris	95.63	BRD-K12762134-001-07-0, BRD-K12762134-001-06-2, BRD-K12762134-001-10-4	Preclinical
XBD173	benzodiazepine receptor ligand	TSPO			Tocris, MedChemEx	99.75	BRD-K45875383-001-02-0, BRD-K45875383-001-01-2	Phase 2
XD-14	bromodomain inhibitor	BRD2, BRD3, BRD4, BRDT			Tocris	87.21	BRD-K69211575-001-01-9	Preclinical
XE-991	potassium channel blocker	KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5			Tocris	98.74	BRD-K42748308-300-02-0	Preclinical
xenalipin					Enamine	98.55	BRD-K99506538-001-03-8	Phase 2
xibenolol	adrenergic receptor antagonist				PrincetonBio	98.27	BRD-A21446384-001-01-1	Phase 3
xilobam					Enamine	88.42	BRD-K79633074-001-01-8	Phase 1
xipamide	carbonic anhydrase inhibitor	SLC12A3	cardiology	edema, hypertension	OxChem	99.61	BRD-K27393415-001-01-0	Launched
XL-147	PI3K inhibitor	PIK3CA, PIK3CD, PIK3CG			Selleck	96.66	BRD-K95901403-001-04-5	Phase 2
XL-647	EGFR inhibitor, VEGFR inhibitor	EGFR, EPHB4, ERBB2, FLT4, KDR			MedChemEx	95.23	BRD-K03765900-001-01-9	Phase 3
XL019	JAK inhibitor	JAK1, JAK2, JAK3			MedChemEx, MedChemEx, Selleck, Selleck	85.4	BRD-K04266228-001-04-6, BRD-K04266228-001-05-3, BRD-K04266228-001-02-0, BRD-K04266228-001-03-8	Phase 1
XL228	Abl kinase inhibitor, insulin growth factor receptor inhibitor, src inhibitor	IGF1R, SRC			MedChemEx, MedChemEx	96.72	BRD-K14274271-001-02-8, BRD-K14274271-001-01-0	Phase 1
XL388	mTOR inhibitor	MTOR			Selleck	97.77	BRD-K03549949-001-01-0	Preclinical
XL888	HSP inhibitor				Selleck	96.96	BRD-A03506276-001-01-5	Phase 1
XMD17-109	MAP kinase inhibitor	MAPK7			MedChemEx, Tocris	98.26	BRD-K48449981-001-01-9, BRD-K48449981-001-02-7	Preclinical
XMD8-92	MAP kinase inhibitor	DCLK2, MAPK7, PLK4, TNK1			MedChemEx, MedChemEx, Tocris	88.71	BRD-K50387473-001-11-0, BRD-K50387473-001-09-4, BRD-K50387473-001-10-2	Preclinical
xylazine	adrenergic receptor agonist	ADRA2A, ADRA2B, ADRA2C	neurology/psychiatry	anesthetic	Selleck, MicroSource	99.59	BRD-K21565985-003-02-3, BRD-K21565985-001-22-5	Launched
xylometazoline	adrenergic receptor agonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C	otolaryngology, allergy	nasal congestion, allergic rhinitis	MicroSource, Selleck	98.38	BRD-K08356259-003-24-7, BRD-K08356259-003-23-9	Launched
xylose					Selleck, Selleck	100	BRD-K10759144-001-03-5, BRD-K10759144-001-04-3	Launched
Y-11	focal adhesion kinase inhibitor	PTK2			Tocris	99.12	BRD-K09317629-004-01-7	Preclinical
Y-134	estrogen receptor antagonist	ESR1, ESR2			Tocris, Tocris	93.3	BRD-K94832621-001-02-3, BRD-K94832621-001-03-1	Preclinical
Y-26763	potassium channel activator	KCNJ8			Tocris	95.72	BRD-K45117373-001-02-9	Phase 1
Y-27152	potassium channel activator	KCNJ8			Tocris	99.08	BRD-K42679050-001-02-1	Phase 1
Y-27632	rho associated kinase inhibitor	PKIA, PKN2, PRKACA, PRKCE, ROCK1, ROCK2			Selleck, Tocris, Selleck	99.62	BRD-K44084986-300-09-2, BRD-K44084986-300-08-4, BRD-K44084986-300-07-6	Preclinical
Y-29794	prolyl endopeptidase inhibitor	PREP			Tocris	64.16	BRD-K48449073-034-02-7	Preclinical
Y-320	interleukin inhibitor	IL17A			Selleck	93.42	BRD-K96259238-001-01-4	Preclinical
Y-39983	rho associated kinase inhibitor	ROCK1, ROCK2			MedChemEx	97.51	BRD-K56751279-300-01-4	Phase 2
YC-1	guanylyl cyclase activator	GUCY1A2, GUCY1A3, GUCY1B3, HIF1A			Tocris	93.54	BRD-K60476892-001-16-1	Preclinical
YIL-781	ghrelin receptor antagonist	GHSR			Tocris	79.24	BRD-K91403886-003-01-4	Preclinical
YK-4-279	apoptosis inhibitor	EWSR1, FLI1			Tocris, MedChemEx	98.2	BRD-A62182663-001-04-8, BRD-A62182663-001-03-0	Preclinical
YM-155	survivin inhibitor	BIRC5			Selleck, MedChemEx	93.58	BRD-K76703230-004-04-1, BRD-K76703230-004-03-3	Phase 2
YM-201636	PI3K inhibitor				Selleck	95.37	BRD-K48488978-001-05-3	Preclinical
YM-244769	sodium/calcium exchange inhibitor				Tocris	94.4	BRD-K52087522-300-01-2	Preclinical
YM-298198	glutamate receptor antagonist	GRM1			Tocris	61.48	BRD-K59650319-003-03-3	Preclinical
YM-511	aromatase inhibitor	CYP19A1			Tocris	98.92	BRD-K38398115-001-01-9	Phase 2
YM-58483	calcium channel blocker	TRPC3, TRPC5, TRPM4			Tocris, EMDBio	99.86	BRD-K42563464-001-02-7, BRD-K42563464-001-01-9	Preclinical
YM-750	ACAT inhibitor	SOAT1			Tocris	98.4	BRD-K91716465-001-01-2	Phase 1
YM-90709	IL5 inhibitor	CSF2RB, IL5RA			MedChemEx, Tocris	88.31	BRD-K06712146-001-03-8, BRD-K06712146-001-02-0	Preclinical
YM-976	phosphodiesterase inhibitor	PDE4A			Tocris, Tocris	97.79	BRD-K12932420-001-03-1, BRD-K12932420-001-02-3	Phase 1
YM022	CCK receptor antagonist	CCKBR			Sigma	99.62	BRD-K09436144-001-01-7	Phase 2
YO-01027	gamma secretase inhibitor				Selleck, Tocris	96.71	BRD-K04622161-001-02-3, BRD-K04622161-001-03-1	Preclinical
yoda-1	piezo channel activator	PIEZO1			Tocris	96.08	BRD-K88570498-001-01-9	Preclinical
yohimbine	adrenergic receptor antagonist	ADRA2A, ADRA2B, ADRA2C, DRD2, DRD3, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, KCNJ1, KCNJ10, KCNJ11, KCNJ12, KCNJ14, KCNJ15, KCNJ8	cardiology	cardiac arrythmia, bradycardia	Tocris, Selleck, MicroSource	97.72	BRD-K35586044-003-15-4, BRD-K35586044-003-14-7, BRD-K35586044-003-16-2	Launched
YS-035	calcium channel blocker				Tocris	96.03	BRD-K06208435-003-08-2	Preclinical
YZ9	phosphofructokinase inhibitor	MIF, PFKFB3			Tocris	97.18	BRD-K53438416-001-01-9	Preclinical
Y16	rho associated kinase inhibitor	RHOA			MedChemEx, MedChemEx	63.43	BRD-K81865756-001-02-5, BRD-K81865756-001-01-7	Preclinical
zacopride	serotonin receptor antagonist	HTR3A, HTR3B, HTR4, HTR5A			Tocris, Tocris	97.84	BRD-A65615053-003-03-0, BRD-A65615053-003-02-2	Phase 2
zafirlukast	leukotriene receptor antagonist	CYSLTR1, CYSLTR2	pulmonary	asthma	Selleck	95.1	BRD-K71289571-001-11-4	Launched
zalcitabine	nucleoside reverse transcriptase inhibitor		infectious disease	human immunodeficiency virus (HIV-1)	Selleck, MicroSource	100	BRD-K85925969-001-16-6, BRD-K85925969-001-17-4	Launched
zaldaride	calmodulin antagonist	CALM1			Tocris, Tocris	96.11	BRD-A26032986-050-02-1, BRD-A26032986-050-03-9	Phase 3
zaleplon	benzodiazepine receptor agonist	GABRA1, GABRB1, GABRG2, TSPO	neurology/psychiatry	insomnia	MicroSource	99.85	BRD-K92657060-001-05-7	Launched
zaltidine	histamine receptor antagonist	HRH2			MedChemEx, MedChemEx	88.8	BRD-K12261274-001-01-6, BRD-K12261274-001-02-4	Phase 3
zaltoprofen	cyclooxygenase inhibitor		endocrinology, neurology/psychiatry	fever, pain relief	Selleck	97.2	BRD-A00578795-001-04-3	Launched
ZAMI-633	urease inhibitor				PrincetonBio	0	BRD-K11984358-001-01-3	Phase 3
zamifenacin	acetylcholine receptor antagonist	CHRM3			Tocris, Tocris	97.71	BRD-K80451230-051-02-6, BRD-K80451230-051-03-4	Phase 3
zanamivir	neuraminidase inhibitor	NEU2	infectious disease	influenza A virus infection	Selleck, Selleck	100	BRD-K23067689-001-03-9, BRD-K23067689-001-02-1	Launched
ZAPA					Tocris	0	BRD-K44825564-065-01-4	Preclinical
zaprinast	phosphodiesterase inhibitor	GPR35, PDE1A, PDE4D, PDE5A, PDE9A			Tocris, Tocris, MicroSource	99.3	BRD-K16542329-001-16-8, BRD-K16542329-001-13-5, BRD-K16542329-001-14-3	Phase 2
zardaverine	phosphodiesterase inhibitor	PDE4D			Tocris, Tocris, Tocris	99.64	BRD-K37561857-001-18-9, BRD-K37561857-001-17-1, BRD-K37561857-001-15-5	Phase 2
zatebradine	HCN channel blocker	HCN1, HCN2, HCN3, HCN4			Tocris, MedChemEx, MedChemEx	94.13	BRD-K92446736-003-02-2, BRD-K92446736-003-03-0, BRD-K92446736-001-01-8	Phase 3
ZCL-278	CDC inhibitor	CDC42			Tocris, Selleck, Selleck	91.54	BRD-K22829793-001-03-6, BRD-K22829793-001-02-8, BRD-K22829793-001-01-0	Preclinical
ZD-2079	adrenergic receptor agonist	ADRB3			Tocris	96.4	BRD-K64157027-003-02-7	Phase 2
ZD-7114	adrenergic receptor agonist	ADRB3			Tocris	97.54	BRD-K28971625-003-01-4	Phase 1
ZD-7155	angiotensin receptor antagonist	AGTR1			Tocris	97.94	BRD-K11373525-003-02-1	Preclinical
ZD-7288	HCN channel blocker	HCN1, HCN2, HCN3, HCN4			Tocris, Tocris	97.52	BRD-K18678457-003-03-6, BRD-K18678457-003-02-8	Phase 2
zeatin					TimTec	96.05	BRD-K90033078-001-08-7	Phase 1
zebularine	DNA methyltransferase inhibitor	CDA, DNMT1			Tocris, Selleck, Selleck	71.32	BRD-K87714311-001-02-7, BRD-K87714311-001-04-3, BRD-K87714311-001-03-5	Preclinical
zibotentan	endothelin receptor antagonist	EDNRA			Selleck	95.3	BRD-K31553034-001-03-0	Phase 3
zidovudine	nucleoside reverse transcriptase inhibitor	TERT	infectious disease	human immunodeficiency virus (HIV-1), acquired immunodeficiency syndrome (AIDS)	Selleck, MicroSource	99.36	BRD-K72903603-001-24-4, BRD-A33692381-001-01-9	Launched
zileuton	leukotriene synthesis inhibitor, lipoxygenase inhibitor	ALOX5	pulmonary	asthma	Selleck, Tocris, MicroSource, Selleck	92.71	BRD-A56359832-001-13-7, BRD-A56359832-001-15-2, BRD-A56359832-001-12-9, BRD-A56359832-001-11-1	Launched
zilpaterol	adrenergic receptor agonist	ADRB2	endocrinology	weight-gain aid	Cayman	97.26	BRD-K42816473-001-01-0	Launched
zimelidine	selective serotonin reuptake inhibitor (SSRI)	MAOA, MAOB, SLC6A4			Tocris	95.65	BRD-K46914825-300-01-0	Withdrawn
zinc-undecylenate	other antifungal		infectious disease	tinea pedis	MicroSource	0	BRD-K13330768-001-01-1	Launched
zindotrine	phosphodiesterase inhibitor				Labotest	0	BRD-K26598477-001-01-0	Phase 2
ziprasidone	dopamine receptor antagonist, serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR3A, HTR6, HTR7, SLC6A4	neurology/psychiatry	schizophrenia, bipolar disorder	MicroSource, Selleck	94.98	BRD-K29582115-066-01-2, BRD-K29582115-003-03-1	Launched
ZK-164015	estrogen receptor antagonist	ESR1, ESR2			Tocris, Tocris	94.03	BRD-K05151076-001-02-6, BRD-K05151076-001-03-4	Preclinical
ZK-200775	kainate receptor antagonist				Tocris, Tocris	97.52	BRD-K67525671-001-02-5, BRD-K67525671-001-03-3	Phase 2
ZK-93423	benzodiazepine receptor agonist	GABRA1, GABRA2, GABRA3, GABRA5, GABRB2, GABRG2			Tocris, Tocris	96.03	BRD-K33882852-003-03-6, BRD-K33882852-003-02-8	Phase 3
ZK-93426	benzodiazepine receptor antagonist	GABRA1, GABRA2, GABRA3, GABRA5			Tocris, Tocris	97.17	BRD-K68392338-003-03-8, BRD-K68392338-003-02-0	Phase 1
ZK811752	CC chemokine receptor antagonist	CCR1			Tocris, MedChemEx	100	BRD-K91825936-001-02-0, BRD-K91825936-001-01-2	Phase 2
ZLN-024	AMPK activator	PRKAA1, PRKAB1, PRKAG1			Tocris	89	BRD-K64103579-003-01-5	Preclinical
ZLN005					Selleck	97.99	BRD-K73073971-001-01-7	Preclinical
ZM-226600	Kir6 channel (KATP) activator				Tocris	95.64	BRD-A62209527-001-04-5	Preclinical
ZM-241385	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3			Tocris, Tocris	99.1	BRD-K19605405-001-03-5, BRD-K19605405-001-02-7	Preclinical
ZM-306416	Abl kinase inhibitor, src inhibitor, VEGFR inhibitor	EGFR, FLT1, FLT4, KDR			Tocris, Selleck	97.56	BRD-K41337261-003-02-8, BRD-K41337261-001-03-0	Preclinical
ZM-323881	VEGFR inhibitor	KDR			Tocris, Tocris, Selleck	95.74	BRD-K67831364-003-04-1, BRD-K67831364-003-05-8, BRD-K67831364-003-03-3	Preclinical
ZM-336372	RAF inhibitor	BRAF, LCK, MAPK14, RAF1			Selleck, Selleck, Tocris, Tocris	92.91	BRD-K73789395-001-09-9, BRD-K73789395-001-13-1, BRD-K73789395-001-14-9, BRD-K73789395-001-10-7	Preclinical
ZM-39923	JAK inhibitor	JAK1, JAK3			Tocris, Selleck, Tocris, Selleck	70.56	BRD-K40624912-003-15-5, BRD-K40624912-003-12-2, BRD-K40624912-003-13-0, BRD-K40624912-003-14-8	Preclinical
ZM-447439	Aurora kinase inhibitor	AURKA, AURKB			Tocris, Selleck, Tocris	96.51	BRD-K72703948-001-10-1, BRD-K72703948-001-09-3, BRD-K72703948-001-12-7	Preclinical
zofenopril-calcium	angiotensin converting enzyme inhibitor	ACE	cardiology	hypertension	MedChemEx	99.29	BRD-K46654563-238-01-0	Launched
zolantidine	histamine receptor antagonist				Tocris	90.72	BRD-K08996725-332-01-7	Preclinical
zoledronic-acid	bone resorption inhibitor	FDPS, GGPS1	endocrinology	Paget's disease	Selleck, Selleck	0	BRD-K84253429-001-04-4, BRD-K84253429-001-03-6	Launched
zolimidine	mucus protecting agent				Enamine	89.09	BRD-K45125084-001-01-4	Launched
zolmitriptan	serotonin receptor agonist	HTR1A, HTR1B, HTR1D, HTR1E, HTR1F	neurology/psychiatry	migraine headache	Tocris, MicroSource, Selleck	95.65	BRD-K54314721-001-11-0, BRD-K54314721-001-10-2, BRD-K54314721-001-09-4	Launched
zolpidem	benzodiazepine receptor agonist	GABRA1, GABRA2, GABRA3	neurology/psychiatry	insomnia	MicroSource	98.52	BRD-K44876623-001-03-7	Launched
zomepirac	prostaglandin synthesis inhibitor	PTGDR2			MedChemEx, Sigma, MicroSource	95.49	BRD-K81326768-236-12-5, BRD-K81326768-236-11-7, BRD-K81326768-001-04-0	Withdrawn
zometapine					Sigma	99.02	BRD-K14571191-001-01-6	Phase 2
zoniporide	sodium/hydrogen exchanger inhibitor	SLC9A1			Tocris	96.95	BRD-K43992824-300-01-0	Phase 3
zonisamide	sodium channel blocker, T-type calcium channel blocker	CA1, CA10, CA11, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9, CACNA1G, CACNA1H, CACNA1I, MAOA, MAOB, SCN10A, SCN11A, SCN1A, SCN1B, SCN2A, SCN2B, SCN3A, SCN3B, SCN4A, SCN4B, SCN5A, SCN7A, SCN8A, SCN9A	neurology/psychiatry	seizures, epilepsy	Tocris, Tocris, Selleck	98.12	BRD-K48300629-001-17-8, BRD-K48300629-001-14-5, BRD-K48300629-001-13-7	Launched
zopolrestat					Sigma	99.44	BRD-K84459715-001-01-6	Phase 2
zosuquidar	P glycoprotein inhibitor	ABCB1, ABCB4			Tocris, Selleck	96.07	BRD-K70557564-305-04-4, BRD-K70557564-305-03-6	Phase 3
zotarolimus	mTOR inhibitor	FKBP1A	cardiology	coronary artery restenosis	Adooq	87.25	BRD-K46843573-001-01-9	Launched
zotepine	dopamine receptor antagonist, serotonin receptor antagonist	ADRA2B, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR6, HTR7, SLC6A2, SLC6A4	neurology/psychiatry	schizophrenia	Prestwick	97.88	BRD-K64557645-001-02-4	Launched
zoxazolamine	myorelaxant				MicroSource, Selleck	98.37	BRD-K66353228-001-14-6, BRD-K66353228-001-13-8	Phase 2
ZSTK-474	PI3K inhibitor	PIK3CB, PIK3CD, PIK3CG			Selleck	98.66	BRD-K63068307-001-08-9	Phase 1/Phase 2
zuclopenthixol	dopamine receptor antagonist	ADRA1A, ADRA2A, DRD1, DRD2, DRD5, HRH1, HTR2A	neurology/psychiatry	schizophrenia, bipolar disorder	Prestwick	97.19	BRD-K28761384-300-01-0	Launched
Z160	N-type calcium channel blocker	CACNA2D1			MedChemEx	89.44	BRD-K16037980-001-01-1	Phase 2
1,12-Besm	polyamine biosynthesis inhibitor				Tocris	96.1	BRD-K04603573-376-01-3	Phase 2
1,2,3,4,5,6-hexabromocyclohexane	JAK inhibitor	JAK2			Tocris	0	BRD-K06817181-001-02-3	Preclinical
1,3-dipropyl-8-phenylxanthine	adenosine receptor antagonist				Tocris	97.89	BRD-K41853443-001-02-9	Preclinical
1,4-butanediol	benzodiazepine receptor agonist, gamma hydroxybutyric acid agonist	MAN1B1, PLA2G2A, PLA2G2E			Sigma	0	BRD-K22346679-001-06-3	Phase 1
1,5-dicaffeoylquinic-acid					AnalytiCon	0	BRD-K53083666-001-01-0	Phase 1
1-((Z)-3-Chloroallyl)-1,3,5,7-tetraazaadamantan-1-ium					BidePharm	94.41	BRD-K88956297-003-01-9	Preclinical
1-(1,2-Diphenylethyl)piperidine-(+/-)	glutamate receptor antagonist				Tocris	98.04	BRD-A86415025-050-01-0	Preclinical
1-(2-chloro-5-methylphenoxy)-3-(isopropylamino)-2-propanol					Enamine	92.38	BRD-A95802703-001-01-0	Preclinical
1-acetyl-4-methylpiperazine	acetylcholine receptor agonist				Tocris	90.28	BRD-K96055017-003-02-7	Preclinical
1-azakenpaullone	glycogen synthase kinase inhibitor	CCNB1, CDK1, CDK5, GSK3B			Selleck	90.5	BRD-K03273112-001-01-8	Preclinical
1-deoxymannojirimycin	alpha mannosidase inhibitor	MAN2A1			Tocris	100	BRD-K89665618-003-02-5	Preclinical
1-EBIO	potassium channel activator	KCNN1, KCNN2, KCNN3, KCNN4			Tocris, Tocris	96.95	BRD-K70586315-001-02-4, BRD-K70586315-001-03-2	Preclinical
1-ethyl-2-pyrrolidone	transdermal absorption-enhancing compound				CombiBlocks	98.42	BRD-K08288352-001-03-6	Preclinical
1-hexadecanal	sphingosine 1 phosphate receptor substrate	DBI, RHO			DuPont	0	BRD-K35114608-001-01-7	Preclinical
1-hexadecanol			dermatology	cosmetic	Selleck, Selleck	0	BRD-K37203094-001-02-5, BRD-K37203094-001-03-3	Launched
1-naphthyl-PP1	src inhibitor	SRC			Tocris, Tocris	98.62	BRD-K29542628-001-03-9, BRD-K29542628-001-04-7	Preclinical
1-octacosanol					Acros	1.71	BRD-K03083257-001-01-6	Phase 2
1-octanol		GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1			Enamine, Enamine	0	BRD-K09338665-001-08-9, BRD-K09338665-001-07-1	Phase 2
1-phenylbiguanide	serotonin receptor agonist	HTR3A, HTR3B			Tocris	95.79	BRD-K31491153-003-05-9	Preclinical
1E-1-(2-hydroxy-5-methylphenyl)-1-dodecanone oxime					Sigma	98.35	BRD-A37752546-001-01-9	Preclinical
1s,2r-phenylpropanolamine	adrenergic receptor agonist	ADRA1A, ADRA2A, ADRB1, ADRB2, DRD1			MicroSource	98.2	BRD-K27853494-003-04-7	Withdrawn
10-deacetylbaccatin	antitumor agent				MedChemEx, Selleck, Selleck	95.89	BRD-K96631475-001-03-2, BRD-K96631475-001-02-4, BRD-K96631475-001-04-0	Preclinical
10-DEBC	AKT inhibitor	PIM1			Tocris, Tocris	94.57	BRD-K70792160-003-04-6, BRD-K70792160-003-06-1	Preclinical
10-hydroxycamptothecin	topoisomerase inhibitor	TOP1			Selleck, Selleck	96.85	BRD-K63784565-001-05-4, BRD-K63784565-001-06-2	Preclinical
10058-F4	c-Myc inhibitor				Tocris, Selleck, Selleck	95.6	BRD-K49460120-001-06-6, BRD-K49460120-001-05-8, BRD-K49460120-001-02-5	Preclinical
12-O-tetradecanoylphorbol-13-acetate	PKC activator	KCNT2, TRPV4			Enzo	97.9	BRD-K68552125-001-05-3	Phase 2
1400W	nitric oxide synthase inhibitor	NOS1, NOS2, NOS3			Tocris	89.27	BRD-K30237152-300-02-5	Preclinical
16,16-dimethylprostaglandin-e2	prostanoid receptor agonist	HPGD			Enzo	100	BRD-K92301463-001-05-5	Phase 2
17-alpha-methyltestosterone	aromatase inhibitor	AR			MedChemEx, MedChemEx	88.24	BRD-K84036904-001-08-8, BRD-K84036904-001-09-6	Launched
17-hydroxyprogesterone-caproate	progesterone receptor agonist	AR, ESR1, ESR2, NR1H4, NR1I2, NR3C1, PGR			MicroSource	97.31	BRD-A29731977-001-04-5	Launched
17-PA	glucocorticoid receptor agonist				Tocris	0	BRD-K07395323-001-01-0	Preclinical
2'-c-methylguanosine	HCV inhibitor				Sigma	99.3	BRD-K78092779-001-01-6	Preclinical
2'-MeCCPA	adenosine receptor agonist	ADORA1			Tocris, Tocris	95.78	BRD-K63932022-001-01-5, BRD-K63932022-001-02-3	Preclinical
2,3-cis/exo-camphanediol					BroadPharm	0	BRD-K44602126-001-01-3	Phase 1
2,3-cis/exo-pinanediol					Maybridge	0	BRD-A75263867-001-01-1	Phase 1
2,3-DCPE	Bcl-XL downregulator	BCL2L1			Tocris	96.91	BRD-K61734568-003-02-1	Preclinical
2,4-dinitrochlorobenzene	thioredoxin inhibitor	TXN			Sigma	0	BRD-K97833335-001-08-2	Phase 2
2,4-dinitrophenol	ATP synthase inhibitor	APP			MicroSource	98.95	BRD-K21910317-001-12-3	Preclinical
2,5-furandimethanol	hemoglobin modulator	HBB			Key	0	BRD-K29791386-001-01-8	Phase 2
2,6-dimethylpiperidine					MicroSource	0	BRD-A21276153-001-01-1	Preclinical
2-(chloromethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one					Enamine	80.5	BRD-K46989997-001-01-8	Preclinical
2-(3-mercaptopropyl)pentanedioic acid	glutamate carboxypeptidase inhibitor	FOLH1			Tocris	84.2	BRD-A66788520-001-01-7	Phase 1
2-[1-(4-piperonyl)piperazinyl]benzothiazole	serotonin receptor agonist	HTR4			Tocris	99.23	BRD-K91868854-001-03-6	Preclinical
2-aminobenzenesulfonamide	carbonic anhydrase inhibitor	CA12, CA14, CA2, CA6, CA9			Prestwick	99.54	BRD-K32681104-001-11-6	Preclinical
2-APB	1,4,5-trisphosphate inhibitor	TRPC1, TRPC3, TRPC4, TRPC5, TRPC6, TRPC7, TRPM2, TRPM3, TRPM6, TRPV1, TRPV6			Tocris	0	BRD-K13346085-001-04-7	Preclinical
2-BFI	imidazoline receptor ligand	ADRA2A, ADRA2B, ADRA2C, MAOA, MAOB			Tocris	97.63	BRD-K22745370-003-02-3	Preclinical
2-chloro-N6-cyclopentyladenosine	adenosine receptor agonist	ADORA1, ADORA2A, ADORA2B, ADORA3			Tocris, Tocris	98.41	BRD-K70088346-001-02-4, BRD-K70088346-001-01-6	Preclinical
2-chloroadenosine	adenosine receptor agonist	ADORA1, ADORA2A, ADORA2B			Tocris	98.42	BRD-K79511609-001-20-0	Preclinical
2-Chloropyrazine					Prestwick	94.15	BRD-K84075000-001-05-5	Preclinical
2-CMDO	dopamine receptor antagonist	DRD2, DRD4			Tocris	95.69	BRD-K92588747-051-02-7	Preclinical
2-cyanopyrimidine	cathepsin inhibitor				Enamine	0	BRD-K95015809-001-02-8	Preclinical
2-Deoxy-2-{[methyl(nitroso)carbamoyl]amino}hexose			oncology, endocrinology	pancreatic cancer, hypoglycemia	Labotest	0	BRD-A55902763-001-01-3	Preclinical
2-deoxyglucose	glycolysis inhibitor	SLC2A1, SLC2A2, SLC2A3, SLC2A4			Enzo	100	BRD-K97808269-001-02-7	Phase 2
2-ethoxybenzoic-acid	analgesic agent				Enamine	97.32	BRD-K04843302-001-02-5	Phase 1
2-ethyl-1,3-hexanediol					Sigma, TCI	0	BRD-A55455283-001-02-1, BRD-A55455283-001-01-3	Preclinical
2-fluoro-2-deoxy-D-galactose		LCT			SantaCruz	100	BRD-A53037300-001-01-0	Phase 1
2-hydroxy-4-((E)-3-(4-hydroxyphenyl)acryloyl)-2-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-6-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)cyclohexane-1,3,5-trione					MedChemEx, MedChemEx	76.37	BRD-A52169337-001-01-9, BRD-A52169337-001-02-7	Preclinical
2-hydroxyethyl-salicylate					Acros	97.62	BRD-K41866823-001-01-3	Launched
2-hydroxyflutamide	androgen receptor antagonist	AR			Enamine, Sigma	99.33	BRD-K82027074-001-07-5, BRD-K82027074-001-08-3	Phase 1/Phase 2
2-hydroxysaclofen	GABA receptor antagonist	GABBR1, GABBR2			Tocris	95.2	BRD-A27924917-001-03-3	Preclinical
2-iminobiotin	nitric oxide synthase inhibitor	NOS1, NOS2			BroadPharm	90.08	BRD-K07954936-001-01-3	Phase 2
2-iodohippuric-acid					Enamine	98.84	BRD-K56634222-001-03-0	Preclinical
2-iodomelatonin	melatonin receptor agonist	MTNR1A, MTNR1B, NQO2			Tocris	89.11	BRD-K25649279-001-02-0	Preclinical
2-methoxyestradiol	hypoxia inducible factor inhibitor	COMT, CYP19A1, CYP1A1, CYP1B1, HIF1A, TUBB			Tocris, Selleck, Tocris	97.09	BRD-K44408410-001-21-8, BRD-K44408410-001-22-6, BRD-K44408410-001-17-6	Phase 2
2-methyl-5-hydroxytryptamine	serotonin receptor agonist	HTR1B, HTR1D, HTR1E, HTR1F, HTR3A, HTR3B, HTR6			Tocris, Tocris	97.17	BRD-K64137799-003-03-3, BRD-K64137799-003-02-5	Preclinical
2-methyl-5-nitrophenol					Enamine	0	BRD-K22327730-001-01-1	Preclinical
2-methylimidazole	cholesterol inhibitor				Sigma	93.95	BRD-K68534611-001-07-8	Preclinical
2-octyldodecan-1-ol					Sigma, Bepharm	0	BRD-A51407134-001-02-7, BRD-A51407134-001-01-9	Preclinical
2-Oleoylglycerol	glucose dependent insulinotropic receptor ligand	GPR119			Cayman	94.8	BRD-K77087341-001-02-4	Phase 1
2-oxoglutaric-acid		OXGR1			Enamine	0	BRD-K89712525-001-02-1	Preclinical
2-oxopropanoate	pyruvate dehydrogenase kinase inhibitor	ABAT, AGXT2, PC, PDHB, PKLR, PKM, SLC16A1, SLC16A2, SLC16A3, SLC16A4, SLC16A5, SLC16A6, SLC16A7, SLC16A8			Sigma	76.6	BRD-K86587225-236-02-5	Preclinical
2-phenylmelatonin	melatonin receptor agonist	MTNR1A, MTNR1B			Tocris, Tocris	97.9	BRD-K41869275-001-03-6, BRD-K41869275-001-02-8	Preclinical
2-PMDQ	adrenergic receptor antagonist	ADRA1A			Tocris	93.6	BRD-A04661934-001-02-9	Preclinical
2-pyridylethylamine	histamine receptor agonist	HRH1			Tocris, Tocris	97.88	BRD-K17874705-300-03-2, BRD-K17874705-300-04-0	Preclinical
2-TEDC	lipoxygenase inhibitor	ALOX12			Tocris	94.84	BRD-K89072800-001-01-8	Preclinical
2-thiouracil					Selleck, MicroSource	100	BRD-K58819470-001-04-2, BRD-K58819470-001-05-9	Preclinical
20-hydroxyecdysone	ecdysone receptor modulator				Selleck	92.15	BRD-K28343777-001-01-6	Preclinical
3'-fluorobenzylspiperone	dopamine receptor ligand	DRD2			Tocris, Tocris	93.86	BRD-K45662124-050-02-3, BRD-K45662124-050-01-5	Preclinical
3,3'-dichlorobenzaldazine	glutamate receptor allosteric ligand	GRM5			Tocris	96.54	BRD-K82903013-001-01-4	Preclinical
3,3'-diindolylmethane	CHK inhibitor, cytochrome P450 activator, indoleamine 2,3-dioxygenase inhibitor	AR, HIF1A, IFNG, PI3			Enzo	87.7	BRD-K37846922-001-09-4	Phase 3
3,4-DCPG-(+/-)	glutamate receptor agonist	GRM8			Tocris	0	BRD-A49947412-001-02-0	Preclinical
3,4-DCPG-(R)	glutamate receptor antagonist				Tocris	0	BRD-K06204668-001-02-6	Preclinical
3,4-DCPG-(S)	glutamate receptor agonist	GRM8			Tocris	0	BRD-K86305586-001-02-3	Preclinical
3,5-DHPG-(S)	glutamate receptor agonist	GRM1			Tocris	0	BRD-K57796080-001-03-7	Preclinical
3-(4-methylbenzylidene)camphor	endocrine disruptor		dermatology	sunscreen lotion	AlfaAesar	98.91	BRD-A55464252-001-01-2	Launched
3-alpha-bis-(4-fluorophenyl)-methoxytropane	dopamine uptake inhibitor	CHRM1, SLC6A2, SLC6A3, SLC6A4			Tocris	92.63	BRD-A85216385-003-02-4	Preclinical
3-alpha-Hydroxy-5-beta-androstan-17-one					Prestwick	100	BRD-A43598550-001-09-4	Preclinical
3-amino-benzamide	PARP inhibitor	PARP1			Selleck, Tocris	96.89	BRD-K08703257-001-12-1, BRD-K08703257-001-13-9	Phase 2
3-anilinopropan-1-ol					Enamine	11.05	BRD-K49721826-001-02-7	Preclinical
3-AQC	serotonin receptor agonist	HTR3A			Tocris	78.92	BRD-K38370968-050-01-3	Preclinical
3-bromo-7-nitroindazole	nitric oxide synthase inhibitor	NOS1, NOS2, NOS3			Tocris, Tocris	97.63	BRD-K24689407-001-07-1, BRD-K24689407-001-06-3	Preclinical
3-bromocamphor					Vitas-M	0	BRD-A62841832-001-01-1	Launched
3-bromopyruvate	hexokinase inhibitor	HK2			MedChemEx, MedChemEx, Enamine	0	BRD-K92980438-001-05-8, BRD-K92980438-001-04-1, BRD-K92980438-001-03-3	Preclinical
3-carboxy-4-hydroxyphenylglycine-(R)	glutamate receptor antagonist	GRIN1, GRIN2A, GRIN2B, GRIN2C			Tocris	85.96	BRD-K76592088-001-02-1	Preclinical
3-carboxy-4-hydroxyphenylglycine-(S)	glutamate receptor antagonist	GRM1, GRM5			Tocris	87.81	BRD-K61585876-001-01-0	Preclinical
3-CPMT	dopamine reuptake inhibitor				Tocris	97.29	BRD-A51713165-003-02-6	Preclinical
3-deazaadenosine	adenosylhomocysteinase inhibitor	AHCY			Enzo	100	BRD-A79431551-001-01-1	Phase 2
3-deazaneplanocin-A	histone lysine methyltransferase inhibitor	EZH2			Selleck, Selleck	97.43	BRD-K77791657-001-01-1, BRD-K77791657-003-01-7	Preclinical
3-deazauridine	cytidine deaminase inhibitor				AMS	99.3	BRD-A26105646-001-06-1	Preclinical
3-hydroxy-3-phenylpentanamide	GABA receptor modulator				Enamine	96.14	BRD-A66143912-001-01-1	Phase 1
3-indolebutyric-acid		B2M, HLA-A, TRAC, TRBC1			Selleck	97.58	BRD-K43187796-001-02-3	Preclinical
3-MATIDA		GRM1			Tocris	0	BRD-A87125127-001-02-2	Preclinical
3-methyl-GABA	GABA aminotransferase activator	ABAT			Tocris	71.72	BRD-A62890442-077-01-0	Preclinical
3-methyladenine	PI3K inhibitor	PI3			Selleck, Selleck	86.92	BRD-K81647657-001-04-3, BRD-K81647657-001-05-0	Preclinical
3-MPPI	adrenergic receptor ligand	ADRA1A			Tocris	86.55	BRD-K62581435-001-03-8	Preclinical
3PO	phosphofructokinase inhibitor	PFKFB3			MedChemEx	92.61	BRD-K58413118-001-01-8	Preclinical
4,4'-DDT					SantaCruz	0	BRD-K51799616-001-05-5	Preclinical
4,4-pentamethylenepiperidine	M2 channel blocker				Tocris	100	BRD-K49545903-003-01-4	Preclinical
4,5,6,7-tetrabromobenzotriazole	casein kinase inhibitor	AKT1, CHEK1, CSNK2A1, GSK3B, LCK, MAP2K1, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, ROCK1, RPS6KB1, SGK1			Tocris, Tocris	97.69	BRD-K97118047-001-03-8, BRD-K97118047-001-04-6	Preclinical
4-(4-fluorobenzoyl)-1-(4-phenylbutyl)-piperidine	serotonin receptor antagonist	HTR2A			Tocris, Tocris	97.38	BRD-K47337578-034-03-3, BRD-K47337578-034-02-5	Preclinical
4-acetyl-1,1-dimethylpiperazinium	acetylcholine receptor agonist				Tocris	87.43	BRD-K97019106-005-02-9	Preclinical
4-aminohippuric-acid		SLC22A6			MicroSource, Selleck, MedChemEx, Selleck, Selleck	100	BRD-K65544384-001-15-8, BRD-K65544384-236-01-0, BRD-K65544384-236-03-6, BRD-K65544384-001-14-1, BRD-K65544384-236-02-8	Launched
4-carboxy-3-hydroxyphenylglycine-(RS)	glutamate receptor agonist, glutamate receptor antagonist	GRM1			Tocris	0	BRD-A80383043-001-03-3	Preclinical
4-carboxy-3-hydroxyphenylglycine-(S)	glutamate receptor agonist, glutamate receptor antagonist	GRM1, GRM2			Tocris	0	BRD-K74133873-001-01-7	Preclinical
4-chlorophenylguanidine	urokinase inhibitor	PLAUR			Tocris	94.15	BRD-K39160765-003-02-9	Preclinical
4-CMTB	free fatty acid receptor agonist	FFAR2			Tocris	95.73	BRD-A54139254-001-09-2	Preclinical
4-DAMP	cholinergic receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5			Tocris	0	BRD-K29313239-005-09-4	Preclinical
4-galactosyllactose		AMY2B			Key	96.9	BRD-A32796301-001-01-6	Preclinical
4-HQN	PARP inhibitor	PARP1			Tocris	96.43	BRD-K91758890-001-10-0	Preclinical
4-hydroxy-phenazone					Prestwick	80.58	BRD-K49759007-001-11-9	Preclinical
4-IBP	sigma receptor agonist	SIGMAR1			Tocris	98.48	BRD-K62537556-001-02-5	Preclinical
4-iodo-L-phenylalanine		DPP4			Key	87.58	BRD-K66664625-001-01-2	Preclinical
4-iodo-6-phenylpyrimidine	macrophage migration inhibiting factor inhibitor	MIF			Tocris	98.51	BRD-K25690923-001-02-4	Preclinical
4-methylgenistein	protein tyrosine kinase inhibitor	CYP19A1, ESRRA, ESRRB, ESRRG, FASN			Selleck	95.83	BRD-K73303757-001-21-6	Preclinical
4-methylhistamine	histamine receptor agonist	HRH4			Tocris	90.32	BRD-K70821460-300-02-4	Preclinical
4-mu-8C	IRE1 inhibitor	ERN1			Selleck	94.67	BRD-K81316007-001-01-8	Preclinical
4-P-PDOT	melatonin receptor antagonist	MTNR1A, MTNR1B			Tocris, Tocris	98.79	BRD-A67482312-001-03-4, BRD-A67482312-001-02-6	Preclinical
4-phenolsulfonic-acid					Acros	92.14	BRD-K41024817-325-01-0	Preclinical
4-phenyl-1,2,3,4-tetrahydroisoquinoline	dopamine release inhibitor				Tocris	0	BRD-M10474530-001-03-1	Preclinical
4-PPBP	sigma receptor ligand	SIGMAR1			Tocris, Tocris	96.19	BRD-K78061844-050-02-7, BRD-K78061844-050-01-9	Preclinical
4-propylbenzoic-acid					Maybridge	0	BRD-K42108215-001-01-5	Preclinical
4-pyrimidinecarbonitrile					Enamine	0	BRD-K04552268-001-02-4	Preclinical
4-tert-butylphenol					Enamine	0	BRD-K06338106-001-01-4	Preclinical
4BP-TQS	nicotinic receptor agonist	CHRNA7			Tocris	72.37	BRD-A18598741-001-01-2	Preclinical
4EGI-1	protein synthesis inhibitor	EIF4E			Selleck, Selleck	70.43	BRD-K52366702-001-01-6, BRD-K52366702-001-02-4	Preclinical
4E1RCat	protein synthesis inhibitor	EIF4E, EIF4G1			Tocris, Selleck, Selleck	93.43	BRD-K67173685-001-07-7, BRD-K67173685-001-08-5, BRD-K67173685-001-06-9	Preclinical
4SC-202	HDAC inhibitor	HDAC1			MedChemEx, MedChemEx, MedChemEx, Selleck	96.41	BRD-K11773281-001-02-0, BRD-K11773281-001-01-2, BRD-K11773281-075-01-6, BRD-K11773281-075-02-4	Phase 1
5'-Chloro-5'-deoxy-ENBA-(+/-)	adenosine receptor agonist	ADORA1			Tocris, Tocris	95.3	BRD-A13598753-001-01-2, BRD-A13598753-001-02-0	Preclinical
5,7-dichlorokynurenic-acid	glutamate receptor antagonist	GLRA2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D			Tocris, Tocris	98.43	BRD-K60287130-001-06-5, BRD-K60287130-001-05-7	Preclinical
5,7-Dihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-2H-chromene-3,4-dione					Sigma	62.12	BRD-A61299447-001-01-0	Preclinical
5-(4chlorophenyl)-4-ethyl-2,4-dihydro-3H-1,2,4-triazol-3-one					AMS	0	BRD-K58146797-001-01-2	Preclinical
5-Amino-3-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione					Berry	98.58	BRD-K87535339-001-01-6	Preclinical
5-aminolevulinic-acid	oxidizing agent	ALAD			MicroSource, Selleck	100	BRD-K57631554-003-07-0, BRD-K57631554-003-06-2	Launched
5-BDBD	purinergic receptor antagonist	P2RX4			Tocris, Tocris	98.81	BRD-K33690734-001-01-5, BRD-K33690734-001-02-3	Preclinical
5-carboxamidotryptamine	serotonin receptor agonist	HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7			Tocris	90.34	BRD-K92382976-050-01-1	Preclinical
5-fluoro-3-pyridyl-methanol					Manchester	96.92	BRD-K73381198-001-01-1	Preclinical
5-fluorouracil	thymidylate synthase inhibitor	DPYD, TYMS	oncology	colorectal cancer, breast cancer, pancreatic cancer, gastric adenocarcinoma	MicroSource, Selleck	100	BRD-K24844714-001-25-2, BRD-K24844714-001-24-5	Launched
5-FP	thymidylate synthase inhibitor	TYMS			Maybridge, Sigma	0	BRD-K34437622-001-06-4, BRD-K34437622-001-08-0	Phase 1
5-HMF					Sigma, OxChem, Sigma	84.12	BRD-K86799112-001-04-6, BRD-K86799112-001-02-0, BRD-K86799112-001-03-8	Phase 2
5-hydroxyectoine					Sigma	97	BRD-K03871161-001-01-9	Preclinical
5-hydroxymethyl-tolterodine	acetylcholine receptor antagonist	CHRM3			Selleck, Selleck	89.75	BRD-K24603946-001-02-1, BRD-K24603946-001-03-9	Phase 1
5-hydroxytryptophan	neurotransmitter	SLC36A1, SLC36A2	neurology/psychiatry	insomnia	Selleck, Selleck	97.09	BRD-A73930134-001-02-2, BRD-A73930134-001-03-0	Launched
5-iodo-A-85380	acetylcholine receptor agonist				Tocris, Tocris	93.6	BRD-K90065682-300-03-4, BRD-K90065682-300-02-6	Phase 2
5-methylfurmethiodide	acetylcholine receptor agonist	CHRM1, CHRM2, CHRM3, CHRM4			Tocris, Tocris	95.87	BRD-K45437867-005-04-1, BRD-K45437867-005-03-3	Preclinical
5-methylhydantoin-(D)					Selleck, Selleck	0	BRD-K06050544-001-03-1, BRD-K06050544-001-04-9	Preclinical
5-methylhydantoin-(L)					Prestwick	89.08	BRD-K56033645-001-07-5	Preclinical
6,_7-dehydro-17-acetoxy-progesterone	steroidal progestin				InterBioScreen	81.26	BRD-K48329353-001-01-3	Preclinical
6-aminochrysene	transferase inhibitor				Sigma	30.33	BRD-K00656370-001-10-5	Phase 2
6-aminopenicillanic-acid					Enamine	0	BRD-K30284967-001-01-8	Preclinical
6-benzylaminopurine	purinergic receptor activator				Prestwick	99.22	BRD-K62929068-001-16-5	Preclinical
6-chloromelatonin	melatonin receptor agonist	MTNR1A, MTNR1B			Tocris, Tocris	97.22	BRD-K34663752-001-10-9, BRD-K34663752-001-09-1	Preclinical
6-iodo-nordihydrocapsaicin	TRPV antagonist	TRPV1			Tocris	92.2	BRD-K49236613-001-02-3	Preclinical
7,8,9,10-tetrahydroazepino[2,1-b]quinazolin-12(6H)-one					Vitas-M	99.06	BRD-K77756533-001-01-4	Preclinical
7-aminocephalosporanic-acid	beta lactamase inhibitor				Selleck, Selleck	100	BRD-K65377893-001-08-2, BRD-K65377893-001-07-4	Preclinical
7-chlorokynurenic-acid	glutamate receptor antagonist	GRIN1, GRIN2A, GRIN2B, GRIN2C			Tocris, Tocris	99.07	BRD-K84214706-001-06-5, BRD-K84214706-001-05-7	Preclinical
7-hydroxy-DPAT	dopamine receptor agonist	DRD2, DRD3			Tocris, Tocris, Tocris	89.47	BRD-A18795974-004-08-1, BRD-A18795974-004-09-9, BRD-A18795974-004-07-3	Preclinical
7-hydroxy-PIPAT	dopamine receptor ligand	DRD3			Tocris	54.71	BRD-A01295252-050-01-2	Preclinical
7-hydroxystaurosporine	CDK inhibitor, CHK inhibitor, PKC inhibitor	CHEK1, MARK3, PDPK1			EMDBio	80.79	BRD-K45293975-001-02-0	Phase 2
7-keto-DHEA	steroid				ChemImpex	98.83	BRD-K07785030-001-01-6	Launched
7-methoxytacrine	acetylcholinesterase inhibitor	ACHE			Enamine	98.23	BRD-K53156626-001-01-3	Phase 2
7-methylxanthine	adenosine receptor antagonist				Sigma	100	BRD-K41592905-001-01-6	Phase 2
7-nitroindazole	nitric oxide synthase inhibitor	NOS1, NOS2, NOS3			Tocris, Tocris, Tocris	96.6	BRD-K04430056-001-18-5, BRD-K04430056-236-02-1, BRD-K04430056-001-17-7	Preclinical
8-bromo-cAMP	PKA activator				Tocris	89.36	BRD-A09554849-236-07-6	Preclinical
8-bromo-cGMP	PKA activator	PRKG1			Tocris	87.24	BRD-A00077618-236-07-6	Preclinical
8-hydroxy-DPAT	serotonin receptor agonist	CDK1, CHEK1, CHEK2, GSK3B, HTR5A, HTR7, LCK, MAPK14, MARK1, PDPK1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG			Tocris	93.13	BRD-A48015106-004-08-9	Preclinical
8-hydroxy-PIPAT	dopamine receptor ligand	DRD2, DRD3			Tocris	97.35	BRD-A60594020-034-01-1	Preclinical
8-M-PDOT	melatonin receptor agonist	MTNR1A, MTNR1B			Tocris, Tocris	97.76	BRD-A07232941-001-03-5, BRD-A07232941-001-02-7	Preclinical
80841-78-7					Sigma	0	BRD-K03044000-001-01-8	Preclinical
9-aminoacridine					Selleck, MicroSource, Selleck	94.54	BRD-K00535541-001-04-8, BRD-K00535541-001-05-5, BRD-K00535541-001-06-3	Preclinical
9-aminocamptothecin	topoisomerase inhibitor	TOP1			Sigma	91.91	BRD-K09291936-001-13-3	Phase 2
9-anthracenecarboxylic-acid		ANO1, CLCN1			Tocris	73.91	BRD-K62607075-001-03-6	Preclinical
